data_2kdw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kdw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -66.93 152.16 46.24 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 165.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -36.3 -55.35 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.153 1.781 . . . . 0.0 114.684 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.01 -2.21 58.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.048 0.928 . . . . 0.0 112.976 -158.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.59 20.22 4.71 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.218 -1.551 . . . . 0.0 111.325 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.73 136.6 43.95 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.095 0.95 . . . . 0.0 109.135 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -85.13 122.74 73.97 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -72.06 133.19 20.97 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.302 1.335 . . . . 0.0 110.653 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . 0.261 2.2 m-80 -144.45 168.3 20.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.361 1.464 . . . . 0.0 110.349 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.39 130.98 70.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 126.182 1.793 . . . . 0.0 107.525 168.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.38 128.92 9.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -88.48 118.53 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.54 83.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 165.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.31 133.46 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 164.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HG ' ' CG2' ' A' ' 155' ' ' VAL . 41.8 m -118.33 120.84 38.83 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -83.39 118.11 23.5 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 112.12 -2.309 . . . . 0.0 105.391 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -47.84 -1.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -76.55 -4.27 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 120.259 1.391 . . . . 0.0 111.548 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' C ' HE21 ' A' ' 21' ' ' GLN . . . 101.76 24.25 8.8 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 119.836 1.198 . . . . 0.0 113.323 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.464 HE21 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -133.47 162.59 31.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -166.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.93 165.21 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -165.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.4 tpt -53.28 129.42 31.55 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 112.629 -2.078 . . . . 0.0 110.101 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -158.63 134.85 9.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 161.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -147.05 141.71 26.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.023 0.916 . . . . 0.0 110.218 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -72.64 135.84 45.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -85.62 124.75 32.51 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.34 133.56 34.61 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.373 2.269 . . . . 0.0 110.911 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.4 -14.54 3.12 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 125.6 1.571 . . . . 0.0 114.133 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -105.44 -35.59 7.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.783 0.792 . . . . 0.0 111.447 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 66.66 27.36 9.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.767 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.78 171.63 14.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -84.15 161.04 20.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -148.12 150.29 33.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.501 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.76 158.8 73.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.432 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.43 154.67 31.8 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.039 3.826 . . . . 0.0 112.027 162.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 169.38 139.37 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 128.053 2.541 . . . . 0.0 105.808 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.86 141.43 11.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 156.52 53.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mt -87.8 138.72 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.253 51.1 t30 -85.71 139.21 35.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 125.089 1.356 . . . . 0.0 109.24 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.51 118.48 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.195 1.93 . . . . 0.0 113.636 -172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.19 89.62 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.036 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -87.63 123.91 32.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.861 1.33 . . . . 0.0 107.744 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.68 165.06 24.78 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.24 -44.11 71.46 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.295 1.038 . . . . 0.0 112.538 -168.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.93 -40.48 72.05 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.318 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -63.86 -44.26 93.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.347 0.659 . . . . 0.0 109.79 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.07 77.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.857 0.863 . . . . 0.0 111.553 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -60.75 -44.07 97.17 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.779 -0.576 . . . . 0.0 109.713 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -69.18 -26.25 64.75 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.884 -1.135 . . . . 0.0 112.539 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -61.65 -52.67 63.38 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.441 -0.787 . . . . 0.0 109.332 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.6 90.61 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.414 0.626 . . . . 0.0 109.848 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.3 tp -52.58 -43.81 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.798 -1.814 . . . . 0.0 111.031 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.15 -49.14 53.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.973 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.72 -33.93 77.13 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.008 1.277 . . . . 0.0 112.105 -174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.77 -45.83 5.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.59 0.709 . . . . 0.0 110.042 -169.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -15.62 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 121.797 -0.564 . . . . 0.0 110.401 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.618 ' HA2' ' HG1' ' A' ' 115' ' ' THR . . . 64.88 37.21 94.02 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 117.093 -1.948 . . . . 0.0 112.209 -172.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -113.87 158.81 20.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.544 1.172 . . . . 0.0 108.87 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -117.69 -177.87 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.881 -0.512 . . . . 0.0 110.209 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.72 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.282 1.833 . . . . 0.0 114.736 -174.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -161.15 -18.5 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.05 -1.031 . . . . 0.0 111.434 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.54 1.11 55.52 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.915 0.864 . . . . 0.0 111.008 -167.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' CG2' HD11 ' A' ' 102' ' ' LEU . 27.9 m -152.42 169.48 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -168.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -142.25 117.49 10.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -167.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.97 130.62 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -36.04 6.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.007 0.923 . . . . 0.0 110.932 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.81 170.29 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.049 0.94 . . . . 0.0 108.715 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -145.99 164.29 32.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 109.475 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -63.57 140.2 58.85 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.764 0.792 . . . . 0.0 108.917 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -64.77 -29.51 70.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.351 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.44 174.22 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -65.47 115.47 5.74 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.673 0.789 . . . . 0.0 109.014 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 156.05 39.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -160.82 159.05 29.44 Favored 'General case' 0 CA--C 1.487 -1.481 0 O-C-N 120.683 -1.261 . . . . 0.0 108.13 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.444 ' OH ' ' HE2' ' A' ' 140' ' ' LYS . 8.3 p90 -159.91 170.03 22.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.61 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -109.38 129.88 55.52 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 111.921 -2.4 . . . . 0.0 106.059 -162.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -70.77 143.54 89.63 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -63.04 155.29 61.8 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -49.84 -45.62 50.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -71.77 -18.68 62.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.6 tp -102.47 -18.17 15.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.678 0.791 . . . . 0.0 111.764 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.3 t -52.0 140.49 6.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -76.21 -38.0 57.03 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.351 2.723 . . . . 0.0 118.351 -170.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.632 ' HA ' ' CG1' ' A' ' 91' ' ' VAL 0.326 10.2 m95 53.48 -8.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 -167.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.17 -27.86 11.32 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.397 1.453 . . . . 0.0 110.276 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.0 p -69.54 151.77 45.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -138.14 114.58 9.13 Favored Pre-proline 0 CA--C 1.499 -1.012 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -55.01 154.13 20.12 Favored 'Cis proline' 0 C--O 1.237 0.436 0 O-C-N 123.151 1.08 . . . . 0.0 113.45 -6.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.632 ' CG1' ' HA ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -55.53 130.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.46 171.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 46.5 t -92.86 108.49 20.03 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 pt -101.77 -2.46 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.762 1.625 . . . . 0.0 111.608 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.24 43.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.597 1.09 . . . . 0.0 112.934 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 113.66 27.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.548 1.539 . . . . 0.0 107.178 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.79 122.56 26.77 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 132.6 26.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.582 1.083 . . . . 0.0 112.844 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -104.31 125.53 50.64 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 165.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -96.17 144.11 26.68 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -118.34 128.62 54.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.7 114.95 19.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.498 HD11 ' CG2' ' A' ' 65' ' ' VAL . 3.3 mm? -110.46 122.16 47.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -79.17 136.73 37.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.81 124.22 24.94 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.76 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.97 -41.15 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.255 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.73 -140.74 0.14 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.82 39.21 Favored Glycine 0 CA--C 1.487 -1.695 0 O-C-N 119.572 -1.955 . . . . 0.0 110.221 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -29.9 -41.26 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 126.846 2.059 . . . . 0.0 114.987 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.62 66.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -106.87 -23.4 12.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.195 1.798 . . . . 0.0 110.358 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mt -56.18 132.33 20.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.17 -25.89 4.81 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 119.127 -0.463 . . . . 0.0 112.173 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.5 mtt 41.0 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 119.338 3.088 . . . . 0.0 119.338 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -121.71 21.96 10.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 123.461 2.846 . . . . 0.0 110.926 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.618 ' HG1' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -60.85 -37.49 82.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.731 2.012 . . . . 0.0 111.172 173.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.88 2.67 53.36 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.86 -0.591 . . . . 0.0 112.589 -166.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 m 66.31 -36.26 0.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 115.03 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -131.53 68.97 81.59 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 125.357 1.463 . . . . 0.0 107.169 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.07 -166.82 0.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.318 2.012 . . . . 0.0 109.927 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -110.3 -19.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.896 -1.049 . . . . 0.0 112.695 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -120.07 151.72 38.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.958 1.254 . . . . 0.0 111.309 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.9 -19.79 7.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.811 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.72 158.52 8.43 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 104.727 -3.349 . . . . 0.0 104.727 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.672 ' O ' ' CE3' ' A' ' 124' ' ' TRP 0.589 0.0 OUTLIER -138.76 -175.39 4.12 Favored 'General case' 0 C--N 1.294 -1.829 2 N-CA-C 126.538 5.755 . . . . 0.0 126.538 -154.136 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 124' ' ' TRP 0.254 12.3 ttt180 -169.54 131.78 1.17 Allowed 'General case' 0 CA--C 1.483 -1.634 1 O-C-N 115.477 -4.515 . . . . 0.0 102.967 171.065 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -72.95 133.66 44.42 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.6 161.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -51.21 151.35 2.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.587 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . 0.331 12.5 t80 -45.66 -90.42 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.229 1.412 . . . . 0.0 112.715 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -45.3 -4.19 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 120.459 3.503 . . . . 0.0 120.459 170.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.1 -51.66 78.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.833 2.561 . . . . 0.0 112.983 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -57.34 -32.57 94.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.165 1.91 . . . . 0.0 113.837 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 t -57.84 -39.61 72.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.547 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . 1.4 mmm-85 -77.32 -26.81 52.56 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.054 -1.654 . . . . 0.0 114.074 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 135' ' ' GLN . 3.9 mm-40 -78.46 -25.3 45.83 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 125.655 1.847 . . . . 0.0 114.499 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 144' ' ' TYR 0.265 13.2 p -79.02 157.76 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 CA-C-O 122.853 1.311 . . . . 0.0 109.861 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.0 m -56.09 150.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.941 1.296 . . . . 0.0 111.03 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -60.21 -34.13 73.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -72.92 -30.77 64.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.828 0.74 . . . . 0.0 111.162 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HE2' ' OH ' ' A' ' 77' ' ' TYR . 10.5 mttt -81.93 -32.21 30.94 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.456 ' CZ ' HH21 ' A' ' 134' ' ' ARG . 29.2 ttp180 -47.11 -48.53 22.98 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 124.77 1.294 . . . . 0.0 112.243 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.46 -45.62 93.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.128 0.966 . . . . 0.0 110.031 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 77' ' ' TYR . 1.1 t -69.3 -40.47 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 O-C-N 120.937 -1.102 . . . . 0.0 110.311 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -67.32 -31.9 72.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 110.502 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -53.17 -41.79 65.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.661 0.785 . . . . 0.0 112.627 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -66.87 -45.39 78.24 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -53.53 -49.42 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 O-C-N 124.312 1.007 . . . . 0.0 109.143 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -65.33 -41.99 93.4 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.742 -0.599 . . . . 0.0 111.203 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.637 -1.289 . . . . 0.0 111.389 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -61.44 -26.26 67.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.596 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.8 -6.9 11.52 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.906 0.775 . . . . 0.0 113.071 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.56 44.44 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.265 0.939 . . . . 0.0 110.504 -167.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.7 m -65.7 -23.67 66.82 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.924 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.39 -32.95 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 120.17 -1.581 . . . . 0.0 109.656 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.502 ' CG2' ' HG ' ' A' ' 16' ' ' CYS . 61.7 t -84.13 -43.07 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.14 -31.43 71.86 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 116.918 -1.515 . . . . 0.0 110.429 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -55.93 -28.83 58.65 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 120.411 1.46 . . . . 0.0 111.401 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.65 -20.29 54.03 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 114.695 -2.574 . . . . 0.0 112.244 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -108.16 -7.92 15.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.787 2.035 . . . . 0.0 110.056 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 1 CA--C 1.682 6.036 2 C-N-CA 137.261 6.224 . . . . 0.0 125.534 174.047 . . . . . . . . 2 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 CA--C 1.542 0.656 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.27 -45.93 71.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.29 0.636 . . . . 0.0 111.949 -170.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -152.01 -85.22 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.537 1.135 . . . . 0.0 109.963 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.3 -39.95 13.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -169.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.3 21.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.102 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.37 137.49 50.45 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.704 1.252 . . . . 0.0 109.796 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -109.93 118.76 49.17 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.163 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.05 135.06 45.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.258 1.972 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -145.41 158.87 43.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.398 1.879 . . . . 0.0 110.543 -172.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -136.44 76.25 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.707 2.003 . . . . 0.0 109.03 -173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.6 126.54 30.22 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mm -90.34 105.21 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.57 79.78 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -62.89 135.12 27.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.8 m -123.6 130.83 53.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 168.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -87.69 136.78 32.81 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.86 -10.01 8.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.188 1.795 . . . . 0.0 114.313 -174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.79 -13.26 62.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.128 0.876 . . . . 0.0 110.825 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.11 38.3 3.37 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.386 1.946 . . . . 0.0 112.163 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -136.38 149.49 48.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.67 167.03 3.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 112.764 -168.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 127.55 32.68 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.622 1.569 . . . . 0.0 110.509 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -156.97 134.63 10.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 168.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.81 146.34 25.63 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -71.32 127.99 34.39 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.25 128.42 34.48 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -53.25 136.97 35.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.429 1.492 . . . . 0.0 110.263 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.27 -37.85 2.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.8 1.19 . . . . 0.0 113.198 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.55 -39.05 25.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.149 0.975 . . . . 0.0 110.091 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.271 17.4 m170 58.92 34.27 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.04 1.736 . . . . 0.0 112.795 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -140.44 158.73 43.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.976 2.11 . . . . 0.0 106.742 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -65.86 152.25 44.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.183 0.993 . . . . 0.0 112.554 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -148.18 156.74 42.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.563 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -69.4 160.72 77.95 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.816 2.446 . . . . 0.0 111.748 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.64 147.12 95.2 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.017 2.478 . . . . 0.0 110.981 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -165.5 153.31 10.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.348 1.859 . . . . 0.0 107.745 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.89 136.84 3.75 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.76 168.83 54.88 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 118.235 1.018 . . . . 0.0 110.853 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.37 140.8 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 108.516 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -85.51 138.0 36.22 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.566 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -58.35 117.32 4.01 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.486 1.457 . . . . 0.0 112.876 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.45 -0.11 84.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.776 1.179 . . . . 0.0 113.046 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.5 120.05 34.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.652 1.226 . . . . 0.0 107.805 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -71.8 165.44 24.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.479 0.712 . . . . 0.0 111.37 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -46.61 64.89 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.239 1.416 . . . . 0.0 111.481 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.37 29.43 0.76 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.577 0.703 . . . . 0.0 110.301 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 -48.66 0.67 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.609 1.964 . . . . 0.0 106.51 170.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.6 74.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.828 1.251 . . . . 0.0 112.015 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -56.92 -45.45 82.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.9 m-85 -73.79 -28.5 61.68 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.027 -1.046 . . . . 0.0 112.052 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -61.39 -46.63 89.37 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.722 -1.236 . . . . 0.0 108.761 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.39 97.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 tp -54.9 -44.6 74.29 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.822 1.649 . . . . 0.0 110.243 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -44.51 88.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.909 0.884 . . . . 0.0 111.252 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.42 -29.08 66.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.781 1.173 . . . . 0.0 112.894 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.26 -48.08 6.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 111.465 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.17 0.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 119.819 1.19 . . . . 0.0 113.69 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 31.31 80.12 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.988 0.813 . . . . 0.0 112.002 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 mt -103.92 152.24 22.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -115.77 -177.29 3.12 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.381 0.673 . . . . 0.0 110.176 -173.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 18.2 ptp180 -71.92 47.55 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.744 2.018 . . . . 0.0 112.575 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -160.68 -19.34 0.05 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.375 1.47 . . . . 0.0 112.341 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -93.85 -0.1 55.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 112.124 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.37 169.33 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.011 0.924 . . . . 0.0 109.448 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -139.36 121.44 15.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.4 mt -74.82 128.01 36.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.92 -30.76 9.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.781 0.433 . . . . 0.0 110.794 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 166.56 29.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.134 0.974 . . . . 0.0 109.366 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.7 p -144.43 158.27 43.84 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.196 1.399 . . . . 0.0 108.244 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -62.95 140.73 58.87 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -60.29 -30.24 69.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -141.83 175.38 9.76 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.707 1.603 . . . . 0.0 106.773 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -66.56 133.51 50.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.79 152.3 22.22 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.126 0.97 . . . . 0.0 108.634 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -150.41 161.05 43.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -140.99 173.82 11.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.381 1.872 . . . . 0.0 106.822 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -97.99 130.75 44.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.32 145.75 98.99 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 170.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -64.93 155.07 69.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.384 2.056 . . . . 0.0 108.465 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -73.15 -24.67 60.62 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.97 0.908 . . . . 0.0 112.816 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.4 tp -99.24 -21.42 16.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.677 0.791 . . . . 0.0 111.727 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.95 141.16 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -75.83 -42.2 50.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 42.5 m95 56.31 9.74 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.868 2.467 . . . . 0.0 114.61 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.08 -17.42 5.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.003 0.921 . . . . 0.0 113.224 -169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 p -73.5 -35.64 65.64 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.691 -0.631 . . . . 0.0 112.075 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 46.13 88.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.461 2.304 . . . . 0.0 112.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.83 143.69 51.54 Favored 'Cis proline' 0 C--N 1.353 0.775 0 CA-C-N 119.617 0.899 . . . . 0.0 113.699 9.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.6 t -56.64 121.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.08 1.352 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -89.48 120.0 30.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.4 pt -115.86 -4.16 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.02 1.328 . . . . 0.0 111.929 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.12 15.88 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.852 1.206 . . . . 0.0 111.074 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -85.69 127.73 34.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -85.31 115.07 22.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -122.95 122.74 39.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 120.187 1.358 . . . . 0.0 112.49 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -103.21 107.14 17.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 167.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -82.53 142.19 32.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.24 132.22 55.9 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.58 118.14 22.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.75 124.14 50.02 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.382 1.073 . . . . 0.0 109.366 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -86.58 134.74 33.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.74 136.63 57.97 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.85 -29.1 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -123.78 120.92 34.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.19 33.52 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 121.667 0.593 . . . . 0.0 113.166 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.46 -29.04 5.96 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.04 1.336 . . . . 0.0 113.251 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.64 68.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.127 0.571 . . . . 0.0 111.998 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -109.64 -11.79 14.72 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.2 mt -59.75 134.08 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.44 63.85 1.31 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.0 mtt -48.49 -26.48 2.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 114.157 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.52 24.67 2.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.945 1.248 . . . . 0.0 112.618 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -44.43 68.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.077 1.751 . . . . 0.0 111.762 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.7 m -96.97 9.67 41.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 m 67.54 -36.69 0.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.467 2.707 . . . . 0.0 114.825 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.2 p -126.53 73.21 73.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.04 1.736 . . . . 0.0 106.985 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -78.98 -165.81 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.783 2.989 . . . . 0.0 110.983 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -106.6 -19.18 13.75 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.609 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.23 157.76 29.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 121.64 2.018 . . . . 0.0 112.095 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.32 -25.88 1.31 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.617 1.567 . . . . 0.0 112.548 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.19 147.32 14.98 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -99.09 154.74 17.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.575 1.15 . . . . 0.0 111.091 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -156.04 112.25 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.166 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -78.17 134.98 37.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.163 1.347 . . . . 0.0 107.867 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.0 160.73 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.721 1.209 . . . . 0.0 109.903 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.34 150.09 3.69 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.523 0.678 . . . . 0.0 110.823 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.34 148.38 32.54 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.0 m95 66.06 -10.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -61.73 -50.74 80.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 121.748 2.067 . . . . 0.0 111.371 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -59.28 -31.26 94.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.037 1.825 . . . . 0.0 112.658 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.45 -37.21 78.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.652 0.781 . . . . 0.0 109.801 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mmm-85 -81.8 -27.98 33.4 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.771 1.168 . . . . 0.0 111.347 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -73.53 -30.43 63.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.873 0.76 . . . . 0.0 111.85 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.96 157.22 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 119.162 0.892 . . . . 0.0 111.74 -169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -52.06 148.88 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.186 1.794 . . . . 0.0 112.401 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -63.26 -32.81 74.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 113.55 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -70.07 -29.88 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.307 0.958 . . . . 0.0 111.054 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -86.11 -40.22 15.92 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 117.45 -1.262 . . . . 0.0 112.212 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -40.7 -49.97 3.07 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.877 1.217 . . . . 0.0 113.675 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.93 -31.12 68.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.6 -40.59 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.846 0.859 . . . . 0.0 110.314 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.24 -30.67 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -56.95 -41.24 77.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.987 -1.071 . . . . 0.0 110.802 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -66.59 -46.9 74.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.297 0.953 . . . . 0.0 109.026 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.73 -44.85 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.9 mtt -70.17 -38.17 75.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.447 -0.783 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -64.52 -37.02 86.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.209 0.913 . . . . 0.0 110.624 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.33 -28.06 66.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 110.592 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -113.31 -12.19 13.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.46 -58.1 8.32 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.663 1.119 . . . . 0.0 111.704 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.9 m -74.38 5.86 4.22 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.84 0.23 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.447 1.899 . . . . 0.0 109.401 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.2 t -118.38 -54.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.9 mtt -60.55 -22.15 63.33 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.889 1.275 . . . . 0.0 111.51 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.4 p -53.7 -40.67 66.23 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 111.844 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.19 -39.49 86.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.125 0.97 . . . . 0.0 109.785 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -84.34 -36.14 22.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.342 0.657 . . . . 0.0 111.093 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 123.653 0.781 . . . . 0.0 109.101 170.165 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.31 150.49 25.86 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.882 1.673 . . . . 0.0 110.062 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.41 -28.5 66.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.912 0.885 . . . . 0.0 113.03 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.94 2.34 43.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.262 1.025 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.72 29.06 11.18 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.575 1.559 . . . . 0.0 112.586 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -109.23 141.29 41.71 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.138 1.469 . . . . 0.0 110.932 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.65 127.45 52.38 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.33 135.66 34.74 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -143.03 159.17 42.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.106 1.762 . . . . 0.0 111.534 -169.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.674 1.59 . . . . 0.0 107.933 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.13 124.0 34.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mm -87.05 118.45 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.54 81.0 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -65.18 145.64 13.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -131.67 131.5 43.19 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 168.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.6 129.86 35.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -44.74 -27.86 0.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.112 1.765 . . . . 0.0 114.482 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.15 15.59 0.16 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.216 1.006 . . . . 0.0 112.561 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.09 17.48 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.212 1.387 . . . . 0.0 112.432 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -129.5 154.55 46.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.166 1.386 . . . . 0.0 108.147 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.19 161.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.511 0.725 . . . . 0.0 112.303 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.22 128.21 34.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.731 1.212 . . . . 0.0 109.813 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.43 133.27 8.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 168.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.02 147.03 25.43 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -67.73 125.46 26.3 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -74.85 128.46 35.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.39 146.05 41.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 169.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.03 -44.4 2.6 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.113 0.863 . . . . 0.0 112.977 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -77.7 -34.48 52.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 109.219 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 54.65 39.48 31.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.654 1.982 . . . . 0.0 111.285 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 p -160.25 170.2 21.62 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -70.72 149.81 46.56 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.457 -0.777 . . . . 0.0 111.398 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -156.25 149.3 24.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.352 1.061 . . . . 0.0 108.6 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -47.79 137.48 10.09 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.583 1.953 . . . . 0.0 111.589 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.13 136.22 50.97 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.974 1.783 . . . . 0.0 109.802 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -162.13 139.76 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.184 2.194 . . . . 0.0 106.006 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.15 -97.75 1.44 Allowed Glycine 0 CA--C 1.531 1.072 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.63 167.31 23.89 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.4 mt -114.58 148.46 17.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -99.78 154.27 37.34 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.698 1.199 . . . . 0.0 110.275 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.27 117.91 4.74 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.939 1.759 . . . . 0.0 111.208 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.53 5.37 89.57 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.997 1.284 . . . . 0.0 112.809 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.48 127.04 34.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.41 160.71 29.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.175 0.99 . . . . 0.0 110.401 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.35 74.57 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.836 0.854 . . . . 0.0 112.92 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.8 -44.23 64.29 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.26 -43.08 96.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.8 1.24 . . . . 0.0 109.421 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.315 0.646 . . . . 0.0 111.509 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -60.14 -42.66 95.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.05 0.841 . . . . 0.0 109.307 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 89.7 m-85 -69.46 -24.53 63.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.604 1.093 . . . . 0.0 112.167 172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -66.99 -50.56 61.88 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.825 -1.172 . . . . 0.0 108.176 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.18 -30.52 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.187 0.903 . . . . 0.0 111.746 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.0 tp -57.3 -39.48 75.86 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -54.47 10.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.251 1.02 . . . . 0.0 110.915 172.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.78 -36.26 80.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.539 1.063 . . . . 0.0 111.893 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -95.72 -52.12 4.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.661 0.784 . . . . 0.0 111.36 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.37 -15.2 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.564 0.62 . . . . 0.0 112.375 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.01 56.46 24.55 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -173.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.4 mt -137.22 158.87 43.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.6 1.96 . . . . 0.0 106.537 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -125.45 -172.61 2.63 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.839 0.856 . . . . 0.0 111.312 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.448 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.0 mtt180 -64.99 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.968 3.307 . . . . 0.0 114.29 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -159.27 -14.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.185 0.994 . . . . 0.0 113.384 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -91.22 2.0 56.69 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.693 1.197 . . . . 0.0 113.093 -169.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.76 169.23 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.952 0.901 . . . . 0.0 110.498 -168.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -134.73 112.91 11.15 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.4 mt -71.51 130.51 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 120.086 1.312 . . . . 0.0 107.515 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.88 -36.22 6.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.007 0.523 . . . . 0.0 111.762 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.76 173.2 16.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.721 1.209 . . . . 0.0 108.938 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 t -150.91 162.26 41.13 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 170.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -64.39 143.33 57.98 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.767 0.712 . . . . 0.0 109.665 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -63.54 -30.66 71.75 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.818 0.447 . . . . 0.0 111.888 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.63 168.86 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.652 1.581 . . . . 0.0 108.093 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -64.67 124.79 22.82 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.13 0.572 . . . . 0.0 109.465 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.93 158.66 27.98 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -142.34 137.35 30.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -145.53 154.48 42.24 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -100.17 146.41 26.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.37 140.82 60.83 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.46 154.2 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.156 1.904 . . . . 0.0 109.093 169.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -44.43 79.9 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.04 -1.038 . . . . 0.0 113.631 -169.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.5 -15.69 62.92 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.131 0.973 . . . . 0.0 112.559 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 tp -99.29 -6.59 27.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.476 1.51 . . . . 0.0 111.929 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.55 145.11 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 120.797 1.635 . . . . 0.0 107.765 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -77.95 -43.68 29.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.838 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.1 m95 59.3 4.17 0.45 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.924 2.49 . . . . 0.0 114.561 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -118.9 -18.12 8.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.599 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -74.23 -38.4 63.53 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.846 -0.534 . . . . 0.0 111.49 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 46.53 87.44 0.12 Allowed Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 127.73 2.412 . . . . 0.0 112.164 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -60.31 138.99 21.89 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.032 1.047 . . . . 0.0 114.305 9.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -57.31 120.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.658 1.583 . . . . 0.0 107.523 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 47.1 t -91.71 126.84 36.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -119.5 -3.19 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.898 1.679 . . . . 0.0 112.08 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.0 37.6 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 120.408 1.458 . . . . 0.0 112.627 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -100.98 125.76 47.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 171.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -89.48 110.69 21.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.81 127.27 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 120.719 1.599 . . . . 0.0 112.153 -171.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -101.11 123.1 44.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -98.3 124.49 42.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.25 136.57 36.55 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.92 116.31 28.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.67 136.28 51.11 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 110.591 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -93.92 136.9 33.72 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.7 tp -82.53 106.94 14.8 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -30.47 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 111.547 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 p -59.73 -60.96 3.01 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 111.436 171.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.54 176.01 38.66 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.166 0.889 . . . . 0.0 111.549 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -43.48 -37.09 2.25 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.441 1.497 . . . . 0.0 112.596 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.35 -21.26 61.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -129.74 -13.41 4.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.54 1.136 . . . . 0.0 112.77 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.57 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.23 50.16 1.62 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.116 0.966 . . . . 0.0 109.653 -169.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.7 mtt -45.46 -15.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 -169.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.06 22.53 10.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.958 1.708 . . . . 0.0 112.613 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 p -65.94 -32.22 73.59 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 112.073 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.58 -3.94 58.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -169.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m 66.33 -40.42 0.35 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.368 2.267 . . . . 0.0 113.072 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -128.15 79.24 74.24 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 126.932 2.093 . . . . 0.0 105.807 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.02 -161.94 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.781 2.987 . . . . 0.0 110.973 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -112.34 -38.41 4.7 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.55 -1.214 . . . . 0.0 112.557 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -106.35 161.3 14.68 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.267 1.849 . . . . 0.0 111.31 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -128.68 -29.44 2.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.575 1.55 . . . . 0.0 112.418 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.57 152.5 22.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -104.3 160.44 14.89 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.066 0.946 . . . . 0.0 111.827 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -154.31 117.85 4.6 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.337 1.855 . . . . 0.0 106.451 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -79.41 130.98 35.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.357 1.435 . . . . 0.0 107.443 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.81 162.27 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.476 1.11 . . . . 0.0 110.268 -170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.8 m -53.64 148.82 9.06 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.703 0.763 . . . . 0.0 111.75 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.18 144.95 48.78 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.38 -1.17 1.3 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -68.44 -49.83 29.86 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 121.385 1.902 . . . . 0.0 111.201 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -63.9 -32.2 66.42 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 121.286 1.495 . . . . 0.0 114.453 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 m -61.29 -31.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 120.093 1.315 . . . . 0.0 111.575 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.22 -14.89 34.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.58 1.082 . . . . 0.0 111.737 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -75.59 -33.77 60.6 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 109.502 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.3 153.77 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.499 1.52 . . . . 0.0 110.377 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.11 149.91 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.438 1.495 . . . . 0.0 111.016 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 m -57.13 -35.63 69.73 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.023 1.329 . . . . 0.0 114.159 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -71.3 -27.55 63.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.102 0.864 . . . . 0.0 111.388 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -98.18 -22.12 16.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.188 0.995 . . . . 0.0 112.358 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -49.54 -43.05 45.54 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.033 0.933 . . . . 0.0 110.947 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.37 -45.55 87.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.669 0.668 . . . . 0.0 111.787 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.45 -35.51 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.743 -0.598 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.56 -30.76 67.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.215 -0.928 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -61.59 -38.63 88.25 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.552 -1.342 . . . . 0.0 109.646 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -64.45 -42.68 95.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.18 1.355 . . . . 0.0 109.937 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.83 -46.55 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 118.934 0.788 . . . . 0.0 109.214 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 46.7 mtt -68.97 -38.07 79.16 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.88 -0.513 . . . . 0.0 110.512 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -66.68 -33.82 76.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.333 1.053 . . . . 0.0 110.764 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.03 -26.04 67.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.355 0.662 . . . . 0.0 111.406 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -120.39 -6.12 9.83 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.39 -58.41 6.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.209 0.913 . . . . 0.0 111.48 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -64.03 -27.15 68.92 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.071 -0.393 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.19 -40.42 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.096 -1.002 . . . . 0.0 108.612 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.02 -41.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.529 0.732 . . . . 0.0 109.345 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 49.2 mtt -71.97 -25.55 61.9 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.04 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.1 m -50.74 -41.14 56.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.477 1.035 . . . . 0.0 111.874 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.02 -37.78 88.58 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -99.7 22.2 11.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.924 0.89 . . . . 0.0 111.97 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 126.247 1.819 . . . . 0.0 109.644 172.115 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.3 mm . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.15 149.25 48.84 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.731 1.612 . . . . 0.0 108.238 171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.86 -32.1 19.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.92 1.35 35.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.05 35.54 7.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.581 1.562 . . . . 0.0 111.531 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.445 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 13.8 m-85 -116.43 139.99 49.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.394 1.097 . . . . 0.0 109.858 -174.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -90.99 122.21 66.95 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.106 -1.426 . . . . 0.0 107.337 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.94 130.83 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.994 1.796 . . . . 0.0 110.238 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -139.1 166.45 24.48 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.211 1.404 . . . . 0.0 109.716 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.75 138.07 50.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.16 123.38 6.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.44 111.72 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -92.52 82.74 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.66 129.27 27.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 169.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.4 m -114.66 121.03 42.12 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -80.54 139.8 36.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.78 -6.52 12.08 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -73.36 -1.82 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.109 0.868 . . . . 0.0 110.629 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.68 26.27 25.36 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 124.995 1.283 . . . . 0.0 112.49 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -124.82 161.97 25.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 0.0 108.409 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.59 163.66 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.2 tpt -53.1 134.16 38.63 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.849 2.06 . . . . 0.0 111.742 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -164.19 137.93 5.37 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 168.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.624 0.726 . . . . 0.0 110.056 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -75.8 135.33 40.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.273 1.429 . . . . 0.0 107.674 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -82.43 130.76 35.17 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -49.1 130.88 19.25 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.023 2.129 . . . . 0.0 110.658 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.26 -35.46 1.97 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.755 1.169 . . . . 0.0 113.539 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -85.13 -35.31 21.84 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.179 0.99 . . . . 0.0 110.337 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.289 91.6 m-70 56.04 34.01 22.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.961 1.705 . . . . 0.0 113.317 -174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m -139.45 157.31 46.06 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.0 2.12 . . . . 0.0 106.288 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -65.92 158.36 28.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.548 1.139 . . . . 0.0 113.35 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.43 150.17 36.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 0.0 109.515 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -66.96 160.69 68.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.668 1.587 . . . . 0.0 111.157 169.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.73 -133.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.738 3.625 . . . . 0.0 110.05 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 76.2 116.92 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.278 2.231 . . . . 0.0 110.225 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.62 18.59 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 153.84 51.19 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.599 1.095 . . . . 0.0 112.888 -169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -90.27 139.01 18.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.839 1.656 . . . . 0.0 107.795 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.53 154.5 68.69 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.347 0.659 . . . . 0.0 110.629 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.82 117.63 4.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.884 1.722 . . . . 0.0 111.341 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.73 6.41 89.4 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.909 1.242 . . . . 0.0 112.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -81.59 130.22 34.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.78 160.37 28.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.409 1.084 . . . . 0.0 110.398 177.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.67 71.21 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 124.456 1.102 . . . . 0.0 112.445 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.05 -42.21 66.55 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.48 -42.57 96.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.869 1.268 . . . . 0.0 109.362 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -37.15 85.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 111.925 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -59.78 -44.94 93.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.122 0.873 . . . . 0.0 109.651 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.4 m-85 -70.31 -29.78 66.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.168 -0.958 . . . . 0.0 112.015 174.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -62.33 -47.6 83.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.502 1.046 . . . . 0.0 109.751 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.16 70.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.91 0.484 . . . . 0.0 111.008 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -58.31 -39.67 79.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.482 1.113 . . . . 0.0 109.939 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -74.07 -50.82 17.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.24 1.416 . . . . 0.0 111.661 175.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.94 -35.0 79.75 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.967 1.258 . . . . 0.0 112.027 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.58 -50.38 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.994 0.918 . . . . 0.0 111.816 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.4 -13.53 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.661 0.785 . . . . 0.0 111.469 -169.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.26 40.88 96.91 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.68 150.23 41.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 107.341 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.0 m -115.22 -175.61 2.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.008 0.923 . . . . 0.0 111.071 -169.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.3 mtt180 -66.09 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.356 2.663 . . . . 0.0 114.203 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -161.4 -16.23 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.773 1.229 . . . . 0.0 112.866 -169.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.59 -0.55 57.37 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.472 1.109 . . . . 0.0 112.484 -169.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.35 168.55 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.326 1.45 . . . . 0.0 108.326 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -137.83 119.97 15.62 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -74.6 129.65 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 120.23 1.377 . . . . 0.0 107.582 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.17 -32.12 7.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.81 0.444 . . . . 0.0 111.549 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.76 167.24 30.61 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.088 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 p -149.77 160.16 43.77 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.005 1.322 . . . . 0.0 107.915 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -63.62 148.22 49.49 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.734 -0.604 . . . . 0.0 110.791 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -64.84 -37.06 86.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.79 0.436 . . . . 0.0 111.253 -171.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.84 172.95 14.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.575 1.95 . . . . 0.0 107.39 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -63.36 125.68 24.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.588 0.755 . . . . 0.0 110.148 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.62 133.44 37.27 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.38 150.38 32.35 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.218 0.917 . . . . 0.0 110.273 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.57 160.36 43.86 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.47 1.108 . . . . 0.0 109.077 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -91.76 128.36 37.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.62 148.22 95.0 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.523 1.129 . . . . 0.0 109.282 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.21 155.7 68.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.671 2.247 . . . . 0.0 109.755 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -54.32 -35.21 62.43 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.79 -24.2 55.93 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.194 0.998 . . . . 0.0 112.971 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.49 -17.36 15.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.947 0.899 . . . . 0.0 111.759 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.4 t -49.01 132.75 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 168.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.74 107.19 16.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -89.21 -1.93 58.28 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.495 0.718 . . . . 0.0 111.021 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.98 -20.82 21.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.754 1.622 . . . . 0.0 110.013 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 p -87.24 162.93 17.17 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.815 0.846 . . . . 0.0 108.811 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -136.69 113.24 9.99 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -54.61 152.4 19.31 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-N 120.21 1.111 . . . . 0.0 113.116 -6.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.44 129.88 26.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.2 t -90.38 109.73 20.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.58 -6.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.825 1.25 . . . . 0.0 112.024 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.445 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -157.46 169.61 34.43 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.086 1.312 . . . . 0.0 113.014 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -115.18 122.91 47.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -101.98 134.06 45.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -152.78 146.74 25.33 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.904 1.229 . . . . 0.0 114.147 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -104.72 127.82 52.62 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 102.788 -3.042 . . . . 0.0 102.788 168.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -97.25 135.72 38.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -112.68 129.75 56.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 110.02 16.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.95 127.81 52.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -83.74 133.53 34.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.0 137.1 51.1 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.34 -38.88 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.7 p -60.56 -61.7 2.4 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.0 1.72 . . . . 0.0 112.145 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 172.24 38.65 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.847 1.259 . . . . 0.0 112.491 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.8 63.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.657 0.783 . . . . 0.0 112.878 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.35 -9.94 5.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.402 1.081 . . . . 0.0 112.744 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.47 130.93 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 169.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.04 49.42 1.66 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.14 0.976 . . . . 0.0 109.146 -170.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.5 ptp -64.53 28.81 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.467 2.307 . . . . 0.0 116.134 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -123.28 21.76 9.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.524 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -35.36 72.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.897 2.079 . . . . 0.0 111.873 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -5.81 56.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.063 1.745 . . . . 0.0 113.306 -170.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.3 m 68.16 -37.82 0.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 128.607 2.763 . . . . 0.0 113.389 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.7 p -124.9 73.14 64.24 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.72 -177.65 2.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.302 2.668 . . . . 0.0 110.979 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.4 -8.2 21.35 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.477 -1.249 . . . . 0.0 111.573 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.54 151.6 50.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 121.341 1.882 . . . . 0.0 112.876 -170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.58 -25.91 3.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.229 1.812 . . . . 0.0 112.648 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.65 157.71 29.97 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -106.99 159.97 15.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -150.47 120.89 7.37 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.047 1.739 . . . . 0.0 106.391 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -82.82 124.19 30.06 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.13 163.15 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.21 1.004 . . . . 0.0 110.953 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.6 m -50.12 144.94 6.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.629 0.772 . . . . 0.0 110.143 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -54.96 -36.12 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.888 0.475 . . . . 0.0 111.964 -169.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -100.39 12.19 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.85 -49.77 10.29 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.53 -32.54 88.07 Favored 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 121.842 1.693 . . . . 0.0 113.782 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -31.38 49.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 119.807 1.185 . . . . 0.0 111.242 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -86.05 -21.92 27.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.6 1.091 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -81.61 -31.1 32.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.69 0.677 . . . . 0.0 111.665 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.1 160.37 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.325 0.584 . . . . 0.0 110.448 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.86 149.01 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.109 0.964 . . . . 0.0 111.261 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -57.42 -35.04 69.56 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.999 1.319 . . . . 0.0 113.912 -169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -73.58 -27.03 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.788 0.722 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -82.53 -38.65 23.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.934 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -42.96 -50.64 5.82 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.874 1.215 . . . . 0.0 112.771 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.62 -26.25 60.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.2 -42.92 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.6 -32.67 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.576 -0.703 . . . . 0.0 110.774 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.11 -29.12 70.11 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.28 -0.888 . . . . 0.0 112.637 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -64.5 -47.89 77.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.714 1.143 . . . . 0.0 108.946 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.23 -44.79 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.1 mtt -64.67 -46.68 81.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.601 -1.19 . . . . 0.0 111.038 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -29.77 69.44 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 121.433 1.924 . . . . 0.0 111.068 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.81 -36.41 82.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.635 0.374 . . . . 0.0 110.357 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -100.02 -16.67 17.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.4 1.08 . . . . 0.0 113.366 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.4 6.87 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.995 1.318 . . . . 0.0 109.899 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -65.25 -21.51 66.75 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.3 -42.45 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.52 -39.37 40.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.2 mtt -72.58 -20.17 61.36 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.413 -0.804 . . . . 0.0 111.122 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.7 m -64.51 -20.27 66.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.865 1.212 . . . . 0.0 112.528 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.4 -29.0 47.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -98.2 -37.27 9.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.239 1.016 . . . . 0.0 111.224 -169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 126.767 2.027 . . . . 0.0 110.204 176.295 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.08 -44.7 68.55 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.126 0.57 . . . . 0.0 111.252 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -154.34 -86.22 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.429 1.092 . . . . 0.0 109.717 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 -45.92 13.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.94 15.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.943 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -99.32 125.57 45.0 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.637 1.718 . . . . 0.0 108.547 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -85.68 126.07 67.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 117.368 -1.301 . . . . 0.0 107.688 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.09 127.49 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.28 1.987 . . . . 0.0 109.244 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -137.27 166.34 24.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.218 1.407 . . . . 0.0 108.99 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.43 141.63 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 127.006 2.122 . . . . 0.0 105.84 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.76 132.71 10.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.89 129.37 48.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.61 86.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 168.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.48 135.84 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.08 124.2 46.32 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.33 127.32 32.62 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 170.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -53.75 -4.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.54 2.336 . . . . 0.0 116.088 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.35 -12.48 60.27 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.8 1.182 . . . . 0.0 111.423 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.42 41.83 2.67 Favored Glycine 0 C--N 1.342 0.916 0 C-N-CA 124.791 1.186 . . . . 0.0 111.811 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.69 155.47 44.91 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.41 162.18 13.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.182 0.993 . . . . 0.0 112.152 -169.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.8 tpp -53.54 130.67 36.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.037 1.735 . . . . 0.0 111.36 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -159.27 131.11 6.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 166.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.19 26.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.194 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -83.62 134.72 34.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.65 130.6 35.11 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.79 145.19 56.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.396 0.679 . . . . 0.0 110.588 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.27 -43.57 2.05 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.947 1.26 . . . . 0.0 112.534 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -78.63 -37.97 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.377 1.071 . . . . 0.0 109.844 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.316 24.3 m170 57.84 43.61 21.41 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.807 2.043 . . . . 0.0 113.734 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 p -146.33 171.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 107.034 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -73.21 156.04 38.96 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.212 -0.93 . . . . 0.0 111.542 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.514 ' NE2' HE22 ' A' ' 37' ' ' GLN . 4.7 tt0 -147.54 145.67 29.17 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.605 0.762 . . . . 0.0 109.968 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.62 143.03 87.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.697 1.199 . . . . 0.0 109.965 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -69.75 139.08 39.38 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.455 2.103 . . . . 0.0 110.238 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.514 HE22 ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -167.48 151.33 6.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.422 1.889 . . . . 0.0 109.035 170.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.94 139.93 7.42 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 146.72 45.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 mt -80.7 138.89 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -96.64 154.77 38.36 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 123.911 0.884 . . . . 0.0 110.52 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.92 123.14 12.72 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.388 2.059 . . . . 0.0 114.703 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.76 4.52 66.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 113.991 -1.458 . . . . 0.0 113.244 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -86.17 123.94 32.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.646 1.223 . . . . 0.0 108.545 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -72.92 162.4 29.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.543 1.137 . . . . 0.0 110.846 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.86 79.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.4 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.84 9.4 6.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.81 . . . . 0.0 111.65 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -111.59 -54.11 2.64 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.19 72.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.541 1.136 . . . . 0.0 112.79 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -60.67 -42.76 97.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.037 0.835 . . . . 0.0 109.567 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -74.18 -24.45 59.37 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.523 -1.36 . . . . 0.0 111.771 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.6 -50.78 71.2 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.08 -1.012 . . . . 0.0 108.434 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.48 -35.66 81.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.102 0.561 . . . . 0.0 111.906 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.68 -41.21 76.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.935 1.294 . . . . 0.0 110.455 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -46.65 54.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.185 0.994 . . . . 0.0 110.551 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.32 -40.26 95.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.294 0.952 . . . . 0.0 111.788 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.44 -51.95 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.496 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.83 -9.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.32 64.38 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 120.938 -1.101 . . . . 0.0 112.339 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.6 mt -105.96 164.59 11.84 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.981 0.912 . . . . 0.0 108.62 171.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -126.96 -175.95 3.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.064 1.346 . . . . 0.0 111.005 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.95 41.24 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.853 2.061 . . . . 0.0 113.206 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -159.76 -21.26 0.07 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.319 0.648 . . . . 0.0 112.725 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -85.31 -0.12 53.76 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.19 168.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.42 1.088 . . . . 0.0 110.523 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -142.93 121.26 12.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 126.087 1.755 . . . . 0.0 106.853 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.89 130.53 36.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 120.808 1.64 . . . . 0.0 107.646 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.66 -34.71 7.23 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.38 0.672 . . . . 0.0 110.886 171.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.79 172.5 18.37 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.37 1.068 . . . . 0.0 109.225 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -149.31 160.58 43.28 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 p -66.13 142.2 57.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.921 0.782 . . . . 0.0 109.375 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -68.73 -22.55 64.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.933 0.493 . . . . 0.0 111.984 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.44 173.58 11.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.534 1.934 . . . . 0.0 107.725 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -76.8 117.15 18.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.49 137.53 52.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -147.35 147.29 30.17 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.745 -0.597 . . . . 0.0 109.795 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -150.76 163.42 38.62 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.109 1.363 . . . . 0.0 107.979 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -87.51 149.45 24.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.361 0.6 . . . . 0.0 109.889 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.49 137.35 32.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.55 151.81 75.14 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.662 2.241 . . . . 0.0 108.426 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -21.81 66.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -169.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.05 -28.45 62.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.823 0.849 . . . . 0.0 112.184 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.3 tp -97.12 -24.13 15.89 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.396 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -45.02 136.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -75.15 -42.51 55.92 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.976 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.3 m95 59.73 1.95 0.33 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.731 2.413 . . . . 0.0 114.156 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -97.57 -23.79 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.014 1.325 . . . . 0.0 111.51 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -73.13 153.41 40.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.868 1.667 . . . . 0.0 109.053 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.94 112.2 10.43 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 117.785 -1.103 . . . . 0.0 108.263 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.99 151.88 17.38 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 CA-C-N 120.509 1.217 . . . . 0.0 111.832 -10.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.35 131.55 27.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.5 p -90.35 127.96 36.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -169.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -105.96 -4.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.296 1.439 . . . . 0.0 110.986 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.15 30.91 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 118.969 0.804 . . . . 0.0 111.705 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.23 119.88 40.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -92.89 130.61 38.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 169.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 142.39 22.41 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.756 1.616 . . . . 0.0 114.447 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -101.77 130.97 48.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -95.38 141.93 28.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -111.44 135.19 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 108.392 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.1 tp -90.83 102.5 15.26 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.44 127.33 46.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.219 0.608 . . . . 0.0 110.207 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -85.19 138.06 32.61 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 168.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -70.4 132.56 45.81 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -112.85 -41.22 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.0 m -139.01 127.7 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.92 -171.27 43.36 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.92 -51.39 0.19 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.416 3.086 . . . . 0.0 112.907 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.03 -34.57 22.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 111.102 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.66 -5.66 19.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.859 0.864 . . . . 0.0 112.536 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.84 142.86 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -132.07 -45.42 0.94 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -170.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mtt 60.17 0.01 0.27 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.85 25.9 3.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.645 2.02 . . . . 0.0 111.19 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.4 t -86.1 -30.31 22.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -85.14 168.38 14.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.176 1.791 . . . . 0.0 110.565 -169.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 m -70.95 -33.52 70.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.985 0.514 . . . . 0.0 111.533 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -142.77 88.55 8.47 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -67.16 -166.07 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.407 2.071 . . . . 0.0 113.547 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.412 ' CD ' HE22 ' A' ' 34' ' ' GLN . 2.6 tp10 -128.28 -54.67 1.27 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.802 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -100.47 168.34 9.8 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.398 0.999 . . . . 0.0 112.561 -169.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.92 -8.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.377 1.071 . . . . 0.0 113.115 176.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.9 149.22 19.89 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -113.45 150.14 33.21 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.453 1.501 . . . . 0.0 110.226 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -148.82 114.02 5.52 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.569 1.547 . . . . 0.0 107.31 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -77.8 133.26 38.25 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.87 160.1 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.973 1.309 . . . . 0.0 109.322 -172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 m -53.65 152.94 4.74 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 110.725 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.41 151.19 13.55 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 67.39 -15.79 0.17 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -57.89 -45.58 99.78 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 121.284 1.856 . . . . 0.0 111.984 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -63.85 -25.44 67.68 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.769 1.646 . . . . 0.0 114.373 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.09 -37.23 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.691 1.132 . . . . 0.0 108.982 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -85.98 -15.9 40.04 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.125 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -82.72 -32.19 28.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.527 1.058 . . . . 0.0 111.955 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m -69.25 164.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 112.204 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.28 151.16 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.471 1.108 . . . . 0.0 110.652 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 m -57.37 -36.16 70.87 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.974 1.31 . . . . 0.0 113.371 -169.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -76.71 -24.72 53.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.183 0.901 . . . . 0.0 111.673 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -87.34 -27.49 22.8 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.431 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -42.83 -50.82 5.63 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.917 1.287 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.89 -37.62 79.12 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.157 0.435 . . . . 0.0 111.158 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.83 -45.46 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.62 -32.15 70.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.906 0.483 . . . . 0.0 110.339 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -57.65 -39.83 77.89 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.443 1.097 . . . . 0.0 110.301 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -63.44 -49.67 72.78 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.948 1.249 . . . . 0.0 108.97 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.46 -45.23 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.84 -47.11 82.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.126 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.18 66.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.181 1.809 . . . . 0.0 112.284 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -66.82 -29.51 69.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.47 0.577 . . . . 0.0 110.427 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -108.66 -21.67 12.59 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.09 0.956 . . . . 0.0 113.455 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.2 36.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.241 1.016 . . . . 0.0 109.816 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 m -65.35 -18.58 65.43 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.4 -34.47 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.004 0.82 . . . . 0.0 108.8 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 88.1 t -71.68 -40.79 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 mtt -59.22 -23.03 61.95 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.541 -1.218 . . . . 0.0 111.759 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.0 m -54.16 -31.34 52.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.822 1.646 . . . . 0.0 112.042 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.33 -28.96 21.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.277 1.031 . . . . 0.0 111.507 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 -30.52 8.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.082 . . . . 0.0 112.781 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 127.168 2.187 . . . . 0.0 109.777 178.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.26 -40.7 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -166.74 104.67 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.772 0.829 . . . . 0.0 110.707 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t0 58.42 44.79 17.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.077 2.151 . . . . 0.0 113.301 169.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.95 34.26 18.78 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.845 -0.975 . . . . 0.0 112.32 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -115.89 132.04 56.76 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.588 1.194 . . . . 0.0 110.552 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -88.41 123.72 67.66 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 130.7 10.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.322 2.015 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.47 163.54 31.69 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.395 1.078 . . . . 0.0 110.655 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.21 130.79 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.667 1.987 . . . . 0.0 107.209 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.38 122.36 7.55 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.48 104.23 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.7 t -87.33 80.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.24 131.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -112.19 128.76 56.33 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -94.58 23.47 5.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 57.05 -1.13 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.651 1.98 . . . . 0.0 116.206 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -99.07 -1.62 39.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.76 0.709 . . . . 0.0 111.914 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.36 27.57 29.99 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 119.196 0.907 . . . . 0.0 111.169 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -141.38 156.2 45.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.992 1.717 . . . . 0.0 106.641 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.01 168.88 19.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.662 0.785 . . . . 0.0 112.712 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.5 tpt -48.1 127.03 11.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.119 2.168 . . . . 0.0 112.017 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -160.65 133.25 6.28 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 168.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.03 29.12 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.38 0.672 . . . . 0.0 109.981 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.9 ttm105 -75.14 140.59 43.48 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.674 1.19 . . . . 0.0 108.184 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -86.23 122.37 30.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.341 1.056 . . . . 0.0 109.679 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -53.98 138.19 37.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.809 1.643 . . . . 0.0 108.611 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.7 -37.19 1.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.07 1.319 . . . . 0.0 113.836 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -90.9 -29.91 17.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.504 1.152 . . . . 0.0 111.267 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 55.56 41.3 30.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.001 1.72 . . . . 0.0 112.602 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 p -145.43 169.76 17.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.055 1.342 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -83.48 148.31 27.31 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.754 -1.216 . . . . 0.0 111.048 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -148.81 156.88 42.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.974 0.893 . . . . 0.0 111.101 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -67.98 163.35 51.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.952 2.101 . . . . 0.0 110.007 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.71 -106.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.208 3.272 . . . . 0.0 110.808 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 63.83 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.185 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.03 144.25 18.34 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.48 148.77 45.91 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.19 133.69 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.71 126.61 87.04 Favored Pre-proline 0 C--O 1.232 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 108.567 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.02 119.23 6.16 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.982 1.788 . . . . 0.0 112.619 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.85 3.69 79.86 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.078 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.07 120.67 41.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -70.62 162.51 28.81 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.155 0.582 . . . . 0.0 111.483 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.25 -45.72 8.7 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 127.18 2.192 . . . . 0.0 113.412 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.7 -47.36 40.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.59 -37.9 82.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.306 0.642 . . . . 0.0 110.511 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.53 -34.97 76.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -60.15 -45.72 92.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -67.68 -27.4 66.81 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.293 -0.88 . . . . 0.0 112.844 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -65.17 -51.13 62.98 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 120.885 -1.135 . . . . 0.0 109.009 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.12 70.54 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.138 0.881 . . . . 0.0 110.911 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.93 -39.87 79.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.27 1.028 . . . . 0.0 109.371 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -52.08 14.83 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.321 1.049 . . . . 0.0 111.415 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.77 -36.98 84.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.236 0.925 . . . . 0.0 111.446 -172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -104.02 -39.01 6.73 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.94 -20.12 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.255 0.622 . . . . 0.0 110.085 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.17 19.42 78.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.488 -1.382 . . . . 0.0 111.945 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 mt -102.22 151.64 21.98 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.521 1.128 . . . . 0.0 108.085 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -113.46 177.45 4.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.693 -0.629 . . . . 0.0 110.064 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -69.99 58.5 0.16 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.073 1.749 . . . . 0.0 112.744 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -163.44 -26.98 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.245 1.818 . . . . 0.0 111.319 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -89.23 -3.39 58.57 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.3 165.26 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.352 0.661 . . . . 0.0 109.741 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -135.43 119.73 17.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.3 mt -74.9 126.55 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -35.1 6.07 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.151 0.98 . . . . 0.0 110.697 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.63 171.67 19.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.353 1.461 . . . . 0.0 108.783 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -148.43 160.57 42.9 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 108.114 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -62.86 148.32 47.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.349 0.522 . . . . 0.0 110.341 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -62.16 -36.71 82.68 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.702 0.401 . . . . 0.0 111.308 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.35 175.03 11.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.4 1.88 . . . . 0.0 107.226 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 70.5 m95 -64.05 127.31 30.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.346 0.658 . . . . 0.0 109.572 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.43 141.21 39.85 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -153.47 151.18 29.56 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.686 -0.634 . . . . 0.0 110.208 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -155.94 160.87 40.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.743 1.617 . . . . 0.0 107.536 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 145.94 24.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.379 0.609 . . . . 0.0 109.593 172.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.74 151.85 93.38 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 125.556 1.542 . . . . 0.0 108.365 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -63.31 152.75 78.37 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 N-CA-C 108.028 -1.566 . . . . 0.0 108.028 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -49.4 -48.28 47.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.07 -17.93 64.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.09 0.956 . . . . 0.0 112.913 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.9 tp -102.57 -9.09 20.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.785 1.234 . . . . 0.0 111.838 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.9 t -56.49 142.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.47 -47.84 30.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -168.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.2 m95 55.36 11.23 0.55 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.9 2.08 . . . . 0.0 114.328 -170.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.46 -24.8 13.79 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.412 1.085 . . . . 0.0 111.175 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.6 p -90.89 168.84 11.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.078 0.951 . . . . 0.0 109.789 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.96 116.87 18.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -63.67 162.37 57.13 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.89 0.996 . . . . 0.0 109.952 -10.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.33 132.86 25.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -90.4 108.72 19.96 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.4 pt -94.12 -15.29 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.418 1.887 . . . . 0.0 111.596 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.25 172.8 34.13 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 120.099 1.318 . . . . 0.0 112.848 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -119.22 123.57 44.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 68.0 tttt -98.46 131.77 44.45 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 172.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.77 137.37 18.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.857 1.208 . . . . 0.0 113.089 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -100.81 131.73 46.55 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -100.28 132.92 45.38 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -109.14 131.34 55.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -86.94 108.4 18.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.09 125.07 50.58 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.885 0.874 . . . . 0.0 108.867 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -83.56 133.32 34.87 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 168.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.3 tp -68.74 124.46 23.71 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.15 -49.71 11.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -135.81 124.35 23.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.6 -163.07 15.56 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.81 -48.17 0.26 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 128.79 2.836 . . . . 0.0 113.175 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.7 -32.74 10.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.725 1.61 . . . . 0.0 112.023 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.78 -24.53 31.03 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.441 0.696 . . . . 0.0 110.695 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -64.76 131.3 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -134.95 -32.08 0.98 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.6 0.76 . . . . 0.0 111.691 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.5 mtt 64.6 -49.63 0.32 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.508 3.123 . . . . 0.0 113.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.48 25.22 2.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.654 1.182 . . . . 0.0 112.986 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -65.46 -28.3 69.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.143 0.577 . . . . 0.0 110.322 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -95.42 10.66 35.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.98 1.312 . . . . 0.0 113.127 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.28 -36.71 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 129.695 3.198 . . . . 0.0 115.793 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 p -128.28 60.88 50.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.74 1.616 . . . . 0.0 108.993 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -70.78 177.84 5.85 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.048 2.499 . . . . 0.0 110.29 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.46 -26.08 35.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.426 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -99.43 139.14 35.53 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.627 1.558 . . . . 0.0 112.684 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -112.53 -31.08 6.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.098 1.759 . . . . 0.0 112.397 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.67 151.81 16.09 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -102.2 155.59 18.11 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.87 0.868 . . . . 0.0 111.901 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -152.58 111.51 3.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.26 1.824 . . . . 0.0 106.947 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -74.17 138.51 43.85 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.874 0.761 . . . . 0.0 109.24 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.41 159.93 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.864 1.265 . . . . 0.0 109.158 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.8 m -55.28 152.55 8.19 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.953 0.501 . . . . 0.0 110.125 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 165.52 13.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.7 m95 65.88 -24.67 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.888 1.675 . . . . 0.0 115.075 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.97 -46.02 96.65 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 120.483 1.492 . . . . 0.0 111.691 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.98 -29.18 81.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 122.012 1.754 . . . . 0.0 113.263 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.42 -10.24 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 111.89 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -108.53 -23.08 12.0 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.898 -1.126 . . . . 0.0 110.97 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.91 -35.73 57.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.314 0.961 . . . . 0.0 111.68 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.89 166.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.869 0.759 . . . . 0.0 111.509 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.77 150.68 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.421 1.088 . . . . 0.0 110.565 174.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 p -53.33 -40.67 65.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.618 1.567 . . . . 0.0 113.633 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -70.33 -32.36 70.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.365 0.53 . . . . 0.0 110.611 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -72.95 -38.61 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -51.6 -48.21 63.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.519 1.054 . . . . 0.0 110.879 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.66 -26.04 62.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.9 -46.51 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.22 -0.925 . . . . 0.0 108.67 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -35.34 80.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 110.976 -170.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -61.19 -28.04 68.85 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.641 -1.287 . . . . 0.0 112.983 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -64.21 -46.76 82.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.3 t -60.81 -48.5 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 109.391 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 mtt -66.43 -37.07 84.38 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.093 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -47.29 82.02 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 119.456 1.025 . . . . 0.0 110.455 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -60.5 -32.58 71.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.264 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -107.8 4.01 25.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -57.44 10.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.476 1.489 . . . . 0.0 110.994 -169.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -59.71 -30.54 68.88 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.237 0.615 . . . . 0.0 111.715 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.02 -8.35 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.736 1.214 . . . . 0.0 111.038 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.22 -35.95 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 O-C-N 121.355 -0.841 . . . . 0.0 109.402 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 54.8 tpp -76.82 -45.33 29.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.269 0.628 . . . . 0.0 111.051 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.6 m -62.97 -31.09 72.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.93 -0.481 . . . . 0.0 111.61 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.48 -34.12 70.54 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.254 0.622 . . . . 0.0 109.868 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -99.25 0.81 43.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.977 0.911 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 CA--C 1.537 0.473 0 C-N-CA 124.592 1.157 . . . . 0.0 109.247 170.421 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.89 141.63 53.13 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 107.337 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -48.8 -30.29 5.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -168.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.37 -5.36 44.45 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.96 38.74 3.75 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 126.059 1.79 . . . . 0.0 110.663 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.0 139.77 53.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.095 1.447 . . . . 0.0 111.628 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -85.57 120.54 73.1 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 116.776 -1.583 . . . . 0.0 107.853 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.42 137.07 27.44 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 121.822 1.681 . . . . 0.0 111.037 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -145.6 157.51 43.97 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.153 1.381 . . . . 0.0 111.609 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.1 74.61 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.419 2.287 . . . . 0.0 107.934 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.77 128.26 44.77 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -86.42 110.11 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -16.26 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 116.89 -1.529 . . . . 0.0 114.742 -169.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm 19.24 109.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 129.127 2.971 . . . . 0.0 114.929 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.2 138.44 33.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -68.51 -4.56 15.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.98 -7.55 54.88 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.852 0.751 . . . . 0.0 110.56 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.86 37.71 4.35 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 126.131 1.824 . . . . 0.0 112.118 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -133.28 155.79 48.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.551 0.74 . . . . 0.0 109.038 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.68 156.89 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.31 1.044 . . . . 0.0 111.295 -168.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.98 131.44 44.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.124 1.769 . . . . 0.0 110.309 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -158.86 139.1 12.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.96 144.24 23.2 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -70.95 138.26 49.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -86.57 125.49 33.83 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.76 137.59 57.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.609 2.364 . . . . 0.0 109.996 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.13 -31.68 1.33 Allowed Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.062 1.315 . . . . 0.0 113.716 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -86.35 -34.15 20.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.453 1.101 . . . . 0.0 110.455 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 57.29 33.46 23.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.046 1.738 . . . . 0.0 112.575 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 p -149.87 -177.79 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.245 1.818 . . . . 0.0 107.231 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -80.46 160.43 25.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.029 -1.044 . . . . 0.0 112.975 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.1 147.74 27.45 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.216 1.006 . . . . 0.0 108.987 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -60.59 143.76 89.9 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.301 1.44 . . . . 0.0 110.21 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.22 153.08 55.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.306 2.004 . . . . 0.0 111.065 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -171.79 149.55 2.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 109.845 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.91 134.28 3.37 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.179 -2.369 . . . . 0.0 107.179 169.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.7 171.72 55.15 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.247 1.024 . . . . 0.0 111.639 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 mt -96.67 146.04 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.815 0.846 . . . . 0.0 109.064 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -87.61 131.71 42.86 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.565 1.546 . . . . 0.0 108.39 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.44 118.07 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.23 1.953 . . . . 0.0 114.08 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.48 3.57 90.03 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.037 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -86.98 131.67 34.02 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.063 0.945 . . . . 0.0 108.554 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.99 161.26 30.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.827 1.251 . . . . 0.0 110.685 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.17 -44.26 64.55 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 125.168 1.387 . . . . 0.0 112.992 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.24 -48.96 48.05 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.6 -39.59 77.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.597 1.159 . . . . 0.0 109.919 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 -34.42 63.86 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.044 0.938 . . . . 0.0 111.983 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -57.33 -39.87 76.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.95 0.795 . . . . 0.0 110.065 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.37 -26.39 66.44 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.742 1.155 . . . . 0.0 113.511 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.33 -49.9 69.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.153 1.342 . . . . 0.0 108.597 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.39 75.56 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 119.451 -0.309 . . . . 0.0 111.316 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.2 -44.9 84.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.753 1.221 . . . . 0.0 109.715 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.1 -47.3 80.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.634 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.72 -39.49 94.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.261 1.391 . . . . 0.0 112.772 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -82.47 -46.67 13.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.166 1.386 . . . . 0.0 110.577 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 m -132.16 1.03 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.348 1.059 . . . . 0.0 112.816 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.84 32.47 79.58 Favored Glycine 0 CA--C 1.521 0.447 0 O-C-N 120.909 -1.12 . . . . 0.0 112.164 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.78 154.54 18.82 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 m -117.49 179.03 4.17 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.842 0.857 . . . . 0.0 109.106 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -73.15 46.75 0.18 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.67 1.588 . . . . 0.0 115.242 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -163.42 -20.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.124 1.769 . . . . 0.0 111.785 -171.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.1 2.92 53.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.091 1.356 . . . . 0.0 112.961 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.75 170.19 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.506 1.522 . . . . 0.0 108.91 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -138.0 120.25 15.77 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.3 mt -77.66 128.37 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 120.658 1.572 . . . . 0.0 107.879 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -104.95 -34.8 7.9 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.842 0.857 . . . . 0.0 111.467 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 173.79 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.156 1.382 . . . . 0.0 108.493 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -150.49 160.88 43.46 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 m -56.02 133.39 51.76 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -66.14 -27.04 67.73 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -147.33 168.09 22.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.248 1.419 . . . . 0.0 108.61 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -68.73 117.93 11.06 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.9 156.7 31.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -143.46 154.35 43.58 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.918 1.687 . . . . 0.0 108.029 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -146.1 172.67 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.639 . . . . 0.0 107.721 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -105.45 133.15 50.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.2 mt -67.75 148.72 98.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.33 146.09 25.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.529 2.153 . . . . 0.0 108.287 169.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -56.07 -44.32 78.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.749 1.159 . . . . 0.0 113.146 -168.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.22 -15.19 62.2 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 112.783 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.18 -0.33 33.36 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.074 1.75 . . . . 0.0 111.618 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.61 141.22 13.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -86.61 128.51 35.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -107.57 -0.36 22.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.308 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -106.56 -12.23 15.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.28 1.032 . . . . 0.0 111.446 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.6 p -73.97 -35.92 64.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 111.535 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 40.47 87.98 0.1 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.164 2.585 . . . . 0.0 112.347 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.1 143.42 42.21 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.03 1.046 . . . . 0.0 114.148 10.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -62.58 131.55 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.9 t -94.01 112.31 24.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.3 pt -97.61 -8.89 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.179 0.991 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.23 176.33 48.01 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.867 1.212 . . . . 0.0 112.827 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -101.95 121.2 41.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -82.89 112.48 19.72 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 103.115 -2.92 . . . . 0.0 103.115 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.61 51.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.985 1.721 . . . . 0.0 112.93 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -120.87 113.72 20.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -85.64 149.63 25.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -112.36 130.02 56.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.86 90.58 5.3 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.68 122.7 32.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.807 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -84.61 136.4 33.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.33 140.81 57.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.47 -56.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -91.92 123.11 35.05 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.54 -170.89 40.73 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.587 0.613 . . . . 0.0 114.482 -169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -48.98 -32.91 9.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.799 1.64 . . . . 0.0 112.88 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -26.1 66.42 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.61 -25.21 13.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.332 1.453 . . . . 0.0 111.306 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 mt -56.05 139.8 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -141.57 85.92 1.98 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 122.252 1.025 . . . . 0.0 108.664 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 mtt -60.25 -12.84 9.9 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.968 0.907 . . . . 0.0 112.791 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -110.1 30.59 6.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.968 1.307 . . . . 0.0 110.304 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -76.39 -31.14 57.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.174 0.59 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -80.38 168.49 18.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.987 0.898 . . . . 0.0 109.319 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m -81.47 -28.37 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.627 1.571 . . . . 0.0 111.14 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -131.15 64.15 72.63 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.393 1.877 . . . . 0.0 108.21 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.34 176.27 5.84 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.71 2.94 . . . . 0.0 111.009 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -114.54 -22.23 9.9 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.185 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -123.09 145.07 48.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 121.404 1.911 . . . . 0.0 111.441 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.54 -40.0 6.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.132 1.373 . . . . 0.0 110.082 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.01 170.92 13.77 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.25 0.929 . . . . 0.0 111.871 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 20.1 t-105 -170.21 -125.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.973 1.709 . . . . 0.0 108.536 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 6.9 ptt180 -153.65 158.17 40.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.543 2.737 . . . . 0.0 106.589 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -80.33 141.38 35.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.004 0.82 . . . . 0.0 109.151 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.56 162.56 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.11 0.964 . . . . 0.0 111.048 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -51.79 151.12 3.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.814 0.846 . . . . 0.0 110.682 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.58 -40.92 69.28 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -96.47 6.55 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.45 0.7 . . . . 0.0 112.682 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.92 -46.44 15.43 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.339 -1.315 . . . . 0.0 111.633 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.94 -36.03 85.11 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.081 1.854 . . . . 0.0 113.685 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.46 -24.85 33.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 O-C-N 121.15 -0.969 . . . . 0.0 111.435 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.55 -17.25 34.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.396 0.998 . . . . 0.0 111.516 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -83.35 -30.72 27.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.55 1.068 . . . . 0.0 111.602 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.89 162.92 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.56 148.82 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.468 0.707 . . . . 0.0 111.427 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 m -56.93 -29.97 63.58 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.694 1.597 . . . . 0.0 114.848 -169.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -79.28 -43.0 24.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.444 1.02 . . . . 0.0 110.478 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -74.46 -27.37 60.56 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 111.157 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -42.07 -46.62 4.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.415 1.486 . . . . 0.0 111.252 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.39 -43.6 85.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.835 0.743 . . . . 0.0 111.396 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.02 -34.74 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.912 -0.493 . . . . 0.0 110.264 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.81 -31.75 70.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.186 -0.946 . . . . 0.0 110.053 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -58.5 -36.14 73.32 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.632 -1.292 . . . . 0.0 111.058 169.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -63.64 -44.36 94.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.211 1.368 . . . . 0.0 109.368 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.68 -45.87 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.096 0.862 . . . . 0.0 109.764 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.02 -45.3 94.21 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.769 -0.582 . . . . 0.0 109.633 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.85 -40.27 96.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.783 1.233 . . . . 0.0 111.034 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.48 -40.02 77.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.745 1.218 . . . . 0.0 110.601 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.57 -10.32 22.2 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.817 1.044 . . . . 0.0 113.817 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.61 -57.34 10.33 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.768 1.167 . . . . 0.0 111.131 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -80.36 15.84 1.48 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.9 t -110.37 -28.07 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.34 -65.94 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.0 109.146 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.4 mtp -59.26 -29.3 67.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.435 1.094 . . . . 0.0 111.231 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -58.37 -27.79 64.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.135 0.974 . . . . 0.0 113.32 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.54 -40.07 92.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.67 0.788 . . . . 0.0 109.479 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -83.91 -31.07 25.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.276 1.03 . . . . 0.0 110.406 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.147 1.379 . . . . 0.0 111.347 178.327 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.91 152.11 28.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.091 0.957 . . . . 0.0 109.644 171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.49 -30.88 68.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.35 7.7 31.19 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.773 0.829 . . . . 0.0 112.581 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 21.27 30.66 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.283 1.42 . . . . 0.0 113.636 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -101.27 144.68 29.82 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 119.038 1.419 . . . . 0.0 110.191 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.36 123.05 65.13 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-O 116.569 -1.682 . . . . 0.0 106.921 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -69.14 126.98 14.4 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.07 1.846 . . . . 0.0 111.03 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -139.86 159.59 41.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.164 1.786 . . . . 0.0 110.335 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.95 140.71 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 106.783 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.12 123.11 5.55 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.71 112.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.92 83.81 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.13 137.6 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -121.16 124.65 45.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 169.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.51 125.2 27.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 169.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -48.32 -18.62 0.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 116.025 -1.94 . . . . 0.0 115.73 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.3 7.06 1.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.619 1.554 . . . . 0.0 112.642 170.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.94 16.64 32.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.493 1.52 . . . . 0.0 113.702 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -121.18 163.49 18.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.136 0.974 . . . . 0.0 108.509 -168.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -105.99 161.66 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -167.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.53 129.92 42.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.23 1.812 . . . . 0.0 111.054 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -161.52 131.17 4.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.25 145.05 31.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -71.88 127.26 31.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -71.93 129.02 37.57 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -38.81 121.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.767 2.427 . . . . 0.0 111.112 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -1.64 21.43 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.567 1.08 . . . . 0.0 115.372 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -100.18 -24.3 14.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.314 1.557 . . . . 0.0 112.435 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 54.61 35.61 24.04 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.549 1.14 . . . . 0.0 112.142 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -146.98 -179.49 6.85 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.369 1.867 . . . . 0.0 107.348 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -117.08 156.46 27.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.236 0.925 . . . . 0.0 111.565 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -151.76 165.49 34.27 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.209 1.404 . . . . 0.0 109.051 -173.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -109.17 160.86 25.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.513 1.125 . . . . 0.0 112.147 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -74.4 69.84 4.94 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.774 2.983 . . . . 0.0 115.011 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -84.6 145.7 27.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.38 149.79 19.38 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.283 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.89 143.18 29.65 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.404 1.002 . . . . 0.0 111.915 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.91 137.23 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.39 146.07 49.79 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 118.777 0.717 . . . . 0.0 109.509 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -53.26 119.34 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.226 1.951 . . . . 0.0 113.731 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.36 7.56 87.45 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.002 1.286 . . . . 0.0 113.262 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.51 -40.15 64.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 112.444 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . 0.292 20.6 m 68.05 152.06 0.08 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.459 1.504 . . . . 0.0 112.543 -170.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.22 -45.03 72.18 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 125.055 1.342 . . . . 0.0 113.347 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.8 4.02 15.1 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.222 0.919 . . . . 0.0 111.904 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.09 -48.96 3.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.44 91.58 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.695 0.798 . . . . 0.0 112.136 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -58.85 -43.39 90.77 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.213 1.005 . . . . 0.0 109.371 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.03 -20.37 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -76.34 -47.68 22.64 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 109.279 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.1 77.71 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.217 0.917 . . . . 0.0 111.028 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.1 tp -48.06 -45.87 32.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 110.754 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -49.43 18.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.475 1.51 . . . . 0.0 111.689 176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.12 -37.31 87.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.804 1.184 . . . . 0.0 110.34 -170.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -94.31 -43.44 8.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.048 1.339 . . . . 0.0 111.006 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.99 -7.94 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.826 0.85 . . . . 0.0 112.451 -169.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.13 16.83 71.32 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 120.378 -1.451 . . . . 0.0 113.731 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.3 mt -95.26 152.07 18.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m -120.14 -176.69 3.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.883 0.873 . . . . 0.0 109.757 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.19 50.97 0.51 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.142 1.777 . . . . 0.0 112.684 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -164.54 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.666 1.586 . . . . 0.0 112.022 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.39 -6.54 58.9 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.256 1.022 . . . . 0.0 113.723 -168.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.29 170.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 123.875 0.87 . . . . 0.0 109.431 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -141.91 120.48 12.51 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -170.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.42 127.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.38 -35.13 6.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.579 0.752 . . . . 0.0 110.985 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.04 166.5 33.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.219 1.408 . . . . 0.0 108.627 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 163.69 34.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.145 0.978 . . . . 0.0 108.793 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -62.95 150.46 42.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.921 0.782 . . . . 0.0 110.836 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.726 0.411 . . . . 0.0 111.182 -171.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.9 173.69 13.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.496 1.918 . . . . 0.0 107.675 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.408 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 93.5 m95 -58.46 121.07 9.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 110.821 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.86 154.41 33.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 140.34 23.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.25 156.58 46.97 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -95.23 153.28 17.74 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.261 0.553 . . . . 0.0 110.91 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -84.16 150.23 57.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -65.69 156.88 61.61 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.685 2.257 . . . . 0.0 109.282 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -59.39 -30.03 68.14 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -74.85 -20.16 59.87 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.962 0.905 . . . . 0.0 113.238 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 tp -105.35 -22.13 13.1 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.704 1.202 . . . . 0.0 111.4 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.16 132.73 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 168.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -89.78 131.08 35.92 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -100.07 3.06 43.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.839 1.255 . . . . 0.0 109.453 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -98.31 -16.68 19.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 110.869 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -74.66 -36.06 62.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.384 -171.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 38.21 88.31 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 127.867 2.467 . . . . 0.0 112.111 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.77 141.81 21.28 Favored 'Cis proline' 0 C--N 1.356 0.932 0 N-CA-C 115.171 1.181 . . . . 0.0 115.171 10.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.45 124.5 8.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.62 92.62 9.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.5 pt -88.64 -12.01 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.912 -1.042 . . . . 0.0 112.025 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.85 43.4 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 120.483 1.492 . . . . 0.0 113.782 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 114.14 25.19 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 66.0 tttt -86.86 125.03 33.72 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 169.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.91 137.89 33.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -106.85 129.16 54.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -103.28 133.55 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.49 130.37 55.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.68 105.52 17.42 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.5 123.62 47.23 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.051 0.94 . . . . 0.0 109.225 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -80.49 138.22 36.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 106.95 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.92 -40.39 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.9 p -92.21 -114.51 0.09 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.9 -169.64 37.36 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.802 0.728 . . . . 0.0 111.911 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.84 -39.1 0.48 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.603 1.961 . . . . 0.0 113.492 171.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.63 69.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.2 -23.19 12.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.045 1.338 . . . . 0.0 111.785 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.06 131.87 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -143.99 77.72 1.56 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 122.348 1.07 . . . . 0.0 109.893 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.7 mtt -64.25 14.08 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.572 1.549 . . . . 0.0 113.244 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -131.29 21.09 4.8 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.648 1.567 . . . . 0.0 111.221 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 t -75.65 -28.04 58.59 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.229 1.012 . . . . 0.0 111.057 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -5.86 52.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.971 1.708 . . . . 0.0 114.519 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.2 m 68.13 -34.22 0.25 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.879 2.872 . . . . 0.0 114.153 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 p -124.04 72.08 54.25 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 169.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.49 -165.6 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.899 3.066 . . . . 0.0 112.027 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -120.48 -12.12 9.0 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.487 1.115 . . . . 0.0 111.893 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -134.59 152.16 51.58 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 120.913 1.688 . . . . 0.0 112.23 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.8 -35.25 5.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.927 1.691 . . . . 0.0 111.766 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -173.09 152.18 15.45 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -94.93 163.14 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.104 1.362 . . . . 0.0 111.354 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -152.92 120.23 5.9 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.889 1.676 . . . . 0.0 106.691 169.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -81.43 70.74 8.35 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.345 1.43 . . . . 0.0 109.247 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.29 156.02 5.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.242 1.417 . . . . 0.0 110.764 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -52.48 153.54 2.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.691 0.796 . . . . 0.0 111.909 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -57.02 152.31 13.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 m95 67.95 -28.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.449 1.9 . . . . 0.0 115.806 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.68 -47.0 98.07 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 121.155 1.798 . . . . 0.0 112.169 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.0 -18.05 62.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.592 1.604 . . . . 0.0 115.507 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.4 t -57.28 -38.11 60.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 120.08 1.309 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -92.64 -19.93 21.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.653 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -72.96 -21.28 60.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 121.297 1.862 . . . . 0.0 111.893 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.7 m -71.82 162.01 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 119.419 1.009 . . . . 0.0 111.034 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -60.6 151.67 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.133 0.973 . . . . 0.0 110.042 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 m -61.63 -29.27 69.95 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -73.87 -26.63 60.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.559 1.072 . . . . 0.0 111.508 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.98 -29.2 25.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.718 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -48.51 -52.13 23.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.566 1.076 . . . . 0.0 112.521 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.2 -41.44 97.05 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.316 0.507 . . . . 0.0 111.221 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -34.75 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.65 -32.8 74.36 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.03 -1.043 . . . . 0.0 110.643 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -57.28 -42.32 81.42 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.061 -1.024 . . . . 0.0 111.07 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.297 18.4 ptp180 -74.64 -34.18 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.908 1.231 . . . . 0.0 110.37 -176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.21 -47.69 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 109.253 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.62 -41.5 88.25 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.583 -0.698 . . . . 0.0 110.953 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -44.17 81.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 111.324 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.09 -27.65 69.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.727 0.411 . . . . 0.0 112.101 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -113.78 -3.97 13.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.57 69.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.71 1.141 . . . . 0.0 111.146 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 m -64.43 -25.79 68.16 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.01 -0.431 . . . . 0.0 111.616 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.17 -40.69 44.16 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.86 -47.04 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.658 0.783 . . . . 0.0 108.978 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.84 -15.8 63.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.929 0.786 . . . . 0.0 111.856 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.3 m -53.34 -38.84 63.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.758 1.163 . . . . 0.0 111.543 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.39 -30.48 71.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -94.44 -21.37 18.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.166 0.986 . . . . 0.0 111.857 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.45 1.1 . . . . 0.0 110.287 170.001 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.7 mm . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.21 148.06 52.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.813 1.245 . . . . 0.0 108.445 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.53 -28.29 53.84 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -79.11 -1.54 36.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.02 30.19 9.08 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.794 1.664 . . . . 0.0 111.825 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 23.2 m-85 -115.19 138.45 50.91 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.618 1.709 . . . . 0.0 110.379 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -81.49 128.44 69.74 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 127.63 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.907 1.738 . . . . 0.0 109.267 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -137.69 163.42 31.34 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.235 1.414 . . . . 0.0 109.963 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.92 135.4 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.709 2.004 . . . . 0.0 105.95 169.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.54 145.59 17.31 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.47 126.03 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 118.805 1.303 . . . . 0.0 107.799 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.65 86.59 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.13 130.45 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.38 121.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 169.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -97.6 40.85 1.14 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.221 1.008 . . . . 0.0 109.327 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 59.8 -70.42 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 130.5 3.52 . . . . 0.0 111.89 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -90.33 -15.58 30.88 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.225 0.953 . . . . 0.0 112.886 -169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.46 42.97 1.49 Allowed Glycine 0 C--N 1.336 0.572 0 CA-C-N 118.366 0.53 . . . . 0.0 113.469 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 57.32 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.168 1.787 . . . . 0.0 114.27 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.69 162.85 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -63.45 134.67 56.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.675 1.99 . . . . 0.0 110.347 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -159.64 134.9 8.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 167.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.2 145.0 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.187 0.595 . . . . 0.0 109.51 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.98 139.78 41.7 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -94.04 125.73 38.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -43.12 131.21 4.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.39 2.676 . . . . 0.0 110.992 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.84 -29.36 1.08 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.991 1.281 . . . . 0.0 113.817 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.35 -36.29 29.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.345 1.058 . . . . 0.0 110.004 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 57.19 31.05 19.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.899 1.68 . . . . 0.0 112.789 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p -150.32 175.28 11.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.089 1.756 . . . . 0.0 107.68 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -76.4 162.08 28.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.866 0.866 . . . . 0.0 112.02 -169.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -144.85 134.55 23.49 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.372 0.606 . . . . 0.0 110.984 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.09 121.93 59.2 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.844 2.057 . . . . 0.0 108.216 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -59.63 135.77 66.42 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.333 2.022 . . . . 0.0 112.689 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.52 145.26 7.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.004 1.321 . . . . 0.0 109.725 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.38 136.11 5.26 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.17 146.49 46.2 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -76.08 129.65 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.08 128.4 87.87 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.737 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -55.57 119.12 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.95 1.767 . . . . 0.0 113.177 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.52 84.21 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.01 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -101.53 119.04 38.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.41 165.35 23.96 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.299 0.639 . . . . 0.0 111.574 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.92 -45.93 60.6 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 125.258 1.423 . . . . 0.0 111.45 -172.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.67 25.41 0.91 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.508 -0.745 . . . . 0.0 110.728 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.06 -46.1 0.78 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.527 1.931 . . . . 0.0 107.091 170.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.83 76.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.882 1.273 . . . . 0.0 111.5 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.37 -44.03 84.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.646 0.778 . . . . 0.0 109.033 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -72.45 -28.61 63.04 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.512 -0.743 . . . . 0.0 112.01 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.76 -46.79 88.08 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.875 -1.14 . . . . 0.0 108.534 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.87 76.43 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.576 -0.703 . . . . 0.0 112.05 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.98 -41.36 78.23 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.36 -49.4 34.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.386 1.475 . . . . 0.0 111.609 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.78 -34.49 75.63 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.208 1.367 . . . . 0.0 112.579 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.9 -57.05 2.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 110.902 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.19 -23.98 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.667 1.187 . . . . 0.0 111.504 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 62.12 5.08 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -135.02 157.75 46.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.875 2.07 . . . . 0.0 106.776 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -121.96 -177.5 3.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.948 0.899 . . . . 0.0 110.811 -169.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -69.51 43.11 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.251 2.621 . . . . 0.0 113.127 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -166.55 -20.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.14 0.976 . . . . 0.0 113.202 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.292 0.496 . . . . 0.0 112.028 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.41 168.45 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.448 1.099 . . . . 0.0 109.99 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.15 121.68 15.16 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.847 2.059 . . . . 0.0 105.995 -171.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -73.88 129.58 36.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 -32.57 6.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.541 0.737 . . . . 0.0 111.554 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.71 169.86 23.68 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.33 1.052 . . . . 0.0 109.636 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -146.99 160.2 42.65 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.745 1.218 . . . . 0.0 109.592 171.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -65.29 143.95 57.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 109.435 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -66.61 -27.35 67.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -153.52 168.81 24.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.23 1.412 . . . . 0.0 109.459 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -63.25 121.01 12.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.785 0.834 . . . . 0.0 109.471 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.48 153.92 33.04 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 150.19 28.88 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.919 -0.488 . . . . 0.0 110.705 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.19 156.46 43.87 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.972 1.709 . . . . 0.0 106.626 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -90.98 145.71 24.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.889 0.313 . . . . 0.0 110.461 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.7 mt -73.4 141.1 79.83 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -60.87 158.05 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.137 1.892 . . . . 0.0 109.42 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -49.31 -48.01 46.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.17 -14.2 60.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.496 1.118 . . . . 0.0 113.091 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -112.85 -1.41 14.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.099 1.76 . . . . 0.0 111.353 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.5 137.24 23.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-N 120.813 1.642 . . . . 0.0 106.673 169.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -93.37 113.67 25.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.05 -9.13 26.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.101 0.96 . . . . 0.0 111.188 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.06 -25.69 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.039 0.936 . . . . 0.0 110.103 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.4 p -71.57 134.14 46.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -120.17 127.19 26.46 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -58.99 154.93 41.42 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.481 1.207 . . . . 0.0 110.907 -10.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -47.58 129.26 3.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.648 1.579 . . . . 0.0 107.959 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.83 113.85 27.68 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.05 -2.75 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 116.52 -1.705 . . . . 0.0 112.528 -170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -171.39 165.53 38.55 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 122.35 2.341 . . . . 0.0 113.066 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -96.48 120.34 36.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -85.6 120.91 27.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 168.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.26 133.52 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 120.8 1.636 . . . . 0.0 113.376 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -100.79 141.89 33.03 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -112.16 137.71 49.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -110.45 133.69 53.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 tt -88.54 123.35 32.96 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 170.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.09 123.99 48.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -81.6 134.04 35.45 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.84 106.66 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.54 -31.04 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.2 p -82.7 -114.16 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.048 0.539 . . . . 0.0 110.07 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.96 166.26 29.55 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.048 1.309 . . . . 0.0 110.445 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.43 -29.03 33.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.823 0.849 . . . . 0.0 112.881 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.25 63.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.271 0.629 . . . . 0.0 112.391 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.38 -23.53 11.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.959 1.703 . . . . 0.0 110.838 -173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -56.47 122.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -89.97 -52.09 5.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.3 mtt 59.78 5.46 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.795 1.638 . . . . 0.0 115.215 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 30.23 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.093 1.77 . . . . 0.0 111.621 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -43.72 69.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.949 1.699 . . . . 0.0 112.079 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.6 -4.47 57.72 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -168.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 66.31 -38.12 0.29 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.774 2.429 . . . . 0.0 113.03 -169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 p -123.32 75.06 52.01 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.871 2.068 . . . . 0.0 105.59 169.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.48 -179.3 4.33 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.182 3.255 . . . . 0.0 111.077 -172.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -100.71 -49.97 4.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.111 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -87.97 154.95 20.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 120.538 1.517 . . . . 0.0 111.521 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -133.47 -27.05 1.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.474 1.51 . . . . 0.0 111.761 -172.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.87 144.21 10.28 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -93.4 154.66 17.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.788 1.235 . . . . 0.0 110.825 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -155.55 109.14 2.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.044 1.338 . . . . 0.0 108.398 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -73.62 137.12 44.02 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.275 -0.891 . . . . 0.0 108.607 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.9 161.11 18.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.808 1.643 . . . . 0.0 108.623 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -53.65 154.43 3.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.31 1.044 . . . . 0.0 110.582 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -56.27 -37.89 70.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.946 0.899 . . . . 0.0 113.263 -168.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -96.73 -3.02 43.23 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.506 -0.746 . . . . 0.0 112.826 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -61.02 -47.64 94.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.734 -1.126 . . . . 0.0 111.709 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.82 -35.71 98.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.593 1.605 . . . . 0.0 112.462 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.63 -33.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 109.877 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -17.67 33.52 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 121.501 -0.75 . . . . 0.0 109.289 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -93.37 -22.91 18.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.135 0.272 . . . . 0.0 111.495 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.75 163.3 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.313 -0.867 . . . . 0.0 112.356 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 m -65.71 153.44 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.268 1.427 . . . . 0.0 110.648 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -57.66 -33.91 68.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.416 1.486 . . . . 0.0 114.361 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -74.76 -26.97 60.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.95 0.796 . . . . 0.0 111.497 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -86.82 -33.35 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -47.23 -48.65 24.17 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.249 1.42 . . . . 0.0 112.288 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.88 -35.22 79.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.735 0.243 . . . . 0.0 111.545 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.2 t -83.47 -33.37 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.227 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.01 -32.89 74.59 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.933 1.242 . . . . 0.0 110.408 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -54.28 -41.98 69.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.03 -1.043 . . . . 0.0 111.416 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -66.48 -44.41 82.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.73 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.64 -49.77 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.3 mmt -64.96 -44.43 89.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.609 0.641 . . . . 0.0 110.325 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -62.07 -37.11 83.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.046 0.839 . . . . 0.0 111.124 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.28 -20.99 58.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.432 0.693 . . . . 0.0 111.532 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.92 -9.03 3.92 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.2 63.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.704 1.593 . . . . 0.0 112.45 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -66.66 -17.98 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.19 -33.18 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.018 1.281 . . . . 0.0 109.827 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.25 -29.91 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.709 -1.244 . . . . 0.0 109.659 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mmt -65.63 -27.14 68.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.456 1.025 . . . . 0.0 110.64 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.4 m -56.07 -39.62 72.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.642 1.11 . . . . 0.0 111.023 172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.0 -52.4 9.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.953 0.901 . . . . 0.0 108.704 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -77.56 -7.64 56.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 124.008 0.923 . . . . 0.0 110.546 169.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.35 36.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.452 2.301 . . . . 0.0 111.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.96 -32.93 0.09 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 131.516 3.927 . . . . 0.0 116.66 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.06 13.77 24.09 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.448 1.099 . . . . 0.0 113.153 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 12.33 56.77 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.396 1.474 . . . . 0.0 113.1 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -102.25 138.88 38.6 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.903 1.351 . . . . 0.0 110.24 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -98.66 115.91 65.59 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.041 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.18 123.46 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.387 2.058 . . . . 0.0 110.863 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -144.19 163.73 32.77 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.616 1.566 . . . . 0.0 108.593 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.24 136.81 59.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 130.82 10.26 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.5 112.88 26.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.32 85.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.31 137.62 24.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -125.11 121.69 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 168.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.95 48.0 1.58 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.496 -0.752 . . . . 0.0 109.169 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 18.0 ptt-85 38.13 23.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.241 3.417 . . . . 0.0 116.894 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.85 7.27 15.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.521 1.128 . . . . 0.0 111.925 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.7 71.08 Favored Glycine 0 N--CA 1.477 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 112.422 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -125.56 150.34 47.56 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.71 1.604 . . . . 0.0 107.049 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.95 165.06 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tpt -57.49 129.32 41.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.589 1.955 . . . . 0.0 111.133 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 7.9 t-105 -160.96 115.89 2.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.51 149.7 50.71 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -76.87 136.63 38.88 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.555 1.542 . . . . 0.0 108.203 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -90.12 128.31 36.3 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.925 0.49 . . . . 0.0 110.342 -169.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.47 135.45 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.096 1.758 . . . . 0.0 110.665 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.79 6.11 76.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.944 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -136.24 -38.89 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.525 1.53 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.28 17.1 m80 60.32 38.08 19.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.762 2.025 . . . . 0.0 112.666 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -133.45 161.01 35.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.206 2.202 . . . . 0.0 106.546 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -76.34 148.98 37.09 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.326 -0.859 . . . . 0.0 112.621 -171.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -148.54 160.72 42.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.515 1.15 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.79 167.15 39.13 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 128.18 2.592 . . . . 0.0 109.072 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.25 -110.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 124.167 3.244 . . . . 0.0 110.721 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 65.82 99.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.597 1.959 . . . . 0.0 112.046 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.79 126.01 6.05 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 144.46 22.18 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.003 1.763 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.32 137.0 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.02 135.87 62.47 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.35 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -58.91 117.53 4.28 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.423 1.415 . . . . 0.0 112.452 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.65 80.09 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.096 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 120.28 35.87 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.25 165.67 21.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.908 0.861 . . . . 0.0 111.455 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.13 -45.05 16.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.728 2.011 . . . . 0.0 115.224 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -44.6 21.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -55.06 -42.98 73.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.89 0.876 . . . . 0.0 110.056 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.09 66.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 112.078 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -62.75 -42.61 99.76 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 81.5 m-85 -68.7 -30.57 69.25 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.179 -1.576 . . . . 0.0 112.78 173.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -58.24 -47.02 84.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.251 0.932 . . . . 0.0 109.131 172.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.89 -44.02 86.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.316 0.646 . . . . 0.0 110.708 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.22 -44.18 64.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 111.034 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -48.28 34.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.75 -1.119 . . . . 0.0 111.809 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.65 -28.19 65.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -93.06 -60.22 1.85 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.095 0.958 . . . . 0.0 110.274 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.66 -17.61 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.769 0.827 . . . . 0.0 111.767 -169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 56.46 23.66 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.9 mt -132.13 157.24 44.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.351 2.261 . . . . 0.0 105.972 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -121.09 -172.93 2.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.793 0.724 . . . . 0.0 110.103 -170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.404 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 24.1 mtt180 -73.23 42.05 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.54 1.936 . . . . 0.0 113.271 -171.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -161.75 -23.62 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.88 0.872 . . . . 0.0 112.994 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.82 0.44 52.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.051 0.387 . . . . 0.0 111.86 -168.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.9 m -146.7 165.24 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.782 1.233 . . . . 0.0 109.136 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -136.64 121.47 18.67 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.357 1.863 . . . . 0.0 106.232 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.02 128.32 37.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.3 -37.87 6.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.43 168.98 25.78 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.154 0.982 . . . . 0.0 108.627 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -144.89 161.87 38.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -61.69 139.55 58.29 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -65.68 -25.68 67.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.35 175.07 12.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 108.542 169.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -71.61 113.87 9.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.296 0.638 . . . . 0.0 109.912 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.88 155.22 40.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 148.42 28.61 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -140.29 157.23 45.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.753 0.821 . . . . 0.0 108.805 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -94.14 126.87 39.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -68.53 148.04 98.1 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 158.69 56.83 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.641 2.227 . . . . 0.0 109.666 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -60.56 -33.7 73.07 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -77.99 -24.27 48.06 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.048 0.939 . . . . 0.0 113.07 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 tp -90.98 -24.49 20.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.213 0.461 . . . . 0.0 110.629 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.77 137.63 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -41.96 34.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.027 0.531 . . . . 0.0 111.987 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 21.8 m95 59.11 4.19 0.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.036 2.534 . . . . 0.0 113.811 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -99.6 -25.56 14.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -72.84 151.54 41.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 109.324 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -132.93 116.0 14.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.671 1.188 . . . . 0.0 107.941 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -58.35 155.44 37.11 Favored 'Cis proline' 0 CA--C 1.538 0.694 0 CA-C-N 120.177 1.099 . . . . 0.0 111.483 -10.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.71 131.85 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.0 t -91.88 106.83 18.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.3 pt -97.32 -8.35 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.505 0.722 . . . . 0.0 112.173 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.73 169.64 42.41 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.396 0.998 . . . . 0.0 111.764 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -110.05 119.33 38.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -80.95 125.49 30.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.75 142.56 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -116.98 128.68 55.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -101.51 147.35 26.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.74 129.45 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -80.14 115.11 19.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.54 125.47 54.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.929 0.892 . . . . 0.0 108.838 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.02 134.51 34.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -73.17 122.11 21.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.65 -50.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -128.31 135.44 49.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.15 -155.12 13.52 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 t70 64.55 -61.47 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.149 2.98 . . . . 0.0 111.792 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.26 -35.87 12.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 0.0 110.773 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -89.79 -12.72 38.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.841 0.856 . . . . 0.0 111.598 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.61 116.2 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -97.27 -35.04 10.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.498 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.0 mtt 58.91 -38.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 130.023 3.329 . . . . 0.0 115.532 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -102.56 33.63 3.1 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.898 1.679 . . . . 0.0 110.889 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -69.61 -51.42 35.2 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -74.7 145.2 43.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 m -70.08 -30.28 67.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.217 . . . . 0.0 111.81 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 p -127.23 75.14 77.14 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.177 1.391 . . . . 0.0 107.887 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.52 -175.1 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.709 2.939 . . . . 0.0 110.416 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.72 -29.86 11.25 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 116.695 -1.621 . . . . 0.0 113.366 171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 159.0 17.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 122.051 2.205 . . . . 0.0 112.271 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.91 -6.12 0.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.063 1.345 . . . . 0.0 113.542 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.6 156.88 28.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -119.05 151.65 37.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 111.42 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -145.01 119.49 9.67 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.888 1.675 . . . . 0.0 106.761 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -78.73 140.48 38.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.614 1.097 . . . . 0.0 108.96 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.71 162.43 32.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.799 0.84 . . . . 0.0 110.214 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.2 m -52.21 148.49 6.36 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.012 0.925 . . . . 0.0 109.865 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.45 -38.37 63.5 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -99.58 3.28 45.31 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.27 -44.6 88.98 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.914 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.82 -28.02 85.75 Favored 'Trans proline' 0 C--N 1.352 0.749 0 CA-C-N 122.005 1.752 . . . . 0.0 112.405 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.41 -10.52 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.901 1.28 . . . . 0.0 112.098 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -106.92 -32.12 8.04 Favored 'General case' 0 CA--C 1.526 0.057 0 O-C-N 120.736 -1.228 . . . . 0.0 110.328 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -79.93 -26.69 40.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.031 0.832 . . . . 0.0 112.503 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.05 160.0 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.088 0.858 . . . . 0.0 110.008 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.74 141.45 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.75 1.22 . . . . 0.0 111.623 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 m -56.78 -35.52 68.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.518 1.527 . . . . 0.0 113.867 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -67.97 -33.74 75.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.756 0.707 . . . . 0.0 110.765 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -88.54 -25.12 22.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.92 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -43.48 -46.49 6.87 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 119.935 1.243 . . . . 0.0 112.695 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.58 -49.44 73.36 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.905 0.775 . . . . 0.0 111.49 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.29 -31.3 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 122.002 -0.436 . . . . 0.0 110.3 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -33.54 75.92 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.554 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -64.24 -35.0 79.41 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 120.725 -1.235 . . . . 0.0 110.479 171.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -60.91 -46.45 90.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.6 1.546 . . . . 0.0 109.804 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.92 -48.22 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 118.764 0.711 . . . . 0.0 109.638 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.7 -36.77 84.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.546 -0.721 . . . . 0.0 110.825 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -65.61 -35.66 81.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.673 1.124 . . . . 0.0 110.72 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.78 -25.32 68.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.235 0.614 . . . . 0.0 111.181 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -118.66 -17.66 9.19 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -42.68 -65.18 0.5 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 -169.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -63.81 -25.81 68.34 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.77 -27.13 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.442 -0.786 . . . . 0.0 109.169 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.99 -41.2 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.83 0.852 . . . . 0.0 109.578 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.4 mtt -68.85 -33.31 73.6 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.028 -170.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.3 m -57.34 -31.55 65.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.849 0.75 . . . . 0.0 112.248 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.5 -30.95 71.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.111 0.414 . . . . 0.0 110.328 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -95.5 -44.06 7.69 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.21 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.543 0.692 0 C-N-CA 123.78 0.832 . . . . 0.0 112.131 -177.222 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.97 150.41 45.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.361 1.065 . . . . 0.0 110.013 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.28 -28.16 67.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.56 0.1 35.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.348 0.522 . . . . 0.0 112.167 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.76 32.09 8.27 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.237 1.875 . . . . 0.0 112.06 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 25.3 m-85 -109.76 133.74 52.8 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.556 1.178 . . . . 0.0 110.176 -176.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -80.85 129.28 68.49 Favored Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.4 121.65 6.94 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.196 1.931 . . . . 0.0 109.32 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.0 165.42 25.37 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.603 1.161 . . . . 0.0 109.787 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.33 146.22 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 127.051 2.14 . . . . 0.0 106.564 169.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.68 146.63 18.08 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.13 135.5 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.43 89.88 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -68.11 129.52 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.96 137.57 51.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 168.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -104.58 27.2 8.15 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 53.62 19.39 1.76 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.755 1.622 . . . . 0.0 115.179 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -118.33 5.86 11.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 110.707 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.24 80.78 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 120.848 -1.158 . . . . 0.0 112.312 -169.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -121.58 142.99 49.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.734 1.214 . . . . 0.0 107.727 -171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.21 163.09 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.8 tpt -55.43 136.9 49.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.483 1.913 . . . . 0.0 111.808 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.41 136.5 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.84 144.89 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.47 140.22 48.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.51 119.7 21.46 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -49.94 132.57 22.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.771 2.029 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.3 -31.53 1.6 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.844 1.212 . . . . 0.0 114.027 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -87.07 -30.9 20.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.417 1.109 . . . . 0.0 110.706 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 58.61 35.0 24.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 p -145.19 169.92 17.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.594 1.958 . . . . 0.0 107.009 169.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.57 158.04 24.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.962 1.256 . . . . 0.0 111.84 -170.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -149.52 148.73 29.74 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.155 1.782 . . . . 0.0 107.489 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -80.57 158.96 70.52 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.607 0.639 . . . . 0.0 111.518 171.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -64.89 141.94 73.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.559 2.173 . . . . 0.0 112.456 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -167.88 142.49 3.61 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.833 1.653 . . . . 0.0 108.944 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.24 143.5 10.13 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.57 152.62 52.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.554 1.073 . . . . 0.0 110.698 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mt -82.01 137.19 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -80.5 137.94 51.55 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.747 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.02 117.52 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.408 1.405 . . . . 0.0 113.037 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.92 1.67 88.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.003 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.55 120.8 31.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.611 1.206 . . . . 0.0 107.799 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -71.24 162.6 29.16 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.143 0.577 . . . . 0.0 111.241 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.23 -44.96 16.73 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 126.936 2.094 . . . . 0.0 113.447 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.92 -49.22 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.13 -39.8 83.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.524 0.73 . . . . 0.0 110.387 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -35.51 79.99 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.195 0.998 . . . . 0.0 111.974 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -58.64 -46.91 86.1 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -66.38 -30.05 70.35 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.717 1.144 . . . . 0.0 112.659 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -59.37 -46.72 87.88 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.075 -1.016 . . . . 0.0 108.736 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.908 0.483 . . . . 0.0 111.566 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 tp -57.74 -39.63 77.78 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.891 -1.131 . . . . 0.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -72.93 -50.44 23.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.211 1.005 . . . . 0.0 111.297 174.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.59 -30.06 68.73 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.469 1.486 . . . . 0.0 112.075 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -97.67 -47.5 5.59 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.033 0.933 . . . . 0.0 111.576 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.23 -19.78 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.375 0.67 . . . . 0.0 110.975 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.21 35.15 82.41 Favored Glycine 0 CA--C 1.526 0.78 0 O-C-N 121.191 -0.943 . . . . 0.0 110.886 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.01 154.28 27.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.23 1.412 . . . . 0.0 108.296 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -116.52 -175.13 2.7 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.896 0.878 . . . . 0.0 110.365 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -73.74 41.14 0.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.286 1.834 . . . . 0.0 113.294 -169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -163.1 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.627 1.171 . . . . 0.0 112.919 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.26 -0.94 51.81 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.89 0.476 . . . . 0.0 111.809 -169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -148.5 171.38 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.949 1.7 . . . . 0.0 108.63 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -140.8 123.91 16.51 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.75 131.24 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 120.485 1.493 . . . . 0.0 107.932 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.63 -36.73 6.36 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.097 0.559 . . . . 0.0 111.324 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 171.45 19.92 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.465 1.106 . . . . 0.0 109.35 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -144.67 162.98 35.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -65.85 138.83 58.15 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -67.67 -19.7 65.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -146.56 170.38 17.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.222 1.809 . . . . 0.0 108.525 170.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -75.58 125.14 28.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.05 152.79 44.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 140.56 21.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -143.82 161.24 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.065 0.946 . . . . 0.0 108.486 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -101.23 133.0 46.46 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 107.571 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.56 143.06 81.75 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 108.452 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.88 155.83 21.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 0.0 110.471 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.82 -45.23 90.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.794 -1.192 . . . . 0.0 113.113 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.56 -12.73 55.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 112.596 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 0.16 26.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.031 1.732 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.15 135.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -90.96 114.88 27.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -100.19 -3.0 32.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.938 0.774 . . . . 0.0 111.694 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -89.43 -18.24 27.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.764 0.825 . . . . 0.0 110.554 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.49 154.57 21.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.537 1.535 . . . . 0.0 108.212 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -134.87 118.55 13.3 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.506 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.75 153.57 34.17 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 120.095 1.069 . . . . 0.0 110.985 -10.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -54.68 130.26 16.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.4 t -93.09 127.15 38.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.253 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.14 -5.4 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 111.807 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -155.85 161.21 30.53 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 121.192 1.815 . . . . 0.0 113.535 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -112.93 105.96 14.14 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -81.55 129.73 34.78 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 170.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.83 127.22 13.12 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 120.285 1.402 . . . . 0.0 112.843 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -98.9 138.5 35.93 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -107.04 144.96 32.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -116.55 131.63 56.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 114.84 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.41 127.93 55.83 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 108.641 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -87.38 134.04 33.63 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.44 123.53 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.66 -37.88 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.1 m -88.69 -127.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.35 0.66 . . . . 0.0 109.913 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.25 178.63 47.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.837 1.199 . . . . 0.0 112.162 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.86 -30.66 15.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.785 1.634 . . . . 0.0 113.053 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.47 -29.23 67.8 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -98.35 -27.43 14.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.357 1.063 . . . . 0.0 111.212 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 143.68 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.722 1.209 . . . . 0.0 107.759 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.33 -41.58 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.549 0.74 . . . . 0.0 111.317 -170.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.7 mtt 55.51 7.35 0.23 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.14 17.83 5.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.741 1.61 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -31.6 72.73 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.705 2.002 . . . . 0.0 111.615 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -7.77 59.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.692 1.997 . . . . 0.0 113.672 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m 68.15 -35.46 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.305 2.642 . . . . 0.0 114.062 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 p -121.77 71.84 30.32 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.345 1.858 . . . . 0.0 106.398 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.56 -174.09 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.587 2.858 . . . . 0.0 111.958 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.98 -10.69 15.45 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.012 169.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.36 146.07 50.88 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.998 1.726 . . . . 0.0 114.99 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -115.96 114.25 24.38 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.767 3.227 . . . . 0.0 102.864 169.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.12 136.02 28.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.622 0.629 . . . . 0.0 113.157 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -131.67 -112.13 0.24 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.163 1.385 . . . . 0.0 109.946 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -150.08 163.06 39.15 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.776 1.23 . . . . 0.0 110.609 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -84.28 155.19 22.54 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.27 169.04 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 110.091 -169.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.2 m -57.45 151.67 16.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.34 0.591 . . . . 0.0 111.49 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -61.29 154.46 23.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.8 m95 66.36 -30.13 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.308 1.843 . . . . 0.0 115.559 -173.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -54.93 -46.28 99.61 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 120.773 1.624 . . . . 0.0 112.177 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -60.07 -26.65 83.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 121.732 1.654 . . . . 0.0 114.989 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.08 -34.11 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.956 1.253 . . . . 0.0 109.077 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -90.11 -19.0 24.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.945 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -80.33 -30.01 38.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.419 1.009 . . . . 0.0 111.988 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.18 163.13 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-N 118.56 0.618 . . . . 0.0 110.207 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.37 153.65 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.838 0.855 . . . . 0.0 111.603 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 m -54.87 -30.33 57.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.608 1.963 . . . . 0.0 115.594 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -84.31 -37.3 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.424 1.011 . . . . 0.0 111.374 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -70.41 -38.58 74.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.384 -0.822 . . . . 0.0 110.219 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -42.98 -45.71 5.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.599 1.56 . . . . 0.0 110.884 171.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.69 -34.8 78.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -173.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.8 -35.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 0.0 110.162 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.26 -32.2 73.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.825 0.739 . . . . 0.0 110.853 -171.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.38 -38.38 80.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.388 -0.82 . . . . 0.0 111.048 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -69.96 -46.47 65.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.46 -46.15 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.822 0.849 . . . . 0.0 109.3 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.3 mtt -69.59 -40.09 76.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.149 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.89 -40.85 94.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.821 1.191 . . . . 0.0 111.036 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.71 -28.13 68.41 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.132 0.973 . . . . 0.0 110.928 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -111.79 -9.18 14.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.09 0.956 . . . . 0.0 113.405 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.13 -59.61 4.0 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.124 0.97 . . . . 0.0 111.714 -169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 m -67.54 -23.03 65.39 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.878 -0.514 . . . . 0.0 111.518 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.75 -35.82 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.8 t -83.93 -42.07 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.719 0.808 . . . . 0.0 109.174 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.39 -30.6 69.55 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.623 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.6 m -55.41 -29.48 58.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.554 1.07 . . . . 0.0 112.122 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.87 -38.49 73.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.088 0.555 . . . . 0.0 110.443 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -92.25 -16.26 26.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.271 0.628 . . . . 0.0 111.02 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 126.18 1.792 . . . . 0.0 110.205 172.588 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 3.2 mp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.59 146.46 51.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -50.75 -31.81 17.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.05 -3.96 47.82 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.74 32.33 7.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.754 2.121 . . . . 0.0 110.578 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -111.27 146.4 37.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.976 1.388 . . . . 0.0 110.017 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.95 123.93 57.91 Favored Pre-proline 0 N--CA 1.467 0.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -68.97 130.6 20.62 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.348 2.032 . . . . 0.0 111.43 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.48 157.35 45.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.288 1.835 . . . . 0.0 111.837 -170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.4 120.52 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.511 1.925 . . . . 0.0 107.082 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 123.97 8.09 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.78 117.49 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 118.636 1.218 . . . . 0.0 108.722 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.33 85.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -66.74 136.52 26.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 168.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -121.74 121.91 38.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -74.36 125.07 27.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -43.6 -27.45 0.3 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.743 2.017 . . . . 0.0 114.456 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.19 2.87 1.37 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.29 30.42 7.38 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.023 1.296 . . . . 0.0 112.29 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.81 164.54 26.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.18 167.53 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 tpt -53.26 126.31 20.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.818 2.447 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -161.83 128.36 3.77 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.6 148.51 31.19 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.52 136.14 47.39 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.34 125.31 29.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -48.68 127.46 13.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 110.189 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 -24.14 1.77 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.133 1.349 . . . . 0.0 114.461 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.83 -32.28 23.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.389 1.076 . . . . 0.0 110.407 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 58.29 30.71 19.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 112.921 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -148.7 173.38 13.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.234 1.813 . . . . 0.0 107.19 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -75.05 163.26 27.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.316 0.962 . . . . 0.0 113.314 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.83 147.65 27.51 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.591 1.156 . . . . 0.0 108.889 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -61.64 150.98 79.89 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.0 1.72 . . . . 0.0 110.35 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.87 151.48 84.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.135 1.89 . . . . 0.0 110.88 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -173.43 168.18 4.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.205 1.802 . . . . 0.0 109.413 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.78 127.58 1.14 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.0 134.64 27.43 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.86 133.12 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.61 124.74 91.14 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.771 1.228 . . . . 0.0 108.875 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.76 118.42 5.19 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.929 1.753 . . . . 0.0 112.487 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.44 1.72 68.61 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.041 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.52 120.0 40.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 m -69.37 160.76 30.71 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 121.248 0.547 . . . . 0.0 111.09 -174.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.04 -42.14 12.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.767 2.027 . . . . 0.0 113.999 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -74.18 -47.69 33.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.49 -40.02 81.63 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 110.11 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.01 -32.92 72.81 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.309 1.044 . . . . 0.0 112.369 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -59.51 -44.82 93.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -67.09 -27.68 67.55 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.748 -1.22 . . . . 0.0 112.649 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -64.75 -44.15 91.04 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.67 -1.269 . . . . 0.0 109.159 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.16 63.4 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 118.453 0.57 . . . . 0.0 110.544 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.99 -43.34 95.24 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 120.951 -1.093 . . . . 0.0 108.999 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -63.67 -57.3 10.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.652 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -25.5 60.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.104 1.774 . . . . 0.0 114.217 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.61 -11.02 12.43 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.927 -1.108 . . . . 0.0 112.654 -169.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.04 -16.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.18 0.992 . . . . 0.0 111.515 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.74 79.03 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 120.221 -1.549 . . . . 0.0 114.243 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -113.47 155.99 24.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.088 1.444 . . . . 0.0 109.104 -171.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -108.7 178.65 4.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.781 1.232 . . . . 0.0 110.227 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -72.77 37.58 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.399 1.88 . . . . 0.0 113.059 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -161.83 -14.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -106.06 18.24 22.35 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.457 1.026 . . . . 0.0 113.177 -168.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.22 175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.459 1.904 . . . . 0.0 109.42 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -140.91 114.39 8.77 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.3 mt -72.94 132.51 33.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.07 -52.4 2.81 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.503 0.502 . . . . 0.0 109.673 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.86 174.19 11.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.57 0.748 . . . . 0.0 111.067 -171.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.5 p -145.82 177.31 9.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.944 1.298 . . . . 0.0 109.001 171.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 6.16 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.98 -16.53 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.014 2.526 . . . . 0.0 115.345 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.4 174.22 12.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.778 2.431 . . . . 0.0 108.674 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -79.16 121.81 25.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.669 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.18 160.95 17.51 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -140.52 141.88 35.27 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 108.838 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -144.83 153.02 41.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 168.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.98 156.19 17.06 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -88.53 141.52 30.44 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 154.77 72.2 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.804 2.336 . . . . 0.0 108.663 170.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -25.56 66.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -169.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.34 -26.6 58.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.124 0.97 . . . . 0.0 112.538 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.2 tp -96.56 -24.03 16.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.89 0.876 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.0 t -48.7 138.03 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.47 -45.36 46.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.493 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.3 m95 57.92 3.63 0.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.212 2.605 . . . . 0.0 114.034 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.95 -17.0 19.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.226 1.41 . . . . 0.0 110.658 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -80.63 143.64 32.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.609 1.564 . . . . 0.0 107.096 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.68 111.88 8.28 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 149.01 20.98 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 119.992 1.033 . . . . 0.0 112.77 -5.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.91 121.08 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.27 108.91 16.81 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.512 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 pt -90.36 -5.4 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.5 161.91 33.59 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -92.88 123.92 36.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -84.35 111.44 19.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 101.955 -3.35 . . . . 0.0 101.955 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.22 139.21 53.52 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.529 1.513 . . . . 0.0 113.162 -173.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.55 124.83 52.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 169.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -104.68 143.44 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.46 131.01 56.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.5 110.34 19.71 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.79 137.57 40.84 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 124.634 1.209 . . . . 0.0 109.422 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -93.35 127.14 38.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.6 112.09 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.2 t -81.25 -37.78 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 p -91.05 -115.3 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.158 0.583 . . . . 0.0 110.889 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.08 175.63 39.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.386 0.994 . . . . 0.0 111.021 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.69 -31.39 57.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.471 1.109 . . . . 0.0 112.321 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.78 65.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -109.66 -22.14 12.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.484 1.114 . . . . 0.0 111.104 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.38 143.24 12.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.0 1.32 . . . . 0.0 107.878 169.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -149.35 78.97 1.39 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.437 0.695 . . . . 0.0 109.404 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 mtt -68.58 16.49 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -116.34 22.97 12.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.438 1.472 . . . . 0.0 111.763 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -38.16 86.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.085 2.154 . . . . 0.0 112.096 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -3.43 50.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.444 1.097 . . . . 0.0 113.802 -169.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.65 -38.69 0.32 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.945 2.498 . . . . 0.0 113.726 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.8 p -126.04 73.01 71.08 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.532 1.933 . . . . 0.0 106.384 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -77.5 -167.41 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.89 3.06 . . . . 0.0 111.121 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.2 -11.32 14.91 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.241 -1.362 . . . . 0.0 112.49 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -135.24 148.41 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 121.703 2.047 . . . . 0.0 114.551 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -116.6 109.31 17.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.457 2.703 . . . . 0.0 103.943 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.13 148.64 32.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.563 1.078 . . . . 0.0 113.928 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -140.67 -119.62 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 0.0 111.333 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 150.19 38.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.134 1.773 . . . . 0.0 109.209 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -82.47 146.21 29.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.731 0.412 . . . . 0.0 110.129 -172.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.92 163.53 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.205 1.002 . . . . 0.0 110.398 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -53.01 154.25 3.02 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 111.382 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -60.81 150.99 30.94 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 64.87 -15.17 0.09 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.03 1.732 . . . . 0.0 115.027 -169.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -60.5 -43.62 93.29 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.706 2.048 . . . . 0.0 111.895 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -58.06 -34.74 98.79 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.712 1.608 . . . . 0.0 112.913 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.9 -51.99 59.75 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -68.97 -22.55 64.1 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.524 -0.735 . . . . 0.0 111.254 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -78.23 -18.32 55.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.65 161.28 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 119.631 1.105 . . . . 0.0 112.491 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.36 146.3 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.321 1.848 . . . . 0.0 112.115 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.1 m -61.83 -30.5 70.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -169.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -69.62 -31.02 68.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.607 1.094 . . . . 0.0 111.018 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -94.18 -32.09 13.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.7 0.8 . . . . 0.0 111.965 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.0 ttp-105 -48.41 -43.6 34.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.081 1.352 . . . . 0.0 113.121 -174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.3 -44.8 95.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.382 0.537 . . . . 0.0 110.867 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.9 t -73.99 -33.52 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.774 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -28.42 67.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.493 1.042 . . . . 0.0 110.437 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -42.9 98.61 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.893 -1.129 . . . . 0.0 109.725 169.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -64.95 -45.02 87.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.65 0.78 . . . . 0.0 110.089 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.7 t -51.27 -53.05 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.248 0.619 . . . . 0.0 109.485 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mtt -69.27 -41.84 76.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.438 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -51.83 -38.31 55.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.389 0.995 . . . . 0.0 111.454 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.46 -18.85 64.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.174 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.36 23.45 1.15 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.525 1.057 . . . . 0.0 113.834 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.26 78.56 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.212 -0.93 . . . . 0.0 110.663 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -60.46 -21.87 62.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.066 0.546 . . . . 0.0 111.707 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.02 -32.71 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.391 0.996 . . . . 0.0 108.373 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.9 t -72.31 -49.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.7 mmt -64.48 -29.52 70.57 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.645 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.5 m -48.82 -34.48 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.028 0.931 . . . . 0.0 112.064 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.22 -30.91 60.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.695 0.398 . . . . 0.0 110.426 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -114.37 -7.85 12.88 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 126.354 1.862 . . . . 0.0 109.004 169.609 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 C--O 1.237 0.436 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 160.42 29.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.284 1.434 . . . . 0.0 109.653 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -24.93 66.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -84.69 -33.88 23.08 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.684 -0.635 . . . . 0.0 111.136 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.03 17.24 0.91 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.323 1.44 . . . . 0.0 112.854 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -84.26 144.44 28.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.455 1.627 . . . . 0.0 109.753 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -88.73 124.08 66.38 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.12 131.4 11.89 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.278 1.985 . . . . 0.0 110.207 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -144.09 162.39 36.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.34 1.056 . . . . 0.0 111.414 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.38 143.36 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.693 2.397 . . . . 0.0 106.425 169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.01 126.46 6.32 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.58 138.86 19.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -118.93 89.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 168.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.65 138.64 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 m -126.11 123.84 39.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.93 144.07 32.17 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -66.34 -5.82 12.03 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.34 -11.59 60.54 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.928 0.786 . . . . 0.0 110.487 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.31 37.79 4.21 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 126.032 1.777 . . . . 0.0 112.426 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -138.01 157.89 45.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 108.844 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 m -100.61 161.25 3.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.5 ttt -58.07 132.38 53.33 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.381 1.472 . . . . 0.0 109.823 169.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.15 136.73 14.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.48 141.98 25.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.143 0.577 . . . . 0.0 110.118 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -71.13 140.26 50.54 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -75.39 142.75 43.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -62.18 125.73 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 109.797 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.25 14.31 71.3 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.281 -0.733 . . . . 0.0 114.387 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -148.5 131.97 16.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -87.7 48.7 1.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 111.819 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -153.37 -179.45 7.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.18 1.392 . . . . 0.0 108.906 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -108.53 155.07 21.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 108.408 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -134.9 143.19 46.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.246 0.93 . . . . 0.0 112.881 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -58.7 138.66 86.41 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.885 0.874 . . . . 0.0 109.785 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.77 145.83 81.97 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -169.65 157.84 7.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.748 1.619 . . . . 0.0 111.743 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.74 138.19 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.36 159.09 51.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.516 1.158 . . . . 0.0 111.515 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.1 mt -91.72 146.9 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 108.355 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -89.52 153.45 48.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.525 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.14 117.97 4.78 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.21 86.98 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.987 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.39 125.69 31.33 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.458 1.129 . . . . 0.0 108.333 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.74 157.63 36.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.746 1.218 . . . . 0.0 110.697 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -41.39 71.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.301 1.04 . . . . 0.0 113.244 -168.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -70.82 -47.18 60.79 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.46 -41.47 80.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.391 1.476 . . . . 0.0 110.01 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.06 81.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.696 0.68 . . . . 0.0 111.914 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -58.9 -44.94 91.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.934 0.788 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.87 -24.03 66.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.042 1.292 . . . . 0.0 113.405 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -63.75 -52.39 60.64 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.466 1.484 . . . . 0.0 108.949 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -36.16 82.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.562 0.345 . . . . 0.0 111.481 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.5 tp -57.23 -41.31 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 110.196 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.08 -45.88 46.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.288 1.035 . . . . 0.0 111.632 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.61 -36.73 79.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.799 1.181 . . . . 0.0 111.975 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.37 -47.77 7.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.126 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.55 -26.75 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.234 0.613 . . . . 0.0 111.142 -169.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.43 27.39 67.86 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.701 -0.624 . . . . 0.0 112.135 -170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.3 mt -105.05 157.63 17.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.547 1.139 . . . . 0.0 108.634 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -118.37 -174.45 2.67 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.614 1.166 . . . . 0.0 109.969 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.01 34.64 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.834 2.054 . . . . 0.0 114.343 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -159.26 -17.89 0.07 Allowed 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -87.02 -1.52 57.94 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.011 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.52 168.72 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.196 1.398 . . . . 0.0 109.203 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.12 122.48 16.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.0 mt -75.38 131.85 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 120.651 1.569 . . . . 0.0 107.497 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.58 -33.9 7.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.774 0.43 . . . . 0.0 111.671 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.28 168.09 28.41 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.016 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.2 p -146.73 159.53 43.36 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.879 1.272 . . . . 0.0 108.043 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -64.33 134.71 55.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -68.0 -18.36 64.7 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -149.06 165.89 30.35 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.307 1.443 . . . . 0.0 107.974 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -65.66 117.84 8.7 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.61 -53.85 29.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER 62.52 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 129.725 3.21 . . . . 0.0 112.775 -178.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -144.61 156.58 44.19 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.12 129.92 55.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.39 143.59 88.11 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.988 0.915 . . . . 0.0 109.257 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -66.72 154.34 74.82 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.837 2.358 . . . . 0.0 109.215 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -58.93 -31.36 68.59 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.55 -24.12 61.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.84 0.856 . . . . 0.0 112.95 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 tp -104.67 -17.2 14.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.19 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -45.68 136.86 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -72.58 -49.69 30.59 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.8 m95 58.86 3.18 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.139 2.575 . . . . 0.0 114.868 -169.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.59 -23.03 16.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.141 0.976 . . . . 0.0 111.52 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.48 158.63 18.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.338 1.855 . . . . 0.0 110.102 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -132.31 112.0 14.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 108.68 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -59.69 157.02 44.09 Favored 'Cis proline' 0 CA--C 1.537 0.668 0 CA-C-N 120.284 1.137 . . . . 0.0 110.51 -10.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.93 130.21 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.3 t -79.01 117.13 19.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.299 -1.319 . . . . 0.0 107.618 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.24 -2.12 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.283 1.433 . . . . 0.0 111.76 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 159.8 33.09 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 120.207 1.367 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -104.52 106.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.7 127.47 32.83 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 143.95 29.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.115 0.87 . . . . 0.0 111.723 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.19 135.2 55.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -108.71 147.76 31.48 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -121.29 124.96 45.88 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 tp -79.73 110.93 15.54 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.5 128.71 52.5 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.9 0.88 . . . . 0.0 109.364 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -87.72 140.82 29.13 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 168.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -70.91 136.15 48.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.29 -41.31 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.1 m -136.07 136.13 39.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.62 176.61 46.89 Favored Glycine 0 C--N 1.331 0.303 0 O-C-N 121.514 -0.741 . . . . 0.0 113.378 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 t70 61.24 -46.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.719 3.608 . . . . 0.0 114.071 -172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.18 21.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.412 1.085 . . . . 0.0 111.389 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -90.81 -23.77 20.5 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.289 0.636 . . . . 0.0 111.193 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mt -66.12 139.43 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -135.18 -37.32 0.79 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.052 0.541 . . . . 0.0 112.071 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.4 mtt 56.85 17.46 3.27 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -132.91 25.4 4.3 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.621 1.1 . . . . 0.0 111.807 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -28.75 63.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.116 1.766 . . . . 0.0 111.436 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -7.0 57.8 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.254 1.821 . . . . 0.0 113.572 -170.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 67.69 -36.68 0.3 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.304 2.642 . . . . 0.0 113.66 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 p -124.29 75.06 60.63 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.58 -174.05 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.611 2.874 . . . . 0.0 111.238 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -107.57 -8.68 16.1 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.171 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.57 152.46 50.77 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 120.59 1.541 . . . . 0.0 112.43 -172.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -121.83 -31.2 3.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.632 1.573 . . . . 0.0 112.278 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.3 11.88 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -113.23 148.4 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.944 1.298 . . . . 0.0 110.847 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -152.05 129.17 11.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.793 1.237 . . . . 0.0 108.44 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -80.38 143.29 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 165.01 9.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.199 0.6 . . . . 0.0 110.233 -169.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -47.41 140.45 5.71 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -50.0 -41.45 47.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -94.12 -11.34 30.72 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -57.24 -44.99 99.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.428 -171.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.51 -23.89 77.32 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.554 1.503 . . . . 0.0 113.807 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -38.93 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 119.041 0.837 . . . . 0.0 109.605 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -87.71 -19.2 27.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.039 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.88 -27.73 66.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 121.032 1.742 . . . . 0.0 110.224 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.59 154.84 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.89 1.276 . . . . 0.0 110.641 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.66 150.23 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.811 1.245 . . . . 0.0 110.288 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -59.13 -31.58 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -168.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -75.25 -31.1 60.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.864 1.211 . . . . 0.0 110.691 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.98 -25.61 27.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.195 -0.907 . . . . 0.0 112.294 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -48.1 -47.98 34.01 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.372 1.442 . . . . 0.0 110.992 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.78 -43.94 87.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.375 0.534 . . . . 0.0 111.067 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.3 -33.96 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.937 -0.477 . . . . 0.0 110.267 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.79 -32.71 74.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.422 1.01 . . . . 0.0 109.522 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp-105 -59.76 -34.48 73.03 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 120.67 -1.269 . . . . 0.0 111.925 170.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -61.8 -46.55 89.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.281 1.4 . . . . 0.0 109.343 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.85 -52.14 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.2 mmt -60.55 -45.01 95.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -60.07 -38.67 83.54 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.239 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.11 -21.38 64.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.209 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -120.19 -22.82 6.46 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.24 64.09 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-N 119.896 1.226 . . . . 0.0 111.427 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -66.83 -25.95 66.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.071 0.85 . . . . 0.0 111.818 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.66 -37.4 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.1 -39.13 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.417 0.687 . . . . 0.0 110.198 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.5 mmt -72.55 -26.47 61.75 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.028 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.8 m -58.07 -32.92 68.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.621 1.1 . . . . 0.0 111.464 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.32 -29.17 69.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -94.45 -40.49 9.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.692 1.197 . . . . 0.0 109.682 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.962 1.305 . . . . 0.0 111.666 -177.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.02 144.32 50.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.672 1.589 . . . . 0.0 107.937 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -47.73 -32.53 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -168.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.74 -3.63 39.14 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.38 28.36 7.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.024 1.773 . . . . 0.0 111.418 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.69 145.38 39.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.125 1.462 . . . . 0.0 110.585 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 122.26 69.03 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 116.588 -1.672 . . . . 0.0 107.194 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.68 126.37 12.63 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.846 1.697 . . . . 0.0 110.111 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -140.37 166.7 23.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.476 1.11 . . . . 0.0 110.633 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.66 148.52 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.567 2.347 . . . . 0.0 106.668 169.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.95 12.1 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -102.57 117.32 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.47 82.25 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -62.62 130.9 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.8 127.39 53.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.75 136.49 32.97 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -66.6 -5.82 12.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.107 1.363 . . . . 0.0 114.317 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -75.41 -7.64 54.59 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.184 0.902 . . . . 0.0 110.496 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 33.7 4.55 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 125.103 1.335 . . . . 0.0 112.276 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -134.29 161.25 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.858 0.863 . . . . 0.0 109.131 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.49 162.61 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.727 0.811 . . . . 0.0 113.155 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.9 tpt -51.74 131.67 30.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.097 2.159 . . . . 0.0 112.085 171.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -161.91 143.88 11.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 167.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.09 143.98 21.84 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -78.07 145.89 35.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -77.9 125.1 28.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.59 140.69 57.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.153 1.381 . . . . 0.0 109.713 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 -40.92 1.73 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.512 1.053 . . . . 0.0 113.524 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.23 -31.95 24.75 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.499 1.149 . . . . 0.0 110.616 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.47 39.44 31.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.592 1.557 . . . . 0.0 112.402 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -135.2 173.87 11.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.591 1.956 . . . . 0.0 107.163 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -80.52 160.53 25.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.603 1.092 . . . . 0.0 111.77 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -151.39 146.88 26.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.675 1.19 . . . . 0.0 109.025 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.81 136.11 51.55 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.963 0.905 . . . . 0.0 110.731 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -65.41 141.28 67.24 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.602 2.201 . . . . 0.0 111.817 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -177.92 150.76 0.64 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.067 2.547 . . . . 0.0 106.337 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.84 142.75 9.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.02 154.62 53.42 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 118.323 1.061 . . . . 0.0 111.34 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.7 127.76 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -67.47 125.55 91.32 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 117.684 -1.15 . . . . 0.0 108.841 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.67 117.97 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.92 1.747 . . . . 0.0 112.803 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.08 0.42 77.52 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.404 1.478 . . . . 0.0 112.923 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -93.82 127.71 39.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.13 160.18 31.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.536 1.135 . . . . 0.0 110.811 -177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.9 64.06 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.063 1.345 . . . . 0.0 113.146 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -71.21 -48.57 50.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.13 -38.22 79.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.536 1.534 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.8 68.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.91 1.284 . . . . 0.0 111.738 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.437 ' HG3' ' CD1' ' A' ' 100' ' ' PHE . 18.2 tmm? -60.64 -43.06 98.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.54 -32.71 74.24 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.246 -0.908 . . . . 0.0 112.213 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -60.67 -46.57 89.83 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.848 -1.157 . . . . 0.0 109.517 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.6 67.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.802 0.728 . . . . 0.0 111.705 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -61.31 -40.84 95.66 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.037 -1.04 . . . . 0.0 108.531 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.85 -55.87 6.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.575 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.6 -38.22 83.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.947 1.703 . . . . 0.0 111.225 -170.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -94.66 -37.96 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.323 0.51 . . . . 0.0 112.041 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -109.63 -20.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.267 0.627 . . . . 0.0 110.668 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.55 48.46 56.72 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.499 -1.376 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 mt -127.68 156.12 42.87 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.831 1.652 . . . . 0.0 107.817 171.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -114.07 -177.16 3.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.142 0.977 . . . . 0.0 110.285 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -73.75 38.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.273 1.829 . . . . 0.0 113.14 -170.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -157.98 -18.69 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.987 1.315 . . . . 0.0 113.202 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -86.03 -2.01 57.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.993 0.517 . . . . 0.0 112.082 -169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -149.14 168.02 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.13 -170.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -137.51 121.4 17.64 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.51 126.55 35.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.87 -32.58 7.86 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.208 0.317 . . . . 0.0 111.271 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.81 162.06 39.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.506 1.122 . . . . 0.0 108.555 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 m -139.86 157.47 45.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -58.89 137.21 57.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.146 0.885 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -61.52 -31.34 71.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.771 0.429 . . . . 0.0 111.453 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -151.65 173.07 15.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.216 1.806 . . . . 0.0 106.754 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -60.08 125.19 22.72 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 109.471 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.98 50.11 1.91 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 127.52 2.328 . . . . 0.0 107.451 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 146.46 47.67 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -169.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -145.52 142.77 29.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.641 0.588 . . . . 0.0 110.199 -170.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -100.18 133.2 44.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.601 1.16 . . . . 0.0 108.536 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.7 148.83 73.55 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 124.428 1.091 . . . . 0.0 111.016 -174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 154.42 74.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.756 2.304 . . . . 0.0 109.265 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -53.59 -31.55 47.37 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -72.04 -32.01 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.519 1.127 . . . . 0.0 111.905 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.52 -24.11 18.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.975 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -58.05 130.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.19 -43.62 41.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.094 0.557 . . . . 0.0 112.361 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 24.8 m95 59.69 4.64 0.58 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 127.382 2.273 . . . . 0.0 113.432 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.78 -21.51 15.15 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.209 1.404 . . . . 0.0 111.066 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -73.78 147.09 43.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.455 1.502 . . . . 0.0 108.651 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -134.84 116.55 12.56 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.44 149.16 31.02 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.952 1.019 . . . . 0.0 111.161 -10.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.39 131.61 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.3 106.69 18.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.0 pt -102.06 -6.14 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.002 0.921 . . . . 0.0 112.409 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.7 163.71 37.22 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 120.232 1.378 . . . . 0.0 113.172 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.5 115.67 27.81 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -85.64 120.22 26.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 101.211 -3.626 . . . . 0.0 101.211 168.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -146.38 138.03 24.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.662 1.119 . . . . 0.0 111.435 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.21 122.67 45.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -98.91 141.34 31.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.437 ' CD1' ' HG3' ' A' ' 50' ' ' MET . 58.5 m-85 -118.84 128.72 54.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 tt -82.59 121.22 26.53 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.47 122.05 46.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.667 -1.151 . . . . 0.0 107.991 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -80.85 133.89 35.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 tp -67.12 136.68 55.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -115.92 -38.15 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m -89.52 -130.5 0.08 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.486 0.714 . . . . 0.0 109.781 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.73 177.1 46.94 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 120.001 1.273 . . . . 0.0 111.914 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -52.67 -31.3 36.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.322 1.449 . . . . 0.0 112.554 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.88 -27.04 66.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -97.16 -28.28 14.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.167 0.987 . . . . 0.0 110.894 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.63 147.04 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.53 1.132 . . . . 0.0 108.025 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -127.17 -50.63 1.43 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.351 0.66 . . . . 0.0 109.684 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 mtt 63.33 -8.26 0.15 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.486 1.914 . . . . 0.0 115.179 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -109.54 24.53 12.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 121.248 1.84 . . . . 0.0 111.616 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -24.9 63.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.303 1.841 . . . . 0.0 112.19 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -6.69 59.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.981 1.713 . . . . 0.0 113.901 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.2 m 68.86 -34.02 0.26 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.387 2.675 . . . . 0.0 114.111 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.11 71.65 63.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.64 -170.21 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.525 2.816 . . . . 0.0 113.561 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -110.53 -42.56 4.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.252 1.021 . . . . 0.0 109.749 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.66 152.47 28.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.521 1.055 . . . . 0.0 113.568 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.16 14.36 13.96 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.473 1.509 . . . . 0.0 112.168 171.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.61 171.44 46.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.01 1.29 . . . . 0.0 113.348 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -164.65 -116.43 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.82 1.248 . . . . 0.0 109.741 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.8 mtp85 -145.81 160.81 41.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.267 3.027 . . . . 0.0 107.51 -170.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -85.77 132.95 34.03 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.51 168.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 110.793 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.4 m -52.7 147.24 8.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.729 0.695 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -52.46 -40.66 62.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -168.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -95.32 -3.73 46.78 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.71 -43.19 82.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.495 1.043 . . . . 0.0 111.765 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.2 -26.41 82.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.535 1.584 . . . . 0.0 113.085 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -12.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 O-C-N 121.435 -0.791 . . . . 0.0 111.374 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -35.73 7.66 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.808 1.186 . . . . 0.0 109.284 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -68.52 -26.54 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.733 1.151 . . . . 0.0 112.297 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.08 159.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 118.885 0.766 . . . . 0.0 110.459 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.3 149.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.574 0.75 . . . . 0.0 111.43 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 m -51.09 -39.01 55.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.035 1.734 . . . . 0.0 114.064 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.37 -40.3 58.22 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.735 0.698 . . . . 0.0 110.222 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -66.53 -32.76 74.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.212 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -44.97 -48.83 11.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.705 1.139 . . . . 0.0 110.789 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.94 -34.74 78.82 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.73 -38.42 19.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.948 -0.47 . . . . 0.0 109.955 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -33.18 75.41 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.961 -0.462 . . . . 0.0 109.837 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -56.22 -40.3 73.85 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.314 -1.327 . . . . 0.0 110.967 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.07 -45.02 90.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.838 1.654 . . . . 0.0 109.155 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.69 -41.68 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.8 mtt -72.0 -39.54 69.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.542 -0.724 . . . . 0.0 110.658 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.69 -37.13 86.18 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.45 -28.34 66.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.093 0.957 . . . . 0.0 111.466 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -122.98 2.68 9.36 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.67 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.414 1.461 . . . . 0.0 111.576 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 p -66.01 -23.03 66.49 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 t -69.39 -39.91 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.69 1.132 . . . . 0.0 108.841 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.02 -44.2 28.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mtt -66.08 -32.77 74.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.568 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.1 m -61.16 -22.13 64.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.521 1.055 . . . . 0.0 112.761 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.25 -21.57 39.35 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 111.546 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -109.53 -37.67 5.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.613 1.165 . . . . 0.0 109.93 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 126.733 2.013 . . . . 0.0 109.486 171.514 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.25 -44.88 71.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.132 0.573 . . . . 0.0 111.833 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -152.05 -80.73 0.1 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.69 0.796 . . . . 0.0 110.83 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.76 -47.48 8.6 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.06 12.64 0.05 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.644 -0.531 . . . . 0.0 114.123 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -96.72 130.67 43.92 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.498 1.149 . . . . 0.0 108.655 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -88.02 127.51 57.33 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.62 135.98 24.95 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.719 1.612 . . . . 0.0 109.92 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -140.65 153.47 46.02 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.709 1.604 . . . . 0.0 111.446 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.69 135.16 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.909 2.084 . . . . 0.0 105.533 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.69 125.92 6.69 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mm -95.49 110.33 24.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.59 86.14 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.68 129.97 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.2 t -106.22 135.3 47.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.81 25.66 4.53 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 54.42 -2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.251 2.22 . . . . 0.0 116.726 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -95.58 14.8 21.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.043 0.838 . . . . 0.0 111.697 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.6 9.48 84.65 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 124.564 1.078 . . . . 0.0 113.112 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -125.45 172.9 9.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.441 1.12 . . . . 0.0 108.875 -169.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.18 170.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.3 tpt -53.13 136.22 36.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.5 2.32 . . . . 0.0 113.72 -170.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -163.1 135.6 5.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.813 1.245 . . . . 0.0 108.166 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.82 158.23 40.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.401 1.48 . . . . 0.0 109.104 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -93.05 130.79 38.53 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -78.92 123.35 27.18 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.887 0.875 . . . . 0.0 109.173 -169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -53.75 134.16 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.267 2.227 . . . . 0.0 110.222 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 -16.88 1.92 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.939 1.257 . . . . 0.0 114.773 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -105.75 -30.8 9.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 110.33 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 58.87 39.65 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.76 1.624 . . . . 0.0 112.791 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 p -140.53 171.29 14.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.712 1.605 . . . . 0.0 108.298 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -79.24 157.59 27.76 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.01 157.29 19.08 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.186 2.194 . . . . 0.0 113.742 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.83 96.47 5.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 168.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 146.25 89.69 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.307 1.338 . . . . 0.0 111.695 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 156.5 149.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.628 3.171 . . . . 0.0 108.231 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.03 143.87 14.64 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.61 144.34 35.35 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.7 mt -73.53 141.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.87 141.53 38.18 Favored Pre-proline 0 N--CA 1.465 0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.368 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -59.34 116.31 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.088 1.859 . . . . 0.0 111.971 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.43 2.39 87.42 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.056 1.312 . . . . 0.0 112.916 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -86.21 128.26 34.87 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.515 1.158 . . . . 0.0 107.996 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.52 157.42 38.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.488 1.115 . . . . 0.0 110.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.8 63.71 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.364 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 1.5 mp0 -64.12 -49.49 71.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -57.47 -36.22 71.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.169 1.388 . . . . 0.0 109.608 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.24 -35.17 66.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.645 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 47' ' ' GLU . 30.6 mtp -56.54 -47.22 79.87 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.369 1.44 . . . . 0.0 109.189 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.76 -26.57 67.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -65.87 -53.07 44.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.843 0.747 . . . . 0.0 109.549 170.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.63 82.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.113 0.87 . . . . 0.0 111.474 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 tp -56.33 -41.78 76.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.528 1.531 . . . . 0.0 110.345 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -44.13 56.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.57 1.148 . . . . 0.0 111.105 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.46 -37.79 83.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.291 0.95 . . . . 0.0 111.826 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.03 -75.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.017 0.927 . . . . 0.0 109.987 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.84 -6.59 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.76 49.78 61.97 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 mt -120.34 156.94 30.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.647 1.579 . . . . 0.0 107.111 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.5 m -112.68 173.63 6.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.158 0.983 . . . . 0.0 109.444 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.97 43.42 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.104 2.162 . . . . 0.0 114.508 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.66 -18.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.102 1.761 . . . . 0.0 112.171 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -88.99 -0.07 57.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.842 0.857 . . . . 0.0 111.71 -172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.37 169.96 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.862 1.265 . . . . 0.0 109.365 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -142.3 129.16 20.6 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 mt -81.34 127.85 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.124 1.329 . . . . 0.0 108.719 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.9 -35.37 6.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.716 0.807 . . . . 0.0 111.898 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.24 165.88 35.07 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.689 0.795 . . . . 0.0 109.848 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.5 p -144.92 160.06 41.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.251 1.02 . . . . 0.0 109.511 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 p -64.94 137.18 57.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -64.75 -25.27 67.85 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -151.16 170.21 19.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.971 1.309 . . . . 0.0 108.667 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -65.99 123.56 20.18 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.227 0.611 . . . . 0.0 109.467 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.43 167.8 19.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.62 154.67 33.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -139.26 162.94 33.77 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -103.82 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.3 mt -69.12 140.59 90.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 151.88 64.65 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.319 2.679 . . . . 0.0 109.294 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -65.5 -21.05 66.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.67 -27.83 61.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.954 0.901 . . . . 0.0 112.332 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.7 tp -94.46 -26.25 16.55 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.614 0.766 . . . . 0.0 110.929 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.35 136.8 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -42.47 42.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.523 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m95 61.81 3.38 0.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.164 2.185 . . . . 0.0 113.718 -169.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -16.69 18.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.245 1.418 . . . . 0.0 111.028 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -76.94 144.26 38.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.983 1.713 . . . . 0.0 107.259 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.79 116.41 9.0 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.468 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.31 150.96 22.04 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.105 1.073 . . . . 0.0 111.927 -10.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 m -57.72 129.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.8 t -88.82 107.37 18.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -111.65 -5.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.6 1.16 . . . . 0.0 112.257 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 168.76 41.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.128 0.876 . . . . 0.0 112.188 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -103.76 107.88 18.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -71.76 121.54 19.09 Favored 'General case' 0 N--CA 1.471 0.617 1 N-CA-C 100.185 -4.006 . . . . 0.0 100.185 167.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.89 132.9 33.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.621 1.555 . . . . 0.0 112.783 -168.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -112.37 128.11 56.2 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -104.25 147.14 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.68 130.05 48.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.2 tp -77.84 111.61 13.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.24 126.99 52.9 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -82.58 134.98 35.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.69 104.65 4.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.87 -33.9 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.8 p -83.6 -119.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.821 0.448 . . . . 0.0 109.848 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.8 174.37 42.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.998 1.285 . . . . 0.0 110.675 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -28.9 15.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.686 1.194 . . . . 0.0 113.012 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.423 0.556 . . . . 0.0 112.082 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.61 -22.04 13.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.551 1.141 . . . . 0.0 111.691 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.6 mt -62.38 102.99 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -92.47 -30.88 15.49 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.168 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.0 mtt 60.84 -44.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 130.093 3.357 . . . . 0.0 114.784 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.27 34.46 1.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.352 1.861 . . . . 0.0 110.469 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -71.21 -49.5 42.84 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -68.55 148.82 49.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -75.72 -27.06 58.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.936 1.695 . . . . 0.0 112.228 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 p -120.74 69.73 17.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.675 1.99 . . . . 0.0 106.58 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.62 -174.67 1.94 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.273 3.315 . . . . 0.0 111.292 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -116.2 -18.24 10.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.386 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.14 150.18 52.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 121.935 2.152 . . . . 0.0 112.067 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.08 -28.9 4.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.708 1.203 . . . . 0.0 112.492 -170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.44 150.41 20.02 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -96.73 156.88 16.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.945 1.298 . . . . 0.0 110.194 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -153.01 103.54 2.75 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -71.57 133.37 45.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.052 1.296 . . . . 0.0 108.658 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 153.8 27.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.909 1.284 . . . . 0.0 108.15 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.5 m -58.48 158.54 7.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.62 0.768 . . . . 0.0 112.672 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.18 151.02 13.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.2 m95 67.1 -23.41 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.171 1.788 . . . . 0.0 115.561 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.0 -47.56 95.08 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 121.059 1.754 . . . . 0.0 111.259 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.82 -32.92 86.58 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.875 1.717 . . . . 0.0 113.234 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.95 -33.02 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.512 0.725 . . . . 0.0 110.35 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -85.92 -26.63 25.45 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.166 0.894 . . . . 0.0 111.744 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -80.53 -27.6 37.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.773 0.715 . . . . 0.0 112.191 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.55 158.78 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.164 0.893 . . . . 0.0 110.097 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.29 148.51 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.215 1.006 . . . . 0.0 111.466 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 m -57.6 -35.67 70.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.956 1.302 . . . . 0.0 113.767 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -71.88 -25.41 61.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.178 0.899 . . . . 0.0 111.635 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -86.75 -40.82 14.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.775 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.27 -51.66 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 112.977 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -66.3 -33.07 74.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.463 0.574 . . . . 0.0 112.397 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.83 -35.24 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.349 0.66 . . . . 0.0 110.193 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.34 -31.98 73.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.532 1.06 . . . . 0.0 110.608 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -55.84 -40.87 73.44 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.368 -0.832 . . . . 0.0 110.559 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -64.36 -45.26 88.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 109.504 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.71 -47.19 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 mtt -66.32 -38.13 86.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.956 -0.465 . . . . 0.0 110.744 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.17 -37.9 89.05 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.021 -1.049 . . . . 0.0 110.286 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.11 -29.81 70.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 111.238 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -115.64 -13.97 11.47 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.79 39.84 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.322 1.419 . . . . 0.0 111.702 -169.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.4 m -64.02 -24.5 67.73 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.022 -0.424 . . . . 0.0 111.612 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.11 -40.95 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -68.63 -45.46 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.486 0.714 . . . . 0.0 110.238 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -71.04 -20.35 62.39 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.039 0.836 . . . . 0.0 111.491 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -59.48 -30.55 68.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.461 1.028 . . . . 0.0 111.824 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.45 -41.1 85.27 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.22 -29.83 22.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.928 -173.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.006 1.322 . . . . 0.0 111.441 178.219 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 mm . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.26 140.03 50.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.276 1.43 . . . . 0.0 108.198 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -31.94 -49.95 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.754 2.422 . . . . 0.0 116.577 -168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -83.97 8.67 14.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.46 35.04 4.24 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.386 1.47 . . . . 0.0 112.258 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -115.61 143.76 44.88 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.613 1.206 . . . . 0.0 112.295 -171.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -82.85 115.86 60.92 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-O 117.435 -1.269 . . . . 0.0 107.817 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 125.29 7.13 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.119 1.88 . . . . 0.0 109.808 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.17 174.35 15.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.374 1.069 . . . . 0.0 109.919 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.4 m -119.94 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.92 9.04 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.33 128.01 38.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.085 0.943 . . . . 0.0 108.746 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.94 88.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.9 mm -67.57 137.21 25.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 168.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -125.57 120.21 30.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -78.14 138.9 38.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -65.22 -7.09 11.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.42 -11.27 60.61 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.125 0.875 . . . . 0.0 110.516 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.67 34.83 4.54 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.378 1.942 . . . . 0.0 112.225 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -131.9 148.01 52.51 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 m -104.98 162.89 4.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.9 tpt -56.39 130.06 43.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.097 1.759 . . . . 0.0 110.376 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -161.73 127.42 3.62 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.33 144.3 32.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -73.06 135.9 44.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -77.61 128.64 34.46 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.96 128.57 16.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.912 2.085 . . . . 0.0 110.44 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.32 -33.19 1.55 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.191 1.376 . . . . 0.0 114.067 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -37.14 21.92 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.415 1.108 . . . . 0.0 109.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.259 14.8 m170 59.21 33.12 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.657 1.583 . . . . 0.0 113.096 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -139.12 162.98 33.62 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.356 2.262 . . . . 0.0 105.805 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -74.19 164.86 26.1 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.405 1.002 . . . . 0.0 113.203 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -151.44 142.8 23.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.641 1.576 . . . . 0.0 108.474 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -73.14 144.94 85.35 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.587 0.755 . . . . 0.0 110.017 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.66 144.73 97.65 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.371 1.381 . . . . 0.0 112.435 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -172.79 138.09 0.8 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.518 2.327 . . . . 0.0 108.505 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.41 -114.09 3.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.272 0.939 . . . . 0.0 110.969 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.81 165.11 35.05 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 128.006 2.717 . . . . 0.0 107.443 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.89 135.08 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -84.44 158.23 60.66 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 119.011 -0.518 . . . . 0.0 109.855 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.7 117.21 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.817 1.678 . . . . 0.0 112.275 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.16 9.24 85.58 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.839 1.209 . . . . 0.0 112.909 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.05 125.19 29.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.361 1.08 . . . . 0.0 108.717 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 159.58 34.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.472 1.109 . . . . 0.0 110.815 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.68 68.76 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.703 1.201 . . . . 0.0 113.436 -169.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.17 -43.42 64.61 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.79 -44.21 97.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.493 1.117 . . . . 0.0 108.886 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.73 71.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.417 1.087 . . . . 0.0 112.292 172.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -65.98 -43.09 88.84 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.211 0.914 . . . . 0.0 109.739 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -65.55 -25.48 67.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.211 1.369 . . . . 0.0 111.727 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.96 -49.61 64.89 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 120.063 1.301 . . . . 0.0 108.64 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.69 83.18 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.82 0.819 . . . . 0.0 110.239 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.45 -40.93 88.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.204 1.401 . . . . 0.0 109.646 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.17 -47.72 55.99 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.17 0.988 . . . . 0.0 111.196 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.44 -35.33 80.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.894 1.679 . . . . 0.0 112.053 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.32 -39.6 9.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.722 0.809 . . . . 0.0 110.422 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -17.35 7.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 111.01 -169.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.08 43.42 99.45 Favored Glycine 0 N--CA 1.451 -0.31 0 O-C-N 120.567 -1.333 . . . . 0.0 110.918 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -117.28 159.32 22.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.638 1.175 . . . . 0.0 108.183 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -122.36 -177.49 3.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.823 1.249 . . . . 0.0 110.271 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -67.93 40.42 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.177 2.591 . . . . 0.0 114.694 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -164.68 -22.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.343 1.057 . . . . 0.0 112.655 -169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.99 -3.92 58.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.446 0.698 . . . . 0.0 112.298 -169.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.4 168.97 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.921 1.288 . . . . 0.0 109.72 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -135.74 119.48 17.22 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 mt -75.76 131.79 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 120.069 1.304 . . . . 0.0 107.738 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.63 -50.72 3.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.262 0.483 . . . . 0.0 110.24 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.39 168.36 20.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.774 0.83 . . . . 0.0 110.618 -170.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.0 p -150.81 161.23 43.06 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.136 1.375 . . . . 0.0 108.23 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -62.49 146.29 52.03 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.936 0.789 . . . . 0.0 109.991 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.6 mtt-85 -64.62 -30.18 71.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.044 0.538 . . . . 0.0 111.523 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.56 172.18 13.96 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.691 1.596 . . . . 0.0 107.546 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -61.11 125.19 22.82 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.63 147.39 39.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -118.71 123.73 45.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.85 126.01 48.65 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.064 -0.969 . . . . 0.0 108.528 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -102.42 112.47 25.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.39 148.9 98.2 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.359 1.063 . . . . 0.0 110.738 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -66.96 151.57 81.9 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 108.333 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -25.25 66.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -74.81 -26.39 59.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.217 1.007 . . . . 0.0 112.432 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.05 -21.12 16.36 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.765 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.4 t -46.59 140.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 168.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -73.82 -44.88 54.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.8 m95 57.17 8.74 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.215 2.206 . . . . 0.0 114.719 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -120.84 -16.62 8.11 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.184 0.994 . . . . 0.0 112.649 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 p -75.08 -36.2 61.78 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 49.32 93.36 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 127.654 2.382 . . . . 0.0 112.271 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.54 147.68 73.09 Favored 'Cis proline' 0 C--N 1.352 0.728 0 CA-C-N 119.774 0.955 . . . . 0.0 111.315 6.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.53 129.36 27.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.1 t -91.87 112.56 24.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.57 -5.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 124.529 1.132 . . . . 0.0 111.808 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.64 43.06 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.818 1.19 . . . . 0.0 115.217 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -106.46 126.75 52.64 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 124.817 1.247 . . . . 0.0 107.739 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -91.64 116.22 28.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.53 108.86 6.12 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.606 0.567 . . . . 0.0 111.208 -168.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -93.44 128.96 39.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 168.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -95.72 135.28 37.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.47 128.43 56.33 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -87.84 109.79 20.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.96 124.45 50.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.229 1.012 . . . . 0.0 109.899 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.19 131.66 34.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.88 135.69 51.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.44 -28.14 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.0 p -88.21 -126.81 0.05 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.211 1.004 . . . . 0.0 110.411 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.93 166.48 35.54 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.21 1.386 . . . . 0.0 110.026 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.24 -30.88 18.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.493 1.117 . . . . 0.0 112.773 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.48 65.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.079 0.552 . . . . 0.0 112.295 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -95.96 -31.83 12.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.775 1.23 . . . . 0.0 110.726 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.38 142.63 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.207 1.403 . . . . 0.0 108.177 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.59 -51.33 1.84 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.7 mtt 63.71 -18.42 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.42 1.888 . . . . 0.0 115.337 -171.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.36 25.33 7.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.836 2.107 . . . . 0.0 112.042 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -35.33 77.13 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.935 2.494 . . . . 0.0 111.698 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -3.58 55.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 113.471 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 m 65.98 -35.98 0.23 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.95 2.5 . . . . 0.0 114.126 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 p -125.95 68.15 62.86 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.739 2.016 . . . . 0.0 106.287 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.19 -172.59 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.017 3.145 . . . . 0.0 111.507 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.43 -17.84 13.89 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.306 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -129.25 146.47 51.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 121.915 2.143 . . . . 0.0 111.842 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.42 -49.04 3.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.382 0.673 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.51 153.25 6.22 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 123.38 0.514 . . . . 0.0 111.836 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 30.6 t-105 -156.41 -130.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.802 1.241 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -152.94 155.22 36.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.806 2.842 . . . . 0.0 106.942 -169.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.4 143.15 37.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 0.85 . . . . 0.0 110.285 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.5 164.76 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.039 0.936 . . . . 0.0 110.52 -169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.25 147.98 5.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.735 0.814 . . . . 0.0 110.011 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -54.14 -40.73 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -93.14 2.76 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.64 -47.82 75.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 120.767 -1.208 . . . . 0.0 111.126 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -64.97 -32.77 53.57 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.913 1.719 . . . . 0.0 112.886 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.65 -33.4 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 119.784 1.174 . . . . 0.0 109.931 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.43 -41.95 75.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.835 1.198 . . . . 0.0 110.063 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -83.83 -18.77 36.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.21 160.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.601 1.091 . . . . 0.0 109.714 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.4 m -51.69 143.59 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.649 1.18 . . . . 0.0 111.576 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.8 m -59.89 -30.97 69.37 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -69.96 -47.18 63.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.144 0.884 . . . . 0.0 109.696 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -75.84 -27.41 57.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.553 -174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -40.2 -49.27 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.556 1.142 . . . . 0.0 112.887 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.88 -38.56 91.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.47 0.577 . . . . 0.0 111.797 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.13 -34.31 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 O-C-N 121.751 -0.593 . . . . 0.0 110.009 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -31.34 72.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.132 0.878 . . . . 0.0 109.97 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -55.65 -36.67 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.231 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -61.67 -51.2 69.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.907 1.23 . . . . 0.0 108.764 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -54.78 -48.05 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.2 mtt -69.53 -41.12 76.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.229 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -58.86 -41.54 87.27 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.953 0.797 . . . . 0.0 110.128 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.63 -33.6 74.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.764 0.426 . . . . 0.0 110.85 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -98.35 -9.43 25.34 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.82 -57.97 7.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.695 1.134 . . . . 0.0 112.036 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.149 -0.345 . . . . 0.0 111.538 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.9 t -73.95 -39.67 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.52 -54.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -62.78 -26.27 68.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.53 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.5 m -57.73 -31.24 66.24 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.267 1.394 . . . . 0.0 111.848 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.23 -27.2 66.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.547 0.739 . . . . 0.0 110.946 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -96.98 -32.07 12.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.82 0.848 . . . . 0.0 110.976 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 124.376 1.071 . . . . 0.0 110.806 -179.809 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -124.18 166.48 15.75 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.477 2.311 . . . . 0.0 108.77 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 42.38 47.5 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.799 2.039 . . . . 0.0 114.517 170.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.34 18.71 8.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.741 2.016 . . . . 0.0 114.267 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.72 -1.14 0.1 OUTLIER Glycine 0 C--N 1.34 0.756 0 N-CA-C 116.611 1.405 . . . . 0.0 116.611 169.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.68 130.43 37.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 120.763 2.282 . . . . 0.0 110.531 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -78.9 115.53 52.95 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.325 -1.321 . . . . 0.0 108.387 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.4 118.02 5.02 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.545 2.163 . . . . 0.0 107.941 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.83 167.86 21.59 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.688 0.795 . . . . 0.0 109.442 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.36 135.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.38 8.29 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.45 105.87 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.59 83.93 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.493 -2.039 . . . . 0.0 105.493 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.11 131.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -122.38 129.02 51.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.75 140.85 30.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -63.04 -0.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 115.101 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -81.36 0.42 37.38 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.999 0.818 . . . . 0.0 109.579 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.55 28.04 37.09 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 124.846 1.213 . . . . 0.0 112.11 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -122.09 154.9 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -113.94 163.02 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -168.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.6 tpt -50.87 130.58 25.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.008 2.123 . . . . 0.0 111.777 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 5.3 t-105 -163.73 124.16 2.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 169.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.56 142.74 45.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.857 1.313 . . . . 0.0 112.972 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.1 ttp85 -78.43 140.65 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.754 2.421 . . . . 0.0 107.902 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -88.0 151.27 22.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.135 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.24 156.62 24.91 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.439 1.495 . . . . 0.0 112.163 171.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.9 25.32 30.1 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.376 0.989 . . . . 0.0 110.88 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -10.0 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 131.294 3.837 . . . . 0.0 117.198 -167.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -151.35 6.64 0.49 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.181 168.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -154.68 147.66 24.61 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 109.058 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -121.08 131.87 54.53 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.18 -176.34 4.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.171 0.988 . . . . 0.0 111.665 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.69 156.64 52.31 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.95 2.1 . . . . 0.0 109.433 -170.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.94 155.11 71.11 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.595 2.864 . . . . 0.0 113.919 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 71.08 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.672 3.589 . . . . 0.0 105.716 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 121.63 7.29 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.481 1.038 . . . . 0.0 114.525 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.89 145.78 14.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.929 2.204 . . . . 0.0 113.445 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.96 136.45 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.632 1.173 . . . . 0.0 108.437 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -77.88 138.61 61.63 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 117.601 -1.19 . . . . 0.0 109.251 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.44 118.76 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.711 1.607 . . . . 0.0 112.678 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.56 89.79 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.109 176.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.95 129.32 35.28 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.08 159.6 34.42 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 124.685 1.194 . . . . 0.0 110.645 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -41.75 66.47 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.492 1.117 . . . . 0.0 113.841 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.76 -47.34 54.35 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.07 -40.61 85.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.149 1.38 . . . . 0.0 109.405 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.93 -27.89 62.12 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.0 1.32 . . . . 0.0 111.593 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.8 -40.85 95.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 79.0 m-85 -68.19 -30.4 69.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.217 -1.552 . . . . 0.0 112.838 172.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.829 -1.169 . . . . 0.0 109.954 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.5 -29.33 65.82 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.663 0.665 . . . . 0.0 112.134 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.84 -41.7 97.77 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.626 -1.296 . . . . 0.0 108.604 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 115' ' ' THR . 7.1 t80 -66.01 -53.75 34.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.327 172.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.62 -28.33 68.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.336 1.426 . . . . 0.0 113.378 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -115.14 -12.08 11.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.26 0.936 . . . . 0.0 113.278 -168.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.97 -20.45 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.092 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.66 55.24 31.64 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.35 -1.469 . . . . 0.0 110.126 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.2 159.51 41.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.499 1.92 . . . . 0.0 106.775 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 m -117.34 -177.18 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.502 1.121 . . . . 0.0 110.458 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 14.6 mtt180 -70.9 36.33 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.369 2.268 . . . . 0.0 113.578 -171.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.52 -19.83 0.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.965 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -83.39 -5.19 59.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 112.525 -169.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.66 167.63 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.583 1.153 . . . . 0.0 109.468 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -136.19 120.18 17.58 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.674 1.99 . . . . 0.0 105.926 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.99 128.92 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.07 -35.85 7.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.16 0.584 . . . . 0.0 111.215 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.16 163.8 39.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.218 1.007 . . . . 0.0 108.756 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -146.09 156.22 43.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 108.1 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 p -63.72 150.55 44.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.013 0.824 . . . . 0.0 109.991 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -70.29 -31.99 69.58 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.041 -0.412 . . . . 0.0 111.49 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.31 176.66 10.36 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.656 1.982 . . . . 0.0 108.077 172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -66.62 117.39 8.72 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.236 0.614 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.78 151.34 46.76 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -145.32 134.01 22.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -149.82 158.52 44.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -95.75 153.61 17.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.285 0.564 . . . . 0.0 111.308 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.25 148.16 46.64 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.05 153.4 67.62 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.37 2.713 . . . . 0.0 109.414 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.39 -20.36 66.34 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.33 -27.41 61.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 tp -94.9 -27.59 15.62 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.061 0.944 . . . . 0.0 110.572 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -56.0 134.04 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -41.28 41.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.6 m95 60.95 5.79 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.88 2.072 . . . . 0.0 113.685 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.81 -19.92 14.11 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.889 1.275 . . . . 0.0 111.837 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -76.6 153.4 35.35 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.979 1.711 . . . . 0.0 108.771 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.66 113.84 9.35 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.027 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -53.91 147.57 16.26 Favored 'Cis proline' 0 CA--C 1.538 0.717 0 CA-C-N 120.199 1.107 . . . . 0.0 111.845 -10.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.32 129.37 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.8 t -80.37 97.98 7.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.2 pt -88.08 -15.98 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.374 1.469 . . . . 0.0 111.865 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 172.78 45.03 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 120.662 1.574 . . . . 0.0 113.028 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -105.87 129.62 54.0 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -97.2 113.91 25.56 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.45 127.54 35.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -103.52 129.52 50.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -103.57 133.6 48.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.99 129.2 55.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.7 tp -83.7 113.84 21.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.48 121.64 44.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 123.749 0.82 . . . . 0.0 109.619 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -83.56 137.19 33.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.05 139.51 58.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.363 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.54 -25.0 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.515 1.126 . . . . 0.0 108.013 169.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.3 p -119.57 -61.82 1.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 110.381 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.4 -147.29 28.31 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -43.64 -36.44 2.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.476 1.91 . . . . 0.0 113.56 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.98 66.98 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -123.33 -16.39 6.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.352 1.461 . . . . 0.0 112.431 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.48 143.89 9.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -134.06 -48.02 0.79 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.043 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.0 mtt 58.86 -1.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.38 23.98 8.83 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.774 2.079 . . . . 0.0 111.262 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.403 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -55.79 -35.64 66.51 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.023 2.529 . . . . 0.0 111.374 169.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.81 3.9 15.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.013 1.725 . . . . 0.0 112.717 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 70.15 -42.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 129.485 3.114 . . . . 0.0 114.483 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.5 p -133.51 34.67 0.26 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 113.914 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.77 160.99 40.09 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.746 1.659 . . . . 0.0 110.461 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.768 1.627 . . . . 0.0 113.609 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.05 144.46 42.99 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.398 0.618 . . . . 0.0 112.657 -168.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 -6.68 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.327 1.051 . . . . 0.0 113.62 -171.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.61 162.84 35.38 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -138.5 149.87 45.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.89 0.845 . . . . 0.0 111.417 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -150.55 128.07 11.49 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.815 1.646 . . . . 0.0 107.134 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -82.0 138.32 34.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.67 167.93 23.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.598 1.159 . . . . 0.0 110.459 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -49.03 144.74 4.52 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.198 0.999 . . . . 0.0 109.601 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -53.89 -36.91 63.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -94.17 -3.66 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.79 -45.8 96.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.011 -1.471 . . . . 0.0 111.974 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.11 -36.32 99.17 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.947 1.731 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -40.01 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -76.68 -29.38 56.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.822 1.192 . . . . 0.0 111.577 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.43 -28.09 46.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.02 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.45 156.04 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.547 1.067 . . . . 0.0 110.947 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.16 148.05 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.46 1.504 . . . . 0.0 111.88 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -58.75 -34.95 71.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.834 1.254 . . . . 0.0 113.911 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -71.36 -25.94 62.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.032 0.833 . . . . 0.0 111.437 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.67 -38.07 15.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.117 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -47.78 -47.48 30.76 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.082 1.31 . . . . 0.0 112.972 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.66 -35.79 81.01 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.383 0.538 . . . . 0.0 112.032 -174.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.64 -35.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.37 0.668 . . . . 0.0 110.596 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.91 -31.9 73.35 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.989 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -56.65 -37.32 70.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.119 169.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.63 -47.4 81.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.091 1.314 . . . . 0.0 108.886 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.22 -50.6 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.722 0.809 . . . . 0.0 109.307 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.8 mtt -65.69 -40.72 92.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.099 -0.477 . . . . 0.0 111.251 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -58.79 -39.77 82.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.444 1.098 . . . . 0.0 110.547 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.9 -23.26 62.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.704 0.402 . . . . 0.0 111.25 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -107.53 -9.6 15.89 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.28 16.98 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.473 1.033 . . . . 0.0 111.542 -169.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -62.81 -25.28 68.17 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.126 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.43 -43.52 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.59 -36.48 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -69.42 -35.81 76.08 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.835 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -59.58 -31.5 69.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.737 1.153 . . . . 0.0 112.031 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.25 -25.17 67.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.152 0.581 . . . . 0.0 111.361 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -104.65 -32.37 8.94 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.166 0.986 . . . . 0.0 110.987 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 124.503 1.121 . . . . 0.0 111.262 -176.628 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.83 -44.31 49.91 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.522 1.129 . . . . 0.0 111.306 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.8 -77.78 0.12 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.904 0.882 . . . . 0.0 111.138 170.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.55 -48.92 7.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.39 6.15 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.316 0.887 . . . . 0.0 115.316 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -96.93 134.33 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.35 1.575 . . . . 0.0 109.902 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -86.38 127.16 62.18 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.776 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.84 130.84 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.397 2.065 . . . . 0.0 108.624 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.48 177.2 11.74 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -130.59 135.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.71 136.23 12.86 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.48 142.23 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 118.94 1.37 . . . . 0.0 107.805 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.42 89.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -66.89 136.46 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -124.45 118.21 26.14 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -74.01 141.88 45.79 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -68.16 -9.66 48.37 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.07 -10.19 59.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.79 0.723 . . . . 0.0 111.328 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.13 39.2 3.35 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 125.926 1.727 . . . . 0.0 112.434 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -136.35 150.91 49.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.65 161.72 4.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.885 0.874 . . . . 0.0 112.68 -169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 128.51 36.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.006 1.322 . . . . 0.0 109.325 170.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.427 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 2.6 t-105 -160.23 128.81 4.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 168.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.1 148.45 41.74 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -69.08 140.68 54.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -77.77 119.86 21.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -44.61 126.33 5.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.544 1.938 . . . . 0.0 110.583 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.65 -2.05 25.75 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.532 1.063 . . . . 0.0 115.259 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -126.93 -24.72 3.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.032 1.416 . . . . 0.0 111.454 -172.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.66 14.29 8.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.284 1.833 . . . . 0.0 115.198 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.2 p -104.45 -143.18 0.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.98 1.312 . . . . 0.0 107.647 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.427 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 62.7 m95 -127.96 168.16 15.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.098 1.317 . . . . 0.0 109.946 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -152.44 150.77 30.0 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.147 0.979 . . . . 0.0 109.42 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -81.6 139.92 47.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.943 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.68 137.83 75.81 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.657 1.571 . . . . 0.0 111.642 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -157.55 147.83 20.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.729 1.212 . . . . 0.0 111.101 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.13 -126.38 5.56 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.523 1.059 . . . . 0.0 112.156 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.51 118.48 0.45 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.62 125.58 39.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -75.46 155.18 85.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.13 116.72 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.638 1.559 . . . . 0.0 111.039 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.25 7.75 87.3 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.079 1.323 . . . . 0.0 113.188 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -80.29 125.26 29.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.427 1.113 . . . . 0.0 108.601 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.72 157.34 37.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.483 1.113 . . . . 0.0 110.312 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.74 -41.09 69.99 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -169.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -71.58 -39.82 70.32 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -65.06 -44.26 89.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -27.03 69.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.383 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.448 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 17.0 tmm? -72.21 -43.74 64.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.411 1.005 . . . . 0.0 109.032 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -66.31 -30.99 71.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.114 0.87 . . . . 0.0 110.903 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -62.21 -49.2 76.72 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.659 -0.651 . . . . 0.0 109.607 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.06 77.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.145 0.978 . . . . 0.0 111.277 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.64 -39.98 95.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.183 1.393 . . . . 0.0 109.446 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.19 -50.87 59.43 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.866 0.866 . . . . 0.0 110.056 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.54 -40.94 88.89 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.521 1.055 . . . . 0.0 112.002 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -95.21 -49.36 5.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.287 0.635 . . . . 0.0 111.082 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.21 -17.7 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.4 0.68 . . . . 0.0 110.599 -169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.71 55.72 29.27 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -134.22 162.94 30.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.287 2.235 . . . . 0.0 106.507 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 m -119.0 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.356 0.662 . . . . 0.0 110.09 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -72.19 49.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.323 1.849 . . . . 0.0 114.503 -171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -163.4 -23.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.57 1.548 . . . . 0.0 112.294 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.27 1.1 52.15 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 m -149.05 171.16 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 109.727 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -138.91 124.53 19.55 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -79.91 131.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 120.655 1.571 . . . . 0.0 107.304 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -102.73 -45.94 4.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.51 169.3 19.86 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.88 0.872 . . . . 0.0 110.554 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -145.86 162.73 37.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 p -65.05 141.97 58.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -67.11 -22.03 65.83 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -170.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -141.85 177.58 8.08 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.523 1.529 . . . . 0.0 107.441 169.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -72.16 129.48 38.58 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.85 160.04 26.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -156.61 151.86 26.49 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 108.345 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.06 172.91 12.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.001 1.72 . . . . 0.0 106.956 172.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -112.84 128.51 56.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.71 145.39 98.08 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -63.3 154.66 66.64 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 108.513 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.72 -29.94 68.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -73.22 -25.83 60.9 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.037 0.935 . . . . 0.0 112.728 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 tp -101.2 -19.38 15.73 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.815 0.846 . . . . 0.0 111.865 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.7 t -48.01 135.23 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -88.53 101.65 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.529 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.37 -2.33 57.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.363 0.665 . . . . 0.0 110.88 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.81 -30.55 40.53 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.636 -0.665 . . . . 0.0 110.096 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.4 161.12 23.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.564 1.146 . . . . 0.0 109.814 -173.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -137.26 114.63 9.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -59.18 153.58 43.04 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.004 1.037 . . . . 0.0 110.828 -10.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.49 138.12 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.7 t -97.56 120.8 38.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 pt -107.47 -10.18 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.282 1.033 . . . . 0.0 112.531 -169.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.97 168.63 40.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.158 0.89 . . . . 0.0 111.673 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -104.61 123.51 47.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -85.26 118.92 25.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 120.37 14.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.96 1.254 . . . . 0.0 113.164 -173.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -98.92 128.92 45.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -97.69 149.65 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.448 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 41.3 m-85 -119.53 126.79 52.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.3 111.58 19.54 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.48 131.23 54.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 124.465 1.103 . . . . 0.0 110.64 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.17 136.26 33.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.12 132.69 44.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -116.16 -37.8 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.7 m -85.2 -133.09 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.96 173.5 46.3 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 120.369 1.441 . . . . 0.0 111.403 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.4 -31.73 46.27 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.966 1.307 . . . . 0.0 112.859 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.45 -27.9 67.42 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.246 0.618 . . . . 0.0 112.431 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.86 -24.73 13.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.37 1.468 . . . . 0.0 110.908 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.46 142.54 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.724 1.61 . . . . 0.0 107.256 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -124.98 -38.77 2.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.51 -15.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.963 2.105 . . . . 0.0 116.173 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.94 27.94 8.98 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.849 1.659 . . . . 0.0 111.574 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -68.62 -36.98 79.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -91.76 6.39 46.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.074 0.949 . . . . 0.0 113.5 -169.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m 67.85 -36.1 0.29 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.489 2.716 . . . . 0.0 114.962 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -128.4 66.84 74.63 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.706 1.602 . . . . 0.0 108.33 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -77.05 -168.62 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.575 2.85 . . . . 0.0 110.467 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.7 -11.0 14.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.525 169.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.51 145.21 49.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 121.017 1.735 . . . . 0.0 114.03 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.62 116.66 25.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.003 2.921 . . . . 0.0 105.004 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.81 143.55 42.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.215 0.912 . . . . 0.0 113.277 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -114.44 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.035 0.934 . . . . 0.0 109.622 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -140.91 155.21 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.951 1.3 . . . . 0.0 110.106 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -79.68 149.6 31.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 161.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.842 0.857 . . . . 0.0 110.003 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -53.3 150.13 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.592 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.44 149.65 20.36 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.1 -15.08 0.13 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 -44.17 99.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 121.322 1.874 . . . . 0.0 111.937 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -63.99 -25.88 66.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.885 1.724 . . . . 0.0 114.702 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.48 -36.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.855 1.207 . . . . 0.0 108.928 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -83.39 -16.26 46.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 117.9 -1.047 . . . . 0.0 112.21 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -86.26 -31.1 21.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.977 1.262 . . . . 0.0 112.341 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -68.88 165.34 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.303 0.956 . . . . 0.0 111.755 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.55 151.24 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.9 1.28 . . . . 0.0 111.148 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -59.12 -34.49 72.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.104 1.362 . . . . 0.0 113.822 -169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -71.55 -26.02 62.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.025 0.829 . . . . 0.0 111.468 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -94.64 -29.32 14.9 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.14 0.976 . . . . 0.0 112.317 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -36.9 -53.71 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.721 2.009 . . . . 0.0 112.638 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -35.29 74.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.418 0.553 . . . . 0.0 110.977 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.2 t -72.7 -36.04 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.648 -0.657 . . . . 0.0 109.682 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -68.15 -34.82 77.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.261 0.937 . . . . 0.0 110.791 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -58.01 -39.54 78.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.577 1.151 . . . . 0.0 111.373 169.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -64.31 -47.44 79.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.144 0.884 . . . . 0.0 109.618 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.31 -45.33 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.593 0.633 . . . . 0.0 109.603 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtt -65.49 -43.22 90.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.647 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -26.03 65.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.3 1.863 . . . . 0.0 112.315 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -65.31 -23.49 67.03 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.718 0.69 . . . . 0.0 110.358 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -116.09 -21.49 9.41 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.358 1.063 . . . . 0.0 113.442 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.1 -58.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.578 1.151 . . . . 0.0 110.607 -172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.5 m -66.17 -21.48 66.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.456 0.571 . . . . 0.0 111.995 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.76 -41.5 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.61 -48.72 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.1 mtt -66.52 -18.79 65.56 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.71 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.7 m -63.19 -24.22 67.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.713 1.142 . . . . 0.0 111.873 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.97 -49.72 27.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.671 0.668 . . . . 0.0 109.348 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.67 -23.42 56.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.704 0.402 . . . . 0.0 111.206 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.91 1.684 . . . . 0.0 109.808 177.037 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.02 162.13 29.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.379 1.472 . . . . 0.0 108.707 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.6 -36.48 64.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.9 5.96 26.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.23 31.24 14.58 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.792 1.187 . . . . 0.0 111.75 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 19.5 m-85 -108.42 134.57 51.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.892 1.346 . . . . 0.0 109.127 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -82.55 127.34 70.95 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.52 130.5 11.82 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.142 1.894 . . . . 0.0 109.322 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.6 160.65 39.37 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.728 1.211 . . . . 0.0 110.705 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.3 148.3 18.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.596 1.958 . . . . 0.0 106.431 169.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.14 131.06 6.11 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.44 127.29 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.53 91.78 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 mm -66.39 134.12 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 168.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.8 m -119.32 126.26 51.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 168.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 19' ' ' GLN . 2.4 t-20 -86.62 35.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.904 -0.498 . . . . 0.0 111.216 -169.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.265 13.7 ptp180 40.87 7.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.906 4.082 . . . . 0.0 116.558 -169.038 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 17' ' ' ASN . 37.4 mt-30 -95.39 3.65 54.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.03 0.932 . . . . 0.0 111.471 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.31 64.34 Favored Glycine 0 N--CA 1.47 0.92 0 O-C-N 121.021 -1.049 . . . . 0.0 112.089 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -121.78 149.81 42.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.571 1.548 . . . . 0.0 107.005 -169.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.3 160.07 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.459 1.104 . . . . 0.0 113.204 -169.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ttt -58.31 134.61 56.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.332 1.453 . . . . 0.0 109.977 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -157.69 133.69 9.38 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 169.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.06 144.31 27.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.504 0.669 . . . . 0.0 110.458 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.92 132.35 36.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.229 1.411 . . . . 0.0 107.786 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -93.72 134.92 35.54 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.59 0.756 . . . . 0.0 109.248 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -47.55 132.79 13.65 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.832 1.253 . . . . 0.0 111.591 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.22 -23.08 0.75 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.615 1.102 . . . . 0.0 113.564 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.31 -37.75 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.923 0.862 . . . . 0.0 108.956 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.46 28.94 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.448 1.499 . . . . 0.0 112.262 -174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -149.78 175.82 11.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.28 1.832 . . . . 0.0 107.266 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -78.06 153.81 31.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.729 0.812 . . . . 0.0 112.639 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -146.48 162.29 38.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 109.37 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -84.67 151.1 57.85 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.886 2.074 . . . . 0.0 110.746 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -68.4 156.97 63.77 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.886 2.391 . . . . 0.0 113.022 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 179.96 148.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.921 2.488 . . . . 0.0 108.322 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 142.15 8.68 Favored Glycine 0 C--N 1.337 0.638 0 O-C-N 121.134 -0.978 . . . . 0.0 110.883 170.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.73 50.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.786 1.184 . . . . 0.0 111.027 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -87.42 134.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.387 1.075 . . . . 0.0 109.108 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -65.82 126.46 91.77 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.627 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.32 118.2 5.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.074 1.849 . . . . 0.0 111.585 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.87 0.17 75.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.577 1.56 . . . . 0.0 113.083 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -83.7 132.93 34.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.677 1.191 . . . . 0.0 108.048 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 159.39 34.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.984 0.913 . . . . 0.0 110.346 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.76 71.81 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.059 1.344 . . . . 0.0 112.315 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.38 -40.6 73.86 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -62.16 -43.5 98.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 108.967 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.956 0.502 . . . . 0.0 111.93 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -61.68 -44.71 96.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.883 0.765 . . . . 0.0 110.06 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -65.78 -29.3 69.78 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.961 1.255 . . . . 0.0 113.046 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -59.38 -50.67 73.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.237 1.381 . . . . 0.0 109.087 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.08 66.79 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.134 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.14 -43.32 99.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.832 -1.167 . . . . 0.0 108.455 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -66.51 -45.12 80.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.702 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -69.49 -48.88 59.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.523 1.51 . . . . 0.0 112.211 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -85.66 -29.59 23.88 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.124 0.97 . . . . 0.0 111.783 -168.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.35 -15.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.5 0.72 . . . . 0.0 110.379 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.25 11.33 70.97 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 120.746 -1.221 . . . . 0.0 113.12 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.37 151.41 21.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.131 0.966 . . . . 0.0 109.189 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -102.74 174.05 6.06 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.034 0.933 . . . . 0.0 108.909 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -70.42 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 115.065 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.41 -11.44 0.18 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.221 1.808 . . . . 0.0 112.705 -169.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -97.91 2.27 48.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.451 0.7 . . . . 0.0 110.96 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.88 171.89 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.751 1.221 . . . . 0.0 108.419 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -140.57 122.61 15.63 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 -171.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -75.47 129.82 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 -34.17 6.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.813 0.445 . . . . 0.0 110.702 176.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.7 166.5 32.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.679 1.192 . . . . 0.0 108.234 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -140.54 157.25 45.76 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -58.62 138.34 56.97 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 119.467 1.03 . . . . 0.0 108.474 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.46 -24.82 66.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.789 0.436 . . . . 0.0 112.074 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.48 174.16 11.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -61.7 126.64 28.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.12 131.31 45.19 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 170.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.37 134.66 52.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -143.02 131.6 22.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 117.51 24.63 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.18 147.47 80.98 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.866 1.266 . . . . 0.0 110.25 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.44 150.54 87.03 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.582 1.521 . . . . 0.0 109.015 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -48.83 -48.44 41.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.016 0.927 . . . . 0.0 113.367 -169.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.88 -16.48 63.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.197 0.999 . . . . 0.0 113.003 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -108.07 -3.75 18.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.169 1.388 . . . . 0.0 111.749 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.41 137.56 21.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 169.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -91.0 127.52 36.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -111.36 0.18 16.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.123 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.84 -17.59 35.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.106 0.562 . . . . 0.0 109.724 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.0 p -91.43 156.51 17.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.257 0.623 . . . . 0.0 109.328 -171.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -131.38 110.25 15.05 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.88 155.94 60.44 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.447 1.195 . . . . 0.0 112.117 -4.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.4 m -60.54 133.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 50.7 t -90.06 99.52 12.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.6 pt -88.89 -6.42 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.416 1.486 . . . . 0.0 112.027 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -158.43 153.72 24.86 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 120.514 1.506 . . . . 0.0 113.566 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.91 94.21 5.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -71.02 126.17 28.85 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.63 111.7 5.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.224 0.92 . . . . 0.0 110.273 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -89.3 125.81 35.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 169.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -98.27 146.8 25.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -123.87 126.14 45.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.815 1.246 . . . . 0.0 107.715 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.2 tp -78.46 111.12 14.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.84 121.92 45.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.022 0.929 . . . . 0.0 108.609 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -82.84 137.25 34.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.35 139.99 58.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.73 -41.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 m -136.41 142.56 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.3 -168.8 40.73 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.713 -0.617 . . . . 0.0 112.937 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.07 -56.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 131.443 3.897 . . . . 0.0 112.882 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.58 -35.44 24.71 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.174 0.99 . . . . 0.0 110.786 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -86.09 -18.72 31.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.405 0.682 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.94 138.8 22.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -153.69 84.81 1.17 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.5 mtt -70.79 24.67 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.249 0.62 . . . . 0.0 112.404 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -132.92 20.43 4.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.999 1.72 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.84 -51.46 50.99 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.926 2.09 . . . . 0.0 110.951 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 m -86.09 3.93 40.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.604 1.162 . . . . 0.0 112.869 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 63.01 117.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 128.07 2.548 . . . . 0.0 112.417 -169.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 p 34.78 53.06 1.49 Allowed Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 111.783 -2.462 . . . . 0.0 113.325 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.37 -54.15 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.898 1.732 . . . . 0.0 113.26 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -160.79 -45.54 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.846 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -115.52 135.92 53.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -169.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.64 -31.9 15.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.714 2.005 . . . . 0.0 112.007 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -170.77 156.63 27.06 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 123.896 0.76 . . . . 0.0 111.75 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -120.48 150.73 40.37 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.082 1.353 . . . . 0.0 111.39 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -150.05 130.1 13.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.758 1.623 . . . . 0.0 108.627 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -84.56 140.0 31.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.03 0.832 . . . . 0.0 108.934 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.17 166.88 17.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.943 1.297 . . . . 0.0 109.835 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -56.26 150.69 13.98 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.893 0.877 . . . . 0.0 111.927 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.42 149.26 34.63 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.5 m95 65.5 -16.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.3 1.84 . . . . 0.0 115.857 -170.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -65.22 -48.38 69.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 121.235 1.834 . . . . 0.0 110.898 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -59.55 -30.23 91.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 121.81 1.682 . . . . 0.0 113.391 173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -39.45 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.544 -0.722 . . . . 0.0 110.027 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -73.16 -37.15 66.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 120.683 -1.261 . . . . 0.0 110.035 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -80.74 -24.92 38.37 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.49 156.92 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.172 0.896 . . . . 0.0 109.352 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.9 m -58.46 150.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.388 1.075 . . . . 0.0 110.711 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 m -59.79 -26.81 66.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.897 1.279 . . . . 0.0 114.406 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -72.06 -45.68 59.82 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.356 0.98 . . . . 0.0 110.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.54 -29.5 52.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.159 -1.4 . . . . 0.0 111.419 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -43.3 -48.17 6.75 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.564 1.529 . . . . 0.0 111.156 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -73.23 -22.29 60.46 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -79.26 -47.48 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.231 -0.918 . . . . 0.0 108.658 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -31.7 70.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.794 0.838 . . . . 0.0 110.568 -169.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -64.95 -33.76 76.8 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.268 -0.895 . . . . 0.0 111.264 172.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -69.92 -44.96 68.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.29 -46.87 85.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.171 0.588 . . . . 0.0 110.001 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 47.2 mtt -66.34 -40.49 89.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.203 -0.936 . . . . 0.0 110.987 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.11 -37.22 86.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.367 0.985 . . . . 0.0 111.01 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.84 -28.06 69.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.805 0.842 . . . . 0.0 110.985 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -113.94 -11.66 12.76 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.07 -54.8 38.46 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.94 1.245 . . . . 0.0 110.755 -170.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -81.12 25.63 0.47 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.615 0.766 . . . . 0.0 112.6 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.69 -18.31 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.164 1.786 . . . . 0.0 108.773 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 73.1 t -96.95 -52.79 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.768 1.227 . . . . 0.0 108.087 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.0 mmt -64.77 -16.41 62.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.283 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 m -48.92 -33.23 10.42 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.874 1.67 . . . . 0.0 113.194 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.9 mt -83.0 -29.58 28.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 110.509 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -96.87 -25.92 15.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.325 1.05 . . . . 0.0 112.189 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 109.592 176.679 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.97 145.81 48.15 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.635 1.574 . . . . 0.0 108.144 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -44.59 -37.49 3.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.058 1.874 . . . . 0.0 116.058 -168.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -81.96 2.13 32.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.51 24.85 11.57 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.776 1.655 . . . . 0.0 112.009 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -111.03 148.7 32.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.668 1.734 . . . . 0.0 110.843 -170.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -87.89 112.45 49.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.211 -1.555 . . . . 0.0 107.412 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.84 130.32 15.53 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.492 2.128 . . . . 0.0 109.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -154.84 170.99 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.465 1.106 . . . . 0.0 110.855 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.91 130.31 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.481 1.513 . . . . 0.0 108.796 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.33 126.63 8.98 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mm -91.5 104.12 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 81.35 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.9 mm -63.79 130.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.17 128.33 55.87 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.82 18.34 6.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 53.5 10.68 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.106 1.762 . . . . 0.0 115.341 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -109.87 6.97 23.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.304 1.041 . . . . 0.0 111.945 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.74 79.28 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.796 -1.19 . . . . 0.0 112.731 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -128.51 158.57 38.03 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.893 1.677 . . . . 0.0 106.851 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.37 167.61 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 128.2 32.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.347 1.859 . . . . 0.0 110.873 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.417 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -164.46 131.53 3.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 167.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.76 142.42 44.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -76.6 144.92 39.27 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -95.71 126.71 41.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -61.17 144.64 53.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.705 0.684 . . . . 0.0 110.586 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 -28.24 0.85 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.361 1.457 . . . . 0.0 114.158 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -97.06 -28.33 14.19 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.606 1.162 . . . . 0.0 110.357 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 65.13 -8.65 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.788 2.435 . . . . 0.0 115.213 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -178.66 6.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.263 1.025 . . . . 0.0 108.455 169.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.417 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 73.8 m95 -90.03 162.07 15.53 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.84 -1.163 . . . . 0.0 110.704 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -140.15 148.03 41.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.045 0.926 . . . . 0.0 110.848 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -79.76 164.9 50.95 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 127.335 2.254 . . . . 0.0 110.186 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.71 -92.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.664 2.91 . . . . 0.0 110.289 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 53.78 61.37 3.12 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.469 1.108 . . . . 0.0 111.563 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.81 117.27 4.46 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.1 142.71 27.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 125.997 1.76 . . . . 0.0 111.485 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.0 mt -77.4 139.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.994 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -77.71 136.06 63.57 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.356 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -54.99 118.27 4.96 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.631 1.554 . . . . 0.0 113.491 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.48 89.74 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.961 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -83.86 123.28 29.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.281 1.032 . . . . 0.0 108.513 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -72.59 160.52 32.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.269 1.028 . . . . 0.0 110.508 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.5 79.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.061 . . . . 0.0 111.129 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.5 12.82 3.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.633 0.773 . . . . 0.0 111.181 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -114.18 -54.21 2.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.408 1.883 . . . . 0.0 106.088 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -33.08 73.41 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.476 1.11 . . . . 0.0 112.335 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -61.29 -45.07 95.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -71.86 -27.87 63.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.617 -0.677 . . . . 0.0 111.292 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -62.19 -48.71 78.83 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.243 -0.91 . . . . 0.0 109.409 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.76 -32.93 73.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.801 0.728 . . . . 0.0 111.362 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 tp -60.34 -40.72 91.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.65 1.18 . . . . 0.0 109.419 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.34 -54.08 9.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.336 1.054 . . . . 0.0 111.456 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.97 -41.72 81.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.635 1.562 . . . . 0.0 110.834 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -92.96 -49.01 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.205 0.457 . . . . 0.0 110.836 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.15 -26.38 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.998 0.519 . . . . 0.0 110.583 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.69 58.84 6.55 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.747 -1.22 . . . . 0.0 110.074 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 mt -138.34 156.18 47.86 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.085 2.154 . . . . 0.0 107.834 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 m -116.75 -178.51 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.868 0.867 . . . . 0.0 111.513 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.74 41.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 128.368 2.667 . . . . 0.0 113.61 -174.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -164.72 -20.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.079 1.352 . . . . 0.0 112.361 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -87.59 -1.04 57.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -169.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.85 167.5 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.151 1.38 . . . . 0.0 108.925 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -138.78 121.37 16.24 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -74.84 130.94 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 120.104 1.32 . . . . 0.0 107.844 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -33.71 6.07 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.008 0.923 . . . . 0.0 111.162 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.74 169.18 25.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.362 1.465 . . . . 0.0 108.546 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 m -145.37 162.04 38.21 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.083 1.353 . . . . 0.0 107.833 172.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -62.06 149.1 42.05 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.425 1.011 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.5 -33.43 75.57 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.151 -0.343 . . . . 0.0 111.153 -169.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.17 -176.21 5.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.914 2.086 . . . . 0.0 106.395 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -61.38 120.17 9.94 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 160.01 29.28 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -161.33 163.2 30.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 120.704 -1.248 . . . . 0.0 111.118 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.49 159.69 41.23 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.145 1.378 . . . . 0.0 107.764 169.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -101.31 127.48 47.91 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 106.657 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -68.49 145.31 97.13 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.43 156.75 57.93 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.033 2.489 . . . . 0.0 110.104 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -52.02 -42.0 62.69 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 113.582 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -76.26 -23.95 54.47 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.285 1.034 . . . . 0.0 113.06 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.33 -24.56 19.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.009 0.524 . . . . 0.0 110.894 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.69 137.38 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -42.98 52.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.925 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.5 m95 59.52 5.21 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.304 2.241 . . . . 0.0 113.547 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.95 -21.84 14.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.367 1.467 . . . . 0.0 111.17 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -70.96 147.4 48.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.264 1.426 . . . . 0.0 108.53 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -134.38 113.43 12.19 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.27 154.83 30.92 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.069 1.06 . . . . 0.0 111.54 -10.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -62.87 128.95 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.7 t -89.79 108.94 19.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.2 pt -101.27 -6.28 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 112.835 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.94 178.3 48.74 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 119.851 1.205 . . . . 0.0 112.017 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -108.82 114.82 28.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -78.45 115.8 18.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.88 110.89 8.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.507 0.594 . . . . 0.0 111.818 -168.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -90.1 125.22 35.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -100.21 132.27 45.67 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.04 133.99 51.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.9 106.16 18.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.37 130.41 55.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.065 0.946 . . . . 0.0 109.494 -173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.07 136.13 33.11 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.4 tp -78.32 124.64 28.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.52 -37.83 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.9 m -115.16 110.86 20.13 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.9 -167.36 9.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.96 1.266 . . . . 0.0 115.284 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -44.83 -33.0 1.76 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.702 2.001 . . . . 0.0 113.657 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.67 67.96 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.62 -25.46 11.32 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.359 1.464 . . . . 0.0 111.519 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.93 123.43 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -94.44 -46.53 6.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mtt 46.95 44.09 14.34 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 111.787 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 26.06 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.722 0.809 . . . . 0.0 112.971 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -44.53 63.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.329 1.452 . . . . 0.0 110.718 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 p -80.99 -15.94 54.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.939 1.696 . . . . 0.0 113.085 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.8 m 68.87 -30.27 0.18 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.714 2.406 . . . . 0.0 112.529 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -119.98 64.85 9.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.596 1.558 . . . . 0.0 111.621 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 -5.0 16.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.002 3.134 . . . . 0.0 114.474 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 65.42 -34.08 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.886 2.474 . . . . 0.0 114.359 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -70.5 128.97 37.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.933 0.788 . . . . 0.0 109.494 175.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.89 -14.8 53.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.515 1.126 . . . . 0.0 111.522 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.4 135.98 4.78 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -150.82 -129.74 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.781 0.432 . . . . 0.0 110.445 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -145.03 162.86 35.9 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.483 1.913 . . . . 0.0 108.508 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -82.14 152.84 26.32 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.338 0.399 . . . . 0.0 110.342 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.25 164.21 35.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.58 0.752 . . . . 0.0 110.718 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -54.11 145.94 15.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.355 1.062 . . . . 0.0 110.385 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -36.81 69.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.626 0.77 . . . . 0.0 111.904 -169.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -90.42 -5.39 56.17 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.05 -1.031 . . . . 0.0 112.639 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.5 -44.21 80.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.454 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.67 -33.82 92.86 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.14 1.8 . . . . 0.0 112.889 176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.59 -36.19 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 O-C-N 121.86 -0.525 . . . . 0.0 109.588 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -83.63 -15.68 48.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.349 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.52 -20.33 19.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.228 0.922 . . . . 0.0 112.982 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.21 165.27 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 119.616 1.098 . . . . 0.0 110.343 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.87 156.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 110.732 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -56.49 -33.22 65.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.312 -169.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -75.54 -30.68 59.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.131 0.878 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -79.24 -36.77 39.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.729 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -43.83 -50.6 7.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.237 1.415 . . . . 0.0 111.613 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.25 -33.52 76.19 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.731 0.412 . . . . 0.0 111.562 -172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.2 t -82.71 -37.94 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.383 0.673 . . . . 0.0 109.799 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -33.31 75.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.302 -0.874 . . . . 0.0 109.995 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -52.72 -40.48 63.06 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.227 1.011 . . . . 0.0 111.582 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.26 -47.43 79.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.43 -47.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.0 mmt -63.58 -47.09 82.91 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.779 0.718 . . . . 0.0 110.172 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -56.7 -46.15 81.4 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.181 0.992 . . . . 0.0 110.721 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.32 -16.36 63.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.073 0.549 . . . . 0.0 111.582 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.44 -5.58 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.132 1.373 . . . . 0.0 113.343 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.36 -59.0 3.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 112.198 -169.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.8 m -62.16 -26.19 68.19 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.703 0.401 . . . . 0.0 112.043 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.17 -28.91 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.061 0.944 . . . . 0.0 109.605 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.65 -41.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 17.0 mmt -63.92 -38.04 89.64 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.604 0.638 . . . . 0.0 110.751 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 63.0 m -61.98 -18.35 60.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.781 0.719 . . . . 0.0 112.698 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -76.19 -26.75 56.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.572 0.624 . . . . 0.0 110.584 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -107.56 -32.25 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.168 0.987 . . . . 0.0 111.002 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 127.185 2.194 . . . . 0.0 110.605 172.797 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.42 -47.12 57.92 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.14 0.576 . . . . 0.0 111.71 -171.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -153.17 -75.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.856 0.862 . . . . 0.0 110.413 171.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.45 -49.2 7.78 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -169.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.49 14.84 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.531 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -94.22 136.35 34.6 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.793 1.297 . . . . 0.0 110.281 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -86.03 114.03 54.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 173.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.62 134.22 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.967 1.778 . . . . 0.0 109.986 -177.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -159.4 176.01 12.64 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.201 1.001 . . . . 0.0 108.747 172.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.36 140.45 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.07 122.98 7.16 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 mm -73.04 121.73 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.68 88.39 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mm -67.34 131.22 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.5 m -114.72 119.76 37.79 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -83.86 136.46 34.11 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -63.82 -9.61 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.036 1.334 . . . . 0.0 114.367 -173.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.24 -12.26 61.36 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 110.841 169.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.78 34.18 4.75 Favored Glycine 0 C--N 1.346 1.09 0 C-N-CA 126.059 1.79 . . . . 0.0 112.685 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.43 151.7 51.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.96 164.15 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -168.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 tpp -50.96 127.26 18.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.243 1.817 . . . . 0.0 111.628 169.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -157.06 129.75 7.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.49 143.48 28.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.227 0.537 . . . . 0.0 110.014 -171.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -74.86 134.04 41.74 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -80.08 133.74 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.486 0.715 . . . . 0.0 109.269 -169.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.79 134.36 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.48 1.512 . . . . 0.0 109.95 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.1 16.32 76.77 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.993 -0.442 . . . . 0.0 112.513 177.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -139.85 163.34 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.124 2.169 . . . . 0.0 107.296 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -114.82 36.17 3.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 p -150.18 171.78 16.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.226 1.811 . . . . 0.0 108.735 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.99 155.34 22.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.997 1.319 . . . . 0.0 109.249 -171.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.38 146.14 41.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.093 0.949 . . . . 0.0 111.793 -170.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -57.14 143.29 72.98 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 0.0 108.549 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.56 152.79 78.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.973 1.782 . . . . 0.0 112.378 173.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -179.12 132.47 0.12 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.758 2.423 . . . . 0.0 107.173 173.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.11 -114.84 2.56 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.8 164.34 34.45 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.43 2.919 . . . . 0.0 106.758 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.53 124.21 72.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -73.76 136.97 76.92 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 116.895 -1.526 . . . . 0.0 107.615 171.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -56.13 117.68 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 121.857 1.699 . . . . 0.0 112.934 -172.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.58 87.16 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.355 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.37 125.62 31.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.49 1.116 . . . . 0.0 108.633 175.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.03 158.68 36.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 110.361 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.38 63.65 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 125.455 1.502 . . . . 0.0 113.859 -169.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.26 -45.08 61.67 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -60.2 -45.18 94.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.999 1.32 . . . . 0.0 108.307 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.56 67.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.196 0.999 . . . . 0.0 112.546 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -72.13 -42.3 66.18 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.653 1.115 . . . . 0.0 109.073 175.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.04 -26.87 67.71 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.971 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -67.35 -48.1 68.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.188 -0.945 . . . . 0.0 109.031 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.9 84.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 119.007 0.821 . . . . 0.0 110.795 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.13 -41.91 89.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.62 1.568 . . . . 0.0 109.38 178.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -46.97 65.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.859 0.863 . . . . 0.0 110.648 172.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.9 -37.18 86.77 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.676 1.126 . . . . 0.0 112.667 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -94.17 -44.02 8.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.524 0.73 . . . . 0.0 111.185 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.55 -2.48 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.04 75.69 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.172 -0.955 . . . . 0.0 111.598 177.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.0 mt -91.12 161.21 15.19 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 108.908 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -118.07 171.51 8.05 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.902 0.881 . . . . 0.0 109.603 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -72.43 57.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.161 1.784 . . . . 0.0 113.89 -171.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -163.89 -25.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.618 1.967 . . . . 0.0 111.359 -172.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -88.15 0.19 56.33 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -168.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 166.78 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.036 0.935 . . . . 0.0 109.792 -169.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -137.2 120.89 17.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -171.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.85 129.9 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.05 -34.87 6.48 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.316 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.93 169.48 22.53 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 109.356 -178.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.1 p -147.81 162.28 39.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 p -66.15 145.0 56.32 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.21 -20.97 63.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -170.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -148.94 171.95 15.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.958 1.703 . . . . 0.0 109.12 171.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -73.1 116.19 13.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.59 153.89 41.05 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.42 153.74 38.94 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.443 0.697 . . . . 0.0 109.204 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.63 164.81 30.57 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.871 1.268 . . . . 0.0 108.548 176.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -118.5 123.86 46.16 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -172.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.01 145.14 99.01 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.599 1.16 . . . . 0.0 108.937 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.0 152.2 80.67 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.463 2.109 . . . . 0.0 109.456 170.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -47.62 -49.08 28.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.548 1.139 . . . . 0.0 113.779 -169.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -64.71 -14.19 57.58 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.154 0.981 . . . . 0.0 113.228 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.77 -9.2 15.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.56 1.544 . . . . 0.0 111.53 -178.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.84 136.73 25.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.63 129.81 38.45 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -101.3 4.5 41.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.791 1.236 . . . . 0.0 109.782 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.15 -12.53 15.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.501 1.121 . . . . 0.0 111.588 -174.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 p -71.66 -33.88 69.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.327 0.651 . . . . 0.0 111.763 -174.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 41.78 89.22 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.906 2.482 . . . . 0.0 112.197 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.22 150.34 71.83 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-N 119.977 1.028 . . . . 0.0 114.761 10.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -54.41 122.17 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.7 t -92.53 105.3 17.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -172.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -102.84 -10.82 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 113.013 -170.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.73 175.65 46.65 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 120.075 1.307 . . . . 0.0 112.482 -174.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.29 126.56 55.38 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -87.27 120.89 29.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.15 128.56 21.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.974 1.261 . . . . 0.0 113.618 -176.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -106.23 134.98 48.52 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -104.85 144.79 31.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -117.67 126.46 52.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.07 107.59 16.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 175.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.4 133.99 47.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.823 175.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -93.6 135.6 34.71 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 168.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.01 141.43 58.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.973 176.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.16 -27.05 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.316 1.047 . . . . 0.0 108.204 169.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -119.94 -53.42 2.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 175.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.02 -146.53 44.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 172.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -40.94 -34.15 0.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.786 2.034 . . . . 0.0 113.573 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.14 -25.73 68.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.794 0.838 . . . . 0.0 113.235 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -130.58 -8.71 4.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.942 1.297 . . . . 0.0 113.324 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.18 134.36 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.65 -31.72 0.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.395 -170.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.1 mtt 64.82 -50.06 0.33 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 129.096 2.958 . . . . 0.0 113.141 -178.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -84.21 20.06 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.255 1.022 . . . . 0.0 113.515 -171.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -63.09 -31.43 72.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 109.749 172.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -83.58 -0.65 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.556 1.143 . . . . 0.0 113.262 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 64.1 -34.21 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.609 2.764 . . . . 0.0 115.543 -175.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -132.28 71.06 79.88 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.942 1.697 . . . . 0.0 107.435 172.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.02 -166.32 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.737 2.958 . . . . 0.0 110.453 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.33 -3.83 26.54 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.401 169.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.79 155.75 49.4 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 121.662 2.028 . . . . 0.0 112.375 -172.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.03 -25.52 2.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.801 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.1 150.75 22.17 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -122.25 146.89 46.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 110.81 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -152.31 124.7 8.23 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.677 1.191 . . . . 0.0 107.89 169.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -76.88 143.94 39.31 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.745 0.702 . . . . 0.0 109.144 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.57 168.15 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.59 0.756 . . . . 0.0 109.692 -169.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.9 m -48.79 145.11 3.98 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.094 1.357 . . . . 0.0 111.054 -177.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -52.58 -38.8 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -168.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -95.92 -4.37 43.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.74 -43.23 91.33 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.156 -1.402 . . . . 0.0 112.31 -170.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -58.05 -34.23 98.2 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 122.173 1.812 . . . . 0.0 113.074 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.69 -45.8 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -64.16 -30.61 71.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.737 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -78.95 -30.94 44.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 112.154 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.27 157.34 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.869 0.758 . . . . 0.0 110.974 -170.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.69 148.68 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.517 1.527 . . . . 0.0 111.709 174.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -57.97 -34.34 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.179 1.392 . . . . 0.0 113.849 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -72.66 -28.11 62.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.815 0.734 . . . . 0.0 111.543 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -89.25 -31.95 17.63 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.141 174.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -47.21 -44.82 22.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.599 1.16 . . . . 0.0 112.24 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.88 -34.33 75.27 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 p -83.81 -32.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.954 -0.466 . . . . 0.0 110.549 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -31.99 73.17 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.054 -1.029 . . . . 0.0 110.306 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -53.24 -40.52 64.62 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.058 -1.026 . . . . 0.0 111.606 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -63.94 -46.4 84.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.26 0.936 . . . . 0.0 109.614 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -53.73 -50.22 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 109.447 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.9 mmt -64.33 -45.1 89.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.273 -177.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -57.6 -44.37 85.36 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.091 0.957 . . . . 0.0 111.091 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -64.63 -25.51 67.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.409 0.684 . . . . 0.0 110.845 -174.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -108.95 -8.82 15.17 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.811 1.245 . . . . 0.0 113.683 -175.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.52 -63.55 1.1 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.348 0.976 . . . . 0.0 112.056 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 m -63.25 -22.31 66.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.216 -0.302 . . . . 0.0 111.778 -178.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -76.1 -36.66 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 O-C-N 121.382 -0.824 . . . . 0.0 108.909 -175.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.43 -48.89 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.6 mtt -65.33 -22.33 66.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.624 0.647 . . . . 0.0 112.725 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.8 m -62.85 -26.79 68.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.458 1.026 . . . . 0.0 111.635 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.9 -51.22 58.03 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.72 -25.79 63.1 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.002 0.521 . . . . 0.0 111.132 -173.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 124.065 0.946 . . . . 0.0 111.637 173.385 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.4 mm -125.58 138.8 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -66.93 152.16 46.24 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 165.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -36.3 -55.35 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.153 1.781 . . . . 0.0 114.684 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.01 -2.21 58.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.048 0.928 . . . . 0.0 112.976 -158.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.59 20.22 4.71 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.218 -1.551 . . . . 0.0 111.325 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.73 136.6 43.95 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.095 0.95 . . . . 0.0 109.135 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -85.13 122.74 73.97 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -72.06 133.19 20.97 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.302 1.335 . . . . 0.0 110.653 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . 0.261 2.2 m-80 -144.45 168.3 20.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.361 1.464 . . . . 0.0 110.349 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.39 130.98 70.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 126.182 1.793 . . . . 0.0 107.525 168.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.38 128.92 9.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -88.48 118.53 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.54 83.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 165.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.31 133.46 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 164.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.502 ' HG ' ' CG2' ' A' ' 155' ' ' VAL . 41.8 m -118.33 120.84 38.83 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -83.39 118.11 23.5 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 112.12 -2.309 . . . . 0.0 105.391 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -47.84 -1.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -76.55 -4.27 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 120.259 1.391 . . . . 0.0 111.548 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' C ' HE21 ' A' ' 21' ' ' GLN . . . 101.76 24.25 8.8 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 119.836 1.198 . . . . 0.0 113.323 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.464 HE21 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -133.47 162.59 31.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -166.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.93 165.21 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -165.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.4 tpt -53.28 129.42 31.55 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 112.629 -2.078 . . . . 0.0 110.101 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -158.63 134.85 9.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 161.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -147.05 141.71 26.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.023 0.916 . . . . 0.0 110.218 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -72.64 135.84 45.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -85.62 124.75 32.51 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.34 133.56 34.61 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.373 2.269 . . . . 0.0 110.911 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.4 -14.54 3.12 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 125.6 1.571 . . . . 0.0 114.133 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -105.44 -35.59 7.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.783 0.792 . . . . 0.0 111.447 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 66.66 27.36 9.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.767 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.78 171.63 14.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -84.15 161.04 20.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -148.12 150.29 33.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.501 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.76 158.8 73.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.432 165.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.43 154.67 31.8 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.039 3.826 . . . . 0.0 112.027 162.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 169.38 139.37 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 128.053 2.541 . . . . 0.0 105.808 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.86 141.43 11.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 156.52 53.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mt -87.8 138.72 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.253 51.1 t30 -85.71 139.21 35.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 125.089 1.356 . . . . 0.0 109.24 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.51 118.48 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.195 1.93 . . . . 0.0 113.636 -172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.19 89.62 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.036 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -87.63 123.91 32.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.861 1.33 . . . . 0.0 107.744 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.68 165.06 24.78 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.24 -44.11 71.46 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.295 1.038 . . . . 0.0 112.538 -168.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.93 -40.48 72.05 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.318 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -63.86 -44.26 93.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.347 0.659 . . . . 0.0 109.79 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.07 77.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.857 0.863 . . . . 0.0 111.553 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -60.75 -44.07 97.17 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.779 -0.576 . . . . 0.0 109.713 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -69.18 -26.25 64.75 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.884 -1.135 . . . . 0.0 112.539 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -61.65 -52.67 63.38 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.441 -0.787 . . . . 0.0 109.332 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.6 90.61 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.414 0.626 . . . . 0.0 109.848 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.3 tp -52.58 -43.81 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.798 -1.814 . . . . 0.0 111.031 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.15 -49.14 53.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.973 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.72 -33.93 77.13 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.008 1.277 . . . . 0.0 112.105 -174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.77 -45.83 5.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.59 0.709 . . . . 0.0 110.042 -169.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -15.62 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 121.797 -0.564 . . . . 0.0 110.401 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.618 ' HA2' ' HG1' ' A' ' 115' ' ' THR . . . 64.88 37.21 94.02 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 117.093 -1.948 . . . . 0.0 112.209 -172.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -113.87 158.81 20.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.544 1.172 . . . . 0.0 108.87 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -117.69 -177.87 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.881 -0.512 . . . . 0.0 110.209 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.72 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.282 1.833 . . . . 0.0 114.736 -174.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -161.15 -18.5 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.05 -1.031 . . . . 0.0 111.434 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.54 1.11 55.52 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.915 0.864 . . . . 0.0 111.008 -167.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' CG2' HD11 ' A' ' 102' ' ' LEU . 27.9 m -152.42 169.48 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -168.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -142.25 117.49 10.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -167.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.97 130.62 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -36.04 6.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.007 0.923 . . . . 0.0 110.932 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.81 170.29 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.049 0.94 . . . . 0.0 108.715 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -145.99 164.29 32.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 109.475 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -63.57 140.2 58.85 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.764 0.792 . . . . 0.0 108.917 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -64.77 -29.51 70.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.351 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.44 174.22 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -65.47 115.47 5.74 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.673 0.789 . . . . 0.0 109.014 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 156.05 39.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -160.82 159.05 29.44 Favored 'General case' 0 CA--C 1.487 -1.481 0 O-C-N 120.683 -1.261 . . . . 0.0 108.13 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.444 ' OH ' ' HE2' ' A' ' 140' ' ' LYS . 8.3 p90 -159.91 170.03 22.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.61 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -109.38 129.88 55.52 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 111.921 -2.4 . . . . 0.0 106.059 -162.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -70.77 143.54 89.63 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -63.04 155.29 61.8 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -49.84 -45.62 50.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -71.77 -18.68 62.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.6 tp -102.47 -18.17 15.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.678 0.791 . . . . 0.0 111.764 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.3 t -52.0 140.49 6.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -76.21 -38.0 57.03 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.351 2.723 . . . . 0.0 118.351 -170.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.632 ' HA ' ' CG1' ' A' ' 91' ' ' VAL 0.326 10.2 m95 53.48 -8.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 -167.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.17 -27.86 11.32 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.397 1.453 . . . . 0.0 110.276 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.0 p -69.54 151.77 45.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -138.14 114.58 9.13 Favored Pre-proline 0 CA--C 1.499 -1.012 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -55.01 154.13 20.12 Favored 'Cis proline' 0 C--O 1.237 0.436 0 O-C-N 123.151 1.08 . . . . 0.0 113.45 -6.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.632 ' CG1' ' HA ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -55.53 130.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.46 171.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 46.5 t -92.86 108.49 20.03 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 pt -101.77 -2.46 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.762 1.625 . . . . 0.0 111.608 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.24 43.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.597 1.09 . . . . 0.0 112.934 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 113.66 27.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.548 1.539 . . . . 0.0 107.178 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.79 122.56 26.77 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 132.6 26.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.582 1.083 . . . . 0.0 112.844 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -104.31 125.53 50.64 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 165.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -96.17 144.11 26.68 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -118.34 128.62 54.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.7 114.95 19.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.498 HD11 ' CG2' ' A' ' 65' ' ' VAL . 3.3 mm? -110.46 122.16 47.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -79.17 136.73 37.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.81 124.22 24.94 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.76 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.97 -41.15 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.255 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.73 -140.74 0.14 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.82 39.21 Favored Glycine 0 CA--C 1.487 -1.695 0 O-C-N 119.572 -1.955 . . . . 0.0 110.221 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -29.9 -41.26 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 126.846 2.059 . . . . 0.0 114.987 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.62 66.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -106.87 -23.4 12.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.195 1.798 . . . . 0.0 110.358 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mt -56.18 132.33 20.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.17 -25.89 4.81 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 119.127 -0.463 . . . . 0.0 112.173 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.5 mtt 41.0 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 119.338 3.088 . . . . 0.0 119.338 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -121.71 21.96 10.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 123.461 2.846 . . . . 0.0 110.926 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.618 ' HG1' ' HA2' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -60.85 -37.49 82.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.731 2.012 . . . . 0.0 111.172 173.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.88 2.67 53.36 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.86 -0.591 . . . . 0.0 112.589 -166.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 m 66.31 -36.26 0.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 115.03 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -131.53 68.97 81.59 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 125.357 1.463 . . . . 0.0 107.169 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.07 -166.82 0.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.318 2.012 . . . . 0.0 109.927 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -110.3 -19.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.896 -1.049 . . . . 0.0 112.695 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -120.07 151.72 38.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.958 1.254 . . . . 0.0 111.309 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.9 -19.79 7.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.811 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.72 158.52 8.43 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 104.727 -3.349 . . . . 0.0 104.727 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.672 ' O ' ' CE3' ' A' ' 124' ' ' TRP 0.589 0.0 OUTLIER -138.76 -175.39 4.12 Favored 'General case' 0 C--N 1.294 -1.829 2 N-CA-C 126.538 5.755 . . . . 0.0 126.538 -154.136 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 124' ' ' TRP 0.254 12.3 ttt180 -169.54 131.78 1.17 Allowed 'General case' 0 CA--C 1.483 -1.634 1 O-C-N 115.477 -4.515 . . . . 0.0 102.967 171.065 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -72.95 133.66 44.42 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.6 161.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -51.21 151.35 2.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.587 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . 0.331 12.5 t80 -45.66 -90.42 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.229 1.412 . . . . 0.0 112.715 -173.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -45.3 -4.19 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 120.459 3.503 . . . . 0.0 120.459 170.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.1 -51.66 78.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.833 2.561 . . . . 0.0 112.983 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -57.34 -32.57 94.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.165 1.91 . . . . 0.0 113.837 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 t -57.84 -39.61 72.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.547 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . 1.4 mmm-85 -77.32 -26.81 52.56 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.054 -1.654 . . . . 0.0 114.074 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 135' ' ' GLN . 3.9 mm-40 -78.46 -25.3 45.83 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 125.655 1.847 . . . . 0.0 114.499 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 144' ' ' TYR 0.265 13.2 p -79.02 157.76 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 CA-C-O 122.853 1.311 . . . . 0.0 109.861 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.0 m -56.09 150.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.941 1.296 . . . . 0.0 111.03 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -60.21 -34.13 73.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -72.92 -30.77 64.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.828 0.74 . . . . 0.0 111.162 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.444 ' HE2' ' OH ' ' A' ' 77' ' ' TYR . 10.5 mttt -81.93 -32.21 30.94 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.456 ' CZ ' HH21 ' A' ' 134' ' ' ARG . 29.2 ttp180 -47.11 -48.53 22.98 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 124.77 1.294 . . . . 0.0 112.243 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.46 -45.62 93.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.128 0.966 . . . . 0.0 110.031 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 77' ' ' TYR . 1.1 t -69.3 -40.47 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 O-C-N 120.937 -1.102 . . . . 0.0 110.311 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -67.32 -31.9 72.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 110.502 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -53.17 -41.79 65.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.661 0.785 . . . . 0.0 112.627 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -66.87 -45.39 78.24 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -53.53 -49.42 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 O-C-N 124.312 1.007 . . . . 0.0 109.143 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -65.33 -41.99 93.4 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.742 -0.599 . . . . 0.0 111.203 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.637 -1.289 . . . . 0.0 111.389 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -61.44 -26.26 67.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.596 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.8 -6.9 11.52 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.906 0.775 . . . . 0.0 113.071 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.56 44.44 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.265 0.939 . . . . 0.0 110.504 -167.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.7 m -65.7 -23.67 66.82 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.924 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.39 -32.95 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 120.17 -1.581 . . . . 0.0 109.656 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.502 ' CG2' ' HG ' ' A' ' 16' ' ' CYS . 61.7 t -84.13 -43.07 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.14 -31.43 71.86 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 116.918 -1.515 . . . . 0.0 110.429 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -55.93 -28.83 58.65 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 120.411 1.46 . . . . 0.0 111.401 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.457 ' O ' ' CD ' ' A' ' 164' ' ' LYS . 1.3 mt -77.65 -20.29 54.03 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 114.695 -2.574 . . . . 0.0 112.244 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 163' ' ' PRO . 35.3 mm-40 -108.16 -7.92 15.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.787 2.035 . . . . 0.0 110.056 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.603 ' C ' ' HA ' ' A' ' 164' ' ' LYS . 3.5 tt0 -125.72 16.69 8.09 Favored 'General case' 1 CA--C 1.682 6.036 2 C-N-CA 137.261 6.224 . . . . 0.0 125.534 174.047 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 1.515 ' N ' ' CA ' ' A' ' 161' ' ' ASN . 8.2 t30 -51.25 -25.08 5.1 Favored 'General case' 2 CA--C 1.858 12.812 3 N-CA-C 136.321 9.378 . . . . 0.0 136.321 126.477 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 1.605 ' CB ' ' CA ' ' A' ' 162' ' ' THR 1.923 0.0 OUTLIER -175.72 106.03 0.25 Allowed Pre-proline 3 N--CA 1.665 10.282 5 C-N-CA 158.435 14.694 . . . . 0.0 80.495 158.427 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.999 ' HA ' ' HG1' ' A' ' 162' ' ' THR 0.835 0.0 OUTLIER -70.05 -34.21 3.18 Favored 'Cis proline' 1 C--N 1.555 11.405 3 C-N-CA 98.832 -11.737 . . . . 0.0 97.154 21.473 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 1.615 ' CB ' ' CA ' ' A' ' 164' ' ' LYS 1.073 15.1 mtmm . . . . . 2 N--CA 1.318 -7.047 3 C-N-CA 139.152 6.981 . . . . 0.0 94.55 107.403 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.3 mm -137.27 148.19 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.27 -45.93 71.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.29 0.636 . . . . 0.0 111.949 -170.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -152.01 -85.22 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.537 1.135 . . . . 0.0 109.963 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.3 -39.95 13.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -169.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.3 21.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.102 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.37 137.49 50.45 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.704 1.252 . . . . 0.0 109.796 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -109.93 118.76 49.17 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.163 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.05 135.06 45.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.258 1.972 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -145.41 158.87 43.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.398 1.879 . . . . 0.0 110.543 -172.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -136.44 76.25 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.707 2.003 . . . . 0.0 109.03 -173.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.6 126.54 30.22 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mm -90.34 105.21 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.57 79.78 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -62.89 135.12 27.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.8 m -123.6 130.83 53.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 168.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -87.69 136.78 32.81 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.86 -10.01 8.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.188 1.795 . . . . 0.0 114.313 -174.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.79 -13.26 62.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.128 0.876 . . . . 0.0 110.825 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.11 38.3 3.37 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.386 1.946 . . . . 0.0 112.163 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -136.38 149.49 48.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.67 167.03 3.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 112.764 -168.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 127.55 32.68 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.622 1.569 . . . . 0.0 110.509 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -156.97 134.63 10.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 168.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.81 146.34 25.63 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -71.32 127.99 34.39 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.25 128.42 34.48 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -53.25 136.97 35.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.429 1.492 . . . . 0.0 110.263 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.27 -37.85 2.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.8 1.19 . . . . 0.0 113.198 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.55 -39.05 25.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.149 0.975 . . . . 0.0 110.091 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.271 17.4 m170 58.92 34.27 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.04 1.736 . . . . 0.0 112.795 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -140.44 158.73 43.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.976 2.11 . . . . 0.0 106.742 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -65.86 152.25 44.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.183 0.993 . . . . 0.0 112.554 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -148.18 156.74 42.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.563 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -69.4 160.72 77.95 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.816 2.446 . . . . 0.0 111.748 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.64 147.12 95.2 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.017 2.478 . . . . 0.0 110.981 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -165.5 153.31 10.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.348 1.859 . . . . 0.0 107.745 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.89 136.84 3.75 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.76 168.83 54.88 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 118.235 1.018 . . . . 0.0 110.853 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.37 140.8 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 108.516 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -85.51 138.0 36.22 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.566 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -58.35 117.32 4.01 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.486 1.457 . . . . 0.0 112.876 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.45 -0.11 84.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.776 1.179 . . . . 0.0 113.046 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.5 120.05 34.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.652 1.226 . . . . 0.0 107.805 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -71.8 165.44 24.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.479 0.712 . . . . 0.0 111.37 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -46.61 64.89 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.239 1.416 . . . . 0.0 111.481 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.37 29.43 0.76 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.577 0.703 . . . . 0.0 110.301 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 -48.66 0.67 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.609 1.964 . . . . 0.0 106.51 170.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.6 74.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.828 1.251 . . . . 0.0 112.015 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -56.92 -45.45 82.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.9 m-85 -73.79 -28.5 61.68 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.027 -1.046 . . . . 0.0 112.052 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -61.39 -46.63 89.37 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.722 -1.236 . . . . 0.0 108.761 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.39 97.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 tp -54.9 -44.6 74.29 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.822 1.649 . . . . 0.0 110.243 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -44.51 88.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.909 0.884 . . . . 0.0 111.252 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.42 -29.08 66.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.781 1.173 . . . . 0.0 112.894 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.26 -48.08 6.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 111.465 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.17 0.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 119.819 1.19 . . . . 0.0 113.69 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 31.31 80.12 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.988 0.813 . . . . 0.0 112.002 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 mt -103.92 152.24 22.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -115.77 -177.29 3.12 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.381 0.673 . . . . 0.0 110.176 -173.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 18.2 ptp180 -71.92 47.55 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.744 2.018 . . . . 0.0 112.575 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -160.68 -19.34 0.05 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.375 1.47 . . . . 0.0 112.341 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -93.85 -0.1 55.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 112.124 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.37 169.33 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.011 0.924 . . . . 0.0 109.448 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -139.36 121.44 15.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.4 mt -74.82 128.01 36.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.92 -30.76 9.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.781 0.433 . . . . 0.0 110.794 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 166.56 29.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.134 0.974 . . . . 0.0 109.366 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.7 p -144.43 158.27 43.84 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.196 1.399 . . . . 0.0 108.244 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -62.95 140.73 58.87 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -60.29 -30.24 69.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -141.83 175.38 9.76 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.707 1.603 . . . . 0.0 106.773 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -66.56 133.51 50.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.79 152.3 22.22 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.126 0.97 . . . . 0.0 108.634 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -150.41 161.05 43.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -140.99 173.82 11.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.381 1.872 . . . . 0.0 106.822 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -97.99 130.75 44.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.32 145.75 98.99 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 170.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -64.93 155.07 69.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.384 2.056 . . . . 0.0 108.465 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -73.15 -24.67 60.62 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.97 0.908 . . . . 0.0 112.816 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.4 tp -99.24 -21.42 16.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.677 0.791 . . . . 0.0 111.727 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.95 141.16 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -75.83 -42.2 50.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -168.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 42.5 m95 56.31 9.74 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.868 2.467 . . . . 0.0 114.61 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.08 -17.42 5.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.003 0.921 . . . . 0.0 113.224 -169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 p -73.5 -35.64 65.64 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.691 -0.631 . . . . 0.0 112.075 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 46.13 88.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.461 2.304 . . . . 0.0 112.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.83 143.69 51.54 Favored 'Cis proline' 0 C--N 1.353 0.775 0 CA-C-N 119.617 0.899 . . . . 0.0 113.699 9.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.6 t -56.64 121.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.08 1.352 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -89.48 120.0 30.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.4 pt -115.86 -4.16 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.02 1.328 . . . . 0.0 111.929 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.12 15.88 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.852 1.206 . . . . 0.0 111.074 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -85.69 127.73 34.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -85.31 115.07 22.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -122.95 122.74 39.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 120.187 1.358 . . . . 0.0 112.49 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -103.21 107.14 17.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 167.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -82.53 142.19 32.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.24 132.22 55.9 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.58 118.14 22.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.75 124.14 50.02 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.382 1.073 . . . . 0.0 109.366 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -86.58 134.74 33.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.74 136.63 57.97 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.85 -29.1 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -123.78 120.92 34.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.19 33.52 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 121.667 0.593 . . . . 0.0 113.166 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.46 -29.04 5.96 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.04 1.336 . . . . 0.0 113.251 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.64 68.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.127 0.571 . . . . 0.0 111.998 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -109.64 -11.79 14.72 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.2 mt -59.75 134.08 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.44 63.85 1.31 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.0 mtt -48.49 -26.48 2.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 114.157 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.52 24.67 2.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.945 1.248 . . . . 0.0 112.618 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -44.43 68.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.077 1.751 . . . . 0.0 111.762 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.7 m -96.97 9.67 41.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 m 67.54 -36.69 0.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.467 2.707 . . . . 0.0 114.825 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.2 p -126.53 73.21 73.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.04 1.736 . . . . 0.0 106.985 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -78.98 -165.81 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.783 2.989 . . . . 0.0 110.983 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -106.6 -19.18 13.75 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.609 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.23 157.76 29.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 121.64 2.018 . . . . 0.0 112.095 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.32 -25.88 1.31 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.617 1.567 . . . . 0.0 112.548 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.19 147.32 14.98 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -99.09 154.74 17.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.575 1.15 . . . . 0.0 111.091 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -156.04 112.25 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.166 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -78.17 134.98 37.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.163 1.347 . . . . 0.0 107.867 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.0 160.73 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.721 1.209 . . . . 0.0 109.903 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.34 150.09 3.69 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.523 0.678 . . . . 0.0 110.823 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.34 148.38 32.54 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.0 m95 66.06 -10.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -61.73 -50.74 80.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 121.748 2.067 . . . . 0.0 111.371 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -59.28 -31.26 94.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.037 1.825 . . . . 0.0 112.658 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.45 -37.21 78.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.652 0.781 . . . . 0.0 109.801 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mmm-85 -81.8 -27.98 33.4 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.771 1.168 . . . . 0.0 111.347 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -73.53 -30.43 63.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.873 0.76 . . . . 0.0 111.85 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.96 157.22 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 119.162 0.892 . . . . 0.0 111.74 -169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -52.06 148.88 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.186 1.794 . . . . 0.0 112.401 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -63.26 -32.81 74.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 113.55 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -70.07 -29.88 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.307 0.958 . . . . 0.0 111.054 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -86.11 -40.22 15.92 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 117.45 -1.262 . . . . 0.0 112.212 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -40.7 -49.97 3.07 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.877 1.217 . . . . 0.0 113.675 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.93 -31.12 68.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.6 -40.59 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.846 0.859 . . . . 0.0 110.314 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.24 -30.67 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -56.95 -41.24 77.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.987 -1.071 . . . . 0.0 110.802 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -66.59 -46.9 74.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.297 0.953 . . . . 0.0 109.026 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.73 -44.85 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.9 mtt -70.17 -38.17 75.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.447 -0.783 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -64.52 -37.02 86.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.209 0.913 . . . . 0.0 110.624 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.33 -28.06 66.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 110.592 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -113.31 -12.19 13.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.46 -58.1 8.32 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.663 1.119 . . . . 0.0 111.704 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.9 m -74.38 5.86 4.22 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.84 0.23 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.447 1.899 . . . . 0.0 109.401 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.2 t -118.38 -54.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.9 mtt -60.55 -22.15 63.33 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.889 1.275 . . . . 0.0 111.51 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.4 p -53.7 -40.67 66.23 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 111.844 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.19 -39.49 86.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.125 0.97 . . . . 0.0 109.785 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -84.34 -36.14 22.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.342 0.657 . . . . 0.0 111.093 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.1 -35.12 79.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.653 0.781 . . . . 0.0 109.101 170.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.46 -16.12 0.07 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 129.745 3.218 . . . . 0.0 116.623 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 p -77.3 -29.33 0.69 Allowed Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -67.68 -37.56 16.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.515 2.143 . . . . 0.0 112.756 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.8 mttm . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.016 1.726 . . . . 0.0 110.197 -176.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.68 137.62 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.31 150.49 25.86 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.882 1.673 . . . . 0.0 110.062 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.41 -28.5 66.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.912 0.885 . . . . 0.0 113.03 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.94 2.34 43.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.262 1.025 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.72 29.06 11.18 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.575 1.559 . . . . 0.0 112.586 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -109.23 141.29 41.71 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.138 1.469 . . . . 0.0 110.932 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.65 127.45 52.38 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.33 135.66 34.74 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -143.03 159.17 42.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.106 1.762 . . . . 0.0 111.534 -169.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.674 1.59 . . . . 0.0 107.933 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.13 124.0 34.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mm -87.05 118.45 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.54 81.0 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -65.18 145.64 13.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -131.67 131.5 43.19 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 168.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.6 129.86 35.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -44.74 -27.86 0.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.112 1.765 . . . . 0.0 114.482 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.15 15.59 0.16 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.216 1.006 . . . . 0.0 112.561 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.09 17.48 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.212 1.387 . . . . 0.0 112.432 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -129.5 154.55 46.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.166 1.386 . . . . 0.0 108.147 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.19 161.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.511 0.725 . . . . 0.0 112.303 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.22 128.21 34.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.731 1.212 . . . . 0.0 109.813 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.43 133.27 8.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 168.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.02 147.03 25.43 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -67.73 125.46 26.3 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -74.85 128.46 35.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.39 146.05 41.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 169.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.03 -44.4 2.6 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.113 0.863 . . . . 0.0 112.977 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -77.7 -34.48 52.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 109.219 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 54.65 39.48 31.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.654 1.982 . . . . 0.0 111.285 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 p -160.25 170.2 21.62 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -70.72 149.81 46.56 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.457 -0.777 . . . . 0.0 111.398 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -156.25 149.3 24.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.352 1.061 . . . . 0.0 108.6 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -47.79 137.48 10.09 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.583 1.953 . . . . 0.0 111.589 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.13 136.22 50.97 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.974 1.783 . . . . 0.0 109.802 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -162.13 139.76 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.184 2.194 . . . . 0.0 106.006 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.15 -97.75 1.44 Allowed Glycine 0 CA--C 1.531 1.072 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.63 167.31 23.89 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.4 mt -114.58 148.46 17.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -99.78 154.27 37.34 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.698 1.199 . . . . 0.0 110.275 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.27 117.91 4.74 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.939 1.759 . . . . 0.0 111.208 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.53 5.37 89.57 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.997 1.284 . . . . 0.0 112.809 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.48 127.04 34.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.41 160.71 29.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.175 0.99 . . . . 0.0 110.401 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.35 74.57 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.836 0.854 . . . . 0.0 112.92 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.8 -44.23 64.29 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.26 -43.08 96.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.8 1.24 . . . . 0.0 109.421 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.315 0.646 . . . . 0.0 111.509 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -60.14 -42.66 95.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.05 0.841 . . . . 0.0 109.307 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 89.7 m-85 -69.46 -24.53 63.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.604 1.093 . . . . 0.0 112.167 172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -66.99 -50.56 61.88 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.825 -1.172 . . . . 0.0 108.176 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.18 -30.52 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.187 0.903 . . . . 0.0 111.746 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.0 tp -57.3 -39.48 75.86 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -54.47 10.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.251 1.02 . . . . 0.0 110.915 172.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.78 -36.26 80.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.539 1.063 . . . . 0.0 111.893 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -95.72 -52.12 4.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.661 0.784 . . . . 0.0 111.36 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.37 -15.2 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.564 0.62 . . . . 0.0 112.375 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.01 56.46 24.55 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -173.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.4 mt -137.22 158.87 43.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.6 1.96 . . . . 0.0 106.537 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -125.45 -172.61 2.63 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.839 0.856 . . . . 0.0 111.312 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.448 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.0 mtt180 -64.99 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.968 3.307 . . . . 0.0 114.29 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -159.27 -14.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.185 0.994 . . . . 0.0 113.384 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -91.22 2.0 56.69 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.693 1.197 . . . . 0.0 113.093 -169.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.76 169.23 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.952 0.901 . . . . 0.0 110.498 -168.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -134.73 112.91 11.15 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.4 mt -71.51 130.51 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 120.086 1.312 . . . . 0.0 107.515 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.88 -36.22 6.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.007 0.523 . . . . 0.0 111.762 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.76 173.2 16.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.721 1.209 . . . . 0.0 108.938 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 t -150.91 162.26 41.13 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 170.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -64.39 143.33 57.98 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.767 0.712 . . . . 0.0 109.665 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -63.54 -30.66 71.75 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.818 0.447 . . . . 0.0 111.888 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.63 168.86 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.652 1.581 . . . . 0.0 108.093 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -64.67 124.79 22.82 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.13 0.572 . . . . 0.0 109.465 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.93 158.66 27.98 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -142.34 137.35 30.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -145.53 154.48 42.24 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -100.17 146.41 26.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.37 140.82 60.83 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.46 154.2 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.156 1.904 . . . . 0.0 109.093 169.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -44.43 79.9 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.04 -1.038 . . . . 0.0 113.631 -169.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.5 -15.69 62.92 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.131 0.973 . . . . 0.0 112.559 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 tp -99.29 -6.59 27.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.476 1.51 . . . . 0.0 111.929 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.55 145.11 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 120.797 1.635 . . . . 0.0 107.765 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -77.95 -43.68 29.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.838 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.1 m95 59.3 4.17 0.45 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.924 2.49 . . . . 0.0 114.561 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -118.9 -18.12 8.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.599 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -74.23 -38.4 63.53 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.846 -0.534 . . . . 0.0 111.49 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 46.53 87.44 0.12 Allowed Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 127.73 2.412 . . . . 0.0 112.164 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -60.31 138.99 21.89 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.032 1.047 . . . . 0.0 114.305 9.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -57.31 120.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.658 1.583 . . . . 0.0 107.523 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 47.1 t -91.71 126.84 36.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -119.5 -3.19 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.898 1.679 . . . . 0.0 112.08 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.0 37.6 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 120.408 1.458 . . . . 0.0 112.627 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -100.98 125.76 47.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 171.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -89.48 110.69 21.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.81 127.27 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 120.719 1.599 . . . . 0.0 112.153 -171.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -101.11 123.1 44.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -98.3 124.49 42.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.25 136.57 36.55 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.92 116.31 28.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.67 136.28 51.11 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 110.591 176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -93.92 136.9 33.72 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.7 tp -82.53 106.94 14.8 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -30.47 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 111.547 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 p -59.73 -60.96 3.01 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 111.436 171.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.54 176.01 38.66 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.166 0.889 . . . . 0.0 111.549 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -43.48 -37.09 2.25 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.441 1.497 . . . . 0.0 112.596 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.35 -21.26 61.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -129.74 -13.41 4.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.54 1.136 . . . . 0.0 112.77 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.57 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.23 50.16 1.62 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.116 0.966 . . . . 0.0 109.653 -169.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.7 mtt -45.46 -15.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 -169.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.06 22.53 10.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.958 1.708 . . . . 0.0 112.613 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 p -65.94 -32.22 73.59 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 112.073 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.58 -3.94 58.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -169.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m 66.33 -40.42 0.35 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.368 2.267 . . . . 0.0 113.072 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -128.15 79.24 74.24 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 126.932 2.093 . . . . 0.0 105.807 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.02 -161.94 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.781 2.987 . . . . 0.0 110.973 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -112.34 -38.41 4.7 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.55 -1.214 . . . . 0.0 112.557 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -106.35 161.3 14.68 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.267 1.849 . . . . 0.0 111.31 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -128.68 -29.44 2.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.575 1.55 . . . . 0.0 112.418 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.57 152.5 22.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -104.3 160.44 14.89 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.066 0.946 . . . . 0.0 111.827 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -154.31 117.85 4.6 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.337 1.855 . . . . 0.0 106.451 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -79.41 130.98 35.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.357 1.435 . . . . 0.0 107.443 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.81 162.27 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.476 1.11 . . . . 0.0 110.268 -170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.8 m -53.64 148.82 9.06 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.703 0.763 . . . . 0.0 111.75 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.18 144.95 48.78 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.38 -1.17 1.3 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -68.44 -49.83 29.86 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 121.385 1.902 . . . . 0.0 111.201 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -63.9 -32.2 66.42 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 121.286 1.495 . . . . 0.0 114.453 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 m -61.29 -31.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 120.093 1.315 . . . . 0.0 111.575 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.22 -14.89 34.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.58 1.082 . . . . 0.0 111.737 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -75.59 -33.77 60.6 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 109.502 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.3 153.77 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.499 1.52 . . . . 0.0 110.377 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.11 149.91 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.438 1.495 . . . . 0.0 111.016 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 m -57.13 -35.63 69.73 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.023 1.329 . . . . 0.0 114.159 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -71.3 -27.55 63.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.102 0.864 . . . . 0.0 111.388 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -98.18 -22.12 16.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.188 0.995 . . . . 0.0 112.358 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -49.54 -43.05 45.54 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.033 0.933 . . . . 0.0 110.947 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.37 -45.55 87.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.669 0.668 . . . . 0.0 111.787 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.45 -35.51 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.743 -0.598 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.56 -30.76 67.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.215 -0.928 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -61.59 -38.63 88.25 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.552 -1.342 . . . . 0.0 109.646 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -64.45 -42.68 95.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.18 1.355 . . . . 0.0 109.937 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.83 -46.55 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 118.934 0.788 . . . . 0.0 109.214 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 46.7 mtt -68.97 -38.07 79.16 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.88 -0.513 . . . . 0.0 110.512 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -66.68 -33.82 76.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.333 1.053 . . . . 0.0 110.764 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.03 -26.04 67.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.355 0.662 . . . . 0.0 111.406 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -120.39 -6.12 9.83 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.39 -58.41 6.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.209 0.913 . . . . 0.0 111.48 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -64.03 -27.15 68.92 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.071 -0.393 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.19 -40.42 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.096 -1.002 . . . . 0.0 108.612 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.02 -41.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.529 0.732 . . . . 0.0 109.345 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 49.2 mtt -71.97 -25.55 61.9 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.04 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.1 m -50.74 -41.14 56.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.477 1.035 . . . . 0.0 111.874 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.02 -37.78 88.58 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -99.7 22.2 11.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.924 0.89 . . . . 0.0 111.97 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.34 8.06 5.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.247 1.819 . . . . 0.0 109.644 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -75.39 -26.69 58.66 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.516 -0.74 . . . . 0.0 110.081 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.4 p -140.7 161.39 54.6 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 131.402 3.881 . . . . 0.0 102.635 169.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.1 73.86 5.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.942 1.761 . . . . 0.0 110.014 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.944 174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.39 138.49 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.15 149.25 48.84 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.731 1.612 . . . . 0.0 108.238 171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.86 -32.1 19.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.92 1.35 35.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.05 35.54 7.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.581 1.562 . . . . 0.0 111.531 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 13.8 m-85 -116.43 139.99 49.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.394 1.097 . . . . 0.0 109.858 -174.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -90.99 122.21 66.95 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.106 -1.426 . . . . 0.0 107.337 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.94 130.83 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.994 1.796 . . . . 0.0 110.238 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -139.1 166.45 24.48 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.211 1.404 . . . . 0.0 109.716 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.75 138.07 50.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.16 123.38 6.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.44 111.72 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -92.52 82.74 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.66 129.27 27.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 169.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.4 m -114.66 121.03 42.12 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -80.54 139.8 36.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.78 -6.52 12.08 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -73.36 -1.82 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.109 0.868 . . . . 0.0 110.629 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.68 26.27 25.36 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 124.995 1.283 . . . . 0.0 112.49 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -124.82 161.97 25.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 0.0 108.409 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.59 163.66 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.2 tpt -53.1 134.16 38.63 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.849 2.06 . . . . 0.0 111.742 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -164.19 137.93 5.37 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 168.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.624 0.726 . . . . 0.0 110.056 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -75.8 135.33 40.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.273 1.429 . . . . 0.0 107.674 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -82.43 130.76 35.17 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -49.1 130.88 19.25 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.023 2.129 . . . . 0.0 110.658 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.26 -35.46 1.97 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.755 1.169 . . . . 0.0 113.539 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -85.13 -35.31 21.84 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.179 0.99 . . . . 0.0 110.337 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.289 91.6 m-70 56.04 34.01 22.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.961 1.705 . . . . 0.0 113.317 -174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m -139.45 157.31 46.06 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.0 2.12 . . . . 0.0 106.288 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -65.92 158.36 28.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.548 1.139 . . . . 0.0 113.35 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.43 150.17 36.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 0.0 109.515 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -66.96 160.69 68.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.668 1.587 . . . . 0.0 111.157 169.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.73 -133.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.738 3.625 . . . . 0.0 110.05 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 76.2 116.92 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.278 2.231 . . . . 0.0 110.225 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.62 18.59 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 153.84 51.19 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.599 1.095 . . . . 0.0 112.888 -169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -90.27 139.01 18.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.839 1.656 . . . . 0.0 107.795 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.53 154.5 68.69 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.347 0.659 . . . . 0.0 110.629 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.82 117.63 4.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.884 1.722 . . . . 0.0 111.341 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.73 6.41 89.4 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.909 1.242 . . . . 0.0 112.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -81.59 130.22 34.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.78 160.37 28.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.409 1.084 . . . . 0.0 110.398 177.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.67 71.21 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 124.456 1.102 . . . . 0.0 112.445 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.05 -42.21 66.55 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.48 -42.57 96.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.869 1.268 . . . . 0.0 109.362 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -37.15 85.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 111.925 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -59.78 -44.94 93.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.122 0.873 . . . . 0.0 109.651 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.4 m-85 -70.31 -29.78 66.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.168 -0.958 . . . . 0.0 112.015 174.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -62.33 -47.6 83.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.502 1.046 . . . . 0.0 109.751 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.16 70.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.91 0.484 . . . . 0.0 111.008 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -58.31 -39.67 79.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.482 1.113 . . . . 0.0 109.939 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -74.07 -50.82 17.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.24 1.416 . . . . 0.0 111.661 175.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.94 -35.0 79.75 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.967 1.258 . . . . 0.0 112.027 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.58 -50.38 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.994 0.918 . . . . 0.0 111.816 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.4 -13.53 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.661 0.785 . . . . 0.0 111.469 -169.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.26 40.88 96.91 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.68 150.23 41.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 107.341 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.0 m -115.22 -175.61 2.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.008 0.923 . . . . 0.0 111.071 -169.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.3 mtt180 -66.09 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.356 2.663 . . . . 0.0 114.203 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -161.4 -16.23 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.773 1.229 . . . . 0.0 112.866 -169.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.59 -0.55 57.37 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.472 1.109 . . . . 0.0 112.484 -169.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.35 168.55 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.326 1.45 . . . . 0.0 108.326 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -137.83 119.97 15.62 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -74.6 129.65 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 120.23 1.377 . . . . 0.0 107.582 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.17 -32.12 7.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.81 0.444 . . . . 0.0 111.549 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.76 167.24 30.61 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.088 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 p -149.77 160.16 43.77 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.005 1.322 . . . . 0.0 107.915 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -63.62 148.22 49.49 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.734 -0.604 . . . . 0.0 110.791 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -64.84 -37.06 86.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.79 0.436 . . . . 0.0 111.253 -171.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.84 172.95 14.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.575 1.95 . . . . 0.0 107.39 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -63.36 125.68 24.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.588 0.755 . . . . 0.0 110.148 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.62 133.44 37.27 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.38 150.38 32.35 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.218 0.917 . . . . 0.0 110.273 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.57 160.36 43.86 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.47 1.108 . . . . 0.0 109.077 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -91.76 128.36 37.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.62 148.22 95.0 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.523 1.129 . . . . 0.0 109.282 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.21 155.7 68.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.671 2.247 . . . . 0.0 109.755 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -54.32 -35.21 62.43 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.79 -24.2 55.93 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.194 0.998 . . . . 0.0 112.971 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.49 -17.36 15.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.947 0.899 . . . . 0.0 111.759 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.4 t -49.01 132.75 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 168.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.74 107.19 16.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -89.21 -1.93 58.28 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.495 0.718 . . . . 0.0 111.021 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.98 -20.82 21.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.754 1.622 . . . . 0.0 110.013 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 p -87.24 162.93 17.17 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.815 0.846 . . . . 0.0 108.811 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -136.69 113.24 9.99 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -54.61 152.4 19.31 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-N 120.21 1.111 . . . . 0.0 113.116 -6.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.44 129.88 26.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.2 t -90.38 109.73 20.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.58 -6.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.825 1.25 . . . . 0.0 112.024 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.445 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -157.46 169.61 34.43 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.086 1.312 . . . . 0.0 113.014 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -115.18 122.91 47.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -101.98 134.06 45.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -152.78 146.74 25.33 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.904 1.229 . . . . 0.0 114.147 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -104.72 127.82 52.62 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 102.788 -3.042 . . . . 0.0 102.788 168.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -97.25 135.72 38.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -112.68 129.75 56.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 110.02 16.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -104.95 127.81 52.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -83.74 133.53 34.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.0 137.1 51.1 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.34 -38.88 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.7 p -60.56 -61.7 2.4 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.0 1.72 . . . . 0.0 112.145 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 172.24 38.65 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.847 1.259 . . . . 0.0 112.491 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.8 63.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.657 0.783 . . . . 0.0 112.878 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.35 -9.94 5.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.402 1.081 . . . . 0.0 112.744 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.47 130.93 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 169.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.04 49.42 1.66 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.14 0.976 . . . . 0.0 109.146 -170.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.5 ptp -64.53 28.81 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.467 2.307 . . . . 0.0 116.134 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -123.28 21.76 9.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.524 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -35.36 72.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.897 2.079 . . . . 0.0 111.873 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -5.81 56.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.063 1.745 . . . . 0.0 113.306 -170.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.3 m 68.16 -37.82 0.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 128.607 2.763 . . . . 0.0 113.389 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.7 p -124.9 73.14 64.24 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.72 -177.65 2.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.302 2.668 . . . . 0.0 110.979 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.4 -8.2 21.35 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.477 -1.249 . . . . 0.0 111.573 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.54 151.6 50.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 121.341 1.882 . . . . 0.0 112.876 -170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.58 -25.91 3.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.229 1.812 . . . . 0.0 112.648 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.65 157.71 29.97 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -106.99 159.97 15.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -150.47 120.89 7.37 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.047 1.739 . . . . 0.0 106.391 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -82.82 124.19 30.06 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.13 163.15 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.21 1.004 . . . . 0.0 110.953 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.6 m -50.12 144.94 6.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.629 0.772 . . . . 0.0 110.143 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -54.96 -36.12 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.888 0.475 . . . . 0.0 111.964 -169.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -100.39 12.19 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.85 -49.77 10.29 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.53 -32.54 88.07 Favored 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 121.842 1.693 . . . . 0.0 113.782 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -31.38 49.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 119.807 1.185 . . . . 0.0 111.242 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -86.05 -21.92 27.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.6 1.091 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -81.61 -31.1 32.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.69 0.677 . . . . 0.0 111.665 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.1 160.37 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.325 0.584 . . . . 0.0 110.448 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.86 149.01 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.109 0.964 . . . . 0.0 111.261 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -57.42 -35.04 69.56 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.999 1.319 . . . . 0.0 113.912 -169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -73.58 -27.03 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.788 0.722 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -82.53 -38.65 23.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.934 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -42.96 -50.64 5.82 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.874 1.215 . . . . 0.0 112.771 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.62 -26.25 60.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.2 -42.92 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.6 -32.67 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.576 -0.703 . . . . 0.0 110.774 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.11 -29.12 70.11 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.28 -0.888 . . . . 0.0 112.637 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -64.5 -47.89 77.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.714 1.143 . . . . 0.0 108.946 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.23 -44.79 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.1 mtt -64.67 -46.68 81.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.601 -1.19 . . . . 0.0 111.038 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -29.77 69.44 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 121.433 1.924 . . . . 0.0 111.068 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.81 -36.41 82.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.635 0.374 . . . . 0.0 110.357 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -100.02 -16.67 17.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.4 1.08 . . . . 0.0 113.366 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.4 6.87 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.995 1.318 . . . . 0.0 109.899 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -65.25 -21.51 66.75 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.3 -42.45 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.52 -39.37 40.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.2 mtt -72.58 -20.17 61.36 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.413 -0.804 . . . . 0.0 111.122 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.7 m -64.51 -20.27 66.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.865 1.212 . . . . 0.0 112.528 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.4 -29.0 47.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 172.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -98.2 -37.27 9.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.239 1.016 . . . . 0.0 111.224 -169.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -94.35 19.58 9.35 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.767 2.027 . . . . 0.0 110.204 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -61.94 -31.1 71.4 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.145 1.378 . . . . 0.0 113.202 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -55.97 12.85 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 112.001 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.86 -18.28 21.95 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 114.079 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.2 tttp . . . . . 0 C--O 1.256 1.415 0 CA-C-N 119.771 1.169 . . . . 0.0 109.59 176.635 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -129.08 147.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.08 -44.7 68.55 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.126 0.57 . . . . 0.0 111.252 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -154.34 -86.22 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.429 1.092 . . . . 0.0 109.717 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 -45.92 13.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.94 15.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.943 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -99.32 125.57 45.0 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.637 1.718 . . . . 0.0 108.547 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -85.68 126.07 67.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 117.368 -1.301 . . . . 0.0 107.688 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.09 127.49 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.28 1.987 . . . . 0.0 109.244 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -137.27 166.34 24.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.218 1.407 . . . . 0.0 108.99 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.43 141.63 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 127.006 2.122 . . . . 0.0 105.84 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.76 132.71 10.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.89 129.37 48.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.61 86.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 168.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.48 135.84 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.08 124.2 46.32 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.33 127.32 32.62 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 170.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -53.75 -4.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.54 2.336 . . . . 0.0 116.088 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.35 -12.48 60.27 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.8 1.182 . . . . 0.0 111.423 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.42 41.83 2.67 Favored Glycine 0 C--N 1.342 0.916 0 C-N-CA 124.791 1.186 . . . . 0.0 111.811 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.69 155.47 44.91 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.41 162.18 13.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.182 0.993 . . . . 0.0 112.152 -169.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.8 tpp -53.54 130.67 36.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.037 1.735 . . . . 0.0 111.36 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -159.27 131.11 6.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 166.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.19 26.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.194 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -83.62 134.72 34.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.65 130.6 35.11 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.79 145.19 56.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.396 0.679 . . . . 0.0 110.588 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.27 -43.57 2.05 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.947 1.26 . . . . 0.0 112.534 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -78.63 -37.97 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.377 1.071 . . . . 0.0 109.844 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.316 24.3 m170 57.84 43.61 21.41 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.807 2.043 . . . . 0.0 113.734 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 p -146.33 171.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 107.034 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -73.21 156.04 38.96 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.212 -0.93 . . . . 0.0 111.542 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.514 ' NE2' HE22 ' A' ' 37' ' ' GLN . 4.7 tt0 -147.54 145.67 29.17 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.605 0.762 . . . . 0.0 109.968 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.62 143.03 87.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.697 1.199 . . . . 0.0 109.965 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -69.75 139.08 39.38 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.455 2.103 . . . . 0.0 110.238 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.514 HE22 ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -167.48 151.33 6.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.422 1.889 . . . . 0.0 109.035 170.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.94 139.93 7.42 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 146.72 45.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 mt -80.7 138.89 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -96.64 154.77 38.36 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 123.911 0.884 . . . . 0.0 110.52 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.92 123.14 12.72 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.388 2.059 . . . . 0.0 114.703 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.76 4.52 66.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 113.991 -1.458 . . . . 0.0 113.244 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -86.17 123.94 32.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.646 1.223 . . . . 0.0 108.545 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -72.92 162.4 29.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.543 1.137 . . . . 0.0 110.846 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.86 79.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.4 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.84 9.4 6.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.81 . . . . 0.0 111.65 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -111.59 -54.11 2.64 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.19 72.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.541 1.136 . . . . 0.0 112.79 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -60.67 -42.76 97.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.037 0.835 . . . . 0.0 109.567 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -74.18 -24.45 59.37 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.523 -1.36 . . . . 0.0 111.771 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.6 -50.78 71.2 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.08 -1.012 . . . . 0.0 108.434 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.48 -35.66 81.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.102 0.561 . . . . 0.0 111.906 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.68 -41.21 76.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.935 1.294 . . . . 0.0 110.455 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -46.65 54.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.185 0.994 . . . . 0.0 110.551 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.32 -40.26 95.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.294 0.952 . . . . 0.0 111.788 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.44 -51.95 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.496 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.83 -9.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.32 64.38 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 120.938 -1.101 . . . . 0.0 112.339 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.6 mt -105.96 164.59 11.84 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.981 0.912 . . . . 0.0 108.62 171.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -126.96 -175.95 3.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.064 1.346 . . . . 0.0 111.005 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.95 41.24 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.853 2.061 . . . . 0.0 113.206 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -159.76 -21.26 0.07 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.319 0.648 . . . . 0.0 112.725 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -85.31 -0.12 53.76 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.19 168.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.42 1.088 . . . . 0.0 110.523 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -142.93 121.26 12.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 126.087 1.755 . . . . 0.0 106.853 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.89 130.53 36.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 120.808 1.64 . . . . 0.0 107.646 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.66 -34.71 7.23 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.38 0.672 . . . . 0.0 110.886 171.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.79 172.5 18.37 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.37 1.068 . . . . 0.0 109.225 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -149.31 160.58 43.28 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 p -66.13 142.2 57.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.921 0.782 . . . . 0.0 109.375 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -68.73 -22.55 64.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.933 0.493 . . . . 0.0 111.984 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.44 173.58 11.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.534 1.934 . . . . 0.0 107.725 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -76.8 117.15 18.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.49 137.53 52.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -147.35 147.29 30.17 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.745 -0.597 . . . . 0.0 109.795 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -150.76 163.42 38.62 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.109 1.363 . . . . 0.0 107.979 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -87.51 149.45 24.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.361 0.6 . . . . 0.0 109.889 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.49 137.35 32.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.55 151.81 75.14 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.662 2.241 . . . . 0.0 108.426 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -21.81 66.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -169.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.05 -28.45 62.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.823 0.849 . . . . 0.0 112.184 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.3 tp -97.12 -24.13 15.89 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.396 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -45.02 136.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -75.15 -42.51 55.92 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.976 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.3 m95 59.73 1.95 0.33 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.731 2.413 . . . . 0.0 114.156 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -97.57 -23.79 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.014 1.325 . . . . 0.0 111.51 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -73.13 153.41 40.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.868 1.667 . . . . 0.0 109.053 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.94 112.2 10.43 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 117.785 -1.103 . . . . 0.0 108.263 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.99 151.88 17.38 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 CA-C-N 120.509 1.217 . . . . 0.0 111.832 -10.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.35 131.55 27.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.5 p -90.35 127.96 36.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -169.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -105.96 -4.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.296 1.439 . . . . 0.0 110.986 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.15 30.91 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 118.969 0.804 . . . . 0.0 111.705 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.23 119.88 40.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -92.89 130.61 38.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 169.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 142.39 22.41 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.756 1.616 . . . . 0.0 114.447 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -101.77 130.97 48.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -95.38 141.93 28.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -111.44 135.19 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 108.392 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.1 tp -90.83 102.5 15.26 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.44 127.33 46.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.219 0.608 . . . . 0.0 110.207 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -85.19 138.06 32.61 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 168.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -70.4 132.56 45.81 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -112.85 -41.22 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.0 m -139.01 127.7 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.92 -171.27 43.36 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.92 -51.39 0.19 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.416 3.086 . . . . 0.0 112.907 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.03 -34.57 22.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 111.102 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.66 -5.66 19.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.859 0.864 . . . . 0.0 112.536 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.84 142.86 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -132.07 -45.42 0.94 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -170.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mtt 60.17 0.01 0.27 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.85 25.9 3.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.645 2.02 . . . . 0.0 111.19 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.4 t -86.1 -30.31 22.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -85.14 168.38 14.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.176 1.791 . . . . 0.0 110.565 -169.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 m -70.95 -33.52 70.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.985 0.514 . . . . 0.0 111.533 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -142.77 88.55 8.47 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -67.16 -166.07 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.407 2.071 . . . . 0.0 113.547 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' CD ' HE22 ' A' ' 34' ' ' GLN . 2.6 tp10 -128.28 -54.67 1.27 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.802 170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -100.47 168.34 9.8 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.398 0.999 . . . . 0.0 112.561 -169.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.92 -8.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.377 1.071 . . . . 0.0 113.115 176.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.9 149.22 19.89 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -113.45 150.14 33.21 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.453 1.501 . . . . 0.0 110.226 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -148.82 114.02 5.52 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.569 1.547 . . . . 0.0 107.31 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -77.8 133.26 38.25 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.87 160.1 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.973 1.309 . . . . 0.0 109.322 -172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 m -53.65 152.94 4.74 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 110.725 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.41 151.19 13.55 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 67.39 -15.79 0.17 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -57.89 -45.58 99.78 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 121.284 1.856 . . . . 0.0 111.984 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -63.85 -25.44 67.68 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.769 1.646 . . . . 0.0 114.373 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.09 -37.23 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.691 1.132 . . . . 0.0 108.982 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -85.98 -15.9 40.04 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.125 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -82.72 -32.19 28.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.527 1.058 . . . . 0.0 111.955 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m -69.25 164.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 112.204 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.28 151.16 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.471 1.108 . . . . 0.0 110.652 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 m -57.37 -36.16 70.87 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.974 1.31 . . . . 0.0 113.371 -169.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -76.71 -24.72 53.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.183 0.901 . . . . 0.0 111.673 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -87.34 -27.49 22.8 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.431 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -42.83 -50.82 5.63 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.917 1.287 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.89 -37.62 79.12 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.157 0.435 . . . . 0.0 111.158 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.83 -45.46 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.62 -32.15 70.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.906 0.483 . . . . 0.0 110.339 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -57.65 -39.83 77.89 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.443 1.097 . . . . 0.0 110.301 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -63.44 -49.67 72.78 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.948 1.249 . . . . 0.0 108.97 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.46 -45.23 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.84 -47.11 82.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.126 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.18 66.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.181 1.809 . . . . 0.0 112.284 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -66.82 -29.51 69.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.47 0.577 . . . . 0.0 110.427 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -108.66 -21.67 12.59 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.09 0.956 . . . . 0.0 113.455 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.2 36.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.241 1.016 . . . . 0.0 109.816 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 m -65.35 -18.58 65.43 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.4 -34.47 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.004 0.82 . . . . 0.0 108.8 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 88.1 t -71.68 -40.79 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 mtt -59.22 -23.03 61.95 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.541 -1.218 . . . . 0.0 111.759 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.0 m -54.16 -31.34 52.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.822 1.646 . . . . 0.0 112.042 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.33 -28.96 21.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.277 1.031 . . . . 0.0 111.507 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 -30.52 8.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.082 . . . . 0.0 112.781 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -102.65 18.61 20.89 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.168 2.187 . . . . 0.0 109.777 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -58.77 -26.69 64.27 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 113.366 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -60.5 7.57 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.157 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.08 -25.68 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.28 2.653 . . . . 0.0 114.119 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt . . . . . 0 C--O 1.254 1.328 0 CA-C-N 119.495 1.043 . . . . 0.0 108.685 -178.14 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.16 144.14 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 170.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.26 -40.7 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -166.74 104.67 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.772 0.829 . . . . 0.0 110.707 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t0 58.42 44.79 17.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.077 2.151 . . . . 0.0 113.301 169.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.95 34.26 18.78 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.845 -0.975 . . . . 0.0 112.32 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -115.89 132.04 56.76 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.588 1.194 . . . . 0.0 110.552 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -88.41 123.72 67.66 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 130.7 10.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.322 2.015 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.47 163.54 31.69 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.395 1.078 . . . . 0.0 110.655 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.21 130.79 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.667 1.987 . . . . 0.0 107.209 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.38 122.36 7.55 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.48 104.23 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.7 t -87.33 80.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.24 131.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -112.19 128.76 56.33 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -94.58 23.47 5.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 57.05 -1.13 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.651 1.98 . . . . 0.0 116.206 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -99.07 -1.62 39.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.76 0.709 . . . . 0.0 111.914 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.36 27.57 29.99 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 119.196 0.907 . . . . 0.0 111.169 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -141.38 156.2 45.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.992 1.717 . . . . 0.0 106.641 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.01 168.88 19.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.662 0.785 . . . . 0.0 112.712 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.5 tpt -48.1 127.03 11.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.119 2.168 . . . . 0.0 112.017 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -160.65 133.25 6.28 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 168.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.03 29.12 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.38 0.672 . . . . 0.0 109.981 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.9 ttm105 -75.14 140.59 43.48 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.674 1.19 . . . . 0.0 108.184 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -86.23 122.37 30.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.341 1.056 . . . . 0.0 109.679 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -53.98 138.19 37.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.809 1.643 . . . . 0.0 108.611 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.7 -37.19 1.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.07 1.319 . . . . 0.0 113.836 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -90.9 -29.91 17.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.504 1.152 . . . . 0.0 111.267 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 55.56 41.3 30.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.001 1.72 . . . . 0.0 112.602 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 p -145.43 169.76 17.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.055 1.342 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -83.48 148.31 27.31 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.754 -1.216 . . . . 0.0 111.048 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -148.81 156.88 42.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.974 0.893 . . . . 0.0 111.101 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -67.98 163.35 51.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.952 2.101 . . . . 0.0 110.007 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.71 -106.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.208 3.272 . . . . 0.0 110.808 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 63.83 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.185 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.03 144.25 18.34 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.48 148.77 45.91 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.19 133.69 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.71 126.61 87.04 Favored Pre-proline 0 C--O 1.232 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 108.567 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.02 119.23 6.16 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.982 1.788 . . . . 0.0 112.619 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.85 3.69 79.86 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.078 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.07 120.67 41.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -70.62 162.51 28.81 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.155 0.582 . . . . 0.0 111.483 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.25 -45.72 8.7 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 127.18 2.192 . . . . 0.0 113.412 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.7 -47.36 40.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.59 -37.9 82.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.306 0.642 . . . . 0.0 110.511 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.53 -34.97 76.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -60.15 -45.72 92.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -67.68 -27.4 66.81 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.293 -0.88 . . . . 0.0 112.844 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -65.17 -51.13 62.98 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 120.885 -1.135 . . . . 0.0 109.009 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.12 70.54 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.138 0.881 . . . . 0.0 110.911 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.93 -39.87 79.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.27 1.028 . . . . 0.0 109.371 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -52.08 14.83 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.321 1.049 . . . . 0.0 111.415 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.77 -36.98 84.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.236 0.925 . . . . 0.0 111.446 -172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -104.02 -39.01 6.73 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.94 -20.12 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.255 0.622 . . . . 0.0 110.085 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.17 19.42 78.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.488 -1.382 . . . . 0.0 111.945 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 mt -102.22 151.64 21.98 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.521 1.128 . . . . 0.0 108.085 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -113.46 177.45 4.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.693 -0.629 . . . . 0.0 110.064 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -69.99 58.5 0.16 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.073 1.749 . . . . 0.0 112.744 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -163.44 -26.98 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.245 1.818 . . . . 0.0 111.319 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -89.23 -3.39 58.57 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.3 165.26 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.352 0.661 . . . . 0.0 109.741 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -135.43 119.73 17.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.3 mt -74.9 126.55 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -35.1 6.07 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.151 0.98 . . . . 0.0 110.697 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.63 171.67 19.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.353 1.461 . . . . 0.0 108.783 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -148.43 160.57 42.9 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 108.114 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -62.86 148.32 47.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.349 0.522 . . . . 0.0 110.341 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -62.16 -36.71 82.68 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.702 0.401 . . . . 0.0 111.308 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.35 175.03 11.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.4 1.88 . . . . 0.0 107.226 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 70.5 m95 -64.05 127.31 30.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.346 0.658 . . . . 0.0 109.572 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.43 141.21 39.85 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -153.47 151.18 29.56 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.686 -0.634 . . . . 0.0 110.208 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -155.94 160.87 40.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.743 1.617 . . . . 0.0 107.536 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 145.94 24.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.379 0.609 . . . . 0.0 109.593 172.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.74 151.85 93.38 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 125.556 1.542 . . . . 0.0 108.365 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -63.31 152.75 78.37 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 N-CA-C 108.028 -1.566 . . . . 0.0 108.028 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -49.4 -48.28 47.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.07 -17.93 64.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.09 0.956 . . . . 0.0 112.913 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.9 tp -102.57 -9.09 20.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.785 1.234 . . . . 0.0 111.838 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.9 t -56.49 142.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.47 -47.84 30.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -168.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.2 m95 55.36 11.23 0.55 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.9 2.08 . . . . 0.0 114.328 -170.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.46 -24.8 13.79 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.412 1.085 . . . . 0.0 111.175 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.6 p -90.89 168.84 11.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.078 0.951 . . . . 0.0 109.789 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.96 116.87 18.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -63.67 162.37 57.13 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.89 0.996 . . . . 0.0 109.952 -10.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.33 132.86 25.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -90.4 108.72 19.96 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.4 pt -94.12 -15.29 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.418 1.887 . . . . 0.0 111.596 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.25 172.8 34.13 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 120.099 1.318 . . . . 0.0 112.848 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -119.22 123.57 44.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 68.0 tttt -98.46 131.77 44.45 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 172.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.77 137.37 18.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.857 1.208 . . . . 0.0 113.089 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -100.81 131.73 46.55 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -100.28 132.92 45.38 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -109.14 131.34 55.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -86.94 108.4 18.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.09 125.07 50.58 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.885 0.874 . . . . 0.0 108.867 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -83.56 133.32 34.87 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 168.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.3 tp -68.74 124.46 23.71 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.15 -49.71 11.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -135.81 124.35 23.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.6 -163.07 15.56 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.81 -48.17 0.26 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 128.79 2.836 . . . . 0.0 113.175 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.7 -32.74 10.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.725 1.61 . . . . 0.0 112.023 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.78 -24.53 31.03 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.441 0.696 . . . . 0.0 110.695 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -64.76 131.3 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -134.95 -32.08 0.98 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.6 0.76 . . . . 0.0 111.691 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.5 mtt 64.6 -49.63 0.32 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.508 3.123 . . . . 0.0 113.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.48 25.22 2.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.654 1.182 . . . . 0.0 112.986 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -65.46 -28.3 69.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.143 0.577 . . . . 0.0 110.322 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -95.42 10.66 35.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.98 1.312 . . . . 0.0 113.127 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.28 -36.71 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 129.695 3.198 . . . . 0.0 115.793 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 p -128.28 60.88 50.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.74 1.616 . . . . 0.0 108.993 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -70.78 177.84 5.85 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.048 2.499 . . . . 0.0 110.29 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.46 -26.08 35.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.426 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -99.43 139.14 35.53 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.627 1.558 . . . . 0.0 112.684 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -112.53 -31.08 6.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.098 1.759 . . . . 0.0 112.397 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.67 151.81 16.09 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -102.2 155.59 18.11 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.87 0.868 . . . . 0.0 111.901 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -152.58 111.51 3.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.26 1.824 . . . . 0.0 106.947 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -74.17 138.51 43.85 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.874 0.761 . . . . 0.0 109.24 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.41 159.93 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.864 1.265 . . . . 0.0 109.158 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.8 m -55.28 152.55 8.19 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.953 0.501 . . . . 0.0 110.125 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 165.52 13.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.7 m95 65.88 -24.67 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.888 1.675 . . . . 0.0 115.075 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.97 -46.02 96.65 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 120.483 1.492 . . . . 0.0 111.691 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.98 -29.18 81.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 122.012 1.754 . . . . 0.0 113.263 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.42 -10.24 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 111.89 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -108.53 -23.08 12.0 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.898 -1.126 . . . . 0.0 110.97 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.91 -35.73 57.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.314 0.961 . . . . 0.0 111.68 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.89 166.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.869 0.759 . . . . 0.0 111.509 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.77 150.68 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.421 1.088 . . . . 0.0 110.565 174.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 p -53.33 -40.67 65.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.618 1.567 . . . . 0.0 113.633 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -70.33 -32.36 70.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.365 0.53 . . . . 0.0 110.611 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -72.95 -38.61 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -51.6 -48.21 63.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.519 1.054 . . . . 0.0 110.879 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.66 -26.04 62.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.9 -46.51 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.22 -0.925 . . . . 0.0 108.67 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -35.34 80.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 110.976 -170.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -61.19 -28.04 68.85 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.641 -1.287 . . . . 0.0 112.983 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -64.21 -46.76 82.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.3 t -60.81 -48.5 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 109.391 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 mtt -66.43 -37.07 84.38 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.093 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -47.29 82.02 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 119.456 1.025 . . . . 0.0 110.455 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -60.5 -32.58 71.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.264 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -107.8 4.01 25.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -57.44 10.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.476 1.489 . . . . 0.0 110.994 -169.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -59.71 -30.54 68.88 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.237 0.615 . . . . 0.0 111.715 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.02 -8.35 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.736 1.214 . . . . 0.0 111.038 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.22 -35.95 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 O-C-N 121.355 -0.841 . . . . 0.0 109.402 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 54.8 tpp -76.82 -45.33 29.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.269 0.628 . . . . 0.0 111.051 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.6 m -62.97 -31.09 72.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.93 -0.481 . . . . 0.0 111.61 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.48 -34.12 70.54 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.254 0.622 . . . . 0.0 109.868 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -99.25 0.81 43.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.977 0.911 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.55 -31.84 13.72 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.592 1.157 . . . . 0.0 109.247 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -65.23 -33.52 76.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.505 1.922 . . . . 0.0 111.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -56.91 22.33 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.397 -0.811 . . . . 0.0 112.434 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.34 -29.64 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.044 2.496 . . . . 0.0 112.534 174.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.587 1.555 . . . . 0.0 109.889 -173.541 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 mm -130.57 134.95 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.89 141.63 53.13 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 107.337 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -48.8 -30.29 5.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -168.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.37 -5.36 44.45 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.96 38.74 3.75 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 126.059 1.79 . . . . 0.0 110.663 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.0 139.77 53.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.095 1.447 . . . . 0.0 111.628 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -85.57 120.54 73.1 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 116.776 -1.583 . . . . 0.0 107.853 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.42 137.07 27.44 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 121.822 1.681 . . . . 0.0 111.037 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -145.6 157.51 43.97 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.153 1.381 . . . . 0.0 111.609 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.1 74.61 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.419 2.287 . . . . 0.0 107.934 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.77 128.26 44.77 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -86.42 110.11 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -16.26 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 116.89 -1.529 . . . . 0.0 114.742 -169.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm 19.24 109.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 129.127 2.971 . . . . 0.0 114.929 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.2 138.44 33.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -68.51 -4.56 15.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.98 -7.55 54.88 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.852 0.751 . . . . 0.0 110.56 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.86 37.71 4.35 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 126.131 1.824 . . . . 0.0 112.118 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -133.28 155.79 48.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.551 0.74 . . . . 0.0 109.038 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.68 156.89 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.31 1.044 . . . . 0.0 111.295 -168.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.98 131.44 44.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.124 1.769 . . . . 0.0 110.309 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -158.86 139.1 12.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.96 144.24 23.2 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -70.95 138.26 49.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -86.57 125.49 33.83 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.76 137.59 57.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.609 2.364 . . . . 0.0 109.996 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.13 -31.68 1.33 Allowed Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.062 1.315 . . . . 0.0 113.716 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -86.35 -34.15 20.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.453 1.101 . . . . 0.0 110.455 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 57.29 33.46 23.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.046 1.738 . . . . 0.0 112.575 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 p -149.87 -177.79 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.245 1.818 . . . . 0.0 107.231 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -80.46 160.43 25.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.029 -1.044 . . . . 0.0 112.975 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.1 147.74 27.45 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.216 1.006 . . . . 0.0 108.987 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -60.59 143.76 89.9 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.301 1.44 . . . . 0.0 110.21 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.22 153.08 55.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.306 2.004 . . . . 0.0 111.065 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -171.79 149.55 2.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 109.845 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.91 134.28 3.37 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.179 -2.369 . . . . 0.0 107.179 169.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.7 171.72 55.15 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.247 1.024 . . . . 0.0 111.639 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 mt -96.67 146.04 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.815 0.846 . . . . 0.0 109.064 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -87.61 131.71 42.86 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.565 1.546 . . . . 0.0 108.39 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.44 118.07 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.23 1.953 . . . . 0.0 114.08 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.48 3.57 90.03 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.037 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -86.98 131.67 34.02 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.063 0.945 . . . . 0.0 108.554 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.99 161.26 30.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.827 1.251 . . . . 0.0 110.685 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.17 -44.26 64.55 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 125.168 1.387 . . . . 0.0 112.992 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.24 -48.96 48.05 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.6 -39.59 77.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.597 1.159 . . . . 0.0 109.919 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 -34.42 63.86 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.044 0.938 . . . . 0.0 111.983 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -57.33 -39.87 76.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.95 0.795 . . . . 0.0 110.065 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.37 -26.39 66.44 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.742 1.155 . . . . 0.0 113.511 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.33 -49.9 69.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.153 1.342 . . . . 0.0 108.597 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.39 75.56 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 119.451 -0.309 . . . . 0.0 111.316 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.2 -44.9 84.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.753 1.221 . . . . 0.0 109.715 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.1 -47.3 80.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.634 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.72 -39.49 94.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.261 1.391 . . . . 0.0 112.772 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -82.47 -46.67 13.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.166 1.386 . . . . 0.0 110.577 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 m -132.16 1.03 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.348 1.059 . . . . 0.0 112.816 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.84 32.47 79.58 Favored Glycine 0 CA--C 1.521 0.447 0 O-C-N 120.909 -1.12 . . . . 0.0 112.164 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.78 154.54 18.82 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 m -117.49 179.03 4.17 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.842 0.857 . . . . 0.0 109.106 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -73.15 46.75 0.18 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.67 1.588 . . . . 0.0 115.242 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -163.42 -20.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.124 1.769 . . . . 0.0 111.785 -171.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.1 2.92 53.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.091 1.356 . . . . 0.0 112.961 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.75 170.19 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.506 1.522 . . . . 0.0 108.91 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -138.0 120.25 15.77 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.3 mt -77.66 128.37 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 120.658 1.572 . . . . 0.0 107.879 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -104.95 -34.8 7.9 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.842 0.857 . . . . 0.0 111.467 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 173.79 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.156 1.382 . . . . 0.0 108.493 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -150.49 160.88 43.46 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 m -56.02 133.39 51.76 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -66.14 -27.04 67.73 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -147.33 168.09 22.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.248 1.419 . . . . 0.0 108.61 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -68.73 117.93 11.06 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.9 156.7 31.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -143.46 154.35 43.58 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.918 1.687 . . . . 0.0 108.029 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -146.1 172.67 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.639 . . . . 0.0 107.721 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -105.45 133.15 50.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.2 mt -67.75 148.72 98.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.33 146.09 25.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.529 2.153 . . . . 0.0 108.287 169.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -56.07 -44.32 78.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.749 1.159 . . . . 0.0 113.146 -168.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.22 -15.19 62.2 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 112.783 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.18 -0.33 33.36 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.074 1.75 . . . . 0.0 111.618 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.61 141.22 13.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -86.61 128.51 35.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -107.57 -0.36 22.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.308 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -106.56 -12.23 15.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.28 1.032 . . . . 0.0 111.446 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.6 p -73.97 -35.92 64.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 111.535 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 40.47 87.98 0.1 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.164 2.585 . . . . 0.0 112.347 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.1 143.42 42.21 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.03 1.046 . . . . 0.0 114.148 10.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -62.58 131.55 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.9 t -94.01 112.31 24.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.3 pt -97.61 -8.89 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.179 0.991 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.23 176.33 48.01 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.867 1.212 . . . . 0.0 112.827 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -101.95 121.2 41.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -82.89 112.48 19.72 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 103.115 -2.92 . . . . 0.0 103.115 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.61 51.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.985 1.721 . . . . 0.0 112.93 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -120.87 113.72 20.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -85.64 149.63 25.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -112.36 130.02 56.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.86 90.58 5.3 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.68 122.7 32.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.807 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -84.61 136.4 33.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.33 140.81 57.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.47 -56.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -91.92 123.11 35.05 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.54 -170.89 40.73 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.587 0.613 . . . . 0.0 114.482 -169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -48.98 -32.91 9.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.799 1.64 . . . . 0.0 112.88 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -26.1 66.42 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.61 -25.21 13.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.332 1.453 . . . . 0.0 111.306 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 mt -56.05 139.8 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -141.57 85.92 1.98 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 122.252 1.025 . . . . 0.0 108.664 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 mtt -60.25 -12.84 9.9 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.968 0.907 . . . . 0.0 112.791 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -110.1 30.59 6.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.968 1.307 . . . . 0.0 110.304 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -76.39 -31.14 57.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.174 0.59 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -80.38 168.49 18.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.987 0.898 . . . . 0.0 109.319 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m -81.47 -28.37 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.627 1.571 . . . . 0.0 111.14 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -131.15 64.15 72.63 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.393 1.877 . . . . 0.0 108.21 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.34 176.27 5.84 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.71 2.94 . . . . 0.0 111.009 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -114.54 -22.23 9.9 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.185 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -123.09 145.07 48.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 121.404 1.911 . . . . 0.0 111.441 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.54 -40.0 6.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.132 1.373 . . . . 0.0 110.082 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.01 170.92 13.77 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.25 0.929 . . . . 0.0 111.871 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 20.1 t-105 -170.21 -125.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.973 1.709 . . . . 0.0 108.536 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 6.9 ptt180 -153.65 158.17 40.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.543 2.737 . . . . 0.0 106.589 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -80.33 141.38 35.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.004 0.82 . . . . 0.0 109.151 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.56 162.56 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.11 0.964 . . . . 0.0 111.048 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -51.79 151.12 3.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.814 0.846 . . . . 0.0 110.682 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.58 -40.92 69.28 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -96.47 6.55 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.45 0.7 . . . . 0.0 112.682 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.92 -46.44 15.43 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.339 -1.315 . . . . 0.0 111.633 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.94 -36.03 85.11 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.081 1.854 . . . . 0.0 113.685 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.46 -24.85 33.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 O-C-N 121.15 -0.969 . . . . 0.0 111.435 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.55 -17.25 34.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.396 0.998 . . . . 0.0 111.516 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -83.35 -30.72 27.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.55 1.068 . . . . 0.0 111.602 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.89 162.92 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.56 148.82 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.468 0.707 . . . . 0.0 111.427 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 m -56.93 -29.97 63.58 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.694 1.597 . . . . 0.0 114.848 -169.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -79.28 -43.0 24.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.444 1.02 . . . . 0.0 110.478 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -74.46 -27.37 60.56 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 111.157 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -42.07 -46.62 4.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.415 1.486 . . . . 0.0 111.252 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.39 -43.6 85.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.835 0.743 . . . . 0.0 111.396 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.02 -34.74 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.912 -0.493 . . . . 0.0 110.264 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.81 -31.75 70.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.186 -0.946 . . . . 0.0 110.053 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -58.5 -36.14 73.32 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.632 -1.292 . . . . 0.0 111.058 169.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -63.64 -44.36 94.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.211 1.368 . . . . 0.0 109.368 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.68 -45.87 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.096 0.862 . . . . 0.0 109.764 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.02 -45.3 94.21 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.769 -0.582 . . . . 0.0 109.633 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.85 -40.27 96.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.783 1.233 . . . . 0.0 111.034 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.48 -40.02 77.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.745 1.218 . . . . 0.0 110.601 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.57 -10.32 22.2 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.817 1.044 . . . . 0.0 113.817 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.61 -57.34 10.33 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.768 1.167 . . . . 0.0 111.131 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -80.36 15.84 1.48 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.9 t -110.37 -28.07 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.34 -65.94 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.0 109.146 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.4 mtp -59.26 -29.3 67.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.435 1.094 . . . . 0.0 111.231 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -58.37 -27.79 64.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.135 0.974 . . . . 0.0 113.32 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.54 -40.07 92.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.67 0.788 . . . . 0.0 109.479 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -83.91 -31.07 25.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.276 1.03 . . . . 0.0 110.406 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.02 -17.83 64.53 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.147 1.379 . . . . 0.0 111.347 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.58 79.79 4.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -35.62 34.73 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -63.13 -17.14 58.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.761 2.974 . . . . 0.0 114.868 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 124.826 1.25 . . . . 0.0 110.287 -175.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.8 mm -131.92 148.67 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.91 152.11 28.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.091 0.957 . . . . 0.0 109.644 171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.49 -30.88 68.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.35 7.7 31.19 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.773 0.829 . . . . 0.0 112.581 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 21.27 30.66 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.283 1.42 . . . . 0.0 113.636 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -101.27 144.68 29.82 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 119.038 1.419 . . . . 0.0 110.191 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.36 123.05 65.13 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-O 116.569 -1.682 . . . . 0.0 106.921 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -69.14 126.98 14.4 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.07 1.846 . . . . 0.0 111.03 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -139.86 159.59 41.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.164 1.786 . . . . 0.0 110.335 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.95 140.71 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 106.783 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.12 123.11 5.55 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 171.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.71 112.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.92 83.81 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.13 137.6 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -121.16 124.65 45.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 169.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.51 125.2 27.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 169.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -48.32 -18.62 0.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 116.025 -1.94 . . . . 0.0 115.73 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.3 7.06 1.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.619 1.554 . . . . 0.0 112.642 170.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.94 16.64 32.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.493 1.52 . . . . 0.0 113.702 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -121.18 163.49 18.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.136 0.974 . . . . 0.0 108.509 -168.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -105.99 161.66 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -167.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.53 129.92 42.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.23 1.812 . . . . 0.0 111.054 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -161.52 131.17 4.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.25 145.05 31.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -71.88 127.26 31.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -71.93 129.02 37.57 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -38.81 121.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.767 2.427 . . . . 0.0 111.112 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -1.64 21.43 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.567 1.08 . . . . 0.0 115.372 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -100.18 -24.3 14.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.314 1.557 . . . . 0.0 112.435 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 54.61 35.61 24.04 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.549 1.14 . . . . 0.0 112.142 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -146.98 -179.49 6.85 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.369 1.867 . . . . 0.0 107.348 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -117.08 156.46 27.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.236 0.925 . . . . 0.0 111.565 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -151.76 165.49 34.27 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.209 1.404 . . . . 0.0 109.051 -173.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -109.17 160.86 25.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.513 1.125 . . . . 0.0 112.147 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -74.4 69.84 4.94 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.774 2.983 . . . . 0.0 115.011 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -84.6 145.7 27.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.38 149.79 19.38 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.283 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.89 143.18 29.65 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.404 1.002 . . . . 0.0 111.915 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.91 137.23 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.39 146.07 49.79 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 118.777 0.717 . . . . 0.0 109.509 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -53.26 119.34 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.226 1.951 . . . . 0.0 113.731 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.36 7.56 87.45 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.002 1.286 . . . . 0.0 113.262 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.51 -40.15 64.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 112.444 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . 0.292 20.6 m 68.05 152.06 0.08 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.459 1.504 . . . . 0.0 112.543 -170.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.22 -45.03 72.18 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 125.055 1.342 . . . . 0.0 113.347 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.8 4.02 15.1 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.222 0.919 . . . . 0.0 111.904 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.09 -48.96 3.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.44 91.58 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.695 0.798 . . . . 0.0 112.136 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -58.85 -43.39 90.77 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.213 1.005 . . . . 0.0 109.371 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.03 -20.37 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -76.34 -47.68 22.64 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 109.279 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.1 77.71 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.217 0.917 . . . . 0.0 111.028 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.1 tp -48.06 -45.87 32.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 110.754 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -49.43 18.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.475 1.51 . . . . 0.0 111.689 176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.12 -37.31 87.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.804 1.184 . . . . 0.0 110.34 -170.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -94.31 -43.44 8.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.048 1.339 . . . . 0.0 111.006 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.99 -7.94 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.826 0.85 . . . . 0.0 112.451 -169.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.13 16.83 71.32 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 120.378 -1.451 . . . . 0.0 113.731 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.3 mt -95.26 152.07 18.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m -120.14 -176.69 3.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.883 0.873 . . . . 0.0 109.757 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.19 50.97 0.51 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.142 1.777 . . . . 0.0 112.684 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -164.54 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.666 1.586 . . . . 0.0 112.022 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.39 -6.54 58.9 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.256 1.022 . . . . 0.0 113.723 -168.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.29 170.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 123.875 0.87 . . . . 0.0 109.431 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -141.91 120.48 12.51 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -170.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.42 127.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.38 -35.13 6.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.579 0.752 . . . . 0.0 110.985 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.04 166.5 33.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.219 1.408 . . . . 0.0 108.627 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 163.69 34.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.145 0.978 . . . . 0.0 108.793 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -62.95 150.46 42.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.921 0.782 . . . . 0.0 110.836 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.726 0.411 . . . . 0.0 111.182 -171.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.9 173.69 13.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.496 1.918 . . . . 0.0 107.675 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.408 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 93.5 m95 -58.46 121.07 9.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 110.821 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.86 154.41 33.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 140.34 23.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.25 156.58 46.97 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -95.23 153.28 17.74 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.261 0.553 . . . . 0.0 110.91 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -84.16 150.23 57.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -65.69 156.88 61.61 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.685 2.257 . . . . 0.0 109.282 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -59.39 -30.03 68.14 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -74.85 -20.16 59.87 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.962 0.905 . . . . 0.0 113.238 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 tp -105.35 -22.13 13.1 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.704 1.202 . . . . 0.0 111.4 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.16 132.73 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 168.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -89.78 131.08 35.92 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -100.07 3.06 43.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.839 1.255 . . . . 0.0 109.453 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -98.31 -16.68 19.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 110.869 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -74.66 -36.06 62.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.384 -171.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 38.21 88.31 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 127.867 2.467 . . . . 0.0 112.111 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.77 141.81 21.28 Favored 'Cis proline' 0 C--N 1.356 0.932 0 N-CA-C 115.171 1.181 . . . . 0.0 115.171 10.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.45 124.5 8.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.62 92.62 9.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.5 pt -88.64 -12.01 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.912 -1.042 . . . . 0.0 112.025 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.85 43.4 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 120.483 1.492 . . . . 0.0 113.782 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 114.14 25.19 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 66.0 tttt -86.86 125.03 33.72 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 169.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.91 137.89 33.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -106.85 129.16 54.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -103.28 133.55 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.49 130.37 55.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.68 105.52 17.42 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.5 123.62 47.23 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.051 0.94 . . . . 0.0 109.225 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -80.49 138.22 36.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 106.95 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.92 -40.39 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.9 p -92.21 -114.51 0.09 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.9 -169.64 37.36 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.802 0.728 . . . . 0.0 111.911 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.84 -39.1 0.48 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.603 1.961 . . . . 0.0 113.492 171.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.63 69.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.2 -23.19 12.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.045 1.338 . . . . 0.0 111.785 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.06 131.87 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -143.99 77.72 1.56 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 122.348 1.07 . . . . 0.0 109.893 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.7 mtt -64.25 14.08 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.572 1.549 . . . . 0.0 113.244 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -131.29 21.09 4.8 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.648 1.567 . . . . 0.0 111.221 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 t -75.65 -28.04 58.59 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.229 1.012 . . . . 0.0 111.057 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -5.86 52.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.971 1.708 . . . . 0.0 114.519 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.2 m 68.13 -34.22 0.25 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.879 2.872 . . . . 0.0 114.153 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 p -124.04 72.08 54.25 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 169.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.49 -165.6 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.899 3.066 . . . . 0.0 112.027 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -120.48 -12.12 9.0 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.487 1.115 . . . . 0.0 111.893 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -134.59 152.16 51.58 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 120.913 1.688 . . . . 0.0 112.23 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.8 -35.25 5.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.927 1.691 . . . . 0.0 111.766 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -173.09 152.18 15.45 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -94.93 163.14 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.104 1.362 . . . . 0.0 111.354 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -152.92 120.23 5.9 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.889 1.676 . . . . 0.0 106.691 169.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -81.43 70.74 8.35 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.345 1.43 . . . . 0.0 109.247 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.29 156.02 5.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.242 1.417 . . . . 0.0 110.764 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -52.48 153.54 2.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.691 0.796 . . . . 0.0 111.909 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -57.02 152.31 13.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 m95 67.95 -28.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.449 1.9 . . . . 0.0 115.806 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.68 -47.0 98.07 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 121.155 1.798 . . . . 0.0 112.169 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.0 -18.05 62.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.592 1.604 . . . . 0.0 115.507 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.4 t -57.28 -38.11 60.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 120.08 1.309 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -92.64 -19.93 21.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.653 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -72.96 -21.28 60.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 121.297 1.862 . . . . 0.0 111.893 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.7 m -71.82 162.01 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 119.419 1.009 . . . . 0.0 111.034 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -60.6 151.67 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.133 0.973 . . . . 0.0 110.042 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 m -61.63 -29.27 69.95 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -73.87 -26.63 60.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.559 1.072 . . . . 0.0 111.508 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.98 -29.2 25.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.718 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -48.51 -52.13 23.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.566 1.076 . . . . 0.0 112.521 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.2 -41.44 97.05 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.316 0.507 . . . . 0.0 111.221 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -34.75 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.65 -32.8 74.36 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.03 -1.043 . . . . 0.0 110.643 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -57.28 -42.32 81.42 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.061 -1.024 . . . . 0.0 111.07 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.297 18.4 ptp180 -74.64 -34.18 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.908 1.231 . . . . 0.0 110.37 -176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.21 -47.69 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 109.253 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.62 -41.5 88.25 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.583 -0.698 . . . . 0.0 110.953 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -44.17 81.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 111.324 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.09 -27.65 69.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.727 0.411 . . . . 0.0 112.101 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -113.78 -3.97 13.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.57 69.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.71 1.141 . . . . 0.0 111.146 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 m -64.43 -25.79 68.16 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.01 -0.431 . . . . 0.0 111.616 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.17 -40.69 44.16 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.86 -47.04 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.658 0.783 . . . . 0.0 108.978 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.84 -15.8 63.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.929 0.786 . . . . 0.0 111.856 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.3 m -53.34 -38.84 63.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.758 1.163 . . . . 0.0 111.543 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.39 -30.48 71.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -94.44 -21.37 18.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.166 0.986 . . . . 0.0 111.857 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.74 -20.65 66.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.45 1.1 . . . . 0.0 110.287 170.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.18 80.75 5.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 p -46.95 -26.35 0.51 Allowed Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -168.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -62.13 -14.21 36.44 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.838 2.359 . . . . 0.0 114.075 169.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.392 1.477 . . . . 0.0 109.889 178.63 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 119.609 -0.234 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.7 mm -127.91 140.85 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.21 148.06 52.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.813 1.245 . . . . 0.0 108.445 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.53 -28.29 53.84 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -79.11 -1.54 36.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.02 30.19 9.08 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.794 1.664 . . . . 0.0 111.825 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 23.2 m-85 -115.19 138.45 50.91 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.618 1.709 . . . . 0.0 110.379 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -81.49 128.44 69.74 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 127.63 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.907 1.738 . . . . 0.0 109.267 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -137.69 163.42 31.34 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.235 1.414 . . . . 0.0 109.963 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.92 135.4 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.709 2.004 . . . . 0.0 105.95 169.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.54 145.59 17.31 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.47 126.03 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 118.805 1.303 . . . . 0.0 107.799 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.65 86.59 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.13 130.45 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.38 121.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 169.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -97.6 40.85 1.14 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.221 1.008 . . . . 0.0 109.327 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 59.8 -70.42 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 130.5 3.52 . . . . 0.0 111.89 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -90.33 -15.58 30.88 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.225 0.953 . . . . 0.0 112.886 -169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.46 42.97 1.49 Allowed Glycine 0 C--N 1.336 0.572 0 CA-C-N 118.366 0.53 . . . . 0.0 113.469 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 57.32 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.168 1.787 . . . . 0.0 114.27 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.69 162.85 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -63.45 134.67 56.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.675 1.99 . . . . 0.0 110.347 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -159.64 134.9 8.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 167.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.2 145.0 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.187 0.595 . . . . 0.0 109.51 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.98 139.78 41.7 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -94.04 125.73 38.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -43.12 131.21 4.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.39 2.676 . . . . 0.0 110.992 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.84 -29.36 1.08 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.991 1.281 . . . . 0.0 113.817 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.35 -36.29 29.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.345 1.058 . . . . 0.0 110.004 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 57.19 31.05 19.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.899 1.68 . . . . 0.0 112.789 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p -150.32 175.28 11.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.089 1.756 . . . . 0.0 107.68 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -76.4 162.08 28.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.866 0.866 . . . . 0.0 112.02 -169.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -144.85 134.55 23.49 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.372 0.606 . . . . 0.0 110.984 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.09 121.93 59.2 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.844 2.057 . . . . 0.0 108.216 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -59.63 135.77 66.42 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.333 2.022 . . . . 0.0 112.689 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.52 145.26 7.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.004 1.321 . . . . 0.0 109.725 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.38 136.11 5.26 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.17 146.49 46.2 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -76.08 129.65 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.08 128.4 87.87 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.737 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -55.57 119.12 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.95 1.767 . . . . 0.0 113.177 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.52 84.21 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.01 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -101.53 119.04 38.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.41 165.35 23.96 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.299 0.639 . . . . 0.0 111.574 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.92 -45.93 60.6 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 125.258 1.423 . . . . 0.0 111.45 -172.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.67 25.41 0.91 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.508 -0.745 . . . . 0.0 110.728 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.06 -46.1 0.78 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.527 1.931 . . . . 0.0 107.091 170.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.83 76.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.882 1.273 . . . . 0.0 111.5 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.37 -44.03 84.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.646 0.778 . . . . 0.0 109.033 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -72.45 -28.61 63.04 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.512 -0.743 . . . . 0.0 112.01 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.76 -46.79 88.08 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.875 -1.14 . . . . 0.0 108.534 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.87 76.43 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.576 -0.703 . . . . 0.0 112.05 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.98 -41.36 78.23 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.36 -49.4 34.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.386 1.475 . . . . 0.0 111.609 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.78 -34.49 75.63 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.208 1.367 . . . . 0.0 112.579 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.9 -57.05 2.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 110.902 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.19 -23.98 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.667 1.187 . . . . 0.0 111.504 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 62.12 5.08 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -135.02 157.75 46.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.875 2.07 . . . . 0.0 106.776 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -121.96 -177.5 3.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.948 0.899 . . . . 0.0 110.811 -169.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -69.51 43.11 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.251 2.621 . . . . 0.0 113.127 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -166.55 -20.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.14 0.976 . . . . 0.0 113.202 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.292 0.496 . . . . 0.0 112.028 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.41 168.45 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.448 1.099 . . . . 0.0 109.99 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.15 121.68 15.16 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.847 2.059 . . . . 0.0 105.995 -171.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -73.88 129.58 36.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 -32.57 6.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.541 0.737 . . . . 0.0 111.554 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.71 169.86 23.68 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.33 1.052 . . . . 0.0 109.636 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -146.99 160.2 42.65 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.745 1.218 . . . . 0.0 109.592 171.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -65.29 143.95 57.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 109.435 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -66.61 -27.35 67.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -153.52 168.81 24.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.23 1.412 . . . . 0.0 109.459 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -63.25 121.01 12.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.785 0.834 . . . . 0.0 109.471 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.48 153.92 33.04 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 150.19 28.88 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.919 -0.488 . . . . 0.0 110.705 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.19 156.46 43.87 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.972 1.709 . . . . 0.0 106.626 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -90.98 145.71 24.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.889 0.313 . . . . 0.0 110.461 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.7 mt -73.4 141.1 79.83 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -60.87 158.05 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.137 1.892 . . . . 0.0 109.42 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -49.31 -48.01 46.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.17 -14.2 60.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.496 1.118 . . . . 0.0 113.091 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -112.85 -1.41 14.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.099 1.76 . . . . 0.0 111.353 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.5 137.24 23.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-N 120.813 1.642 . . . . 0.0 106.673 169.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -93.37 113.67 25.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.05 -9.13 26.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.101 0.96 . . . . 0.0 111.188 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.06 -25.69 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.039 0.936 . . . . 0.0 110.103 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.4 p -71.57 134.14 46.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -120.17 127.19 26.46 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -58.99 154.93 41.42 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.481 1.207 . . . . 0.0 110.907 -10.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -47.58 129.26 3.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.648 1.579 . . . . 0.0 107.959 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.83 113.85 27.68 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.05 -2.75 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 116.52 -1.705 . . . . 0.0 112.528 -170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -171.39 165.53 38.55 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 122.35 2.341 . . . . 0.0 113.066 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -96.48 120.34 36.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -85.6 120.91 27.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 168.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.26 133.52 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 120.8 1.636 . . . . 0.0 113.376 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -100.79 141.89 33.03 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -112.16 137.71 49.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -110.45 133.69 53.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 tt -88.54 123.35 32.96 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 170.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.09 123.99 48.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -81.6 134.04 35.45 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.84 106.66 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.54 -31.04 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.2 p -82.7 -114.16 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.048 0.539 . . . . 0.0 110.07 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.96 166.26 29.55 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.048 1.309 . . . . 0.0 110.445 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.43 -29.03 33.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.823 0.849 . . . . 0.0 112.881 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.25 63.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.271 0.629 . . . . 0.0 112.391 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.38 -23.53 11.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.959 1.703 . . . . 0.0 110.838 -173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -56.47 122.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -89.97 -52.09 5.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.3 mtt 59.78 5.46 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.795 1.638 . . . . 0.0 115.215 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 30.23 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.093 1.77 . . . . 0.0 111.621 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -43.72 69.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.949 1.699 . . . . 0.0 112.079 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.6 -4.47 57.72 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -168.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 66.31 -38.12 0.29 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.774 2.429 . . . . 0.0 113.03 -169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 p -123.32 75.06 52.01 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.871 2.068 . . . . 0.0 105.59 169.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.48 -179.3 4.33 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.182 3.255 . . . . 0.0 111.077 -172.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -100.71 -49.97 4.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.111 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -87.97 154.95 20.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 120.538 1.517 . . . . 0.0 111.521 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -133.47 -27.05 1.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.474 1.51 . . . . 0.0 111.761 -172.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.87 144.21 10.28 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -93.4 154.66 17.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.788 1.235 . . . . 0.0 110.825 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -155.55 109.14 2.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.044 1.338 . . . . 0.0 108.398 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -73.62 137.12 44.02 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.275 -0.891 . . . . 0.0 108.607 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.9 161.11 18.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.808 1.643 . . . . 0.0 108.623 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -53.65 154.43 3.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.31 1.044 . . . . 0.0 110.582 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -56.27 -37.89 70.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.946 0.899 . . . . 0.0 113.263 -168.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -96.73 -3.02 43.23 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.506 -0.746 . . . . 0.0 112.826 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -61.02 -47.64 94.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.734 -1.126 . . . . 0.0 111.709 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.82 -35.71 98.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.593 1.605 . . . . 0.0 112.462 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.63 -33.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 109.877 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -17.67 33.52 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 121.501 -0.75 . . . . 0.0 109.289 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -93.37 -22.91 18.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.135 0.272 . . . . 0.0 111.495 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.75 163.3 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.313 -0.867 . . . . 0.0 112.356 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 m -65.71 153.44 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.268 1.427 . . . . 0.0 110.648 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -57.66 -33.91 68.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.416 1.486 . . . . 0.0 114.361 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -74.76 -26.97 60.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.95 0.796 . . . . 0.0 111.497 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -86.82 -33.35 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -47.23 -48.65 24.17 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.249 1.42 . . . . 0.0 112.288 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.88 -35.22 79.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.735 0.243 . . . . 0.0 111.545 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.2 t -83.47 -33.37 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.227 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.01 -32.89 74.59 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.933 1.242 . . . . 0.0 110.408 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -54.28 -41.98 69.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.03 -1.043 . . . . 0.0 111.416 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -66.48 -44.41 82.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.73 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.64 -49.77 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.3 mmt -64.96 -44.43 89.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.609 0.641 . . . . 0.0 110.325 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -62.07 -37.11 83.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.046 0.839 . . . . 0.0 111.124 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.28 -20.99 58.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.432 0.693 . . . . 0.0 111.532 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.92 -9.03 3.92 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.2 63.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.704 1.593 . . . . 0.0 112.45 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -66.66 -17.98 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.19 -33.18 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.018 1.281 . . . . 0.0 109.827 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.25 -29.91 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.709 -1.244 . . . . 0.0 109.659 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mmt -65.63 -27.14 68.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.456 1.025 . . . . 0.0 110.64 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.4 m -56.07 -39.62 72.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.642 1.11 . . . . 0.0 111.023 172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.0 -52.4 9.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.953 0.901 . . . . 0.0 108.704 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -77.56 -7.64 56.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.55 -24.86 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.008 0.923 . . . . 0.0 110.546 169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -23.93 48.01 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.111 -0.993 . . . . 0.0 112.004 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -53.13 30.4 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 112.019 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.33 -30.82 3.9 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.349 2.699 . . . . 0.0 112.91 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.845 1.658 . . . . 0.0 110.994 -171.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.463 0.173 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm -128.36 147.92 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.35 36.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.452 2.301 . . . . 0.0 111.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.96 -32.93 0.09 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 131.516 3.927 . . . . 0.0 116.66 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.06 13.77 24.09 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.448 1.099 . . . . 0.0 113.153 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 12.33 56.77 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.396 1.474 . . . . 0.0 113.1 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -102.25 138.88 38.6 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.903 1.351 . . . . 0.0 110.24 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -98.66 115.91 65.59 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.041 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.18 123.46 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.387 2.058 . . . . 0.0 110.863 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -144.19 163.73 32.77 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.616 1.566 . . . . 0.0 108.593 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.24 136.81 59.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 130.82 10.26 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.5 112.88 26.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.32 85.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.31 137.62 24.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -125.11 121.69 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 168.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.95 48.0 1.58 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.496 -0.752 . . . . 0.0 109.169 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 18.0 ptt-85 38.13 23.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.241 3.417 . . . . 0.0 116.894 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.85 7.27 15.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.521 1.128 . . . . 0.0 111.925 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.7 71.08 Favored Glycine 0 N--CA 1.477 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 112.422 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -125.56 150.34 47.56 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.71 1.604 . . . . 0.0 107.049 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.95 165.06 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tpt -57.49 129.32 41.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.589 1.955 . . . . 0.0 111.133 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 7.9 t-105 -160.96 115.89 2.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.51 149.7 50.71 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -76.87 136.63 38.88 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.555 1.542 . . . . 0.0 108.203 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -90.12 128.31 36.3 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.925 0.49 . . . . 0.0 110.342 -169.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.47 135.45 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.096 1.758 . . . . 0.0 110.665 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.79 6.11 76.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.944 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -136.24 -38.89 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.525 1.53 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.28 17.1 m80 60.32 38.08 19.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.762 2.025 . . . . 0.0 112.666 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -133.45 161.01 35.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.206 2.202 . . . . 0.0 106.546 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -76.34 148.98 37.09 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.326 -0.859 . . . . 0.0 112.621 -171.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -148.54 160.72 42.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.515 1.15 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.79 167.15 39.13 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 128.18 2.592 . . . . 0.0 109.072 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.25 -110.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 124.167 3.244 . . . . 0.0 110.721 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 65.82 99.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.597 1.959 . . . . 0.0 112.046 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.79 126.01 6.05 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 144.46 22.18 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.003 1.763 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.32 137.0 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.02 135.87 62.47 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.35 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -58.91 117.53 4.28 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.423 1.415 . . . . 0.0 112.452 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.65 80.09 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.096 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 120.28 35.87 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.25 165.67 21.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.908 0.861 . . . . 0.0 111.455 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.13 -45.05 16.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.728 2.011 . . . . 0.0 115.224 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -44.6 21.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -55.06 -42.98 73.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.89 0.876 . . . . 0.0 110.056 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.09 66.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 112.078 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -62.75 -42.61 99.76 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 81.5 m-85 -68.7 -30.57 69.25 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.179 -1.576 . . . . 0.0 112.78 173.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -58.24 -47.02 84.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.251 0.932 . . . . 0.0 109.131 172.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.89 -44.02 86.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.316 0.646 . . . . 0.0 110.708 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.22 -44.18 64.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 111.034 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -48.28 34.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.75 -1.119 . . . . 0.0 111.809 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.65 -28.19 65.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -93.06 -60.22 1.85 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.095 0.958 . . . . 0.0 110.274 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.66 -17.61 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.769 0.827 . . . . 0.0 111.767 -169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 56.46 23.66 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.9 mt -132.13 157.24 44.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.351 2.261 . . . . 0.0 105.972 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -121.09 -172.93 2.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.793 0.724 . . . . 0.0 110.103 -170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.404 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 24.1 mtt180 -73.23 42.05 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.54 1.936 . . . . 0.0 113.271 -171.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -161.75 -23.62 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.88 0.872 . . . . 0.0 112.994 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.82 0.44 52.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.051 0.387 . . . . 0.0 111.86 -168.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.9 m -146.7 165.24 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.782 1.233 . . . . 0.0 109.136 -171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -136.64 121.47 18.67 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.357 1.863 . . . . 0.0 106.232 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.02 128.32 37.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.3 -37.87 6.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.43 168.98 25.78 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.154 0.982 . . . . 0.0 108.627 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -144.89 161.87 38.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -61.69 139.55 58.29 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -65.68 -25.68 67.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.35 175.07 12.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 108.542 169.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -71.61 113.87 9.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.296 0.638 . . . . 0.0 109.912 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.88 155.22 40.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 148.42 28.61 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -140.29 157.23 45.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.753 0.821 . . . . 0.0 108.805 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -94.14 126.87 39.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -68.53 148.04 98.1 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 158.69 56.83 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.641 2.227 . . . . 0.0 109.666 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -60.56 -33.7 73.07 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -77.99 -24.27 48.06 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.048 0.939 . . . . 0.0 113.07 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 tp -90.98 -24.49 20.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.213 0.461 . . . . 0.0 110.629 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.77 137.63 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -41.96 34.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.027 0.531 . . . . 0.0 111.987 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 21.8 m95 59.11 4.19 0.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.036 2.534 . . . . 0.0 113.811 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -99.6 -25.56 14.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -72.84 151.54 41.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 109.324 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -132.93 116.0 14.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.671 1.188 . . . . 0.0 107.941 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -58.35 155.44 37.11 Favored 'Cis proline' 0 CA--C 1.538 0.694 0 CA-C-N 120.177 1.099 . . . . 0.0 111.483 -10.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.71 131.85 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.0 t -91.88 106.83 18.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.3 pt -97.32 -8.35 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.505 0.722 . . . . 0.0 112.173 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.73 169.64 42.41 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.396 0.998 . . . . 0.0 111.764 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -110.05 119.33 38.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -80.95 125.49 30.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.75 142.56 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -116.98 128.68 55.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -101.51 147.35 26.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.74 129.45 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -80.14 115.11 19.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.54 125.47 54.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.929 0.892 . . . . 0.0 108.838 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.02 134.51 34.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -73.17 122.11 21.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.65 -50.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -128.31 135.44 49.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.15 -155.12 13.52 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 t70 64.55 -61.47 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.149 2.98 . . . . 0.0 111.792 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.26 -35.87 12.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 0.0 110.773 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -89.79 -12.72 38.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.841 0.856 . . . . 0.0 111.598 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.61 116.2 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -97.27 -35.04 10.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.498 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.0 mtt 58.91 -38.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 130.023 3.329 . . . . 0.0 115.532 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -102.56 33.63 3.1 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.898 1.679 . . . . 0.0 110.889 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -69.61 -51.42 35.2 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -74.7 145.2 43.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 m -70.08 -30.28 67.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.217 . . . . 0.0 111.81 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 p -127.23 75.14 77.14 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.177 1.391 . . . . 0.0 107.887 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.52 -175.1 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.709 2.939 . . . . 0.0 110.416 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.72 -29.86 11.25 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 116.695 -1.621 . . . . 0.0 113.366 171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 159.0 17.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 122.051 2.205 . . . . 0.0 112.271 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.91 -6.12 0.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.063 1.345 . . . . 0.0 113.542 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.6 156.88 28.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -119.05 151.65 37.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 111.42 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -145.01 119.49 9.67 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.888 1.675 . . . . 0.0 106.761 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -78.73 140.48 38.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.614 1.097 . . . . 0.0 108.96 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.71 162.43 32.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.799 0.84 . . . . 0.0 110.214 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.2 m -52.21 148.49 6.36 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.012 0.925 . . . . 0.0 109.865 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.45 -38.37 63.5 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -99.58 3.28 45.31 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.27 -44.6 88.98 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.914 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.82 -28.02 85.75 Favored 'Trans proline' 0 C--N 1.352 0.749 0 CA-C-N 122.005 1.752 . . . . 0.0 112.405 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.41 -10.52 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.901 1.28 . . . . 0.0 112.098 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -106.92 -32.12 8.04 Favored 'General case' 0 CA--C 1.526 0.057 0 O-C-N 120.736 -1.228 . . . . 0.0 110.328 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -79.93 -26.69 40.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.031 0.832 . . . . 0.0 112.503 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.05 160.0 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.088 0.858 . . . . 0.0 110.008 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.74 141.45 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.75 1.22 . . . . 0.0 111.623 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 m -56.78 -35.52 68.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.518 1.527 . . . . 0.0 113.867 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -67.97 -33.74 75.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.756 0.707 . . . . 0.0 110.765 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -88.54 -25.12 22.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.92 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -43.48 -46.49 6.87 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 119.935 1.243 . . . . 0.0 112.695 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.58 -49.44 73.36 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.905 0.775 . . . . 0.0 111.49 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.29 -31.3 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 122.002 -0.436 . . . . 0.0 110.3 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -33.54 75.92 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.554 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -64.24 -35.0 79.41 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 120.725 -1.235 . . . . 0.0 110.479 171.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -60.91 -46.45 90.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.6 1.546 . . . . 0.0 109.804 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.92 -48.22 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 118.764 0.711 . . . . 0.0 109.638 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.7 -36.77 84.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.546 -0.721 . . . . 0.0 110.825 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -65.61 -35.66 81.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.673 1.124 . . . . 0.0 110.72 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.78 -25.32 68.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.235 0.614 . . . . 0.0 111.181 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -118.66 -17.66 9.19 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -42.68 -65.18 0.5 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 -169.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -63.81 -25.81 68.34 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.77 -27.13 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.442 -0.786 . . . . 0.0 109.169 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.99 -41.2 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.83 0.852 . . . . 0.0 109.578 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.4 mtt -68.85 -33.31 73.6 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.028 -170.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.3 m -57.34 -31.55 65.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.849 0.75 . . . . 0.0 112.248 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.5 -30.95 71.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.111 0.414 . . . . 0.0 110.328 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -95.5 -44.06 7.69 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.21 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -61.54 -23.54 66.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.78 0.832 . . . . 0.0 112.131 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -64.55 -38.84 92.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.528 1.131 . . . . 0.0 112.032 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.268 0.1 OUTLIER -135.23 -73.41 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.104 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.43 -27.32 33.81 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.908 2.405 . . . . 0.0 113.589 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? . . . . . 0 C--O 1.255 1.365 0 C-N-CA 127.242 2.217 . . . . 0.0 112.457 -176.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 119.55 -0.262 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm -129.82 142.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.97 150.41 45.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.361 1.065 . . . . 0.0 110.013 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.28 -28.16 67.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.56 0.1 35.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.348 0.522 . . . . 0.0 112.167 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.76 32.09 8.27 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.237 1.875 . . . . 0.0 112.06 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 25.3 m-85 -109.76 133.74 52.8 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.556 1.178 . . . . 0.0 110.176 -176.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -80.85 129.28 68.49 Favored Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.4 121.65 6.94 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.196 1.931 . . . . 0.0 109.32 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.0 165.42 25.37 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.603 1.161 . . . . 0.0 109.787 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.33 146.22 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 127.051 2.14 . . . . 0.0 106.564 169.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.68 146.63 18.08 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.13 135.5 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.43 89.88 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -68.11 129.52 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.96 137.57 51.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 168.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -104.58 27.2 8.15 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 53.62 19.39 1.76 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.755 1.622 . . . . 0.0 115.179 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -118.33 5.86 11.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 110.707 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.24 80.78 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 120.848 -1.158 . . . . 0.0 112.312 -169.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -121.58 142.99 49.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.734 1.214 . . . . 0.0 107.727 -171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.21 163.09 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.8 tpt -55.43 136.9 49.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.483 1.913 . . . . 0.0 111.808 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.41 136.5 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.84 144.89 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.47 140.22 48.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.51 119.7 21.46 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -49.94 132.57 22.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.771 2.029 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.3 -31.53 1.6 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.844 1.212 . . . . 0.0 114.027 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -87.07 -30.9 20.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.417 1.109 . . . . 0.0 110.706 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 58.61 35.0 24.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 p -145.19 169.92 17.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.594 1.958 . . . . 0.0 107.009 169.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.57 158.04 24.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.962 1.256 . . . . 0.0 111.84 -170.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -149.52 148.73 29.74 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.155 1.782 . . . . 0.0 107.489 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -80.57 158.96 70.52 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.607 0.639 . . . . 0.0 111.518 171.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -64.89 141.94 73.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.559 2.173 . . . . 0.0 112.456 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -167.88 142.49 3.61 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.833 1.653 . . . . 0.0 108.944 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.24 143.5 10.13 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.57 152.62 52.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.554 1.073 . . . . 0.0 110.698 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mt -82.01 137.19 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -80.5 137.94 51.55 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.747 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.02 117.52 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.408 1.405 . . . . 0.0 113.037 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.92 1.67 88.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.003 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.55 120.8 31.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.611 1.206 . . . . 0.0 107.799 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -71.24 162.6 29.16 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.143 0.577 . . . . 0.0 111.241 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.23 -44.96 16.73 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 126.936 2.094 . . . . 0.0 113.447 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.92 -49.22 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.13 -39.8 83.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.524 0.73 . . . . 0.0 110.387 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -35.51 79.99 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.195 0.998 . . . . 0.0 111.974 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -58.64 -46.91 86.1 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -66.38 -30.05 70.35 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.717 1.144 . . . . 0.0 112.659 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -59.37 -46.72 87.88 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.075 -1.016 . . . . 0.0 108.736 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.908 0.483 . . . . 0.0 111.566 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 tp -57.74 -39.63 77.78 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.891 -1.131 . . . . 0.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -72.93 -50.44 23.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.211 1.005 . . . . 0.0 111.297 174.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.59 -30.06 68.73 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.469 1.486 . . . . 0.0 112.075 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -97.67 -47.5 5.59 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.033 0.933 . . . . 0.0 111.576 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.23 -19.78 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.375 0.67 . . . . 0.0 110.975 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.21 35.15 82.41 Favored Glycine 0 CA--C 1.526 0.78 0 O-C-N 121.191 -0.943 . . . . 0.0 110.886 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.01 154.28 27.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.23 1.412 . . . . 0.0 108.296 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -116.52 -175.13 2.7 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.896 0.878 . . . . 0.0 110.365 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -73.74 41.14 0.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.286 1.834 . . . . 0.0 113.294 -169.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -163.1 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.627 1.171 . . . . 0.0 112.919 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.26 -0.94 51.81 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.89 0.476 . . . . 0.0 111.809 -169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -148.5 171.38 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.949 1.7 . . . . 0.0 108.63 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -140.8 123.91 16.51 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.75 131.24 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 120.485 1.493 . . . . 0.0 107.932 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.63 -36.73 6.36 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.097 0.559 . . . . 0.0 111.324 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 171.45 19.92 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.465 1.106 . . . . 0.0 109.35 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -144.67 162.98 35.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -65.85 138.83 58.15 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -67.67 -19.7 65.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -146.56 170.38 17.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.222 1.809 . . . . 0.0 108.525 170.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -75.58 125.14 28.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.05 152.79 44.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 140.56 21.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -143.82 161.24 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.065 0.946 . . . . 0.0 108.486 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -101.23 133.0 46.46 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 107.571 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.56 143.06 81.75 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 108.452 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.88 155.83 21.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 0.0 110.471 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.82 -45.23 90.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.794 -1.192 . . . . 0.0 113.113 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.56 -12.73 55.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 112.596 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 0.16 26.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.031 1.732 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.15 135.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -90.96 114.88 27.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -100.19 -3.0 32.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.938 0.774 . . . . 0.0 111.694 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -89.43 -18.24 27.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.764 0.825 . . . . 0.0 110.554 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.49 154.57 21.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.537 1.535 . . . . 0.0 108.212 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -134.87 118.55 13.3 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.506 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.75 153.57 34.17 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 120.095 1.069 . . . . 0.0 110.985 -10.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -54.68 130.26 16.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.4 t -93.09 127.15 38.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.253 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.14 -5.4 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 111.807 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -155.85 161.21 30.53 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 121.192 1.815 . . . . 0.0 113.535 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -112.93 105.96 14.14 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -81.55 129.73 34.78 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 170.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.83 127.22 13.12 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 120.285 1.402 . . . . 0.0 112.843 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -98.9 138.5 35.93 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -107.04 144.96 32.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -116.55 131.63 56.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 114.84 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.41 127.93 55.83 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 108.641 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -87.38 134.04 33.63 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.44 123.53 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.66 -37.88 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.1 m -88.69 -127.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.35 0.66 . . . . 0.0 109.913 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.25 178.63 47.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.837 1.199 . . . . 0.0 112.162 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.86 -30.66 15.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.785 1.634 . . . . 0.0 113.053 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.47 -29.23 67.8 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -98.35 -27.43 14.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.357 1.063 . . . . 0.0 111.212 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 143.68 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.722 1.209 . . . . 0.0 107.759 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.33 -41.58 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.549 0.74 . . . . 0.0 111.317 -170.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.7 mtt 55.51 7.35 0.23 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.14 17.83 5.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.741 1.61 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -31.6 72.73 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.705 2.002 . . . . 0.0 111.615 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -7.77 59.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.692 1.997 . . . . 0.0 113.672 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m 68.15 -35.46 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.305 2.642 . . . . 0.0 114.062 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 p -121.77 71.84 30.32 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.345 1.858 . . . . 0.0 106.398 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.56 -174.09 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.587 2.858 . . . . 0.0 111.958 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.98 -10.69 15.45 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.012 169.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.36 146.07 50.88 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.998 1.726 . . . . 0.0 114.99 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -115.96 114.25 24.38 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.767 3.227 . . . . 0.0 102.864 169.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.12 136.02 28.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.622 0.629 . . . . 0.0 113.157 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -131.67 -112.13 0.24 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.163 1.385 . . . . 0.0 109.946 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -150.08 163.06 39.15 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.776 1.23 . . . . 0.0 110.609 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -84.28 155.19 22.54 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.27 169.04 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 110.091 -169.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.2 m -57.45 151.67 16.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.34 0.591 . . . . 0.0 111.49 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -61.29 154.46 23.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.8 m95 66.36 -30.13 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.308 1.843 . . . . 0.0 115.559 -173.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -54.93 -46.28 99.61 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 120.773 1.624 . . . . 0.0 112.177 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -60.07 -26.65 83.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 121.732 1.654 . . . . 0.0 114.989 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.08 -34.11 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.956 1.253 . . . . 0.0 109.077 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -90.11 -19.0 24.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.945 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -80.33 -30.01 38.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.419 1.009 . . . . 0.0 111.988 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.18 163.13 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-N 118.56 0.618 . . . . 0.0 110.207 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.37 153.65 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.838 0.855 . . . . 0.0 111.603 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 m -54.87 -30.33 57.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.608 1.963 . . . . 0.0 115.594 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -84.31 -37.3 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.424 1.011 . . . . 0.0 111.374 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -70.41 -38.58 74.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.384 -0.822 . . . . 0.0 110.219 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -42.98 -45.71 5.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.599 1.56 . . . . 0.0 110.884 171.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.69 -34.8 78.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -173.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.8 -35.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 0.0 110.162 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.26 -32.2 73.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.825 0.739 . . . . 0.0 110.853 -171.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.38 -38.38 80.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.388 -0.82 . . . . 0.0 111.048 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -69.96 -46.47 65.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.46 -46.15 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.822 0.849 . . . . 0.0 109.3 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.3 mtt -69.59 -40.09 76.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.149 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.89 -40.85 94.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.821 1.191 . . . . 0.0 111.036 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.71 -28.13 68.41 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.132 0.973 . . . . 0.0 110.928 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -111.79 -9.18 14.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.09 0.956 . . . . 0.0 113.405 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.13 -59.61 4.0 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.124 0.97 . . . . 0.0 111.714 -169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 m -67.54 -23.03 65.39 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.878 -0.514 . . . . 0.0 111.518 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.75 -35.82 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.8 t -83.93 -42.07 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.719 0.808 . . . . 0.0 109.174 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.39 -30.6 69.55 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.623 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.6 m -55.41 -29.48 58.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.554 1.07 . . . . 0.0 112.122 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.87 -38.49 73.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.088 0.555 . . . . 0.0 110.443 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -92.25 -16.26 26.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.271 0.628 . . . . 0.0 111.02 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -94.14 32.77 1.45 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.18 1.792 . . . . 0.0 110.205 172.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -107.44 31.22 5.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.261 1.024 . . . . 0.0 110.493 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.322 21.3 p 50.73 33.24 0.21 Allowed Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -72.1 -28.19 16.13 Favored 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 122.405 1.895 . . . . 0.0 110.041 169.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.364 1.465 . . . . 0.0 109.255 -173.725 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 tpt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 119.526 -0.273 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 3.2 mp 72.54 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 127.367 2.267 . . . . 0.0 108.381 -169.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.59 146.46 51.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -50.75 -31.81 17.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.05 -3.96 47.82 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.74 32.33 7.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.754 2.121 . . . . 0.0 110.578 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -111.27 146.4 37.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.976 1.388 . . . . 0.0 110.017 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.95 123.93 57.91 Favored Pre-proline 0 N--CA 1.467 0.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -68.97 130.6 20.62 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.348 2.032 . . . . 0.0 111.43 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.48 157.35 45.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.288 1.835 . . . . 0.0 111.837 -170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.4 120.52 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.511 1.925 . . . . 0.0 107.082 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 123.97 8.09 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.78 117.49 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 118.636 1.218 . . . . 0.0 108.722 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.33 85.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -66.74 136.52 26.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 168.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -121.74 121.91 38.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -74.36 125.07 27.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -43.6 -27.45 0.3 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.743 2.017 . . . . 0.0 114.456 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.19 2.87 1.37 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.29 30.42 7.38 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.023 1.296 . . . . 0.0 112.29 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.81 164.54 26.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.18 167.53 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 tpt -53.26 126.31 20.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.818 2.447 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -161.83 128.36 3.77 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.6 148.51 31.19 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.52 136.14 47.39 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.34 125.31 29.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -48.68 127.46 13.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 110.189 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 -24.14 1.77 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.133 1.349 . . . . 0.0 114.461 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.83 -32.28 23.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.389 1.076 . . . . 0.0 110.407 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 58.29 30.71 19.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 112.921 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -148.7 173.38 13.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.234 1.813 . . . . 0.0 107.19 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -75.05 163.26 27.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.316 0.962 . . . . 0.0 113.314 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.83 147.65 27.51 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.591 1.156 . . . . 0.0 108.889 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -61.64 150.98 79.89 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.0 1.72 . . . . 0.0 110.35 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.87 151.48 84.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.135 1.89 . . . . 0.0 110.88 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -173.43 168.18 4.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.205 1.802 . . . . 0.0 109.413 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.78 127.58 1.14 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.0 134.64 27.43 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.86 133.12 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.61 124.74 91.14 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.771 1.228 . . . . 0.0 108.875 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.76 118.42 5.19 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.929 1.753 . . . . 0.0 112.487 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.44 1.72 68.61 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.041 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.52 120.0 40.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 m -69.37 160.76 30.71 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 121.248 0.547 . . . . 0.0 111.09 -174.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.04 -42.14 12.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.767 2.027 . . . . 0.0 113.999 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -74.18 -47.69 33.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.49 -40.02 81.63 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 110.11 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.01 -32.92 72.81 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.309 1.044 . . . . 0.0 112.369 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -59.51 -44.82 93.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -67.09 -27.68 67.55 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.748 -1.22 . . . . 0.0 112.649 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -64.75 -44.15 91.04 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.67 -1.269 . . . . 0.0 109.159 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.16 63.4 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 118.453 0.57 . . . . 0.0 110.544 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.99 -43.34 95.24 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 120.951 -1.093 . . . . 0.0 108.999 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -63.67 -57.3 10.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.652 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -25.5 60.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.104 1.774 . . . . 0.0 114.217 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.61 -11.02 12.43 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.927 -1.108 . . . . 0.0 112.654 -169.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.04 -16.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.18 0.992 . . . . 0.0 111.515 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.74 79.03 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 120.221 -1.549 . . . . 0.0 114.243 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -113.47 155.99 24.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.088 1.444 . . . . 0.0 109.104 -171.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -108.7 178.65 4.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.781 1.232 . . . . 0.0 110.227 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -72.77 37.58 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.399 1.88 . . . . 0.0 113.059 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -161.83 -14.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -106.06 18.24 22.35 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.457 1.026 . . . . 0.0 113.177 -168.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.22 175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.459 1.904 . . . . 0.0 109.42 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -140.91 114.39 8.77 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.3 mt -72.94 132.51 33.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.07 -52.4 2.81 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.503 0.502 . . . . 0.0 109.673 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.86 174.19 11.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.57 0.748 . . . . 0.0 111.067 -171.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.5 p -145.82 177.31 9.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.944 1.298 . . . . 0.0 109.001 171.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 6.16 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.98 -16.53 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.014 2.526 . . . . 0.0 115.345 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.4 174.22 12.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.778 2.431 . . . . 0.0 108.674 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -79.16 121.81 25.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.669 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.18 160.95 17.51 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -140.52 141.88 35.27 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 108.838 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -144.83 153.02 41.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 168.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.98 156.19 17.06 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -88.53 141.52 30.44 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 154.77 72.2 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.804 2.336 . . . . 0.0 108.663 170.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -25.56 66.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -169.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.34 -26.6 58.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.124 0.97 . . . . 0.0 112.538 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.2 tp -96.56 -24.03 16.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.89 0.876 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.0 t -48.7 138.03 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.47 -45.36 46.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.493 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.3 m95 57.92 3.63 0.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.212 2.605 . . . . 0.0 114.034 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.95 -17.0 19.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.226 1.41 . . . . 0.0 110.658 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -80.63 143.64 32.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.609 1.564 . . . . 0.0 107.096 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.68 111.88 8.28 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 149.01 20.98 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 119.992 1.033 . . . . 0.0 112.77 -5.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.91 121.08 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.27 108.91 16.81 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.512 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 pt -90.36 -5.4 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.5 161.91 33.59 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -92.88 123.92 36.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -84.35 111.44 19.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 101.955 -3.35 . . . . 0.0 101.955 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.22 139.21 53.52 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.529 1.513 . . . . 0.0 113.162 -173.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.55 124.83 52.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 169.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -104.68 143.44 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.46 131.01 56.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.5 110.34 19.71 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.3 mt -102.79 137.57 40.84 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 124.634 1.209 . . . . 0.0 109.422 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -93.35 127.14 38.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.6 112.09 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.2 t -81.25 -37.78 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 p -91.05 -115.3 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.158 0.583 . . . . 0.0 110.889 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.08 175.63 39.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.386 0.994 . . . . 0.0 111.021 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.69 -31.39 57.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.471 1.109 . . . . 0.0 112.321 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.78 65.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -109.66 -22.14 12.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.484 1.114 . . . . 0.0 111.104 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.38 143.24 12.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.0 1.32 . . . . 0.0 107.878 169.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -149.35 78.97 1.39 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.437 0.695 . . . . 0.0 109.404 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 mtt -68.58 16.49 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -116.34 22.97 12.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.438 1.472 . . . . 0.0 111.763 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -38.16 86.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.085 2.154 . . . . 0.0 112.096 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -3.43 50.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.444 1.097 . . . . 0.0 113.802 -169.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.65 -38.69 0.32 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.945 2.498 . . . . 0.0 113.726 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.8 p -126.04 73.01 71.08 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.532 1.933 . . . . 0.0 106.384 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -77.5 -167.41 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.89 3.06 . . . . 0.0 111.121 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.2 -11.32 14.91 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.241 -1.362 . . . . 0.0 112.49 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -135.24 148.41 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 121.703 2.047 . . . . 0.0 114.551 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -116.6 109.31 17.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.457 2.703 . . . . 0.0 103.943 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.13 148.64 32.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.563 1.078 . . . . 0.0 113.928 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -140.67 -119.62 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 0.0 111.333 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 150.19 38.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.134 1.773 . . . . 0.0 109.209 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -82.47 146.21 29.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.731 0.412 . . . . 0.0 110.129 -172.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.92 163.53 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.205 1.002 . . . . 0.0 110.398 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -53.01 154.25 3.02 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 111.382 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -60.81 150.99 30.94 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 64.87 -15.17 0.09 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.03 1.732 . . . . 0.0 115.027 -169.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -60.5 -43.62 93.29 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.706 2.048 . . . . 0.0 111.895 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -58.06 -34.74 98.79 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.712 1.608 . . . . 0.0 112.913 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.9 -51.99 59.75 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -68.97 -22.55 64.1 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.524 -0.735 . . . . 0.0 111.254 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -78.23 -18.32 55.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.65 161.28 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 119.631 1.105 . . . . 0.0 112.491 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.36 146.3 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.321 1.848 . . . . 0.0 112.115 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.1 m -61.83 -30.5 70.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -169.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -69.62 -31.02 68.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.607 1.094 . . . . 0.0 111.018 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -94.18 -32.09 13.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.7 0.8 . . . . 0.0 111.965 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.0 ttp-105 -48.41 -43.6 34.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.081 1.352 . . . . 0.0 113.121 -174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.3 -44.8 95.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.382 0.537 . . . . 0.0 110.867 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.9 t -73.99 -33.52 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.774 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -28.42 67.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.493 1.042 . . . . 0.0 110.437 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -42.9 98.61 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.893 -1.129 . . . . 0.0 109.725 169.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -64.95 -45.02 87.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.65 0.78 . . . . 0.0 110.089 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.7 t -51.27 -53.05 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.248 0.619 . . . . 0.0 109.485 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mtt -69.27 -41.84 76.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.438 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -51.83 -38.31 55.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.389 0.995 . . . . 0.0 111.454 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.46 -18.85 64.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.174 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.36 23.45 1.15 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.525 1.057 . . . . 0.0 113.834 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.26 78.56 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.212 -0.93 . . . . 0.0 110.663 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -60.46 -21.87 62.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.066 0.546 . . . . 0.0 111.707 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.02 -32.71 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.391 0.996 . . . . 0.0 108.373 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.9 t -72.31 -49.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.7 mmt -64.48 -29.52 70.57 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.645 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.5 m -48.82 -34.48 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.028 0.931 . . . . 0.0 112.064 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.22 -30.91 60.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.695 0.398 . . . . 0.0 110.426 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -114.37 -7.85 12.88 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.23 25.02 12.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.354 1.862 . . . . 0.0 109.004 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.98 -32.93 71.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 111.197 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.9 p -139.59 167.6 18.09 Favored Pre-proline 0 N--CA 1.441 -0.923 0 C-N-CA 131.659 3.984 . . . . 0.0 102.649 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.45 58.28 6.26 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.168 1.912 . . . . 0.0 110.62 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.126 176.157 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 mm -125.36 146.87 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 160.42 29.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.284 1.434 . . . . 0.0 109.653 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -24.93 66.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -84.69 -33.88 23.08 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.684 -0.635 . . . . 0.0 111.136 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.03 17.24 0.91 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.323 1.44 . . . . 0.0 112.854 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -84.26 144.44 28.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.455 1.627 . . . . 0.0 109.753 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -88.73 124.08 66.38 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 170.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.12 131.4 11.89 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.278 1.985 . . . . 0.0 110.207 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -144.09 162.39 36.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.34 1.056 . . . . 0.0 111.414 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.38 143.36 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.693 2.397 . . . . 0.0 106.425 169.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.01 126.46 6.32 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.58 138.86 19.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -118.93 89.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 168.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.65 138.64 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 m -126.11 123.84 39.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.93 144.07 32.17 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -66.34 -5.82 12.03 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.34 -11.59 60.54 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.928 0.786 . . . . 0.0 110.487 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.31 37.79 4.21 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 126.032 1.777 . . . . 0.0 112.426 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -138.01 157.89 45.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 108.844 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 m -100.61 161.25 3.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.5 ttt -58.07 132.38 53.33 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.381 1.472 . . . . 0.0 109.823 169.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.15 136.73 14.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.48 141.98 25.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.143 0.577 . . . . 0.0 110.118 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -71.13 140.26 50.54 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -75.39 142.75 43.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -62.18 125.73 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 109.797 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.25 14.31 71.3 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.281 -0.733 . . . . 0.0 114.387 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -148.5 131.97 16.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -87.7 48.7 1.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 111.819 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -153.37 -179.45 7.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.18 1.392 . . . . 0.0 108.906 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -108.53 155.07 21.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 108.408 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -134.9 143.19 46.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.246 0.93 . . . . 0.0 112.881 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -58.7 138.66 86.41 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.885 0.874 . . . . 0.0 109.785 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.77 145.83 81.97 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -169.65 157.84 7.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.748 1.619 . . . . 0.0 111.743 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.74 138.19 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.36 159.09 51.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.516 1.158 . . . . 0.0 111.515 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.1 mt -91.72 146.9 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 108.355 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -89.52 153.45 48.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.525 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.14 117.97 4.78 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.21 86.98 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.987 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.39 125.69 31.33 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.458 1.129 . . . . 0.0 108.333 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.74 157.63 36.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.746 1.218 . . . . 0.0 110.697 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -41.39 71.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.301 1.04 . . . . 0.0 113.244 -168.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -70.82 -47.18 60.79 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.46 -41.47 80.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.391 1.476 . . . . 0.0 110.01 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.06 81.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.696 0.68 . . . . 0.0 111.914 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -58.9 -44.94 91.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.934 0.788 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.87 -24.03 66.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.042 1.292 . . . . 0.0 113.405 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -63.75 -52.39 60.64 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.466 1.484 . . . . 0.0 108.949 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -36.16 82.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.562 0.345 . . . . 0.0 111.481 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.5 tp -57.23 -41.31 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 110.196 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.08 -45.88 46.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.288 1.035 . . . . 0.0 111.632 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.61 -36.73 79.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.799 1.181 . . . . 0.0 111.975 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.37 -47.77 7.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.126 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.55 -26.75 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.234 0.613 . . . . 0.0 111.142 -169.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.43 27.39 67.86 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.701 -0.624 . . . . 0.0 112.135 -170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.3 mt -105.05 157.63 17.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.547 1.139 . . . . 0.0 108.634 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -118.37 -174.45 2.67 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.614 1.166 . . . . 0.0 109.969 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.01 34.64 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.834 2.054 . . . . 0.0 114.343 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -159.26 -17.89 0.07 Allowed 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -87.02 -1.52 57.94 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.011 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.52 168.72 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.196 1.398 . . . . 0.0 109.203 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.12 122.48 16.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.0 mt -75.38 131.85 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 120.651 1.569 . . . . 0.0 107.497 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.58 -33.9 7.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.774 0.43 . . . . 0.0 111.671 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.28 168.09 28.41 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.016 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.2 p -146.73 159.53 43.36 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.879 1.272 . . . . 0.0 108.043 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -64.33 134.71 55.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -68.0 -18.36 64.7 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -149.06 165.89 30.35 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.307 1.443 . . . . 0.0 107.974 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -65.66 117.84 8.7 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.61 -53.85 29.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER 62.52 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 129.725 3.21 . . . . 0.0 112.775 -178.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -144.61 156.58 44.19 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.12 129.92 55.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.39 143.59 88.11 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.988 0.915 . . . . 0.0 109.257 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -66.72 154.34 74.82 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.837 2.358 . . . . 0.0 109.215 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -58.93 -31.36 68.59 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.55 -24.12 61.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.84 0.856 . . . . 0.0 112.95 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 tp -104.67 -17.2 14.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.19 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -45.68 136.86 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -72.58 -49.69 30.59 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.8 m95 58.86 3.18 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.139 2.575 . . . . 0.0 114.868 -169.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.59 -23.03 16.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.141 0.976 . . . . 0.0 111.52 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.48 158.63 18.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.338 1.855 . . . . 0.0 110.102 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -132.31 112.0 14.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 108.68 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -59.69 157.02 44.09 Favored 'Cis proline' 0 CA--C 1.537 0.668 0 CA-C-N 120.284 1.137 . . . . 0.0 110.51 -10.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.93 130.21 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.3 t -79.01 117.13 19.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.299 -1.319 . . . . 0.0 107.618 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.24 -2.12 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.283 1.433 . . . . 0.0 111.76 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 159.8 33.09 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 120.207 1.367 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -104.52 106.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.7 127.47 32.83 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 143.95 29.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.115 0.87 . . . . 0.0 111.723 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.19 135.2 55.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -108.71 147.76 31.48 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -121.29 124.96 45.88 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 tp -79.73 110.93 15.54 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.5 128.71 52.5 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.9 0.88 . . . . 0.0 109.364 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -87.72 140.82 29.13 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 168.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -70.91 136.15 48.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.29 -41.31 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.1 m -136.07 136.13 39.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.62 176.61 46.89 Favored Glycine 0 C--N 1.331 0.303 0 O-C-N 121.514 -0.741 . . . . 0.0 113.378 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 t70 61.24 -46.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.719 3.608 . . . . 0.0 114.071 -172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.18 21.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.412 1.085 . . . . 0.0 111.389 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -90.81 -23.77 20.5 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.289 0.636 . . . . 0.0 111.193 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mt -66.12 139.43 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -135.18 -37.32 0.79 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.052 0.541 . . . . 0.0 112.071 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.4 mtt 56.85 17.46 3.27 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -132.91 25.4 4.3 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.621 1.1 . . . . 0.0 111.807 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -28.75 63.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.116 1.766 . . . . 0.0 111.436 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -7.0 57.8 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.254 1.821 . . . . 0.0 113.572 -170.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 67.69 -36.68 0.3 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.304 2.642 . . . . 0.0 113.66 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 p -124.29 75.06 60.63 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.58 -174.05 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.611 2.874 . . . . 0.0 111.238 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -107.57 -8.68 16.1 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.171 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.57 152.46 50.77 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 120.59 1.541 . . . . 0.0 112.43 -172.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -121.83 -31.2 3.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.632 1.573 . . . . 0.0 112.278 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.3 11.88 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -113.23 148.4 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.944 1.298 . . . . 0.0 110.847 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -152.05 129.17 11.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.793 1.237 . . . . 0.0 108.44 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -80.38 143.29 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 165.01 9.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.199 0.6 . . . . 0.0 110.233 -169.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -47.41 140.45 5.71 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -50.0 -41.45 47.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -94.12 -11.34 30.72 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -57.24 -44.99 99.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.428 -171.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.51 -23.89 77.32 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.554 1.503 . . . . 0.0 113.807 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -38.93 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 119.041 0.837 . . . . 0.0 109.605 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -87.71 -19.2 27.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.039 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.88 -27.73 66.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 121.032 1.742 . . . . 0.0 110.224 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.59 154.84 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.89 1.276 . . . . 0.0 110.641 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.66 150.23 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.811 1.245 . . . . 0.0 110.288 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -59.13 -31.58 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -168.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -75.25 -31.1 60.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.864 1.211 . . . . 0.0 110.691 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.98 -25.61 27.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.195 -0.907 . . . . 0.0 112.294 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -48.1 -47.98 34.01 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.372 1.442 . . . . 0.0 110.992 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.78 -43.94 87.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.375 0.534 . . . . 0.0 111.067 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.3 -33.96 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.937 -0.477 . . . . 0.0 110.267 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.79 -32.71 74.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.422 1.01 . . . . 0.0 109.522 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp-105 -59.76 -34.48 73.03 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 120.67 -1.269 . . . . 0.0 111.925 170.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -61.8 -46.55 89.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.281 1.4 . . . . 0.0 109.343 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.85 -52.14 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.2 mmt -60.55 -45.01 95.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -60.07 -38.67 83.54 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.239 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.11 -21.38 64.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.209 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -120.19 -22.82 6.46 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.24 64.09 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-N 119.896 1.226 . . . . 0.0 111.427 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -66.83 -25.95 66.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.071 0.85 . . . . 0.0 111.818 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.66 -37.4 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.1 -39.13 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.417 0.687 . . . . 0.0 110.198 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.5 mmt -72.55 -26.47 61.75 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.028 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.8 m -58.07 -32.92 68.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.621 1.1 . . . . 0.0 111.464 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.32 -29.17 69.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -94.45 -40.49 9.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.692 1.197 . . . . 0.0 109.682 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -69.09 -26.57 65.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.962 1.305 . . . . 0.0 111.666 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -75.0 -45.84 39.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.35 -45.3 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -62.76 -36.85 59.95 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.953 2.435 . . . . 0.0 113.62 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.9 tptt . . . . . 0 C--O 1.253 1.26 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.693 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.8 mm -127.41 134.82 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.02 144.32 50.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.672 1.589 . . . . 0.0 107.937 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -47.73 -32.53 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -168.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.74 -3.63 39.14 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.38 28.36 7.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.024 1.773 . . . . 0.0 111.418 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.69 145.38 39.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.125 1.462 . . . . 0.0 110.585 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 122.26 69.03 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 116.588 -1.672 . . . . 0.0 107.194 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.68 126.37 12.63 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.846 1.697 . . . . 0.0 110.111 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -140.37 166.7 23.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.476 1.11 . . . . 0.0 110.633 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.66 148.52 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.567 2.347 . . . . 0.0 106.668 169.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.95 12.1 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -102.57 117.32 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.47 82.25 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -62.62 130.9 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.8 127.39 53.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.75 136.49 32.97 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -66.6 -5.82 12.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.107 1.363 . . . . 0.0 114.317 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -75.41 -7.64 54.59 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.184 0.902 . . . . 0.0 110.496 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 33.7 4.55 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 125.103 1.335 . . . . 0.0 112.276 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -134.29 161.25 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.858 0.863 . . . . 0.0 109.131 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.49 162.61 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.727 0.811 . . . . 0.0 113.155 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.9 tpt -51.74 131.67 30.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.097 2.159 . . . . 0.0 112.085 171.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -161.91 143.88 11.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 167.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.09 143.98 21.84 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -78.07 145.89 35.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -77.9 125.1 28.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.59 140.69 57.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.153 1.381 . . . . 0.0 109.713 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 -40.92 1.73 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.512 1.053 . . . . 0.0 113.524 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.23 -31.95 24.75 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.499 1.149 . . . . 0.0 110.616 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.47 39.44 31.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.592 1.557 . . . . 0.0 112.402 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -135.2 173.87 11.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.591 1.956 . . . . 0.0 107.163 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -80.52 160.53 25.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.603 1.092 . . . . 0.0 111.77 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -151.39 146.88 26.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.675 1.19 . . . . 0.0 109.025 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.81 136.11 51.55 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.963 0.905 . . . . 0.0 110.731 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -65.41 141.28 67.24 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.602 2.201 . . . . 0.0 111.817 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -177.92 150.76 0.64 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.067 2.547 . . . . 0.0 106.337 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.84 142.75 9.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.02 154.62 53.42 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 118.323 1.061 . . . . 0.0 111.34 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.7 127.76 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -67.47 125.55 91.32 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 117.684 -1.15 . . . . 0.0 108.841 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.67 117.97 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.92 1.747 . . . . 0.0 112.803 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.08 0.42 77.52 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.404 1.478 . . . . 0.0 112.923 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -93.82 127.71 39.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.13 160.18 31.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.536 1.135 . . . . 0.0 110.811 -177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.9 64.06 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.063 1.345 . . . . 0.0 113.146 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -71.21 -48.57 50.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.13 -38.22 79.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.536 1.534 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.8 68.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.91 1.284 . . . . 0.0 111.738 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.437 ' HG3' ' CD1' ' A' ' 100' ' ' PHE . 18.2 tmm? -60.64 -43.06 98.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.54 -32.71 74.24 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.246 -0.908 . . . . 0.0 112.213 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -60.67 -46.57 89.83 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.848 -1.157 . . . . 0.0 109.517 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.6 67.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.802 0.728 . . . . 0.0 111.705 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -61.31 -40.84 95.66 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.037 -1.04 . . . . 0.0 108.531 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.85 -55.87 6.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.575 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.6 -38.22 83.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.947 1.703 . . . . 0.0 111.225 -170.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -94.66 -37.96 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.323 0.51 . . . . 0.0 112.041 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -109.63 -20.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.267 0.627 . . . . 0.0 110.668 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.55 48.46 56.72 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.499 -1.376 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 mt -127.68 156.12 42.87 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.831 1.652 . . . . 0.0 107.817 171.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -114.07 -177.16 3.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.142 0.977 . . . . 0.0 110.285 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -73.75 38.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.273 1.829 . . . . 0.0 113.14 -170.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -157.98 -18.69 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.987 1.315 . . . . 0.0 113.202 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -86.03 -2.01 57.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.993 0.517 . . . . 0.0 112.082 -169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -149.14 168.02 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.13 -170.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -137.51 121.4 17.64 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.51 126.55 35.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.87 -32.58 7.86 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.208 0.317 . . . . 0.0 111.271 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.81 162.06 39.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.506 1.122 . . . . 0.0 108.555 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 m -139.86 157.47 45.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -58.89 137.21 57.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.146 0.885 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -61.52 -31.34 71.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.771 0.429 . . . . 0.0 111.453 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -151.65 173.07 15.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.216 1.806 . . . . 0.0 106.754 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -60.08 125.19 22.72 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 109.471 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.98 50.11 1.91 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 127.52 2.328 . . . . 0.0 107.451 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 146.46 47.67 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -169.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -145.52 142.77 29.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.641 0.588 . . . . 0.0 110.199 -170.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -100.18 133.2 44.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.601 1.16 . . . . 0.0 108.536 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.7 148.83 73.55 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 124.428 1.091 . . . . 0.0 111.016 -174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 154.42 74.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.756 2.304 . . . . 0.0 109.265 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -53.59 -31.55 47.37 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -72.04 -32.01 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.519 1.127 . . . . 0.0 111.905 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.52 -24.11 18.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.975 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -58.05 130.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.19 -43.62 41.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.094 0.557 . . . . 0.0 112.361 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 24.8 m95 59.69 4.64 0.58 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 127.382 2.273 . . . . 0.0 113.432 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.78 -21.51 15.15 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.209 1.404 . . . . 0.0 111.066 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -73.78 147.09 43.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.455 1.502 . . . . 0.0 108.651 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -134.84 116.55 12.56 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.44 149.16 31.02 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.952 1.019 . . . . 0.0 111.161 -10.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.39 131.61 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.3 106.69 18.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.0 pt -102.06 -6.14 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.002 0.921 . . . . 0.0 112.409 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.7 163.71 37.22 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 120.232 1.378 . . . . 0.0 113.172 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.5 115.67 27.81 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -85.64 120.22 26.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 101.211 -3.626 . . . . 0.0 101.211 168.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -146.38 138.03 24.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.662 1.119 . . . . 0.0 111.435 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.21 122.67 45.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -98.91 141.34 31.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.437 ' CD1' ' HG3' ' A' ' 50' ' ' MET . 58.5 m-85 -118.84 128.72 54.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 tt -82.59 121.22 26.53 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.47 122.05 46.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.667 -1.151 . . . . 0.0 107.991 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -80.85 133.89 35.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 tp -67.12 136.68 55.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -115.92 -38.15 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m -89.52 -130.5 0.08 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.486 0.714 . . . . 0.0 109.781 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.73 177.1 46.94 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 120.001 1.273 . . . . 0.0 111.914 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -52.67 -31.3 36.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.322 1.449 . . . . 0.0 112.554 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.88 -27.04 66.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -97.16 -28.28 14.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.167 0.987 . . . . 0.0 110.894 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.63 147.04 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.53 1.132 . . . . 0.0 108.025 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -127.17 -50.63 1.43 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.351 0.66 . . . . 0.0 109.684 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 mtt 63.33 -8.26 0.15 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.486 1.914 . . . . 0.0 115.179 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -109.54 24.53 12.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 121.248 1.84 . . . . 0.0 111.616 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -24.9 63.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.303 1.841 . . . . 0.0 112.19 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -6.69 59.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.981 1.713 . . . . 0.0 113.901 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.2 m 68.86 -34.02 0.26 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.387 2.675 . . . . 0.0 114.111 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.11 71.65 63.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.64 -170.21 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.525 2.816 . . . . 0.0 113.561 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -110.53 -42.56 4.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.252 1.021 . . . . 0.0 109.749 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.66 152.47 28.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.521 1.055 . . . . 0.0 113.568 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.16 14.36 13.96 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.473 1.509 . . . . 0.0 112.168 171.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.61 171.44 46.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.01 1.29 . . . . 0.0 113.348 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -164.65 -116.43 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.82 1.248 . . . . 0.0 109.741 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.8 mtp85 -145.81 160.81 41.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.267 3.027 . . . . 0.0 107.51 -170.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -85.77 132.95 34.03 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.51 168.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 110.793 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.4 m -52.7 147.24 8.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.729 0.695 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -52.46 -40.66 62.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -168.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -95.32 -3.73 46.78 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.71 -43.19 82.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.495 1.043 . . . . 0.0 111.765 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.2 -26.41 82.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.535 1.584 . . . . 0.0 113.085 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -12.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 O-C-N 121.435 -0.791 . . . . 0.0 111.374 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -35.73 7.66 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.808 1.186 . . . . 0.0 109.284 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -68.52 -26.54 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.733 1.151 . . . . 0.0 112.297 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.08 159.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 118.885 0.766 . . . . 0.0 110.459 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.3 149.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.574 0.75 . . . . 0.0 111.43 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 m -51.09 -39.01 55.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.035 1.734 . . . . 0.0 114.064 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.37 -40.3 58.22 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.735 0.698 . . . . 0.0 110.222 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -66.53 -32.76 74.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.212 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -44.97 -48.83 11.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.705 1.139 . . . . 0.0 110.789 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.94 -34.74 78.82 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.73 -38.42 19.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.948 -0.47 . . . . 0.0 109.955 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -33.18 75.41 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.961 -0.462 . . . . 0.0 109.837 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -56.22 -40.3 73.85 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.314 -1.327 . . . . 0.0 110.967 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.07 -45.02 90.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.838 1.654 . . . . 0.0 109.155 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.69 -41.68 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.8 mtt -72.0 -39.54 69.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.542 -0.724 . . . . 0.0 110.658 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.69 -37.13 86.18 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.45 -28.34 66.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.093 0.957 . . . . 0.0 111.466 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -122.98 2.68 9.36 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.67 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.414 1.461 . . . . 0.0 111.576 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 p -66.01 -23.03 66.49 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 t -69.39 -39.91 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.69 1.132 . . . . 0.0 108.841 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.02 -44.2 28.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mtt -66.08 -32.77 74.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.568 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.1 m -61.16 -22.13 64.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.521 1.055 . . . . 0.0 112.761 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.25 -21.57 39.35 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 111.546 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -109.53 -37.67 5.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.613 1.165 . . . . 0.0 109.93 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -89.55 30.53 1.01 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.733 2.013 . . . . 0.0 109.486 171.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -75.74 -43.91 44.48 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.701 -0.624 . . . . 0.0 111.76 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.474 ' H ' ' CD ' ' A' ' 163' ' ' PRO . 7.9 p -129.7 -25.04 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.75 2.02 . . . . 0.0 115.124 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.474 ' CD ' ' H ' ' A' ' 162' ' ' THR . 51.9 Cg_exo -65.09 -27.41 57.29 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.598 2.198 . . . . 0.0 112.993 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 C--O 1.253 1.279 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 171.637 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.395 0.141 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm -137.91 147.99 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.25 -44.88 71.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.132 0.573 . . . . 0.0 111.833 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -152.05 -80.73 0.1 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.69 0.796 . . . . 0.0 110.83 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.76 -47.48 8.6 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.06 12.64 0.05 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.644 -0.531 . . . . 0.0 114.123 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -96.72 130.67 43.92 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.498 1.149 . . . . 0.0 108.655 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -88.02 127.51 57.33 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.62 135.98 24.95 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.719 1.612 . . . . 0.0 109.92 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -140.65 153.47 46.02 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.709 1.604 . . . . 0.0 111.446 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.69 135.16 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.909 2.084 . . . . 0.0 105.533 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.69 125.92 6.69 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mm -95.49 110.33 24.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.59 86.14 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.68 129.97 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.2 t -106.22 135.3 47.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 168.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.81 25.66 4.53 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 54.42 -2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.251 2.22 . . . . 0.0 116.726 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -95.58 14.8 21.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.043 0.838 . . . . 0.0 111.697 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.6 9.48 84.65 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 124.564 1.078 . . . . 0.0 113.112 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -125.45 172.9 9.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.441 1.12 . . . . 0.0 108.875 -169.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.18 170.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.3 tpt -53.13 136.22 36.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.5 2.32 . . . . 0.0 113.72 -170.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -163.1 135.6 5.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.813 1.245 . . . . 0.0 108.166 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.82 158.23 40.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.401 1.48 . . . . 0.0 109.104 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -93.05 130.79 38.53 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -78.92 123.35 27.18 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.887 0.875 . . . . 0.0 109.173 -169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -53.75 134.16 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.267 2.227 . . . . 0.0 110.222 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 -16.88 1.92 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.939 1.257 . . . . 0.0 114.773 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -105.75 -30.8 9.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 110.33 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 58.87 39.65 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.76 1.624 . . . . 0.0 112.791 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 p -140.53 171.29 14.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.712 1.605 . . . . 0.0 108.298 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -79.24 157.59 27.76 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.01 157.29 19.08 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.186 2.194 . . . . 0.0 113.742 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.83 96.47 5.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 168.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 146.25 89.69 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.307 1.338 . . . . 0.0 111.695 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 156.5 149.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.628 3.171 . . . . 0.0 108.231 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.03 143.87 14.64 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.61 144.34 35.35 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.7 mt -73.53 141.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.87 141.53 38.18 Favored Pre-proline 0 N--CA 1.465 0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.368 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -59.34 116.31 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.088 1.859 . . . . 0.0 111.971 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.43 2.39 87.42 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.056 1.312 . . . . 0.0 112.916 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -86.21 128.26 34.87 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.515 1.158 . . . . 0.0 107.996 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.52 157.42 38.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.488 1.115 . . . . 0.0 110.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.8 63.71 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.364 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 1.5 mp0 -64.12 -49.49 71.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -57.47 -36.22 71.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.169 1.388 . . . . 0.0 109.608 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.24 -35.17 66.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.645 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' A' ' 47' ' ' GLU . 30.6 mtp -56.54 -47.22 79.87 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.369 1.44 . . . . 0.0 109.189 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.76 -26.57 67.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -65.87 -53.07 44.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.843 0.747 . . . . 0.0 109.549 170.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.63 82.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.113 0.87 . . . . 0.0 111.474 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 tp -56.33 -41.78 76.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.528 1.531 . . . . 0.0 110.345 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -44.13 56.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.57 1.148 . . . . 0.0 111.105 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.46 -37.79 83.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.291 0.95 . . . . 0.0 111.826 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.03 -75.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.017 0.927 . . . . 0.0 109.987 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.84 -6.59 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.76 49.78 61.97 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 mt -120.34 156.94 30.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.647 1.579 . . . . 0.0 107.111 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.5 m -112.68 173.63 6.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.158 0.983 . . . . 0.0 109.444 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.97 43.42 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.104 2.162 . . . . 0.0 114.508 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.66 -18.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.102 1.761 . . . . 0.0 112.171 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -88.99 -0.07 57.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.842 0.857 . . . . 0.0 111.71 -172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.37 169.96 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.862 1.265 . . . . 0.0 109.365 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -142.3 129.16 20.6 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 mt -81.34 127.85 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.124 1.329 . . . . 0.0 108.719 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.9 -35.37 6.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.716 0.807 . . . . 0.0 111.898 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.24 165.88 35.07 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.689 0.795 . . . . 0.0 109.848 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.5 p -144.92 160.06 41.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.251 1.02 . . . . 0.0 109.511 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 p -64.94 137.18 57.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -64.75 -25.27 67.85 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -151.16 170.21 19.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.971 1.309 . . . . 0.0 108.667 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -65.99 123.56 20.18 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.227 0.611 . . . . 0.0 109.467 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.43 167.8 19.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.62 154.67 33.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -139.26 162.94 33.77 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -103.82 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.3 mt -69.12 140.59 90.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 151.88 64.65 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.319 2.679 . . . . 0.0 109.294 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -65.5 -21.05 66.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.67 -27.83 61.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.954 0.901 . . . . 0.0 112.332 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.7 tp -94.46 -26.25 16.55 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.614 0.766 . . . . 0.0 110.929 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.35 136.8 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -42.47 42.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.523 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m95 61.81 3.38 0.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.164 2.185 . . . . 0.0 113.718 -169.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -16.69 18.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.245 1.418 . . . . 0.0 111.028 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -76.94 144.26 38.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.983 1.713 . . . . 0.0 107.259 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.79 116.41 9.0 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.468 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.31 150.96 22.04 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.105 1.073 . . . . 0.0 111.927 -10.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 m -57.72 129.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.8 t -88.82 107.37 18.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -111.65 -5.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.6 1.16 . . . . 0.0 112.257 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 168.76 41.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.128 0.876 . . . . 0.0 112.188 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -103.76 107.88 18.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -71.76 121.54 19.09 Favored 'General case' 0 N--CA 1.471 0.617 1 N-CA-C 100.185 -4.006 . . . . 0.0 100.185 167.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.89 132.9 33.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.621 1.555 . . . . 0.0 112.783 -168.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -112.37 128.11 56.2 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -104.25 147.14 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.68 130.05 48.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.2 tp -77.84 111.61 13.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.24 126.99 52.9 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -82.58 134.98 35.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.69 104.65 4.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.87 -33.9 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.8 p -83.6 -119.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.821 0.448 . . . . 0.0 109.848 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.8 174.37 42.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.998 1.285 . . . . 0.0 110.675 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -28.9 15.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.686 1.194 . . . . 0.0 113.012 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.423 0.556 . . . . 0.0 112.082 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.61 -22.04 13.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.551 1.141 . . . . 0.0 111.691 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.6 mt -62.38 102.99 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -92.47 -30.88 15.49 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.168 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.0 mtt 60.84 -44.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 130.093 3.357 . . . . 0.0 114.784 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.27 34.46 1.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.352 1.861 . . . . 0.0 110.469 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -71.21 -49.5 42.84 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -68.55 148.82 49.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -75.72 -27.06 58.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.936 1.695 . . . . 0.0 112.228 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 p -120.74 69.73 17.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.675 1.99 . . . . 0.0 106.58 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.62 -174.67 1.94 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.273 3.315 . . . . 0.0 111.292 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -116.2 -18.24 10.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.386 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.14 150.18 52.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 121.935 2.152 . . . . 0.0 112.067 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.08 -28.9 4.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.708 1.203 . . . . 0.0 112.492 -170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.44 150.41 20.02 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -96.73 156.88 16.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.945 1.298 . . . . 0.0 110.194 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -153.01 103.54 2.75 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -71.57 133.37 45.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.052 1.296 . . . . 0.0 108.658 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 153.8 27.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.909 1.284 . . . . 0.0 108.15 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.5 m -58.48 158.54 7.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.62 0.768 . . . . 0.0 112.672 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.18 151.02 13.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.2 m95 67.1 -23.41 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.171 1.788 . . . . 0.0 115.561 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.0 -47.56 95.08 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 121.059 1.754 . . . . 0.0 111.259 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.82 -32.92 86.58 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.875 1.717 . . . . 0.0 113.234 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.95 -33.02 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.512 0.725 . . . . 0.0 110.35 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -85.92 -26.63 25.45 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.166 0.894 . . . . 0.0 111.744 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -80.53 -27.6 37.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.773 0.715 . . . . 0.0 112.191 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.55 158.78 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.164 0.893 . . . . 0.0 110.097 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.29 148.51 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.215 1.006 . . . . 0.0 111.466 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 m -57.6 -35.67 70.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.956 1.302 . . . . 0.0 113.767 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -71.88 -25.41 61.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.178 0.899 . . . . 0.0 111.635 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -86.75 -40.82 14.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.775 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.27 -51.66 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 112.977 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -66.3 -33.07 74.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.463 0.574 . . . . 0.0 112.397 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.83 -35.24 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.349 0.66 . . . . 0.0 110.193 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.34 -31.98 73.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.532 1.06 . . . . 0.0 110.608 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -55.84 -40.87 73.44 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.368 -0.832 . . . . 0.0 110.559 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -64.36 -45.26 88.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 109.504 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.71 -47.19 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 mtt -66.32 -38.13 86.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.956 -0.465 . . . . 0.0 110.744 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.17 -37.9 89.05 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.021 -1.049 . . . . 0.0 110.286 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.11 -29.81 70.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 111.238 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -115.64 -13.97 11.47 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.79 39.84 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.322 1.419 . . . . 0.0 111.702 -169.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.4 m -64.02 -24.5 67.73 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.022 -0.424 . . . . 0.0 111.612 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.11 -40.95 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.8 t -68.63 -45.46 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.486 0.714 . . . . 0.0 110.238 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -71.04 -20.35 62.39 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.039 0.836 . . . . 0.0 111.491 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -59.48 -30.55 68.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.461 1.028 . . . . 0.0 111.824 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.45 -41.1 85.27 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.22 -29.83 22.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.928 -173.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -12.95 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.006 1.322 . . . . 0.0 111.441 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -95.13 76.77 3.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -37.12 30.34 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -169.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -66.93 -12.13 34.87 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.341 2.694 . . . . 0.0 115.321 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 60.0 tttp . . . . . 0 C--O 1.252 1.226 0 CA-C-N 120.612 1.551 . . . . 0.0 109.241 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.339 0.114 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 mm -139.28 142.7 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.26 140.03 50.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.276 1.43 . . . . 0.0 108.198 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -31.94 -49.95 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.754 2.422 . . . . 0.0 116.577 -168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -83.97 8.67 14.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.46 35.04 4.24 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.386 1.47 . . . . 0.0 112.258 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -115.61 143.76 44.88 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.613 1.206 . . . . 0.0 112.295 -171.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -82.85 115.86 60.92 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-O 117.435 -1.269 . . . . 0.0 107.817 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 125.29 7.13 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.119 1.88 . . . . 0.0 109.808 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.17 174.35 15.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.374 1.069 . . . . 0.0 109.919 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.4 m -119.94 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.92 9.04 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.33 128.01 38.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.085 0.943 . . . . 0.0 108.746 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.94 88.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.9 mm -67.57 137.21 25.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 168.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -125.57 120.21 30.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -78.14 138.9 38.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -65.22 -7.09 11.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.42 -11.27 60.61 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.125 0.875 . . . . 0.0 110.516 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.67 34.83 4.54 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.378 1.942 . . . . 0.0 112.225 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -131.9 148.01 52.51 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 m -104.98 162.89 4.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.9 tpt -56.39 130.06 43.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.097 1.759 . . . . 0.0 110.376 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -161.73 127.42 3.62 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.33 144.3 32.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -73.06 135.9 44.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -77.61 128.64 34.46 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.96 128.57 16.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.912 2.085 . . . . 0.0 110.44 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.32 -33.19 1.55 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.191 1.376 . . . . 0.0 114.067 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -37.14 21.92 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.415 1.108 . . . . 0.0 109.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.259 14.8 m170 59.21 33.12 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.657 1.583 . . . . 0.0 113.096 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -139.12 162.98 33.62 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.356 2.262 . . . . 0.0 105.805 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -74.19 164.86 26.1 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.405 1.002 . . . . 0.0 113.203 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -151.44 142.8 23.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.641 1.576 . . . . 0.0 108.474 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -73.14 144.94 85.35 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.587 0.755 . . . . 0.0 110.017 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.66 144.73 97.65 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.371 1.381 . . . . 0.0 112.435 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -172.79 138.09 0.8 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.518 2.327 . . . . 0.0 108.505 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.41 -114.09 3.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.272 0.939 . . . . 0.0 110.969 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.81 165.11 35.05 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 128.006 2.717 . . . . 0.0 107.443 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.89 135.08 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -84.44 158.23 60.66 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 119.011 -0.518 . . . . 0.0 109.855 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.7 117.21 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.817 1.678 . . . . 0.0 112.275 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.16 9.24 85.58 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.839 1.209 . . . . 0.0 112.909 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.05 125.19 29.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.361 1.08 . . . . 0.0 108.717 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 159.58 34.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.472 1.109 . . . . 0.0 110.815 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.68 68.76 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.703 1.201 . . . . 0.0 113.436 -169.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.17 -43.42 64.61 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.79 -44.21 97.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.493 1.117 . . . . 0.0 108.886 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.73 71.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.417 1.087 . . . . 0.0 112.292 172.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -65.98 -43.09 88.84 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.211 0.914 . . . . 0.0 109.739 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -65.55 -25.48 67.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.211 1.369 . . . . 0.0 111.727 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.96 -49.61 64.89 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 120.063 1.301 . . . . 0.0 108.64 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.69 83.18 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.82 0.819 . . . . 0.0 110.239 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.45 -40.93 88.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.204 1.401 . . . . 0.0 109.646 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.17 -47.72 55.99 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.17 0.988 . . . . 0.0 111.196 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.44 -35.33 80.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.894 1.679 . . . . 0.0 112.053 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.32 -39.6 9.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.722 0.809 . . . . 0.0 110.422 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -17.35 7.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 111.01 -169.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.08 43.42 99.45 Favored Glycine 0 N--CA 1.451 -0.31 0 O-C-N 120.567 -1.333 . . . . 0.0 110.918 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -117.28 159.32 22.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.638 1.175 . . . . 0.0 108.183 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -122.36 -177.49 3.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.823 1.249 . . . . 0.0 110.271 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -67.93 40.42 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.177 2.591 . . . . 0.0 114.694 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -164.68 -22.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.343 1.057 . . . . 0.0 112.655 -169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.99 -3.92 58.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.446 0.698 . . . . 0.0 112.298 -169.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.4 168.97 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.921 1.288 . . . . 0.0 109.72 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -135.74 119.48 17.22 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 mt -75.76 131.79 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 120.069 1.304 . . . . 0.0 107.738 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.63 -50.72 3.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.262 0.483 . . . . 0.0 110.24 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.39 168.36 20.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.774 0.83 . . . . 0.0 110.618 -170.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.0 p -150.81 161.23 43.06 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.136 1.375 . . . . 0.0 108.23 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -62.49 146.29 52.03 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.936 0.789 . . . . 0.0 109.991 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.6 mtt-85 -64.62 -30.18 71.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.044 0.538 . . . . 0.0 111.523 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.56 172.18 13.96 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.691 1.596 . . . . 0.0 107.546 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -61.11 125.19 22.82 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.63 147.39 39.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -118.71 123.73 45.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.85 126.01 48.65 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.064 -0.969 . . . . 0.0 108.528 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -102.42 112.47 25.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.39 148.9 98.2 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.359 1.063 . . . . 0.0 110.738 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -66.96 151.57 81.9 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 108.333 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -25.25 66.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -74.81 -26.39 59.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.217 1.007 . . . . 0.0 112.432 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.05 -21.12 16.36 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.765 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.4 t -46.59 140.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 168.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -73.82 -44.88 54.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.8 m95 57.17 8.74 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.215 2.206 . . . . 0.0 114.719 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -120.84 -16.62 8.11 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.184 0.994 . . . . 0.0 112.649 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 p -75.08 -36.2 61.78 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 49.32 93.36 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 127.654 2.382 . . . . 0.0 112.271 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.54 147.68 73.09 Favored 'Cis proline' 0 C--N 1.352 0.728 0 CA-C-N 119.774 0.955 . . . . 0.0 111.315 6.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.53 129.36 27.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.1 t -91.87 112.56 24.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.57 -5.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 124.529 1.132 . . . . 0.0 111.808 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.64 43.06 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.818 1.19 . . . . 0.0 115.217 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -106.46 126.75 52.64 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 124.817 1.247 . . . . 0.0 107.739 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -91.64 116.22 28.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.53 108.86 6.12 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.606 0.567 . . . . 0.0 111.208 -168.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -93.44 128.96 39.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 168.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -95.72 135.28 37.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.47 128.43 56.33 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -87.84 109.79 20.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.96 124.45 50.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.229 1.012 . . . . 0.0 109.899 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.19 131.66 34.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.88 135.69 51.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.44 -28.14 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.0 p -88.21 -126.81 0.05 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.211 1.004 . . . . 0.0 110.411 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.93 166.48 35.54 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.21 1.386 . . . . 0.0 110.026 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.24 -30.88 18.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.493 1.117 . . . . 0.0 112.773 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.48 65.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.079 0.552 . . . . 0.0 112.295 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -95.96 -31.83 12.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.775 1.23 . . . . 0.0 110.726 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.38 142.63 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.207 1.403 . . . . 0.0 108.177 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.59 -51.33 1.84 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.7 mtt 63.71 -18.42 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.42 1.888 . . . . 0.0 115.337 -171.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.36 25.33 7.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.836 2.107 . . . . 0.0 112.042 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -35.33 77.13 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.935 2.494 . . . . 0.0 111.698 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -3.58 55.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 113.471 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 m 65.98 -35.98 0.23 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.95 2.5 . . . . 0.0 114.126 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 p -125.95 68.15 62.86 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.739 2.016 . . . . 0.0 106.287 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.19 -172.59 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.017 3.145 . . . . 0.0 111.507 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.43 -17.84 13.89 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.306 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -129.25 146.47 51.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 121.915 2.143 . . . . 0.0 111.842 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.42 -49.04 3.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.382 0.673 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.51 153.25 6.22 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 123.38 0.514 . . . . 0.0 111.836 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 30.6 t-105 -156.41 -130.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.802 1.241 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -152.94 155.22 36.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.806 2.842 . . . . 0.0 106.942 -169.272 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.4 143.15 37.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 0.85 . . . . 0.0 110.285 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.5 164.76 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.039 0.936 . . . . 0.0 110.52 -169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.25 147.98 5.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.735 0.814 . . . . 0.0 110.011 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -54.14 -40.73 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -93.14 2.76 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.64 -47.82 75.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 120.767 -1.208 . . . . 0.0 111.126 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -64.97 -32.77 53.57 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.913 1.719 . . . . 0.0 112.886 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.65 -33.4 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 119.784 1.174 . . . . 0.0 109.931 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.43 -41.95 75.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.835 1.198 . . . . 0.0 110.063 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -83.83 -18.77 36.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.21 160.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.601 1.091 . . . . 0.0 109.714 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.4 m -51.69 143.59 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.649 1.18 . . . . 0.0 111.576 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.8 m -59.89 -30.97 69.37 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -69.96 -47.18 63.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.144 0.884 . . . . 0.0 109.696 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -75.84 -27.41 57.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.553 -174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -40.2 -49.27 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.556 1.142 . . . . 0.0 112.887 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.88 -38.56 91.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.47 0.577 . . . . 0.0 111.797 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.13 -34.31 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 O-C-N 121.751 -0.593 . . . . 0.0 110.009 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -31.34 72.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.132 0.878 . . . . 0.0 109.97 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -55.65 -36.67 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.231 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -61.67 -51.2 69.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.907 1.23 . . . . 0.0 108.764 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -54.78 -48.05 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.2 mtt -69.53 -41.12 76.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.229 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -58.86 -41.54 87.27 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.953 0.797 . . . . 0.0 110.128 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.63 -33.6 74.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.764 0.426 . . . . 0.0 110.85 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -98.35 -9.43 25.34 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.82 -57.97 7.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.695 1.134 . . . . 0.0 112.036 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.149 -0.345 . . . . 0.0 111.538 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.9 t -73.95 -39.67 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.52 -54.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -62.78 -26.27 68.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.53 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.5 m -57.73 -31.24 66.24 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.267 1.394 . . . . 0.0 111.848 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.23 -27.2 66.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.547 0.739 . . . . 0.0 110.946 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -96.98 -32.07 12.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.82 0.848 . . . . 0.0 110.976 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.78 -29.14 65.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.376 1.071 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -113.93 81.39 1.52 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -40.85 79.88 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.004 0.921 . . . . 0.0 112.759 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -61.07 -16.73 47.67 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.902 3.068 . . . . 0.0 115.277 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.945 -179.412 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 119.685 -0.198 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.8 149.52 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -124.18 166.48 15.75 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.477 2.311 . . . . 0.0 108.77 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 42.38 47.5 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.799 2.039 . . . . 0.0 114.517 170.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.34 18.71 8.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.741 2.016 . . . . 0.0 114.267 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.72 -1.14 0.1 OUTLIER Glycine 0 C--N 1.34 0.756 0 N-CA-C 116.611 1.405 . . . . 0.0 116.611 169.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.68 130.43 37.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 120.763 2.282 . . . . 0.0 110.531 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -78.9 115.53 52.95 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.325 -1.321 . . . . 0.0 108.387 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.4 118.02 5.02 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.545 2.163 . . . . 0.0 107.941 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.83 167.86 21.59 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.688 0.795 . . . . 0.0 109.442 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.36 135.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.38 8.29 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.45 105.87 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.59 83.93 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.493 -2.039 . . . . 0.0 105.493 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.11 131.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -122.38 129.02 51.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.75 140.85 30.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -63.04 -0.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 115.101 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -81.36 0.42 37.38 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.999 0.818 . . . . 0.0 109.579 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.55 28.04 37.09 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 124.846 1.213 . . . . 0.0 112.11 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -122.09 154.9 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -113.94 163.02 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -168.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.6 tpt -50.87 130.58 25.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.008 2.123 . . . . 0.0 111.777 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 5.3 t-105 -163.73 124.16 2.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 169.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.56 142.74 45.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.857 1.313 . . . . 0.0 112.972 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.1 ttp85 -78.43 140.65 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.754 2.421 . . . . 0.0 107.902 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -88.0 151.27 22.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.135 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.24 156.62 24.91 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.439 1.495 . . . . 0.0 112.163 171.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.9 25.32 30.1 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.376 0.989 . . . . 0.0 110.88 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -10.0 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 131.294 3.837 . . . . 0.0 117.198 -167.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -151.35 6.64 0.49 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.181 168.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -154.68 147.66 24.61 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 109.058 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -121.08 131.87 54.53 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.18 -176.34 4.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.171 0.988 . . . . 0.0 111.665 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.69 156.64 52.31 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.95 2.1 . . . . 0.0 109.433 -170.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.94 155.11 71.11 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.595 2.864 . . . . 0.0 113.919 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 71.08 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.672 3.589 . . . . 0.0 105.716 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 121.63 7.29 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.481 1.038 . . . . 0.0 114.525 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.89 145.78 14.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.929 2.204 . . . . 0.0 113.445 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.96 136.45 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.632 1.173 . . . . 0.0 108.437 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -77.88 138.61 61.63 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 117.601 -1.19 . . . . 0.0 109.251 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.44 118.76 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.711 1.607 . . . . 0.0 112.678 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.56 89.79 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.109 176.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.95 129.32 35.28 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.08 159.6 34.42 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 124.685 1.194 . . . . 0.0 110.645 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -41.75 66.47 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.492 1.117 . . . . 0.0 113.841 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.76 -47.34 54.35 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.07 -40.61 85.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.149 1.38 . . . . 0.0 109.405 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.93 -27.89 62.12 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.0 1.32 . . . . 0.0 111.593 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.8 -40.85 95.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 79.0 m-85 -68.19 -30.4 69.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.217 -1.552 . . . . 0.0 112.838 172.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.829 -1.169 . . . . 0.0 109.954 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.5 -29.33 65.82 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.663 0.665 . . . . 0.0 112.134 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.84 -41.7 97.77 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.626 -1.296 . . . . 0.0 108.604 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 115' ' ' THR . 7.1 t80 -66.01 -53.75 34.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.327 172.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.62 -28.33 68.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.336 1.426 . . . . 0.0 113.378 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -115.14 -12.08 11.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.26 0.936 . . . . 0.0 113.278 -168.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.97 -20.45 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.092 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.66 55.24 31.64 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.35 -1.469 . . . . 0.0 110.126 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.2 159.51 41.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.499 1.92 . . . . 0.0 106.775 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 m -117.34 -177.18 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.502 1.121 . . . . 0.0 110.458 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 14.6 mtt180 -70.9 36.33 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.369 2.268 . . . . 0.0 113.578 -171.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.52 -19.83 0.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.965 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -83.39 -5.19 59.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 112.525 -169.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.66 167.63 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.583 1.153 . . . . 0.0 109.468 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -136.19 120.18 17.58 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.674 1.99 . . . . 0.0 105.926 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.99 128.92 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.07 -35.85 7.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.16 0.584 . . . . 0.0 111.215 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.16 163.8 39.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.218 1.007 . . . . 0.0 108.756 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -146.09 156.22 43.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 108.1 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 p -63.72 150.55 44.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.013 0.824 . . . . 0.0 109.991 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -70.29 -31.99 69.58 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.041 -0.412 . . . . 0.0 111.49 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.31 176.66 10.36 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.656 1.982 . . . . 0.0 108.077 172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -66.62 117.39 8.72 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.236 0.614 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.78 151.34 46.76 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -145.32 134.01 22.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -149.82 158.52 44.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -95.75 153.61 17.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.285 0.564 . . . . 0.0 111.308 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.25 148.16 46.64 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.05 153.4 67.62 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.37 2.713 . . . . 0.0 109.414 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.39 -20.36 66.34 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.33 -27.41 61.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 tp -94.9 -27.59 15.62 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.061 0.944 . . . . 0.0 110.572 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -56.0 134.04 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -41.28 41.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.6 m95 60.95 5.79 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.88 2.072 . . . . 0.0 113.685 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.81 -19.92 14.11 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.889 1.275 . . . . 0.0 111.837 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -76.6 153.4 35.35 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.979 1.711 . . . . 0.0 108.771 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.66 113.84 9.35 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.027 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -53.91 147.57 16.26 Favored 'Cis proline' 0 CA--C 1.538 0.717 0 CA-C-N 120.199 1.107 . . . . 0.0 111.845 -10.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.32 129.37 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.8 t -80.37 97.98 7.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.2 pt -88.08 -15.98 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.374 1.469 . . . . 0.0 111.865 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 172.78 45.03 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 120.662 1.574 . . . . 0.0 113.028 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -105.87 129.62 54.0 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -97.2 113.91 25.56 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.45 127.54 35.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -103.52 129.52 50.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -103.57 133.6 48.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.99 129.2 55.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.7 tp -83.7 113.84 21.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.48 121.64 44.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 123.749 0.82 . . . . 0.0 109.619 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -83.56 137.19 33.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.4 mt -63.05 139.51 58.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.363 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.54 -25.0 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.515 1.126 . . . . 0.0 108.013 169.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.3 p -119.57 -61.82 1.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 110.381 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.4 -147.29 28.31 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -43.64 -36.44 2.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.476 1.91 . . . . 0.0 113.56 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.98 66.98 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -123.33 -16.39 6.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.352 1.461 . . . . 0.0 112.431 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.48 143.89 9.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -134.06 -48.02 0.79 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.043 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.0 mtt 58.86 -1.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.38 23.98 8.83 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.774 2.079 . . . . 0.0 111.262 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.403 ' HB ' ' CE2' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -55.79 -35.64 66.51 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.023 2.529 . . . . 0.0 111.374 169.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.81 3.9 15.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.013 1.725 . . . . 0.0 112.717 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 70.15 -42.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 129.485 3.114 . . . . 0.0 114.483 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.5 p -133.51 34.67 0.26 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 113.914 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.77 160.99 40.09 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.746 1.659 . . . . 0.0 110.461 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.768 1.627 . . . . 0.0 113.609 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.05 144.46 42.99 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.398 0.618 . . . . 0.0 112.657 -168.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 -6.68 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.327 1.051 . . . . 0.0 113.62 -171.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.61 162.84 35.38 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -138.5 149.87 45.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.89 0.845 . . . . 0.0 111.417 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -150.55 128.07 11.49 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.815 1.646 . . . . 0.0 107.134 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -82.0 138.32 34.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.67 167.93 23.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.598 1.159 . . . . 0.0 110.459 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -49.03 144.74 4.52 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.198 0.999 . . . . 0.0 109.601 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -53.89 -36.91 63.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -94.17 -3.66 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.79 -45.8 96.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.011 -1.471 . . . . 0.0 111.974 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.11 -36.32 99.17 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.947 1.731 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -40.01 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -76.68 -29.38 56.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.822 1.192 . . . . 0.0 111.577 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.43 -28.09 46.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.02 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.45 156.04 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.547 1.067 . . . . 0.0 110.947 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.16 148.05 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.46 1.504 . . . . 0.0 111.88 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -58.75 -34.95 71.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.834 1.254 . . . . 0.0 113.911 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -71.36 -25.94 62.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.032 0.833 . . . . 0.0 111.437 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.67 -38.07 15.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.117 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -47.78 -47.48 30.76 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.082 1.31 . . . . 0.0 112.972 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.66 -35.79 81.01 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.383 0.538 . . . . 0.0 112.032 -174.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.64 -35.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.37 0.668 . . . . 0.0 110.596 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.91 -31.9 73.35 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.989 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -56.65 -37.32 70.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.119 169.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.63 -47.4 81.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.091 1.314 . . . . 0.0 108.886 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.22 -50.6 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.722 0.809 . . . . 0.0 109.307 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.8 mtt -65.69 -40.72 92.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.099 -0.477 . . . . 0.0 111.251 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -58.79 -39.77 82.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.444 1.098 . . . . 0.0 110.547 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.9 -23.26 62.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.704 0.402 . . . . 0.0 111.25 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -107.53 -9.6 15.89 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.28 16.98 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.473 1.033 . . . . 0.0 111.542 -169.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -62.81 -25.28 68.17 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.126 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.43 -43.52 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.59 -36.48 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -69.42 -35.81 76.08 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.835 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -59.58 -31.5 69.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.737 1.153 . . . . 0.0 112.031 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.25 -25.17 67.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.152 0.581 . . . . 0.0 111.361 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -104.65 -32.37 8.94 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.166 0.986 . . . . 0.0 110.987 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.34 -28.3 62.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.503 1.121 . . . . 0.0 111.262 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -99.65 79.98 2.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -39.26 68.6 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.25 1.02 . . . . 0.0 112.449 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.67 -16.41 52.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.628 2.885 . . . . 0.0 115.092 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.806 1.242 . . . . 0.0 110.357 -177.207 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 119.557 -0.258 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.03 143.39 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.83 -44.31 49.91 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.522 1.129 . . . . 0.0 111.306 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.8 -77.78 0.12 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.904 0.882 . . . . 0.0 111.138 170.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.55 -48.92 7.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.39 6.15 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.316 0.887 . . . . 0.0 115.316 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -96.93 134.33 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.35 1.575 . . . . 0.0 109.902 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -86.38 127.16 62.18 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.776 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.84 130.84 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.397 2.065 . . . . 0.0 108.624 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.48 177.2 11.74 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -130.59 135.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.71 136.23 12.86 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.48 142.23 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 118.94 1.37 . . . . 0.0 107.805 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.42 89.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -66.89 136.46 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -124.45 118.21 26.14 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -74.01 141.88 45.79 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -68.16 -9.66 48.37 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.07 -10.19 59.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.79 0.723 . . . . 0.0 111.328 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.13 39.2 3.35 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 125.926 1.727 . . . . 0.0 112.434 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -136.35 150.91 49.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.65 161.72 4.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.885 0.874 . . . . 0.0 112.68 -169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 128.51 36.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.006 1.322 . . . . 0.0 109.325 170.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.427 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 2.6 t-105 -160.23 128.81 4.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 168.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.1 148.45 41.74 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -69.08 140.68 54.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -77.77 119.86 21.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -44.61 126.33 5.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.544 1.938 . . . . 0.0 110.583 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.65 -2.05 25.75 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.532 1.063 . . . . 0.0 115.259 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -126.93 -24.72 3.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.032 1.416 . . . . 0.0 111.454 -172.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.66 14.29 8.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.284 1.833 . . . . 0.0 115.198 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.2 p -104.45 -143.18 0.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.98 1.312 . . . . 0.0 107.647 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.427 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 62.7 m95 -127.96 168.16 15.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.098 1.317 . . . . 0.0 109.946 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -152.44 150.77 30.0 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.147 0.979 . . . . 0.0 109.42 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -81.6 139.92 47.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.943 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.68 137.83 75.81 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.657 1.571 . . . . 0.0 111.642 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -157.55 147.83 20.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.729 1.212 . . . . 0.0 111.101 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.13 -126.38 5.56 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.523 1.059 . . . . 0.0 112.156 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.51 118.48 0.45 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.62 125.58 39.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -75.46 155.18 85.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.13 116.72 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.638 1.559 . . . . 0.0 111.039 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.25 7.75 87.3 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.079 1.323 . . . . 0.0 113.188 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -80.29 125.26 29.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.427 1.113 . . . . 0.0 108.601 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.72 157.34 37.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.483 1.113 . . . . 0.0 110.312 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.74 -41.09 69.99 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -169.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -71.58 -39.82 70.32 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -65.06 -44.26 89.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -27.03 69.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.383 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.448 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 17.0 tmm? -72.21 -43.74 64.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.411 1.005 . . . . 0.0 109.032 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -66.31 -30.99 71.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.114 0.87 . . . . 0.0 110.903 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -62.21 -49.2 76.72 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.659 -0.651 . . . . 0.0 109.607 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.06 77.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.145 0.978 . . . . 0.0 111.277 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.64 -39.98 95.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.183 1.393 . . . . 0.0 109.446 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.19 -50.87 59.43 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.866 0.866 . . . . 0.0 110.056 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.54 -40.94 88.89 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.521 1.055 . . . . 0.0 112.002 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -95.21 -49.36 5.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.287 0.635 . . . . 0.0 111.082 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.21 -17.7 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.4 0.68 . . . . 0.0 110.599 -169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.71 55.72 29.27 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -134.22 162.94 30.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.287 2.235 . . . . 0.0 106.507 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 m -119.0 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.356 0.662 . . . . 0.0 110.09 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -72.19 49.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.323 1.849 . . . . 0.0 114.503 -171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -163.4 -23.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.57 1.548 . . . . 0.0 112.294 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.27 1.1 52.15 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 m -149.05 171.16 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 109.727 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -138.91 124.53 19.55 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -79.91 131.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 120.655 1.571 . . . . 0.0 107.304 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -102.73 -45.94 4.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.51 169.3 19.86 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.88 0.872 . . . . 0.0 110.554 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -145.86 162.73 37.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 p -65.05 141.97 58.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -67.11 -22.03 65.83 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -170.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -141.85 177.58 8.08 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.523 1.529 . . . . 0.0 107.441 169.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -72.16 129.48 38.58 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.85 160.04 26.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -156.61 151.86 26.49 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 108.345 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.06 172.91 12.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.001 1.72 . . . . 0.0 106.956 172.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -112.84 128.51 56.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.71 145.39 98.08 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -63.3 154.66 66.64 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 108.513 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.72 -29.94 68.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -73.22 -25.83 60.9 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.037 0.935 . . . . 0.0 112.728 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 tp -101.2 -19.38 15.73 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.815 0.846 . . . . 0.0 111.865 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.7 t -48.01 135.23 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -88.53 101.65 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.529 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.37 -2.33 57.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.363 0.665 . . . . 0.0 110.88 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.81 -30.55 40.53 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.636 -0.665 . . . . 0.0 110.096 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.4 161.12 23.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.564 1.146 . . . . 0.0 109.814 -173.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -137.26 114.63 9.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -59.18 153.58 43.04 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.004 1.037 . . . . 0.0 110.828 -10.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.49 138.12 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.7 t -97.56 120.8 38.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 pt -107.47 -10.18 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.282 1.033 . . . . 0.0 112.531 -169.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.97 168.63 40.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.158 0.89 . . . . 0.0 111.673 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -104.61 123.51 47.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -85.26 118.92 25.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 120.37 14.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.96 1.254 . . . . 0.0 113.164 -173.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -98.92 128.92 45.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -97.69 149.65 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.448 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 41.3 m-85 -119.53 126.79 52.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.3 111.58 19.54 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.9 mt -107.48 131.23 54.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 124.465 1.103 . . . . 0.0 110.64 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.17 136.26 33.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.12 132.69 44.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -116.16 -37.8 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.7 m -85.2 -133.09 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.96 173.5 46.3 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 120.369 1.441 . . . . 0.0 111.403 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.4 -31.73 46.27 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.966 1.307 . . . . 0.0 112.859 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.45 -27.9 67.42 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.246 0.618 . . . . 0.0 112.431 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.86 -24.73 13.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.37 1.468 . . . . 0.0 110.908 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.46 142.54 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.724 1.61 . . . . 0.0 107.256 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -124.98 -38.77 2.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.51 -15.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.963 2.105 . . . . 0.0 116.173 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.94 27.94 8.98 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.849 1.659 . . . . 0.0 111.574 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -68.62 -36.98 79.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -91.76 6.39 46.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.074 0.949 . . . . 0.0 113.5 -169.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m 67.85 -36.1 0.29 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.489 2.716 . . . . 0.0 114.962 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -128.4 66.84 74.63 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.706 1.602 . . . . 0.0 108.33 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -77.05 -168.62 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.575 2.85 . . . . 0.0 110.467 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.7 -11.0 14.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.525 169.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.51 145.21 49.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 121.017 1.735 . . . . 0.0 114.03 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.62 116.66 25.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.003 2.921 . . . . 0.0 105.004 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.81 143.55 42.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.215 0.912 . . . . 0.0 113.277 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -114.44 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.035 0.934 . . . . 0.0 109.622 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -140.91 155.21 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.951 1.3 . . . . 0.0 110.106 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -79.68 149.6 31.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 161.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.842 0.857 . . . . 0.0 110.003 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -53.3 150.13 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.592 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.44 149.65 20.36 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.1 -15.08 0.13 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 -44.17 99.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 121.322 1.874 . . . . 0.0 111.937 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -63.99 -25.88 66.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.885 1.724 . . . . 0.0 114.702 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.48 -36.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.855 1.207 . . . . 0.0 108.928 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -83.39 -16.26 46.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 117.9 -1.047 . . . . 0.0 112.21 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -86.26 -31.1 21.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.977 1.262 . . . . 0.0 112.341 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -68.88 165.34 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.303 0.956 . . . . 0.0 111.755 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.55 151.24 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.9 1.28 . . . . 0.0 111.148 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -59.12 -34.49 72.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.104 1.362 . . . . 0.0 113.822 -169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -71.55 -26.02 62.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.025 0.829 . . . . 0.0 111.468 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -94.64 -29.32 14.9 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.14 0.976 . . . . 0.0 112.317 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -36.9 -53.71 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.721 2.009 . . . . 0.0 112.638 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -35.29 74.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.418 0.553 . . . . 0.0 110.977 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.2 t -72.7 -36.04 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.648 -0.657 . . . . 0.0 109.682 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -68.15 -34.82 77.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.261 0.937 . . . . 0.0 110.791 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -58.01 -39.54 78.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.577 1.151 . . . . 0.0 111.373 169.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -64.31 -47.44 79.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.144 0.884 . . . . 0.0 109.618 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.31 -45.33 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.593 0.633 . . . . 0.0 109.603 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtt -65.49 -43.22 90.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.647 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -26.03 65.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.3 1.863 . . . . 0.0 112.315 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -65.31 -23.49 67.03 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.718 0.69 . . . . 0.0 110.358 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -116.09 -21.49 9.41 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.358 1.063 . . . . 0.0 113.442 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.1 -58.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.578 1.151 . . . . 0.0 110.607 -172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.5 m -66.17 -21.48 66.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.456 0.571 . . . . 0.0 111.995 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.76 -41.5 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.61 -48.72 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.1 mtt -66.52 -18.79 65.56 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.71 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.7 m -63.19 -24.22 67.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.713 1.142 . . . . 0.0 111.873 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.97 -49.72 27.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.671 0.668 . . . . 0.0 109.348 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.67 -23.42 56.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.704 0.402 . . . . 0.0 111.206 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -96.16 41.14 1.11 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.91 1.684 . . . . 0.0 109.808 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.76 30.96 5.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.977 0.911 . . . . 0.0 110.382 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.306 20.3 p 49.38 36.37 0.34 Allowed Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.463 1.905 . . . . 0.0 115.966 -173.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.54 -27.21 23.03 Favored 'Trans proline' 0 C--N 1.36 1.147 0 CA-C-N 121.835 1.691 . . . . 0.0 110.078 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.968 1.707 . . . . 0.0 109.346 -175.79 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 119.89 -0.1 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.4 136.16 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.02 162.13 29.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.379 1.472 . . . . 0.0 108.707 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.6 -36.48 64.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.9 5.96 26.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.23 31.24 14.58 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.792 1.187 . . . . 0.0 111.75 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 19.5 m-85 -108.42 134.57 51.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.892 1.346 . . . . 0.0 109.127 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -82.55 127.34 70.95 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.52 130.5 11.82 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.142 1.894 . . . . 0.0 109.322 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.6 160.65 39.37 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.728 1.211 . . . . 0.0 110.705 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.3 148.3 18.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.596 1.958 . . . . 0.0 106.431 169.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.14 131.06 6.11 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.44 127.29 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.53 91.78 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 mm -66.39 134.12 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 168.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.8 m -119.32 126.26 51.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 168.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 19' ' ' GLN . 2.4 t-20 -86.62 35.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.904 -0.498 . . . . 0.0 111.216 -169.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.265 13.7 ptp180 40.87 7.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.906 4.082 . . . . 0.0 116.558 -169.038 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 17' ' ' ASN . 37.4 mt-30 -95.39 3.65 54.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.03 0.932 . . . . 0.0 111.471 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.31 64.34 Favored Glycine 0 N--CA 1.47 0.92 0 O-C-N 121.021 -1.049 . . . . 0.0 112.089 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -121.78 149.81 42.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.571 1.548 . . . . 0.0 107.005 -169.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.3 160.07 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.459 1.104 . . . . 0.0 113.204 -169.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ttt -58.31 134.61 56.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.332 1.453 . . . . 0.0 109.977 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -157.69 133.69 9.38 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 169.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.06 144.31 27.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.504 0.669 . . . . 0.0 110.458 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.92 132.35 36.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.229 1.411 . . . . 0.0 107.786 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -93.72 134.92 35.54 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.59 0.756 . . . . 0.0 109.248 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -47.55 132.79 13.65 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.832 1.253 . . . . 0.0 111.591 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.22 -23.08 0.75 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.615 1.102 . . . . 0.0 113.564 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.31 -37.75 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.923 0.862 . . . . 0.0 108.956 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.46 28.94 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.448 1.499 . . . . 0.0 112.262 -174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -149.78 175.82 11.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.28 1.832 . . . . 0.0 107.266 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -78.06 153.81 31.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.729 0.812 . . . . 0.0 112.639 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -146.48 162.29 38.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 109.37 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -84.67 151.1 57.85 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.886 2.074 . . . . 0.0 110.746 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -68.4 156.97 63.77 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.886 2.391 . . . . 0.0 113.022 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 179.96 148.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.921 2.488 . . . . 0.0 108.322 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 142.15 8.68 Favored Glycine 0 C--N 1.337 0.638 0 O-C-N 121.134 -0.978 . . . . 0.0 110.883 170.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.73 50.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.786 1.184 . . . . 0.0 111.027 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -87.42 134.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.387 1.075 . . . . 0.0 109.108 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -65.82 126.46 91.77 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.627 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.32 118.2 5.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.074 1.849 . . . . 0.0 111.585 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.87 0.17 75.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.577 1.56 . . . . 0.0 113.083 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -83.7 132.93 34.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.677 1.191 . . . . 0.0 108.048 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 159.39 34.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.984 0.913 . . . . 0.0 110.346 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.76 71.81 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.059 1.344 . . . . 0.0 112.315 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.38 -40.6 73.86 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -62.16 -43.5 98.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 108.967 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.956 0.502 . . . . 0.0 111.93 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -61.68 -44.71 96.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.883 0.765 . . . . 0.0 110.06 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -65.78 -29.3 69.78 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.961 1.255 . . . . 0.0 113.046 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -59.38 -50.67 73.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.237 1.381 . . . . 0.0 109.087 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.08 66.79 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.134 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.14 -43.32 99.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.832 -1.167 . . . . 0.0 108.455 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -66.51 -45.12 80.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.702 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -69.49 -48.88 59.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.523 1.51 . . . . 0.0 112.211 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -85.66 -29.59 23.88 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.124 0.97 . . . . 0.0 111.783 -168.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.35 -15.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.5 0.72 . . . . 0.0 110.379 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.25 11.33 70.97 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 120.746 -1.221 . . . . 0.0 113.12 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.37 151.41 21.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.131 0.966 . . . . 0.0 109.189 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -102.74 174.05 6.06 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.034 0.933 . . . . 0.0 108.909 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -70.42 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 115.065 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.41 -11.44 0.18 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.221 1.808 . . . . 0.0 112.705 -169.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -97.91 2.27 48.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.451 0.7 . . . . 0.0 110.96 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.88 171.89 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.751 1.221 . . . . 0.0 108.419 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -140.57 122.61 15.63 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 -171.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -75.47 129.82 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 -34.17 6.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.813 0.445 . . . . 0.0 110.702 176.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.7 166.5 32.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.679 1.192 . . . . 0.0 108.234 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -140.54 157.25 45.76 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -58.62 138.34 56.97 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 119.467 1.03 . . . . 0.0 108.474 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.46 -24.82 66.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.789 0.436 . . . . 0.0 112.074 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.48 174.16 11.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -61.7 126.64 28.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.12 131.31 45.19 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 170.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.37 134.66 52.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -143.02 131.6 22.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 117.51 24.63 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.18 147.47 80.98 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.866 1.266 . . . . 0.0 110.25 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.44 150.54 87.03 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.582 1.521 . . . . 0.0 109.015 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -48.83 -48.44 41.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.016 0.927 . . . . 0.0 113.367 -169.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.88 -16.48 63.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.197 0.999 . . . . 0.0 113.003 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -108.07 -3.75 18.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.169 1.388 . . . . 0.0 111.749 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.41 137.56 21.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 169.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -91.0 127.52 36.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -111.36 0.18 16.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.123 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.84 -17.59 35.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.106 0.562 . . . . 0.0 109.724 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.0 p -91.43 156.51 17.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.257 0.623 . . . . 0.0 109.328 -171.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -131.38 110.25 15.05 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.88 155.94 60.44 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.447 1.195 . . . . 0.0 112.117 -4.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.4 m -60.54 133.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 50.7 t -90.06 99.52 12.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.6 pt -88.89 -6.42 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.416 1.486 . . . . 0.0 112.027 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -158.43 153.72 24.86 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 120.514 1.506 . . . . 0.0 113.566 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.91 94.21 5.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -71.02 126.17 28.85 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.63 111.7 5.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.224 0.92 . . . . 0.0 110.273 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -89.3 125.81 35.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 169.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -98.27 146.8 25.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -123.87 126.14 45.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.815 1.246 . . . . 0.0 107.715 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.2 tp -78.46 111.12 14.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.84 121.92 45.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.022 0.929 . . . . 0.0 108.609 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -82.84 137.25 34.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.35 139.99 58.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.73 -41.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 m -136.41 142.56 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.3 -168.8 40.73 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.713 -0.617 . . . . 0.0 112.937 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.07 -56.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 131.443 3.897 . . . . 0.0 112.882 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.58 -35.44 24.71 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.174 0.99 . . . . 0.0 110.786 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -86.09 -18.72 31.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.405 0.682 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.94 138.8 22.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -153.69 84.81 1.17 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.5 mtt -70.79 24.67 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.249 0.62 . . . . 0.0 112.404 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -132.92 20.43 4.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.999 1.72 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.84 -51.46 50.99 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.926 2.09 . . . . 0.0 110.951 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 m -86.09 3.93 40.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.604 1.162 . . . . 0.0 112.869 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 63.01 117.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 128.07 2.548 . . . . 0.0 112.417 -169.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 p 34.78 53.06 1.49 Allowed Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 111.783 -2.462 . . . . 0.0 113.325 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.37 -54.15 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.898 1.732 . . . . 0.0 113.26 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -160.79 -45.54 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.846 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -115.52 135.92 53.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -169.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.64 -31.9 15.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.714 2.005 . . . . 0.0 112.007 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -170.77 156.63 27.06 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 123.896 0.76 . . . . 0.0 111.75 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -120.48 150.73 40.37 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.082 1.353 . . . . 0.0 111.39 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -150.05 130.1 13.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.758 1.623 . . . . 0.0 108.627 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -84.56 140.0 31.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.03 0.832 . . . . 0.0 108.934 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.17 166.88 17.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.943 1.297 . . . . 0.0 109.835 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -56.26 150.69 13.98 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.893 0.877 . . . . 0.0 111.927 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.42 149.26 34.63 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.5 m95 65.5 -16.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.3 1.84 . . . . 0.0 115.857 -170.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -65.22 -48.38 69.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 121.235 1.834 . . . . 0.0 110.898 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -59.55 -30.23 91.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 121.81 1.682 . . . . 0.0 113.391 173.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -39.45 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.544 -0.722 . . . . 0.0 110.027 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -73.16 -37.15 66.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 120.683 -1.261 . . . . 0.0 110.035 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -80.74 -24.92 38.37 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.49 156.92 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.172 0.896 . . . . 0.0 109.352 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.9 m -58.46 150.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.388 1.075 . . . . 0.0 110.711 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 m -59.79 -26.81 66.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.897 1.279 . . . . 0.0 114.406 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -72.06 -45.68 59.82 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.356 0.98 . . . . 0.0 110.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.54 -29.5 52.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.159 -1.4 . . . . 0.0 111.419 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -43.3 -48.17 6.75 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.564 1.529 . . . . 0.0 111.156 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -73.23 -22.29 60.46 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -79.26 -47.48 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.231 -0.918 . . . . 0.0 108.658 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -31.7 70.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.794 0.838 . . . . 0.0 110.568 -169.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -64.95 -33.76 76.8 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.268 -0.895 . . . . 0.0 111.264 172.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -69.92 -44.96 68.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.29 -46.87 85.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.171 0.588 . . . . 0.0 110.001 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 47.2 mtt -66.34 -40.49 89.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.203 -0.936 . . . . 0.0 110.987 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.11 -37.22 86.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.367 0.985 . . . . 0.0 111.01 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.84 -28.06 69.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.805 0.842 . . . . 0.0 110.985 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -113.94 -11.66 12.76 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.07 -54.8 38.46 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.94 1.245 . . . . 0.0 110.755 -170.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -81.12 25.63 0.47 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.615 0.766 . . . . 0.0 112.6 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.69 -18.31 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.164 1.786 . . . . 0.0 108.773 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 73.1 t -96.95 -52.79 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.768 1.227 . . . . 0.0 108.087 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.0 mmt -64.77 -16.41 62.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.283 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 m -48.92 -33.23 10.42 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.874 1.67 . . . . 0.0 113.194 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.9 mt -83.0 -29.58 28.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 110.509 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -96.87 -25.92 15.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.325 1.05 . . . . 0.0 112.189 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -106.52 26.68 9.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 109.592 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.43 -33.21 69.2 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.593 1.157 . . . . 0.0 112.456 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -57.25 2.85 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.728 1.211 . . . . 0.0 112.374 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.11 -30.41 20.71 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.157 2.571 . . . . 0.0 113.419 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--O 1.255 1.346 0 C-N-CA 124.883 1.273 . . . . 0.0 109.816 -171.607 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -137.19 140.16 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.97 145.81 48.15 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.635 1.574 . . . . 0.0 108.144 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -44.59 -37.49 3.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.058 1.874 . . . . 0.0 116.058 -168.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -81.96 2.13 32.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.51 24.85 11.57 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.776 1.655 . . . . 0.0 112.009 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -111.03 148.7 32.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.668 1.734 . . . . 0.0 110.843 -170.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -87.89 112.45 49.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.211 -1.555 . . . . 0.0 107.412 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.84 130.32 15.53 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.492 2.128 . . . . 0.0 109.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -154.84 170.99 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.465 1.106 . . . . 0.0 110.855 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.91 130.31 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.481 1.513 . . . . 0.0 108.796 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.33 126.63 8.98 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mm -91.5 104.12 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 81.35 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.9 mm -63.79 130.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.17 128.33 55.87 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.82 18.34 6.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 53.5 10.68 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.106 1.762 . . . . 0.0 115.341 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -109.87 6.97 23.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.304 1.041 . . . . 0.0 111.945 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.74 79.28 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.796 -1.19 . . . . 0.0 112.731 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -128.51 158.57 38.03 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.893 1.677 . . . . 0.0 106.851 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.37 167.61 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 128.2 32.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.347 1.859 . . . . 0.0 110.873 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.417 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -164.46 131.53 3.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 167.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.76 142.42 44.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -76.6 144.92 39.27 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -95.71 126.71 41.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -61.17 144.64 53.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.705 0.684 . . . . 0.0 110.586 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 -28.24 0.85 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.361 1.457 . . . . 0.0 114.158 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -97.06 -28.33 14.19 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.606 1.162 . . . . 0.0 110.357 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 65.13 -8.65 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.788 2.435 . . . . 0.0 115.213 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -178.66 6.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.263 1.025 . . . . 0.0 108.455 169.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.417 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 73.8 m95 -90.03 162.07 15.53 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.84 -1.163 . . . . 0.0 110.704 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -140.15 148.03 41.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.045 0.926 . . . . 0.0 110.848 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -79.76 164.9 50.95 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 127.335 2.254 . . . . 0.0 110.186 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.71 -92.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.664 2.91 . . . . 0.0 110.289 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 53.78 61.37 3.12 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.469 1.108 . . . . 0.0 111.563 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.81 117.27 4.46 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.1 142.71 27.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 125.997 1.76 . . . . 0.0 111.485 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.0 mt -77.4 139.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.994 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -77.71 136.06 63.57 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.356 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -54.99 118.27 4.96 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.631 1.554 . . . . 0.0 113.491 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.48 89.74 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.961 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -83.86 123.28 29.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.281 1.032 . . . . 0.0 108.513 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -72.59 160.52 32.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.269 1.028 . . . . 0.0 110.508 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.5 79.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.061 . . . . 0.0 111.129 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.5 12.82 3.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.633 0.773 . . . . 0.0 111.181 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -114.18 -54.21 2.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.408 1.883 . . . . 0.0 106.088 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -33.08 73.41 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.476 1.11 . . . . 0.0 112.335 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -61.29 -45.07 95.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -71.86 -27.87 63.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.617 -0.677 . . . . 0.0 111.292 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -62.19 -48.71 78.83 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.243 -0.91 . . . . 0.0 109.409 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.76 -32.93 73.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.801 0.728 . . . . 0.0 111.362 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 tp -60.34 -40.72 91.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.65 1.18 . . . . 0.0 109.419 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.34 -54.08 9.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.336 1.054 . . . . 0.0 111.456 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.97 -41.72 81.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.635 1.562 . . . . 0.0 110.834 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -92.96 -49.01 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.205 0.457 . . . . 0.0 110.836 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.15 -26.38 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.998 0.519 . . . . 0.0 110.583 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.69 58.84 6.55 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.747 -1.22 . . . . 0.0 110.074 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 mt -138.34 156.18 47.86 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.085 2.154 . . . . 0.0 107.834 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 m -116.75 -178.51 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.868 0.867 . . . . 0.0 111.513 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.74 41.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 128.368 2.667 . . . . 0.0 113.61 -174.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -164.72 -20.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.079 1.352 . . . . 0.0 112.361 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -87.59 -1.04 57.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -169.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.85 167.5 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.151 1.38 . . . . 0.0 108.925 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -138.78 121.37 16.24 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -74.84 130.94 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 120.104 1.32 . . . . 0.0 107.844 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -33.71 6.07 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.008 0.923 . . . . 0.0 111.162 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.74 169.18 25.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.362 1.465 . . . . 0.0 108.546 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 m -145.37 162.04 38.21 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.083 1.353 . . . . 0.0 107.833 172.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -62.06 149.1 42.05 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.425 1.011 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.5 -33.43 75.57 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.151 -0.343 . . . . 0.0 111.153 -169.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.17 -176.21 5.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.914 2.086 . . . . 0.0 106.395 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -61.38 120.17 9.94 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 160.01 29.28 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -161.33 163.2 30.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 120.704 -1.248 . . . . 0.0 111.118 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.49 159.69 41.23 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.145 1.378 . . . . 0.0 107.764 169.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -101.31 127.48 47.91 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 106.657 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -68.49 145.31 97.13 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.43 156.75 57.93 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.033 2.489 . . . . 0.0 110.104 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -52.02 -42.0 62.69 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 113.582 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -76.26 -23.95 54.47 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.285 1.034 . . . . 0.0 113.06 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.33 -24.56 19.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.009 0.524 . . . . 0.0 110.894 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.69 137.38 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -42.98 52.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.925 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.5 m95 59.52 5.21 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.304 2.241 . . . . 0.0 113.547 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.95 -21.84 14.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.367 1.467 . . . . 0.0 111.17 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -70.96 147.4 48.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.264 1.426 . . . . 0.0 108.53 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -134.38 113.43 12.19 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.27 154.83 30.92 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.069 1.06 . . . . 0.0 111.54 -10.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -62.87 128.95 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.7 t -89.79 108.94 19.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.2 pt -101.27 -6.28 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 112.835 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.94 178.3 48.74 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 119.851 1.205 . . . . 0.0 112.017 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -108.82 114.82 28.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -78.45 115.8 18.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.88 110.89 8.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.507 0.594 . . . . 0.0 111.818 -168.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -90.1 125.22 35.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -100.21 132.27 45.67 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.04 133.99 51.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.9 106.16 18.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.37 130.41 55.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.065 0.946 . . . . 0.0 109.494 -173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.07 136.13 33.11 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.4 tp -78.32 124.64 28.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.52 -37.83 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.9 m -115.16 110.86 20.13 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.9 -167.36 9.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.96 1.266 . . . . 0.0 115.284 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -44.83 -33.0 1.76 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.702 2.001 . . . . 0.0 113.657 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.67 67.96 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.62 -25.46 11.32 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.359 1.464 . . . . 0.0 111.519 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.93 123.43 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -94.44 -46.53 6.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mtt 46.95 44.09 14.34 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 111.787 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 26.06 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.722 0.809 . . . . 0.0 112.971 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -44.53 63.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.329 1.452 . . . . 0.0 110.718 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 p -80.99 -15.94 54.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.939 1.696 . . . . 0.0 113.085 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.8 m 68.87 -30.27 0.18 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.714 2.406 . . . . 0.0 112.529 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -119.98 64.85 9.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.596 1.558 . . . . 0.0 111.621 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 -5.0 16.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.002 3.134 . . . . 0.0 114.474 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 65.42 -34.08 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.886 2.474 . . . . 0.0 114.359 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -70.5 128.97 37.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.933 0.788 . . . . 0.0 109.494 175.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.89 -14.8 53.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.515 1.126 . . . . 0.0 111.522 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.4 135.98 4.78 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -150.82 -129.74 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.781 0.432 . . . . 0.0 110.445 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -145.03 162.86 35.9 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.483 1.913 . . . . 0.0 108.508 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -82.14 152.84 26.32 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.338 0.399 . . . . 0.0 110.342 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.25 164.21 35.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.58 0.752 . . . . 0.0 110.718 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -54.11 145.94 15.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.355 1.062 . . . . 0.0 110.385 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -36.81 69.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.626 0.77 . . . . 0.0 111.904 -169.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -90.42 -5.39 56.17 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.05 -1.031 . . . . 0.0 112.639 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.5 -44.21 80.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.454 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.67 -33.82 92.86 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.14 1.8 . . . . 0.0 112.889 176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.59 -36.19 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 O-C-N 121.86 -0.525 . . . . 0.0 109.588 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -83.63 -15.68 48.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.349 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.52 -20.33 19.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.228 0.922 . . . . 0.0 112.982 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.21 165.27 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 119.616 1.098 . . . . 0.0 110.343 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.87 156.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 110.732 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -56.49 -33.22 65.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.312 -169.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -75.54 -30.68 59.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.131 0.878 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -79.24 -36.77 39.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.729 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -43.83 -50.6 7.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.237 1.415 . . . . 0.0 111.613 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.25 -33.52 76.19 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.731 0.412 . . . . 0.0 111.562 -172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.2 t -82.71 -37.94 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.383 0.673 . . . . 0.0 109.799 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -33.31 75.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.302 -0.874 . . . . 0.0 109.995 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -52.72 -40.48 63.06 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.227 1.011 . . . . 0.0 111.582 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.26 -47.43 79.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.43 -47.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.0 mmt -63.58 -47.09 82.91 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.779 0.718 . . . . 0.0 110.172 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -56.7 -46.15 81.4 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.181 0.992 . . . . 0.0 110.721 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.32 -16.36 63.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.073 0.549 . . . . 0.0 111.582 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.44 -5.58 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.132 1.373 . . . . 0.0 113.343 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.36 -59.0 3.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 112.198 -169.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.8 m -62.16 -26.19 68.19 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.703 0.401 . . . . 0.0 112.043 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.17 -28.91 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.061 0.944 . . . . 0.0 109.605 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.65 -41.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 17.0 mmt -63.92 -38.04 89.64 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.604 0.638 . . . . 0.0 110.751 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 63.0 m -61.98 -18.35 60.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.781 0.719 . . . . 0.0 112.698 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -76.19 -26.75 56.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.572 0.624 . . . . 0.0 110.584 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -107.56 -32.25 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.168 0.987 . . . . 0.0 111.002 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -82.59 16.08 2.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.185 2.194 . . . . 0.0 110.605 172.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.55 -34.26 77.84 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.74 1.616 . . . . 0.0 113.716 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -47.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 123.61 0.764 . . . . 0.0 111.421 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.33 -33.95 93.95 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.62 2.88 . . . . 0.0 114.391 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.9 tptt . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.938 -176.792 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.64 145.87 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.42 -47.12 57.92 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.14 0.576 . . . . 0.0 111.71 -171.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -153.17 -75.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.856 0.862 . . . . 0.0 110.413 171.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.45 -49.2 7.78 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -169.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.49 14.84 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.531 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -94.22 136.35 34.6 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.793 1.297 . . . . 0.0 110.281 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -86.03 114.03 54.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 173.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.62 134.22 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.967 1.778 . . . . 0.0 109.986 -177.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -159.4 176.01 12.64 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.201 1.001 . . . . 0.0 108.747 172.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.36 140.45 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.07 122.98 7.16 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 mm -73.04 121.73 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.68 88.39 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mm -67.34 131.22 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.5 m -114.72 119.76 37.79 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -83.86 136.46 34.11 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -63.82 -9.61 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.036 1.334 . . . . 0.0 114.367 -173.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.24 -12.26 61.36 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 110.841 169.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.78 34.18 4.75 Favored Glycine 0 C--N 1.346 1.09 0 C-N-CA 126.059 1.79 . . . . 0.0 112.685 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.43 151.7 51.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.96 164.15 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -168.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 tpp -50.96 127.26 18.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.243 1.817 . . . . 0.0 111.628 169.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -157.06 129.75 7.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.49 143.48 28.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.227 0.537 . . . . 0.0 110.014 -171.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -74.86 134.04 41.74 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -80.08 133.74 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.486 0.715 . . . . 0.0 109.269 -169.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.79 134.36 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.48 1.512 . . . . 0.0 109.95 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.1 16.32 76.77 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.993 -0.442 . . . . 0.0 112.513 177.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -139.85 163.34 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.124 2.169 . . . . 0.0 107.296 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -114.82 36.17 3.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 p -150.18 171.78 16.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.226 1.811 . . . . 0.0 108.735 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.99 155.34 22.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.997 1.319 . . . . 0.0 109.249 -171.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.38 146.14 41.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.093 0.949 . . . . 0.0 111.793 -170.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -57.14 143.29 72.98 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 0.0 108.549 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.56 152.79 78.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.973 1.782 . . . . 0.0 112.378 173.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -179.12 132.47 0.12 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.758 2.423 . . . . 0.0 107.173 173.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.11 -114.84 2.56 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.8 164.34 34.45 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.43 2.919 . . . . 0.0 106.758 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.53 124.21 72.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -73.76 136.97 76.92 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 116.895 -1.526 . . . . 0.0 107.615 171.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -56.13 117.68 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 121.857 1.699 . . . . 0.0 112.934 -172.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.58 87.16 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.355 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.37 125.62 31.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.49 1.116 . . . . 0.0 108.633 175.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.03 158.68 36.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 110.361 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.38 63.65 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 125.455 1.502 . . . . 0.0 113.859 -169.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.26 -45.08 61.67 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -60.2 -45.18 94.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.999 1.32 . . . . 0.0 108.307 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.56 67.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.196 0.999 . . . . 0.0 112.546 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -72.13 -42.3 66.18 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.653 1.115 . . . . 0.0 109.073 175.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.04 -26.87 67.71 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.971 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -67.35 -48.1 68.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.188 -0.945 . . . . 0.0 109.031 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.9 84.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 119.007 0.821 . . . . 0.0 110.795 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.13 -41.91 89.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.62 1.568 . . . . 0.0 109.38 178.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -46.97 65.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.859 0.863 . . . . 0.0 110.648 172.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.9 -37.18 86.77 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.676 1.126 . . . . 0.0 112.667 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -94.17 -44.02 8.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.524 0.73 . . . . 0.0 111.185 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 m -123.55 -2.48 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.04 75.69 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.172 -0.955 . . . . 0.0 111.598 177.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.0 mt -91.12 161.21 15.19 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 108.908 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -118.07 171.51 8.05 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.902 0.881 . . . . 0.0 109.603 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -72.43 57.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.161 1.784 . . . . 0.0 113.89 -171.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -163.89 -25.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.618 1.967 . . . . 0.0 111.359 -172.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -88.15 0.19 56.33 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -168.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 166.78 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.036 0.935 . . . . 0.0 109.792 -169.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -137.2 120.89 17.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -171.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.85 129.9 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.05 -34.87 6.48 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.316 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.93 169.48 22.53 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 109.356 -178.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.1 p -147.81 162.28 39.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 p -66.15 145.0 56.32 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.21 -20.97 63.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -170.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -148.94 171.95 15.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.958 1.703 . . . . 0.0 109.12 171.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -73.1 116.19 13.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.59 153.89 41.05 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.42 153.74 38.94 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.443 0.697 . . . . 0.0 109.204 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.63 164.81 30.57 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.871 1.268 . . . . 0.0 108.548 176.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -118.5 123.86 46.16 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -172.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.01 145.14 99.01 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.599 1.16 . . . . 0.0 108.937 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.0 152.2 80.67 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.463 2.109 . . . . 0.0 109.456 170.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -47.62 -49.08 28.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.548 1.139 . . . . 0.0 113.779 -169.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -64.71 -14.19 57.58 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.154 0.981 . . . . 0.0 113.228 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.77 -9.2 15.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.56 1.544 . . . . 0.0 111.53 -178.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.84 136.73 25.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.63 129.81 38.45 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -101.3 4.5 41.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.791 1.236 . . . . 0.0 109.782 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.15 -12.53 15.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.501 1.121 . . . . 0.0 111.588 -174.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 p -71.66 -33.88 69.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.327 0.651 . . . . 0.0 111.763 -174.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 41.78 89.22 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.906 2.482 . . . . 0.0 112.197 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.22 150.34 71.83 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-N 119.977 1.028 . . . . 0.0 114.761 10.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -54.41 122.17 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.7 t -92.53 105.3 17.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -172.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -102.84 -10.82 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 113.013 -170.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.73 175.65 46.65 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 120.075 1.307 . . . . 0.0 112.482 -174.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.29 126.56 55.38 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -87.27 120.89 29.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.15 128.56 21.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.974 1.261 . . . . 0.0 113.618 -176.397 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -106.23 134.98 48.52 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -104.85 144.79 31.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -117.67 126.46 52.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.07 107.59 16.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 175.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.4 133.99 47.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.823 175.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -93.6 135.6 34.71 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 168.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.01 141.43 58.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.973 176.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.16 -27.05 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.316 1.047 . . . . 0.0 108.204 169.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -119.94 -53.42 2.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 175.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.02 -146.53 44.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 172.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -40.94 -34.15 0.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.786 2.034 . . . . 0.0 113.573 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.14 -25.73 68.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.794 0.838 . . . . 0.0 113.235 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -130.58 -8.71 4.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.942 1.297 . . . . 0.0 113.324 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.18 134.36 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.65 -31.72 0.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.395 -170.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.1 mtt 64.82 -50.06 0.33 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 129.096 2.958 . . . . 0.0 113.141 -178.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -84.21 20.06 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.255 1.022 . . . . 0.0 113.515 -171.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -63.09 -31.43 72.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 109.749 172.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -83.58 -0.65 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.556 1.143 . . . . 0.0 113.262 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 64.1 -34.21 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.609 2.764 . . . . 0.0 115.543 -175.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -132.28 71.06 79.88 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.942 1.697 . . . . 0.0 107.435 172.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.02 -166.32 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.737 2.958 . . . . 0.0 110.453 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.33 -3.83 26.54 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.401 169.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.79 155.75 49.4 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 121.662 2.028 . . . . 0.0 112.375 -172.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.03 -25.52 2.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.801 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.1 150.75 22.17 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -122.25 146.89 46.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 110.81 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -152.31 124.7 8.23 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.677 1.191 . . . . 0.0 107.89 169.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -76.88 143.94 39.31 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.745 0.702 . . . . 0.0 109.144 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.57 168.15 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.59 0.756 . . . . 0.0 109.692 -169.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.9 m -48.79 145.11 3.98 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.094 1.357 . . . . 0.0 111.054 -177.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -52.58 -38.8 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -168.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -95.92 -4.37 43.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.74 -43.23 91.33 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.156 -1.402 . . . . 0.0 112.31 -170.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -58.05 -34.23 98.2 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 122.173 1.812 . . . . 0.0 113.074 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.69 -45.8 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -64.16 -30.61 71.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.737 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -78.95 -30.94 44.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 112.154 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.27 157.34 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.869 0.758 . . . . 0.0 110.974 -170.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.69 148.68 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.517 1.527 . . . . 0.0 111.709 174.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -57.97 -34.34 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.179 1.392 . . . . 0.0 113.849 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -72.66 -28.11 62.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.815 0.734 . . . . 0.0 111.543 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -89.25 -31.95 17.63 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.141 174.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -47.21 -44.82 22.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.599 1.16 . . . . 0.0 112.24 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.88 -34.33 75.27 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 p -83.81 -32.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.954 -0.466 . . . . 0.0 110.549 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -31.99 73.17 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.054 -1.029 . . . . 0.0 110.306 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -53.24 -40.52 64.62 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.058 -1.026 . . . . 0.0 111.606 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -63.94 -46.4 84.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.26 0.936 . . . . 0.0 109.614 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -53.73 -50.22 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 109.447 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.9 mmt -64.33 -45.1 89.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.273 -177.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -57.6 -44.37 85.36 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.091 0.957 . . . . 0.0 111.091 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -64.63 -25.51 67.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.409 0.684 . . . . 0.0 110.845 -174.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -108.95 -8.82 15.17 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.811 1.245 . . . . 0.0 113.683 -175.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.52 -63.55 1.1 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.348 0.976 . . . . 0.0 112.056 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 m -63.25 -22.31 66.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.216 -0.302 . . . . 0.0 111.778 -178.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -76.1 -36.66 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 O-C-N 121.382 -0.824 . . . . 0.0 108.909 -175.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.43 -48.89 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.6 mtt -65.33 -22.33 66.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.624 0.647 . . . . 0.0 112.725 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.8 m -62.85 -26.79 68.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.458 1.026 . . . . 0.0 111.635 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.9 -51.22 58.03 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.72 -25.79 63.1 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.002 0.521 . . . . 0.0 111.132 -173.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.46 -21.15 62.82 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.065 0.946 . . . . 0.0 111.637 173.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -101.23 28.44 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 112.424 -169.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.6 p 45.98 47.48 4.18 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.55 1.14 . . . . 0.0 109.897 -172.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . 0.342 0.0 OUTLIER 25.71 48.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 127.173 5.249 . . . . 0.0 117.51 -168.507 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.252 1.233 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.541 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 3' ' ' ASP . 51.4 mm . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 2' ' ' ILE . 59.9 t0 -66.93 152.16 46.24 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 165.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -36.3 -55.35 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.153 1.781 . . . . 0.0 114.684 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.01 -2.21 58.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.048 0.928 . . . . 0.0 112.976 -158.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.59 20.22 4.71 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.218 -1.551 . . . . 0.0 111.325 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.73 136.6 43.95 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.095 0.95 . . . . 0.0 109.135 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -85.13 122.74 73.97 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -72.06 133.19 20.97 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.302 1.335 . . . . 0.0 110.653 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . 0.261 2.2 m-80 -144.45 168.3 20.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.361 1.464 . . . . 0.0 110.349 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.39 130.98 70.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 126.182 1.793 . . . . 0.0 107.525 168.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.38 128.92 9.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -88.48 118.53 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.54 83.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 165.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.31 133.46 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 164.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 m -118.33 120.84 38.83 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -83.39 118.11 23.5 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 112.12 -2.309 . . . . 0.0 105.391 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' A' ' 18' ' ' ARG . 16.9 mtt180 -47.84 -1.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -76.55 -4.27 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 120.259 1.391 . . . . 0.0 111.548 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.76 24.25 8.8 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 119.836 1.198 . . . . 0.0 113.323 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.47 162.59 31.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.93 165.21 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -165.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.4 tpt -53.28 129.42 31.55 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 112.629 -2.078 . . . . 0.0 110.101 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -158.63 134.85 9.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 161.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -147.05 141.71 26.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.023 0.916 . . . . 0.0 110.218 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -72.64 135.84 45.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -85.62 124.75 32.51 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.34 133.56 34.61 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.373 2.269 . . . . 0.0 110.911 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.4 -14.54 3.12 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 125.6 1.571 . . . . 0.0 114.133 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -105.44 -35.59 7.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.783 0.792 . . . . 0.0 111.447 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.4 m80 66.66 27.36 9.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.767 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.78 171.63 14.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -84.15 161.04 20.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -148.12 150.29 33.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.501 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' NZ ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -65.76 158.8 73.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.432 165.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' PHE . 2.9 Cg_exo -77.43 154.67 31.8 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.039 3.826 . . . . 0.0 112.027 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 169.38 139.37 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 128.053 2.541 . . . . 0.0 105.808 171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.86 141.43 11.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 156.52 53.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mt -87.8 138.72 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.253 51.1 t30 -85.71 139.21 35.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 125.089 1.356 . . . . 0.0 109.24 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.51 118.48 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.195 1.93 . . . . 0.0 113.636 -172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.19 89.62 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.036 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -87.63 123.91 32.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.861 1.33 . . . . 0.0 107.744 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.68 165.06 24.78 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.24 -44.11 71.46 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.295 1.038 . . . . 0.0 112.538 -168.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.93 -40.48 72.05 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.318 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -63.86 -44.26 93.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.347 0.659 . . . . 0.0 109.79 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.07 77.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.857 0.863 . . . . 0.0 111.553 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -60.75 -44.07 97.17 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.779 -0.576 . . . . 0.0 109.713 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -69.18 -26.25 64.75 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.884 -1.135 . . . . 0.0 112.539 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -61.65 -52.67 63.38 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.441 -0.787 . . . . 0.0 109.332 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.6 90.61 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.414 0.626 . . . . 0.0 109.848 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.3 tp -52.58 -43.81 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.798 -1.814 . . . . 0.0 111.031 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.15 -49.14 53.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.973 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.72 -33.93 77.13 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.008 1.277 . . . . 0.0 112.105 -174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.77 -45.83 5.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.59 0.709 . . . . 0.0 110.042 -169.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -15.62 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 121.797 -0.564 . . . . 0.0 110.401 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.88 37.21 94.02 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 117.093 -1.948 . . . . 0.0 112.209 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -113.87 158.81 20.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.544 1.172 . . . . 0.0 108.87 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -117.69 -177.87 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.881 -0.512 . . . . 0.0 110.209 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.72 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.282 1.833 . . . . 0.0 114.736 -174.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -161.15 -18.5 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.05 -1.031 . . . . 0.0 111.434 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.54 1.11 55.52 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.915 0.864 . . . . 0.0 111.008 -167.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 102' ' ' LEU . 27.9 m -152.42 169.48 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -168.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -142.25 117.49 10.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -167.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.97 130.62 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -36.04 6.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.007 0.923 . . . . 0.0 110.932 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.81 170.29 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.049 0.94 . . . . 0.0 108.715 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -145.99 164.29 32.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 109.475 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -63.57 140.2 58.85 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.764 0.792 . . . . 0.0 108.917 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -64.77 -29.51 70.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.351 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.44 174.22 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -65.47 115.47 5.74 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.673 0.789 . . . . 0.0 109.014 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 156.05 39.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -160.82 159.05 29.44 Favored 'General case' 0 CA--C 1.487 -1.481 0 O-C-N 120.683 -1.261 . . . . 0.0 108.13 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.3 p90 -159.91 170.03 22.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.61 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -109.38 129.88 55.52 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 111.921 -2.4 . . . . 0.0 106.059 -162.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -70.77 143.54 89.63 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -63.04 155.29 61.8 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -49.84 -45.62 50.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -71.77 -18.68 62.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.6 tp -102.47 -18.17 15.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.678 0.791 . . . . 0.0 111.764 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.3 t -52.0 140.49 6.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -76.21 -38.0 57.03 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.351 2.723 . . . . 0.0 118.351 -170.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.716 ' HA ' ' CG1' ' A' ' 91' ' ' VAL 0.326 10.2 m95 53.48 -8.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 -167.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.17 -27.86 11.32 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.397 1.453 . . . . 0.0 110.276 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.0 p -69.54 151.77 45.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -138.14 114.58 9.13 Favored Pre-proline 0 CA--C 1.499 -1.012 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -55.01 154.13 20.12 Favored 'Cis proline' 0 C--O 1.237 0.436 0 O-C-N 123.151 1.08 . . . . 0.0 113.45 -6.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -55.53 130.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.46 171.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 46.5 t -92.86 108.49 20.03 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 pt -101.77 -2.46 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.762 1.625 . . . . 0.0 111.608 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.24 43.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.597 1.09 . . . . 0.0 112.934 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 113.66 27.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.548 1.539 . . . . 0.0 107.178 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.79 122.56 26.77 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 132.6 26.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.582 1.083 . . . . 0.0 112.844 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -104.31 125.53 50.64 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 165.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -96.17 144.11 26.68 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -118.34 128.62 54.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.7 114.95 19.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 65' ' ' VAL . 3.3 mm? -110.46 122.16 47.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -79.17 136.73 37.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.472 HD21 ' HA2' ' A' ' 107' ' ' GLY . 19.1 tp -72.81 124.22 24.94 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.76 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.97 -41.15 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.255 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -89.73 -140.74 0.14 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.007 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.472 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . -179.84 -168.82 39.21 Favored Glycine 0 CA--C 1.487 -1.695 0 O-C-N 119.572 -1.955 . . . . 0.0 110.221 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -29.9 -41.26 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 126.846 2.059 . . . . 0.0 114.987 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.62 66.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 54.0 mm-40 -106.87 -23.4 12.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.195 1.798 . . . . 0.0 110.358 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mt -56.18 132.33 20.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.17 -25.89 4.81 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 119.127 -0.463 . . . . 0.0 112.173 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.5 mtt 41.0 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 119.338 3.088 . . . . 0.0 119.338 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -121.71 21.96 10.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 123.461 2.846 . . . . 0.0 110.926 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -37.49 82.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.731 2.012 . . . . 0.0 111.172 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.88 2.67 53.36 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.86 -0.591 . . . . 0.0 112.589 -166.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 m 66.31 -36.26 0.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 115.03 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -131.53 68.97 81.59 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 125.357 1.463 . . . . 0.0 107.169 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.07 -166.82 0.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.318 2.012 . . . . 0.0 109.927 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -110.3 -19.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.896 -1.049 . . . . 0.0 112.695 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -120.07 151.72 38.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.958 1.254 . . . . 0.0 111.309 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.9 -19.79 7.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.811 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.72 158.52 8.43 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 104.727 -3.349 . . . . 0.0 104.727 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.672 ' O ' ' CE3' ' A' ' 124' ' ' TRP 0.589 0.0 OUTLIER -138.76 -175.39 4.12 Favored 'General case' 0 C--N 1.294 -1.829 2 N-CA-C 126.538 5.755 . . . . 0.0 126.538 -154.136 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 124' ' ' TRP 0.254 12.3 ttt180 -169.54 131.78 1.17 Allowed 'General case' 0 CA--C 1.483 -1.634 1 O-C-N 115.477 -4.515 . . . . 0.0 102.967 171.065 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -72.95 133.66 44.42 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.6 161.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -51.21 151.35 2.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.587 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.413 ' O ' ' HD2' ' A' ' 132' ' ' PRO 0.331 12.5 t80 -45.66 -90.42 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.229 1.412 . . . . 0.0 112.715 -173.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -45.3 -4.19 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 120.459 3.503 . . . . 0.0 120.459 170.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.1 -51.66 78.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.833 2.561 . . . . 0.0 112.983 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 129' ' ' TYR . 58.2 Cg_exo -57.34 -32.57 94.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.165 1.91 . . . . 0.0 113.837 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 t -57.84 -39.61 72.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.642 ' HE ' ' HA ' ' A' ' 134' ' ' ARG . 1.4 mmm-85 -77.32 -26.81 52.56 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.054 -1.654 . . . . 0.0 114.074 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.571 ' HA ' ' OE1' ' A' ' 135' ' ' GLN . 3.9 mm-40 -78.46 -25.3 45.83 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 125.655 1.847 . . . . 0.0 114.499 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG11 ' HD2' ' A' ' 144' ' ' TYR 0.265 13.2 p -79.02 157.76 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 CA-C-O 122.853 1.311 . . . . 0.0 109.861 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.0 m -56.09 150.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.941 1.296 . . . . 0.0 111.03 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -60.21 -34.13 73.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -72.92 -30.77 64.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.828 0.74 . . . . 0.0 111.162 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' NZ ' ' CZ ' ' A' ' 35' ' ' PHE . 10.5 mttt -81.93 -32.21 30.94 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.533 ' CZ ' HH21 ' A' ' 134' ' ' ARG . 29.2 ttp180 -47.11 -48.53 22.98 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 124.77 1.294 . . . . 0.0 112.243 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.46 -45.62 93.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.128 0.966 . . . . 0.0 110.031 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 77' ' ' TYR . 1.1 t -69.3 -40.47 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 O-C-N 120.937 -1.102 . . . . 0.0 110.311 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.498 ' HD2' HG11 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -67.32 -31.9 72.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 110.502 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -53.17 -41.79 65.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.661 0.785 . . . . 0.0 112.627 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -66.87 -45.39 78.24 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -53.53 -49.42 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 O-C-N 124.312 1.007 . . . . 0.0 109.143 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -65.33 -41.99 93.4 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.742 -0.599 . . . . 0.0 111.203 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.637 -1.289 . . . . 0.0 111.389 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -61.44 -26.26 67.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.596 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.8 -6.9 11.52 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.906 0.775 . . . . 0.0 113.071 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.56 44.44 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.265 0.939 . . . . 0.0 110.504 -167.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.7 m -65.7 -23.67 66.82 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.924 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.39 -32.95 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 120.17 -1.581 . . . . 0.0 109.656 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.13 -43.07 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.14 -31.43 71.86 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 116.918 -1.515 . . . . 0.0 110.429 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -55.93 -28.83 58.65 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 120.411 1.46 . . . . 0.0 111.401 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.65 -20.29 54.03 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 114.695 -2.574 . . . . 0.0 112.244 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -108.16 -7.92 15.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.787 2.035 . . . . 0.0 110.056 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 1 CA--C 1.682 6.036 2 C-N-CA 137.261 6.224 . . . . 0.0 125.534 174.047 . . . . . . . . 2 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 CA--C 1.542 0.656 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.27 -45.93 71.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.29 0.636 . . . . 0.0 111.949 -170.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -152.01 -85.22 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.537 1.135 . . . . 0.0 109.963 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.3 -39.95 13.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -169.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.3 21.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.102 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.37 137.49 50.45 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.704 1.252 . . . . 0.0 109.796 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -109.93 118.76 49.17 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.163 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.05 135.06 45.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.258 1.972 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -145.41 158.87 43.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.398 1.879 . . . . 0.0 110.543 -172.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -136.44 76.25 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.707 2.003 . . . . 0.0 109.03 -173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.6 126.54 30.22 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mm -90.34 105.21 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.57 79.78 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -62.89 135.12 27.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.8 m -123.6 130.83 53.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 168.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -87.69 136.78 32.81 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.86 -10.01 8.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.188 1.795 . . . . 0.0 114.313 -174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.79 -13.26 62.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.128 0.876 . . . . 0.0 110.825 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.11 38.3 3.37 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.386 1.946 . . . . 0.0 112.163 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -136.38 149.49 48.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.67 167.03 3.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 112.764 -168.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 127.55 32.68 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.622 1.569 . . . . 0.0 110.509 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -156.97 134.63 10.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 168.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.81 146.34 25.63 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -71.32 127.99 34.39 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.25 128.42 34.48 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -53.25 136.97 35.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.429 1.492 . . . . 0.0 110.263 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.27 -37.85 2.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.8 1.19 . . . . 0.0 113.198 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.55 -39.05 25.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.149 0.975 . . . . 0.0 110.091 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.271 17.4 m170 58.92 34.27 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.04 1.736 . . . . 0.0 112.795 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -140.44 158.73 43.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.976 2.11 . . . . 0.0 106.742 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -65.86 152.25 44.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.183 0.993 . . . . 0.0 112.554 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -148.18 156.74 42.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.563 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -69.4 160.72 77.95 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.816 2.446 . . . . 0.0 111.748 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.64 147.12 95.2 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.017 2.478 . . . . 0.0 110.981 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -165.5 153.31 10.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.348 1.859 . . . . 0.0 107.745 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.89 136.84 3.75 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.76 168.83 54.88 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 118.235 1.018 . . . . 0.0 110.853 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.37 140.8 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 108.516 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -85.51 138.0 36.22 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.566 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -58.35 117.32 4.01 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.486 1.457 . . . . 0.0 112.876 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.45 -0.11 84.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.776 1.179 . . . . 0.0 113.046 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.5 120.05 34.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.652 1.226 . . . . 0.0 107.805 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -71.8 165.44 24.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.479 0.712 . . . . 0.0 111.37 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -46.61 64.89 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.239 1.416 . . . . 0.0 111.481 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.37 29.43 0.76 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.577 0.703 . . . . 0.0 110.301 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.01 -48.66 0.67 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.609 1.964 . . . . 0.0 106.51 170.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.6 74.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.828 1.251 . . . . 0.0 112.015 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -56.92 -45.45 82.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.9 m-85 -73.79 -28.5 61.68 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.027 -1.046 . . . . 0.0 112.052 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -61.39 -46.63 89.37 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.722 -1.236 . . . . 0.0 108.761 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.39 97.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 tp -54.9 -44.6 74.29 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.822 1.649 . . . . 0.0 110.243 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -44.51 88.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.909 0.884 . . . . 0.0 111.252 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.42 -29.08 66.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.781 1.173 . . . . 0.0 112.894 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.26 -48.08 6.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 111.465 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.17 0.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 119.819 1.19 . . . . 0.0 113.69 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 31.31 80.12 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.988 0.813 . . . . 0.0 112.002 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 mt -103.92 152.24 22.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -115.77 -177.29 3.12 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.381 0.673 . . . . 0.0 110.176 -173.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 18.2 ptp180 -71.92 47.55 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.744 2.018 . . . . 0.0 112.575 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -160.68 -19.34 0.05 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.375 1.47 . . . . 0.0 112.341 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -93.85 -0.1 55.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 112.124 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.37 169.33 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.011 0.924 . . . . 0.0 109.448 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -139.36 121.44 15.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.4 mt -74.82 128.01 36.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.92 -30.76 9.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.781 0.433 . . . . 0.0 110.794 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 166.56 29.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.134 0.974 . . . . 0.0 109.366 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.7 p -144.43 158.27 43.84 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.196 1.399 . . . . 0.0 108.244 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -62.95 140.73 58.87 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -60.29 -30.24 69.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -141.83 175.38 9.76 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.707 1.603 . . . . 0.0 106.773 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -66.56 133.51 50.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -87.79 152.3 22.22 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.126 0.97 . . . . 0.0 108.634 169.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -150.41 161.05 43.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -140.99 173.82 11.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.381 1.872 . . . . 0.0 106.822 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -97.99 130.75 44.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.32 145.75 98.99 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 170.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -64.93 155.07 69.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.384 2.056 . . . . 0.0 108.465 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -73.15 -24.67 60.62 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.97 0.908 . . . . 0.0 112.816 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.4 tp -99.24 -21.42 16.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.677 0.791 . . . . 0.0 111.727 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.95 141.16 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -75.83 -42.2 50.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 42.5 m95 56.31 9.74 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.868 2.467 . . . . 0.0 114.61 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.08 -17.42 5.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.003 0.921 . . . . 0.0 113.224 -169.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 p -73.5 -35.64 65.64 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.691 -0.631 . . . . 0.0 112.075 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 46.13 88.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.461 2.304 . . . . 0.0 112.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.83 143.69 51.54 Favored 'Cis proline' 0 C--N 1.353 0.775 0 CA-C-N 119.617 0.899 . . . . 0.0 113.699 9.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.6 t -56.64 121.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.08 1.352 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -89.48 120.0 30.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.4 pt -115.86 -4.16 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.02 1.328 . . . . 0.0 111.929 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.12 15.88 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.852 1.206 . . . . 0.0 111.074 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -85.69 127.73 34.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -85.31 115.07 22.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -122.95 122.74 39.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 120.187 1.358 . . . . 0.0 112.49 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -103.21 107.14 17.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 167.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -82.53 142.19 32.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.24 132.22 55.9 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.58 118.14 22.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.75 124.14 50.02 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.382 1.073 . . . . 0.0 109.366 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -86.58 134.74 33.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.74 136.63 57.97 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.85 -29.1 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -123.78 120.92 34.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.19 33.52 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 121.667 0.593 . . . . 0.0 113.166 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.46 -29.04 5.96 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.04 1.336 . . . . 0.0 113.251 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.64 68.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.127 0.571 . . . . 0.0 111.998 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -109.64 -11.79 14.72 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.2 mt -59.75 134.08 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.44 63.85 1.31 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.0 mtt -48.49 -26.48 2.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 114.157 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.52 24.67 2.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.945 1.248 . . . . 0.0 112.618 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -44.43 68.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.077 1.751 . . . . 0.0 111.762 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.7 m -96.97 9.67 41.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 m 67.54 -36.69 0.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.467 2.707 . . . . 0.0 114.825 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.2 p -126.53 73.21 73.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.04 1.736 . . . . 0.0 106.985 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -78.98 -165.81 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.783 2.989 . . . . 0.0 110.983 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -106.6 -19.18 13.75 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.609 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.23 157.76 29.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 121.64 2.018 . . . . 0.0 112.095 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.32 -25.88 1.31 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.617 1.567 . . . . 0.0 112.548 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.19 147.32 14.98 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -99.09 154.74 17.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.575 1.15 . . . . 0.0 111.091 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -156.04 112.25 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.166 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -78.17 134.98 37.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.163 1.347 . . . . 0.0 107.867 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.0 160.73 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.721 1.209 . . . . 0.0 109.903 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.34 150.09 3.69 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.523 0.678 . . . . 0.0 110.823 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.34 148.38 32.54 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.0 m95 66.06 -10.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -61.73 -50.74 80.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 121.748 2.067 . . . . 0.0 111.371 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -59.28 -31.26 94.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.037 1.825 . . . . 0.0 112.658 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.45 -37.21 78.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.652 0.781 . . . . 0.0 109.801 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mmm-85 -81.8 -27.98 33.4 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.771 1.168 . . . . 0.0 111.347 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -73.53 -30.43 63.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.873 0.76 . . . . 0.0 111.85 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.96 157.22 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 119.162 0.892 . . . . 0.0 111.74 -169.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -52.06 148.88 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.186 1.794 . . . . 0.0 112.401 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -63.26 -32.81 74.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 113.55 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -70.07 -29.88 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.307 0.958 . . . . 0.0 111.054 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -86.11 -40.22 15.92 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 117.45 -1.262 . . . . 0.0 112.212 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -40.7 -49.97 3.07 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.877 1.217 . . . . 0.0 113.675 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.93 -31.12 68.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 75' ' ' LEU . 24.3 t -78.6 -40.59 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.846 0.859 . . . . 0.0 110.314 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.24 -30.67 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -56.95 -41.24 77.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.987 -1.071 . . . . 0.0 110.802 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -66.59 -46.9 74.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.297 0.953 . . . . 0.0 109.026 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.73 -44.85 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.9 mtt -70.17 -38.17 75.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.447 -0.783 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -64.52 -37.02 86.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.209 0.913 . . . . 0.0 110.624 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.33 -28.06 66.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 110.592 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -113.31 -12.19 13.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.46 -58.1 8.32 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.663 1.119 . . . . 0.0 111.704 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.9 m -74.38 5.86 4.22 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.84 0.23 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.447 1.899 . . . . 0.0 109.401 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.2 t -118.38 -54.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.9 mtt -60.55 -22.15 63.33 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.889 1.275 . . . . 0.0 111.51 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.4 p -53.7 -40.67 66.23 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 111.844 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.19 -39.49 86.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.125 0.97 . . . . 0.0 109.785 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -84.34 -36.14 22.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.342 0.657 . . . . 0.0 111.093 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 123.653 0.781 . . . . 0.0 109.101 170.165 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.31 150.49 25.86 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.882 1.673 . . . . 0.0 110.062 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.41 -28.5 66.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.912 0.885 . . . . 0.0 113.03 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.94 2.34 43.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.262 1.025 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.72 29.06 11.18 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.575 1.559 . . . . 0.0 112.586 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -109.23 141.29 41.71 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.138 1.469 . . . . 0.0 110.932 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.65 127.45 52.38 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.33 135.66 34.74 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -143.03 159.17 42.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.106 1.762 . . . . 0.0 111.534 -169.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.674 1.59 . . . . 0.0 107.933 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.13 124.0 34.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mm -87.05 118.45 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.54 81.0 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -65.18 145.64 13.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -131.67 131.5 43.19 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 168.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.6 129.86 35.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -44.74 -27.86 0.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.112 1.765 . . . . 0.0 114.482 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.15 15.59 0.16 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.216 1.006 . . . . 0.0 112.561 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.09 17.48 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.212 1.387 . . . . 0.0 112.432 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -129.5 154.55 46.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.166 1.386 . . . . 0.0 108.147 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.19 161.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.511 0.725 . . . . 0.0 112.303 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.22 128.21 34.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.731 1.212 . . . . 0.0 109.813 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.43 133.27 8.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 168.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 121' ' ' PHE . . . -153.02 147.03 25.43 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -67.73 125.46 26.3 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -74.85 128.46 35.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.39 146.05 41.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 169.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.03 -44.4 2.6 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.113 0.863 . . . . 0.0 112.977 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -77.7 -34.48 52.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 109.219 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 54.65 39.48 31.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.654 1.982 . . . . 0.0 111.285 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 p -160.25 170.2 21.62 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -70.72 149.81 46.56 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.457 -0.777 . . . . 0.0 111.398 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -156.25 149.3 24.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.352 1.061 . . . . 0.0 108.6 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -47.79 137.48 10.09 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.583 1.953 . . . . 0.0 111.589 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.13 136.22 50.97 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.974 1.783 . . . . 0.0 109.802 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -162.13 139.76 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.184 2.194 . . . . 0.0 106.006 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.15 -97.75 1.44 Allowed Glycine 0 CA--C 1.531 1.072 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.63 167.31 23.89 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.4 mt -114.58 148.46 17.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -99.78 154.27 37.34 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.698 1.199 . . . . 0.0 110.275 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.27 117.91 4.74 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.939 1.759 . . . . 0.0 111.208 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.53 5.37 89.57 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.997 1.284 . . . . 0.0 112.809 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.48 127.04 34.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.41 160.71 29.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.175 0.99 . . . . 0.0 110.401 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.35 74.57 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.836 0.854 . . . . 0.0 112.92 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.8 -44.23 64.29 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.26 -43.08 96.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.8 1.24 . . . . 0.0 109.421 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.315 0.646 . . . . 0.0 111.509 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -60.14 -42.66 95.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.05 0.841 . . . . 0.0 109.307 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 89.7 m-85 -69.46 -24.53 63.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.604 1.093 . . . . 0.0 112.167 172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -66.99 -50.56 61.88 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.825 -1.172 . . . . 0.0 108.176 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.18 -30.52 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.187 0.903 . . . . 0.0 111.746 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.0 tp -57.3 -39.48 75.86 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -54.47 10.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.251 1.02 . . . . 0.0 110.915 172.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.78 -36.26 80.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.539 1.063 . . . . 0.0 111.893 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -95.72 -52.12 4.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.661 0.784 . . . . 0.0 111.36 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.37 -15.2 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.564 0.62 . . . . 0.0 112.375 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.01 56.46 24.55 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -173.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.4 mt -137.22 158.87 43.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.6 1.96 . . . . 0.0 106.537 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -125.45 -172.61 2.63 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.839 0.856 . . . . 0.0 111.312 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.0 mtt180 -64.99 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.968 3.307 . . . . 0.0 114.29 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -159.27 -14.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.185 0.994 . . . . 0.0 113.384 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -91.22 2.0 56.69 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.693 1.197 . . . . 0.0 113.093 -169.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.76 169.23 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.952 0.901 . . . . 0.0 110.498 -168.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -134.73 112.91 11.15 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 102' ' ' LEU . 45.4 mt -71.51 130.51 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 120.086 1.312 . . . . 0.0 107.515 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.88 -36.22 6.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.007 0.523 . . . . 0.0 111.762 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.76 173.2 16.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.721 1.209 . . . . 0.0 108.938 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 t -150.91 162.26 41.13 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 170.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -64.39 143.33 57.98 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.767 0.712 . . . . 0.0 109.665 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -63.54 -30.66 71.75 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.818 0.447 . . . . 0.0 111.888 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.63 168.86 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.652 1.581 . . . . 0.0 108.093 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -64.67 124.79 22.82 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.13 0.572 . . . . 0.0 109.465 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.93 158.66 27.98 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -142.34 137.35 30.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -145.53 154.48 42.24 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -100.17 146.41 26.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.37 140.82 60.83 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.46 154.2 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.156 1.904 . . . . 0.0 109.093 169.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -44.43 79.9 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.04 -1.038 . . . . 0.0 113.631 -169.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.5 -15.69 62.92 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.131 0.973 . . . . 0.0 112.559 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 tp -99.29 -6.59 27.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.476 1.51 . . . . 0.0 111.929 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.55 145.11 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 120.797 1.635 . . . . 0.0 107.765 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -77.95 -43.68 29.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.838 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.1 m95 59.3 4.17 0.45 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.924 2.49 . . . . 0.0 114.561 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -118.9 -18.12 8.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.599 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -74.23 -38.4 63.53 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.846 -0.534 . . . . 0.0 111.49 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 46.53 87.44 0.12 Allowed Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 127.73 2.412 . . . . 0.0 112.164 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -60.31 138.99 21.89 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.032 1.047 . . . . 0.0 114.305 9.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -57.31 120.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.658 1.583 . . . . 0.0 107.523 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 47.1 t -91.71 126.84 36.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -119.5 -3.19 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.898 1.679 . . . . 0.0 112.08 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.0 37.6 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 120.408 1.458 . . . . 0.0 112.627 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -100.98 125.76 47.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 171.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -89.48 110.69 21.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.81 127.27 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 120.719 1.599 . . . . 0.0 112.153 -171.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -101.11 123.1 44.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -98.3 124.49 42.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.25 136.57 36.55 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.92 116.31 28.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 67' ' ' ILE . 30.4 mt -111.67 136.28 51.11 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 110.591 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -93.92 136.9 33.72 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.7 tp -82.53 106.94 14.8 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -30.47 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 111.547 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 p -59.73 -60.96 3.01 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 111.436 171.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.54 176.01 38.66 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.166 0.889 . . . . 0.0 111.549 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -43.48 -37.09 2.25 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.441 1.497 . . . . 0.0 112.596 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.35 -21.26 61.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -129.74 -13.41 4.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.54 1.136 . . . . 0.0 112.77 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.57 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.23 50.16 1.62 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.116 0.966 . . . . 0.0 109.653 -169.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.7 mtt -45.46 -15.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 -169.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.06 22.53 10.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.958 1.708 . . . . 0.0 112.613 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 p -65.94 -32.22 73.59 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 112.073 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.58 -3.94 58.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -169.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m 66.33 -40.42 0.35 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.368 2.267 . . . . 0.0 113.072 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -128.15 79.24 74.24 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 126.932 2.093 . . . . 0.0 105.807 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.02 -161.94 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.781 2.987 . . . . 0.0 110.973 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -112.34 -38.41 4.7 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.55 -1.214 . . . . 0.0 112.557 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 43.1 m-85 -106.35 161.3 14.68 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.267 1.849 . . . . 0.0 111.31 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -128.68 -29.44 2.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.575 1.55 . . . . 0.0 112.418 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.57 152.5 22.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -104.3 160.44 14.89 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.066 0.946 . . . . 0.0 111.827 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -154.31 117.85 4.6 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.337 1.855 . . . . 0.0 106.451 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -79.41 130.98 35.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.357 1.435 . . . . 0.0 107.443 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.81 162.27 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.476 1.11 . . . . 0.0 110.268 -170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.8 m -53.64 148.82 9.06 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.703 0.763 . . . . 0.0 111.75 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.18 144.95 48.78 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.38 -1.17 1.3 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -68.44 -49.83 29.86 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 121.385 1.902 . . . . 0.0 111.201 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -63.9 -32.2 66.42 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 121.286 1.495 . . . . 0.0 114.453 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 m -61.29 -31.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 120.093 1.315 . . . . 0.0 111.575 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.22 -14.89 34.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.58 1.082 . . . . 0.0 111.737 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -75.59 -33.77 60.6 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 109.502 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.3 153.77 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.499 1.52 . . . . 0.0 110.377 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.11 149.91 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.438 1.495 . . . . 0.0 111.016 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 m -57.13 -35.63 69.73 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.023 1.329 . . . . 0.0 114.159 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -71.3 -27.55 63.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.102 0.864 . . . . 0.0 111.388 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -98.18 -22.12 16.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.188 0.995 . . . . 0.0 112.358 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -49.54 -43.05 45.54 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.033 0.933 . . . . 0.0 110.947 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.37 -45.55 87.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.669 0.668 . . . . 0.0 111.787 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.45 -35.51 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.743 -0.598 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.56 -30.76 67.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.215 -0.928 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -61.59 -38.63 88.25 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.552 -1.342 . . . . 0.0 109.646 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -64.45 -42.68 95.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.18 1.355 . . . . 0.0 109.937 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.83 -46.55 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 118.934 0.788 . . . . 0.0 109.214 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 46.7 mtt -68.97 -38.07 79.16 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.88 -0.513 . . . . 0.0 110.512 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -66.68 -33.82 76.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.333 1.053 . . . . 0.0 110.764 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.03 -26.04 67.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.355 0.662 . . . . 0.0 111.406 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -120.39 -6.12 9.83 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.39 -58.41 6.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.209 0.913 . . . . 0.0 111.48 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -64.03 -27.15 68.92 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.071 -0.393 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.19 -40.42 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.096 -1.002 . . . . 0.0 108.612 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.02 -41.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.529 0.732 . . . . 0.0 109.345 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 49.2 mtt -71.97 -25.55 61.9 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.04 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.1 m -50.74 -41.14 56.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.477 1.035 . . . . 0.0 111.874 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.02 -37.78 88.58 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -99.7 22.2 11.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.924 0.89 . . . . 0.0 111.97 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 126.247 1.819 . . . . 0.0 109.644 172.115 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.3 mm . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.15 149.25 48.84 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.731 1.612 . . . . 0.0 108.238 171.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.86 -32.1 19.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.92 1.35 35.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.05 35.54 7.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.581 1.562 . . . . 0.0 111.531 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 13.8 m-85 -116.43 139.99 49.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.394 1.097 . . . . 0.0 109.858 -174.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -90.99 122.21 66.95 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.106 -1.426 . . . . 0.0 107.337 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.94 130.83 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.994 1.796 . . . . 0.0 110.238 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -139.1 166.45 24.48 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.211 1.404 . . . . 0.0 109.716 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.75 138.07 50.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.16 123.38 6.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.44 111.72 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -92.52 82.74 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.66 129.27 27.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 169.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.4 m -114.66 121.03 42.12 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -80.54 139.8 36.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.78 -6.52 12.08 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -73.36 -1.82 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.109 0.868 . . . . 0.0 110.629 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.68 26.27 25.36 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 124.995 1.283 . . . . 0.0 112.49 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -124.82 161.97 25.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 0.0 108.409 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.59 163.66 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.2 tpt -53.1 134.16 38.63 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.849 2.06 . . . . 0.0 111.742 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -164.19 137.93 5.37 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 168.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.624 0.726 . . . . 0.0 110.056 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -75.8 135.33 40.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.273 1.429 . . . . 0.0 107.674 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -82.43 130.76 35.17 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -49.1 130.88 19.25 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.023 2.129 . . . . 0.0 110.658 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.26 -35.46 1.97 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.755 1.169 . . . . 0.0 113.539 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -85.13 -35.31 21.84 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.179 0.99 . . . . 0.0 110.337 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.289 91.6 m-70 56.04 34.01 22.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.961 1.705 . . . . 0.0 113.317 -174.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m -139.45 157.31 46.06 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.0 2.12 . . . . 0.0 106.288 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -65.92 158.36 28.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.548 1.139 . . . . 0.0 113.35 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.43 150.17 36.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 0.0 109.515 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -66.96 160.69 68.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.668 1.587 . . . . 0.0 111.157 169.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.73 -133.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.738 3.625 . . . . 0.0 110.05 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 76.2 116.92 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.278 2.231 . . . . 0.0 110.225 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.62 18.59 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 153.84 51.19 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.599 1.095 . . . . 0.0 112.888 -169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -90.27 139.01 18.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.839 1.656 . . . . 0.0 107.795 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.53 154.5 68.69 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.347 0.659 . . . . 0.0 110.629 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.82 117.63 4.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.884 1.722 . . . . 0.0 111.341 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.73 6.41 89.4 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.909 1.242 . . . . 0.0 112.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -81.59 130.22 34.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.78 160.37 28.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.409 1.084 . . . . 0.0 110.398 177.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.67 71.21 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 124.456 1.102 . . . . 0.0 112.445 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.05 -42.21 66.55 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.48 -42.57 96.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.869 1.268 . . . . 0.0 109.362 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -37.15 85.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 111.925 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -59.78 -44.94 93.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.122 0.873 . . . . 0.0 109.651 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.4 m-85 -70.31 -29.78 66.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.168 -0.958 . . . . 0.0 112.015 174.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -62.33 -47.6 83.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.502 1.046 . . . . 0.0 109.751 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.16 70.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.91 0.484 . . . . 0.0 111.008 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -58.31 -39.67 79.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.482 1.113 . . . . 0.0 109.939 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -74.07 -50.82 17.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.24 1.416 . . . . 0.0 111.661 175.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.94 -35.0 79.75 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.967 1.258 . . . . 0.0 112.027 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.58 -50.38 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.994 0.918 . . . . 0.0 111.816 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.4 -13.53 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.661 0.785 . . . . 0.0 111.469 -169.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.26 40.88 96.91 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.68 150.23 41.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 107.341 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.0 m -115.22 -175.61 2.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.008 0.923 . . . . 0.0 111.071 -169.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.3 mtt180 -66.09 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.356 2.663 . . . . 0.0 114.203 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -161.4 -16.23 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.773 1.229 . . . . 0.0 112.866 -169.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.59 -0.55 57.37 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.472 1.109 . . . . 0.0 112.484 -169.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.35 168.55 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.326 1.45 . . . . 0.0 108.326 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -137.83 119.97 15.62 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -74.6 129.65 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 120.23 1.377 . . . . 0.0 107.582 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.17 -32.12 7.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.81 0.444 . . . . 0.0 111.549 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.76 167.24 30.61 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.088 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 p -149.77 160.16 43.77 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.005 1.322 . . . . 0.0 107.915 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -63.62 148.22 49.49 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.734 -0.604 . . . . 0.0 110.791 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -64.84 -37.06 86.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.79 0.436 . . . . 0.0 111.253 -171.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.84 172.95 14.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.575 1.95 . . . . 0.0 107.39 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -63.36 125.68 24.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.588 0.755 . . . . 0.0 110.148 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.62 133.44 37.27 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.38 150.38 32.35 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.218 0.917 . . . . 0.0 110.273 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.57 160.36 43.86 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.47 1.108 . . . . 0.0 109.077 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -91.76 128.36 37.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.62 148.22 95.0 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.523 1.129 . . . . 0.0 109.282 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.21 155.7 68.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.671 2.247 . . . . 0.0 109.755 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -54.32 -35.21 62.43 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.79 -24.2 55.93 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.194 0.998 . . . . 0.0 112.971 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.49 -17.36 15.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.947 0.899 . . . . 0.0 111.759 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.4 t -49.01 132.75 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 168.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.74 107.19 16.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -89.21 -1.93 58.28 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.495 0.718 . . . . 0.0 111.021 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.98 -20.82 21.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.754 1.622 . . . . 0.0 110.013 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 p -87.24 162.93 17.17 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.815 0.846 . . . . 0.0 108.811 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -136.69 113.24 9.99 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -54.61 152.4 19.31 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-N 120.21 1.111 . . . . 0.0 113.116 -6.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.44 129.88 26.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.2 t -90.38 109.73 20.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.58 -6.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.825 1.25 . . . . 0.0 112.024 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.454 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -157.46 169.61 34.43 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.086 1.312 . . . . 0.0 113.014 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -115.18 122.91 47.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -101.98 134.06 45.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -152.78 146.74 25.33 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.904 1.229 . . . . 0.0 114.147 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -104.72 127.82 52.62 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 102.788 -3.042 . . . . 0.0 102.788 168.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -97.25 135.72 38.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -112.68 129.75 56.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 110.02 16.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -104.95 127.81 52.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -83.74 133.53 34.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.0 137.1 51.1 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.34 -38.88 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.7 p -60.56 -61.7 2.4 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.0 1.72 . . . . 0.0 112.145 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 172.24 38.65 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.847 1.259 . . . . 0.0 112.491 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.8 63.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.657 0.783 . . . . 0.0 112.878 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.35 -9.94 5.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.402 1.081 . . . . 0.0 112.744 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.47 130.93 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 169.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.04 49.42 1.66 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.14 0.976 . . . . 0.0 109.146 -170.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.5 ptp -64.53 28.81 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.467 2.307 . . . . 0.0 116.134 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -123.28 21.76 9.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.524 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -35.36 72.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.897 2.079 . . . . 0.0 111.873 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -5.81 56.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.063 1.745 . . . . 0.0 113.306 -170.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.3 m 68.16 -37.82 0.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 128.607 2.763 . . . . 0.0 113.389 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.7 p -124.9 73.14 64.24 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.72 -177.65 2.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.302 2.668 . . . . 0.0 110.979 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.4 -8.2 21.35 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.477 -1.249 . . . . 0.0 111.573 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.54 151.6 50.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 121.341 1.882 . . . . 0.0 112.876 -170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.58 -25.91 3.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.229 1.812 . . . . 0.0 112.648 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.65 157.71 29.97 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -106.99 159.97 15.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -150.47 120.89 7.37 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.047 1.739 . . . . 0.0 106.391 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -82.82 124.19 30.06 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.13 163.15 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.21 1.004 . . . . 0.0 110.953 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.6 m -50.12 144.94 6.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.629 0.772 . . . . 0.0 110.143 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -54.96 -36.12 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.888 0.475 . . . . 0.0 111.964 -169.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -100.39 12.19 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.85 -49.77 10.29 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.53 -32.54 88.07 Favored 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 121.842 1.693 . . . . 0.0 113.782 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -31.38 49.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 119.807 1.185 . . . . 0.0 111.242 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -86.05 -21.92 27.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.6 1.091 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -81.61 -31.1 32.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.69 0.677 . . . . 0.0 111.665 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.1 160.37 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.325 0.584 . . . . 0.0 110.448 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.86 149.01 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.109 0.964 . . . . 0.0 111.261 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -57.42 -35.04 69.56 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.999 1.319 . . . . 0.0 113.912 -169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -73.58 -27.03 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.788 0.722 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -82.53 -38.65 23.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.934 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -42.96 -50.64 5.82 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.874 1.215 . . . . 0.0 112.771 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.62 -26.25 60.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.2 -42.92 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.6 -32.67 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.576 -0.703 . . . . 0.0 110.774 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.11 -29.12 70.11 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.28 -0.888 . . . . 0.0 112.637 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -64.5 -47.89 77.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.714 1.143 . . . . 0.0 108.946 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.23 -44.79 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.1 mtt -64.67 -46.68 81.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.601 -1.19 . . . . 0.0 111.038 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -29.77 69.44 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 121.433 1.924 . . . . 0.0 111.068 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.81 -36.41 82.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.635 0.374 . . . . 0.0 110.357 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -100.02 -16.67 17.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.4 1.08 . . . . 0.0 113.366 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.4 6.87 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.995 1.318 . . . . 0.0 109.899 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -65.25 -21.51 66.75 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.3 -42.45 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.52 -39.37 40.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.2 mtt -72.58 -20.17 61.36 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.413 -0.804 . . . . 0.0 111.122 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.7 m -64.51 -20.27 66.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.865 1.212 . . . . 0.0 112.528 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.4 -29.0 47.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -98.2 -37.27 9.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.239 1.016 . . . . 0.0 111.224 -169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 126.767 2.027 . . . . 0.0 110.204 176.295 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.08 -44.7 68.55 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.126 0.57 . . . . 0.0 111.252 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -154.34 -86.22 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.429 1.092 . . . . 0.0 109.717 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 -45.92 13.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.94 15.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.943 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -99.32 125.57 45.0 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.637 1.718 . . . . 0.0 108.547 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -85.68 126.07 67.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 117.368 -1.301 . . . . 0.0 107.688 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.09 127.49 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.28 1.987 . . . . 0.0 109.244 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -137.27 166.34 24.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.218 1.407 . . . . 0.0 108.99 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.43 141.63 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 127.006 2.122 . . . . 0.0 105.84 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.76 132.71 10.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.89 129.37 48.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.61 86.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 168.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.48 135.84 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.08 124.2 46.32 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.33 127.32 32.62 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 170.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -53.75 -4.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.54 2.336 . . . . 0.0 116.088 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.35 -12.48 60.27 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.8 1.182 . . . . 0.0 111.423 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.42 41.83 2.67 Favored Glycine 0 C--N 1.342 0.916 0 C-N-CA 124.791 1.186 . . . . 0.0 111.811 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.69 155.47 44.91 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.41 162.18 13.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.182 0.993 . . . . 0.0 112.152 -169.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.8 tpp -53.54 130.67 36.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.037 1.735 . . . . 0.0 111.36 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' A' ' 24' ' ' TRP . 1.4 t-105 -159.27 131.11 6.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 166.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.19 26.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.194 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -83.62 134.72 34.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.65 130.6 35.11 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.79 145.19 56.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.396 0.679 . . . . 0.0 110.588 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.27 -43.57 2.05 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.947 1.26 . . . . 0.0 112.534 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -78.63 -37.97 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.377 1.071 . . . . 0.0 109.844 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.316 24.3 m170 57.84 43.61 21.41 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.807 2.043 . . . . 0.0 113.734 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 p -146.33 171.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 107.034 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -73.21 156.04 38.96 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.212 -0.93 . . . . 0.0 111.542 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.54 145.67 29.17 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.605 0.762 . . . . 0.0 109.968 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.62 143.03 87.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.697 1.199 . . . . 0.0 109.965 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -69.75 139.08 39.38 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.455 2.103 . . . . 0.0 110.238 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 151.33 6.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.422 1.889 . . . . 0.0 109.035 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.94 139.93 7.42 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 146.72 45.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 mt -80.7 138.89 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -96.64 154.77 38.36 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 123.911 0.884 . . . . 0.0 110.52 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.92 123.14 12.72 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.388 2.059 . . . . 0.0 114.703 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.76 4.52 66.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 113.991 -1.458 . . . . 0.0 113.244 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -86.17 123.94 32.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.646 1.223 . . . . 0.0 108.545 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -72.92 162.4 29.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.543 1.137 . . . . 0.0 110.846 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.86 79.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.4 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.84 9.4 6.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.81 . . . . 0.0 111.65 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -111.59 -54.11 2.64 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.19 72.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.541 1.136 . . . . 0.0 112.79 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -60.67 -42.76 97.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.037 0.835 . . . . 0.0 109.567 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -74.18 -24.45 59.37 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.523 -1.36 . . . . 0.0 111.771 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.6 -50.78 71.2 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.08 -1.012 . . . . 0.0 108.434 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.48 -35.66 81.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.102 0.561 . . . . 0.0 111.906 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.68 -41.21 76.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.935 1.294 . . . . 0.0 110.455 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -46.65 54.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.185 0.994 . . . . 0.0 110.551 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.32 -40.26 95.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.294 0.952 . . . . 0.0 111.788 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.44 -51.95 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.496 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.83 -9.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.32 64.38 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 120.938 -1.101 . . . . 0.0 112.339 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.6 mt -105.96 164.59 11.84 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.981 0.912 . . . . 0.0 108.62 171.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -126.96 -175.95 3.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.064 1.346 . . . . 0.0 111.005 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.95 41.24 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.853 2.061 . . . . 0.0 113.206 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -159.76 -21.26 0.07 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.319 0.648 . . . . 0.0 112.725 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -85.31 -0.12 53.76 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.19 168.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.42 1.088 . . . . 0.0 110.523 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -142.93 121.26 12.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 126.087 1.755 . . . . 0.0 106.853 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.89 130.53 36.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 120.808 1.64 . . . . 0.0 107.646 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.66 -34.71 7.23 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.38 0.672 . . . . 0.0 110.886 171.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.79 172.5 18.37 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.37 1.068 . . . . 0.0 109.225 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -149.31 160.58 43.28 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 p -66.13 142.2 57.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.921 0.782 . . . . 0.0 109.375 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -68.73 -22.55 64.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.933 0.493 . . . . 0.0 111.984 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.44 173.58 11.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.534 1.934 . . . . 0.0 107.725 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -76.8 117.15 18.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.49 137.53 52.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -147.35 147.29 30.17 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.745 -0.597 . . . . 0.0 109.795 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -150.76 163.42 38.62 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.109 1.363 . . . . 0.0 107.979 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -87.51 149.45 24.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.361 0.6 . . . . 0.0 109.889 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.49 137.35 32.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.55 151.81 75.14 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.662 2.241 . . . . 0.0 108.426 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -21.81 66.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -169.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.05 -28.45 62.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.823 0.849 . . . . 0.0 112.184 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.3 tp -97.12 -24.13 15.89 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.396 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -45.02 136.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -75.15 -42.51 55.92 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.976 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.3 m95 59.73 1.95 0.33 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.731 2.413 . . . . 0.0 114.156 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -97.57 -23.79 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.014 1.325 . . . . 0.0 111.51 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -73.13 153.41 40.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.868 1.667 . . . . 0.0 109.053 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.94 112.2 10.43 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 117.785 -1.103 . . . . 0.0 108.263 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.99 151.88 17.38 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 CA-C-N 120.509 1.217 . . . . 0.0 111.832 -10.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.35 131.55 27.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.5 p -90.35 127.96 36.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -169.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -105.96 -4.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.296 1.439 . . . . 0.0 110.986 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.15 30.91 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 118.969 0.804 . . . . 0.0 111.705 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.23 119.88 40.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -92.89 130.61 38.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 169.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 142.39 22.41 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.756 1.616 . . . . 0.0 114.447 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -101.77 130.97 48.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -95.38 141.93 28.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -111.44 135.19 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 108.392 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.1 tp -90.83 102.5 15.26 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.3 mt -100.44 127.33 46.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.219 0.608 . . . . 0.0 110.207 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -85.19 138.06 32.61 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 168.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -70.4 132.56 45.81 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -112.85 -41.22 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.0 m -139.01 127.7 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.92 -171.27 43.36 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.92 -51.39 0.19 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.416 3.086 . . . . 0.0 112.907 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.03 -34.57 22.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 111.102 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.66 -5.66 19.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.859 0.864 . . . . 0.0 112.536 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.84 142.86 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -132.07 -45.42 0.94 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -170.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mtt 60.17 0.01 0.27 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.85 25.9 3.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.645 2.02 . . . . 0.0 111.19 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.4 t -86.1 -30.31 22.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -85.14 168.38 14.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.176 1.791 . . . . 0.0 110.565 -169.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 m -70.95 -33.52 70.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.985 0.514 . . . . 0.0 111.533 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -142.77 88.55 8.47 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -67.16 -166.07 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.407 2.071 . . . . 0.0 113.547 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.28 -54.67 1.27 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.802 170.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -100.47 168.34 9.8 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.398 0.999 . . . . 0.0 112.561 -169.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.92 -8.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.377 1.071 . . . . 0.0 113.115 176.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.9 149.22 19.89 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -113.45 150.14 33.21 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.453 1.501 . . . . 0.0 110.226 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -148.82 114.02 5.52 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.569 1.547 . . . . 0.0 107.31 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -77.8 133.26 38.25 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.87 160.1 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.973 1.309 . . . . 0.0 109.322 -172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 m -53.65 152.94 4.74 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 110.725 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.41 151.19 13.55 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 67.39 -15.79 0.17 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -57.89 -45.58 99.78 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 121.284 1.856 . . . . 0.0 111.984 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -63.85 -25.44 67.68 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.769 1.646 . . . . 0.0 114.373 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.09 -37.23 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.691 1.132 . . . . 0.0 108.982 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -85.98 -15.9 40.04 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.125 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -82.72 -32.19 28.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.527 1.058 . . . . 0.0 111.955 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m -69.25 164.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 112.204 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.28 151.16 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.471 1.108 . . . . 0.0 110.652 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 m -57.37 -36.16 70.87 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.974 1.31 . . . . 0.0 113.371 -169.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -76.71 -24.72 53.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.183 0.901 . . . . 0.0 111.673 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -87.34 -27.49 22.8 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.431 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -42.83 -50.82 5.63 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.917 1.287 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.89 -37.62 79.12 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.157 0.435 . . . . 0.0 111.158 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.83 -45.46 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.62 -32.15 70.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.906 0.483 . . . . 0.0 110.339 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -57.65 -39.83 77.89 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.443 1.097 . . . . 0.0 110.301 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -63.44 -49.67 72.78 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.948 1.249 . . . . 0.0 108.97 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.46 -45.23 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.84 -47.11 82.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.126 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.18 66.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.181 1.809 . . . . 0.0 112.284 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -66.82 -29.51 69.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.47 0.577 . . . . 0.0 110.427 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -108.66 -21.67 12.59 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.09 0.956 . . . . 0.0 113.455 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.2 36.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.241 1.016 . . . . 0.0 109.816 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 m -65.35 -18.58 65.43 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.4 -34.47 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.004 0.82 . . . . 0.0 108.8 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 88.1 t -71.68 -40.79 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 mtt -59.22 -23.03 61.95 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.541 -1.218 . . . . 0.0 111.759 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.0 m -54.16 -31.34 52.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.822 1.646 . . . . 0.0 112.042 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.33 -28.96 21.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.277 1.031 . . . . 0.0 111.507 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 -30.52 8.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.082 . . . . 0.0 112.781 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 127.168 2.187 . . . . 0.0 109.777 178.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.26 -40.7 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -166.74 104.67 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.772 0.829 . . . . 0.0 110.707 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t0 58.42 44.79 17.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.077 2.151 . . . . 0.0 113.301 169.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.95 34.26 18.78 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.845 -0.975 . . . . 0.0 112.32 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -115.89 132.04 56.76 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.588 1.194 . . . . 0.0 110.552 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -88.41 123.72 67.66 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 130.7 10.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.322 2.015 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.47 163.54 31.69 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.395 1.078 . . . . 0.0 110.655 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.21 130.79 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.667 1.987 . . . . 0.0 107.209 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.38 122.36 7.55 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.48 104.23 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.7 t -87.33 80.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.24 131.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -112.19 128.76 56.33 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -94.58 23.47 5.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 57.05 -1.13 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.651 1.98 . . . . 0.0 116.206 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -99.07 -1.62 39.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.76 0.709 . . . . 0.0 111.914 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.36 27.57 29.99 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 119.196 0.907 . . . . 0.0 111.169 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -141.38 156.2 45.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.992 1.717 . . . . 0.0 106.641 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.01 168.88 19.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.662 0.785 . . . . 0.0 112.712 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.5 tpt -48.1 127.03 11.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.119 2.168 . . . . 0.0 112.017 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -160.65 133.25 6.28 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 168.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.03 29.12 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.38 0.672 . . . . 0.0 109.981 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.9 ttm105 -75.14 140.59 43.48 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.674 1.19 . . . . 0.0 108.184 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -86.23 122.37 30.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.341 1.056 . . . . 0.0 109.679 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -53.98 138.19 37.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.809 1.643 . . . . 0.0 108.611 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.7 -37.19 1.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.07 1.319 . . . . 0.0 113.836 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -90.9 -29.91 17.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.504 1.152 . . . . 0.0 111.267 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 55.56 41.3 30.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.001 1.72 . . . . 0.0 112.602 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 p -145.43 169.76 17.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.055 1.342 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -83.48 148.31 27.31 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.754 -1.216 . . . . 0.0 111.048 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -148.81 156.88 42.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.974 0.893 . . . . 0.0 111.101 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -67.98 163.35 51.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.952 2.101 . . . . 0.0 110.007 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.71 -106.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.208 3.272 . . . . 0.0 110.808 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 63.83 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.185 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.03 144.25 18.34 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.48 148.77 45.91 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.19 133.69 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.71 126.61 87.04 Favored Pre-proline 0 C--O 1.232 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 108.567 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.02 119.23 6.16 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.982 1.788 . . . . 0.0 112.619 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.85 3.69 79.86 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.078 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.07 120.67 41.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -70.62 162.51 28.81 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.155 0.582 . . . . 0.0 111.483 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.25 -45.72 8.7 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 127.18 2.192 . . . . 0.0 113.412 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.7 -47.36 40.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.59 -37.9 82.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.306 0.642 . . . . 0.0 110.511 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.53 -34.97 76.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -60.15 -45.72 92.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -67.68 -27.4 66.81 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.293 -0.88 . . . . 0.0 112.844 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -65.17 -51.13 62.98 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 120.885 -1.135 . . . . 0.0 109.009 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.12 70.54 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.138 0.881 . . . . 0.0 110.911 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.93 -39.87 79.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.27 1.028 . . . . 0.0 109.371 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -52.08 14.83 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.321 1.049 . . . . 0.0 111.415 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.77 -36.98 84.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.236 0.925 . . . . 0.0 111.446 -172.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -104.02 -39.01 6.73 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.94 -20.12 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.255 0.622 . . . . 0.0 110.085 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.17 19.42 78.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.488 -1.382 . . . . 0.0 111.945 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 mt -102.22 151.64 21.98 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.521 1.128 . . . . 0.0 108.085 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -113.46 177.45 4.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.693 -0.629 . . . . 0.0 110.064 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -69.99 58.5 0.16 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.073 1.749 . . . . 0.0 112.744 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -163.44 -26.98 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.245 1.818 . . . . 0.0 111.319 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -89.23 -3.39 58.57 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.3 165.26 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.352 0.661 . . . . 0.0 109.741 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -135.43 119.73 17.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.3 mt -74.9 126.55 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -35.1 6.07 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.151 0.98 . . . . 0.0 110.697 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.63 171.67 19.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.353 1.461 . . . . 0.0 108.783 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -148.43 160.57 42.9 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 108.114 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -62.86 148.32 47.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.349 0.522 . . . . 0.0 110.341 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -62.16 -36.71 82.68 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.702 0.401 . . . . 0.0 111.308 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.35 175.03 11.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.4 1.88 . . . . 0.0 107.226 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.515 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 70.5 m95 -64.05 127.31 30.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.346 0.658 . . . . 0.0 109.572 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.43 141.21 39.85 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -153.47 151.18 29.56 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.686 -0.634 . . . . 0.0 110.208 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -155.94 160.87 40.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.743 1.617 . . . . 0.0 107.536 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 145.94 24.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.379 0.609 . . . . 0.0 109.593 172.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.74 151.85 93.38 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 125.556 1.542 . . . . 0.0 108.365 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -63.31 152.75 78.37 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 N-CA-C 108.028 -1.566 . . . . 0.0 108.028 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -49.4 -48.28 47.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.07 -17.93 64.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.09 0.956 . . . . 0.0 112.913 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.9 tp -102.57 -9.09 20.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.785 1.234 . . . . 0.0 111.838 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.9 t -56.49 142.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.47 -47.84 30.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -168.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.2 m95 55.36 11.23 0.55 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.9 2.08 . . . . 0.0 114.328 -170.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.46 -24.8 13.79 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.412 1.085 . . . . 0.0 111.175 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.6 p -90.89 168.84 11.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.078 0.951 . . . . 0.0 109.789 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.96 116.87 18.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -63.67 162.37 57.13 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.89 0.996 . . . . 0.0 109.952 -10.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.33 132.86 25.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -90.4 108.72 19.96 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.4 pt -94.12 -15.29 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.418 1.887 . . . . 0.0 111.596 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.25 172.8 34.13 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 120.099 1.318 . . . . 0.0 112.848 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -119.22 123.57 44.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 68.0 tttt -98.46 131.77 44.45 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 172.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.77 137.37 18.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.857 1.208 . . . . 0.0 113.089 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -100.81 131.73 46.55 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -100.28 132.92 45.38 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -109.14 131.34 55.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -86.94 108.4 18.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -107.09 125.07 50.58 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.885 0.874 . . . . 0.0 108.867 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -83.56 133.32 34.87 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 168.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.3 tp -68.74 124.46 23.71 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.15 -49.71 11.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -135.81 124.35 23.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.6 -163.07 15.56 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.81 -48.17 0.26 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 128.79 2.836 . . . . 0.0 113.175 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.7 -32.74 10.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.725 1.61 . . . . 0.0 112.023 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.78 -24.53 31.03 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.441 0.696 . . . . 0.0 110.695 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -64.76 131.3 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -134.95 -32.08 0.98 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.6 0.76 . . . . 0.0 111.691 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.5 mtt 64.6 -49.63 0.32 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.508 3.123 . . . . 0.0 113.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.48 25.22 2.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.654 1.182 . . . . 0.0 112.986 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -65.46 -28.3 69.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.143 0.577 . . . . 0.0 110.322 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -95.42 10.66 35.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.98 1.312 . . . . 0.0 113.127 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.28 -36.71 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 129.695 3.198 . . . . 0.0 115.793 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 p -128.28 60.88 50.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.74 1.616 . . . . 0.0 108.993 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -70.78 177.84 5.85 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.048 2.499 . . . . 0.0 110.29 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.46 -26.08 35.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.426 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -99.43 139.14 35.53 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.627 1.558 . . . . 0.0 112.684 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -112.53 -31.08 6.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.098 1.759 . . . . 0.0 112.397 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.67 151.81 16.09 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -102.2 155.59 18.11 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.87 0.868 . . . . 0.0 111.901 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -152.58 111.51 3.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.26 1.824 . . . . 0.0 106.947 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -74.17 138.51 43.85 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.874 0.761 . . . . 0.0 109.24 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.41 159.93 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.864 1.265 . . . . 0.0 109.158 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.8 m -55.28 152.55 8.19 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.953 0.501 . . . . 0.0 110.125 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 165.52 13.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.7 m95 65.88 -24.67 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.888 1.675 . . . . 0.0 115.075 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.97 -46.02 96.65 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 120.483 1.492 . . . . 0.0 111.691 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.98 -29.18 81.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 122.012 1.754 . . . . 0.0 113.263 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.42 -10.24 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 111.89 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -108.53 -23.08 12.0 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.898 -1.126 . . . . 0.0 110.97 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.91 -35.73 57.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.314 0.961 . . . . 0.0 111.68 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.89 166.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.869 0.759 . . . . 0.0 111.509 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.77 150.68 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.421 1.088 . . . . 0.0 110.565 174.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 p -53.33 -40.67 65.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.618 1.567 . . . . 0.0 113.633 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -70.33 -32.36 70.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.365 0.53 . . . . 0.0 110.611 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -72.95 -38.61 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -51.6 -48.21 63.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.519 1.054 . . . . 0.0 110.879 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.66 -26.04 62.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.9 -46.51 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.22 -0.925 . . . . 0.0 108.67 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -35.34 80.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 110.976 -170.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -61.19 -28.04 68.85 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.641 -1.287 . . . . 0.0 112.983 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -64.21 -46.76 82.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.3 t -60.81 -48.5 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 109.391 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 mtt -66.43 -37.07 84.38 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.093 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -47.29 82.02 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 119.456 1.025 . . . . 0.0 110.455 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -60.5 -32.58 71.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.264 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -107.8 4.01 25.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -57.44 10.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.476 1.489 . . . . 0.0 110.994 -169.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -59.71 -30.54 68.88 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.237 0.615 . . . . 0.0 111.715 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.02 -8.35 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.736 1.214 . . . . 0.0 111.038 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.22 -35.95 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 O-C-N 121.355 -0.841 . . . . 0.0 109.402 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 54.8 tpp -76.82 -45.33 29.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.269 0.628 . . . . 0.0 111.051 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.6 m -62.97 -31.09 72.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.93 -0.481 . . . . 0.0 111.61 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.48 -34.12 70.54 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.254 0.622 . . . . 0.0 109.868 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -99.25 0.81 43.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.977 0.911 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 CA--C 1.537 0.473 0 C-N-CA 124.592 1.157 . . . . 0.0 109.247 170.421 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.89 141.63 53.13 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 107.337 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -48.8 -30.29 5.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -168.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.37 -5.36 44.45 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.96 38.74 3.75 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 126.059 1.79 . . . . 0.0 110.663 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.0 139.77 53.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.095 1.447 . . . . 0.0 111.628 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -85.57 120.54 73.1 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 116.776 -1.583 . . . . 0.0 107.853 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.42 137.07 27.44 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 121.822 1.681 . . . . 0.0 111.037 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -145.6 157.51 43.97 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.153 1.381 . . . . 0.0 111.609 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.1 74.61 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.419 2.287 . . . . 0.0 107.934 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.77 128.26 44.77 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -86.42 110.11 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -16.26 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 116.89 -1.529 . . . . 0.0 114.742 -169.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm 19.24 109.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 129.127 2.971 . . . . 0.0 114.929 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.2 138.44 33.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -68.51 -4.56 15.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.98 -7.55 54.88 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.852 0.751 . . . . 0.0 110.56 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.86 37.71 4.35 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 126.131 1.824 . . . . 0.0 112.118 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -133.28 155.79 48.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.551 0.74 . . . . 0.0 109.038 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.68 156.89 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.31 1.044 . . . . 0.0 111.295 -168.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.98 131.44 44.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.124 1.769 . . . . 0.0 110.309 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -158.86 139.1 12.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.96 144.24 23.2 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -70.95 138.26 49.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -86.57 125.49 33.83 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.76 137.59 57.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.609 2.364 . . . . 0.0 109.996 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.13 -31.68 1.33 Allowed Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.062 1.315 . . . . 0.0 113.716 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -86.35 -34.15 20.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.453 1.101 . . . . 0.0 110.455 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 57.29 33.46 23.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.046 1.738 . . . . 0.0 112.575 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 p -149.87 -177.79 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.245 1.818 . . . . 0.0 107.231 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -80.46 160.43 25.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.029 -1.044 . . . . 0.0 112.975 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.1 147.74 27.45 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.216 1.006 . . . . 0.0 108.987 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -60.59 143.76 89.9 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.301 1.44 . . . . 0.0 110.21 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.22 153.08 55.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.306 2.004 . . . . 0.0 111.065 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -171.79 149.55 2.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 109.845 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.91 134.28 3.37 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.179 -2.369 . . . . 0.0 107.179 169.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.7 171.72 55.15 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.247 1.024 . . . . 0.0 111.639 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 mt -96.67 146.04 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.815 0.846 . . . . 0.0 109.064 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -87.61 131.71 42.86 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.565 1.546 . . . . 0.0 108.39 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.44 118.07 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.23 1.953 . . . . 0.0 114.08 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.48 3.57 90.03 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.037 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -86.98 131.67 34.02 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.063 0.945 . . . . 0.0 108.554 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.99 161.26 30.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.827 1.251 . . . . 0.0 110.685 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.17 -44.26 64.55 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 125.168 1.387 . . . . 0.0 112.992 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.24 -48.96 48.05 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -57.6 -39.59 77.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.597 1.159 . . . . 0.0 109.919 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 -34.42 63.86 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.044 0.938 . . . . 0.0 111.983 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -57.33 -39.87 76.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.95 0.795 . . . . 0.0 110.065 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.37 -26.39 66.44 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.742 1.155 . . . . 0.0 113.511 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.33 -49.9 69.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.153 1.342 . . . . 0.0 108.597 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.39 75.56 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 119.451 -0.309 . . . . 0.0 111.316 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.2 -44.9 84.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.753 1.221 . . . . 0.0 109.715 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.1 -47.3 80.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.634 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.72 -39.49 94.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.261 1.391 . . . . 0.0 112.772 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -82.47 -46.67 13.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.166 1.386 . . . . 0.0 110.577 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 m -132.16 1.03 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.348 1.059 . . . . 0.0 112.816 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.84 32.47 79.58 Favored Glycine 0 CA--C 1.521 0.447 0 O-C-N 120.909 -1.12 . . . . 0.0 112.164 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.78 154.54 18.82 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 m -117.49 179.03 4.17 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.842 0.857 . . . . 0.0 109.106 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -73.15 46.75 0.18 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.67 1.588 . . . . 0.0 115.242 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -163.42 -20.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.124 1.769 . . . . 0.0 111.785 -171.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.1 2.92 53.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.091 1.356 . . . . 0.0 112.961 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.75 170.19 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.506 1.522 . . . . 0.0 108.91 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -138.0 120.25 15.77 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.3 mt -77.66 128.37 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 120.658 1.572 . . . . 0.0 107.879 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -104.95 -34.8 7.9 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.842 0.857 . . . . 0.0 111.467 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 173.79 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.156 1.382 . . . . 0.0 108.493 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -150.49 160.88 43.46 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 m -56.02 133.39 51.76 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -66.14 -27.04 67.73 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -147.33 168.09 22.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.248 1.419 . . . . 0.0 108.61 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -68.73 117.93 11.06 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.9 156.7 31.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -143.46 154.35 43.58 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.918 1.687 . . . . 0.0 108.029 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -146.1 172.67 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.639 . . . . 0.0 107.721 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -105.45 133.15 50.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.2 mt -67.75 148.72 98.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.33 146.09 25.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.529 2.153 . . . . 0.0 108.287 169.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -56.07 -44.32 78.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.749 1.159 . . . . 0.0 113.146 -168.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.22 -15.19 62.2 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 112.783 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.18 -0.33 33.36 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.074 1.75 . . . . 0.0 111.618 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.61 141.22 13.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -86.61 128.51 35.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -107.57 -0.36 22.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.308 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -106.56 -12.23 15.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.28 1.032 . . . . 0.0 111.446 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.6 p -73.97 -35.92 64.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 111.535 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 40.47 87.98 0.1 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.164 2.585 . . . . 0.0 112.347 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.1 143.42 42.21 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.03 1.046 . . . . 0.0 114.148 10.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -62.58 131.55 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.9 t -94.01 112.31 24.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.3 pt -97.61 -8.89 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.179 0.991 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.23 176.33 48.01 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.867 1.212 . . . . 0.0 112.827 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -101.95 121.2 41.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -82.89 112.48 19.72 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 103.115 -2.92 . . . . 0.0 103.115 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.61 51.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.985 1.721 . . . . 0.0 112.93 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -120.87 113.72 20.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -85.64 149.63 25.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -112.36 130.02 56.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.86 90.58 5.3 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 102' ' ' LEU . 26.3 mt -88.68 122.7 32.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.807 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -84.61 136.4 33.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.33 140.81 57.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.47 -56.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -91.92 123.11 35.05 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.54 -170.89 40.73 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.587 0.613 . . . . 0.0 114.482 -169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -48.98 -32.91 9.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.799 1.64 . . . . 0.0 112.88 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -26.1 66.42 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.61 -25.21 13.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.332 1.453 . . . . 0.0 111.306 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 mt -56.05 139.8 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -141.57 85.92 1.98 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 122.252 1.025 . . . . 0.0 108.664 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 mtt -60.25 -12.84 9.9 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.968 0.907 . . . . 0.0 112.791 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -110.1 30.59 6.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.968 1.307 . . . . 0.0 110.304 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -76.39 -31.14 57.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.174 0.59 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -80.38 168.49 18.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.987 0.898 . . . . 0.0 109.319 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m -81.47 -28.37 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.627 1.571 . . . . 0.0 111.14 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -131.15 64.15 72.63 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.393 1.877 . . . . 0.0 108.21 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.34 176.27 5.84 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.71 2.94 . . . . 0.0 111.009 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -114.54 -22.23 9.9 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.185 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -123.09 145.07 48.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 121.404 1.911 . . . . 0.0 111.441 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.54 -40.0 6.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.132 1.373 . . . . 0.0 110.082 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.01 170.92 13.77 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.25 0.929 . . . . 0.0 111.871 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 20.1 t-105 -170.21 -125.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.973 1.709 . . . . 0.0 108.536 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 6.9 ptt180 -153.65 158.17 40.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.543 2.737 . . . . 0.0 106.589 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -80.33 141.38 35.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.004 0.82 . . . . 0.0 109.151 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.56 162.56 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.11 0.964 . . . . 0.0 111.048 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -51.79 151.12 3.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.814 0.846 . . . . 0.0 110.682 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.58 -40.92 69.28 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -96.47 6.55 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.45 0.7 . . . . 0.0 112.682 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.92 -46.44 15.43 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.339 -1.315 . . . . 0.0 111.633 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.94 -36.03 85.11 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.081 1.854 . . . . 0.0 113.685 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.46 -24.85 33.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 O-C-N 121.15 -0.969 . . . . 0.0 111.435 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.55 -17.25 34.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.396 0.998 . . . . 0.0 111.516 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -83.35 -30.72 27.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.55 1.068 . . . . 0.0 111.602 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.89 162.92 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.56 148.82 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.468 0.707 . . . . 0.0 111.427 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 m -56.93 -29.97 63.58 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.694 1.597 . . . . 0.0 114.848 -169.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -79.28 -43.0 24.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.444 1.02 . . . . 0.0 110.478 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -74.46 -27.37 60.56 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 111.157 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -42.07 -46.62 4.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.415 1.486 . . . . 0.0 111.252 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.39 -43.6 85.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.835 0.743 . . . . 0.0 111.396 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.02 -34.74 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.912 -0.493 . . . . 0.0 110.264 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.81 -31.75 70.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.186 -0.946 . . . . 0.0 110.053 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -58.5 -36.14 73.32 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.632 -1.292 . . . . 0.0 111.058 169.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -63.64 -44.36 94.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.211 1.368 . . . . 0.0 109.368 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.68 -45.87 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.096 0.862 . . . . 0.0 109.764 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.02 -45.3 94.21 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.769 -0.582 . . . . 0.0 109.633 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.85 -40.27 96.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.783 1.233 . . . . 0.0 111.034 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.48 -40.02 77.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.745 1.218 . . . . 0.0 110.601 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.57 -10.32 22.2 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.817 1.044 . . . . 0.0 113.817 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.61 -57.34 10.33 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.768 1.167 . . . . 0.0 111.131 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -80.36 15.84 1.48 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.9 t -110.37 -28.07 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.34 -65.94 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.0 109.146 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.4 mtp -59.26 -29.3 67.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.435 1.094 . . . . 0.0 111.231 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -58.37 -27.79 64.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.135 0.974 . . . . 0.0 113.32 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.54 -40.07 92.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.67 0.788 . . . . 0.0 109.479 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -83.91 -31.07 25.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.276 1.03 . . . . 0.0 110.406 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.147 1.379 . . . . 0.0 111.347 178.327 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.91 152.11 28.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.091 0.957 . . . . 0.0 109.644 171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.49 -30.88 68.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.35 7.7 31.19 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.773 0.829 . . . . 0.0 112.581 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 21.27 30.66 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.283 1.42 . . . . 0.0 113.636 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -101.27 144.68 29.82 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 119.038 1.419 . . . . 0.0 110.191 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.36 123.05 65.13 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-O 116.569 -1.682 . . . . 0.0 106.921 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -69.14 126.98 14.4 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.07 1.846 . . . . 0.0 111.03 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -139.86 159.59 41.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.164 1.786 . . . . 0.0 110.335 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.95 140.71 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 106.783 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.12 123.11 5.55 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.71 112.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.92 83.81 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.13 137.6 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -121.16 124.65 45.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 169.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.51 125.2 27.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 169.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -48.32 -18.62 0.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 116.025 -1.94 . . . . 0.0 115.73 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.3 7.06 1.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.619 1.554 . . . . 0.0 112.642 170.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.94 16.64 32.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.493 1.52 . . . . 0.0 113.702 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -121.18 163.49 18.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.136 0.974 . . . . 0.0 108.509 -168.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -105.99 161.66 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -167.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.53 129.92 42.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.23 1.812 . . . . 0.0 111.054 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -161.52 131.17 4.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.25 145.05 31.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -71.88 127.26 31.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -71.93 129.02 37.57 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -38.81 121.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.767 2.427 . . . . 0.0 111.112 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -1.64 21.43 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.567 1.08 . . . . 0.0 115.372 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -100.18 -24.3 14.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.314 1.557 . . . . 0.0 112.435 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 54.61 35.61 24.04 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.549 1.14 . . . . 0.0 112.142 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -146.98 -179.49 6.85 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.369 1.867 . . . . 0.0 107.348 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -117.08 156.46 27.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.236 0.925 . . . . 0.0 111.565 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -151.76 165.49 34.27 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.209 1.404 . . . . 0.0 109.051 -173.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -109.17 160.86 25.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.513 1.125 . . . . 0.0 112.147 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -74.4 69.84 4.94 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.774 2.983 . . . . 0.0 115.011 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -84.6 145.7 27.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.38 149.79 19.38 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.283 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.89 143.18 29.65 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.404 1.002 . . . . 0.0 111.915 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.91 137.23 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.39 146.07 49.79 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 118.777 0.717 . . . . 0.0 109.509 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -53.26 119.34 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.226 1.951 . . . . 0.0 113.731 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.36 7.56 87.45 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.002 1.286 . . . . 0.0 113.262 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.51 -40.15 64.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 112.444 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . 0.292 20.6 m 68.05 152.06 0.08 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.459 1.504 . . . . 0.0 112.543 -170.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.22 -45.03 72.18 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 125.055 1.342 . . . . 0.0 113.347 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.8 4.02 15.1 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.222 0.919 . . . . 0.0 111.904 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.09 -48.96 3.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.44 91.58 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.695 0.798 . . . . 0.0 112.136 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -58.85 -43.39 90.77 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.213 1.005 . . . . 0.0 109.371 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.03 -20.37 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -76.34 -47.68 22.64 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 109.279 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.1 77.71 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.217 0.917 . . . . 0.0 111.028 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.1 tp -48.06 -45.87 32.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 110.754 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -49.43 18.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.475 1.51 . . . . 0.0 111.689 176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.12 -37.31 87.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.804 1.184 . . . . 0.0 110.34 -170.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -94.31 -43.44 8.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.048 1.339 . . . . 0.0 111.006 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.99 -7.94 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.826 0.85 . . . . 0.0 112.451 -169.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.13 16.83 71.32 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 120.378 -1.451 . . . . 0.0 113.731 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.3 mt -95.26 152.07 18.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m -120.14 -176.69 3.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.883 0.873 . . . . 0.0 109.757 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.19 50.97 0.51 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.142 1.777 . . . . 0.0 112.684 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -164.54 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.666 1.586 . . . . 0.0 112.022 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.39 -6.54 58.9 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.256 1.022 . . . . 0.0 113.723 -168.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' A' ' 102' ' ' LEU . 33.5 m -147.29 170.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 123.875 0.87 . . . . 0.0 109.431 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -141.91 120.48 12.51 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -170.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.42 127.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.38 -35.13 6.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.579 0.752 . . . . 0.0 110.985 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.04 166.5 33.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.219 1.408 . . . . 0.0 108.627 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 163.69 34.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.145 0.978 . . . . 0.0 108.793 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -62.95 150.46 42.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.921 0.782 . . . . 0.0 110.836 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.726 0.411 . . . . 0.0 111.182 -171.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.9 173.69 13.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.496 1.918 . . . . 0.0 107.675 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.417 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 93.5 m95 -58.46 121.07 9.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 110.821 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.86 154.41 33.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 140.34 23.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.25 156.58 46.97 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -95.23 153.28 17.74 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.261 0.553 . . . . 0.0 110.91 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -84.16 150.23 57.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -65.69 156.88 61.61 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.685 2.257 . . . . 0.0 109.282 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -59.39 -30.03 68.14 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -74.85 -20.16 59.87 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.962 0.905 . . . . 0.0 113.238 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 tp -105.35 -22.13 13.1 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.704 1.202 . . . . 0.0 111.4 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.16 132.73 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 168.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -89.78 131.08 35.92 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -100.07 3.06 43.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.839 1.255 . . . . 0.0 109.453 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -98.31 -16.68 19.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 110.869 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -74.66 -36.06 62.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.384 -171.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 38.21 88.31 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 127.867 2.467 . . . . 0.0 112.111 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.77 141.81 21.28 Favored 'Cis proline' 0 C--N 1.356 0.932 0 N-CA-C 115.171 1.181 . . . . 0.0 115.171 10.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.45 124.5 8.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.62 92.62 9.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.5 pt -88.64 -12.01 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.912 -1.042 . . . . 0.0 112.025 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.85 43.4 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 120.483 1.492 . . . . 0.0 113.782 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 114.14 25.19 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 66.0 tttt -86.86 125.03 33.72 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 169.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.91 137.89 33.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -106.85 129.16 54.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -103.28 133.55 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.49 130.37 55.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.68 105.52 17.42 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.6 mm? -103.5 123.62 47.23 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.051 0.94 . . . . 0.0 109.225 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -80.49 138.22 36.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 106.95 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.92 -40.39 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.9 p -92.21 -114.51 0.09 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.9 -169.64 37.36 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.802 0.728 . . . . 0.0 111.911 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.84 -39.1 0.48 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.603 1.961 . . . . 0.0 113.492 171.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.63 69.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.2 -23.19 12.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.045 1.338 . . . . 0.0 111.785 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.06 131.87 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -143.99 77.72 1.56 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 122.348 1.07 . . . . 0.0 109.893 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.7 mtt -64.25 14.08 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.572 1.549 . . . . 0.0 113.244 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -131.29 21.09 4.8 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.648 1.567 . . . . 0.0 111.221 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 t -75.65 -28.04 58.59 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.229 1.012 . . . . 0.0 111.057 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -5.86 52.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.971 1.708 . . . . 0.0 114.519 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.2 m 68.13 -34.22 0.25 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.879 2.872 . . . . 0.0 114.153 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 p -124.04 72.08 54.25 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 169.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.49 -165.6 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.899 3.066 . . . . 0.0 112.027 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -120.48 -12.12 9.0 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.487 1.115 . . . . 0.0 111.893 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -134.59 152.16 51.58 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 120.913 1.688 . . . . 0.0 112.23 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.8 -35.25 5.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.927 1.691 . . . . 0.0 111.766 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -173.09 152.18 15.45 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -94.93 163.14 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.104 1.362 . . . . 0.0 111.354 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -152.92 120.23 5.9 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.889 1.676 . . . . 0.0 106.691 169.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -81.43 70.74 8.35 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.345 1.43 . . . . 0.0 109.247 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.29 156.02 5.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.242 1.417 . . . . 0.0 110.764 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -52.48 153.54 2.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.691 0.796 . . . . 0.0 111.909 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -57.02 152.31 13.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 m95 67.95 -28.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.449 1.9 . . . . 0.0 115.806 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.68 -47.0 98.07 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 121.155 1.798 . . . . 0.0 112.169 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.0 -18.05 62.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.592 1.604 . . . . 0.0 115.507 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.4 t -57.28 -38.11 60.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 120.08 1.309 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -92.64 -19.93 21.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.653 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -72.96 -21.28 60.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 121.297 1.862 . . . . 0.0 111.893 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.7 m -71.82 162.01 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 119.419 1.009 . . . . 0.0 111.034 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -60.6 151.67 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.133 0.973 . . . . 0.0 110.042 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 m -61.63 -29.27 69.95 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -73.87 -26.63 60.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.559 1.072 . . . . 0.0 111.508 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.98 -29.2 25.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.718 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -48.51 -52.13 23.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.566 1.076 . . . . 0.0 112.521 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.2 -41.44 97.05 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.316 0.507 . . . . 0.0 111.221 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -34.75 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.65 -32.8 74.36 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.03 -1.043 . . . . 0.0 110.643 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -57.28 -42.32 81.42 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.061 -1.024 . . . . 0.0 111.07 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.297 18.4 ptp180 -74.64 -34.18 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.908 1.231 . . . . 0.0 110.37 -176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.21 -47.69 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 109.253 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.62 -41.5 88.25 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.583 -0.698 . . . . 0.0 110.953 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -44.17 81.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 111.324 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.09 -27.65 69.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.727 0.411 . . . . 0.0 112.101 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -113.78 -3.97 13.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.57 69.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.71 1.141 . . . . 0.0 111.146 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 m -64.43 -25.79 68.16 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.01 -0.431 . . . . 0.0 111.616 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.17 -40.69 44.16 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.86 -47.04 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.658 0.783 . . . . 0.0 108.978 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.84 -15.8 63.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.929 0.786 . . . . 0.0 111.856 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.3 m -53.34 -38.84 63.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.758 1.163 . . . . 0.0 111.543 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.39 -30.48 71.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -94.44 -21.37 18.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.166 0.986 . . . . 0.0 111.857 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.45 1.1 . . . . 0.0 110.287 170.001 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.7 mm . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.21 148.06 52.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.813 1.245 . . . . 0.0 108.445 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.53 -28.29 53.84 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -79.11 -1.54 36.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.02 30.19 9.08 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.794 1.664 . . . . 0.0 111.825 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 23.2 m-85 -115.19 138.45 50.91 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.618 1.709 . . . . 0.0 110.379 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -81.49 128.44 69.74 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 127.63 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.907 1.738 . . . . 0.0 109.267 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -137.69 163.42 31.34 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.235 1.414 . . . . 0.0 109.963 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.92 135.4 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.709 2.004 . . . . 0.0 105.95 169.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.54 145.59 17.31 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.47 126.03 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 118.805 1.303 . . . . 0.0 107.799 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.65 86.59 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.13 130.45 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.38 121.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 169.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -97.6 40.85 1.14 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.221 1.008 . . . . 0.0 109.327 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 59.8 -70.42 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 130.5 3.52 . . . . 0.0 111.89 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -90.33 -15.58 30.88 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.225 0.953 . . . . 0.0 112.886 -169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.46 42.97 1.49 Allowed Glycine 0 C--N 1.336 0.572 0 CA-C-N 118.366 0.53 . . . . 0.0 113.469 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 57.32 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.168 1.787 . . . . 0.0 114.27 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.69 162.85 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -63.45 134.67 56.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.675 1.99 . . . . 0.0 110.347 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -159.64 134.9 8.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 167.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.2 145.0 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.187 0.595 . . . . 0.0 109.51 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.98 139.78 41.7 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -94.04 125.73 38.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -43.12 131.21 4.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.39 2.676 . . . . 0.0 110.992 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.84 -29.36 1.08 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.991 1.281 . . . . 0.0 113.817 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.35 -36.29 29.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.345 1.058 . . . . 0.0 110.004 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 57.19 31.05 19.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.899 1.68 . . . . 0.0 112.789 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p -150.32 175.28 11.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.089 1.756 . . . . 0.0 107.68 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -76.4 162.08 28.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.866 0.866 . . . . 0.0 112.02 -169.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -144.85 134.55 23.49 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.372 0.606 . . . . 0.0 110.984 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.09 121.93 59.2 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.844 2.057 . . . . 0.0 108.216 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -59.63 135.77 66.42 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.333 2.022 . . . . 0.0 112.689 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.52 145.26 7.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.004 1.321 . . . . 0.0 109.725 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.38 136.11 5.26 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.17 146.49 46.2 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -76.08 129.65 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.08 128.4 87.87 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.737 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -55.57 119.12 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.95 1.767 . . . . 0.0 113.177 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.52 84.21 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.01 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -101.53 119.04 38.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.41 165.35 23.96 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.299 0.639 . . . . 0.0 111.574 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.92 -45.93 60.6 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 125.258 1.423 . . . . 0.0 111.45 -172.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.67 25.41 0.91 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.508 -0.745 . . . . 0.0 110.728 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.06 -46.1 0.78 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.527 1.931 . . . . 0.0 107.091 170.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.83 76.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.882 1.273 . . . . 0.0 111.5 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.37 -44.03 84.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.646 0.778 . . . . 0.0 109.033 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -72.45 -28.61 63.04 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.512 -0.743 . . . . 0.0 112.01 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.76 -46.79 88.08 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.875 -1.14 . . . . 0.0 108.534 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.87 76.43 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.576 -0.703 . . . . 0.0 112.05 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.98 -41.36 78.23 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.36 -49.4 34.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.386 1.475 . . . . 0.0 111.609 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.78 -34.49 75.63 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.208 1.367 . . . . 0.0 112.579 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.9 -57.05 2.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 110.902 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.19 -23.98 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.667 1.187 . . . . 0.0 111.504 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 62.12 5.08 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -135.02 157.75 46.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.875 2.07 . . . . 0.0 106.776 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -121.96 -177.5 3.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.948 0.899 . . . . 0.0 110.811 -169.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -69.51 43.11 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.251 2.621 . . . . 0.0 113.127 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -166.55 -20.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.14 0.976 . . . . 0.0 113.202 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.292 0.496 . . . . 0.0 112.028 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 102' ' ' LEU . 29.1 m -148.41 168.45 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.448 1.099 . . . . 0.0 109.99 -169.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.15 121.68 15.16 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.847 2.059 . . . . 0.0 105.995 -171.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -73.88 129.58 36.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 -32.57 6.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.541 0.737 . . . . 0.0 111.554 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.71 169.86 23.68 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.33 1.052 . . . . 0.0 109.636 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -146.99 160.2 42.65 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.745 1.218 . . . . 0.0 109.592 171.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -65.29 143.95 57.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 109.435 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -66.61 -27.35 67.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -153.52 168.81 24.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.23 1.412 . . . . 0.0 109.459 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -63.25 121.01 12.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.785 0.834 . . . . 0.0 109.471 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.48 153.92 33.04 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 150.19 28.88 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.919 -0.488 . . . . 0.0 110.705 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.19 156.46 43.87 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.972 1.709 . . . . 0.0 106.626 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -90.98 145.71 24.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.889 0.313 . . . . 0.0 110.461 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.7 mt -73.4 141.1 79.83 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -60.87 158.05 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.137 1.892 . . . . 0.0 109.42 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -49.31 -48.01 46.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.17 -14.2 60.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.496 1.118 . . . . 0.0 113.091 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -112.85 -1.41 14.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.099 1.76 . . . . 0.0 111.353 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.5 137.24 23.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-N 120.813 1.642 . . . . 0.0 106.673 169.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -93.37 113.67 25.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.05 -9.13 26.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.101 0.96 . . . . 0.0 111.188 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.06 -25.69 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.039 0.936 . . . . 0.0 110.103 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.4 p -71.57 134.14 46.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -120.17 127.19 26.46 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -58.99 154.93 41.42 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.481 1.207 . . . . 0.0 110.907 -10.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -47.58 129.26 3.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.648 1.579 . . . . 0.0 107.959 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.83 113.85 27.68 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.05 -2.75 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 116.52 -1.705 . . . . 0.0 112.528 -170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -171.39 165.53 38.55 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 122.35 2.341 . . . . 0.0 113.066 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -96.48 120.34 36.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -85.6 120.91 27.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 168.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.26 133.52 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 120.8 1.636 . . . . 0.0 113.376 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -100.79 141.89 33.03 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -112.16 137.71 49.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -110.45 133.69 53.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 tt -88.54 123.35 32.96 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 170.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.4 mm? -117.09 123.99 48.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -81.6 134.04 35.45 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.84 106.66 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.54 -31.04 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.2 p -82.7 -114.16 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.048 0.539 . . . . 0.0 110.07 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.96 166.26 29.55 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.048 1.309 . . . . 0.0 110.445 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.43 -29.03 33.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.823 0.849 . . . . 0.0 112.881 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.25 63.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.271 0.629 . . . . 0.0 112.391 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.38 -23.53 11.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.959 1.703 . . . . 0.0 110.838 -173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -56.47 122.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -89.97 -52.09 5.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.3 mtt 59.78 5.46 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.795 1.638 . . . . 0.0 115.215 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 30.23 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.093 1.77 . . . . 0.0 111.621 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -43.72 69.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.949 1.699 . . . . 0.0 112.079 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.6 -4.47 57.72 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -168.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 66.31 -38.12 0.29 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.774 2.429 . . . . 0.0 113.03 -169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 p -123.32 75.06 52.01 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.871 2.068 . . . . 0.0 105.59 169.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.48 -179.3 4.33 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.182 3.255 . . . . 0.0 111.077 -172.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -100.71 -49.97 4.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.111 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -87.97 154.95 20.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 120.538 1.517 . . . . 0.0 111.521 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -133.47 -27.05 1.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.474 1.51 . . . . 0.0 111.761 -172.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.87 144.21 10.28 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -93.4 154.66 17.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.788 1.235 . . . . 0.0 110.825 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -155.55 109.14 2.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.044 1.338 . . . . 0.0 108.398 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -73.62 137.12 44.02 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.275 -0.891 . . . . 0.0 108.607 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.9 161.11 18.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.808 1.643 . . . . 0.0 108.623 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -53.65 154.43 3.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.31 1.044 . . . . 0.0 110.582 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -56.27 -37.89 70.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.946 0.899 . . . . 0.0 113.263 -168.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -96.73 -3.02 43.23 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.506 -0.746 . . . . 0.0 112.826 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -61.02 -47.64 94.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.734 -1.126 . . . . 0.0 111.709 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.82 -35.71 98.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.593 1.605 . . . . 0.0 112.462 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.63 -33.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 109.877 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -17.67 33.52 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 121.501 -0.75 . . . . 0.0 109.289 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -93.37 -22.91 18.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.135 0.272 . . . . 0.0 111.495 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.75 163.3 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.313 -0.867 . . . . 0.0 112.356 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 m -65.71 153.44 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.268 1.427 . . . . 0.0 110.648 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -57.66 -33.91 68.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.416 1.486 . . . . 0.0 114.361 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -74.76 -26.97 60.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.95 0.796 . . . . 0.0 111.497 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -86.82 -33.35 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -47.23 -48.65 24.17 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.249 1.42 . . . . 0.0 112.288 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.88 -35.22 79.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.735 0.243 . . . . 0.0 111.545 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.2 t -83.47 -33.37 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.227 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.01 -32.89 74.59 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.933 1.242 . . . . 0.0 110.408 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -54.28 -41.98 69.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.03 -1.043 . . . . 0.0 111.416 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -66.48 -44.41 82.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.73 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.64 -49.77 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.3 mmt -64.96 -44.43 89.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.609 0.641 . . . . 0.0 110.325 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -62.07 -37.11 83.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.046 0.839 . . . . 0.0 111.124 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.28 -20.99 58.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.432 0.693 . . . . 0.0 111.532 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.92 -9.03 3.92 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.2 63.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.704 1.593 . . . . 0.0 112.45 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -66.66 -17.98 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.19 -33.18 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.018 1.281 . . . . 0.0 109.827 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.25 -29.91 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.709 -1.244 . . . . 0.0 109.659 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mmt -65.63 -27.14 68.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.456 1.025 . . . . 0.0 110.64 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.4 m -56.07 -39.62 72.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.642 1.11 . . . . 0.0 111.023 172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.0 -52.4 9.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.953 0.901 . . . . 0.0 108.704 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -77.56 -7.64 56.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 124.008 0.923 . . . . 0.0 110.546 169.87 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.35 36.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.452 2.301 . . . . 0.0 111.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.96 -32.93 0.09 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 131.516 3.927 . . . . 0.0 116.66 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.06 13.77 24.09 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.448 1.099 . . . . 0.0 113.153 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 12.33 56.77 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.396 1.474 . . . . 0.0 113.1 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -102.25 138.88 38.6 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.903 1.351 . . . . 0.0 110.24 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -98.66 115.91 65.59 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.041 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.18 123.46 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.387 2.058 . . . . 0.0 110.863 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 95' ' ' GLN . 3.4 p30 -144.19 163.73 32.77 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.616 1.566 . . . . 0.0 108.593 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.24 136.81 59.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 130.82 10.26 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.5 112.88 26.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.32 85.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.31 137.62 24.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -125.11 121.69 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 168.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.95 48.0 1.58 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.496 -0.752 . . . . 0.0 109.169 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 18.0 ptt-85 38.13 23.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.241 3.417 . . . . 0.0 116.894 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.85 7.27 15.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.521 1.128 . . . . 0.0 111.925 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.7 71.08 Favored Glycine 0 N--CA 1.477 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 112.422 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -125.56 150.34 47.56 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.71 1.604 . . . . 0.0 107.049 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.95 165.06 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tpt -57.49 129.32 41.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.589 1.955 . . . . 0.0 111.133 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 7.9 t-105 -160.96 115.89 2.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.51 149.7 50.71 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -76.87 136.63 38.88 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.555 1.542 . . . . 0.0 108.203 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -90.12 128.31 36.3 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.925 0.49 . . . . 0.0 110.342 -169.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.47 135.45 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.096 1.758 . . . . 0.0 110.665 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.79 6.11 76.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.944 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -136.24 -38.89 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.525 1.53 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.28 17.1 m80 60.32 38.08 19.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.762 2.025 . . . . 0.0 112.666 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -133.45 161.01 35.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.206 2.202 . . . . 0.0 106.546 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -76.34 148.98 37.09 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.326 -0.859 . . . . 0.0 112.621 -171.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -148.54 160.72 42.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.515 1.15 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.79 167.15 39.13 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 128.18 2.592 . . . . 0.0 109.072 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.25 -110.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 124.167 3.244 . . . . 0.0 110.721 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 65.82 99.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.597 1.959 . . . . 0.0 112.046 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.79 126.01 6.05 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 144.46 22.18 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.003 1.763 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.32 137.0 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.02 135.87 62.47 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.35 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -58.91 117.53 4.28 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.423 1.415 . . . . 0.0 112.452 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.65 80.09 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.096 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 120.28 35.87 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.25 165.67 21.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.908 0.861 . . . . 0.0 111.455 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.13 -45.05 16.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.728 2.011 . . . . 0.0 115.224 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -44.6 21.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -55.06 -42.98 73.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.89 0.876 . . . . 0.0 110.056 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.09 66.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 112.078 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -62.75 -42.61 99.76 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 81.5 m-85 -68.7 -30.57 69.25 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.179 -1.576 . . . . 0.0 112.78 173.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -58.24 -47.02 84.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.251 0.932 . . . . 0.0 109.131 172.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.89 -44.02 86.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.316 0.646 . . . . 0.0 110.708 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.22 -44.18 64.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 111.034 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -48.28 34.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.75 -1.119 . . . . 0.0 111.809 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.65 -28.19 65.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -93.06 -60.22 1.85 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.095 0.958 . . . . 0.0 110.274 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.66 -17.61 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.769 0.827 . . . . 0.0 111.767 -169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 56.46 23.66 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.9 mt -132.13 157.24 44.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.351 2.261 . . . . 0.0 105.972 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -121.09 -172.93 2.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.793 0.724 . . . . 0.0 110.103 -170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 24.1 mtt180 -73.23 42.05 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.54 1.936 . . . . 0.0 113.271 -171.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -161.75 -23.62 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.88 0.872 . . . . 0.0 112.994 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.82 0.44 52.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.051 0.387 . . . . 0.0 111.86 -168.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HD12 ' A' ' 102' ' ' LEU . 34.9 m -146.7 165.24 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.782 1.233 . . . . 0.0 109.136 -171.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -136.64 121.47 18.67 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.357 1.863 . . . . 0.0 106.232 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.02 128.32 37.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.3 -37.87 6.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.43 168.98 25.78 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.154 0.982 . . . . 0.0 108.627 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -144.89 161.87 38.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -61.69 139.55 58.29 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -65.68 -25.68 67.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.35 175.07 12.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 108.542 169.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -71.61 113.87 9.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.296 0.638 . . . . 0.0 109.912 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.88 155.22 40.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 148.42 28.61 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -140.29 157.23 45.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.753 0.821 . . . . 0.0 108.805 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -94.14 126.87 39.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -68.53 148.04 98.1 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 158.69 56.83 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.641 2.227 . . . . 0.0 109.666 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -60.56 -33.7 73.07 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -77.99 -24.27 48.06 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.048 0.939 . . . . 0.0 113.07 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 tp -90.98 -24.49 20.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.213 0.461 . . . . 0.0 110.629 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.77 137.63 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -41.96 34.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.027 0.531 . . . . 0.0 111.987 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 21.8 m95 59.11 4.19 0.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.036 2.534 . . . . 0.0 113.811 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -99.6 -25.56 14.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -72.84 151.54 41.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 109.324 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -132.93 116.0 14.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.671 1.188 . . . . 0.0 107.941 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -58.35 155.44 37.11 Favored 'Cis proline' 0 CA--C 1.538 0.694 0 CA-C-N 120.177 1.099 . . . . 0.0 111.483 -10.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.71 131.85 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.0 t -91.88 106.83 18.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.3 pt -97.32 -8.35 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.505 0.722 . . . . 0.0 112.173 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.73 169.64 42.41 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.396 0.998 . . . . 0.0 111.764 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 10' ' ' ASN . 11.1 mp0 -110.05 119.33 38.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -80.95 125.49 30.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.75 142.56 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -116.98 128.68 55.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -101.51 147.35 26.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.74 129.45 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -80.14 115.11 19.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -112.54 125.47 54.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.929 0.892 . . . . 0.0 108.838 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.02 134.51 34.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -73.17 122.11 21.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.65 -50.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -128.31 135.44 49.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.15 -155.12 13.52 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 t70 64.55 -61.47 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.149 2.98 . . . . 0.0 111.792 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.26 -35.87 12.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 0.0 110.773 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -89.79 -12.72 38.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.841 0.856 . . . . 0.0 111.598 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.61 116.2 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -97.27 -35.04 10.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.498 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.0 mtt 58.91 -38.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 130.023 3.329 . . . . 0.0 115.532 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -102.56 33.63 3.1 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.898 1.679 . . . . 0.0 110.889 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -69.61 -51.42 35.2 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -74.7 145.2 43.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 m -70.08 -30.28 67.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.217 . . . . 0.0 111.81 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 p -127.23 75.14 77.14 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.177 1.391 . . . . 0.0 107.887 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.52 -175.1 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.709 2.939 . . . . 0.0 110.416 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.72 -29.86 11.25 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 116.695 -1.621 . . . . 0.0 113.366 171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 159.0 17.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 122.051 2.205 . . . . 0.0 112.271 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.91 -6.12 0.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.063 1.345 . . . . 0.0 113.542 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.6 156.88 28.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -119.05 151.65 37.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 111.42 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -145.01 119.49 9.67 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.888 1.675 . . . . 0.0 106.761 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -78.73 140.48 38.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.614 1.097 . . . . 0.0 108.96 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.71 162.43 32.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.799 0.84 . . . . 0.0 110.214 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.2 m -52.21 148.49 6.36 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.012 0.925 . . . . 0.0 109.865 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.45 -38.37 63.5 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -99.58 3.28 45.31 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.27 -44.6 88.98 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.914 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.82 -28.02 85.75 Favored 'Trans proline' 0 C--N 1.352 0.749 0 CA-C-N 122.005 1.752 . . . . 0.0 112.405 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.41 -10.52 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.901 1.28 . . . . 0.0 112.098 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -106.92 -32.12 8.04 Favored 'General case' 0 CA--C 1.526 0.057 0 O-C-N 120.736 -1.228 . . . . 0.0 110.328 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -79.93 -26.69 40.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.031 0.832 . . . . 0.0 112.503 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.05 160.0 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.088 0.858 . . . . 0.0 110.008 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.74 141.45 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.75 1.22 . . . . 0.0 111.623 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 m -56.78 -35.52 68.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.518 1.527 . . . . 0.0 113.867 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -67.97 -33.74 75.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.756 0.707 . . . . 0.0 110.765 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -88.54 -25.12 22.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.92 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -43.48 -46.49 6.87 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 119.935 1.243 . . . . 0.0 112.695 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.58 -49.44 73.36 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.905 0.775 . . . . 0.0 111.49 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.29 -31.3 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 122.002 -0.436 . . . . 0.0 110.3 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -33.54 75.92 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.554 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -64.24 -35.0 79.41 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 120.725 -1.235 . . . . 0.0 110.479 171.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -60.91 -46.45 90.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.6 1.546 . . . . 0.0 109.804 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.92 -48.22 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 118.764 0.711 . . . . 0.0 109.638 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.7 -36.77 84.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.546 -0.721 . . . . 0.0 110.825 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -65.61 -35.66 81.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.673 1.124 . . . . 0.0 110.72 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.78 -25.32 68.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.235 0.614 . . . . 0.0 111.181 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -118.66 -17.66 9.19 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -42.68 -65.18 0.5 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 -169.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -63.81 -25.81 68.34 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.77 -27.13 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.442 -0.786 . . . . 0.0 109.169 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.99 -41.2 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.83 0.852 . . . . 0.0 109.578 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.4 mtt -68.85 -33.31 73.6 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.028 -170.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.3 m -57.34 -31.55 65.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.849 0.75 . . . . 0.0 112.248 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.5 -30.95 71.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.111 0.414 . . . . 0.0 110.328 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -95.5 -44.06 7.69 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.21 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.543 0.692 0 C-N-CA 123.78 0.832 . . . . 0.0 112.131 -177.222 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.97 150.41 45.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.361 1.065 . . . . 0.0 110.013 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.28 -28.16 67.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.56 0.1 35.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.348 0.522 . . . . 0.0 112.167 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.76 32.09 8.27 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.237 1.875 . . . . 0.0 112.06 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 25.3 m-85 -109.76 133.74 52.8 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.556 1.178 . . . . 0.0 110.176 -176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -80.85 129.28 68.49 Favored Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.4 121.65 6.94 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.196 1.931 . . . . 0.0 109.32 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.0 165.42 25.37 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.603 1.161 . . . . 0.0 109.787 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.33 146.22 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 127.051 2.14 . . . . 0.0 106.564 169.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.68 146.63 18.08 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.13 135.5 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.43 89.88 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -68.11 129.52 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.96 137.57 51.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 168.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -104.58 27.2 8.15 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 53.62 19.39 1.76 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.755 1.622 . . . . 0.0 115.179 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -118.33 5.86 11.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 110.707 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.24 80.78 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 120.848 -1.158 . . . . 0.0 112.312 -169.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -121.58 142.99 49.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.734 1.214 . . . . 0.0 107.727 -171.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.21 163.09 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.8 tpt -55.43 136.9 49.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.483 1.913 . . . . 0.0 111.808 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.41 136.5 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.84 144.89 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.47 140.22 48.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.51 119.7 21.46 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -49.94 132.57 22.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.771 2.029 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.3 -31.53 1.6 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.844 1.212 . . . . 0.0 114.027 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -87.07 -30.9 20.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.417 1.109 . . . . 0.0 110.706 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 58.61 35.0 24.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 p -145.19 169.92 17.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.594 1.958 . . . . 0.0 107.009 169.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.57 158.04 24.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.962 1.256 . . . . 0.0 111.84 -170.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -149.52 148.73 29.74 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.155 1.782 . . . . 0.0 107.489 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -80.57 158.96 70.52 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.607 0.639 . . . . 0.0 111.518 171.597 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -64.89 141.94 73.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.559 2.173 . . . . 0.0 112.456 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -167.88 142.49 3.61 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.833 1.653 . . . . 0.0 108.944 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.24 143.5 10.13 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.57 152.62 52.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.554 1.073 . . . . 0.0 110.698 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mt -82.01 137.19 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -80.5 137.94 51.55 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.747 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.02 117.52 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.408 1.405 . . . . 0.0 113.037 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.92 1.67 88.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.003 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.55 120.8 31.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.611 1.206 . . . . 0.0 107.799 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -71.24 162.6 29.16 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.143 0.577 . . . . 0.0 111.241 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.23 -44.96 16.73 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 126.936 2.094 . . . . 0.0 113.447 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.92 -49.22 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.13 -39.8 83.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.524 0.73 . . . . 0.0 110.387 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -35.51 79.99 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.195 0.998 . . . . 0.0 111.974 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -58.64 -46.91 86.1 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -66.38 -30.05 70.35 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.717 1.144 . . . . 0.0 112.659 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -59.37 -46.72 87.88 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.075 -1.016 . . . . 0.0 108.736 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.908 0.483 . . . . 0.0 111.566 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 tp -57.74 -39.63 77.78 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.891 -1.131 . . . . 0.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -72.93 -50.44 23.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.211 1.005 . . . . 0.0 111.297 174.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.59 -30.06 68.73 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.469 1.486 . . . . 0.0 112.075 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -97.67 -47.5 5.59 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.033 0.933 . . . . 0.0 111.576 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.23 -19.78 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.375 0.67 . . . . 0.0 110.975 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.21 35.15 82.41 Favored Glycine 0 CA--C 1.526 0.78 0 O-C-N 121.191 -0.943 . . . . 0.0 110.886 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.01 154.28 27.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.23 1.412 . . . . 0.0 108.296 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -116.52 -175.13 2.7 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.896 0.878 . . . . 0.0 110.365 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -73.74 41.14 0.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.286 1.834 . . . . 0.0 113.294 -169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -163.1 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.627 1.171 . . . . 0.0 112.919 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.26 -0.94 51.81 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.89 0.476 . . . . 0.0 111.809 -169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -148.5 171.38 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.949 1.7 . . . . 0.0 108.63 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -140.8 123.91 16.51 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.75 131.24 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 120.485 1.493 . . . . 0.0 107.932 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.63 -36.73 6.36 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.097 0.559 . . . . 0.0 111.324 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 171.45 19.92 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.465 1.106 . . . . 0.0 109.35 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -144.67 162.98 35.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -65.85 138.83 58.15 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -67.67 -19.7 65.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -146.56 170.38 17.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.222 1.809 . . . . 0.0 108.525 170.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -75.58 125.14 28.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.05 152.79 44.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 140.56 21.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -143.82 161.24 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.065 0.946 . . . . 0.0 108.486 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -101.23 133.0 46.46 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 107.571 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.56 143.06 81.75 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 108.452 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.88 155.83 21.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 0.0 110.471 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.82 -45.23 90.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.794 -1.192 . . . . 0.0 113.113 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.56 -12.73 55.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 112.596 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 0.16 26.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.031 1.732 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.15 135.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -90.96 114.88 27.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -100.19 -3.0 32.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.938 0.774 . . . . 0.0 111.694 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -89.43 -18.24 27.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.764 0.825 . . . . 0.0 110.554 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.49 154.57 21.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.537 1.535 . . . . 0.0 108.212 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -134.87 118.55 13.3 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.506 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.75 153.57 34.17 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 120.095 1.069 . . . . 0.0 110.985 -10.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -54.68 130.26 16.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.4 t -93.09 127.15 38.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.253 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.14 -5.4 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 111.807 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -155.85 161.21 30.53 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 121.192 1.815 . . . . 0.0 113.535 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -112.93 105.96 14.14 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -81.55 129.73 34.78 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 170.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.83 127.22 13.12 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 120.285 1.402 . . . . 0.0 112.843 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -98.9 138.5 35.93 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -107.04 144.96 32.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -116.55 131.63 56.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 114.84 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -111.41 127.93 55.83 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 108.641 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -87.38 134.04 33.63 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD21 ' HA2' ' A' ' 107' ' ' GLY . 55.1 tp -64.44 123.53 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.66 -37.88 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.1 m -88.69 -127.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.35 0.66 . . . . 0.0 109.913 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 177.25 178.63 47.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.837 1.199 . . . . 0.0 112.162 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.86 -30.66 15.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.785 1.634 . . . . 0.0 113.053 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.47 -29.23 67.8 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -98.35 -27.43 14.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.357 1.063 . . . . 0.0 111.212 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 143.68 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.722 1.209 . . . . 0.0 107.759 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.33 -41.58 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.549 0.74 . . . . 0.0 111.317 -170.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.7 mtt 55.51 7.35 0.23 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.14 17.83 5.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.741 1.61 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -31.6 72.73 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.705 2.002 . . . . 0.0 111.615 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -7.77 59.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.692 1.997 . . . . 0.0 113.672 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m 68.15 -35.46 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.305 2.642 . . . . 0.0 114.062 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 p -121.77 71.84 30.32 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.345 1.858 . . . . 0.0 106.398 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.56 -174.09 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.587 2.858 . . . . 0.0 111.958 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.98 -10.69 15.45 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.012 169.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.36 146.07 50.88 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.998 1.726 . . . . 0.0 114.99 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -115.96 114.25 24.38 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.767 3.227 . . . . 0.0 102.864 169.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.12 136.02 28.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.622 0.629 . . . . 0.0 113.157 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -131.67 -112.13 0.24 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.163 1.385 . . . . 0.0 109.946 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -150.08 163.06 39.15 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.776 1.23 . . . . 0.0 110.609 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -84.28 155.19 22.54 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.27 169.04 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 110.091 -169.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.2 m -57.45 151.67 16.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.34 0.591 . . . . 0.0 111.49 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -61.29 154.46 23.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.8 m95 66.36 -30.13 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.308 1.843 . . . . 0.0 115.559 -173.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -54.93 -46.28 99.61 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 120.773 1.624 . . . . 0.0 112.177 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -60.07 -26.65 83.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 121.732 1.654 . . . . 0.0 114.989 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.08 -34.11 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.956 1.253 . . . . 0.0 109.077 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -90.11 -19.0 24.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.945 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -80.33 -30.01 38.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.419 1.009 . . . . 0.0 111.988 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.18 163.13 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-N 118.56 0.618 . . . . 0.0 110.207 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.37 153.65 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.838 0.855 . . . . 0.0 111.603 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 m -54.87 -30.33 57.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.608 1.963 . . . . 0.0 115.594 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -84.31 -37.3 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.424 1.011 . . . . 0.0 111.374 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -70.41 -38.58 74.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.384 -0.822 . . . . 0.0 110.219 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -42.98 -45.71 5.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.599 1.56 . . . . 0.0 110.884 171.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.69 -34.8 78.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -173.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.8 -35.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 0.0 110.162 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.26 -32.2 73.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.825 0.739 . . . . 0.0 110.853 -171.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.38 -38.38 80.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.388 -0.82 . . . . 0.0 111.048 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -69.96 -46.47 65.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.46 -46.15 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.822 0.849 . . . . 0.0 109.3 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.3 mtt -69.59 -40.09 76.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.149 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.89 -40.85 94.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.821 1.191 . . . . 0.0 111.036 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.71 -28.13 68.41 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.132 0.973 . . . . 0.0 110.928 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -111.79 -9.18 14.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.09 0.956 . . . . 0.0 113.405 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.13 -59.61 4.0 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.124 0.97 . . . . 0.0 111.714 -169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 m -67.54 -23.03 65.39 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.878 -0.514 . . . . 0.0 111.518 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.75 -35.82 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.8 t -83.93 -42.07 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.719 0.808 . . . . 0.0 109.174 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.39 -30.6 69.55 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.623 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.6 m -55.41 -29.48 58.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.554 1.07 . . . . 0.0 112.122 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.87 -38.49 73.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.088 0.555 . . . . 0.0 110.443 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -92.25 -16.26 26.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.271 0.628 . . . . 0.0 111.02 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 126.18 1.792 . . . . 0.0 110.205 172.588 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 3.2 mp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.59 146.46 51.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -50.75 -31.81 17.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.05 -3.96 47.82 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.74 32.33 7.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.754 2.121 . . . . 0.0 110.578 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -111.27 146.4 37.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.976 1.388 . . . . 0.0 110.017 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.95 123.93 57.91 Favored Pre-proline 0 N--CA 1.467 0.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -68.97 130.6 20.62 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.348 2.032 . . . . 0.0 111.43 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.48 157.35 45.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.288 1.835 . . . . 0.0 111.837 -170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.4 120.52 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.511 1.925 . . . . 0.0 107.082 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 123.97 8.09 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.78 117.49 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 118.636 1.218 . . . . 0.0 108.722 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.33 85.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -66.74 136.52 26.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 168.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -121.74 121.91 38.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -74.36 125.07 27.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -43.6 -27.45 0.3 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.743 2.017 . . . . 0.0 114.456 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.19 2.87 1.37 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.29 30.42 7.38 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.023 1.296 . . . . 0.0 112.29 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.81 164.54 26.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.18 167.53 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 tpt -53.26 126.31 20.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.818 2.447 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -161.83 128.36 3.77 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.6 148.51 31.19 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.52 136.14 47.39 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.34 125.31 29.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -48.68 127.46 13.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 110.189 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 -24.14 1.77 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.133 1.349 . . . . 0.0 114.461 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.83 -32.28 23.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.389 1.076 . . . . 0.0 110.407 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 58.29 30.71 19.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 112.921 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -148.7 173.38 13.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.234 1.813 . . . . 0.0 107.19 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -75.05 163.26 27.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.316 0.962 . . . . 0.0 113.314 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.83 147.65 27.51 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.591 1.156 . . . . 0.0 108.889 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -61.64 150.98 79.89 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.0 1.72 . . . . 0.0 110.35 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.87 151.48 84.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.135 1.89 . . . . 0.0 110.88 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -173.43 168.18 4.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.205 1.802 . . . . 0.0 109.413 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.78 127.58 1.14 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.0 134.64 27.43 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.86 133.12 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.61 124.74 91.14 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.771 1.228 . . . . 0.0 108.875 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.76 118.42 5.19 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.929 1.753 . . . . 0.0 112.487 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.44 1.72 68.61 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.041 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.52 120.0 40.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 m -69.37 160.76 30.71 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 121.248 0.547 . . . . 0.0 111.09 -174.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.04 -42.14 12.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.767 2.027 . . . . 0.0 113.999 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -74.18 -47.69 33.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.49 -40.02 81.63 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 110.11 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.01 -32.92 72.81 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.309 1.044 . . . . 0.0 112.369 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.401 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.5 tmm? -59.51 -44.82 93.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -67.09 -27.68 67.55 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.748 -1.22 . . . . 0.0 112.649 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -64.75 -44.15 91.04 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.67 -1.269 . . . . 0.0 109.159 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.16 63.4 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 118.453 0.57 . . . . 0.0 110.544 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.99 -43.34 95.24 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 120.951 -1.093 . . . . 0.0 108.999 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -63.67 -57.3 10.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.652 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -25.5 60.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.104 1.774 . . . . 0.0 114.217 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.61 -11.02 12.43 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.927 -1.108 . . . . 0.0 112.654 -169.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.04 -16.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.18 0.992 . . . . 0.0 111.515 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.74 79.03 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 120.221 -1.549 . . . . 0.0 114.243 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -113.47 155.99 24.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.088 1.444 . . . . 0.0 109.104 -171.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -108.7 178.65 4.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.781 1.232 . . . . 0.0 110.227 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -72.77 37.58 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.399 1.88 . . . . 0.0 113.059 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -161.83 -14.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -106.06 18.24 22.35 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.457 1.026 . . . . 0.0 113.177 -168.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.22 175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.459 1.904 . . . . 0.0 109.42 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -140.91 114.39 8.77 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HA ' HD23 ' A' ' 102' ' ' LEU . 41.3 mt -72.94 132.51 33.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.07 -52.4 2.81 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.503 0.502 . . . . 0.0 109.673 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.86 174.19 11.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.57 0.748 . . . . 0.0 111.067 -171.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.5 p -145.82 177.31 9.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.944 1.298 . . . . 0.0 109.001 171.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 6.16 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.98 -16.53 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.014 2.526 . . . . 0.0 115.345 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.4 174.22 12.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.778 2.431 . . . . 0.0 108.674 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -79.16 121.81 25.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.669 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.18 160.95 17.51 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -140.52 141.88 35.27 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 108.838 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -144.83 153.02 41.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 168.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.98 156.19 17.06 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -88.53 141.52 30.44 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 154.77 72.2 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.804 2.336 . . . . 0.0 108.663 170.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -25.56 66.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -169.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.34 -26.6 58.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.124 0.97 . . . . 0.0 112.538 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.2 tp -96.56 -24.03 16.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.89 0.876 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.0 t -48.7 138.03 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.47 -45.36 46.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.493 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.3 m95 57.92 3.63 0.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.212 2.605 . . . . 0.0 114.034 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.95 -17.0 19.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.226 1.41 . . . . 0.0 110.658 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -80.63 143.64 32.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.609 1.564 . . . . 0.0 107.096 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.68 111.88 8.28 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 149.01 20.98 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 119.992 1.033 . . . . 0.0 112.77 -5.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.91 121.08 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.27 108.91 16.81 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.512 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 pt -90.36 -5.4 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.5 161.91 33.59 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -92.88 123.92 36.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -84.35 111.44 19.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 101.955 -3.35 . . . . 0.0 101.955 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.22 139.21 53.52 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.529 1.513 . . . . 0.0 113.162 -173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.55 124.83 52.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 169.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -104.68 143.44 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 61.1 m-85 -118.46 131.01 56.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.5 110.34 19.71 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 102' ' ' LEU . 15.3 mt -102.79 137.57 40.84 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 124.634 1.209 . . . . 0.0 109.422 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -93.35 127.14 38.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.6 112.09 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.2 t -81.25 -37.78 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 p -91.05 -115.3 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.158 0.583 . . . . 0.0 110.889 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.08 175.63 39.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.386 0.994 . . . . 0.0 111.021 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.69 -31.39 57.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.471 1.109 . . . . 0.0 112.321 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.78 65.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -109.66 -22.14 12.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.484 1.114 . . . . 0.0 111.104 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.38 143.24 12.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.0 1.32 . . . . 0.0 107.878 169.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -149.35 78.97 1.39 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.437 0.695 . . . . 0.0 109.404 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 mtt -68.58 16.49 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -116.34 22.97 12.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.438 1.472 . . . . 0.0 111.763 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -38.16 86.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.085 2.154 . . . . 0.0 112.096 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -3.43 50.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.444 1.097 . . . . 0.0 113.802 -169.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.65 -38.69 0.32 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.945 2.498 . . . . 0.0 113.726 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.8 p -126.04 73.01 71.08 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.532 1.933 . . . . 0.0 106.384 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -77.5 -167.41 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.89 3.06 . . . . 0.0 111.121 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.2 -11.32 14.91 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.241 -1.362 . . . . 0.0 112.49 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -135.24 148.41 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 121.703 2.047 . . . . 0.0 114.551 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -116.6 109.31 17.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.457 2.703 . . . . 0.0 103.943 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.13 148.64 32.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.563 1.078 . . . . 0.0 113.928 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -140.67 -119.62 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 0.0 111.333 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 150.19 38.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.134 1.773 . . . . 0.0 109.209 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -82.47 146.21 29.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.731 0.412 . . . . 0.0 110.129 -172.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.92 163.53 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.205 1.002 . . . . 0.0 110.398 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -53.01 154.25 3.02 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 111.382 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -60.81 150.99 30.94 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 64.87 -15.17 0.09 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.03 1.732 . . . . 0.0 115.027 -169.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -60.5 -43.62 93.29 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.706 2.048 . . . . 0.0 111.895 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -58.06 -34.74 98.79 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.712 1.608 . . . . 0.0 112.913 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.9 -51.99 59.75 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -68.97 -22.55 64.1 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.524 -0.735 . . . . 0.0 111.254 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -78.23 -18.32 55.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.65 161.28 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 119.631 1.105 . . . . 0.0 112.491 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.36 146.3 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.321 1.848 . . . . 0.0 112.115 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.1 m -61.83 -30.5 70.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -169.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -69.62 -31.02 68.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.607 1.094 . . . . 0.0 111.018 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -94.18 -32.09 13.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.7 0.8 . . . . 0.0 111.965 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.0 ttp-105 -48.41 -43.6 34.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.081 1.352 . . . . 0.0 113.121 -174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.3 -44.8 95.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.382 0.537 . . . . 0.0 110.867 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.9 t -73.99 -33.52 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.774 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -28.42 67.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.493 1.042 . . . . 0.0 110.437 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -42.9 98.61 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.893 -1.129 . . . . 0.0 109.725 169.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -64.95 -45.02 87.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.65 0.78 . . . . 0.0 110.089 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.7 t -51.27 -53.05 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.248 0.619 . . . . 0.0 109.485 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mtt -69.27 -41.84 76.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.438 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -51.83 -38.31 55.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.389 0.995 . . . . 0.0 111.454 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.46 -18.85 64.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.174 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.36 23.45 1.15 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.525 1.057 . . . . 0.0 113.834 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.26 78.56 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.212 -0.93 . . . . 0.0 110.663 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -60.46 -21.87 62.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.066 0.546 . . . . 0.0 111.707 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.02 -32.71 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.391 0.996 . . . . 0.0 108.373 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.9 t -72.31 -49.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.7 mmt -64.48 -29.52 70.57 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.645 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.5 m -48.82 -34.48 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.028 0.931 . . . . 0.0 112.064 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.22 -30.91 60.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.695 0.398 . . . . 0.0 110.426 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -114.37 -7.85 12.88 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 126.354 1.862 . . . . 0.0 109.004 169.609 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 C--O 1.237 0.436 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 160.42 29.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.284 1.434 . . . . 0.0 109.653 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -24.93 66.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -84.69 -33.88 23.08 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.684 -0.635 . . . . 0.0 111.136 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.03 17.24 0.91 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.323 1.44 . . . . 0.0 112.854 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -84.26 144.44 28.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.455 1.627 . . . . 0.0 109.753 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.413 ' HD2' HD21 ' A' ' 10' ' ' ASN . 1.1 tmt_? -88.73 124.08 66.38 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 170.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.12 131.4 11.89 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.278 1.985 . . . . 0.0 110.207 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.413 HD21 ' HD2' ' A' ' 8' ' ' ARG . 22.7 m-80 -144.09 162.39 36.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.34 1.056 . . . . 0.0 111.414 -173.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.38 143.36 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.693 2.397 . . . . 0.0 106.425 169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.01 126.46 6.32 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.58 138.86 19.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -118.93 89.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 168.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.65 138.64 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 m -126.11 123.84 39.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.93 144.07 32.17 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -66.34 -5.82 12.03 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.34 -11.59 60.54 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.928 0.786 . . . . 0.0 110.487 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.31 37.79 4.21 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 126.032 1.777 . . . . 0.0 112.426 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -138.01 157.89 45.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 108.844 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 m -100.61 161.25 3.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.5 ttt -58.07 132.38 53.33 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.381 1.472 . . . . 0.0 109.823 169.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.15 136.73 14.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.48 141.98 25.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.143 0.577 . . . . 0.0 110.118 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -71.13 140.26 50.54 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -75.39 142.75 43.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -62.18 125.73 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 109.797 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.25 14.31 71.3 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.281 -0.733 . . . . 0.0 114.387 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -148.5 131.97 16.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -87.7 48.7 1.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 111.819 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -153.37 -179.45 7.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.18 1.392 . . . . 0.0 108.906 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -108.53 155.07 21.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 108.408 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -134.9 143.19 46.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.246 0.93 . . . . 0.0 112.881 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -58.7 138.66 86.41 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.885 0.874 . . . . 0.0 109.785 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.77 145.83 81.97 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -169.65 157.84 7.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.748 1.619 . . . . 0.0 111.743 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.74 138.19 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.36 159.09 51.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.516 1.158 . . . . 0.0 111.515 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.1 mt -91.72 146.9 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 108.355 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -89.52 153.45 48.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.525 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.14 117.97 4.78 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.21 86.98 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.987 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.39 125.69 31.33 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.458 1.129 . . . . 0.0 108.333 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.74 157.63 36.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.746 1.218 . . . . 0.0 110.697 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -41.39 71.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.301 1.04 . . . . 0.0 113.244 -168.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -70.82 -47.18 60.79 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -57.46 -41.47 80.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.391 1.476 . . . . 0.0 110.01 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.06 81.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.696 0.68 . . . . 0.0 111.914 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -58.9 -44.94 91.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.934 0.788 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.87 -24.03 66.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.042 1.292 . . . . 0.0 113.405 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -63.75 -52.39 60.64 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.466 1.484 . . . . 0.0 108.949 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -36.16 82.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.562 0.345 . . . . 0.0 111.481 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.5 tp -57.23 -41.31 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 110.196 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.08 -45.88 46.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.288 1.035 . . . . 0.0 111.632 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.61 -36.73 79.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.799 1.181 . . . . 0.0 111.975 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.37 -47.77 7.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.126 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.55 -26.75 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.234 0.613 . . . . 0.0 111.142 -169.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.43 27.39 67.86 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.701 -0.624 . . . . 0.0 112.135 -170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.3 mt -105.05 157.63 17.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.547 1.139 . . . . 0.0 108.634 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -118.37 -174.45 2.67 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.614 1.166 . . . . 0.0 109.969 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.01 34.64 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.834 2.054 . . . . 0.0 114.343 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -159.26 -17.89 0.07 Allowed 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -87.02 -1.52 57.94 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.011 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.52 168.72 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.196 1.398 . . . . 0.0 109.203 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.12 122.48 16.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.0 mt -75.38 131.85 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 120.651 1.569 . . . . 0.0 107.497 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.58 -33.9 7.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.774 0.43 . . . . 0.0 111.671 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.28 168.09 28.41 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.016 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.2 p -146.73 159.53 43.36 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.879 1.272 . . . . 0.0 108.043 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -64.33 134.71 55.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -68.0 -18.36 64.7 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -149.06 165.89 30.35 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.307 1.443 . . . . 0.0 107.974 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -65.66 117.84 8.7 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.61 -53.85 29.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER 62.52 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 129.725 3.21 . . . . 0.0 112.775 -178.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -144.61 156.58 44.19 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.12 129.92 55.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.39 143.59 88.11 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.988 0.915 . . . . 0.0 109.257 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -66.72 154.34 74.82 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.837 2.358 . . . . 0.0 109.215 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -58.93 -31.36 68.59 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.55 -24.12 61.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.84 0.856 . . . . 0.0 112.95 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 tp -104.67 -17.2 14.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.19 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -45.68 136.86 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -72.58 -49.69 30.59 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.8 m95 58.86 3.18 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.139 2.575 . . . . 0.0 114.868 -169.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.59 -23.03 16.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.141 0.976 . . . . 0.0 111.52 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.48 158.63 18.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.338 1.855 . . . . 0.0 110.102 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -132.31 112.0 14.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 108.68 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -59.69 157.02 44.09 Favored 'Cis proline' 0 CA--C 1.537 0.668 0 CA-C-N 120.284 1.137 . . . . 0.0 110.51 -10.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.93 130.21 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.3 t -79.01 117.13 19.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.299 -1.319 . . . . 0.0 107.618 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.24 -2.12 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.283 1.433 . . . . 0.0 111.76 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 159.8 33.09 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 120.207 1.367 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -104.52 106.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.7 127.47 32.83 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 143.95 29.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.115 0.87 . . . . 0.0 111.723 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.19 135.2 55.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -108.71 147.76 31.48 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -121.29 124.96 45.88 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 tp -79.73 110.93 15.54 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.2 mm? -104.5 128.71 52.5 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.9 0.88 . . . . 0.0 109.364 176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -87.72 140.82 29.13 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 168.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -70.91 136.15 48.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.29 -41.31 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.1 m -136.07 136.13 39.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.62 176.61 46.89 Favored Glycine 0 C--N 1.331 0.303 0 O-C-N 121.514 -0.741 . . . . 0.0 113.378 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 t70 61.24 -46.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.719 3.608 . . . . 0.0 114.071 -172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.18 21.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.412 1.085 . . . . 0.0 111.389 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -90.81 -23.77 20.5 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.289 0.636 . . . . 0.0 111.193 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mt -66.12 139.43 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -135.18 -37.32 0.79 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.052 0.541 . . . . 0.0 112.071 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.4 mtt 56.85 17.46 3.27 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -132.91 25.4 4.3 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.621 1.1 . . . . 0.0 111.807 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -28.75 63.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.116 1.766 . . . . 0.0 111.436 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -7.0 57.8 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.254 1.821 . . . . 0.0 113.572 -170.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 67.69 -36.68 0.3 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.304 2.642 . . . . 0.0 113.66 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 p -124.29 75.06 60.63 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.58 -174.05 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.611 2.874 . . . . 0.0 111.238 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -107.57 -8.68 16.1 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.171 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.57 152.46 50.77 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 120.59 1.541 . . . . 0.0 112.43 -172.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -121.83 -31.2 3.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.632 1.573 . . . . 0.0 112.278 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.3 11.88 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -113.23 148.4 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.944 1.298 . . . . 0.0 110.847 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -152.05 129.17 11.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.793 1.237 . . . . 0.0 108.44 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -80.38 143.29 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 165.01 9.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.199 0.6 . . . . 0.0 110.233 -169.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -47.41 140.45 5.71 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -50.0 -41.45 47.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -94.12 -11.34 30.72 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -57.24 -44.99 99.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.428 -171.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.51 -23.89 77.32 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.554 1.503 . . . . 0.0 113.807 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -38.93 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 119.041 0.837 . . . . 0.0 109.605 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -87.71 -19.2 27.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.039 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.88 -27.73 66.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 121.032 1.742 . . . . 0.0 110.224 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.59 154.84 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.89 1.276 . . . . 0.0 110.641 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.66 150.23 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.811 1.245 . . . . 0.0 110.288 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -59.13 -31.58 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -168.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -75.25 -31.1 60.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.864 1.211 . . . . 0.0 110.691 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.98 -25.61 27.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.195 -0.907 . . . . 0.0 112.294 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -48.1 -47.98 34.01 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.372 1.442 . . . . 0.0 110.992 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.78 -43.94 87.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.375 0.534 . . . . 0.0 111.067 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.3 -33.96 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.937 -0.477 . . . . 0.0 110.267 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.79 -32.71 74.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.422 1.01 . . . . 0.0 109.522 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp-105 -59.76 -34.48 73.03 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 120.67 -1.269 . . . . 0.0 111.925 170.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -61.8 -46.55 89.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.281 1.4 . . . . 0.0 109.343 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.85 -52.14 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.2 mmt -60.55 -45.01 95.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -60.07 -38.67 83.54 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.239 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.11 -21.38 64.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.209 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -120.19 -22.82 6.46 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.24 64.09 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-N 119.896 1.226 . . . . 0.0 111.427 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -66.83 -25.95 66.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.071 0.85 . . . . 0.0 111.818 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.66 -37.4 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.1 -39.13 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.417 0.687 . . . . 0.0 110.198 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.5 mmt -72.55 -26.47 61.75 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.028 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.8 m -58.07 -32.92 68.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.621 1.1 . . . . 0.0 111.464 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.32 -29.17 69.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -94.45 -40.49 9.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.692 1.197 . . . . 0.0 109.682 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.962 1.305 . . . . 0.0 111.666 -177.963 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.02 144.32 50.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.672 1.589 . . . . 0.0 107.937 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -47.73 -32.53 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -168.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.74 -3.63 39.14 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.38 28.36 7.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.024 1.773 . . . . 0.0 111.418 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.69 145.38 39.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.125 1.462 . . . . 0.0 110.585 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 122.26 69.03 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 116.588 -1.672 . . . . 0.0 107.194 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.68 126.37 12.63 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.846 1.697 . . . . 0.0 110.111 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -140.37 166.7 23.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.476 1.11 . . . . 0.0 110.633 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.66 148.52 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.567 2.347 . . . . 0.0 106.668 169.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.95 12.1 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -102.57 117.32 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.47 82.25 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -62.62 130.9 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.8 127.39 53.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.75 136.49 32.97 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -66.6 -5.82 12.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.107 1.363 . . . . 0.0 114.317 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -75.41 -7.64 54.59 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.184 0.902 . . . . 0.0 110.496 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 33.7 4.55 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 125.103 1.335 . . . . 0.0 112.276 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -134.29 161.25 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.858 0.863 . . . . 0.0 109.131 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.49 162.61 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.727 0.811 . . . . 0.0 113.155 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.9 tpt -51.74 131.67 30.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.097 2.159 . . . . 0.0 112.085 171.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -161.91 143.88 11.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 167.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.09 143.98 21.84 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -78.07 145.89 35.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -77.9 125.1 28.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.59 140.69 57.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.153 1.381 . . . . 0.0 109.713 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 -40.92 1.73 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.512 1.053 . . . . 0.0 113.524 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.23 -31.95 24.75 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.499 1.149 . . . . 0.0 110.616 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.47 39.44 31.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.592 1.557 . . . . 0.0 112.402 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -135.2 173.87 11.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.591 1.956 . . . . 0.0 107.163 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -80.52 160.53 25.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.603 1.092 . . . . 0.0 111.77 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -151.39 146.88 26.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.675 1.19 . . . . 0.0 109.025 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.81 136.11 51.55 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.963 0.905 . . . . 0.0 110.731 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -65.41 141.28 67.24 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.602 2.201 . . . . 0.0 111.817 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -177.92 150.76 0.64 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.067 2.547 . . . . 0.0 106.337 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.84 142.75 9.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.02 154.62 53.42 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 118.323 1.061 . . . . 0.0 111.34 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.7 127.76 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -67.47 125.55 91.32 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 117.684 -1.15 . . . . 0.0 108.841 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.67 117.97 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.92 1.747 . . . . 0.0 112.803 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.08 0.42 77.52 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.404 1.478 . . . . 0.0 112.923 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -93.82 127.71 39.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.13 160.18 31.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.536 1.135 . . . . 0.0 110.811 -177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.9 64.06 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.063 1.345 . . . . 0.0 113.146 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -71.21 -48.57 50.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -59.13 -38.22 79.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.536 1.534 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.8 68.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.91 1.284 . . . . 0.0 111.738 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.457 ' HG3' ' CD1' ' A' ' 100' ' ' PHE . 18.2 tmm? -60.64 -43.06 98.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.54 -32.71 74.24 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.246 -0.908 . . . . 0.0 112.213 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -60.67 -46.57 89.83 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.848 -1.157 . . . . 0.0 109.517 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.6 67.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.802 0.728 . . . . 0.0 111.705 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -61.31 -40.84 95.66 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.037 -1.04 . . . . 0.0 108.531 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.85 -55.87 6.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.575 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.6 -38.22 83.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.947 1.703 . . . . 0.0 111.225 -170.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -94.66 -37.96 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.323 0.51 . . . . 0.0 112.041 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -109.63 -20.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.267 0.627 . . . . 0.0 110.668 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.55 48.46 56.72 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.499 -1.376 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 mt -127.68 156.12 42.87 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.831 1.652 . . . . 0.0 107.817 171.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -114.07 -177.16 3.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.142 0.977 . . . . 0.0 110.285 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -73.75 38.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.273 1.829 . . . . 0.0 113.14 -170.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -157.98 -18.69 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.987 1.315 . . . . 0.0 113.202 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -86.03 -2.01 57.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.993 0.517 . . . . 0.0 112.082 -169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HB ' HD12 ' A' ' 102' ' ' LEU . 27.5 m -149.14 168.02 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.13 -170.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -137.51 121.4 17.64 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.51 126.55 35.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.87 -32.58 7.86 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.208 0.317 . . . . 0.0 111.271 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.81 162.06 39.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.506 1.122 . . . . 0.0 108.555 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 m -139.86 157.47 45.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -58.89 137.21 57.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.146 0.885 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -61.52 -31.34 71.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.771 0.429 . . . . 0.0 111.453 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -151.65 173.07 15.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.216 1.806 . . . . 0.0 106.754 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -60.08 125.19 22.72 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 109.471 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.98 50.11 1.91 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 127.52 2.328 . . . . 0.0 107.451 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 146.46 47.67 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -169.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -145.52 142.77 29.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.641 0.588 . . . . 0.0 110.199 -170.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -100.18 133.2 44.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.601 1.16 . . . . 0.0 108.536 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.7 148.83 73.55 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 124.428 1.091 . . . . 0.0 111.016 -174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 154.42 74.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.756 2.304 . . . . 0.0 109.265 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -53.59 -31.55 47.37 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -72.04 -32.01 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.519 1.127 . . . . 0.0 111.905 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.52 -24.11 18.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.975 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -58.05 130.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.19 -43.62 41.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.094 0.557 . . . . 0.0 112.361 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 24.8 m95 59.69 4.64 0.58 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 127.382 2.273 . . . . 0.0 113.432 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.78 -21.51 15.15 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.209 1.404 . . . . 0.0 111.066 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -73.78 147.09 43.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.455 1.502 . . . . 0.0 108.651 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -134.84 116.55 12.56 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.44 149.16 31.02 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.952 1.019 . . . . 0.0 111.161 -10.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.39 131.61 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.3 106.69 18.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.0 pt -102.06 -6.14 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.002 0.921 . . . . 0.0 112.409 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.7 163.71 37.22 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 120.232 1.378 . . . . 0.0 113.172 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.5 115.67 27.81 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -85.64 120.22 26.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 101.211 -3.626 . . . . 0.0 101.211 168.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -146.38 138.03 24.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.662 1.119 . . . . 0.0 111.435 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.21 122.67 45.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -98.91 141.34 31.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 50' ' ' MET . 58.5 m-85 -118.84 128.72 54.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 tt -82.59 121.22 26.53 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.443 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.5 mm? -113.47 122.05 46.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.667 -1.151 . . . . 0.0 107.991 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -80.85 133.89 35.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 tp -67.12 136.68 55.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -115.92 -38.15 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m -89.52 -130.5 0.08 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.486 0.714 . . . . 0.0 109.781 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.73 177.1 46.94 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 120.001 1.273 . . . . 0.0 111.914 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -52.67 -31.3 36.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.322 1.449 . . . . 0.0 112.554 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.88 -27.04 66.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -97.16 -28.28 14.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.167 0.987 . . . . 0.0 110.894 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.63 147.04 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.53 1.132 . . . . 0.0 108.025 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -127.17 -50.63 1.43 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.351 0.66 . . . . 0.0 109.684 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 mtt 63.33 -8.26 0.15 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.486 1.914 . . . . 0.0 115.179 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -109.54 24.53 12.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 121.248 1.84 . . . . 0.0 111.616 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -24.9 63.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.303 1.841 . . . . 0.0 112.19 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -6.69 59.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.981 1.713 . . . . 0.0 113.901 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.2 m 68.86 -34.02 0.26 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.387 2.675 . . . . 0.0 114.111 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.11 71.65 63.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.64 -170.21 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.525 2.816 . . . . 0.0 113.561 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -110.53 -42.56 4.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.252 1.021 . . . . 0.0 109.749 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.66 152.47 28.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.521 1.055 . . . . 0.0 113.568 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.16 14.36 13.96 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.473 1.509 . . . . 0.0 112.168 171.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.61 171.44 46.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.01 1.29 . . . . 0.0 113.348 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -164.65 -116.43 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.82 1.248 . . . . 0.0 109.741 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.8 mtp85 -145.81 160.81 41.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.267 3.027 . . . . 0.0 107.51 -170.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -85.77 132.95 34.03 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.51 168.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 110.793 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.4 m -52.7 147.24 8.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.729 0.695 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -52.46 -40.66 62.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -168.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -95.32 -3.73 46.78 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.71 -43.19 82.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.495 1.043 . . . . 0.0 111.765 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.2 -26.41 82.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.535 1.584 . . . . 0.0 113.085 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -12.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 O-C-N 121.435 -0.791 . . . . 0.0 111.374 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -35.73 7.66 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.808 1.186 . . . . 0.0 109.284 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -68.52 -26.54 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.733 1.151 . . . . 0.0 112.297 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.08 159.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 118.885 0.766 . . . . 0.0 110.459 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.3 149.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.574 0.75 . . . . 0.0 111.43 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 m -51.09 -39.01 55.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.035 1.734 . . . . 0.0 114.064 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.37 -40.3 58.22 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.735 0.698 . . . . 0.0 110.222 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -66.53 -32.76 74.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.212 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -44.97 -48.83 11.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.705 1.139 . . . . 0.0 110.789 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.94 -34.74 78.82 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.73 -38.42 19.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.948 -0.47 . . . . 0.0 109.955 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -33.18 75.41 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.961 -0.462 . . . . 0.0 109.837 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -56.22 -40.3 73.85 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.314 -1.327 . . . . 0.0 110.967 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.07 -45.02 90.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.838 1.654 . . . . 0.0 109.155 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.69 -41.68 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.8 mtt -72.0 -39.54 69.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.542 -0.724 . . . . 0.0 110.658 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.69 -37.13 86.18 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.45 -28.34 66.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.093 0.957 . . . . 0.0 111.466 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -122.98 2.68 9.36 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.67 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.414 1.461 . . . . 0.0 111.576 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 p -66.01 -23.03 66.49 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 t -69.39 -39.91 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.69 1.132 . . . . 0.0 108.841 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.02 -44.2 28.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mtt -66.08 -32.77 74.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.568 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.1 m -61.16 -22.13 64.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.521 1.055 . . . . 0.0 112.761 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.25 -21.57 39.35 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 111.546 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -109.53 -37.67 5.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.613 1.165 . . . . 0.0 109.93 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 126.733 2.013 . . . . 0.0 109.486 171.514 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.25 -44.88 71.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.132 0.573 . . . . 0.0 111.833 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -152.05 -80.73 0.1 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.69 0.796 . . . . 0.0 110.83 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.76 -47.48 8.6 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.06 12.64 0.05 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.644 -0.531 . . . . 0.0 114.123 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -96.72 130.67 43.92 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.498 1.149 . . . . 0.0 108.655 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -88.02 127.51 57.33 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.62 135.98 24.95 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.719 1.612 . . . . 0.0 109.92 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -140.65 153.47 46.02 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.709 1.604 . . . . 0.0 111.446 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.69 135.16 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.909 2.084 . . . . 0.0 105.533 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.69 125.92 6.69 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mm -95.49 110.33 24.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.59 86.14 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.68 129.97 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 155' ' ' VAL . 44.2 t -106.22 135.3 47.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 168.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.81 25.66 4.53 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 54.42 -2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.251 2.22 . . . . 0.0 116.726 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -95.58 14.8 21.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.043 0.838 . . . . 0.0 111.697 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.6 9.48 84.65 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 124.564 1.078 . . . . 0.0 113.112 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -125.45 172.9 9.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.441 1.12 . . . . 0.0 108.875 -169.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.18 170.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.3 tpt -53.13 136.22 36.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.5 2.32 . . . . 0.0 113.72 -170.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -163.1 135.6 5.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.813 1.245 . . . . 0.0 108.166 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.82 158.23 40.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.401 1.48 . . . . 0.0 109.104 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -93.05 130.79 38.53 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -78.92 123.35 27.18 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.887 0.875 . . . . 0.0 109.173 -169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -53.75 134.16 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.267 2.227 . . . . 0.0 110.222 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 -16.88 1.92 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.939 1.257 . . . . 0.0 114.773 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -105.75 -30.8 9.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 110.33 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 58.87 39.65 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.76 1.624 . . . . 0.0 112.791 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 p -140.53 171.29 14.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.712 1.605 . . . . 0.0 108.298 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -79.24 157.59 27.76 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.01 157.29 19.08 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.186 2.194 . . . . 0.0 113.742 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.83 96.47 5.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 168.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 146.25 89.69 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.307 1.338 . . . . 0.0 111.695 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 156.5 149.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.628 3.171 . . . . 0.0 108.231 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.03 143.87 14.64 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.61 144.34 35.35 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.7 mt -73.53 141.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.87 141.53 38.18 Favored Pre-proline 0 N--CA 1.465 0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.368 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -59.34 116.31 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.088 1.859 . . . . 0.0 111.971 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.43 2.39 87.42 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.056 1.312 . . . . 0.0 112.916 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -86.21 128.26 34.87 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.515 1.158 . . . . 0.0 107.996 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.52 157.42 38.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.488 1.115 . . . . 0.0 110.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.8 63.71 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.364 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 1.5 mp0 -64.12 -49.49 71.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -57.47 -36.22 71.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.169 1.388 . . . . 0.0 109.608 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.24 -35.17 66.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.645 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 47' ' ' GLU . 30.6 mtp -56.54 -47.22 79.87 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.369 1.44 . . . . 0.0 109.189 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.76 -26.57 67.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -65.87 -53.07 44.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.843 0.747 . . . . 0.0 109.549 170.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.63 82.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.113 0.87 . . . . 0.0 111.474 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 tp -56.33 -41.78 76.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.528 1.531 . . . . 0.0 110.345 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -44.13 56.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.57 1.148 . . . . 0.0 111.105 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.46 -37.79 83.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.291 0.95 . . . . 0.0 111.826 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.03 -75.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.017 0.927 . . . . 0.0 109.987 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.84 -6.59 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.76 49.78 61.97 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 mt -120.34 156.94 30.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.647 1.579 . . . . 0.0 107.111 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.5 m -112.68 173.63 6.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.158 0.983 . . . . 0.0 109.444 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.97 43.42 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.104 2.162 . . . . 0.0 114.508 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.66 -18.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.102 1.761 . . . . 0.0 112.171 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -88.99 -0.07 57.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.842 0.857 . . . . 0.0 111.71 -172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.37 169.96 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.862 1.265 . . . . 0.0 109.365 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -142.3 129.16 20.6 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 mt -81.34 127.85 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.124 1.329 . . . . 0.0 108.719 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.9 -35.37 6.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.716 0.807 . . . . 0.0 111.898 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.24 165.88 35.07 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.689 0.795 . . . . 0.0 109.848 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.5 p -144.92 160.06 41.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.251 1.02 . . . . 0.0 109.511 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 p -64.94 137.18 57.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -64.75 -25.27 67.85 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -151.16 170.21 19.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.971 1.309 . . . . 0.0 108.667 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -65.99 123.56 20.18 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.227 0.611 . . . . 0.0 109.467 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.43 167.8 19.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.62 154.67 33.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -139.26 162.94 33.77 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -103.82 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.3 mt -69.12 140.59 90.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 151.88 64.65 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.319 2.679 . . . . 0.0 109.294 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -65.5 -21.05 66.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -169.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.67 -27.83 61.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.954 0.901 . . . . 0.0 112.332 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.7 tp -94.46 -26.25 16.55 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.614 0.766 . . . . 0.0 110.929 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.35 136.8 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -42.47 42.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.523 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m95 61.81 3.38 0.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.164 2.185 . . . . 0.0 113.718 -169.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -16.69 18.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.245 1.418 . . . . 0.0 111.028 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -76.94 144.26 38.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.983 1.713 . . . . 0.0 107.259 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.79 116.41 9.0 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.468 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.31 150.96 22.04 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.105 1.073 . . . . 0.0 111.927 -10.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 m -57.72 129.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.8 t -88.82 107.37 18.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -111.65 -5.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.6 1.16 . . . . 0.0 112.257 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 168.76 41.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.128 0.876 . . . . 0.0 112.188 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -103.76 107.88 18.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -71.76 121.54 19.09 Favored 'General case' 0 N--CA 1.471 0.617 1 N-CA-C 100.185 -4.006 . . . . 0.0 100.185 167.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.89 132.9 33.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.621 1.555 . . . . 0.0 112.783 -168.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -112.37 128.11 56.2 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -104.25 147.14 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.68 130.05 48.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.2 tp -77.84 111.61 13.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -106.24 126.99 52.9 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -82.58 134.98 35.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.69 104.65 4.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.87 -33.9 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.8 p -83.6 -119.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.821 0.448 . . . . 0.0 109.848 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.8 174.37 42.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.998 1.285 . . . . 0.0 110.675 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -28.9 15.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.686 1.194 . . . . 0.0 113.012 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.423 0.556 . . . . 0.0 112.082 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.61 -22.04 13.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.551 1.141 . . . . 0.0 111.691 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.6 mt -62.38 102.99 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -92.47 -30.88 15.49 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.168 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.0 mtt 60.84 -44.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 130.093 3.357 . . . . 0.0 114.784 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.27 34.46 1.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.352 1.861 . . . . 0.0 110.469 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -71.21 -49.5 42.84 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -68.55 148.82 49.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -75.72 -27.06 58.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.936 1.695 . . . . 0.0 112.228 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 p -120.74 69.73 17.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.675 1.99 . . . . 0.0 106.58 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.62 -174.67 1.94 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.273 3.315 . . . . 0.0 111.292 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -116.2 -18.24 10.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.386 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.14 150.18 52.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 121.935 2.152 . . . . 0.0 112.067 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.08 -28.9 4.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.708 1.203 . . . . 0.0 112.492 -170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.44 150.41 20.02 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -96.73 156.88 16.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.945 1.298 . . . . 0.0 110.194 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -153.01 103.54 2.75 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -71.57 133.37 45.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.052 1.296 . . . . 0.0 108.658 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 153.8 27.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.909 1.284 . . . . 0.0 108.15 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.5 m -58.48 158.54 7.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.62 0.768 . . . . 0.0 112.672 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.18 151.02 13.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.2 m95 67.1 -23.41 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.171 1.788 . . . . 0.0 115.561 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.0 -47.56 95.08 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 121.059 1.754 . . . . 0.0 111.259 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.82 -32.92 86.58 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.875 1.717 . . . . 0.0 113.234 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.95 -33.02 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.512 0.725 . . . . 0.0 110.35 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -85.92 -26.63 25.45 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.166 0.894 . . . . 0.0 111.744 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -80.53 -27.6 37.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.773 0.715 . . . . 0.0 112.191 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.55 158.78 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.164 0.893 . . . . 0.0 110.097 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.29 148.51 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.215 1.006 . . . . 0.0 111.466 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 m -57.6 -35.67 70.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.956 1.302 . . . . 0.0 113.767 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -71.88 -25.41 61.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.178 0.899 . . . . 0.0 111.635 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -86.75 -40.82 14.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.775 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.27 -51.66 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 112.977 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -66.3 -33.07 74.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.463 0.574 . . . . 0.0 112.397 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.83 -35.24 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.349 0.66 . . . . 0.0 110.193 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.34 -31.98 73.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.532 1.06 . . . . 0.0 110.608 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -55.84 -40.87 73.44 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.368 -0.832 . . . . 0.0 110.559 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -64.36 -45.26 88.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 109.504 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.71 -47.19 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 mtt -66.32 -38.13 86.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.956 -0.465 . . . . 0.0 110.744 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.17 -37.9 89.05 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.021 -1.049 . . . . 0.0 110.286 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.11 -29.81 70.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 111.238 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -115.64 -13.97 11.47 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.79 39.84 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.322 1.419 . . . . 0.0 111.702 -169.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.4 m -64.02 -24.5 67.73 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.022 -0.424 . . . . 0.0 111.612 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.11 -40.95 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.437 HG13 ' SG ' ' A' ' 16' ' ' CYS . 39.8 t -68.63 -45.46 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.486 0.714 . . . . 0.0 110.238 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -71.04 -20.35 62.39 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.039 0.836 . . . . 0.0 111.491 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -59.48 -30.55 68.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.461 1.028 . . . . 0.0 111.824 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.45 -41.1 85.27 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.22 -29.83 22.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.928 -173.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.006 1.322 . . . . 0.0 111.441 178.219 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 mm . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.26 140.03 50.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.276 1.43 . . . . 0.0 108.198 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -31.94 -49.95 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.754 2.422 . . . . 0.0 116.577 -168.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -83.97 8.67 14.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.46 35.04 4.24 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.386 1.47 . . . . 0.0 112.258 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -115.61 143.76 44.88 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.613 1.206 . . . . 0.0 112.295 -171.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -82.85 115.86 60.92 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-O 117.435 -1.269 . . . . 0.0 107.817 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 125.29 7.13 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.119 1.88 . . . . 0.0 109.808 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.17 174.35 15.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.374 1.069 . . . . 0.0 109.919 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 50' ' ' MET . 31.4 m -119.94 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.92 9.04 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.33 128.01 38.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.085 0.943 . . . . 0.0 108.746 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.94 88.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.9 mm -67.57 137.21 25.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 168.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -125.57 120.21 30.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -78.14 138.9 38.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -65.22 -7.09 11.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.42 -11.27 60.61 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.125 0.875 . . . . 0.0 110.516 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.67 34.83 4.54 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.378 1.942 . . . . 0.0 112.225 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -131.9 148.01 52.51 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 m -104.98 162.89 4.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.9 tpt -56.39 130.06 43.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.097 1.759 . . . . 0.0 110.376 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -161.73 127.42 3.62 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.33 144.3 32.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -73.06 135.9 44.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -77.61 128.64 34.46 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.96 128.57 16.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.912 2.085 . . . . 0.0 110.44 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.32 -33.19 1.55 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.191 1.376 . . . . 0.0 114.067 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -37.14 21.92 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.415 1.108 . . . . 0.0 109.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.259 14.8 m170 59.21 33.12 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.657 1.583 . . . . 0.0 113.096 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -139.12 162.98 33.62 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.356 2.262 . . . . 0.0 105.805 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -74.19 164.86 26.1 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.405 1.002 . . . . 0.0 113.203 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -151.44 142.8 23.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.641 1.576 . . . . 0.0 108.474 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -73.14 144.94 85.35 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.587 0.755 . . . . 0.0 110.017 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.66 144.73 97.65 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.371 1.381 . . . . 0.0 112.435 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -172.79 138.09 0.8 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.518 2.327 . . . . 0.0 108.505 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.41 -114.09 3.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.272 0.939 . . . . 0.0 110.969 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.81 165.11 35.05 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 128.006 2.717 . . . . 0.0 107.443 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.89 135.08 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -84.44 158.23 60.66 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 119.011 -0.518 . . . . 0.0 109.855 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.7 117.21 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.817 1.678 . . . . 0.0 112.275 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.16 9.24 85.58 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.839 1.209 . . . . 0.0 112.909 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.05 125.19 29.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.361 1.08 . . . . 0.0 108.717 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 159.58 34.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.472 1.109 . . . . 0.0 110.815 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.68 68.76 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.703 1.201 . . . . 0.0 113.436 -169.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.17 -43.42 64.61 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.79 -44.21 97.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.493 1.117 . . . . 0.0 108.886 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.73 71.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.417 1.087 . . . . 0.0 112.292 172.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HA ' HG21 ' A' ' 11' ' ' VAL . 15.6 tmm? -65.98 -43.09 88.84 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.211 0.914 . . . . 0.0 109.739 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -65.55 -25.48 67.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.211 1.369 . . . . 0.0 111.727 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.96 -49.61 64.89 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 120.063 1.301 . . . . 0.0 108.64 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.69 83.18 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.82 0.819 . . . . 0.0 110.239 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.45 -40.93 88.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.204 1.401 . . . . 0.0 109.646 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.17 -47.72 55.99 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.17 0.988 . . . . 0.0 111.196 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.44 -35.33 80.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.894 1.679 . . . . 0.0 112.053 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.32 -39.6 9.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.722 0.809 . . . . 0.0 110.422 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -17.35 7.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 111.01 -169.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.08 43.42 99.45 Favored Glycine 0 N--CA 1.451 -0.31 0 O-C-N 120.567 -1.333 . . . . 0.0 110.918 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -117.28 159.32 22.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.638 1.175 . . . . 0.0 108.183 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -122.36 -177.49 3.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.823 1.249 . . . . 0.0 110.271 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -67.93 40.42 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.177 2.591 . . . . 0.0 114.694 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -164.68 -22.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.343 1.057 . . . . 0.0 112.655 -169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.99 -3.92 58.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.446 0.698 . . . . 0.0 112.298 -169.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.4 168.97 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.921 1.288 . . . . 0.0 109.72 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -135.74 119.48 17.22 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 mt -75.76 131.79 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 120.069 1.304 . . . . 0.0 107.738 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.63 -50.72 3.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.262 0.483 . . . . 0.0 110.24 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.39 168.36 20.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.774 0.83 . . . . 0.0 110.618 -170.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.0 p -150.81 161.23 43.06 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.136 1.375 . . . . 0.0 108.23 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -62.49 146.29 52.03 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.936 0.789 . . . . 0.0 109.991 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.6 mtt-85 -64.62 -30.18 71.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.044 0.538 . . . . 0.0 111.523 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.56 172.18 13.96 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.691 1.596 . . . . 0.0 107.546 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -61.11 125.19 22.82 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.63 147.39 39.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -118.71 123.73 45.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.85 126.01 48.65 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.064 -0.969 . . . . 0.0 108.528 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -102.42 112.47 25.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.39 148.9 98.2 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.359 1.063 . . . . 0.0 110.738 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -66.96 151.57 81.9 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 108.333 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -25.25 66.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -74.81 -26.39 59.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.217 1.007 . . . . 0.0 112.432 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.05 -21.12 16.36 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.765 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.4 t -46.59 140.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 168.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -73.82 -44.88 54.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.8 m95 57.17 8.74 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.215 2.206 . . . . 0.0 114.719 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -120.84 -16.62 8.11 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.184 0.994 . . . . 0.0 112.649 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 p -75.08 -36.2 61.78 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 49.32 93.36 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 127.654 2.382 . . . . 0.0 112.271 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.54 147.68 73.09 Favored 'Cis proline' 0 C--N 1.352 0.728 0 CA-C-N 119.774 0.955 . . . . 0.0 111.315 6.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.53 129.36 27.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.1 t -91.87 112.56 24.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.57 -5.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 124.529 1.132 . . . . 0.0 111.808 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.64 43.06 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.818 1.19 . . . . 0.0 115.217 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -106.46 126.75 52.64 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 124.817 1.247 . . . . 0.0 107.739 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -91.64 116.22 28.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.53 108.86 6.12 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.606 0.567 . . . . 0.0 111.208 -168.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -93.44 128.96 39.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 168.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -95.72 135.28 37.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.47 128.43 56.33 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -87.84 109.79 20.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mm? -107.96 124.45 50.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.229 1.012 . . . . 0.0 109.899 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.19 131.66 34.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.88 135.69 51.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.44 -28.14 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.0 p -88.21 -126.81 0.05 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.211 1.004 . . . . 0.0 110.411 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.93 166.48 35.54 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.21 1.386 . . . . 0.0 110.026 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.24 -30.88 18.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.493 1.117 . . . . 0.0 112.773 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.48 65.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.079 0.552 . . . . 0.0 112.295 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -95.96 -31.83 12.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.775 1.23 . . . . 0.0 110.726 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.38 142.63 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.207 1.403 . . . . 0.0 108.177 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.59 -51.33 1.84 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.7 mtt 63.71 -18.42 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.42 1.888 . . . . 0.0 115.337 -171.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.36 25.33 7.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.836 2.107 . . . . 0.0 112.042 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -35.33 77.13 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.935 2.494 . . . . 0.0 111.698 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -3.58 55.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 113.471 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 m 65.98 -35.98 0.23 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.95 2.5 . . . . 0.0 114.126 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 p -125.95 68.15 62.86 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.739 2.016 . . . . 0.0 106.287 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.19 -172.59 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.017 3.145 . . . . 0.0 111.507 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.43 -17.84 13.89 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.306 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -129.25 146.47 51.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 121.915 2.143 . . . . 0.0 111.842 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.42 -49.04 3.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.382 0.673 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.51 153.25 6.22 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 123.38 0.514 . . . . 0.0 111.836 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 30.6 t-105 -156.41 -130.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.802 1.241 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -152.94 155.22 36.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.806 2.842 . . . . 0.0 106.942 -169.272 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.4 143.15 37.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 0.85 . . . . 0.0 110.285 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.5 164.76 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.039 0.936 . . . . 0.0 110.52 -169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.25 147.98 5.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.735 0.814 . . . . 0.0 110.011 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -54.14 -40.73 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -93.14 2.76 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.64 -47.82 75.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 120.767 -1.208 . . . . 0.0 111.126 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -64.97 -32.77 53.57 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.913 1.719 . . . . 0.0 112.886 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.65 -33.4 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 119.784 1.174 . . . . 0.0 109.931 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.43 -41.95 75.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.835 1.198 . . . . 0.0 110.063 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -83.83 -18.77 36.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.21 160.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.601 1.091 . . . . 0.0 109.714 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.4 m -51.69 143.59 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.649 1.18 . . . . 0.0 111.576 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.8 m -59.89 -30.97 69.37 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -69.96 -47.18 63.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.144 0.884 . . . . 0.0 109.696 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -75.84 -27.41 57.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.553 -174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -40.2 -49.27 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.556 1.142 . . . . 0.0 112.887 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.88 -38.56 91.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.47 0.577 . . . . 0.0 111.797 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.13 -34.31 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 O-C-N 121.751 -0.593 . . . . 0.0 110.009 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -31.34 72.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.132 0.878 . . . . 0.0 109.97 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -55.65 -36.67 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.231 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -61.67 -51.2 69.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.907 1.23 . . . . 0.0 108.764 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -54.78 -48.05 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.2 mtt -69.53 -41.12 76.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.229 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -58.86 -41.54 87.27 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.953 0.797 . . . . 0.0 110.128 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.63 -33.6 74.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.764 0.426 . . . . 0.0 110.85 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -98.35 -9.43 25.34 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.82 -57.97 7.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.695 1.134 . . . . 0.0 112.036 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.149 -0.345 . . . . 0.0 111.538 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.9 t -73.95 -39.67 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.52 -54.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -62.78 -26.27 68.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.53 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.5 m -57.73 -31.24 66.24 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.267 1.394 . . . . 0.0 111.848 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.23 -27.2 66.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.547 0.739 . . . . 0.0 110.946 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -96.98 -32.07 12.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.82 0.848 . . . . 0.0 110.976 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 124.376 1.071 . . . . 0.0 110.806 -179.809 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -124.18 166.48 15.75 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.477 2.311 . . . . 0.0 108.77 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 42.38 47.5 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.799 2.039 . . . . 0.0 114.517 170.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.34 18.71 8.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.741 2.016 . . . . 0.0 114.267 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.72 -1.14 0.1 OUTLIER Glycine 0 C--N 1.34 0.756 0 N-CA-C 116.611 1.405 . . . . 0.0 116.611 169.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.68 130.43 37.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 120.763 2.282 . . . . 0.0 110.531 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -78.9 115.53 52.95 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.325 -1.321 . . . . 0.0 108.387 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.4 118.02 5.02 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.545 2.163 . . . . 0.0 107.941 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.83 167.86 21.59 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.688 0.795 . . . . 0.0 109.442 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.36 135.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.38 8.29 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.45 105.87 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.59 83.93 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.493 -2.039 . . . . 0.0 105.493 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.11 131.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -122.38 129.02 51.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.75 140.85 30.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -63.04 -0.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 115.101 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -81.36 0.42 37.38 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.999 0.818 . . . . 0.0 109.579 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.55 28.04 37.09 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 124.846 1.213 . . . . 0.0 112.11 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -122.09 154.9 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -113.94 163.02 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -168.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.6 tpt -50.87 130.58 25.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.008 2.123 . . . . 0.0 111.777 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 5.3 t-105 -163.73 124.16 2.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 169.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.56 142.74 45.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.857 1.313 . . . . 0.0 112.972 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.1 ttp85 -78.43 140.65 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.754 2.421 . . . . 0.0 107.902 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -88.0 151.27 22.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.135 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.24 156.62 24.91 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.439 1.495 . . . . 0.0 112.163 171.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.9 25.32 30.1 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.376 0.989 . . . . 0.0 110.88 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -10.0 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 131.294 3.837 . . . . 0.0 117.198 -167.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -151.35 6.64 0.49 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.181 168.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -154.68 147.66 24.61 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 109.058 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -121.08 131.87 54.53 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.18 -176.34 4.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.171 0.988 . . . . 0.0 111.665 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.69 156.64 52.31 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.95 2.1 . . . . 0.0 109.433 -170.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.94 155.11 71.11 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.595 2.864 . . . . 0.0 113.919 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 71.08 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.672 3.589 . . . . 0.0 105.716 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 121.63 7.29 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.481 1.038 . . . . 0.0 114.525 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.89 145.78 14.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.929 2.204 . . . . 0.0 113.445 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.96 136.45 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.632 1.173 . . . . 0.0 108.437 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -77.88 138.61 61.63 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 117.601 -1.19 . . . . 0.0 109.251 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.44 118.76 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.711 1.607 . . . . 0.0 112.678 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.56 89.79 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.109 176.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.95 129.32 35.28 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.08 159.6 34.42 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 124.685 1.194 . . . . 0.0 110.645 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -41.75 66.47 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.492 1.117 . . . . 0.0 113.841 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.76 -47.34 54.35 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -59.07 -40.61 85.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.149 1.38 . . . . 0.0 109.405 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.93 -27.89 62.12 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.0 1.32 . . . . 0.0 111.593 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.8 -40.85 95.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 79.0 m-85 -68.19 -30.4 69.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.217 -1.552 . . . . 0.0 112.838 172.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.829 -1.169 . . . . 0.0 109.954 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.5 -29.33 65.82 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.663 0.665 . . . . 0.0 112.134 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.84 -41.7 97.77 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.626 -1.296 . . . . 0.0 108.604 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.01 -53.75 34.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.327 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.62 -28.33 68.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.336 1.426 . . . . 0.0 113.378 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -115.14 -12.08 11.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.26 0.936 . . . . 0.0 113.278 -168.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.97 -20.45 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.092 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.66 55.24 31.64 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.35 -1.469 . . . . 0.0 110.126 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.2 159.51 41.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.499 1.92 . . . . 0.0 106.775 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 m -117.34 -177.18 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.502 1.121 . . . . 0.0 110.458 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 14.6 mtt180 -70.9 36.33 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.369 2.268 . . . . 0.0 113.578 -171.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.52 -19.83 0.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.965 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -83.39 -5.19 59.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 112.525 -169.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.66 167.63 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.583 1.153 . . . . 0.0 109.468 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -136.19 120.18 17.58 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.674 1.99 . . . . 0.0 105.926 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.99 128.92 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.07 -35.85 7.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.16 0.584 . . . . 0.0 111.215 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.16 163.8 39.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.218 1.007 . . . . 0.0 108.756 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -146.09 156.22 43.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 108.1 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 p -63.72 150.55 44.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.013 0.824 . . . . 0.0 109.991 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -70.29 -31.99 69.58 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.041 -0.412 . . . . 0.0 111.49 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.31 176.66 10.36 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.656 1.982 . . . . 0.0 108.077 172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -66.62 117.39 8.72 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.236 0.614 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.78 151.34 46.76 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -145.32 134.01 22.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -149.82 158.52 44.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -95.75 153.61 17.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.285 0.564 . . . . 0.0 111.308 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.25 148.16 46.64 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.05 153.4 67.62 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.37 2.713 . . . . 0.0 109.414 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.39 -20.36 66.34 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.33 -27.41 61.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 tp -94.9 -27.59 15.62 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.061 0.944 . . . . 0.0 110.572 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -56.0 134.04 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -41.28 41.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.6 m95 60.95 5.79 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.88 2.072 . . . . 0.0 113.685 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.81 -19.92 14.11 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.889 1.275 . . . . 0.0 111.837 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -76.6 153.4 35.35 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.979 1.711 . . . . 0.0 108.771 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.66 113.84 9.35 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.027 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -53.91 147.57 16.26 Favored 'Cis proline' 0 CA--C 1.538 0.717 0 CA-C-N 120.199 1.107 . . . . 0.0 111.845 -10.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.32 129.37 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.8 t -80.37 97.98 7.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.2 pt -88.08 -15.98 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.374 1.469 . . . . 0.0 111.865 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 172.78 45.03 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 120.662 1.574 . . . . 0.0 113.028 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -105.87 129.62 54.0 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -97.2 113.91 25.56 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.45 127.54 35.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -103.52 129.52 50.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -103.57 133.6 48.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.99 129.2 55.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.7 tp -83.7 113.84 21.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.5 mm? -113.48 121.64 44.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 123.749 0.82 . . . . 0.0 109.619 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -83.56 137.19 33.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' HA2' ' A' ' 107' ' ' GLY . 73.4 mt -63.05 139.51 58.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.363 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.54 -25.0 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.515 1.126 . . . . 0.0 108.013 169.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.3 p -119.57 -61.82 1.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 110.381 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.545 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 80.4 -147.29 28.31 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -43.64 -36.44 2.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.476 1.91 . . . . 0.0 113.56 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.98 66.98 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -123.33 -16.39 6.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.352 1.461 . . . . 0.0 112.431 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.48 143.89 9.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -134.06 -48.02 0.79 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.043 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.0 mtt 58.86 -1.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.38 23.98 8.83 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.774 2.079 . . . . 0.0 111.262 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -35.64 66.51 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.023 2.529 . . . . 0.0 111.374 169.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.81 3.9 15.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.013 1.725 . . . . 0.0 112.717 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 70.15 -42.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 129.485 3.114 . . . . 0.0 114.483 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.5 p -133.51 34.67 0.26 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 113.914 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.77 160.99 40.09 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.746 1.659 . . . . 0.0 110.461 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.768 1.627 . . . . 0.0 113.609 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.05 144.46 42.99 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.398 0.618 . . . . 0.0 112.657 -168.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 -6.68 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.327 1.051 . . . . 0.0 113.62 -171.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.61 162.84 35.38 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -138.5 149.87 45.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.89 0.845 . . . . 0.0 111.417 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -150.55 128.07 11.49 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.815 1.646 . . . . 0.0 107.134 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -82.0 138.32 34.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.67 167.93 23.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.598 1.159 . . . . 0.0 110.459 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -49.03 144.74 4.52 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.198 0.999 . . . . 0.0 109.601 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -53.89 -36.91 63.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -94.17 -3.66 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.79 -45.8 96.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.011 -1.471 . . . . 0.0 111.974 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.11 -36.32 99.17 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.947 1.731 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -40.01 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -76.68 -29.38 56.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.822 1.192 . . . . 0.0 111.577 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.43 -28.09 46.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.02 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.45 156.04 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.547 1.067 . . . . 0.0 110.947 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.16 148.05 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.46 1.504 . . . . 0.0 111.88 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -58.75 -34.95 71.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.834 1.254 . . . . 0.0 113.911 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -71.36 -25.94 62.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.032 0.833 . . . . 0.0 111.437 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.67 -38.07 15.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.117 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -47.78 -47.48 30.76 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.082 1.31 . . . . 0.0 112.972 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.66 -35.79 81.01 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.383 0.538 . . . . 0.0 112.032 -174.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.64 -35.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.37 0.668 . . . . 0.0 110.596 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.91 -31.9 73.35 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.989 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -56.65 -37.32 70.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.119 169.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.63 -47.4 81.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.091 1.314 . . . . 0.0 108.886 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.22 -50.6 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.722 0.809 . . . . 0.0 109.307 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.8 mtt -65.69 -40.72 92.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.099 -0.477 . . . . 0.0 111.251 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -58.79 -39.77 82.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.444 1.098 . . . . 0.0 110.547 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.9 -23.26 62.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.704 0.402 . . . . 0.0 111.25 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -107.53 -9.6 15.89 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.28 16.98 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.473 1.033 . . . . 0.0 111.542 -169.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -62.81 -25.28 68.17 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.126 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.43 -43.52 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.59 -36.48 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -69.42 -35.81 76.08 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.835 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -59.58 -31.5 69.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.737 1.153 . . . . 0.0 112.031 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.25 -25.17 67.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.152 0.581 . . . . 0.0 111.361 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -104.65 -32.37 8.94 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.166 0.986 . . . . 0.0 110.987 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 124.503 1.121 . . . . 0.0 111.262 -176.628 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.83 -44.31 49.91 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.522 1.129 . . . . 0.0 111.306 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.8 -77.78 0.12 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.904 0.882 . . . . 0.0 111.138 170.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.55 -48.92 7.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.39 6.15 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.316 0.887 . . . . 0.0 115.316 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -96.93 134.33 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.35 1.575 . . . . 0.0 109.902 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -86.38 127.16 62.18 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.776 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.84 130.84 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.397 2.065 . . . . 0.0 108.624 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.48 177.2 11.74 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -130.59 135.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.71 136.23 12.86 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.48 142.23 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 118.94 1.37 . . . . 0.0 107.805 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.42 89.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -66.89 136.46 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -124.45 118.21 26.14 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -74.01 141.88 45.79 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -68.16 -9.66 48.37 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.07 -10.19 59.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.79 0.723 . . . . 0.0 111.328 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.13 39.2 3.35 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 125.926 1.727 . . . . 0.0 112.434 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -136.35 150.91 49.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.65 161.72 4.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.885 0.874 . . . . 0.0 112.68 -169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 128.51 36.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.006 1.322 . . . . 0.0 109.325 170.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.427 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 2.6 t-105 -160.23 128.81 4.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 168.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.1 148.45 41.74 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -69.08 140.68 54.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -77.77 119.86 21.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -44.61 126.33 5.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.544 1.938 . . . . 0.0 110.583 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.65 -2.05 25.75 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.532 1.063 . . . . 0.0 115.259 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -126.93 -24.72 3.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.032 1.416 . . . . 0.0 111.454 -172.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.66 14.29 8.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.284 1.833 . . . . 0.0 115.198 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.2 p -104.45 -143.18 0.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.98 1.312 . . . . 0.0 107.647 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.427 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 62.7 m95 -127.96 168.16 15.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.098 1.317 . . . . 0.0 109.946 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -152.44 150.77 30.0 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.147 0.979 . . . . 0.0 109.42 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -81.6 139.92 47.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.943 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.68 137.83 75.81 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.657 1.571 . . . . 0.0 111.642 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -157.55 147.83 20.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.729 1.212 . . . . 0.0 111.101 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.13 -126.38 5.56 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.523 1.059 . . . . 0.0 112.156 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.51 118.48 0.45 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.62 125.58 39.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -75.46 155.18 85.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.13 116.72 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.638 1.559 . . . . 0.0 111.039 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.25 7.75 87.3 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.079 1.323 . . . . 0.0 113.188 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -80.29 125.26 29.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.427 1.113 . . . . 0.0 108.601 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.72 157.34 37.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.483 1.113 . . . . 0.0 110.312 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.74 -41.09 69.99 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -169.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -71.58 -39.82 70.32 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -65.06 -44.26 89.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -27.03 69.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.383 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.466 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 17.0 tmm? -72.21 -43.74 64.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.411 1.005 . . . . 0.0 109.032 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -66.31 -30.99 71.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.114 0.87 . . . . 0.0 110.903 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -62.21 -49.2 76.72 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.659 -0.651 . . . . 0.0 109.607 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.06 77.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.145 0.978 . . . . 0.0 111.277 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.64 -39.98 95.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.183 1.393 . . . . 0.0 109.446 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.19 -50.87 59.43 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.866 0.866 . . . . 0.0 110.056 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.54 -40.94 88.89 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.521 1.055 . . . . 0.0 112.002 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -95.21 -49.36 5.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.287 0.635 . . . . 0.0 111.082 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.21 -17.7 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.4 0.68 . . . . 0.0 110.599 -169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.71 55.72 29.27 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -134.22 162.94 30.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.287 2.235 . . . . 0.0 106.507 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 m -119.0 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.356 0.662 . . . . 0.0 110.09 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -72.19 49.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.323 1.849 . . . . 0.0 114.503 -171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -163.4 -23.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.57 1.548 . . . . 0.0 112.294 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.27 1.1 52.15 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 m -149.05 171.16 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 109.727 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -138.91 124.53 19.55 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -79.91 131.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 120.655 1.571 . . . . 0.0 107.304 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -102.73 -45.94 4.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.51 169.3 19.86 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.88 0.872 . . . . 0.0 110.554 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -145.86 162.73 37.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 p -65.05 141.97 58.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -67.11 -22.03 65.83 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -170.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -141.85 177.58 8.08 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.523 1.529 . . . . 0.0 107.441 169.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -72.16 129.48 38.58 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 75' ' ' LEU . 4.2 mm? -79.85 160.04 26.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -156.61 151.86 26.49 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 108.345 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.06 172.91 12.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.001 1.72 . . . . 0.0 106.956 172.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -112.84 128.51 56.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.71 145.39 98.08 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -63.3 154.66 66.64 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 108.513 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.72 -29.94 68.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -73.22 -25.83 60.9 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.037 0.935 . . . . 0.0 112.728 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 tp -101.2 -19.38 15.73 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.815 0.846 . . . . 0.0 111.865 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.7 t -48.01 135.23 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -88.53 101.65 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.529 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.37 -2.33 57.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.363 0.665 . . . . 0.0 110.88 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.81 -30.55 40.53 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.636 -0.665 . . . . 0.0 110.096 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.4 161.12 23.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.564 1.146 . . . . 0.0 109.814 -173.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -137.26 114.63 9.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -59.18 153.58 43.04 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.004 1.037 . . . . 0.0 110.828 -10.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.49 138.12 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.7 t -97.56 120.8 38.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 pt -107.47 -10.18 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.282 1.033 . . . . 0.0 112.531 -169.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.97 168.63 40.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.158 0.89 . . . . 0.0 111.673 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -104.61 123.51 47.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -85.26 118.92 25.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 120.37 14.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.96 1.254 . . . . 0.0 113.164 -173.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -98.92 128.92 45.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -97.69 149.65 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 41.3 m-85 -119.53 126.79 52.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.3 111.58 19.54 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 102' ' ' LEU . 19.9 mt -107.48 131.23 54.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 124.465 1.103 . . . . 0.0 110.64 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.17 136.26 33.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.12 132.69 44.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -116.16 -37.8 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.7 m -85.2 -133.09 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.96 173.5 46.3 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 120.369 1.441 . . . . 0.0 111.403 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.4 -31.73 46.27 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.966 1.307 . . . . 0.0 112.859 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.45 -27.9 67.42 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.246 0.618 . . . . 0.0 112.431 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.86 -24.73 13.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.37 1.468 . . . . 0.0 110.908 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.46 142.54 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.724 1.61 . . . . 0.0 107.256 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -124.98 -38.77 2.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.51 -15.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.963 2.105 . . . . 0.0 116.173 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.94 27.94 8.98 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.849 1.659 . . . . 0.0 111.574 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -68.62 -36.98 79.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -91.76 6.39 46.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.074 0.949 . . . . 0.0 113.5 -169.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m 67.85 -36.1 0.29 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.489 2.716 . . . . 0.0 114.962 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -128.4 66.84 74.63 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.706 1.602 . . . . 0.0 108.33 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -77.05 -168.62 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.575 2.85 . . . . 0.0 110.467 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.7 -11.0 14.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.525 169.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.51 145.21 49.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 121.017 1.735 . . . . 0.0 114.03 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.62 116.66 25.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.003 2.921 . . . . 0.0 105.004 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.81 143.55 42.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.215 0.912 . . . . 0.0 113.277 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -114.44 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.035 0.934 . . . . 0.0 109.622 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -140.91 155.21 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.951 1.3 . . . . 0.0 110.106 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -79.68 149.6 31.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 161.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.842 0.857 . . . . 0.0 110.003 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -53.3 150.13 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.592 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.44 149.65 20.36 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.1 -15.08 0.13 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 -44.17 99.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 121.322 1.874 . . . . 0.0 111.937 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -63.99 -25.88 66.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.885 1.724 . . . . 0.0 114.702 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.48 -36.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.855 1.207 . . . . 0.0 108.928 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -83.39 -16.26 46.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 117.9 -1.047 . . . . 0.0 112.21 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -86.26 -31.1 21.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.977 1.262 . . . . 0.0 112.341 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -68.88 165.34 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.303 0.956 . . . . 0.0 111.755 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.55 151.24 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.9 1.28 . . . . 0.0 111.148 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -59.12 -34.49 72.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.104 1.362 . . . . 0.0 113.822 -169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -71.55 -26.02 62.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.025 0.829 . . . . 0.0 111.468 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -94.64 -29.32 14.9 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.14 0.976 . . . . 0.0 112.317 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -36.9 -53.71 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.721 2.009 . . . . 0.0 112.638 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -35.29 74.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.418 0.553 . . . . 0.0 110.977 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 75' ' ' LEU . 72.2 t -72.7 -36.04 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.648 -0.657 . . . . 0.0 109.682 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -68.15 -34.82 77.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.261 0.937 . . . . 0.0 110.791 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -58.01 -39.54 78.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.577 1.151 . . . . 0.0 111.373 169.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -64.31 -47.44 79.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.144 0.884 . . . . 0.0 109.618 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.31 -45.33 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.593 0.633 . . . . 0.0 109.603 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtt -65.49 -43.22 90.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.647 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -26.03 65.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.3 1.863 . . . . 0.0 112.315 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -65.31 -23.49 67.03 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.718 0.69 . . . . 0.0 110.358 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -116.09 -21.49 9.41 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.358 1.063 . . . . 0.0 113.442 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.1 -58.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.578 1.151 . . . . 0.0 110.607 -172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.5 m -66.17 -21.48 66.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.456 0.571 . . . . 0.0 111.995 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.76 -41.5 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.61 -48.72 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.1 mtt -66.52 -18.79 65.56 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.71 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.7 m -63.19 -24.22 67.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.713 1.142 . . . . 0.0 111.873 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.97 -49.72 27.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.671 0.668 . . . . 0.0 109.348 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.67 -23.42 56.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.704 0.402 . . . . 0.0 111.206 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.91 1.684 . . . . 0.0 109.808 177.037 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.02 162.13 29.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.379 1.472 . . . . 0.0 108.707 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.6 -36.48 64.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.9 5.96 26.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.23 31.24 14.58 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.792 1.187 . . . . 0.0 111.75 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 19.5 m-85 -108.42 134.57 51.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.892 1.346 . . . . 0.0 109.127 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -82.55 127.34 70.95 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.52 130.5 11.82 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.142 1.894 . . . . 0.0 109.322 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.6 160.65 39.37 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.728 1.211 . . . . 0.0 110.705 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.3 148.3 18.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.596 1.958 . . . . 0.0 106.431 169.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.14 131.06 6.11 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.44 127.29 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.53 91.78 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 mm -66.39 134.12 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 168.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.8 m -119.32 126.26 51.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 168.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -86.62 35.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.904 -0.498 . . . . 0.0 111.216 -169.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.265 13.7 ptp180 40.87 7.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.906 4.082 . . . . 0.0 116.558 -169.038 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -95.39 3.65 54.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.03 0.932 . . . . 0.0 111.471 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.31 64.34 Favored Glycine 0 N--CA 1.47 0.92 0 O-C-N 121.021 -1.049 . . . . 0.0 112.089 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -121.78 149.81 42.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.571 1.548 . . . . 0.0 107.005 -169.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.3 160.07 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.459 1.104 . . . . 0.0 113.204 -169.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ttt -58.31 134.61 56.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.332 1.453 . . . . 0.0 109.977 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -157.69 133.69 9.38 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 169.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.06 144.31 27.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.504 0.669 . . . . 0.0 110.458 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.92 132.35 36.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.229 1.411 . . . . 0.0 107.786 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -93.72 134.92 35.54 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.59 0.756 . . . . 0.0 109.248 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -47.55 132.79 13.65 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.832 1.253 . . . . 0.0 111.591 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.22 -23.08 0.75 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.615 1.102 . . . . 0.0 113.564 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.31 -37.75 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.923 0.862 . . . . 0.0 108.956 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.46 28.94 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.448 1.499 . . . . 0.0 112.262 -174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -149.78 175.82 11.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.28 1.832 . . . . 0.0 107.266 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -78.06 153.81 31.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.729 0.812 . . . . 0.0 112.639 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -146.48 162.29 38.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 109.37 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -84.67 151.1 57.85 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.886 2.074 . . . . 0.0 110.746 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -68.4 156.97 63.77 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.886 2.391 . . . . 0.0 113.022 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 179.96 148.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.921 2.488 . . . . 0.0 108.322 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 142.15 8.68 Favored Glycine 0 C--N 1.337 0.638 0 O-C-N 121.134 -0.978 . . . . 0.0 110.883 170.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.73 50.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.786 1.184 . . . . 0.0 111.027 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -87.42 134.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.387 1.075 . . . . 0.0 109.108 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -65.82 126.46 91.77 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.627 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.32 118.2 5.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.074 1.849 . . . . 0.0 111.585 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.87 0.17 75.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.577 1.56 . . . . 0.0 113.083 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -83.7 132.93 34.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.677 1.191 . . . . 0.0 108.048 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 159.39 34.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.984 0.913 . . . . 0.0 110.346 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.76 71.81 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.059 1.344 . . . . 0.0 112.315 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.38 -40.6 73.86 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -62.16 -43.5 98.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 108.967 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.956 0.502 . . . . 0.0 111.93 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -61.68 -44.71 96.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.883 0.765 . . . . 0.0 110.06 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -65.78 -29.3 69.78 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.961 1.255 . . . . 0.0 113.046 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -59.38 -50.67 73.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.237 1.381 . . . . 0.0 109.087 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.08 66.79 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.134 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.14 -43.32 99.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.832 -1.167 . . . . 0.0 108.455 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -66.51 -45.12 80.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.702 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -69.49 -48.88 59.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.523 1.51 . . . . 0.0 112.211 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -85.66 -29.59 23.88 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.124 0.97 . . . . 0.0 111.783 -168.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.35 -15.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.5 0.72 . . . . 0.0 110.379 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.25 11.33 70.97 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 120.746 -1.221 . . . . 0.0 113.12 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.37 151.41 21.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.131 0.966 . . . . 0.0 109.189 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -102.74 174.05 6.06 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.034 0.933 . . . . 0.0 108.909 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -70.42 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 115.065 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.41 -11.44 0.18 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.221 1.808 . . . . 0.0 112.705 -169.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -97.91 2.27 48.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.451 0.7 . . . . 0.0 110.96 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.88 171.89 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.751 1.221 . . . . 0.0 108.419 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -140.57 122.61 15.63 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 -171.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -75.47 129.82 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 -34.17 6.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.813 0.445 . . . . 0.0 110.702 176.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.7 166.5 32.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.679 1.192 . . . . 0.0 108.234 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -140.54 157.25 45.76 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -58.62 138.34 56.97 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 119.467 1.03 . . . . 0.0 108.474 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.46 -24.82 66.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.789 0.436 . . . . 0.0 112.074 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.48 174.16 11.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -61.7 126.64 28.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.12 131.31 45.19 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 170.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.37 134.66 52.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -143.02 131.6 22.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 117.51 24.63 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.18 147.47 80.98 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.866 1.266 . . . . 0.0 110.25 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.44 150.54 87.03 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.582 1.521 . . . . 0.0 109.015 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -48.83 -48.44 41.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.016 0.927 . . . . 0.0 113.367 -169.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.88 -16.48 63.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.197 0.999 . . . . 0.0 113.003 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -108.07 -3.75 18.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.169 1.388 . . . . 0.0 111.749 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.41 137.56 21.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 169.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -91.0 127.52 36.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -111.36 0.18 16.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.123 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.84 -17.59 35.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.106 0.562 . . . . 0.0 109.724 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.0 p -91.43 156.51 17.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.257 0.623 . . . . 0.0 109.328 -171.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -131.38 110.25 15.05 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.88 155.94 60.44 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.447 1.195 . . . . 0.0 112.117 -4.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.4 m -60.54 133.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 50.7 t -90.06 99.52 12.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.6 pt -88.89 -6.42 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.416 1.486 . . . . 0.0 112.027 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -158.43 153.72 24.86 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 120.514 1.506 . . . . 0.0 113.566 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.91 94.21 5.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -71.02 126.17 28.85 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.63 111.7 5.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.224 0.92 . . . . 0.0 110.273 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -89.3 125.81 35.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 169.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -98.27 146.8 25.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -123.87 126.14 45.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.815 1.246 . . . . 0.0 107.715 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.2 tp -78.46 111.12 14.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.7 mm? -106.84 121.92 45.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.022 0.929 . . . . 0.0 108.609 174.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -82.84 137.25 34.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.35 139.99 58.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.73 -41.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 m -136.41 142.56 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.3 -168.8 40.73 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.713 -0.617 . . . . 0.0 112.937 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.07 -56.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 131.443 3.897 . . . . 0.0 112.882 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.58 -35.44 24.71 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.174 0.99 . . . . 0.0 110.786 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -86.09 -18.72 31.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.405 0.682 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.94 138.8 22.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -153.69 84.81 1.17 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.5 mtt -70.79 24.67 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.249 0.62 . . . . 0.0 112.404 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -132.92 20.43 4.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.999 1.72 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.84 -51.46 50.99 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.926 2.09 . . . . 0.0 110.951 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 m -86.09 3.93 40.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.604 1.162 . . . . 0.0 112.869 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 63.01 117.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 128.07 2.548 . . . . 0.0 112.417 -169.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 p 34.78 53.06 1.49 Allowed Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 111.783 -2.462 . . . . 0.0 113.325 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.37 -54.15 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.898 1.732 . . . . 0.0 113.26 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -160.79 -45.54 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.846 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -115.52 135.92 53.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -169.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.64 -31.9 15.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.714 2.005 . . . . 0.0 112.007 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -170.77 156.63 27.06 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 123.896 0.76 . . . . 0.0 111.75 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -120.48 150.73 40.37 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.082 1.353 . . . . 0.0 111.39 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -150.05 130.1 13.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.758 1.623 . . . . 0.0 108.627 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -84.56 140.0 31.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.03 0.832 . . . . 0.0 108.934 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.17 166.88 17.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.943 1.297 . . . . 0.0 109.835 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -56.26 150.69 13.98 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.893 0.877 . . . . 0.0 111.927 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.42 149.26 34.63 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.5 m95 65.5 -16.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.3 1.84 . . . . 0.0 115.857 -170.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -65.22 -48.38 69.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 121.235 1.834 . . . . 0.0 110.898 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -59.55 -30.23 91.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 121.81 1.682 . . . . 0.0 113.391 173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -39.45 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.544 -0.722 . . . . 0.0 110.027 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -73.16 -37.15 66.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 120.683 -1.261 . . . . 0.0 110.035 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -80.74 -24.92 38.37 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.49 156.92 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.172 0.896 . . . . 0.0 109.352 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.9 m -58.46 150.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.388 1.075 . . . . 0.0 110.711 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 m -59.79 -26.81 66.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.897 1.279 . . . . 0.0 114.406 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -72.06 -45.68 59.82 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.356 0.98 . . . . 0.0 110.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.54 -29.5 52.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.159 -1.4 . . . . 0.0 111.419 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -43.3 -48.17 6.75 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.564 1.529 . . . . 0.0 111.156 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -73.23 -22.29 60.46 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -79.26 -47.48 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.231 -0.918 . . . . 0.0 108.658 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -31.7 70.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.794 0.838 . . . . 0.0 110.568 -169.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -64.95 -33.76 76.8 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.268 -0.895 . . . . 0.0 111.264 172.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -69.92 -44.96 68.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.29 -46.87 85.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.171 0.588 . . . . 0.0 110.001 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 47.2 mtt -66.34 -40.49 89.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.203 -0.936 . . . . 0.0 110.987 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.11 -37.22 86.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.367 0.985 . . . . 0.0 111.01 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.84 -28.06 69.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.805 0.842 . . . . 0.0 110.985 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -113.94 -11.66 12.76 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.07 -54.8 38.46 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.94 1.245 . . . . 0.0 110.755 -170.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -81.12 25.63 0.47 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.615 0.766 . . . . 0.0 112.6 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.69 -18.31 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.164 1.786 . . . . 0.0 108.773 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 73.1 t -96.95 -52.79 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.768 1.227 . . . . 0.0 108.087 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.0 mmt -64.77 -16.41 62.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.283 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 m -48.92 -33.23 10.42 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.874 1.67 . . . . 0.0 113.194 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.9 mt -83.0 -29.58 28.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 110.509 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -96.87 -25.92 15.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.325 1.05 . . . . 0.0 112.189 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 109.592 176.679 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.97 145.81 48.15 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.635 1.574 . . . . 0.0 108.144 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -44.59 -37.49 3.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.058 1.874 . . . . 0.0 116.058 -168.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -81.96 2.13 32.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.51 24.85 11.57 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.776 1.655 . . . . 0.0 112.009 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -111.03 148.7 32.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.668 1.734 . . . . 0.0 110.843 -170.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -87.89 112.45 49.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.211 -1.555 . . . . 0.0 107.412 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.84 130.32 15.53 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.492 2.128 . . . . 0.0 109.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -154.84 170.99 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.465 1.106 . . . . 0.0 110.855 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.91 130.31 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.481 1.513 . . . . 0.0 108.796 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.33 126.63 8.98 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mm -91.5 104.12 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 81.35 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.9 mm -63.79 130.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.17 128.33 55.87 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.82 18.34 6.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 53.5 10.68 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.106 1.762 . . . . 0.0 115.341 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -109.87 6.97 23.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.304 1.041 . . . . 0.0 111.945 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.74 79.28 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.796 -1.19 . . . . 0.0 112.731 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -128.51 158.57 38.03 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.893 1.677 . . . . 0.0 106.851 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.37 167.61 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 128.2 32.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.347 1.859 . . . . 0.0 110.873 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.417 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -164.46 131.53 3.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 167.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.76 142.42 44.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -76.6 144.92 39.27 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -95.71 126.71 41.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -61.17 144.64 53.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.705 0.684 . . . . 0.0 110.586 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 -28.24 0.85 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.361 1.457 . . . . 0.0 114.158 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -97.06 -28.33 14.19 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.606 1.162 . . . . 0.0 110.357 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 65.13 -8.65 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.788 2.435 . . . . 0.0 115.213 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -178.66 6.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.263 1.025 . . . . 0.0 108.455 169.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.417 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 73.8 m95 -90.03 162.07 15.53 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.84 -1.163 . . . . 0.0 110.704 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -140.15 148.03 41.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.045 0.926 . . . . 0.0 110.848 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -79.76 164.9 50.95 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 127.335 2.254 . . . . 0.0 110.186 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.71 -92.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.664 2.91 . . . . 0.0 110.289 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 53.78 61.37 3.12 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.469 1.108 . . . . 0.0 111.563 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.81 117.27 4.46 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.1 142.71 27.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 125.997 1.76 . . . . 0.0 111.485 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.0 mt -77.4 139.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.994 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -77.71 136.06 63.57 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.356 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -54.99 118.27 4.96 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.631 1.554 . . . . 0.0 113.491 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.48 89.74 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.961 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -83.86 123.28 29.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.281 1.032 . . . . 0.0 108.513 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -72.59 160.52 32.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.269 1.028 . . . . 0.0 110.508 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.5 79.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.061 . . . . 0.0 111.129 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.5 12.82 3.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.633 0.773 . . . . 0.0 111.181 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -114.18 -54.21 2.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.408 1.883 . . . . 0.0 106.088 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -33.08 73.41 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.476 1.11 . . . . 0.0 112.335 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -61.29 -45.07 95.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -71.86 -27.87 63.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.617 -0.677 . . . . 0.0 111.292 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -62.19 -48.71 78.83 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.243 -0.91 . . . . 0.0 109.409 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.76 -32.93 73.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.801 0.728 . . . . 0.0 111.362 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 tp -60.34 -40.72 91.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.65 1.18 . . . . 0.0 109.419 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.34 -54.08 9.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.336 1.054 . . . . 0.0 111.456 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.97 -41.72 81.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.635 1.562 . . . . 0.0 110.834 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -92.96 -49.01 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.205 0.457 . . . . 0.0 110.836 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.15 -26.38 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.998 0.519 . . . . 0.0 110.583 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.69 58.84 6.55 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.747 -1.22 . . . . 0.0 110.074 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 mt -138.34 156.18 47.86 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.085 2.154 . . . . 0.0 107.834 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 m -116.75 -178.51 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.868 0.867 . . . . 0.0 111.513 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.74 41.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 128.368 2.667 . . . . 0.0 113.61 -174.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -164.72 -20.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.079 1.352 . . . . 0.0 112.361 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -87.59 -1.04 57.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -169.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.85 167.5 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.151 1.38 . . . . 0.0 108.925 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -138.78 121.37 16.24 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -74.84 130.94 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 120.104 1.32 . . . . 0.0 107.844 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -33.71 6.07 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.008 0.923 . . . . 0.0 111.162 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.74 169.18 25.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.362 1.465 . . . . 0.0 108.546 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 m -145.37 162.04 38.21 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.083 1.353 . . . . 0.0 107.833 172.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -62.06 149.1 42.05 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.425 1.011 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.5 -33.43 75.57 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.151 -0.343 . . . . 0.0 111.153 -169.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.17 -176.21 5.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.914 2.086 . . . . 0.0 106.395 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -61.38 120.17 9.94 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 160.01 29.28 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -161.33 163.2 30.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 120.704 -1.248 . . . . 0.0 111.118 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.49 159.69 41.23 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.145 1.378 . . . . 0.0 107.764 169.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -101.31 127.48 47.91 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 106.657 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -68.49 145.31 97.13 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.43 156.75 57.93 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.033 2.489 . . . . 0.0 110.104 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -52.02 -42.0 62.69 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 113.582 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -76.26 -23.95 54.47 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.285 1.034 . . . . 0.0 113.06 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.33 -24.56 19.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.009 0.524 . . . . 0.0 110.894 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.69 137.38 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -42.98 52.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.925 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.5 m95 59.52 5.21 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.304 2.241 . . . . 0.0 113.547 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.95 -21.84 14.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.367 1.467 . . . . 0.0 111.17 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -70.96 147.4 48.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.264 1.426 . . . . 0.0 108.53 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -134.38 113.43 12.19 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.27 154.83 30.92 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.069 1.06 . . . . 0.0 111.54 -10.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -62.87 128.95 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.7 t -89.79 108.94 19.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.2 pt -101.27 -6.28 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 112.835 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.94 178.3 48.74 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 119.851 1.205 . . . . 0.0 112.017 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -108.82 114.82 28.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -78.45 115.8 18.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.88 110.89 8.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.507 0.594 . . . . 0.0 111.818 -168.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -90.1 125.22 35.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -100.21 132.27 45.67 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.04 133.99 51.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.9 106.16 18.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -108.37 130.41 55.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.065 0.946 . . . . 0.0 109.494 -173.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.07 136.13 33.11 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.4 tp -78.32 124.64 28.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.52 -37.83 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.9 m -115.16 110.86 20.13 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.9 -167.36 9.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.96 1.266 . . . . 0.0 115.284 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -44.83 -33.0 1.76 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.702 2.001 . . . . 0.0 113.657 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.67 67.96 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.62 -25.46 11.32 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.359 1.464 . . . . 0.0 111.519 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.93 123.43 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -94.44 -46.53 6.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mtt 46.95 44.09 14.34 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 111.787 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 26.06 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.722 0.809 . . . . 0.0 112.971 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -44.53 63.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.329 1.452 . . . . 0.0 110.718 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 p -80.99 -15.94 54.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.939 1.696 . . . . 0.0 113.085 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.8 m 68.87 -30.27 0.18 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.714 2.406 . . . . 0.0 112.529 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -119.98 64.85 9.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.596 1.558 . . . . 0.0 111.621 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 -5.0 16.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.002 3.134 . . . . 0.0 114.474 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 65.42 -34.08 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.886 2.474 . . . . 0.0 114.359 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -70.5 128.97 37.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.933 0.788 . . . . 0.0 109.494 175.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.89 -14.8 53.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.515 1.126 . . . . 0.0 111.522 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.4 135.98 4.78 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -150.82 -129.74 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.781 0.432 . . . . 0.0 110.445 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -145.03 162.86 35.9 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.483 1.913 . . . . 0.0 108.508 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -82.14 152.84 26.32 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.338 0.399 . . . . 0.0 110.342 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.25 164.21 35.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.58 0.752 . . . . 0.0 110.718 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -54.11 145.94 15.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.355 1.062 . . . . 0.0 110.385 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -36.81 69.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.626 0.77 . . . . 0.0 111.904 -169.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -90.42 -5.39 56.17 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.05 -1.031 . . . . 0.0 112.639 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.5 -44.21 80.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.454 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.67 -33.82 92.86 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.14 1.8 . . . . 0.0 112.889 176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.59 -36.19 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 O-C-N 121.86 -0.525 . . . . 0.0 109.588 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -83.63 -15.68 48.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.349 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.52 -20.33 19.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.228 0.922 . . . . 0.0 112.982 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.21 165.27 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 119.616 1.098 . . . . 0.0 110.343 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.87 156.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 110.732 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -56.49 -33.22 65.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.312 -169.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -75.54 -30.68 59.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.131 0.878 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -79.24 -36.77 39.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.729 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -43.83 -50.6 7.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.237 1.415 . . . . 0.0 111.613 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.25 -33.52 76.19 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.731 0.412 . . . . 0.0 111.562 -172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.2 t -82.71 -37.94 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.383 0.673 . . . . 0.0 109.799 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -33.31 75.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.302 -0.874 . . . . 0.0 109.995 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -52.72 -40.48 63.06 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.227 1.011 . . . . 0.0 111.582 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.26 -47.43 79.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.43 -47.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.0 mmt -63.58 -47.09 82.91 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.779 0.718 . . . . 0.0 110.172 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -56.7 -46.15 81.4 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.181 0.992 . . . . 0.0 110.721 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.32 -16.36 63.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.073 0.549 . . . . 0.0 111.582 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.44 -5.58 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.132 1.373 . . . . 0.0 113.343 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.36 -59.0 3.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 112.198 -169.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.8 m -62.16 -26.19 68.19 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.703 0.401 . . . . 0.0 112.043 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.17 -28.91 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.061 0.944 . . . . 0.0 109.605 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.65 -41.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 17.0 mmt -63.92 -38.04 89.64 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.604 0.638 . . . . 0.0 110.751 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 63.0 m -61.98 -18.35 60.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.781 0.719 . . . . 0.0 112.698 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -76.19 -26.75 56.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.572 0.624 . . . . 0.0 110.584 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -107.56 -32.25 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.168 0.987 . . . . 0.0 111.002 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 127.185 2.194 . . . . 0.0 110.605 172.797 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.42 -47.12 57.92 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.14 0.576 . . . . 0.0 111.71 -171.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -153.17 -75.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.856 0.862 . . . . 0.0 110.413 171.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.45 -49.2 7.78 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -169.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.49 14.84 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.531 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -94.22 136.35 34.6 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.793 1.297 . . . . 0.0 110.281 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -86.03 114.03 54.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 173.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.62 134.22 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.967 1.778 . . . . 0.0 109.986 -177.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -159.4 176.01 12.64 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.201 1.001 . . . . 0.0 108.747 172.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.36 140.45 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.07 122.98 7.16 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 mm -73.04 121.73 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.68 88.39 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mm -67.34 131.22 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.5 m -114.72 119.76 37.79 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -83.86 136.46 34.11 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -63.82 -9.61 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.036 1.334 . . . . 0.0 114.367 -173.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.24 -12.26 61.36 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 110.841 169.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.78 34.18 4.75 Favored Glycine 0 C--N 1.346 1.09 0 C-N-CA 126.059 1.79 . . . . 0.0 112.685 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.43 151.7 51.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.96 164.15 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -168.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 tpp -50.96 127.26 18.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.243 1.817 . . . . 0.0 111.628 169.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -157.06 129.75 7.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.49 143.48 28.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.227 0.537 . . . . 0.0 110.014 -171.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -74.86 134.04 41.74 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -80.08 133.74 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.486 0.715 . . . . 0.0 109.269 -169.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.79 134.36 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.48 1.512 . . . . 0.0 109.95 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.1 16.32 76.77 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.993 -0.442 . . . . 0.0 112.513 177.134 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -139.85 163.34 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.124 2.169 . . . . 0.0 107.296 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -114.82 36.17 3.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 p -150.18 171.78 16.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.226 1.811 . . . . 0.0 108.735 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.99 155.34 22.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.997 1.319 . . . . 0.0 109.249 -171.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.38 146.14 41.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.093 0.949 . . . . 0.0 111.793 -170.509 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -57.14 143.29 72.98 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 0.0 108.549 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.56 152.79 78.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.973 1.782 . . . . 0.0 112.378 173.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -179.12 132.47 0.12 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.758 2.423 . . . . 0.0 107.173 173.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.11 -114.84 2.56 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.8 164.34 34.45 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.43 2.919 . . . . 0.0 106.758 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.53 124.21 72.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -73.76 136.97 76.92 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 116.895 -1.526 . . . . 0.0 107.615 171.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -56.13 117.68 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 121.857 1.699 . . . . 0.0 112.934 -172.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.58 87.16 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.355 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.37 125.62 31.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.49 1.116 . . . . 0.0 108.633 175.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.03 158.68 36.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 110.361 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.38 63.65 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 125.455 1.502 . . . . 0.0 113.859 -169.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.26 -45.08 61.67 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -60.2 -45.18 94.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.999 1.32 . . . . 0.0 108.307 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.56 67.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.196 0.999 . . . . 0.0 112.546 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -72.13 -42.3 66.18 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.653 1.115 . . . . 0.0 109.073 175.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.04 -26.87 67.71 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.971 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -67.35 -48.1 68.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.188 -0.945 . . . . 0.0 109.031 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.9 84.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 119.007 0.821 . . . . 0.0 110.795 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.13 -41.91 89.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.62 1.568 . . . . 0.0 109.38 178.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -46.97 65.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.859 0.863 . . . . 0.0 110.648 172.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.9 -37.18 86.77 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.676 1.126 . . . . 0.0 112.667 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -94.17 -44.02 8.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.524 0.73 . . . . 0.0 111.185 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 113' ' ' MET . 14.6 m -123.55 -2.48 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.04 75.69 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.172 -0.955 . . . . 0.0 111.598 177.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.0 mt -91.12 161.21 15.19 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 108.908 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -118.07 171.51 8.05 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.902 0.881 . . . . 0.0 109.603 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -72.43 57.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.161 1.784 . . . . 0.0 113.89 -171.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' H ' ' A' ' 64' ' ' ASP . 21.0 pttp -163.89 -25.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.618 1.967 . . . . 0.0 111.359 -172.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' H ' ' H ' ' A' ' 63' ' ' LYS . 65.6 m-20 -88.15 0.19 56.33 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -168.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 166.78 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.036 0.935 . . . . 0.0 109.792 -169.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -137.2 120.89 17.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -171.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.85 129.9 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.05 -34.87 6.48 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.316 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.93 169.48 22.53 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 109.356 -178.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.1 p -147.81 162.28 39.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.21 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 p -66.15 145.0 56.32 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.21 -20.97 63.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -170.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -148.94 171.95 15.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.958 1.703 . . . . 0.0 109.12 171.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -73.1 116.19 13.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.59 153.89 41.05 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.42 153.74 38.94 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.443 0.697 . . . . 0.0 109.204 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.63 164.81 30.57 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.871 1.268 . . . . 0.0 108.548 176.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -118.5 123.86 46.16 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -172.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.01 145.14 99.01 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.599 1.16 . . . . 0.0 108.937 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.0 152.2 80.67 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.463 2.109 . . . . 0.0 109.456 170.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -47.62 -49.08 28.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.548 1.139 . . . . 0.0 113.779 -169.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -64.71 -14.19 57.58 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.154 0.981 . . . . 0.0 113.228 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.77 -9.2 15.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.56 1.544 . . . . 0.0 111.53 -178.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.84 136.73 25.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.63 129.81 38.45 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -101.3 4.5 41.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.791 1.236 . . . . 0.0 109.782 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.15 -12.53 15.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.501 1.121 . . . . 0.0 111.588 -174.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 p -71.66 -33.88 69.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.327 0.651 . . . . 0.0 111.763 -174.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 41.78 89.22 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.906 2.482 . . . . 0.0 112.197 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.22 150.34 71.83 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-N 119.977 1.028 . . . . 0.0 114.761 10.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -54.41 122.17 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.7 t -92.53 105.3 17.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -172.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -102.84 -10.82 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 113.013 -170.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.73 175.65 46.65 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 120.075 1.307 . . . . 0.0 112.482 -174.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.29 126.56 55.38 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -87.27 120.89 29.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.15 128.56 21.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.974 1.261 . . . . 0.0 113.618 -176.397 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -106.23 134.98 48.52 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -104.85 144.79 31.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -117.67 126.46 52.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.07 107.59 16.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 175.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 102' ' ' LEU . 31.3 mt -103.4 133.99 47.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.823 175.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -93.6 135.6 34.71 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 168.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.615 HD22 ' HA2' ' A' ' 107' ' ' GLY . 67.7 mt -66.01 141.43 58.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.973 176.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.16 -27.05 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.316 1.047 . . . . 0.0 108.204 169.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -119.94 -53.42 2.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 175.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 69.02 -146.53 44.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 172.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -40.94 -34.15 0.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.786 2.034 . . . . 0.0 113.573 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.14 -25.73 68.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.794 0.838 . . . . 0.0 113.235 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -130.58 -8.71 4.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.942 1.297 . . . . 0.0 113.324 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.18 134.36 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.65 -31.72 0.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.395 -170.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 58' ' ' VAL . 36.1 mtt 64.82 -50.06 0.33 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 129.096 2.958 . . . . 0.0 113.141 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -84.21 20.06 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.255 1.022 . . . . 0.0 113.515 -171.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -63.09 -31.43 72.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 109.749 172.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -83.58 -0.65 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.556 1.143 . . . . 0.0 113.262 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 64.1 -34.21 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.609 2.764 . . . . 0.0 115.543 -175.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -132.28 71.06 79.88 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.942 1.697 . . . . 0.0 107.435 172.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.02 -166.32 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.737 2.958 . . . . 0.0 110.453 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.33 -3.83 26.54 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.401 169.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.79 155.75 49.4 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 121.662 2.028 . . . . 0.0 112.375 -172.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.03 -25.52 2.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.801 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.1 150.75 22.17 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -122.25 146.89 46.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 110.81 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -152.31 124.7 8.23 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.677 1.191 . . . . 0.0 107.89 169.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -76.88 143.94 39.31 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.745 0.702 . . . . 0.0 109.144 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.57 168.15 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.59 0.756 . . . . 0.0 109.692 -169.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.9 m -48.79 145.11 3.98 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.094 1.357 . . . . 0.0 111.054 -177.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -52.58 -38.8 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -168.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -95.92 -4.37 43.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.74 -43.23 91.33 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.156 -1.402 . . . . 0.0 112.31 -170.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -58.05 -34.23 98.2 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 122.173 1.812 . . . . 0.0 113.074 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.69 -45.8 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -64.16 -30.61 71.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.737 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -78.95 -30.94 44.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 112.154 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.27 157.34 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.869 0.758 . . . . 0.0 110.974 -170.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.69 148.68 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.517 1.527 . . . . 0.0 111.709 174.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -57.97 -34.34 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.179 1.392 . . . . 0.0 113.849 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -72.66 -28.11 62.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.815 0.734 . . . . 0.0 111.543 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -89.25 -31.95 17.63 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.141 174.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -47.21 -44.82 22.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.599 1.16 . . . . 0.0 112.24 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.88 -34.33 75.27 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 p -83.81 -32.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.954 -0.466 . . . . 0.0 110.549 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -31.99 73.17 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.054 -1.029 . . . . 0.0 110.306 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -53.24 -40.52 64.62 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.058 -1.026 . . . . 0.0 111.606 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -63.94 -46.4 84.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.26 0.936 . . . . 0.0 109.614 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -53.73 -50.22 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 109.447 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.9 mmt -64.33 -45.1 89.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.273 -177.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -57.6 -44.37 85.36 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.091 0.957 . . . . 0.0 111.091 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -64.63 -25.51 67.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.409 0.684 . . . . 0.0 110.845 -174.693 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -108.95 -8.82 15.17 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.811 1.245 . . . . 0.0 113.683 -175.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.52 -63.55 1.1 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.348 0.976 . . . . 0.0 112.056 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 m -63.25 -22.31 66.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.216 -0.302 . . . . 0.0 111.778 -178.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -76.1 -36.66 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 O-C-N 121.382 -0.824 . . . . 0.0 108.909 -175.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.43 -48.89 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.6 mtt -65.33 -22.33 66.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.624 0.647 . . . . 0.0 112.725 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.8 m -62.85 -26.79 68.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.458 1.026 . . . . 0.0 111.635 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.9 -51.22 58.03 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.72 -25.79 63.1 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.002 0.521 . . . . 0.0 111.132 -173.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 124.065 0.946 . . . . 0.0 111.637 173.385 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 3' ' ' ASP . 51.4 mm -125.58 138.8 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 2' ' ' ILE . 59.9 t0 -66.93 152.16 46.24 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 165.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -36.3 -55.35 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.153 1.781 . . . . 0.0 114.684 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.01 -2.21 58.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.048 0.928 . . . . 0.0 112.976 -158.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.59 20.22 4.71 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.218 -1.551 . . . . 0.0 111.325 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.73 136.6 43.95 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.095 0.95 . . . . 0.0 109.135 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -85.13 122.74 73.97 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -72.06 133.19 20.97 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.302 1.335 . . . . 0.0 110.653 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . 0.261 2.2 m-80 -144.45 168.3 20.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.361 1.464 . . . . 0.0 110.349 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.39 130.98 70.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 126.182 1.793 . . . . 0.0 107.525 168.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.38 128.92 9.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -88.48 118.53 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.54 83.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 165.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.31 133.46 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 164.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 m -118.33 120.84 38.83 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -83.39 118.11 23.5 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 112.12 -2.309 . . . . 0.0 105.391 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' A' ' 18' ' ' ARG . 16.9 mtt180 -47.84 -1.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -76.55 -4.27 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 120.259 1.391 . . . . 0.0 111.548 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.76 24.25 8.8 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 119.836 1.198 . . . . 0.0 113.323 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.47 162.59 31.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -166.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.93 165.21 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -165.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.4 tpt -53.28 129.42 31.55 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 112.629 -2.078 . . . . 0.0 110.101 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -158.63 134.85 9.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 161.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -147.05 141.71 26.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.023 0.916 . . . . 0.0 110.218 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -72.64 135.84 45.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -85.62 124.75 32.51 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.34 133.56 34.61 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.373 2.269 . . . . 0.0 110.911 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.4 -14.54 3.12 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 125.6 1.571 . . . . 0.0 114.133 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -105.44 -35.59 7.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.783 0.792 . . . . 0.0 111.447 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.4 m80 66.66 27.36 9.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.767 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.78 171.63 14.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -84.15 161.04 20.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -148.12 150.29 33.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.501 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' NZ ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -65.76 158.8 73.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.432 165.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' PHE . 2.9 Cg_exo -77.43 154.67 31.8 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.039 3.826 . . . . 0.0 112.027 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 169.38 139.37 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 128.053 2.541 . . . . 0.0 105.808 171.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.86 141.43 11.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 156.52 53.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mt -87.8 138.72 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.253 51.1 t30 -85.71 139.21 35.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 125.089 1.356 . . . . 0.0 109.24 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.51 118.48 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.195 1.93 . . . . 0.0 113.636 -172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.19 89.62 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.036 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -87.63 123.91 32.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.861 1.33 . . . . 0.0 107.744 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.68 165.06 24.78 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.24 -44.11 71.46 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.295 1.038 . . . . 0.0 112.538 -168.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.93 -40.48 72.05 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.318 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -63.86 -44.26 93.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.347 0.659 . . . . 0.0 109.79 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.07 77.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.857 0.863 . . . . 0.0 111.553 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -60.75 -44.07 97.17 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.779 -0.576 . . . . 0.0 109.713 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -69.18 -26.25 64.75 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.884 -1.135 . . . . 0.0 112.539 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -61.65 -52.67 63.38 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.441 -0.787 . . . . 0.0 109.332 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.6 90.61 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.414 0.626 . . . . 0.0 109.848 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.3 tp -52.58 -43.81 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.798 -1.814 . . . . 0.0 111.031 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.15 -49.14 53.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.973 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.72 -33.93 77.13 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.008 1.277 . . . . 0.0 112.105 -174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.77 -45.83 5.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.59 0.709 . . . . 0.0 110.042 -169.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -15.62 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 121.797 -0.564 . . . . 0.0 110.401 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.88 37.21 94.02 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 117.093 -1.948 . . . . 0.0 112.209 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -113.87 158.81 20.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.544 1.172 . . . . 0.0 108.87 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -117.69 -177.87 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.881 -0.512 . . . . 0.0 110.209 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.72 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.282 1.833 . . . . 0.0 114.736 -174.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -161.15 -18.5 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.05 -1.031 . . . . 0.0 111.434 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.54 1.11 55.52 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.915 0.864 . . . . 0.0 111.008 -167.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 102' ' ' LEU . 27.9 m -152.42 169.48 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -168.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -142.25 117.49 10.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -167.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.97 130.62 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -36.04 6.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.007 0.923 . . . . 0.0 110.932 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.81 170.29 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.049 0.94 . . . . 0.0 108.715 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -145.99 164.29 32.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 109.475 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -63.57 140.2 58.85 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.764 0.792 . . . . 0.0 108.917 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -64.77 -29.51 70.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.351 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.44 174.22 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -65.47 115.47 5.74 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.673 0.789 . . . . 0.0 109.014 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 156.05 39.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -160.82 159.05 29.44 Favored 'General case' 0 CA--C 1.487 -1.481 0 O-C-N 120.683 -1.261 . . . . 0.0 108.13 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.3 p90 -159.91 170.03 22.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.61 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -109.38 129.88 55.52 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 111.921 -2.4 . . . . 0.0 106.059 -162.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -70.77 143.54 89.63 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -63.04 155.29 61.8 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -49.84 -45.62 50.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -71.77 -18.68 62.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.6 tp -102.47 -18.17 15.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.678 0.791 . . . . 0.0 111.764 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.3 t -52.0 140.49 6.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -76.21 -38.0 57.03 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.351 2.723 . . . . 0.0 118.351 -170.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.716 ' HA ' ' CG1' ' A' ' 91' ' ' VAL 0.326 10.2 m95 53.48 -8.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 -167.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.17 -27.86 11.32 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.397 1.453 . . . . 0.0 110.276 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.0 p -69.54 151.77 45.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -138.14 114.58 9.13 Favored Pre-proline 0 CA--C 1.499 -1.012 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -55.01 154.13 20.12 Favored 'Cis proline' 0 C--O 1.237 0.436 0 O-C-N 123.151 1.08 . . . . 0.0 113.45 -6.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -55.53 130.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.46 171.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 46.5 t -92.86 108.49 20.03 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 pt -101.77 -2.46 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.762 1.625 . . . . 0.0 111.608 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.24 43.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.597 1.09 . . . . 0.0 112.934 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 113.66 27.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.548 1.539 . . . . 0.0 107.178 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.79 122.56 26.77 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 132.6 26.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.582 1.083 . . . . 0.0 112.844 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -104.31 125.53 50.64 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 165.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -96.17 144.11 26.68 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -118.34 128.62 54.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.7 114.95 19.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 65' ' ' VAL . 3.3 mm? -110.46 122.16 47.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -79.17 136.73 37.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.472 HD21 ' HA2' ' A' ' 107' ' ' GLY . 19.1 tp -72.81 124.22 24.94 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.76 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.97 -41.15 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.255 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -89.73 -140.74 0.14 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.472 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . -179.84 -168.82 39.21 Favored Glycine 0 CA--C 1.487 -1.695 0 O-C-N 119.572 -1.955 . . . . 0.0 110.221 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -29.9 -41.26 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 126.846 2.059 . . . . 0.0 114.987 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.62 66.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 54.0 mm-40 -106.87 -23.4 12.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.195 1.798 . . . . 0.0 110.358 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mt -56.18 132.33 20.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.17 -25.89 4.81 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 119.127 -0.463 . . . . 0.0 112.173 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.5 mtt 41.0 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 119.338 3.088 . . . . 0.0 119.338 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -121.71 21.96 10.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 123.461 2.846 . . . . 0.0 110.926 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -37.49 82.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.731 2.012 . . . . 0.0 111.172 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.88 2.67 53.36 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.86 -0.591 . . . . 0.0 112.589 -166.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 m 66.31 -36.26 0.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 115.03 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -131.53 68.97 81.59 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 125.357 1.463 . . . . 0.0 107.169 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.07 -166.82 0.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.318 2.012 . . . . 0.0 109.927 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -110.3 -19.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.896 -1.049 . . . . 0.0 112.695 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -120.07 151.72 38.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.958 1.254 . . . . 0.0 111.309 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.9 -19.79 7.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.811 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.72 158.52 8.43 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 104.727 -3.349 . . . . 0.0 104.727 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.672 ' O ' ' CE3' ' A' ' 124' ' ' TRP 0.589 0.0 OUTLIER -138.76 -175.39 4.12 Favored 'General case' 0 C--N 1.294 -1.829 2 N-CA-C 126.538 5.755 . . . . 0.0 126.538 -154.136 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 124' ' ' TRP 0.254 12.3 ttt180 -169.54 131.78 1.17 Allowed 'General case' 0 CA--C 1.483 -1.634 1 O-C-N 115.477 -4.515 . . . . 0.0 102.967 171.065 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -72.95 133.66 44.42 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.6 161.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -51.21 151.35 2.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.587 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.413 ' O ' ' HD2' ' A' ' 132' ' ' PRO 0.331 12.5 t80 -45.66 -90.42 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.229 1.412 . . . . 0.0 112.715 -173.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -45.3 -4.19 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 120.459 3.503 . . . . 0.0 120.459 170.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.1 -51.66 78.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.833 2.561 . . . . 0.0 112.983 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 129' ' ' TYR . 58.2 Cg_exo -57.34 -32.57 94.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.165 1.91 . . . . 0.0 113.837 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 t -57.84 -39.61 72.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.642 ' HE ' ' HA ' ' A' ' 134' ' ' ARG . 1.4 mmm-85 -77.32 -26.81 52.56 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.054 -1.654 . . . . 0.0 114.074 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.571 ' HA ' ' OE1' ' A' ' 135' ' ' GLN . 3.9 mm-40 -78.46 -25.3 45.83 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 125.655 1.847 . . . . 0.0 114.499 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG11 ' HD2' ' A' ' 144' ' ' TYR 0.265 13.2 p -79.02 157.76 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 CA-C-O 122.853 1.311 . . . . 0.0 109.861 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.0 m -56.09 150.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.941 1.296 . . . . 0.0 111.03 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -60.21 -34.13 73.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -72.92 -30.77 64.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.828 0.74 . . . . 0.0 111.162 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' NZ ' ' CZ ' ' A' ' 35' ' ' PHE . 10.5 mttt -81.93 -32.21 30.94 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.533 ' CZ ' HH21 ' A' ' 134' ' ' ARG . 29.2 ttp180 -47.11 -48.53 22.98 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 124.77 1.294 . . . . 0.0 112.243 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.46 -45.62 93.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.128 0.966 . . . . 0.0 110.031 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 77' ' ' TYR . 1.1 t -69.3 -40.47 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 O-C-N 120.937 -1.102 . . . . 0.0 110.311 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.498 ' HD2' HG11 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -67.32 -31.9 72.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 110.502 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -53.17 -41.79 65.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.661 0.785 . . . . 0.0 112.627 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -66.87 -45.39 78.24 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -53.53 -49.42 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 O-C-N 124.312 1.007 . . . . 0.0 109.143 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -65.33 -41.99 93.4 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.742 -0.599 . . . . 0.0 111.203 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.637 -1.289 . . . . 0.0 111.389 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -61.44 -26.26 67.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.596 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.8 -6.9 11.52 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.906 0.775 . . . . 0.0 113.071 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.56 44.44 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.265 0.939 . . . . 0.0 110.504 -167.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.7 m -65.7 -23.67 66.82 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.924 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.39 -32.95 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 120.17 -1.581 . . . . 0.0 109.656 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.13 -43.07 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.14 -31.43 71.86 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 116.918 -1.515 . . . . 0.0 110.429 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -55.93 -28.83 58.65 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 120.411 1.46 . . . . 0.0 111.401 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' A' ' 164' ' ' LYS . 1.3 mt -77.65 -20.29 54.03 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 114.695 -2.574 . . . . 0.0 112.244 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.528 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 35.3 mm-40 -108.16 -7.92 15.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.787 2.035 . . . . 0.0 110.056 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.923 ' C ' ' HA ' ' A' ' 164' ' ' LYS . 3.5 tt0 -125.72 16.69 8.09 Favored 'General case' 1 CA--C 1.682 6.036 2 C-N-CA 137.261 6.224 . . . . 0.0 125.534 174.047 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 1.515 ' N ' ' CA ' ' A' ' 161' ' ' ASN . 8.2 t30 -51.25 -25.08 5.1 Favored 'General case' 2 CA--C 1.858 12.812 3 N-CA-C 136.321 9.378 . . . . 0.0 136.321 126.477 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 1.605 ' CA ' ' CB ' ' A' ' 162' ' ' THR 1.923 0.0 OUTLIER -175.72 106.03 0.25 Allowed Pre-proline 3 N--CA 1.665 10.282 5 C-N-CA 158.435 14.694 . . . . 0.0 80.495 158.427 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.751 ' HA ' ' CB ' ' A' ' 162' ' ' THR 0.835 0.0 OUTLIER -70.05 -34.21 3.18 Favored 'Cis proline' 1 C--N 1.555 11.405 3 C-N-CA 98.832 -11.737 . . . . 0.0 97.154 21.473 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 1.615 ' CA ' ' CB ' ' A' ' 164' ' ' LYS 1.073 15.1 mtmm . . . . . 2 N--CA 1.318 -7.047 3 C-N-CA 139.152 6.981 . . . . 0.0 94.55 107.403 . . . . . . . . 4 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.3 mm -137.27 148.19 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.27 -45.93 71.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.29 0.636 . . . . 0.0 111.949 -170.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -152.01 -85.22 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.537 1.135 . . . . 0.0 109.963 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.3 -39.95 13.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -169.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.3 21.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.102 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.37 137.49 50.45 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.704 1.252 . . . . 0.0 109.796 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -109.93 118.76 49.17 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.163 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.05 135.06 45.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.258 1.972 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -145.41 158.87 43.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.398 1.879 . . . . 0.0 110.543 -172.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -136.44 76.25 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.707 2.003 . . . . 0.0 109.03 -173.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.6 126.54 30.22 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mm -90.34 105.21 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.57 79.78 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -62.89 135.12 27.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.8 m -123.6 130.83 53.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 168.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -87.69 136.78 32.81 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.86 -10.01 8.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.188 1.795 . . . . 0.0 114.313 -174.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.79 -13.26 62.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.128 0.876 . . . . 0.0 110.825 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.11 38.3 3.37 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.386 1.946 . . . . 0.0 112.163 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -136.38 149.49 48.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.67 167.03 3.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 112.764 -168.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 127.55 32.68 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.622 1.569 . . . . 0.0 110.509 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -156.97 134.63 10.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 168.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.81 146.34 25.63 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -71.32 127.99 34.39 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.25 128.42 34.48 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -53.25 136.97 35.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.429 1.492 . . . . 0.0 110.263 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.27 -37.85 2.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.8 1.19 . . . . 0.0 113.198 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.55 -39.05 25.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.149 0.975 . . . . 0.0 110.091 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.271 17.4 m170 58.92 34.27 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.04 1.736 . . . . 0.0 112.795 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -140.44 158.73 43.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.976 2.11 . . . . 0.0 106.742 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -65.86 152.25 44.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.183 0.993 . . . . 0.0 112.554 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -148.18 156.74 42.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.563 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -69.4 160.72 77.95 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.816 2.446 . . . . 0.0 111.748 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.64 147.12 95.2 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.017 2.478 . . . . 0.0 110.981 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -165.5 153.31 10.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.348 1.859 . . . . 0.0 107.745 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.89 136.84 3.75 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.76 168.83 54.88 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 118.235 1.018 . . . . 0.0 110.853 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.37 140.8 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 108.516 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -85.51 138.0 36.22 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.566 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -58.35 117.32 4.01 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.486 1.457 . . . . 0.0 112.876 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.45 -0.11 84.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.776 1.179 . . . . 0.0 113.046 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.5 120.05 34.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.652 1.226 . . . . 0.0 107.805 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -71.8 165.44 24.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.479 0.712 . . . . 0.0 111.37 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -46.61 64.89 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.239 1.416 . . . . 0.0 111.481 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.37 29.43 0.76 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.577 0.703 . . . . 0.0 110.301 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.01 -48.66 0.67 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.609 1.964 . . . . 0.0 106.51 170.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.6 74.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.828 1.251 . . . . 0.0 112.015 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -56.92 -45.45 82.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.9 m-85 -73.79 -28.5 61.68 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.027 -1.046 . . . . 0.0 112.052 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -61.39 -46.63 89.37 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.722 -1.236 . . . . 0.0 108.761 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.39 97.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 tp -54.9 -44.6 74.29 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.822 1.649 . . . . 0.0 110.243 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -44.51 88.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.909 0.884 . . . . 0.0 111.252 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.42 -29.08 66.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.781 1.173 . . . . 0.0 112.894 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.26 -48.08 6.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 111.465 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.17 0.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 119.819 1.19 . . . . 0.0 113.69 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 31.31 80.12 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.988 0.813 . . . . 0.0 112.002 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 mt -103.92 152.24 22.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -115.77 -177.29 3.12 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.381 0.673 . . . . 0.0 110.176 -173.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 18.2 ptp180 -71.92 47.55 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.744 2.018 . . . . 0.0 112.575 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -160.68 -19.34 0.05 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.375 1.47 . . . . 0.0 112.341 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -93.85 -0.1 55.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 112.124 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.37 169.33 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.011 0.924 . . . . 0.0 109.448 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -139.36 121.44 15.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.4 mt -74.82 128.01 36.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.92 -30.76 9.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.781 0.433 . . . . 0.0 110.794 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 166.56 29.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.134 0.974 . . . . 0.0 109.366 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.7 p -144.43 158.27 43.84 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.196 1.399 . . . . 0.0 108.244 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -62.95 140.73 58.87 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -60.29 -30.24 69.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -141.83 175.38 9.76 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.707 1.603 . . . . 0.0 106.773 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -66.56 133.51 50.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -87.79 152.3 22.22 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.126 0.97 . . . . 0.0 108.634 169.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -150.41 161.05 43.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -140.99 173.82 11.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.381 1.872 . . . . 0.0 106.822 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -97.99 130.75 44.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.32 145.75 98.99 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 170.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -64.93 155.07 69.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.384 2.056 . . . . 0.0 108.465 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -73.15 -24.67 60.62 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.97 0.908 . . . . 0.0 112.816 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.4 tp -99.24 -21.42 16.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.677 0.791 . . . . 0.0 111.727 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.95 141.16 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -75.83 -42.2 50.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -168.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 42.5 m95 56.31 9.74 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.868 2.467 . . . . 0.0 114.61 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.08 -17.42 5.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.003 0.921 . . . . 0.0 113.224 -169.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 p -73.5 -35.64 65.64 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.691 -0.631 . . . . 0.0 112.075 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 46.13 88.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.461 2.304 . . . . 0.0 112.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.83 143.69 51.54 Favored 'Cis proline' 0 C--N 1.353 0.775 0 CA-C-N 119.617 0.899 . . . . 0.0 113.699 9.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.6 t -56.64 121.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.08 1.352 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -89.48 120.0 30.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.4 pt -115.86 -4.16 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.02 1.328 . . . . 0.0 111.929 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.12 15.88 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.852 1.206 . . . . 0.0 111.074 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -85.69 127.73 34.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -85.31 115.07 22.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -122.95 122.74 39.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 120.187 1.358 . . . . 0.0 112.49 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -103.21 107.14 17.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 167.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -82.53 142.19 32.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.24 132.22 55.9 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.58 118.14 22.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.75 124.14 50.02 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.382 1.073 . . . . 0.0 109.366 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -86.58 134.74 33.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.74 136.63 57.97 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.85 -29.1 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -123.78 120.92 34.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.19 33.52 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 121.667 0.593 . . . . 0.0 113.166 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.46 -29.04 5.96 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.04 1.336 . . . . 0.0 113.251 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.64 68.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.127 0.571 . . . . 0.0 111.998 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -109.64 -11.79 14.72 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.2 mt -59.75 134.08 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.44 63.85 1.31 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.0 mtt -48.49 -26.48 2.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 114.157 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.52 24.67 2.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.945 1.248 . . . . 0.0 112.618 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -44.43 68.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.077 1.751 . . . . 0.0 111.762 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.7 m -96.97 9.67 41.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 m 67.54 -36.69 0.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.467 2.707 . . . . 0.0 114.825 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.2 p -126.53 73.21 73.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.04 1.736 . . . . 0.0 106.985 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -78.98 -165.81 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.783 2.989 . . . . 0.0 110.983 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -106.6 -19.18 13.75 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.609 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.23 157.76 29.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 121.64 2.018 . . . . 0.0 112.095 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.32 -25.88 1.31 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.617 1.567 . . . . 0.0 112.548 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.19 147.32 14.98 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -99.09 154.74 17.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.575 1.15 . . . . 0.0 111.091 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -156.04 112.25 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.166 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -78.17 134.98 37.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.163 1.347 . . . . 0.0 107.867 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.0 160.73 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.721 1.209 . . . . 0.0 109.903 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.34 150.09 3.69 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.523 0.678 . . . . 0.0 110.823 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.34 148.38 32.54 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.0 m95 66.06 -10.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -61.73 -50.74 80.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 121.748 2.067 . . . . 0.0 111.371 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -59.28 -31.26 94.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.037 1.825 . . . . 0.0 112.658 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.45 -37.21 78.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.652 0.781 . . . . 0.0 109.801 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mmm-85 -81.8 -27.98 33.4 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.771 1.168 . . . . 0.0 111.347 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -73.53 -30.43 63.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.873 0.76 . . . . 0.0 111.85 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.96 157.22 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 119.162 0.892 . . . . 0.0 111.74 -169.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -52.06 148.88 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.186 1.794 . . . . 0.0 112.401 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -63.26 -32.81 74.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 113.55 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -70.07 -29.88 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.307 0.958 . . . . 0.0 111.054 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -86.11 -40.22 15.92 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 117.45 -1.262 . . . . 0.0 112.212 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -40.7 -49.97 3.07 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.877 1.217 . . . . 0.0 113.675 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.93 -31.12 68.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 75' ' ' LEU . 24.3 t -78.6 -40.59 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.846 0.859 . . . . 0.0 110.314 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.24 -30.67 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -56.95 -41.24 77.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.987 -1.071 . . . . 0.0 110.802 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -66.59 -46.9 74.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.297 0.953 . . . . 0.0 109.026 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.73 -44.85 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.9 mtt -70.17 -38.17 75.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.447 -0.783 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -64.52 -37.02 86.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.209 0.913 . . . . 0.0 110.624 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.33 -28.06 66.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 110.592 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -113.31 -12.19 13.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.46 -58.1 8.32 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.663 1.119 . . . . 0.0 111.704 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.9 m -74.38 5.86 4.22 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.84 0.23 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.447 1.899 . . . . 0.0 109.401 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.2 t -118.38 -54.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.9 mtt -60.55 -22.15 63.33 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.889 1.275 . . . . 0.0 111.51 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.4 p -53.7 -40.67 66.23 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 111.844 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.19 -39.49 86.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.125 0.97 . . . . 0.0 109.785 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -84.34 -36.14 22.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.342 0.657 . . . . 0.0 111.093 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.1 -35.12 79.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.653 0.781 . . . . 0.0 109.101 170.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.46 -16.12 0.07 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 129.745 3.218 . . . . 0.0 116.623 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 p -77.3 -29.33 0.69 Allowed Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -67.68 -37.56 16.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.515 2.143 . . . . 0.0 112.756 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.8 mttm . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.016 1.726 . . . . 0.0 110.197 -176.798 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.68 137.62 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.31 150.49 25.86 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.882 1.673 . . . . 0.0 110.062 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.41 -28.5 66.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.912 0.885 . . . . 0.0 113.03 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.94 2.34 43.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.262 1.025 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.72 29.06 11.18 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.575 1.559 . . . . 0.0 112.586 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -109.23 141.29 41.71 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.138 1.469 . . . . 0.0 110.932 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.65 127.45 52.38 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.33 135.66 34.74 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -143.03 159.17 42.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.106 1.762 . . . . 0.0 111.534 -169.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.674 1.59 . . . . 0.0 107.933 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.13 124.0 34.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mm -87.05 118.45 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.54 81.0 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -65.18 145.64 13.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -131.67 131.5 43.19 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 168.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.6 129.86 35.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -44.74 -27.86 0.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.112 1.765 . . . . 0.0 114.482 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.15 15.59 0.16 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.216 1.006 . . . . 0.0 112.561 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.09 17.48 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.212 1.387 . . . . 0.0 112.432 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -129.5 154.55 46.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.166 1.386 . . . . 0.0 108.147 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.19 161.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.511 0.725 . . . . 0.0 112.303 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.22 128.21 34.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.731 1.212 . . . . 0.0 109.813 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.43 133.27 8.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 168.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 121' ' ' PHE . . . -153.02 147.03 25.43 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -67.73 125.46 26.3 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -74.85 128.46 35.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.39 146.05 41.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 169.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.03 -44.4 2.6 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.113 0.863 . . . . 0.0 112.977 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -77.7 -34.48 52.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 109.219 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 54.65 39.48 31.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.654 1.982 . . . . 0.0 111.285 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 p -160.25 170.2 21.62 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -70.72 149.81 46.56 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.457 -0.777 . . . . 0.0 111.398 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -156.25 149.3 24.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.352 1.061 . . . . 0.0 108.6 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -47.79 137.48 10.09 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.583 1.953 . . . . 0.0 111.589 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.13 136.22 50.97 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.974 1.783 . . . . 0.0 109.802 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -162.13 139.76 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.184 2.194 . . . . 0.0 106.006 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.15 -97.75 1.44 Allowed Glycine 0 CA--C 1.531 1.072 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.63 167.31 23.89 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.4 mt -114.58 148.46 17.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -99.78 154.27 37.34 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.698 1.199 . . . . 0.0 110.275 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.27 117.91 4.74 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.939 1.759 . . . . 0.0 111.208 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.53 5.37 89.57 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.997 1.284 . . . . 0.0 112.809 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.48 127.04 34.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.41 160.71 29.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.175 0.99 . . . . 0.0 110.401 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.35 74.57 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.836 0.854 . . . . 0.0 112.92 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.8 -44.23 64.29 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.26 -43.08 96.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.8 1.24 . . . . 0.0 109.421 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.315 0.646 . . . . 0.0 111.509 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -60.14 -42.66 95.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.05 0.841 . . . . 0.0 109.307 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 89.7 m-85 -69.46 -24.53 63.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.604 1.093 . . . . 0.0 112.167 172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -66.99 -50.56 61.88 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.825 -1.172 . . . . 0.0 108.176 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.18 -30.52 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.187 0.903 . . . . 0.0 111.746 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.0 tp -57.3 -39.48 75.86 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -54.47 10.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.251 1.02 . . . . 0.0 110.915 172.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.78 -36.26 80.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.539 1.063 . . . . 0.0 111.893 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -95.72 -52.12 4.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.661 0.784 . . . . 0.0 111.36 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.37 -15.2 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.564 0.62 . . . . 0.0 112.375 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.01 56.46 24.55 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -173.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.4 mt -137.22 158.87 43.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.6 1.96 . . . . 0.0 106.537 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -125.45 -172.61 2.63 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.839 0.856 . . . . 0.0 111.312 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.0 mtt180 -64.99 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.968 3.307 . . . . 0.0 114.29 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -159.27 -14.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.185 0.994 . . . . 0.0 113.384 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -91.22 2.0 56.69 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.693 1.197 . . . . 0.0 113.093 -169.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.76 169.23 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.952 0.901 . . . . 0.0 110.498 -168.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -134.73 112.91 11.15 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 102' ' ' LEU . 45.4 mt -71.51 130.51 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 120.086 1.312 . . . . 0.0 107.515 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.88 -36.22 6.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.007 0.523 . . . . 0.0 111.762 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.76 173.2 16.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.721 1.209 . . . . 0.0 108.938 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 t -150.91 162.26 41.13 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 170.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -64.39 143.33 57.98 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.767 0.712 . . . . 0.0 109.665 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -63.54 -30.66 71.75 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.818 0.447 . . . . 0.0 111.888 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.63 168.86 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.652 1.581 . . . . 0.0 108.093 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -64.67 124.79 22.82 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.13 0.572 . . . . 0.0 109.465 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.93 158.66 27.98 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -142.34 137.35 30.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -145.53 154.48 42.24 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -100.17 146.41 26.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.37 140.82 60.83 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.46 154.2 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.156 1.904 . . . . 0.0 109.093 169.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -44.43 79.9 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.04 -1.038 . . . . 0.0 113.631 -169.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.5 -15.69 62.92 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.131 0.973 . . . . 0.0 112.559 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 tp -99.29 -6.59 27.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.476 1.51 . . . . 0.0 111.929 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.55 145.11 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 120.797 1.635 . . . . 0.0 107.765 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -77.95 -43.68 29.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.838 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.1 m95 59.3 4.17 0.45 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.924 2.49 . . . . 0.0 114.561 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -118.9 -18.12 8.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.599 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -74.23 -38.4 63.53 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.846 -0.534 . . . . 0.0 111.49 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 46.53 87.44 0.12 Allowed Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 127.73 2.412 . . . . 0.0 112.164 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -60.31 138.99 21.89 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.032 1.047 . . . . 0.0 114.305 9.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -57.31 120.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.658 1.583 . . . . 0.0 107.523 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 47.1 t -91.71 126.84 36.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -119.5 -3.19 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.898 1.679 . . . . 0.0 112.08 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.0 37.6 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 120.408 1.458 . . . . 0.0 112.627 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -100.98 125.76 47.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 171.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -89.48 110.69 21.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.81 127.27 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 120.719 1.599 . . . . 0.0 112.153 -171.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -101.11 123.1 44.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -98.3 124.49 42.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.25 136.57 36.55 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.92 116.31 28.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 67' ' ' ILE . 30.4 mt -111.67 136.28 51.11 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 110.591 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -93.92 136.9 33.72 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.7 tp -82.53 106.94 14.8 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -30.47 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 111.547 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 p -59.73 -60.96 3.01 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 111.436 171.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.54 176.01 38.66 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.166 0.889 . . . . 0.0 111.549 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -43.48 -37.09 2.25 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.441 1.497 . . . . 0.0 112.596 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.35 -21.26 61.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -129.74 -13.41 4.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.54 1.136 . . . . 0.0 112.77 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.57 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.23 50.16 1.62 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.116 0.966 . . . . 0.0 109.653 -169.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.7 mtt -45.46 -15.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 -169.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.06 22.53 10.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.958 1.708 . . . . 0.0 112.613 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 p -65.94 -32.22 73.59 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 112.073 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.58 -3.94 58.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -169.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m 66.33 -40.42 0.35 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.368 2.267 . . . . 0.0 113.072 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -128.15 79.24 74.24 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 126.932 2.093 . . . . 0.0 105.807 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.02 -161.94 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.781 2.987 . . . . 0.0 110.973 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -112.34 -38.41 4.7 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.55 -1.214 . . . . 0.0 112.557 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 43.1 m-85 -106.35 161.3 14.68 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.267 1.849 . . . . 0.0 111.31 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -128.68 -29.44 2.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.575 1.55 . . . . 0.0 112.418 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.57 152.5 22.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -104.3 160.44 14.89 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.066 0.946 . . . . 0.0 111.827 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -154.31 117.85 4.6 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.337 1.855 . . . . 0.0 106.451 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -79.41 130.98 35.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.357 1.435 . . . . 0.0 107.443 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.81 162.27 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.476 1.11 . . . . 0.0 110.268 -170.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.8 m -53.64 148.82 9.06 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.703 0.763 . . . . 0.0 111.75 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.18 144.95 48.78 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.38 -1.17 1.3 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -68.44 -49.83 29.86 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 121.385 1.902 . . . . 0.0 111.201 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -63.9 -32.2 66.42 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 121.286 1.495 . . . . 0.0 114.453 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 m -61.29 -31.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 120.093 1.315 . . . . 0.0 111.575 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.22 -14.89 34.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.58 1.082 . . . . 0.0 111.737 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -75.59 -33.77 60.6 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 109.502 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.3 153.77 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.499 1.52 . . . . 0.0 110.377 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.11 149.91 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.438 1.495 . . . . 0.0 111.016 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 m -57.13 -35.63 69.73 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.023 1.329 . . . . 0.0 114.159 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -71.3 -27.55 63.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.102 0.864 . . . . 0.0 111.388 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -98.18 -22.12 16.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.188 0.995 . . . . 0.0 112.358 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -49.54 -43.05 45.54 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.033 0.933 . . . . 0.0 110.947 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.37 -45.55 87.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.669 0.668 . . . . 0.0 111.787 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.45 -35.51 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.743 -0.598 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.56 -30.76 67.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.215 -0.928 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -61.59 -38.63 88.25 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.552 -1.342 . . . . 0.0 109.646 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -64.45 -42.68 95.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.18 1.355 . . . . 0.0 109.937 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.83 -46.55 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 118.934 0.788 . . . . 0.0 109.214 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 46.7 mtt -68.97 -38.07 79.16 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.88 -0.513 . . . . 0.0 110.512 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -66.68 -33.82 76.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.333 1.053 . . . . 0.0 110.764 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.03 -26.04 67.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.355 0.662 . . . . 0.0 111.406 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -120.39 -6.12 9.83 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.39 -58.41 6.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.209 0.913 . . . . 0.0 111.48 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -64.03 -27.15 68.92 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.071 -0.393 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.19 -40.42 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.096 -1.002 . . . . 0.0 108.612 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.02 -41.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.529 0.732 . . . . 0.0 109.345 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 49.2 mtt -71.97 -25.55 61.9 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.04 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.1 m -50.74 -41.14 56.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.477 1.035 . . . . 0.0 111.874 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.02 -37.78 88.58 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -99.7 22.2 11.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.924 0.89 . . . . 0.0 111.97 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.34 8.06 5.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.247 1.819 . . . . 0.0 109.644 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -75.39 -26.69 58.66 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.516 -0.74 . . . . 0.0 110.081 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.4 p -140.7 161.39 54.6 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 131.402 3.881 . . . . 0.0 102.635 169.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.1 73.86 5.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.942 1.761 . . . . 0.0 110.014 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.944 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.39 138.49 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.15 149.25 48.84 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.731 1.612 . . . . 0.0 108.238 171.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.86 -32.1 19.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.92 1.35 35.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.05 35.54 7.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.581 1.562 . . . . 0.0 111.531 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 13.8 m-85 -116.43 139.99 49.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.394 1.097 . . . . 0.0 109.858 -174.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -90.99 122.21 66.95 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.106 -1.426 . . . . 0.0 107.337 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.94 130.83 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.994 1.796 . . . . 0.0 110.238 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -139.1 166.45 24.48 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.211 1.404 . . . . 0.0 109.716 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.75 138.07 50.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.16 123.38 6.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.44 111.72 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -92.52 82.74 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.66 129.27 27.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 169.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.4 m -114.66 121.03 42.12 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -80.54 139.8 36.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.78 -6.52 12.08 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -73.36 -1.82 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.109 0.868 . . . . 0.0 110.629 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.68 26.27 25.36 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 124.995 1.283 . . . . 0.0 112.49 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -124.82 161.97 25.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 0.0 108.409 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.59 163.66 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.2 tpt -53.1 134.16 38.63 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.849 2.06 . . . . 0.0 111.742 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -164.19 137.93 5.37 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 168.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.624 0.726 . . . . 0.0 110.056 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -75.8 135.33 40.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.273 1.429 . . . . 0.0 107.674 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -82.43 130.76 35.17 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -49.1 130.88 19.25 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.023 2.129 . . . . 0.0 110.658 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.26 -35.46 1.97 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.755 1.169 . . . . 0.0 113.539 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -85.13 -35.31 21.84 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.179 0.99 . . . . 0.0 110.337 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.289 91.6 m-70 56.04 34.01 22.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.961 1.705 . . . . 0.0 113.317 -174.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m -139.45 157.31 46.06 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.0 2.12 . . . . 0.0 106.288 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -65.92 158.36 28.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.548 1.139 . . . . 0.0 113.35 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.43 150.17 36.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 0.0 109.515 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -66.96 160.69 68.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.668 1.587 . . . . 0.0 111.157 169.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.73 -133.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.738 3.625 . . . . 0.0 110.05 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 76.2 116.92 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.278 2.231 . . . . 0.0 110.225 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.62 18.59 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 153.84 51.19 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.599 1.095 . . . . 0.0 112.888 -169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -90.27 139.01 18.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.839 1.656 . . . . 0.0 107.795 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.53 154.5 68.69 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.347 0.659 . . . . 0.0 110.629 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.82 117.63 4.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.884 1.722 . . . . 0.0 111.341 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.73 6.41 89.4 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.909 1.242 . . . . 0.0 112.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -81.59 130.22 34.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.78 160.37 28.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.409 1.084 . . . . 0.0 110.398 177.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.67 71.21 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 124.456 1.102 . . . . 0.0 112.445 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.05 -42.21 66.55 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.48 -42.57 96.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.869 1.268 . . . . 0.0 109.362 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -37.15 85.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 111.925 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -59.78 -44.94 93.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.122 0.873 . . . . 0.0 109.651 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.4 m-85 -70.31 -29.78 66.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.168 -0.958 . . . . 0.0 112.015 174.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -62.33 -47.6 83.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.502 1.046 . . . . 0.0 109.751 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.16 70.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.91 0.484 . . . . 0.0 111.008 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -58.31 -39.67 79.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.482 1.113 . . . . 0.0 109.939 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -74.07 -50.82 17.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.24 1.416 . . . . 0.0 111.661 175.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.94 -35.0 79.75 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.967 1.258 . . . . 0.0 112.027 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.58 -50.38 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.994 0.918 . . . . 0.0 111.816 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.4 -13.53 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.661 0.785 . . . . 0.0 111.469 -169.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.26 40.88 96.91 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.68 150.23 41.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 107.341 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.0 m -115.22 -175.61 2.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.008 0.923 . . . . 0.0 111.071 -169.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.3 mtt180 -66.09 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.356 2.663 . . . . 0.0 114.203 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -161.4 -16.23 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.773 1.229 . . . . 0.0 112.866 -169.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.59 -0.55 57.37 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.472 1.109 . . . . 0.0 112.484 -169.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.35 168.55 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.326 1.45 . . . . 0.0 108.326 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -137.83 119.97 15.62 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -74.6 129.65 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 120.23 1.377 . . . . 0.0 107.582 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.17 -32.12 7.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.81 0.444 . . . . 0.0 111.549 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.76 167.24 30.61 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.088 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 p -149.77 160.16 43.77 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.005 1.322 . . . . 0.0 107.915 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -63.62 148.22 49.49 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.734 -0.604 . . . . 0.0 110.791 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -64.84 -37.06 86.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.79 0.436 . . . . 0.0 111.253 -171.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.84 172.95 14.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.575 1.95 . . . . 0.0 107.39 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -63.36 125.68 24.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.588 0.755 . . . . 0.0 110.148 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.62 133.44 37.27 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.38 150.38 32.35 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.218 0.917 . . . . 0.0 110.273 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.57 160.36 43.86 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.47 1.108 . . . . 0.0 109.077 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -91.76 128.36 37.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.62 148.22 95.0 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.523 1.129 . . . . 0.0 109.282 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.21 155.7 68.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.671 2.247 . . . . 0.0 109.755 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -54.32 -35.21 62.43 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.79 -24.2 55.93 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.194 0.998 . . . . 0.0 112.971 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.49 -17.36 15.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.947 0.899 . . . . 0.0 111.759 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.4 t -49.01 132.75 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 168.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.74 107.19 16.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -89.21 -1.93 58.28 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.495 0.718 . . . . 0.0 111.021 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.98 -20.82 21.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.754 1.622 . . . . 0.0 110.013 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 p -87.24 162.93 17.17 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.815 0.846 . . . . 0.0 108.811 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -136.69 113.24 9.99 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -54.61 152.4 19.31 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-N 120.21 1.111 . . . . 0.0 113.116 -6.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.44 129.88 26.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.2 t -90.38 109.73 20.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.58 -6.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.825 1.25 . . . . 0.0 112.024 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.454 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -157.46 169.61 34.43 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.086 1.312 . . . . 0.0 113.014 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -115.18 122.91 47.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -101.98 134.06 45.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -152.78 146.74 25.33 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.904 1.229 . . . . 0.0 114.147 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -104.72 127.82 52.62 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 102.788 -3.042 . . . . 0.0 102.788 168.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -97.25 135.72 38.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -112.68 129.75 56.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 110.02 16.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -104.95 127.81 52.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -83.74 133.53 34.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.0 137.1 51.1 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.34 -38.88 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.7 p -60.56 -61.7 2.4 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.0 1.72 . . . . 0.0 112.145 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 172.24 38.65 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.847 1.259 . . . . 0.0 112.491 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.8 63.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.657 0.783 . . . . 0.0 112.878 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.35 -9.94 5.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.402 1.081 . . . . 0.0 112.744 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.47 130.93 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 169.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.04 49.42 1.66 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.14 0.976 . . . . 0.0 109.146 -170.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.5 ptp -64.53 28.81 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.467 2.307 . . . . 0.0 116.134 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -123.28 21.76 9.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.524 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -35.36 72.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.897 2.079 . . . . 0.0 111.873 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -5.81 56.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.063 1.745 . . . . 0.0 113.306 -170.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.3 m 68.16 -37.82 0.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 128.607 2.763 . . . . 0.0 113.389 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.7 p -124.9 73.14 64.24 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.72 -177.65 2.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.302 2.668 . . . . 0.0 110.979 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.4 -8.2 21.35 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.477 -1.249 . . . . 0.0 111.573 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.54 151.6 50.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 121.341 1.882 . . . . 0.0 112.876 -170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.58 -25.91 3.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.229 1.812 . . . . 0.0 112.648 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.65 157.71 29.97 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -106.99 159.97 15.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -150.47 120.89 7.37 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.047 1.739 . . . . 0.0 106.391 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -82.82 124.19 30.06 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.13 163.15 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.21 1.004 . . . . 0.0 110.953 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.6 m -50.12 144.94 6.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.629 0.772 . . . . 0.0 110.143 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -54.96 -36.12 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.888 0.475 . . . . 0.0 111.964 -169.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -100.39 12.19 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.85 -49.77 10.29 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.53 -32.54 88.07 Favored 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 121.842 1.693 . . . . 0.0 113.782 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -31.38 49.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 119.807 1.185 . . . . 0.0 111.242 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -86.05 -21.92 27.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.6 1.091 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -81.61 -31.1 32.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.69 0.677 . . . . 0.0 111.665 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.1 160.37 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.325 0.584 . . . . 0.0 110.448 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.86 149.01 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.109 0.964 . . . . 0.0 111.261 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -57.42 -35.04 69.56 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.999 1.319 . . . . 0.0 113.912 -169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -73.58 -27.03 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.788 0.722 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -82.53 -38.65 23.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.934 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -42.96 -50.64 5.82 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.874 1.215 . . . . 0.0 112.771 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.62 -26.25 60.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.2 -42.92 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.6 -32.67 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.576 -0.703 . . . . 0.0 110.774 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.11 -29.12 70.11 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.28 -0.888 . . . . 0.0 112.637 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -64.5 -47.89 77.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.714 1.143 . . . . 0.0 108.946 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.23 -44.79 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.1 mtt -64.67 -46.68 81.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.601 -1.19 . . . . 0.0 111.038 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -29.77 69.44 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 121.433 1.924 . . . . 0.0 111.068 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.81 -36.41 82.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.635 0.374 . . . . 0.0 110.357 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -100.02 -16.67 17.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.4 1.08 . . . . 0.0 113.366 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.4 6.87 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.995 1.318 . . . . 0.0 109.899 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -65.25 -21.51 66.75 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.3 -42.45 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.52 -39.37 40.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.2 mtt -72.58 -20.17 61.36 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.413 -0.804 . . . . 0.0 111.122 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.7 m -64.51 -20.27 66.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.865 1.212 . . . . 0.0 112.528 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.4 -29.0 47.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 172.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -98.2 -37.27 9.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.239 1.016 . . . . 0.0 111.224 -169.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -94.35 19.58 9.35 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.767 2.027 . . . . 0.0 110.204 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -61.94 -31.1 71.4 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.145 1.378 . . . . 0.0 113.202 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -55.97 12.85 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 112.001 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.86 -18.28 21.95 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 114.079 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.2 tttp . . . . . 0 C--O 1.256 1.415 0 CA-C-N 119.771 1.169 . . . . 0.0 109.59 176.635 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -129.08 147.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.08 -44.7 68.55 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.126 0.57 . . . . 0.0 111.252 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -154.34 -86.22 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.429 1.092 . . . . 0.0 109.717 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 -45.92 13.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.94 15.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.943 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -99.32 125.57 45.0 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.637 1.718 . . . . 0.0 108.547 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -85.68 126.07 67.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 117.368 -1.301 . . . . 0.0 107.688 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.09 127.49 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.28 1.987 . . . . 0.0 109.244 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -137.27 166.34 24.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.218 1.407 . . . . 0.0 108.99 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.43 141.63 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 127.006 2.122 . . . . 0.0 105.84 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.76 132.71 10.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.89 129.37 48.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.61 86.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 168.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.48 135.84 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.08 124.2 46.32 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.33 127.32 32.62 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 170.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -53.75 -4.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.54 2.336 . . . . 0.0 116.088 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.35 -12.48 60.27 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.8 1.182 . . . . 0.0 111.423 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.42 41.83 2.67 Favored Glycine 0 C--N 1.342 0.916 0 C-N-CA 124.791 1.186 . . . . 0.0 111.811 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.69 155.47 44.91 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.41 162.18 13.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.182 0.993 . . . . 0.0 112.152 -169.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.8 tpp -53.54 130.67 36.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.037 1.735 . . . . 0.0 111.36 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' A' ' 24' ' ' TRP . 1.4 t-105 -159.27 131.11 6.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 166.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.19 26.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.194 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -83.62 134.72 34.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.65 130.6 35.11 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.79 145.19 56.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.396 0.679 . . . . 0.0 110.588 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.27 -43.57 2.05 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.947 1.26 . . . . 0.0 112.534 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -78.63 -37.97 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.377 1.071 . . . . 0.0 109.844 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.316 24.3 m170 57.84 43.61 21.41 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.807 2.043 . . . . 0.0 113.734 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 p -146.33 171.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 107.034 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -73.21 156.04 38.96 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.212 -0.93 . . . . 0.0 111.542 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -147.54 145.67 29.17 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.605 0.762 . . . . 0.0 109.968 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.62 143.03 87.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.697 1.199 . . . . 0.0 109.965 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -69.75 139.08 39.38 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.455 2.103 . . . . 0.0 110.238 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 151.33 6.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.422 1.889 . . . . 0.0 109.035 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.94 139.93 7.42 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 146.72 45.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 mt -80.7 138.89 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -96.64 154.77 38.36 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 123.911 0.884 . . . . 0.0 110.52 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.92 123.14 12.72 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.388 2.059 . . . . 0.0 114.703 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.76 4.52 66.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 113.991 -1.458 . . . . 0.0 113.244 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -86.17 123.94 32.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.646 1.223 . . . . 0.0 108.545 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -72.92 162.4 29.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.543 1.137 . . . . 0.0 110.846 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.86 79.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.4 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.84 9.4 6.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.81 . . . . 0.0 111.65 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -111.59 -54.11 2.64 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.19 72.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.541 1.136 . . . . 0.0 112.79 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -60.67 -42.76 97.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.037 0.835 . . . . 0.0 109.567 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -74.18 -24.45 59.37 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.523 -1.36 . . . . 0.0 111.771 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.6 -50.78 71.2 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.08 -1.012 . . . . 0.0 108.434 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.48 -35.66 81.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.102 0.561 . . . . 0.0 111.906 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.68 -41.21 76.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.935 1.294 . . . . 0.0 110.455 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -46.65 54.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.185 0.994 . . . . 0.0 110.551 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.32 -40.26 95.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.294 0.952 . . . . 0.0 111.788 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.44 -51.95 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.496 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.83 -9.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.32 64.38 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 120.938 -1.101 . . . . 0.0 112.339 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.6 mt -105.96 164.59 11.84 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.981 0.912 . . . . 0.0 108.62 171.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -126.96 -175.95 3.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.064 1.346 . . . . 0.0 111.005 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.95 41.24 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.853 2.061 . . . . 0.0 113.206 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -159.76 -21.26 0.07 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.319 0.648 . . . . 0.0 112.725 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -85.31 -0.12 53.76 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.19 168.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.42 1.088 . . . . 0.0 110.523 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -142.93 121.26 12.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 126.087 1.755 . . . . 0.0 106.853 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.89 130.53 36.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 120.808 1.64 . . . . 0.0 107.646 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.66 -34.71 7.23 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.38 0.672 . . . . 0.0 110.886 171.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.79 172.5 18.37 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.37 1.068 . . . . 0.0 109.225 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -149.31 160.58 43.28 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 p -66.13 142.2 57.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.921 0.782 . . . . 0.0 109.375 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -68.73 -22.55 64.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.933 0.493 . . . . 0.0 111.984 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.44 173.58 11.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.534 1.934 . . . . 0.0 107.725 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -76.8 117.15 18.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.49 137.53 52.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -147.35 147.29 30.17 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.745 -0.597 . . . . 0.0 109.795 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -150.76 163.42 38.62 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.109 1.363 . . . . 0.0 107.979 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -87.51 149.45 24.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.361 0.6 . . . . 0.0 109.889 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.49 137.35 32.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.55 151.81 75.14 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.662 2.241 . . . . 0.0 108.426 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -21.81 66.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -169.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.05 -28.45 62.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.823 0.849 . . . . 0.0 112.184 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.3 tp -97.12 -24.13 15.89 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.396 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -45.02 136.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -75.15 -42.51 55.92 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.976 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.3 m95 59.73 1.95 0.33 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.731 2.413 . . . . 0.0 114.156 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -97.57 -23.79 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.014 1.325 . . . . 0.0 111.51 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -73.13 153.41 40.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.868 1.667 . . . . 0.0 109.053 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.94 112.2 10.43 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 117.785 -1.103 . . . . 0.0 108.263 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.99 151.88 17.38 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 CA-C-N 120.509 1.217 . . . . 0.0 111.832 -10.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.35 131.55 27.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.5 p -90.35 127.96 36.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -169.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -105.96 -4.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.296 1.439 . . . . 0.0 110.986 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.15 30.91 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 118.969 0.804 . . . . 0.0 111.705 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.23 119.88 40.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -92.89 130.61 38.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 169.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 142.39 22.41 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.756 1.616 . . . . 0.0 114.447 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -101.77 130.97 48.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -95.38 141.93 28.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -111.44 135.19 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 108.392 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.1 tp -90.83 102.5 15.26 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.3 mt -100.44 127.33 46.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.219 0.608 . . . . 0.0 110.207 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -85.19 138.06 32.61 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 168.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -70.4 132.56 45.81 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -112.85 -41.22 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.0 m -139.01 127.7 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.92 -171.27 43.36 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.92 -51.39 0.19 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.416 3.086 . . . . 0.0 112.907 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.03 -34.57 22.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 111.102 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.66 -5.66 19.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.859 0.864 . . . . 0.0 112.536 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.84 142.86 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -132.07 -45.42 0.94 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -170.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mtt 60.17 0.01 0.27 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.85 25.9 3.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.645 2.02 . . . . 0.0 111.19 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.4 t -86.1 -30.31 22.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -85.14 168.38 14.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.176 1.791 . . . . 0.0 110.565 -169.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 m -70.95 -33.52 70.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.985 0.514 . . . . 0.0 111.533 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -142.77 88.55 8.47 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -67.16 -166.07 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.407 2.071 . . . . 0.0 113.547 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.28 -54.67 1.27 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.802 170.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -100.47 168.34 9.8 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.398 0.999 . . . . 0.0 112.561 -169.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.92 -8.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.377 1.071 . . . . 0.0 113.115 176.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.9 149.22 19.89 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -113.45 150.14 33.21 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.453 1.501 . . . . 0.0 110.226 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -148.82 114.02 5.52 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.569 1.547 . . . . 0.0 107.31 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -77.8 133.26 38.25 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.87 160.1 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.973 1.309 . . . . 0.0 109.322 -172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 m -53.65 152.94 4.74 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 110.725 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.41 151.19 13.55 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 67.39 -15.79 0.17 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -57.89 -45.58 99.78 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 121.284 1.856 . . . . 0.0 111.984 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -63.85 -25.44 67.68 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.769 1.646 . . . . 0.0 114.373 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.09 -37.23 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.691 1.132 . . . . 0.0 108.982 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -85.98 -15.9 40.04 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.125 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -82.72 -32.19 28.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.527 1.058 . . . . 0.0 111.955 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m -69.25 164.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 112.204 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.28 151.16 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.471 1.108 . . . . 0.0 110.652 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 m -57.37 -36.16 70.87 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.974 1.31 . . . . 0.0 113.371 -169.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -76.71 -24.72 53.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.183 0.901 . . . . 0.0 111.673 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -87.34 -27.49 22.8 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.431 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -42.83 -50.82 5.63 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.917 1.287 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.89 -37.62 79.12 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.157 0.435 . . . . 0.0 111.158 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.83 -45.46 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.62 -32.15 70.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.906 0.483 . . . . 0.0 110.339 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -57.65 -39.83 77.89 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.443 1.097 . . . . 0.0 110.301 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -63.44 -49.67 72.78 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.948 1.249 . . . . 0.0 108.97 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.46 -45.23 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.84 -47.11 82.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.126 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.18 66.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.181 1.809 . . . . 0.0 112.284 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -66.82 -29.51 69.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.47 0.577 . . . . 0.0 110.427 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -108.66 -21.67 12.59 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.09 0.956 . . . . 0.0 113.455 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.2 36.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.241 1.016 . . . . 0.0 109.816 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 m -65.35 -18.58 65.43 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.4 -34.47 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.004 0.82 . . . . 0.0 108.8 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 88.1 t -71.68 -40.79 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 mtt -59.22 -23.03 61.95 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.541 -1.218 . . . . 0.0 111.759 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.0 m -54.16 -31.34 52.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.822 1.646 . . . . 0.0 112.042 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.33 -28.96 21.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.277 1.031 . . . . 0.0 111.507 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 -30.52 8.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.082 . . . . 0.0 112.781 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -102.65 18.61 20.89 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.168 2.187 . . . . 0.0 109.777 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -58.77 -26.69 64.27 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 113.366 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -60.5 7.57 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.157 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.08 -25.68 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.28 2.653 . . . . 0.0 114.119 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt . . . . . 0 C--O 1.254 1.328 0 CA-C-N 119.495 1.043 . . . . 0.0 108.685 -178.14 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.16 144.14 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 170.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.26 -40.7 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -166.74 104.67 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.772 0.829 . . . . 0.0 110.707 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t0 58.42 44.79 17.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.077 2.151 . . . . 0.0 113.301 169.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.95 34.26 18.78 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.845 -0.975 . . . . 0.0 112.32 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -115.89 132.04 56.76 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.588 1.194 . . . . 0.0 110.552 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -88.41 123.72 67.66 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 130.7 10.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.322 2.015 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.47 163.54 31.69 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.395 1.078 . . . . 0.0 110.655 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.21 130.79 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.667 1.987 . . . . 0.0 107.209 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.38 122.36 7.55 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.48 104.23 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.7 t -87.33 80.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.24 131.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -112.19 128.76 56.33 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -94.58 23.47 5.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 57.05 -1.13 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.651 1.98 . . . . 0.0 116.206 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -99.07 -1.62 39.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.76 0.709 . . . . 0.0 111.914 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.36 27.57 29.99 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 119.196 0.907 . . . . 0.0 111.169 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -141.38 156.2 45.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.992 1.717 . . . . 0.0 106.641 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.01 168.88 19.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.662 0.785 . . . . 0.0 112.712 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.5 tpt -48.1 127.03 11.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.119 2.168 . . . . 0.0 112.017 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -160.65 133.25 6.28 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 168.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.03 29.12 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.38 0.672 . . . . 0.0 109.981 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.9 ttm105 -75.14 140.59 43.48 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.674 1.19 . . . . 0.0 108.184 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -86.23 122.37 30.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.341 1.056 . . . . 0.0 109.679 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -53.98 138.19 37.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.809 1.643 . . . . 0.0 108.611 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.7 -37.19 1.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.07 1.319 . . . . 0.0 113.836 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -90.9 -29.91 17.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.504 1.152 . . . . 0.0 111.267 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 55.56 41.3 30.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.001 1.72 . . . . 0.0 112.602 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 p -145.43 169.76 17.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.055 1.342 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -83.48 148.31 27.31 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.754 -1.216 . . . . 0.0 111.048 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -148.81 156.88 42.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.974 0.893 . . . . 0.0 111.101 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -67.98 163.35 51.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.952 2.101 . . . . 0.0 110.007 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.71 -106.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.208 3.272 . . . . 0.0 110.808 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 63.83 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.185 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.03 144.25 18.34 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.48 148.77 45.91 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.19 133.69 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.71 126.61 87.04 Favored Pre-proline 0 C--O 1.232 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 108.567 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.02 119.23 6.16 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.982 1.788 . . . . 0.0 112.619 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.85 3.69 79.86 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.078 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.07 120.67 41.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -70.62 162.51 28.81 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.155 0.582 . . . . 0.0 111.483 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.25 -45.72 8.7 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 127.18 2.192 . . . . 0.0 113.412 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.7 -47.36 40.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.59 -37.9 82.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.306 0.642 . . . . 0.0 110.511 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.53 -34.97 76.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -60.15 -45.72 92.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -67.68 -27.4 66.81 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.293 -0.88 . . . . 0.0 112.844 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -65.17 -51.13 62.98 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 120.885 -1.135 . . . . 0.0 109.009 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.12 70.54 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.138 0.881 . . . . 0.0 110.911 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.93 -39.87 79.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.27 1.028 . . . . 0.0 109.371 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -52.08 14.83 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.321 1.049 . . . . 0.0 111.415 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.77 -36.98 84.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.236 0.925 . . . . 0.0 111.446 -172.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -104.02 -39.01 6.73 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.94 -20.12 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.255 0.622 . . . . 0.0 110.085 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.17 19.42 78.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.488 -1.382 . . . . 0.0 111.945 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 mt -102.22 151.64 21.98 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.521 1.128 . . . . 0.0 108.085 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -113.46 177.45 4.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.693 -0.629 . . . . 0.0 110.064 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -69.99 58.5 0.16 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.073 1.749 . . . . 0.0 112.744 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -163.44 -26.98 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.245 1.818 . . . . 0.0 111.319 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -89.23 -3.39 58.57 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.3 165.26 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.352 0.661 . . . . 0.0 109.741 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -135.43 119.73 17.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.3 mt -74.9 126.55 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -35.1 6.07 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.151 0.98 . . . . 0.0 110.697 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.63 171.67 19.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.353 1.461 . . . . 0.0 108.783 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -148.43 160.57 42.9 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 108.114 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -62.86 148.32 47.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.349 0.522 . . . . 0.0 110.341 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -62.16 -36.71 82.68 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.702 0.401 . . . . 0.0 111.308 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.35 175.03 11.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.4 1.88 . . . . 0.0 107.226 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.515 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 70.5 m95 -64.05 127.31 30.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.346 0.658 . . . . 0.0 109.572 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.43 141.21 39.85 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -153.47 151.18 29.56 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.686 -0.634 . . . . 0.0 110.208 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -155.94 160.87 40.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.743 1.617 . . . . 0.0 107.536 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 145.94 24.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.379 0.609 . . . . 0.0 109.593 172.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.74 151.85 93.38 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 125.556 1.542 . . . . 0.0 108.365 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -63.31 152.75 78.37 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 N-CA-C 108.028 -1.566 . . . . 0.0 108.028 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -49.4 -48.28 47.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.07 -17.93 64.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.09 0.956 . . . . 0.0 112.913 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.9 tp -102.57 -9.09 20.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.785 1.234 . . . . 0.0 111.838 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.9 t -56.49 142.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.47 -47.84 30.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -168.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.2 m95 55.36 11.23 0.55 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.9 2.08 . . . . 0.0 114.328 -170.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.46 -24.8 13.79 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.412 1.085 . . . . 0.0 111.175 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.6 p -90.89 168.84 11.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.078 0.951 . . . . 0.0 109.789 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.96 116.87 18.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -63.67 162.37 57.13 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.89 0.996 . . . . 0.0 109.952 -10.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.33 132.86 25.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -90.4 108.72 19.96 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.4 pt -94.12 -15.29 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.418 1.887 . . . . 0.0 111.596 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.25 172.8 34.13 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 120.099 1.318 . . . . 0.0 112.848 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -119.22 123.57 44.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 68.0 tttt -98.46 131.77 44.45 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 172.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.77 137.37 18.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.857 1.208 . . . . 0.0 113.089 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -100.81 131.73 46.55 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -100.28 132.92 45.38 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -109.14 131.34 55.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -86.94 108.4 18.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -107.09 125.07 50.58 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.885 0.874 . . . . 0.0 108.867 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -83.56 133.32 34.87 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 168.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.3 tp -68.74 124.46 23.71 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.15 -49.71 11.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -135.81 124.35 23.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.6 -163.07 15.56 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.81 -48.17 0.26 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 128.79 2.836 . . . . 0.0 113.175 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.7 -32.74 10.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.725 1.61 . . . . 0.0 112.023 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.78 -24.53 31.03 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.441 0.696 . . . . 0.0 110.695 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -64.76 131.3 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -134.95 -32.08 0.98 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.6 0.76 . . . . 0.0 111.691 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.5 mtt 64.6 -49.63 0.32 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.508 3.123 . . . . 0.0 113.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.48 25.22 2.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.654 1.182 . . . . 0.0 112.986 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -65.46 -28.3 69.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.143 0.577 . . . . 0.0 110.322 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -95.42 10.66 35.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.98 1.312 . . . . 0.0 113.127 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.28 -36.71 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 129.695 3.198 . . . . 0.0 115.793 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 p -128.28 60.88 50.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.74 1.616 . . . . 0.0 108.993 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -70.78 177.84 5.85 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.048 2.499 . . . . 0.0 110.29 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.46 -26.08 35.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.426 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -99.43 139.14 35.53 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.627 1.558 . . . . 0.0 112.684 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -112.53 -31.08 6.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.098 1.759 . . . . 0.0 112.397 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.67 151.81 16.09 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -102.2 155.59 18.11 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.87 0.868 . . . . 0.0 111.901 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -152.58 111.51 3.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.26 1.824 . . . . 0.0 106.947 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -74.17 138.51 43.85 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.874 0.761 . . . . 0.0 109.24 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.41 159.93 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.864 1.265 . . . . 0.0 109.158 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.8 m -55.28 152.55 8.19 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.953 0.501 . . . . 0.0 110.125 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 165.52 13.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.7 m95 65.88 -24.67 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.888 1.675 . . . . 0.0 115.075 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.97 -46.02 96.65 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 120.483 1.492 . . . . 0.0 111.691 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.98 -29.18 81.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 122.012 1.754 . . . . 0.0 113.263 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.42 -10.24 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 111.89 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -108.53 -23.08 12.0 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.898 -1.126 . . . . 0.0 110.97 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.91 -35.73 57.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.314 0.961 . . . . 0.0 111.68 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.89 166.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.869 0.759 . . . . 0.0 111.509 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.77 150.68 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.421 1.088 . . . . 0.0 110.565 174.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 p -53.33 -40.67 65.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.618 1.567 . . . . 0.0 113.633 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -70.33 -32.36 70.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.365 0.53 . . . . 0.0 110.611 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -72.95 -38.61 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -51.6 -48.21 63.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.519 1.054 . . . . 0.0 110.879 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.66 -26.04 62.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.9 -46.51 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.22 -0.925 . . . . 0.0 108.67 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -35.34 80.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 110.976 -170.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -61.19 -28.04 68.85 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.641 -1.287 . . . . 0.0 112.983 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -64.21 -46.76 82.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.3 t -60.81 -48.5 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 109.391 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 mtt -66.43 -37.07 84.38 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.093 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -47.29 82.02 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 119.456 1.025 . . . . 0.0 110.455 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -60.5 -32.58 71.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.264 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -107.8 4.01 25.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -57.44 10.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.476 1.489 . . . . 0.0 110.994 -169.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -59.71 -30.54 68.88 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.237 0.615 . . . . 0.0 111.715 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.02 -8.35 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.736 1.214 . . . . 0.0 111.038 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.22 -35.95 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 O-C-N 121.355 -0.841 . . . . 0.0 109.402 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 54.8 tpp -76.82 -45.33 29.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.269 0.628 . . . . 0.0 111.051 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.6 m -62.97 -31.09 72.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.93 -0.481 . . . . 0.0 111.61 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.48 -34.12 70.54 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.254 0.622 . . . . 0.0 109.868 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -99.25 0.81 43.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.977 0.911 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.55 -31.84 13.72 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.592 1.157 . . . . 0.0 109.247 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -65.23 -33.52 76.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.505 1.922 . . . . 0.0 111.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -56.91 22.33 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.397 -0.811 . . . . 0.0 112.434 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.34 -29.64 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.044 2.496 . . . . 0.0 112.534 174.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.587 1.555 . . . . 0.0 109.889 -173.541 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 mm -130.57 134.95 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.89 141.63 53.13 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 107.337 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -48.8 -30.29 5.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -168.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.37 -5.36 44.45 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.96 38.74 3.75 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 126.059 1.79 . . . . 0.0 110.663 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.0 139.77 53.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.095 1.447 . . . . 0.0 111.628 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -85.57 120.54 73.1 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 116.776 -1.583 . . . . 0.0 107.853 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.42 137.07 27.44 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 121.822 1.681 . . . . 0.0 111.037 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -145.6 157.51 43.97 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.153 1.381 . . . . 0.0 111.609 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.1 74.61 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.419 2.287 . . . . 0.0 107.934 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.77 128.26 44.77 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -86.42 110.11 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -16.26 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 116.89 -1.529 . . . . 0.0 114.742 -169.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm 19.24 109.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 129.127 2.971 . . . . 0.0 114.929 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.2 138.44 33.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -68.51 -4.56 15.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.98 -7.55 54.88 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.852 0.751 . . . . 0.0 110.56 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.86 37.71 4.35 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 126.131 1.824 . . . . 0.0 112.118 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -133.28 155.79 48.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.551 0.74 . . . . 0.0 109.038 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.68 156.89 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.31 1.044 . . . . 0.0 111.295 -168.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.98 131.44 44.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.124 1.769 . . . . 0.0 110.309 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -158.86 139.1 12.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.96 144.24 23.2 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -70.95 138.26 49.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -86.57 125.49 33.83 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.76 137.59 57.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.609 2.364 . . . . 0.0 109.996 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.13 -31.68 1.33 Allowed Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.062 1.315 . . . . 0.0 113.716 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -86.35 -34.15 20.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.453 1.101 . . . . 0.0 110.455 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 57.29 33.46 23.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.046 1.738 . . . . 0.0 112.575 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 p -149.87 -177.79 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.245 1.818 . . . . 0.0 107.231 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -80.46 160.43 25.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.029 -1.044 . . . . 0.0 112.975 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.1 147.74 27.45 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.216 1.006 . . . . 0.0 108.987 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -60.59 143.76 89.9 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.301 1.44 . . . . 0.0 110.21 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.22 153.08 55.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.306 2.004 . . . . 0.0 111.065 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -171.79 149.55 2.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 109.845 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.91 134.28 3.37 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.179 -2.369 . . . . 0.0 107.179 169.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.7 171.72 55.15 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.247 1.024 . . . . 0.0 111.639 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 mt -96.67 146.04 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.815 0.846 . . . . 0.0 109.064 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -87.61 131.71 42.86 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.565 1.546 . . . . 0.0 108.39 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.44 118.07 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.23 1.953 . . . . 0.0 114.08 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.48 3.57 90.03 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.037 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -86.98 131.67 34.02 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.063 0.945 . . . . 0.0 108.554 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.99 161.26 30.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.827 1.251 . . . . 0.0 110.685 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.17 -44.26 64.55 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 125.168 1.387 . . . . 0.0 112.992 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.24 -48.96 48.05 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -57.6 -39.59 77.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.597 1.159 . . . . 0.0 109.919 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 -34.42 63.86 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.044 0.938 . . . . 0.0 111.983 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -57.33 -39.87 76.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.95 0.795 . . . . 0.0 110.065 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.37 -26.39 66.44 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.742 1.155 . . . . 0.0 113.511 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.33 -49.9 69.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.153 1.342 . . . . 0.0 108.597 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.39 75.56 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 119.451 -0.309 . . . . 0.0 111.316 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.2 -44.9 84.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.753 1.221 . . . . 0.0 109.715 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.1 -47.3 80.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.634 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.72 -39.49 94.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.261 1.391 . . . . 0.0 112.772 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -82.47 -46.67 13.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.166 1.386 . . . . 0.0 110.577 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 m -132.16 1.03 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.348 1.059 . . . . 0.0 112.816 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.84 32.47 79.58 Favored Glycine 0 CA--C 1.521 0.447 0 O-C-N 120.909 -1.12 . . . . 0.0 112.164 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.78 154.54 18.82 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 m -117.49 179.03 4.17 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.842 0.857 . . . . 0.0 109.106 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -73.15 46.75 0.18 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.67 1.588 . . . . 0.0 115.242 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -163.42 -20.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.124 1.769 . . . . 0.0 111.785 -171.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.1 2.92 53.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.091 1.356 . . . . 0.0 112.961 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.75 170.19 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.506 1.522 . . . . 0.0 108.91 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -138.0 120.25 15.77 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.3 mt -77.66 128.37 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 120.658 1.572 . . . . 0.0 107.879 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -104.95 -34.8 7.9 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.842 0.857 . . . . 0.0 111.467 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 173.79 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.156 1.382 . . . . 0.0 108.493 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -150.49 160.88 43.46 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 m -56.02 133.39 51.76 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -66.14 -27.04 67.73 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -147.33 168.09 22.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.248 1.419 . . . . 0.0 108.61 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -68.73 117.93 11.06 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.9 156.7 31.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -143.46 154.35 43.58 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.918 1.687 . . . . 0.0 108.029 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -146.1 172.67 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.639 . . . . 0.0 107.721 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -105.45 133.15 50.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.2 mt -67.75 148.72 98.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.33 146.09 25.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.529 2.153 . . . . 0.0 108.287 169.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -56.07 -44.32 78.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.749 1.159 . . . . 0.0 113.146 -168.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.22 -15.19 62.2 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 112.783 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.18 -0.33 33.36 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.074 1.75 . . . . 0.0 111.618 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.61 141.22 13.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -86.61 128.51 35.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -107.57 -0.36 22.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.308 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -106.56 -12.23 15.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.28 1.032 . . . . 0.0 111.446 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.6 p -73.97 -35.92 64.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 111.535 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 40.47 87.98 0.1 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.164 2.585 . . . . 0.0 112.347 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.1 143.42 42.21 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.03 1.046 . . . . 0.0 114.148 10.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -62.58 131.55 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.9 t -94.01 112.31 24.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.3 pt -97.61 -8.89 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.179 0.991 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.23 176.33 48.01 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.867 1.212 . . . . 0.0 112.827 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -101.95 121.2 41.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -82.89 112.48 19.72 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 103.115 -2.92 . . . . 0.0 103.115 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.61 51.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.985 1.721 . . . . 0.0 112.93 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -120.87 113.72 20.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -85.64 149.63 25.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -112.36 130.02 56.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.86 90.58 5.3 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 102' ' ' LEU . 26.3 mt -88.68 122.7 32.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.807 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -84.61 136.4 33.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.33 140.81 57.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.47 -56.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -91.92 123.11 35.05 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.54 -170.89 40.73 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.587 0.613 . . . . 0.0 114.482 -169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -48.98 -32.91 9.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.799 1.64 . . . . 0.0 112.88 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -26.1 66.42 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.61 -25.21 13.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.332 1.453 . . . . 0.0 111.306 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 mt -56.05 139.8 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -141.57 85.92 1.98 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 122.252 1.025 . . . . 0.0 108.664 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 mtt -60.25 -12.84 9.9 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.968 0.907 . . . . 0.0 112.791 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -110.1 30.59 6.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.968 1.307 . . . . 0.0 110.304 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -76.39 -31.14 57.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.174 0.59 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -80.38 168.49 18.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.987 0.898 . . . . 0.0 109.319 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m -81.47 -28.37 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.627 1.571 . . . . 0.0 111.14 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -131.15 64.15 72.63 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.393 1.877 . . . . 0.0 108.21 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.34 176.27 5.84 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.71 2.94 . . . . 0.0 111.009 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -114.54 -22.23 9.9 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.185 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -123.09 145.07 48.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 121.404 1.911 . . . . 0.0 111.441 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.54 -40.0 6.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.132 1.373 . . . . 0.0 110.082 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.01 170.92 13.77 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.25 0.929 . . . . 0.0 111.871 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 20.1 t-105 -170.21 -125.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.973 1.709 . . . . 0.0 108.536 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 6.9 ptt180 -153.65 158.17 40.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.543 2.737 . . . . 0.0 106.589 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -80.33 141.38 35.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.004 0.82 . . . . 0.0 109.151 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.56 162.56 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.11 0.964 . . . . 0.0 111.048 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -51.79 151.12 3.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.814 0.846 . . . . 0.0 110.682 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.58 -40.92 69.28 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -96.47 6.55 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.45 0.7 . . . . 0.0 112.682 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.92 -46.44 15.43 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.339 -1.315 . . . . 0.0 111.633 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.94 -36.03 85.11 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.081 1.854 . . . . 0.0 113.685 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.46 -24.85 33.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 O-C-N 121.15 -0.969 . . . . 0.0 111.435 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.55 -17.25 34.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.396 0.998 . . . . 0.0 111.516 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -83.35 -30.72 27.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.55 1.068 . . . . 0.0 111.602 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.89 162.92 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.56 148.82 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.468 0.707 . . . . 0.0 111.427 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 m -56.93 -29.97 63.58 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.694 1.597 . . . . 0.0 114.848 -169.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -79.28 -43.0 24.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.444 1.02 . . . . 0.0 110.478 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -74.46 -27.37 60.56 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 111.157 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -42.07 -46.62 4.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.415 1.486 . . . . 0.0 111.252 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.39 -43.6 85.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.835 0.743 . . . . 0.0 111.396 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.02 -34.74 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.912 -0.493 . . . . 0.0 110.264 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.81 -31.75 70.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.186 -0.946 . . . . 0.0 110.053 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -58.5 -36.14 73.32 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.632 -1.292 . . . . 0.0 111.058 169.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -63.64 -44.36 94.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.211 1.368 . . . . 0.0 109.368 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.68 -45.87 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.096 0.862 . . . . 0.0 109.764 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.02 -45.3 94.21 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.769 -0.582 . . . . 0.0 109.633 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.85 -40.27 96.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.783 1.233 . . . . 0.0 111.034 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.48 -40.02 77.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.745 1.218 . . . . 0.0 110.601 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.57 -10.32 22.2 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.817 1.044 . . . . 0.0 113.817 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.61 -57.34 10.33 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.768 1.167 . . . . 0.0 111.131 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -80.36 15.84 1.48 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.9 t -110.37 -28.07 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.34 -65.94 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.0 109.146 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.4 mtp -59.26 -29.3 67.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.435 1.094 . . . . 0.0 111.231 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -58.37 -27.79 64.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.135 0.974 . . . . 0.0 113.32 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.54 -40.07 92.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.67 0.788 . . . . 0.0 109.479 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -83.91 -31.07 25.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.276 1.03 . . . . 0.0 110.406 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.02 -17.83 64.53 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.147 1.379 . . . . 0.0 111.347 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.58 79.79 4.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -35.62 34.73 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -63.13 -17.14 58.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.761 2.974 . . . . 0.0 114.868 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 124.826 1.25 . . . . 0.0 110.287 -175.995 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.8 mm -131.92 148.67 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.91 152.11 28.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.091 0.957 . . . . 0.0 109.644 171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.49 -30.88 68.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.35 7.7 31.19 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.773 0.829 . . . . 0.0 112.581 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 21.27 30.66 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.283 1.42 . . . . 0.0 113.636 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -101.27 144.68 29.82 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 119.038 1.419 . . . . 0.0 110.191 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.36 123.05 65.13 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-O 116.569 -1.682 . . . . 0.0 106.921 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -69.14 126.98 14.4 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.07 1.846 . . . . 0.0 111.03 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -139.86 159.59 41.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.164 1.786 . . . . 0.0 110.335 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.95 140.71 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 106.783 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.12 123.11 5.55 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 171.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.71 112.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.92 83.81 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.13 137.6 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -121.16 124.65 45.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 169.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.51 125.2 27.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 169.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -48.32 -18.62 0.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 116.025 -1.94 . . . . 0.0 115.73 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.3 7.06 1.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.619 1.554 . . . . 0.0 112.642 170.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.94 16.64 32.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.493 1.52 . . . . 0.0 113.702 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -121.18 163.49 18.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.136 0.974 . . . . 0.0 108.509 -168.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -105.99 161.66 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -167.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.53 129.92 42.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.23 1.812 . . . . 0.0 111.054 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -161.52 131.17 4.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.25 145.05 31.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -71.88 127.26 31.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -71.93 129.02 37.57 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -38.81 121.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.767 2.427 . . . . 0.0 111.112 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -1.64 21.43 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.567 1.08 . . . . 0.0 115.372 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -100.18 -24.3 14.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.314 1.557 . . . . 0.0 112.435 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 54.61 35.61 24.04 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.549 1.14 . . . . 0.0 112.142 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -146.98 -179.49 6.85 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.369 1.867 . . . . 0.0 107.348 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -117.08 156.46 27.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.236 0.925 . . . . 0.0 111.565 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -151.76 165.49 34.27 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.209 1.404 . . . . 0.0 109.051 -173.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -109.17 160.86 25.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.513 1.125 . . . . 0.0 112.147 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -74.4 69.84 4.94 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.774 2.983 . . . . 0.0 115.011 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -84.6 145.7 27.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.38 149.79 19.38 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.283 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.89 143.18 29.65 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.404 1.002 . . . . 0.0 111.915 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.91 137.23 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.39 146.07 49.79 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 118.777 0.717 . . . . 0.0 109.509 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -53.26 119.34 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.226 1.951 . . . . 0.0 113.731 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.36 7.56 87.45 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.002 1.286 . . . . 0.0 113.262 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.51 -40.15 64.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 112.444 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . 0.292 20.6 m 68.05 152.06 0.08 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.459 1.504 . . . . 0.0 112.543 -170.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.22 -45.03 72.18 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 125.055 1.342 . . . . 0.0 113.347 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.8 4.02 15.1 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.222 0.919 . . . . 0.0 111.904 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.09 -48.96 3.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.44 91.58 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.695 0.798 . . . . 0.0 112.136 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -58.85 -43.39 90.77 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.213 1.005 . . . . 0.0 109.371 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.03 -20.37 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -76.34 -47.68 22.64 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 109.279 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.1 77.71 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.217 0.917 . . . . 0.0 111.028 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.1 tp -48.06 -45.87 32.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 110.754 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -49.43 18.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.475 1.51 . . . . 0.0 111.689 176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.12 -37.31 87.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.804 1.184 . . . . 0.0 110.34 -170.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -94.31 -43.44 8.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.048 1.339 . . . . 0.0 111.006 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.99 -7.94 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.826 0.85 . . . . 0.0 112.451 -169.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.13 16.83 71.32 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 120.378 -1.451 . . . . 0.0 113.731 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.3 mt -95.26 152.07 18.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m -120.14 -176.69 3.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.883 0.873 . . . . 0.0 109.757 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.19 50.97 0.51 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.142 1.777 . . . . 0.0 112.684 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -164.54 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.666 1.586 . . . . 0.0 112.022 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.39 -6.54 58.9 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.256 1.022 . . . . 0.0 113.723 -168.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' A' ' 102' ' ' LEU . 33.5 m -147.29 170.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 123.875 0.87 . . . . 0.0 109.431 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -141.91 120.48 12.51 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -170.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.42 127.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.38 -35.13 6.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.579 0.752 . . . . 0.0 110.985 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.04 166.5 33.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.219 1.408 . . . . 0.0 108.627 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 163.69 34.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.145 0.978 . . . . 0.0 108.793 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -62.95 150.46 42.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.921 0.782 . . . . 0.0 110.836 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.726 0.411 . . . . 0.0 111.182 -171.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.9 173.69 13.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.496 1.918 . . . . 0.0 107.675 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.417 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 93.5 m95 -58.46 121.07 9.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 110.821 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.86 154.41 33.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 140.34 23.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.25 156.58 46.97 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -95.23 153.28 17.74 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.261 0.553 . . . . 0.0 110.91 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -84.16 150.23 57.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -65.69 156.88 61.61 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.685 2.257 . . . . 0.0 109.282 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -59.39 -30.03 68.14 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -74.85 -20.16 59.87 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.962 0.905 . . . . 0.0 113.238 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 tp -105.35 -22.13 13.1 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.704 1.202 . . . . 0.0 111.4 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.16 132.73 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 168.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -89.78 131.08 35.92 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -100.07 3.06 43.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.839 1.255 . . . . 0.0 109.453 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -98.31 -16.68 19.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 110.869 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -74.66 -36.06 62.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.384 -171.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 38.21 88.31 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 127.867 2.467 . . . . 0.0 112.111 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.77 141.81 21.28 Favored 'Cis proline' 0 C--N 1.356 0.932 0 N-CA-C 115.171 1.181 . . . . 0.0 115.171 10.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.45 124.5 8.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.62 92.62 9.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.5 pt -88.64 -12.01 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.912 -1.042 . . . . 0.0 112.025 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.85 43.4 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 120.483 1.492 . . . . 0.0 113.782 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 114.14 25.19 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 66.0 tttt -86.86 125.03 33.72 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 169.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.91 137.89 33.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -106.85 129.16 54.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -103.28 133.55 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.49 130.37 55.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.68 105.52 17.42 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.6 mm? -103.5 123.62 47.23 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.051 0.94 . . . . 0.0 109.225 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -80.49 138.22 36.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 106.95 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.92 -40.39 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.9 p -92.21 -114.51 0.09 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.9 -169.64 37.36 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.802 0.728 . . . . 0.0 111.911 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.84 -39.1 0.48 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.603 1.961 . . . . 0.0 113.492 171.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.63 69.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.2 -23.19 12.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.045 1.338 . . . . 0.0 111.785 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.06 131.87 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -143.99 77.72 1.56 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 122.348 1.07 . . . . 0.0 109.893 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.7 mtt -64.25 14.08 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.572 1.549 . . . . 0.0 113.244 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -131.29 21.09 4.8 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.648 1.567 . . . . 0.0 111.221 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 t -75.65 -28.04 58.59 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.229 1.012 . . . . 0.0 111.057 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -5.86 52.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.971 1.708 . . . . 0.0 114.519 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.2 m 68.13 -34.22 0.25 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.879 2.872 . . . . 0.0 114.153 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 p -124.04 72.08 54.25 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 169.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.49 -165.6 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.899 3.066 . . . . 0.0 112.027 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -120.48 -12.12 9.0 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.487 1.115 . . . . 0.0 111.893 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -134.59 152.16 51.58 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 120.913 1.688 . . . . 0.0 112.23 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.8 -35.25 5.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.927 1.691 . . . . 0.0 111.766 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -173.09 152.18 15.45 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -94.93 163.14 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.104 1.362 . . . . 0.0 111.354 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -152.92 120.23 5.9 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.889 1.676 . . . . 0.0 106.691 169.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -81.43 70.74 8.35 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.345 1.43 . . . . 0.0 109.247 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.29 156.02 5.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.242 1.417 . . . . 0.0 110.764 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -52.48 153.54 2.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.691 0.796 . . . . 0.0 111.909 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -57.02 152.31 13.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 m95 67.95 -28.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.449 1.9 . . . . 0.0 115.806 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.68 -47.0 98.07 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 121.155 1.798 . . . . 0.0 112.169 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.0 -18.05 62.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.592 1.604 . . . . 0.0 115.507 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.4 t -57.28 -38.11 60.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 120.08 1.309 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -92.64 -19.93 21.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.653 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -72.96 -21.28 60.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 121.297 1.862 . . . . 0.0 111.893 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.7 m -71.82 162.01 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 119.419 1.009 . . . . 0.0 111.034 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -60.6 151.67 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.133 0.973 . . . . 0.0 110.042 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 m -61.63 -29.27 69.95 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -73.87 -26.63 60.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.559 1.072 . . . . 0.0 111.508 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.98 -29.2 25.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.718 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -48.51 -52.13 23.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.566 1.076 . . . . 0.0 112.521 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.2 -41.44 97.05 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.316 0.507 . . . . 0.0 111.221 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -34.75 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.65 -32.8 74.36 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.03 -1.043 . . . . 0.0 110.643 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -57.28 -42.32 81.42 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.061 -1.024 . . . . 0.0 111.07 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.297 18.4 ptp180 -74.64 -34.18 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.908 1.231 . . . . 0.0 110.37 -176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.21 -47.69 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 109.253 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.62 -41.5 88.25 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.583 -0.698 . . . . 0.0 110.953 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -44.17 81.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 111.324 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.09 -27.65 69.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.727 0.411 . . . . 0.0 112.101 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -113.78 -3.97 13.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.57 69.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.71 1.141 . . . . 0.0 111.146 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 m -64.43 -25.79 68.16 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.01 -0.431 . . . . 0.0 111.616 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.17 -40.69 44.16 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.86 -47.04 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.658 0.783 . . . . 0.0 108.978 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.84 -15.8 63.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.929 0.786 . . . . 0.0 111.856 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.3 m -53.34 -38.84 63.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.758 1.163 . . . . 0.0 111.543 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.39 -30.48 71.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -94.44 -21.37 18.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.166 0.986 . . . . 0.0 111.857 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.74 -20.65 66.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.45 1.1 . . . . 0.0 110.287 170.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.18 80.75 5.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 p -46.95 -26.35 0.51 Allowed Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -168.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -62.13 -14.21 36.44 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.838 2.359 . . . . 0.0 114.075 169.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.392 1.477 . . . . 0.0 109.889 178.63 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 119.609 -0.234 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.7 mm -127.91 140.85 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.21 148.06 52.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.813 1.245 . . . . 0.0 108.445 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.53 -28.29 53.84 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -79.11 -1.54 36.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.02 30.19 9.08 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.794 1.664 . . . . 0.0 111.825 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 23.2 m-85 -115.19 138.45 50.91 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.618 1.709 . . . . 0.0 110.379 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -81.49 128.44 69.74 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 127.63 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.907 1.738 . . . . 0.0 109.267 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -137.69 163.42 31.34 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.235 1.414 . . . . 0.0 109.963 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.92 135.4 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.709 2.004 . . . . 0.0 105.95 169.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.54 145.59 17.31 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.47 126.03 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 118.805 1.303 . . . . 0.0 107.799 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.65 86.59 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.13 130.45 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.38 121.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 169.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -97.6 40.85 1.14 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.221 1.008 . . . . 0.0 109.327 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 59.8 -70.42 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 130.5 3.52 . . . . 0.0 111.89 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -90.33 -15.58 30.88 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.225 0.953 . . . . 0.0 112.886 -169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.46 42.97 1.49 Allowed Glycine 0 C--N 1.336 0.572 0 CA-C-N 118.366 0.53 . . . . 0.0 113.469 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 57.32 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.168 1.787 . . . . 0.0 114.27 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.69 162.85 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -63.45 134.67 56.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.675 1.99 . . . . 0.0 110.347 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -159.64 134.9 8.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 167.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.2 145.0 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.187 0.595 . . . . 0.0 109.51 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.98 139.78 41.7 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -94.04 125.73 38.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -43.12 131.21 4.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.39 2.676 . . . . 0.0 110.992 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.84 -29.36 1.08 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.991 1.281 . . . . 0.0 113.817 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.35 -36.29 29.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.345 1.058 . . . . 0.0 110.004 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 57.19 31.05 19.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.899 1.68 . . . . 0.0 112.789 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p -150.32 175.28 11.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.089 1.756 . . . . 0.0 107.68 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -76.4 162.08 28.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.866 0.866 . . . . 0.0 112.02 -169.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -144.85 134.55 23.49 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.372 0.606 . . . . 0.0 110.984 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.09 121.93 59.2 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.844 2.057 . . . . 0.0 108.216 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -59.63 135.77 66.42 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.333 2.022 . . . . 0.0 112.689 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.52 145.26 7.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.004 1.321 . . . . 0.0 109.725 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.38 136.11 5.26 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.17 146.49 46.2 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -76.08 129.65 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.08 128.4 87.87 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.737 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -55.57 119.12 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.95 1.767 . . . . 0.0 113.177 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.52 84.21 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.01 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -101.53 119.04 38.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.41 165.35 23.96 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.299 0.639 . . . . 0.0 111.574 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.92 -45.93 60.6 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 125.258 1.423 . . . . 0.0 111.45 -172.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.67 25.41 0.91 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.508 -0.745 . . . . 0.0 110.728 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.06 -46.1 0.78 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.527 1.931 . . . . 0.0 107.091 170.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.83 76.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.882 1.273 . . . . 0.0 111.5 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.37 -44.03 84.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.646 0.778 . . . . 0.0 109.033 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -72.45 -28.61 63.04 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.512 -0.743 . . . . 0.0 112.01 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.76 -46.79 88.08 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.875 -1.14 . . . . 0.0 108.534 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.87 76.43 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.576 -0.703 . . . . 0.0 112.05 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.98 -41.36 78.23 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.36 -49.4 34.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.386 1.475 . . . . 0.0 111.609 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.78 -34.49 75.63 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.208 1.367 . . . . 0.0 112.579 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.9 -57.05 2.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 110.902 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.19 -23.98 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.667 1.187 . . . . 0.0 111.504 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 62.12 5.08 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -135.02 157.75 46.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.875 2.07 . . . . 0.0 106.776 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -121.96 -177.5 3.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.948 0.899 . . . . 0.0 110.811 -169.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -69.51 43.11 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.251 2.621 . . . . 0.0 113.127 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -166.55 -20.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.14 0.976 . . . . 0.0 113.202 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.292 0.496 . . . . 0.0 112.028 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 102' ' ' LEU . 29.1 m -148.41 168.45 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.448 1.099 . . . . 0.0 109.99 -169.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.15 121.68 15.16 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.847 2.059 . . . . 0.0 105.995 -171.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -73.88 129.58 36.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 -32.57 6.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.541 0.737 . . . . 0.0 111.554 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.71 169.86 23.68 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.33 1.052 . . . . 0.0 109.636 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -146.99 160.2 42.65 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.745 1.218 . . . . 0.0 109.592 171.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -65.29 143.95 57.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 109.435 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -66.61 -27.35 67.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -153.52 168.81 24.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.23 1.412 . . . . 0.0 109.459 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -63.25 121.01 12.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.785 0.834 . . . . 0.0 109.471 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.48 153.92 33.04 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 150.19 28.88 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.919 -0.488 . . . . 0.0 110.705 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.19 156.46 43.87 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.972 1.709 . . . . 0.0 106.626 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -90.98 145.71 24.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.889 0.313 . . . . 0.0 110.461 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.7 mt -73.4 141.1 79.83 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -60.87 158.05 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.137 1.892 . . . . 0.0 109.42 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -49.31 -48.01 46.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.17 -14.2 60.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.496 1.118 . . . . 0.0 113.091 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -112.85 -1.41 14.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.099 1.76 . . . . 0.0 111.353 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.5 137.24 23.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-N 120.813 1.642 . . . . 0.0 106.673 169.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -93.37 113.67 25.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.05 -9.13 26.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.101 0.96 . . . . 0.0 111.188 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.06 -25.69 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.039 0.936 . . . . 0.0 110.103 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.4 p -71.57 134.14 46.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -120.17 127.19 26.46 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -58.99 154.93 41.42 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.481 1.207 . . . . 0.0 110.907 -10.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -47.58 129.26 3.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.648 1.579 . . . . 0.0 107.959 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.83 113.85 27.68 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.05 -2.75 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 116.52 -1.705 . . . . 0.0 112.528 -170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -171.39 165.53 38.55 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 122.35 2.341 . . . . 0.0 113.066 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -96.48 120.34 36.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -85.6 120.91 27.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 168.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.26 133.52 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 120.8 1.636 . . . . 0.0 113.376 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -100.79 141.89 33.03 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -112.16 137.71 49.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -110.45 133.69 53.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 tt -88.54 123.35 32.96 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 170.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.4 mm? -117.09 123.99 48.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -81.6 134.04 35.45 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.84 106.66 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.54 -31.04 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.2 p -82.7 -114.16 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.048 0.539 . . . . 0.0 110.07 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.96 166.26 29.55 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.048 1.309 . . . . 0.0 110.445 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.43 -29.03 33.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.823 0.849 . . . . 0.0 112.881 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.25 63.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.271 0.629 . . . . 0.0 112.391 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.38 -23.53 11.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.959 1.703 . . . . 0.0 110.838 -173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -56.47 122.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -89.97 -52.09 5.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.3 mtt 59.78 5.46 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.795 1.638 . . . . 0.0 115.215 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 30.23 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.093 1.77 . . . . 0.0 111.621 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -43.72 69.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.949 1.699 . . . . 0.0 112.079 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.6 -4.47 57.72 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -168.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 66.31 -38.12 0.29 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.774 2.429 . . . . 0.0 113.03 -169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 p -123.32 75.06 52.01 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.871 2.068 . . . . 0.0 105.59 169.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.48 -179.3 4.33 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.182 3.255 . . . . 0.0 111.077 -172.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -100.71 -49.97 4.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.111 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -87.97 154.95 20.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 120.538 1.517 . . . . 0.0 111.521 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -133.47 -27.05 1.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.474 1.51 . . . . 0.0 111.761 -172.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.87 144.21 10.28 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -93.4 154.66 17.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.788 1.235 . . . . 0.0 110.825 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -155.55 109.14 2.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.044 1.338 . . . . 0.0 108.398 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -73.62 137.12 44.02 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.275 -0.891 . . . . 0.0 108.607 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.9 161.11 18.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.808 1.643 . . . . 0.0 108.623 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -53.65 154.43 3.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.31 1.044 . . . . 0.0 110.582 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -56.27 -37.89 70.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.946 0.899 . . . . 0.0 113.263 -168.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -96.73 -3.02 43.23 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.506 -0.746 . . . . 0.0 112.826 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -61.02 -47.64 94.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.734 -1.126 . . . . 0.0 111.709 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.82 -35.71 98.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.593 1.605 . . . . 0.0 112.462 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.63 -33.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 109.877 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -17.67 33.52 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 121.501 -0.75 . . . . 0.0 109.289 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -93.37 -22.91 18.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.135 0.272 . . . . 0.0 111.495 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.75 163.3 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.313 -0.867 . . . . 0.0 112.356 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 m -65.71 153.44 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.268 1.427 . . . . 0.0 110.648 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -57.66 -33.91 68.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.416 1.486 . . . . 0.0 114.361 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -74.76 -26.97 60.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.95 0.796 . . . . 0.0 111.497 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -86.82 -33.35 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -47.23 -48.65 24.17 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.249 1.42 . . . . 0.0 112.288 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.88 -35.22 79.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.735 0.243 . . . . 0.0 111.545 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.2 t -83.47 -33.37 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.227 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.01 -32.89 74.59 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.933 1.242 . . . . 0.0 110.408 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -54.28 -41.98 69.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.03 -1.043 . . . . 0.0 111.416 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -66.48 -44.41 82.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.73 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.64 -49.77 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.3 mmt -64.96 -44.43 89.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.609 0.641 . . . . 0.0 110.325 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -62.07 -37.11 83.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.046 0.839 . . . . 0.0 111.124 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.28 -20.99 58.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.432 0.693 . . . . 0.0 111.532 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.92 -9.03 3.92 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.2 63.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.704 1.593 . . . . 0.0 112.45 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -66.66 -17.98 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.19 -33.18 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.018 1.281 . . . . 0.0 109.827 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.25 -29.91 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.709 -1.244 . . . . 0.0 109.659 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mmt -65.63 -27.14 68.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.456 1.025 . . . . 0.0 110.64 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.4 m -56.07 -39.62 72.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.642 1.11 . . . . 0.0 111.023 172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.0 -52.4 9.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.953 0.901 . . . . 0.0 108.704 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -77.56 -7.64 56.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.55 -24.86 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.008 0.923 . . . . 0.0 110.546 169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -23.93 48.01 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.111 -0.993 . . . . 0.0 112.004 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -53.13 30.4 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 112.019 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.33 -30.82 3.9 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.349 2.699 . . . . 0.0 112.91 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.845 1.658 . . . . 0.0 110.994 -171.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.463 0.173 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm -128.36 147.92 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.35 36.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.452 2.301 . . . . 0.0 111.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.96 -32.93 0.09 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 131.516 3.927 . . . . 0.0 116.66 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.06 13.77 24.09 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.448 1.099 . . . . 0.0 113.153 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 12.33 56.77 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.396 1.474 . . . . 0.0 113.1 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -102.25 138.88 38.6 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.903 1.351 . . . . 0.0 110.24 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -98.66 115.91 65.59 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.041 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.18 123.46 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.387 2.058 . . . . 0.0 110.863 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 95' ' ' GLN . 3.4 p30 -144.19 163.73 32.77 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.616 1.566 . . . . 0.0 108.593 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.24 136.81 59.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 130.82 10.26 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.5 112.88 26.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.32 85.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.31 137.62 24.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -125.11 121.69 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 168.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.95 48.0 1.58 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.496 -0.752 . . . . 0.0 109.169 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 18.0 ptt-85 38.13 23.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.241 3.417 . . . . 0.0 116.894 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.85 7.27 15.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.521 1.128 . . . . 0.0 111.925 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.7 71.08 Favored Glycine 0 N--CA 1.477 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 112.422 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -125.56 150.34 47.56 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.71 1.604 . . . . 0.0 107.049 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.95 165.06 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tpt -57.49 129.32 41.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.589 1.955 . . . . 0.0 111.133 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 7.9 t-105 -160.96 115.89 2.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.51 149.7 50.71 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -76.87 136.63 38.88 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.555 1.542 . . . . 0.0 108.203 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -90.12 128.31 36.3 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.925 0.49 . . . . 0.0 110.342 -169.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.47 135.45 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.096 1.758 . . . . 0.0 110.665 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.79 6.11 76.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.944 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -136.24 -38.89 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.525 1.53 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.28 17.1 m80 60.32 38.08 19.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.762 2.025 . . . . 0.0 112.666 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -133.45 161.01 35.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.206 2.202 . . . . 0.0 106.546 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -76.34 148.98 37.09 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.326 -0.859 . . . . 0.0 112.621 -171.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -148.54 160.72 42.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.515 1.15 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.79 167.15 39.13 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 128.18 2.592 . . . . 0.0 109.072 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.25 -110.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 124.167 3.244 . . . . 0.0 110.721 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 65.82 99.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.597 1.959 . . . . 0.0 112.046 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.79 126.01 6.05 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 144.46 22.18 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.003 1.763 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.32 137.0 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.02 135.87 62.47 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.35 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -58.91 117.53 4.28 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.423 1.415 . . . . 0.0 112.452 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.65 80.09 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.096 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 120.28 35.87 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.25 165.67 21.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.908 0.861 . . . . 0.0 111.455 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.13 -45.05 16.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.728 2.011 . . . . 0.0 115.224 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -44.6 21.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -55.06 -42.98 73.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.89 0.876 . . . . 0.0 110.056 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.09 66.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 112.078 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -62.75 -42.61 99.76 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 81.5 m-85 -68.7 -30.57 69.25 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.179 -1.576 . . . . 0.0 112.78 173.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -58.24 -47.02 84.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.251 0.932 . . . . 0.0 109.131 172.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.89 -44.02 86.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.316 0.646 . . . . 0.0 110.708 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.22 -44.18 64.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 111.034 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -48.28 34.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.75 -1.119 . . . . 0.0 111.809 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.65 -28.19 65.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -93.06 -60.22 1.85 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.095 0.958 . . . . 0.0 110.274 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.66 -17.61 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.769 0.827 . . . . 0.0 111.767 -169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 56.46 23.66 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.9 mt -132.13 157.24 44.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.351 2.261 . . . . 0.0 105.972 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -121.09 -172.93 2.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.793 0.724 . . . . 0.0 110.103 -170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 24.1 mtt180 -73.23 42.05 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.54 1.936 . . . . 0.0 113.271 -171.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -161.75 -23.62 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.88 0.872 . . . . 0.0 112.994 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.82 0.44 52.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.051 0.387 . . . . 0.0 111.86 -168.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HD12 ' A' ' 102' ' ' LEU . 34.9 m -146.7 165.24 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.782 1.233 . . . . 0.0 109.136 -171.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -136.64 121.47 18.67 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.357 1.863 . . . . 0.0 106.232 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.02 128.32 37.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.3 -37.87 6.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.43 168.98 25.78 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.154 0.982 . . . . 0.0 108.627 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -144.89 161.87 38.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -61.69 139.55 58.29 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -65.68 -25.68 67.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.35 175.07 12.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 108.542 169.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -71.61 113.87 9.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.296 0.638 . . . . 0.0 109.912 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.88 155.22 40.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 148.42 28.61 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -140.29 157.23 45.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.753 0.821 . . . . 0.0 108.805 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -94.14 126.87 39.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -68.53 148.04 98.1 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 158.69 56.83 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.641 2.227 . . . . 0.0 109.666 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -60.56 -33.7 73.07 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -77.99 -24.27 48.06 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.048 0.939 . . . . 0.0 113.07 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 tp -90.98 -24.49 20.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.213 0.461 . . . . 0.0 110.629 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.77 137.63 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -41.96 34.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.027 0.531 . . . . 0.0 111.987 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 21.8 m95 59.11 4.19 0.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.036 2.534 . . . . 0.0 113.811 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -99.6 -25.56 14.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -72.84 151.54 41.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 109.324 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -132.93 116.0 14.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.671 1.188 . . . . 0.0 107.941 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -58.35 155.44 37.11 Favored 'Cis proline' 0 CA--C 1.538 0.694 0 CA-C-N 120.177 1.099 . . . . 0.0 111.483 -10.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.71 131.85 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.0 t -91.88 106.83 18.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.3 pt -97.32 -8.35 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.505 0.722 . . . . 0.0 112.173 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.73 169.64 42.41 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.396 0.998 . . . . 0.0 111.764 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 10' ' ' ASN . 11.1 mp0 -110.05 119.33 38.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -80.95 125.49 30.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.75 142.56 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -116.98 128.68 55.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -101.51 147.35 26.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.74 129.45 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -80.14 115.11 19.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -112.54 125.47 54.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.929 0.892 . . . . 0.0 108.838 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.02 134.51 34.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -73.17 122.11 21.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.65 -50.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -128.31 135.44 49.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.15 -155.12 13.52 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 t70 64.55 -61.47 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.149 2.98 . . . . 0.0 111.792 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.26 -35.87 12.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 0.0 110.773 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -89.79 -12.72 38.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.841 0.856 . . . . 0.0 111.598 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.61 116.2 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -97.27 -35.04 10.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.498 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.0 mtt 58.91 -38.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 130.023 3.329 . . . . 0.0 115.532 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -102.56 33.63 3.1 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.898 1.679 . . . . 0.0 110.889 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -69.61 -51.42 35.2 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -74.7 145.2 43.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 m -70.08 -30.28 67.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.217 . . . . 0.0 111.81 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 p -127.23 75.14 77.14 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.177 1.391 . . . . 0.0 107.887 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.52 -175.1 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.709 2.939 . . . . 0.0 110.416 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.72 -29.86 11.25 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 116.695 -1.621 . . . . 0.0 113.366 171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 159.0 17.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 122.051 2.205 . . . . 0.0 112.271 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.91 -6.12 0.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.063 1.345 . . . . 0.0 113.542 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.6 156.88 28.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -119.05 151.65 37.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 111.42 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -145.01 119.49 9.67 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.888 1.675 . . . . 0.0 106.761 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -78.73 140.48 38.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.614 1.097 . . . . 0.0 108.96 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.71 162.43 32.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.799 0.84 . . . . 0.0 110.214 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.2 m -52.21 148.49 6.36 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.012 0.925 . . . . 0.0 109.865 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.45 -38.37 63.5 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -99.58 3.28 45.31 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.27 -44.6 88.98 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.914 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.82 -28.02 85.75 Favored 'Trans proline' 0 C--N 1.352 0.749 0 CA-C-N 122.005 1.752 . . . . 0.0 112.405 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.41 -10.52 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.901 1.28 . . . . 0.0 112.098 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -106.92 -32.12 8.04 Favored 'General case' 0 CA--C 1.526 0.057 0 O-C-N 120.736 -1.228 . . . . 0.0 110.328 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -79.93 -26.69 40.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.031 0.832 . . . . 0.0 112.503 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.05 160.0 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.088 0.858 . . . . 0.0 110.008 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.74 141.45 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.75 1.22 . . . . 0.0 111.623 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 m -56.78 -35.52 68.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.518 1.527 . . . . 0.0 113.867 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -67.97 -33.74 75.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.756 0.707 . . . . 0.0 110.765 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -88.54 -25.12 22.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.92 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -43.48 -46.49 6.87 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 119.935 1.243 . . . . 0.0 112.695 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.58 -49.44 73.36 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.905 0.775 . . . . 0.0 111.49 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.29 -31.3 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 122.002 -0.436 . . . . 0.0 110.3 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -33.54 75.92 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.554 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -64.24 -35.0 79.41 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 120.725 -1.235 . . . . 0.0 110.479 171.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -60.91 -46.45 90.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.6 1.546 . . . . 0.0 109.804 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.92 -48.22 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 118.764 0.711 . . . . 0.0 109.638 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.7 -36.77 84.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.546 -0.721 . . . . 0.0 110.825 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -65.61 -35.66 81.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.673 1.124 . . . . 0.0 110.72 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.78 -25.32 68.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.235 0.614 . . . . 0.0 111.181 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -118.66 -17.66 9.19 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -42.68 -65.18 0.5 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 -169.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -63.81 -25.81 68.34 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.77 -27.13 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.442 -0.786 . . . . 0.0 109.169 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.99 -41.2 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.83 0.852 . . . . 0.0 109.578 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.4 mtt -68.85 -33.31 73.6 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.028 -170.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.3 m -57.34 -31.55 65.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.849 0.75 . . . . 0.0 112.248 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.5 -30.95 71.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.111 0.414 . . . . 0.0 110.328 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -95.5 -44.06 7.69 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.21 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -61.54 -23.54 66.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.78 0.832 . . . . 0.0 112.131 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -64.55 -38.84 92.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.528 1.131 . . . . 0.0 112.032 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.268 0.1 OUTLIER -135.23 -73.41 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.104 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.43 -27.32 33.81 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.908 2.405 . . . . 0.0 113.589 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? . . . . . 0 C--O 1.255 1.365 0 C-N-CA 127.242 2.217 . . . . 0.0 112.457 -176.398 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 119.55 -0.262 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm -129.82 142.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.97 150.41 45.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.361 1.065 . . . . 0.0 110.013 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.28 -28.16 67.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.56 0.1 35.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.348 0.522 . . . . 0.0 112.167 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.76 32.09 8.27 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.237 1.875 . . . . 0.0 112.06 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 25.3 m-85 -109.76 133.74 52.8 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.556 1.178 . . . . 0.0 110.176 -176.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -80.85 129.28 68.49 Favored Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.4 121.65 6.94 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.196 1.931 . . . . 0.0 109.32 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.0 165.42 25.37 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.603 1.161 . . . . 0.0 109.787 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.33 146.22 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 127.051 2.14 . . . . 0.0 106.564 169.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.68 146.63 18.08 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.13 135.5 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.43 89.88 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -68.11 129.52 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.96 137.57 51.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 168.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -104.58 27.2 8.15 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 53.62 19.39 1.76 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.755 1.622 . . . . 0.0 115.179 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -118.33 5.86 11.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 110.707 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.24 80.78 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 120.848 -1.158 . . . . 0.0 112.312 -169.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -121.58 142.99 49.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.734 1.214 . . . . 0.0 107.727 -171.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.21 163.09 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.8 tpt -55.43 136.9 49.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.483 1.913 . . . . 0.0 111.808 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.41 136.5 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.84 144.89 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.47 140.22 48.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.51 119.7 21.46 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -49.94 132.57 22.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.771 2.029 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.3 -31.53 1.6 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.844 1.212 . . . . 0.0 114.027 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -87.07 -30.9 20.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.417 1.109 . . . . 0.0 110.706 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 58.61 35.0 24.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 p -145.19 169.92 17.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.594 1.958 . . . . 0.0 107.009 169.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.57 158.04 24.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.962 1.256 . . . . 0.0 111.84 -170.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -149.52 148.73 29.74 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.155 1.782 . . . . 0.0 107.489 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -80.57 158.96 70.52 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.607 0.639 . . . . 0.0 111.518 171.597 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -64.89 141.94 73.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.559 2.173 . . . . 0.0 112.456 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -167.88 142.49 3.61 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.833 1.653 . . . . 0.0 108.944 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.24 143.5 10.13 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.57 152.62 52.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.554 1.073 . . . . 0.0 110.698 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mt -82.01 137.19 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -80.5 137.94 51.55 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.747 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.02 117.52 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.408 1.405 . . . . 0.0 113.037 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.92 1.67 88.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.003 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.55 120.8 31.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.611 1.206 . . . . 0.0 107.799 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -71.24 162.6 29.16 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.143 0.577 . . . . 0.0 111.241 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.23 -44.96 16.73 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 126.936 2.094 . . . . 0.0 113.447 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.92 -49.22 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.13 -39.8 83.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.524 0.73 . . . . 0.0 110.387 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -35.51 79.99 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.195 0.998 . . . . 0.0 111.974 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -58.64 -46.91 86.1 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -66.38 -30.05 70.35 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.717 1.144 . . . . 0.0 112.659 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -59.37 -46.72 87.88 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.075 -1.016 . . . . 0.0 108.736 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.908 0.483 . . . . 0.0 111.566 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 tp -57.74 -39.63 77.78 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.891 -1.131 . . . . 0.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -72.93 -50.44 23.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.211 1.005 . . . . 0.0 111.297 174.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.59 -30.06 68.73 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.469 1.486 . . . . 0.0 112.075 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -97.67 -47.5 5.59 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.033 0.933 . . . . 0.0 111.576 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.23 -19.78 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.375 0.67 . . . . 0.0 110.975 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.21 35.15 82.41 Favored Glycine 0 CA--C 1.526 0.78 0 O-C-N 121.191 -0.943 . . . . 0.0 110.886 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.01 154.28 27.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.23 1.412 . . . . 0.0 108.296 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -116.52 -175.13 2.7 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.896 0.878 . . . . 0.0 110.365 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -73.74 41.14 0.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.286 1.834 . . . . 0.0 113.294 -169.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -163.1 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.627 1.171 . . . . 0.0 112.919 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.26 -0.94 51.81 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.89 0.476 . . . . 0.0 111.809 -169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -148.5 171.38 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.949 1.7 . . . . 0.0 108.63 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -140.8 123.91 16.51 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.75 131.24 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 120.485 1.493 . . . . 0.0 107.932 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.63 -36.73 6.36 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.097 0.559 . . . . 0.0 111.324 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 171.45 19.92 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.465 1.106 . . . . 0.0 109.35 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -144.67 162.98 35.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -65.85 138.83 58.15 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -67.67 -19.7 65.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -146.56 170.38 17.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.222 1.809 . . . . 0.0 108.525 170.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -75.58 125.14 28.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.05 152.79 44.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 140.56 21.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -143.82 161.24 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.065 0.946 . . . . 0.0 108.486 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -101.23 133.0 46.46 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 107.571 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.56 143.06 81.75 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 108.452 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.88 155.83 21.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 0.0 110.471 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.82 -45.23 90.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.794 -1.192 . . . . 0.0 113.113 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.56 -12.73 55.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 112.596 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 0.16 26.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.031 1.732 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.15 135.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -90.96 114.88 27.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -100.19 -3.0 32.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.938 0.774 . . . . 0.0 111.694 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -89.43 -18.24 27.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.764 0.825 . . . . 0.0 110.554 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.49 154.57 21.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.537 1.535 . . . . 0.0 108.212 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -134.87 118.55 13.3 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.506 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.75 153.57 34.17 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 120.095 1.069 . . . . 0.0 110.985 -10.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -54.68 130.26 16.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.4 t -93.09 127.15 38.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.253 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.14 -5.4 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 111.807 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -155.85 161.21 30.53 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 121.192 1.815 . . . . 0.0 113.535 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -112.93 105.96 14.14 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -81.55 129.73 34.78 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 170.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.83 127.22 13.12 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 120.285 1.402 . . . . 0.0 112.843 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -98.9 138.5 35.93 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -107.04 144.96 32.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -116.55 131.63 56.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 114.84 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -111.41 127.93 55.83 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 108.641 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -87.38 134.04 33.63 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD21 ' HA2' ' A' ' 107' ' ' GLY . 55.1 tp -64.44 123.53 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.66 -37.88 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.1 m -88.69 -127.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.35 0.66 . . . . 0.0 109.913 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 177.25 178.63 47.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.837 1.199 . . . . 0.0 112.162 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.86 -30.66 15.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.785 1.634 . . . . 0.0 113.053 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.47 -29.23 67.8 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -98.35 -27.43 14.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.357 1.063 . . . . 0.0 111.212 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 143.68 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.722 1.209 . . . . 0.0 107.759 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.33 -41.58 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.549 0.74 . . . . 0.0 111.317 -170.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.7 mtt 55.51 7.35 0.23 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.14 17.83 5.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.741 1.61 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -31.6 72.73 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.705 2.002 . . . . 0.0 111.615 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -7.77 59.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.692 1.997 . . . . 0.0 113.672 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m 68.15 -35.46 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.305 2.642 . . . . 0.0 114.062 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 p -121.77 71.84 30.32 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.345 1.858 . . . . 0.0 106.398 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.56 -174.09 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.587 2.858 . . . . 0.0 111.958 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.98 -10.69 15.45 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.012 169.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.36 146.07 50.88 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.998 1.726 . . . . 0.0 114.99 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -115.96 114.25 24.38 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.767 3.227 . . . . 0.0 102.864 169.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.12 136.02 28.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.622 0.629 . . . . 0.0 113.157 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -131.67 -112.13 0.24 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.163 1.385 . . . . 0.0 109.946 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -150.08 163.06 39.15 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.776 1.23 . . . . 0.0 110.609 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -84.28 155.19 22.54 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.27 169.04 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 110.091 -169.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.2 m -57.45 151.67 16.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.34 0.591 . . . . 0.0 111.49 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -61.29 154.46 23.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.8 m95 66.36 -30.13 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.308 1.843 . . . . 0.0 115.559 -173.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -54.93 -46.28 99.61 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 120.773 1.624 . . . . 0.0 112.177 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -60.07 -26.65 83.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 121.732 1.654 . . . . 0.0 114.989 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.08 -34.11 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.956 1.253 . . . . 0.0 109.077 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -90.11 -19.0 24.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.945 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -80.33 -30.01 38.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.419 1.009 . . . . 0.0 111.988 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.18 163.13 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-N 118.56 0.618 . . . . 0.0 110.207 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.37 153.65 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.838 0.855 . . . . 0.0 111.603 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 m -54.87 -30.33 57.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.608 1.963 . . . . 0.0 115.594 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -84.31 -37.3 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.424 1.011 . . . . 0.0 111.374 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -70.41 -38.58 74.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.384 -0.822 . . . . 0.0 110.219 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -42.98 -45.71 5.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.599 1.56 . . . . 0.0 110.884 171.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.69 -34.8 78.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -173.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.8 -35.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 0.0 110.162 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.26 -32.2 73.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.825 0.739 . . . . 0.0 110.853 -171.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.38 -38.38 80.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.388 -0.82 . . . . 0.0 111.048 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -69.96 -46.47 65.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.46 -46.15 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.822 0.849 . . . . 0.0 109.3 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.3 mtt -69.59 -40.09 76.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.149 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.89 -40.85 94.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.821 1.191 . . . . 0.0 111.036 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.71 -28.13 68.41 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.132 0.973 . . . . 0.0 110.928 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -111.79 -9.18 14.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.09 0.956 . . . . 0.0 113.405 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.13 -59.61 4.0 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.124 0.97 . . . . 0.0 111.714 -169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 m -67.54 -23.03 65.39 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.878 -0.514 . . . . 0.0 111.518 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.75 -35.82 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.8 t -83.93 -42.07 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.719 0.808 . . . . 0.0 109.174 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.39 -30.6 69.55 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.623 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.6 m -55.41 -29.48 58.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.554 1.07 . . . . 0.0 112.122 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.87 -38.49 73.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.088 0.555 . . . . 0.0 110.443 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -92.25 -16.26 26.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.271 0.628 . . . . 0.0 111.02 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -94.14 32.77 1.45 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.18 1.792 . . . . 0.0 110.205 172.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -107.44 31.22 5.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.261 1.024 . . . . 0.0 110.493 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.322 21.3 p 50.73 33.24 0.21 Allowed Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -72.1 -28.19 16.13 Favored 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 122.405 1.895 . . . . 0.0 110.041 169.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.364 1.465 . . . . 0.0 109.255 -173.725 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 tpt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 119.526 -0.273 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 3.2 mp 72.54 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 127.367 2.267 . . . . 0.0 108.381 -169.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.59 146.46 51.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -50.75 -31.81 17.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.05 -3.96 47.82 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.74 32.33 7.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.754 2.121 . . . . 0.0 110.578 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -111.27 146.4 37.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.976 1.388 . . . . 0.0 110.017 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.95 123.93 57.91 Favored Pre-proline 0 N--CA 1.467 0.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -68.97 130.6 20.62 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.348 2.032 . . . . 0.0 111.43 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.48 157.35 45.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.288 1.835 . . . . 0.0 111.837 -170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.4 120.52 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.511 1.925 . . . . 0.0 107.082 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 123.97 8.09 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.78 117.49 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 118.636 1.218 . . . . 0.0 108.722 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.33 85.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -66.74 136.52 26.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 168.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -121.74 121.91 38.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -74.36 125.07 27.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -43.6 -27.45 0.3 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.743 2.017 . . . . 0.0 114.456 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.19 2.87 1.37 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.29 30.42 7.38 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.023 1.296 . . . . 0.0 112.29 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.81 164.54 26.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.18 167.53 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 tpt -53.26 126.31 20.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.818 2.447 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -161.83 128.36 3.77 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.6 148.51 31.19 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.52 136.14 47.39 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.34 125.31 29.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -48.68 127.46 13.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 110.189 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 -24.14 1.77 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.133 1.349 . . . . 0.0 114.461 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.83 -32.28 23.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.389 1.076 . . . . 0.0 110.407 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 58.29 30.71 19.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 112.921 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -148.7 173.38 13.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.234 1.813 . . . . 0.0 107.19 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -75.05 163.26 27.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.316 0.962 . . . . 0.0 113.314 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.83 147.65 27.51 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.591 1.156 . . . . 0.0 108.889 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -61.64 150.98 79.89 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.0 1.72 . . . . 0.0 110.35 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.87 151.48 84.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.135 1.89 . . . . 0.0 110.88 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -173.43 168.18 4.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.205 1.802 . . . . 0.0 109.413 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.78 127.58 1.14 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.0 134.64 27.43 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.86 133.12 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.61 124.74 91.14 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.771 1.228 . . . . 0.0 108.875 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.76 118.42 5.19 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.929 1.753 . . . . 0.0 112.487 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.44 1.72 68.61 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.041 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.52 120.0 40.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 m -69.37 160.76 30.71 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 121.248 0.547 . . . . 0.0 111.09 -174.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.04 -42.14 12.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.767 2.027 . . . . 0.0 113.999 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -74.18 -47.69 33.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.49 -40.02 81.63 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 110.11 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.01 -32.92 72.81 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.309 1.044 . . . . 0.0 112.369 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.401 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.5 tmm? -59.51 -44.82 93.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -67.09 -27.68 67.55 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.748 -1.22 . . . . 0.0 112.649 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -64.75 -44.15 91.04 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.67 -1.269 . . . . 0.0 109.159 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.16 63.4 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 118.453 0.57 . . . . 0.0 110.544 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.99 -43.34 95.24 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 120.951 -1.093 . . . . 0.0 108.999 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -63.67 -57.3 10.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.652 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -25.5 60.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.104 1.774 . . . . 0.0 114.217 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.61 -11.02 12.43 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.927 -1.108 . . . . 0.0 112.654 -169.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.04 -16.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.18 0.992 . . . . 0.0 111.515 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.74 79.03 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 120.221 -1.549 . . . . 0.0 114.243 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -113.47 155.99 24.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.088 1.444 . . . . 0.0 109.104 -171.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -108.7 178.65 4.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.781 1.232 . . . . 0.0 110.227 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -72.77 37.58 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.399 1.88 . . . . 0.0 113.059 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -161.83 -14.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -106.06 18.24 22.35 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.457 1.026 . . . . 0.0 113.177 -168.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.22 175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.459 1.904 . . . . 0.0 109.42 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -140.91 114.39 8.77 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HA ' HD23 ' A' ' 102' ' ' LEU . 41.3 mt -72.94 132.51 33.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.07 -52.4 2.81 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.503 0.502 . . . . 0.0 109.673 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.86 174.19 11.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.57 0.748 . . . . 0.0 111.067 -171.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.5 p -145.82 177.31 9.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.944 1.298 . . . . 0.0 109.001 171.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 6.16 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.98 -16.53 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.014 2.526 . . . . 0.0 115.345 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.4 174.22 12.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.778 2.431 . . . . 0.0 108.674 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -79.16 121.81 25.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.669 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.18 160.95 17.51 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -140.52 141.88 35.27 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 108.838 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -144.83 153.02 41.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 168.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.98 156.19 17.06 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -88.53 141.52 30.44 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 154.77 72.2 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.804 2.336 . . . . 0.0 108.663 170.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -25.56 66.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -169.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.34 -26.6 58.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.124 0.97 . . . . 0.0 112.538 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.2 tp -96.56 -24.03 16.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.89 0.876 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.0 t -48.7 138.03 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.47 -45.36 46.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.493 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.3 m95 57.92 3.63 0.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.212 2.605 . . . . 0.0 114.034 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.95 -17.0 19.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.226 1.41 . . . . 0.0 110.658 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -80.63 143.64 32.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.609 1.564 . . . . 0.0 107.096 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.68 111.88 8.28 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 149.01 20.98 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 119.992 1.033 . . . . 0.0 112.77 -5.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.91 121.08 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.27 108.91 16.81 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.512 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 pt -90.36 -5.4 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.5 161.91 33.59 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -92.88 123.92 36.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -84.35 111.44 19.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 101.955 -3.35 . . . . 0.0 101.955 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.22 139.21 53.52 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.529 1.513 . . . . 0.0 113.162 -173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.55 124.83 52.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 169.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -104.68 143.44 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 61.1 m-85 -118.46 131.01 56.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.5 110.34 19.71 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 102' ' ' LEU . 15.3 mt -102.79 137.57 40.84 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 124.634 1.209 . . . . 0.0 109.422 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -93.35 127.14 38.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.6 112.09 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.2 t -81.25 -37.78 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 p -91.05 -115.3 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.158 0.583 . . . . 0.0 110.889 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.08 175.63 39.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.386 0.994 . . . . 0.0 111.021 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.69 -31.39 57.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.471 1.109 . . . . 0.0 112.321 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.78 65.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -109.66 -22.14 12.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.484 1.114 . . . . 0.0 111.104 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.38 143.24 12.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.0 1.32 . . . . 0.0 107.878 169.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -149.35 78.97 1.39 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.437 0.695 . . . . 0.0 109.404 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 mtt -68.58 16.49 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -116.34 22.97 12.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.438 1.472 . . . . 0.0 111.763 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -38.16 86.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.085 2.154 . . . . 0.0 112.096 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -3.43 50.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.444 1.097 . . . . 0.0 113.802 -169.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.65 -38.69 0.32 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.945 2.498 . . . . 0.0 113.726 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.8 p -126.04 73.01 71.08 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.532 1.933 . . . . 0.0 106.384 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -77.5 -167.41 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.89 3.06 . . . . 0.0 111.121 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.2 -11.32 14.91 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.241 -1.362 . . . . 0.0 112.49 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -135.24 148.41 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 121.703 2.047 . . . . 0.0 114.551 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -116.6 109.31 17.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.457 2.703 . . . . 0.0 103.943 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.13 148.64 32.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.563 1.078 . . . . 0.0 113.928 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -140.67 -119.62 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 0.0 111.333 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 150.19 38.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.134 1.773 . . . . 0.0 109.209 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -82.47 146.21 29.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.731 0.412 . . . . 0.0 110.129 -172.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.92 163.53 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.205 1.002 . . . . 0.0 110.398 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -53.01 154.25 3.02 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 111.382 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -60.81 150.99 30.94 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 64.87 -15.17 0.09 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.03 1.732 . . . . 0.0 115.027 -169.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -60.5 -43.62 93.29 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.706 2.048 . . . . 0.0 111.895 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -58.06 -34.74 98.79 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.712 1.608 . . . . 0.0 112.913 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.9 -51.99 59.75 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -68.97 -22.55 64.1 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.524 -0.735 . . . . 0.0 111.254 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -78.23 -18.32 55.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.65 161.28 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 119.631 1.105 . . . . 0.0 112.491 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.36 146.3 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.321 1.848 . . . . 0.0 112.115 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.1 m -61.83 -30.5 70.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -169.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -69.62 -31.02 68.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.607 1.094 . . . . 0.0 111.018 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -94.18 -32.09 13.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.7 0.8 . . . . 0.0 111.965 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.0 ttp-105 -48.41 -43.6 34.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.081 1.352 . . . . 0.0 113.121 -174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.3 -44.8 95.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.382 0.537 . . . . 0.0 110.867 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.9 t -73.99 -33.52 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.774 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -28.42 67.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.493 1.042 . . . . 0.0 110.437 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -42.9 98.61 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.893 -1.129 . . . . 0.0 109.725 169.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -64.95 -45.02 87.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.65 0.78 . . . . 0.0 110.089 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.7 t -51.27 -53.05 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.248 0.619 . . . . 0.0 109.485 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mtt -69.27 -41.84 76.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.438 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -51.83 -38.31 55.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.389 0.995 . . . . 0.0 111.454 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.46 -18.85 64.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.174 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.36 23.45 1.15 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.525 1.057 . . . . 0.0 113.834 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.26 78.56 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.212 -0.93 . . . . 0.0 110.663 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -60.46 -21.87 62.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.066 0.546 . . . . 0.0 111.707 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.02 -32.71 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.391 0.996 . . . . 0.0 108.373 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.9 t -72.31 -49.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.7 mmt -64.48 -29.52 70.57 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.645 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.5 m -48.82 -34.48 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.028 0.931 . . . . 0.0 112.064 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.22 -30.91 60.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.695 0.398 . . . . 0.0 110.426 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -114.37 -7.85 12.88 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.23 25.02 12.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.354 1.862 . . . . 0.0 109.004 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.98 -32.93 71.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 111.197 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.9 p -139.59 167.6 18.09 Favored Pre-proline 0 N--CA 1.441 -0.923 0 C-N-CA 131.659 3.984 . . . . 0.0 102.649 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.45 58.28 6.26 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.168 1.912 . . . . 0.0 110.62 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.126 176.157 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 mm -125.36 146.87 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 160.42 29.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.284 1.434 . . . . 0.0 109.653 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -24.93 66.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -84.69 -33.88 23.08 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.684 -0.635 . . . . 0.0 111.136 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.03 17.24 0.91 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.323 1.44 . . . . 0.0 112.854 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -84.26 144.44 28.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.455 1.627 . . . . 0.0 109.753 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.413 ' HD2' HD21 ' A' ' 10' ' ' ASN . 1.1 tmt_? -88.73 124.08 66.38 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 170.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.12 131.4 11.89 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.278 1.985 . . . . 0.0 110.207 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.413 HD21 ' HD2' ' A' ' 8' ' ' ARG . 22.7 m-80 -144.09 162.39 36.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.34 1.056 . . . . 0.0 111.414 -173.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.38 143.36 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.693 2.397 . . . . 0.0 106.425 169.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.01 126.46 6.32 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.58 138.86 19.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -118.93 89.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 168.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.65 138.64 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 m -126.11 123.84 39.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.93 144.07 32.17 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -66.34 -5.82 12.03 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.34 -11.59 60.54 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.928 0.786 . . . . 0.0 110.487 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.31 37.79 4.21 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 126.032 1.777 . . . . 0.0 112.426 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -138.01 157.89 45.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 108.844 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 m -100.61 161.25 3.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.5 ttt -58.07 132.38 53.33 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.381 1.472 . . . . 0.0 109.823 169.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.15 136.73 14.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.48 141.98 25.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.143 0.577 . . . . 0.0 110.118 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -71.13 140.26 50.54 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -75.39 142.75 43.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -62.18 125.73 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 109.797 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.25 14.31 71.3 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.281 -0.733 . . . . 0.0 114.387 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -148.5 131.97 16.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -87.7 48.7 1.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 111.819 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -153.37 -179.45 7.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.18 1.392 . . . . 0.0 108.906 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -108.53 155.07 21.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 108.408 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -134.9 143.19 46.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.246 0.93 . . . . 0.0 112.881 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -58.7 138.66 86.41 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.885 0.874 . . . . 0.0 109.785 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.77 145.83 81.97 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -169.65 157.84 7.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.748 1.619 . . . . 0.0 111.743 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.74 138.19 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.36 159.09 51.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.516 1.158 . . . . 0.0 111.515 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.1 mt -91.72 146.9 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 108.355 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -89.52 153.45 48.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.525 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.14 117.97 4.78 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.21 86.98 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.987 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.39 125.69 31.33 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.458 1.129 . . . . 0.0 108.333 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.74 157.63 36.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.746 1.218 . . . . 0.0 110.697 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -41.39 71.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.301 1.04 . . . . 0.0 113.244 -168.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -70.82 -47.18 60.79 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -57.46 -41.47 80.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.391 1.476 . . . . 0.0 110.01 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.06 81.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.696 0.68 . . . . 0.0 111.914 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -58.9 -44.94 91.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.934 0.788 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.87 -24.03 66.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.042 1.292 . . . . 0.0 113.405 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -63.75 -52.39 60.64 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.466 1.484 . . . . 0.0 108.949 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -36.16 82.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.562 0.345 . . . . 0.0 111.481 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.5 tp -57.23 -41.31 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 110.196 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.08 -45.88 46.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.288 1.035 . . . . 0.0 111.632 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.61 -36.73 79.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.799 1.181 . . . . 0.0 111.975 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.37 -47.77 7.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.126 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.55 -26.75 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.234 0.613 . . . . 0.0 111.142 -169.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.43 27.39 67.86 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.701 -0.624 . . . . 0.0 112.135 -170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.3 mt -105.05 157.63 17.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.547 1.139 . . . . 0.0 108.634 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -118.37 -174.45 2.67 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.614 1.166 . . . . 0.0 109.969 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.01 34.64 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.834 2.054 . . . . 0.0 114.343 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -159.26 -17.89 0.07 Allowed 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -87.02 -1.52 57.94 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.011 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.52 168.72 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.196 1.398 . . . . 0.0 109.203 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.12 122.48 16.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.0 mt -75.38 131.85 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 120.651 1.569 . . . . 0.0 107.497 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.58 -33.9 7.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.774 0.43 . . . . 0.0 111.671 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.28 168.09 28.41 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.016 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.2 p -146.73 159.53 43.36 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.879 1.272 . . . . 0.0 108.043 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -64.33 134.71 55.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -68.0 -18.36 64.7 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -149.06 165.89 30.35 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.307 1.443 . . . . 0.0 107.974 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -65.66 117.84 8.7 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.61 -53.85 29.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER 62.52 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 129.725 3.21 . . . . 0.0 112.775 -178.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -144.61 156.58 44.19 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.12 129.92 55.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.39 143.59 88.11 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.988 0.915 . . . . 0.0 109.257 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -66.72 154.34 74.82 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.837 2.358 . . . . 0.0 109.215 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -58.93 -31.36 68.59 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.55 -24.12 61.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.84 0.856 . . . . 0.0 112.95 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 tp -104.67 -17.2 14.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.19 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -45.68 136.86 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -72.58 -49.69 30.59 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.8 m95 58.86 3.18 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.139 2.575 . . . . 0.0 114.868 -169.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.59 -23.03 16.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.141 0.976 . . . . 0.0 111.52 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.48 158.63 18.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.338 1.855 . . . . 0.0 110.102 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -132.31 112.0 14.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 108.68 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -59.69 157.02 44.09 Favored 'Cis proline' 0 CA--C 1.537 0.668 0 CA-C-N 120.284 1.137 . . . . 0.0 110.51 -10.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.93 130.21 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.3 t -79.01 117.13 19.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.299 -1.319 . . . . 0.0 107.618 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.24 -2.12 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.283 1.433 . . . . 0.0 111.76 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 159.8 33.09 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 120.207 1.367 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -104.52 106.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.7 127.47 32.83 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 143.95 29.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.115 0.87 . . . . 0.0 111.723 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.19 135.2 55.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -108.71 147.76 31.48 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -121.29 124.96 45.88 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 tp -79.73 110.93 15.54 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.2 mm? -104.5 128.71 52.5 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.9 0.88 . . . . 0.0 109.364 176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -87.72 140.82 29.13 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 168.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -70.91 136.15 48.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.29 -41.31 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.1 m -136.07 136.13 39.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.62 176.61 46.89 Favored Glycine 0 C--N 1.331 0.303 0 O-C-N 121.514 -0.741 . . . . 0.0 113.378 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 t70 61.24 -46.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.719 3.608 . . . . 0.0 114.071 -172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.18 21.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.412 1.085 . . . . 0.0 111.389 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -90.81 -23.77 20.5 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.289 0.636 . . . . 0.0 111.193 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mt -66.12 139.43 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -135.18 -37.32 0.79 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.052 0.541 . . . . 0.0 112.071 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.4 mtt 56.85 17.46 3.27 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -132.91 25.4 4.3 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.621 1.1 . . . . 0.0 111.807 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -28.75 63.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.116 1.766 . . . . 0.0 111.436 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -7.0 57.8 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.254 1.821 . . . . 0.0 113.572 -170.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 67.69 -36.68 0.3 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.304 2.642 . . . . 0.0 113.66 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 p -124.29 75.06 60.63 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.58 -174.05 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.611 2.874 . . . . 0.0 111.238 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -107.57 -8.68 16.1 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.171 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.57 152.46 50.77 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 120.59 1.541 . . . . 0.0 112.43 -172.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -121.83 -31.2 3.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.632 1.573 . . . . 0.0 112.278 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.3 11.88 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -113.23 148.4 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.944 1.298 . . . . 0.0 110.847 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -152.05 129.17 11.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.793 1.237 . . . . 0.0 108.44 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -80.38 143.29 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 165.01 9.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.199 0.6 . . . . 0.0 110.233 -169.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -47.41 140.45 5.71 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -50.0 -41.45 47.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -94.12 -11.34 30.72 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -57.24 -44.99 99.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.428 -171.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.51 -23.89 77.32 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.554 1.503 . . . . 0.0 113.807 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -38.93 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 119.041 0.837 . . . . 0.0 109.605 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -87.71 -19.2 27.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.039 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.88 -27.73 66.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 121.032 1.742 . . . . 0.0 110.224 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.59 154.84 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.89 1.276 . . . . 0.0 110.641 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.66 150.23 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.811 1.245 . . . . 0.0 110.288 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -59.13 -31.58 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -168.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -75.25 -31.1 60.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.864 1.211 . . . . 0.0 110.691 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.98 -25.61 27.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.195 -0.907 . . . . 0.0 112.294 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -48.1 -47.98 34.01 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.372 1.442 . . . . 0.0 110.992 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.78 -43.94 87.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.375 0.534 . . . . 0.0 111.067 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.3 -33.96 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.937 -0.477 . . . . 0.0 110.267 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.79 -32.71 74.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.422 1.01 . . . . 0.0 109.522 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp-105 -59.76 -34.48 73.03 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 120.67 -1.269 . . . . 0.0 111.925 170.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -61.8 -46.55 89.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.281 1.4 . . . . 0.0 109.343 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.85 -52.14 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.2 mmt -60.55 -45.01 95.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -60.07 -38.67 83.54 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.239 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.11 -21.38 64.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.209 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -120.19 -22.82 6.46 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.24 64.09 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-N 119.896 1.226 . . . . 0.0 111.427 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -66.83 -25.95 66.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.071 0.85 . . . . 0.0 111.818 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.66 -37.4 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.1 -39.13 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.417 0.687 . . . . 0.0 110.198 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.5 mmt -72.55 -26.47 61.75 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.028 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.8 m -58.07 -32.92 68.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.621 1.1 . . . . 0.0 111.464 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.32 -29.17 69.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -94.45 -40.49 9.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.692 1.197 . . . . 0.0 109.682 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -69.09 -26.57 65.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.962 1.305 . . . . 0.0 111.666 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -75.0 -45.84 39.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.35 -45.3 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -62.76 -36.85 59.95 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.953 2.435 . . . . 0.0 113.62 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.9 tptt . . . . . 0 C--O 1.253 1.26 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.693 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.8 mm -127.41 134.82 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.02 144.32 50.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.672 1.589 . . . . 0.0 107.937 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -47.73 -32.53 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -168.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.74 -3.63 39.14 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.38 28.36 7.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.024 1.773 . . . . 0.0 111.418 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.69 145.38 39.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.125 1.462 . . . . 0.0 110.585 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 122.26 69.03 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 116.588 -1.672 . . . . 0.0 107.194 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.68 126.37 12.63 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.846 1.697 . . . . 0.0 110.111 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -140.37 166.7 23.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.476 1.11 . . . . 0.0 110.633 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.66 148.52 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.567 2.347 . . . . 0.0 106.668 169.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.95 12.1 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -102.57 117.32 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.47 82.25 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -62.62 130.9 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.8 127.39 53.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.75 136.49 32.97 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -66.6 -5.82 12.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.107 1.363 . . . . 0.0 114.317 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -75.41 -7.64 54.59 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.184 0.902 . . . . 0.0 110.496 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 33.7 4.55 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 125.103 1.335 . . . . 0.0 112.276 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -134.29 161.25 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.858 0.863 . . . . 0.0 109.131 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.49 162.61 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.727 0.811 . . . . 0.0 113.155 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.9 tpt -51.74 131.67 30.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.097 2.159 . . . . 0.0 112.085 171.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -161.91 143.88 11.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 167.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.09 143.98 21.84 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -78.07 145.89 35.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -77.9 125.1 28.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.59 140.69 57.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.153 1.381 . . . . 0.0 109.713 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 -40.92 1.73 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.512 1.053 . . . . 0.0 113.524 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.23 -31.95 24.75 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.499 1.149 . . . . 0.0 110.616 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.47 39.44 31.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.592 1.557 . . . . 0.0 112.402 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -135.2 173.87 11.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.591 1.956 . . . . 0.0 107.163 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -80.52 160.53 25.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.603 1.092 . . . . 0.0 111.77 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -151.39 146.88 26.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.675 1.19 . . . . 0.0 109.025 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.81 136.11 51.55 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.963 0.905 . . . . 0.0 110.731 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -65.41 141.28 67.24 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.602 2.201 . . . . 0.0 111.817 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -177.92 150.76 0.64 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.067 2.547 . . . . 0.0 106.337 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.84 142.75 9.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.02 154.62 53.42 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 118.323 1.061 . . . . 0.0 111.34 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.7 127.76 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -67.47 125.55 91.32 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 117.684 -1.15 . . . . 0.0 108.841 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.67 117.97 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.92 1.747 . . . . 0.0 112.803 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.08 0.42 77.52 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.404 1.478 . . . . 0.0 112.923 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -93.82 127.71 39.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.13 160.18 31.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.536 1.135 . . . . 0.0 110.811 -177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.9 64.06 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.063 1.345 . . . . 0.0 113.146 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -71.21 -48.57 50.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -59.13 -38.22 79.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.536 1.534 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.8 68.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.91 1.284 . . . . 0.0 111.738 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.457 ' HG3' ' CD1' ' A' ' 100' ' ' PHE . 18.2 tmm? -60.64 -43.06 98.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.54 -32.71 74.24 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.246 -0.908 . . . . 0.0 112.213 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -60.67 -46.57 89.83 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.848 -1.157 . . . . 0.0 109.517 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.6 67.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.802 0.728 . . . . 0.0 111.705 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -61.31 -40.84 95.66 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.037 -1.04 . . . . 0.0 108.531 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.85 -55.87 6.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.575 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.6 -38.22 83.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.947 1.703 . . . . 0.0 111.225 -170.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -94.66 -37.96 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.323 0.51 . . . . 0.0 112.041 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -109.63 -20.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.267 0.627 . . . . 0.0 110.668 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.55 48.46 56.72 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.499 -1.376 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 mt -127.68 156.12 42.87 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.831 1.652 . . . . 0.0 107.817 171.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -114.07 -177.16 3.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.142 0.977 . . . . 0.0 110.285 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -73.75 38.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.273 1.829 . . . . 0.0 113.14 -170.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -157.98 -18.69 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.987 1.315 . . . . 0.0 113.202 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -86.03 -2.01 57.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.993 0.517 . . . . 0.0 112.082 -169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HB ' HD12 ' A' ' 102' ' ' LEU . 27.5 m -149.14 168.02 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.13 -170.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -137.51 121.4 17.64 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.51 126.55 35.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.87 -32.58 7.86 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.208 0.317 . . . . 0.0 111.271 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.81 162.06 39.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.506 1.122 . . . . 0.0 108.555 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 m -139.86 157.47 45.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -58.89 137.21 57.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.146 0.885 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -61.52 -31.34 71.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.771 0.429 . . . . 0.0 111.453 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -151.65 173.07 15.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.216 1.806 . . . . 0.0 106.754 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -60.08 125.19 22.72 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 109.471 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.98 50.11 1.91 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 127.52 2.328 . . . . 0.0 107.451 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 146.46 47.67 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -169.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -145.52 142.77 29.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.641 0.588 . . . . 0.0 110.199 -170.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -100.18 133.2 44.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.601 1.16 . . . . 0.0 108.536 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.7 148.83 73.55 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 124.428 1.091 . . . . 0.0 111.016 -174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 154.42 74.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.756 2.304 . . . . 0.0 109.265 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -53.59 -31.55 47.37 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -72.04 -32.01 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.519 1.127 . . . . 0.0 111.905 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.52 -24.11 18.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.975 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -58.05 130.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.19 -43.62 41.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.094 0.557 . . . . 0.0 112.361 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 24.8 m95 59.69 4.64 0.58 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 127.382 2.273 . . . . 0.0 113.432 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.78 -21.51 15.15 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.209 1.404 . . . . 0.0 111.066 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -73.78 147.09 43.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.455 1.502 . . . . 0.0 108.651 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -134.84 116.55 12.56 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.44 149.16 31.02 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.952 1.019 . . . . 0.0 111.161 -10.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.39 131.61 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.3 106.69 18.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.0 pt -102.06 -6.14 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.002 0.921 . . . . 0.0 112.409 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.7 163.71 37.22 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 120.232 1.378 . . . . 0.0 113.172 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.5 115.67 27.81 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -85.64 120.22 26.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 101.211 -3.626 . . . . 0.0 101.211 168.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -146.38 138.03 24.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.662 1.119 . . . . 0.0 111.435 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.21 122.67 45.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -98.91 141.34 31.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 50' ' ' MET . 58.5 m-85 -118.84 128.72 54.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 tt -82.59 121.22 26.53 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.443 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.5 mm? -113.47 122.05 46.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.667 -1.151 . . . . 0.0 107.991 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -80.85 133.89 35.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 tp -67.12 136.68 55.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -115.92 -38.15 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m -89.52 -130.5 0.08 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.486 0.714 . . . . 0.0 109.781 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.73 177.1 46.94 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 120.001 1.273 . . . . 0.0 111.914 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -52.67 -31.3 36.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.322 1.449 . . . . 0.0 112.554 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.88 -27.04 66.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -97.16 -28.28 14.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.167 0.987 . . . . 0.0 110.894 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.63 147.04 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.53 1.132 . . . . 0.0 108.025 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -127.17 -50.63 1.43 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.351 0.66 . . . . 0.0 109.684 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 mtt 63.33 -8.26 0.15 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.486 1.914 . . . . 0.0 115.179 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -109.54 24.53 12.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 121.248 1.84 . . . . 0.0 111.616 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -24.9 63.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.303 1.841 . . . . 0.0 112.19 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -6.69 59.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.981 1.713 . . . . 0.0 113.901 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.2 m 68.86 -34.02 0.26 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.387 2.675 . . . . 0.0 114.111 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.11 71.65 63.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.64 -170.21 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.525 2.816 . . . . 0.0 113.561 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -110.53 -42.56 4.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.252 1.021 . . . . 0.0 109.749 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.66 152.47 28.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.521 1.055 . . . . 0.0 113.568 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.16 14.36 13.96 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.473 1.509 . . . . 0.0 112.168 171.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.61 171.44 46.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.01 1.29 . . . . 0.0 113.348 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -164.65 -116.43 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.82 1.248 . . . . 0.0 109.741 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.8 mtp85 -145.81 160.81 41.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.267 3.027 . . . . 0.0 107.51 -170.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -85.77 132.95 34.03 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.51 168.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 110.793 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.4 m -52.7 147.24 8.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.729 0.695 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -52.46 -40.66 62.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -168.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -95.32 -3.73 46.78 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.71 -43.19 82.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.495 1.043 . . . . 0.0 111.765 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.2 -26.41 82.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.535 1.584 . . . . 0.0 113.085 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -12.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 O-C-N 121.435 -0.791 . . . . 0.0 111.374 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -35.73 7.66 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.808 1.186 . . . . 0.0 109.284 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -68.52 -26.54 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.733 1.151 . . . . 0.0 112.297 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.08 159.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 118.885 0.766 . . . . 0.0 110.459 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.3 149.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.574 0.75 . . . . 0.0 111.43 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 m -51.09 -39.01 55.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.035 1.734 . . . . 0.0 114.064 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.37 -40.3 58.22 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.735 0.698 . . . . 0.0 110.222 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -66.53 -32.76 74.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.212 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -44.97 -48.83 11.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.705 1.139 . . . . 0.0 110.789 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.94 -34.74 78.82 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.73 -38.42 19.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.948 -0.47 . . . . 0.0 109.955 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -33.18 75.41 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.961 -0.462 . . . . 0.0 109.837 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -56.22 -40.3 73.85 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.314 -1.327 . . . . 0.0 110.967 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.07 -45.02 90.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.838 1.654 . . . . 0.0 109.155 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.69 -41.68 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.8 mtt -72.0 -39.54 69.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.542 -0.724 . . . . 0.0 110.658 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.69 -37.13 86.18 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.45 -28.34 66.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.093 0.957 . . . . 0.0 111.466 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -122.98 2.68 9.36 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.67 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.414 1.461 . . . . 0.0 111.576 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 p -66.01 -23.03 66.49 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 t -69.39 -39.91 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.69 1.132 . . . . 0.0 108.841 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.02 -44.2 28.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mtt -66.08 -32.77 74.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.568 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.1 m -61.16 -22.13 64.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.521 1.055 . . . . 0.0 112.761 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.25 -21.57 39.35 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 111.546 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -109.53 -37.67 5.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.613 1.165 . . . . 0.0 109.93 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -89.55 30.53 1.01 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.733 2.013 . . . . 0.0 109.486 171.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -75.74 -43.91 44.48 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.701 -0.624 . . . . 0.0 111.76 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.563 ' H ' ' CD ' ' A' ' 163' ' ' PRO . 7.9 p -129.7 -25.04 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.75 2.02 . . . . 0.0 115.124 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.563 ' CD ' ' H ' ' A' ' 162' ' ' THR . 51.9 Cg_exo -65.09 -27.41 57.29 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.598 2.198 . . . . 0.0 112.993 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 C--O 1.253 1.279 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 171.637 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.395 0.141 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm -137.91 147.99 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.25 -44.88 71.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.132 0.573 . . . . 0.0 111.833 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -152.05 -80.73 0.1 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.69 0.796 . . . . 0.0 110.83 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.76 -47.48 8.6 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.06 12.64 0.05 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.644 -0.531 . . . . 0.0 114.123 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -96.72 130.67 43.92 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.498 1.149 . . . . 0.0 108.655 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -88.02 127.51 57.33 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.62 135.98 24.95 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.719 1.612 . . . . 0.0 109.92 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -140.65 153.47 46.02 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.709 1.604 . . . . 0.0 111.446 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.69 135.16 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.909 2.084 . . . . 0.0 105.533 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.69 125.92 6.69 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mm -95.49 110.33 24.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.59 86.14 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.68 129.97 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 155' ' ' VAL . 44.2 t -106.22 135.3 47.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 168.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.81 25.66 4.53 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 54.42 -2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.251 2.22 . . . . 0.0 116.726 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -95.58 14.8 21.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.043 0.838 . . . . 0.0 111.697 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.6 9.48 84.65 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 124.564 1.078 . . . . 0.0 113.112 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -125.45 172.9 9.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.441 1.12 . . . . 0.0 108.875 -169.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.18 170.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.3 tpt -53.13 136.22 36.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.5 2.32 . . . . 0.0 113.72 -170.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -163.1 135.6 5.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.813 1.245 . . . . 0.0 108.166 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.82 158.23 40.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.401 1.48 . . . . 0.0 109.104 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -93.05 130.79 38.53 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -78.92 123.35 27.18 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.887 0.875 . . . . 0.0 109.173 -169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -53.75 134.16 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.267 2.227 . . . . 0.0 110.222 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 -16.88 1.92 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.939 1.257 . . . . 0.0 114.773 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -105.75 -30.8 9.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 110.33 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 58.87 39.65 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.76 1.624 . . . . 0.0 112.791 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 p -140.53 171.29 14.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.712 1.605 . . . . 0.0 108.298 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -79.24 157.59 27.76 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.01 157.29 19.08 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.186 2.194 . . . . 0.0 113.742 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.83 96.47 5.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 168.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 146.25 89.69 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.307 1.338 . . . . 0.0 111.695 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 156.5 149.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.628 3.171 . . . . 0.0 108.231 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.03 143.87 14.64 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.61 144.34 35.35 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.7 mt -73.53 141.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.87 141.53 38.18 Favored Pre-proline 0 N--CA 1.465 0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.368 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -59.34 116.31 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.088 1.859 . . . . 0.0 111.971 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.43 2.39 87.42 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.056 1.312 . . . . 0.0 112.916 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -86.21 128.26 34.87 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.515 1.158 . . . . 0.0 107.996 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.52 157.42 38.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.488 1.115 . . . . 0.0 110.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.8 63.71 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.364 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 1.5 mp0 -64.12 -49.49 71.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -57.47 -36.22 71.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.169 1.388 . . . . 0.0 109.608 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.24 -35.17 66.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.645 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 47' ' ' GLU . 30.6 mtp -56.54 -47.22 79.87 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.369 1.44 . . . . 0.0 109.189 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.76 -26.57 67.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -65.87 -53.07 44.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.843 0.747 . . . . 0.0 109.549 170.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.63 82.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.113 0.87 . . . . 0.0 111.474 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 tp -56.33 -41.78 76.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.528 1.531 . . . . 0.0 110.345 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -44.13 56.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.57 1.148 . . . . 0.0 111.105 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.46 -37.79 83.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.291 0.95 . . . . 0.0 111.826 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.03 -75.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.017 0.927 . . . . 0.0 109.987 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.84 -6.59 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.76 49.78 61.97 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 mt -120.34 156.94 30.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.647 1.579 . . . . 0.0 107.111 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.5 m -112.68 173.63 6.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.158 0.983 . . . . 0.0 109.444 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.97 43.42 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.104 2.162 . . . . 0.0 114.508 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.66 -18.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.102 1.761 . . . . 0.0 112.171 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -88.99 -0.07 57.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.842 0.857 . . . . 0.0 111.71 -172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.37 169.96 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.862 1.265 . . . . 0.0 109.365 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -142.3 129.16 20.6 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 mt -81.34 127.85 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.124 1.329 . . . . 0.0 108.719 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.9 -35.37 6.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.716 0.807 . . . . 0.0 111.898 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.24 165.88 35.07 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.689 0.795 . . . . 0.0 109.848 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.5 p -144.92 160.06 41.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.251 1.02 . . . . 0.0 109.511 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 p -64.94 137.18 57.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -64.75 -25.27 67.85 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -151.16 170.21 19.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.971 1.309 . . . . 0.0 108.667 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -65.99 123.56 20.18 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.227 0.611 . . . . 0.0 109.467 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.43 167.8 19.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.62 154.67 33.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -139.26 162.94 33.77 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -103.82 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.3 mt -69.12 140.59 90.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 151.88 64.65 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.319 2.679 . . . . 0.0 109.294 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -65.5 -21.05 66.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -169.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.67 -27.83 61.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.954 0.901 . . . . 0.0 112.332 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.7 tp -94.46 -26.25 16.55 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.614 0.766 . . . . 0.0 110.929 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.35 136.8 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -42.47 42.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.523 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m95 61.81 3.38 0.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.164 2.185 . . . . 0.0 113.718 -169.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -16.69 18.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.245 1.418 . . . . 0.0 111.028 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -76.94 144.26 38.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.983 1.713 . . . . 0.0 107.259 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.79 116.41 9.0 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.468 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.31 150.96 22.04 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.105 1.073 . . . . 0.0 111.927 -10.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 m -57.72 129.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.8 t -88.82 107.37 18.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -111.65 -5.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.6 1.16 . . . . 0.0 112.257 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 168.76 41.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.128 0.876 . . . . 0.0 112.188 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -103.76 107.88 18.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -71.76 121.54 19.09 Favored 'General case' 0 N--CA 1.471 0.617 1 N-CA-C 100.185 -4.006 . . . . 0.0 100.185 167.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.89 132.9 33.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.621 1.555 . . . . 0.0 112.783 -168.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -112.37 128.11 56.2 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -104.25 147.14 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.68 130.05 48.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.2 tp -77.84 111.61 13.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -106.24 126.99 52.9 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -82.58 134.98 35.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.69 104.65 4.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.87 -33.9 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.8 p -83.6 -119.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.821 0.448 . . . . 0.0 109.848 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.8 174.37 42.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.998 1.285 . . . . 0.0 110.675 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -28.9 15.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.686 1.194 . . . . 0.0 113.012 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.423 0.556 . . . . 0.0 112.082 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.61 -22.04 13.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.551 1.141 . . . . 0.0 111.691 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.6 mt -62.38 102.99 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -92.47 -30.88 15.49 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.168 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.0 mtt 60.84 -44.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 130.093 3.357 . . . . 0.0 114.784 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.27 34.46 1.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.352 1.861 . . . . 0.0 110.469 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -71.21 -49.5 42.84 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -68.55 148.82 49.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -75.72 -27.06 58.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.936 1.695 . . . . 0.0 112.228 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 p -120.74 69.73 17.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.675 1.99 . . . . 0.0 106.58 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.62 -174.67 1.94 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.273 3.315 . . . . 0.0 111.292 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -116.2 -18.24 10.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.386 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.14 150.18 52.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 121.935 2.152 . . . . 0.0 112.067 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.08 -28.9 4.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.708 1.203 . . . . 0.0 112.492 -170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.44 150.41 20.02 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -96.73 156.88 16.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.945 1.298 . . . . 0.0 110.194 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -153.01 103.54 2.75 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -71.57 133.37 45.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.052 1.296 . . . . 0.0 108.658 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 153.8 27.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.909 1.284 . . . . 0.0 108.15 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.5 m -58.48 158.54 7.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.62 0.768 . . . . 0.0 112.672 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.18 151.02 13.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.2 m95 67.1 -23.41 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.171 1.788 . . . . 0.0 115.561 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.0 -47.56 95.08 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 121.059 1.754 . . . . 0.0 111.259 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.82 -32.92 86.58 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.875 1.717 . . . . 0.0 113.234 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.95 -33.02 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.512 0.725 . . . . 0.0 110.35 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -85.92 -26.63 25.45 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.166 0.894 . . . . 0.0 111.744 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -80.53 -27.6 37.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.773 0.715 . . . . 0.0 112.191 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.55 158.78 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.164 0.893 . . . . 0.0 110.097 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.29 148.51 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.215 1.006 . . . . 0.0 111.466 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 m -57.6 -35.67 70.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.956 1.302 . . . . 0.0 113.767 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -71.88 -25.41 61.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.178 0.899 . . . . 0.0 111.635 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -86.75 -40.82 14.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.775 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.27 -51.66 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 112.977 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -66.3 -33.07 74.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.463 0.574 . . . . 0.0 112.397 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.83 -35.24 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.349 0.66 . . . . 0.0 110.193 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.34 -31.98 73.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.532 1.06 . . . . 0.0 110.608 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -55.84 -40.87 73.44 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.368 -0.832 . . . . 0.0 110.559 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -64.36 -45.26 88.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 109.504 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.71 -47.19 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 mtt -66.32 -38.13 86.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.956 -0.465 . . . . 0.0 110.744 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.17 -37.9 89.05 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.021 -1.049 . . . . 0.0 110.286 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.11 -29.81 70.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 111.238 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -115.64 -13.97 11.47 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.79 39.84 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.322 1.419 . . . . 0.0 111.702 -169.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.4 m -64.02 -24.5 67.73 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.022 -0.424 . . . . 0.0 111.612 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.11 -40.95 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.437 HG13 ' SG ' ' A' ' 16' ' ' CYS . 39.8 t -68.63 -45.46 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.486 0.714 . . . . 0.0 110.238 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -71.04 -20.35 62.39 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.039 0.836 . . . . 0.0 111.491 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -59.48 -30.55 68.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.461 1.028 . . . . 0.0 111.824 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.45 -41.1 85.27 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.22 -29.83 22.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.928 -173.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -12.95 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.006 1.322 . . . . 0.0 111.441 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -95.13 76.77 3.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -37.12 30.34 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -169.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -66.93 -12.13 34.87 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.341 2.694 . . . . 0.0 115.321 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 60.0 tttp . . . . . 0 C--O 1.252 1.226 0 CA-C-N 120.612 1.551 . . . . 0.0 109.241 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.339 0.114 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 mm -139.28 142.7 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.26 140.03 50.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.276 1.43 . . . . 0.0 108.198 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -31.94 -49.95 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.754 2.422 . . . . 0.0 116.577 -168.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -83.97 8.67 14.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.46 35.04 4.24 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.386 1.47 . . . . 0.0 112.258 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -115.61 143.76 44.88 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.613 1.206 . . . . 0.0 112.295 -171.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -82.85 115.86 60.92 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-O 117.435 -1.269 . . . . 0.0 107.817 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 125.29 7.13 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.119 1.88 . . . . 0.0 109.808 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.17 174.35 15.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.374 1.069 . . . . 0.0 109.919 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 50' ' ' MET . 31.4 m -119.94 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.92 9.04 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.33 128.01 38.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.085 0.943 . . . . 0.0 108.746 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.94 88.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.9 mm -67.57 137.21 25.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 168.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -125.57 120.21 30.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -78.14 138.9 38.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -65.22 -7.09 11.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.42 -11.27 60.61 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.125 0.875 . . . . 0.0 110.516 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.67 34.83 4.54 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.378 1.942 . . . . 0.0 112.225 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -131.9 148.01 52.51 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 m -104.98 162.89 4.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.9 tpt -56.39 130.06 43.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.097 1.759 . . . . 0.0 110.376 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -161.73 127.42 3.62 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.33 144.3 32.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -73.06 135.9 44.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -77.61 128.64 34.46 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.96 128.57 16.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.912 2.085 . . . . 0.0 110.44 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.32 -33.19 1.55 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.191 1.376 . . . . 0.0 114.067 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -37.14 21.92 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.415 1.108 . . . . 0.0 109.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.259 14.8 m170 59.21 33.12 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.657 1.583 . . . . 0.0 113.096 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -139.12 162.98 33.62 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.356 2.262 . . . . 0.0 105.805 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -74.19 164.86 26.1 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.405 1.002 . . . . 0.0 113.203 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -151.44 142.8 23.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.641 1.576 . . . . 0.0 108.474 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -73.14 144.94 85.35 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.587 0.755 . . . . 0.0 110.017 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.66 144.73 97.65 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.371 1.381 . . . . 0.0 112.435 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -172.79 138.09 0.8 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.518 2.327 . . . . 0.0 108.505 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.41 -114.09 3.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.272 0.939 . . . . 0.0 110.969 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.81 165.11 35.05 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 128.006 2.717 . . . . 0.0 107.443 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.89 135.08 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -84.44 158.23 60.66 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 119.011 -0.518 . . . . 0.0 109.855 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.7 117.21 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.817 1.678 . . . . 0.0 112.275 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.16 9.24 85.58 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.839 1.209 . . . . 0.0 112.909 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.05 125.19 29.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.361 1.08 . . . . 0.0 108.717 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 159.58 34.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.472 1.109 . . . . 0.0 110.815 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.68 68.76 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.703 1.201 . . . . 0.0 113.436 -169.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.17 -43.42 64.61 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -60.79 -44.21 97.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.493 1.117 . . . . 0.0 108.886 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.73 71.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.417 1.087 . . . . 0.0 112.292 172.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HA ' HG21 ' A' ' 11' ' ' VAL . 15.6 tmm? -65.98 -43.09 88.84 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.211 0.914 . . . . 0.0 109.739 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -65.55 -25.48 67.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.211 1.369 . . . . 0.0 111.727 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.96 -49.61 64.89 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 120.063 1.301 . . . . 0.0 108.64 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.69 83.18 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.82 0.819 . . . . 0.0 110.239 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.45 -40.93 88.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.204 1.401 . . . . 0.0 109.646 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.17 -47.72 55.99 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.17 0.988 . . . . 0.0 111.196 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.44 -35.33 80.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.894 1.679 . . . . 0.0 112.053 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.32 -39.6 9.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.722 0.809 . . . . 0.0 110.422 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -17.35 7.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 111.01 -169.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.08 43.42 99.45 Favored Glycine 0 N--CA 1.451 -0.31 0 O-C-N 120.567 -1.333 . . . . 0.0 110.918 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -117.28 159.32 22.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.638 1.175 . . . . 0.0 108.183 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -122.36 -177.49 3.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.823 1.249 . . . . 0.0 110.271 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -67.93 40.42 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.177 2.591 . . . . 0.0 114.694 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -164.68 -22.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.343 1.057 . . . . 0.0 112.655 -169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.99 -3.92 58.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.446 0.698 . . . . 0.0 112.298 -169.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.4 168.97 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.921 1.288 . . . . 0.0 109.72 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -135.74 119.48 17.22 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 mt -75.76 131.79 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 120.069 1.304 . . . . 0.0 107.738 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.63 -50.72 3.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.262 0.483 . . . . 0.0 110.24 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.39 168.36 20.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.774 0.83 . . . . 0.0 110.618 -170.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.0 p -150.81 161.23 43.06 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.136 1.375 . . . . 0.0 108.23 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -62.49 146.29 52.03 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.936 0.789 . . . . 0.0 109.991 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.6 mtt-85 -64.62 -30.18 71.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.044 0.538 . . . . 0.0 111.523 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.56 172.18 13.96 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.691 1.596 . . . . 0.0 107.546 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -61.11 125.19 22.82 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.63 147.39 39.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -118.71 123.73 45.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.85 126.01 48.65 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.064 -0.969 . . . . 0.0 108.528 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -102.42 112.47 25.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.39 148.9 98.2 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.359 1.063 . . . . 0.0 110.738 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -66.96 151.57 81.9 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 108.333 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -25.25 66.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -74.81 -26.39 59.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.217 1.007 . . . . 0.0 112.432 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.05 -21.12 16.36 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.765 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.4 t -46.59 140.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 168.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -73.82 -44.88 54.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.8 m95 57.17 8.74 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.215 2.206 . . . . 0.0 114.719 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -120.84 -16.62 8.11 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.184 0.994 . . . . 0.0 112.649 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 p -75.08 -36.2 61.78 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 49.32 93.36 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 127.654 2.382 . . . . 0.0 112.271 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.54 147.68 73.09 Favored 'Cis proline' 0 C--N 1.352 0.728 0 CA-C-N 119.774 0.955 . . . . 0.0 111.315 6.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.53 129.36 27.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.1 t -91.87 112.56 24.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.57 -5.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 124.529 1.132 . . . . 0.0 111.808 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.64 43.06 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.818 1.19 . . . . 0.0 115.217 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -106.46 126.75 52.64 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 124.817 1.247 . . . . 0.0 107.739 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -91.64 116.22 28.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.53 108.86 6.12 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.606 0.567 . . . . 0.0 111.208 -168.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -93.44 128.96 39.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 168.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -95.72 135.28 37.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.47 128.43 56.33 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -87.84 109.79 20.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mm? -107.96 124.45 50.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.229 1.012 . . . . 0.0 109.899 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.19 131.66 34.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.88 135.69 51.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.44 -28.14 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.0 p -88.21 -126.81 0.05 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.211 1.004 . . . . 0.0 110.411 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.93 166.48 35.54 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.21 1.386 . . . . 0.0 110.026 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.24 -30.88 18.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.493 1.117 . . . . 0.0 112.773 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.48 65.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.079 0.552 . . . . 0.0 112.295 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -95.96 -31.83 12.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.775 1.23 . . . . 0.0 110.726 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.38 142.63 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.207 1.403 . . . . 0.0 108.177 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.59 -51.33 1.84 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.7 mtt 63.71 -18.42 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.42 1.888 . . . . 0.0 115.337 -171.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.36 25.33 7.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.836 2.107 . . . . 0.0 112.042 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -35.33 77.13 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.935 2.494 . . . . 0.0 111.698 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -3.58 55.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 113.471 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 m 65.98 -35.98 0.23 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.95 2.5 . . . . 0.0 114.126 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 p -125.95 68.15 62.86 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.739 2.016 . . . . 0.0 106.287 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.19 -172.59 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.017 3.145 . . . . 0.0 111.507 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.43 -17.84 13.89 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.306 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -129.25 146.47 51.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 121.915 2.143 . . . . 0.0 111.842 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.42 -49.04 3.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.382 0.673 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.51 153.25 6.22 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 123.38 0.514 . . . . 0.0 111.836 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 30.6 t-105 -156.41 -130.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.802 1.241 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -152.94 155.22 36.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.806 2.842 . . . . 0.0 106.942 -169.272 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.4 143.15 37.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 0.85 . . . . 0.0 110.285 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.5 164.76 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.039 0.936 . . . . 0.0 110.52 -169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.25 147.98 5.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.735 0.814 . . . . 0.0 110.011 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -54.14 -40.73 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -93.14 2.76 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.64 -47.82 75.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 120.767 -1.208 . . . . 0.0 111.126 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -64.97 -32.77 53.57 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.913 1.719 . . . . 0.0 112.886 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.65 -33.4 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 119.784 1.174 . . . . 0.0 109.931 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.43 -41.95 75.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.835 1.198 . . . . 0.0 110.063 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -83.83 -18.77 36.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.21 160.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.601 1.091 . . . . 0.0 109.714 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.4 m -51.69 143.59 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.649 1.18 . . . . 0.0 111.576 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.8 m -59.89 -30.97 69.37 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -69.96 -47.18 63.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.144 0.884 . . . . 0.0 109.696 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -75.84 -27.41 57.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.553 -174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -40.2 -49.27 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.556 1.142 . . . . 0.0 112.887 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.88 -38.56 91.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.47 0.577 . . . . 0.0 111.797 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.13 -34.31 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 O-C-N 121.751 -0.593 . . . . 0.0 110.009 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -31.34 72.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.132 0.878 . . . . 0.0 109.97 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -55.65 -36.67 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.231 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -61.67 -51.2 69.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.907 1.23 . . . . 0.0 108.764 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -54.78 -48.05 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.2 mtt -69.53 -41.12 76.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.229 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -58.86 -41.54 87.27 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.953 0.797 . . . . 0.0 110.128 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.63 -33.6 74.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.764 0.426 . . . . 0.0 110.85 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -98.35 -9.43 25.34 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.82 -57.97 7.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.695 1.134 . . . . 0.0 112.036 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.149 -0.345 . . . . 0.0 111.538 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.9 t -73.95 -39.67 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.52 -54.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -62.78 -26.27 68.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.53 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.5 m -57.73 -31.24 66.24 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.267 1.394 . . . . 0.0 111.848 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.23 -27.2 66.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.547 0.739 . . . . 0.0 110.946 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -96.98 -32.07 12.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.82 0.848 . . . . 0.0 110.976 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.78 -29.14 65.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.376 1.071 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -113.93 81.39 1.52 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -40.85 79.88 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.004 0.921 . . . . 0.0 112.759 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -61.07 -16.73 47.67 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.902 3.068 . . . . 0.0 115.277 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.945 -179.412 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 119.685 -0.198 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.8 149.52 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -124.18 166.48 15.75 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.477 2.311 . . . . 0.0 108.77 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 42.38 47.5 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.799 2.039 . . . . 0.0 114.517 170.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.34 18.71 8.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.741 2.016 . . . . 0.0 114.267 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.72 -1.14 0.1 OUTLIER Glycine 0 C--N 1.34 0.756 0 N-CA-C 116.611 1.405 . . . . 0.0 116.611 169.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.68 130.43 37.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 120.763 2.282 . . . . 0.0 110.531 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -78.9 115.53 52.95 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.325 -1.321 . . . . 0.0 108.387 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.4 118.02 5.02 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.545 2.163 . . . . 0.0 107.941 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.83 167.86 21.59 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.688 0.795 . . . . 0.0 109.442 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.36 135.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.38 8.29 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.45 105.87 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.59 83.93 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.493 -2.039 . . . . 0.0 105.493 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.11 131.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -122.38 129.02 51.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.75 140.85 30.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -63.04 -0.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 115.101 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -81.36 0.42 37.38 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.999 0.818 . . . . 0.0 109.579 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.55 28.04 37.09 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 124.846 1.213 . . . . 0.0 112.11 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -122.09 154.9 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -113.94 163.02 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -168.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.6 tpt -50.87 130.58 25.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.008 2.123 . . . . 0.0 111.777 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 5.3 t-105 -163.73 124.16 2.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 169.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.56 142.74 45.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.857 1.313 . . . . 0.0 112.972 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.1 ttp85 -78.43 140.65 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.754 2.421 . . . . 0.0 107.902 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -88.0 151.27 22.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.135 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.24 156.62 24.91 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.439 1.495 . . . . 0.0 112.163 171.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.9 25.32 30.1 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.376 0.989 . . . . 0.0 110.88 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -10.0 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 131.294 3.837 . . . . 0.0 117.198 -167.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -151.35 6.64 0.49 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.181 168.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -154.68 147.66 24.61 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 109.058 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -121.08 131.87 54.53 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.18 -176.34 4.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.171 0.988 . . . . 0.0 111.665 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.69 156.64 52.31 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.95 2.1 . . . . 0.0 109.433 -170.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.94 155.11 71.11 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.595 2.864 . . . . 0.0 113.919 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 71.08 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.672 3.589 . . . . 0.0 105.716 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 121.63 7.29 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.481 1.038 . . . . 0.0 114.525 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.89 145.78 14.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.929 2.204 . . . . 0.0 113.445 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.96 136.45 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.632 1.173 . . . . 0.0 108.437 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -77.88 138.61 61.63 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 117.601 -1.19 . . . . 0.0 109.251 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.44 118.76 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.711 1.607 . . . . 0.0 112.678 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.56 89.79 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.109 176.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.95 129.32 35.28 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.08 159.6 34.42 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 124.685 1.194 . . . . 0.0 110.645 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -41.75 66.47 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.492 1.117 . . . . 0.0 113.841 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.76 -47.34 54.35 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -59.07 -40.61 85.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.149 1.38 . . . . 0.0 109.405 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.93 -27.89 62.12 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.0 1.32 . . . . 0.0 111.593 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.8 -40.85 95.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 79.0 m-85 -68.19 -30.4 69.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.217 -1.552 . . . . 0.0 112.838 172.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.829 -1.169 . . . . 0.0 109.954 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.5 -29.33 65.82 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.663 0.665 . . . . 0.0 112.134 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.84 -41.7 97.77 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.626 -1.296 . . . . 0.0 108.604 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.01 -53.75 34.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.327 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.62 -28.33 68.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.336 1.426 . . . . 0.0 113.378 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -115.14 -12.08 11.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.26 0.936 . . . . 0.0 113.278 -168.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.97 -20.45 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.092 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.66 55.24 31.64 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.35 -1.469 . . . . 0.0 110.126 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.2 159.51 41.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.499 1.92 . . . . 0.0 106.775 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 m -117.34 -177.18 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.502 1.121 . . . . 0.0 110.458 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 14.6 mtt180 -70.9 36.33 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.369 2.268 . . . . 0.0 113.578 -171.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.52 -19.83 0.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.965 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -83.39 -5.19 59.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 112.525 -169.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.66 167.63 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.583 1.153 . . . . 0.0 109.468 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -136.19 120.18 17.58 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.674 1.99 . . . . 0.0 105.926 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.99 128.92 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.07 -35.85 7.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.16 0.584 . . . . 0.0 111.215 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.16 163.8 39.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.218 1.007 . . . . 0.0 108.756 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -146.09 156.22 43.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 108.1 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 p -63.72 150.55 44.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.013 0.824 . . . . 0.0 109.991 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -70.29 -31.99 69.58 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.041 -0.412 . . . . 0.0 111.49 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.31 176.66 10.36 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.656 1.982 . . . . 0.0 108.077 172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -66.62 117.39 8.72 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.236 0.614 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.78 151.34 46.76 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -145.32 134.01 22.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -149.82 158.52 44.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -95.75 153.61 17.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.285 0.564 . . . . 0.0 111.308 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.25 148.16 46.64 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.05 153.4 67.62 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.37 2.713 . . . . 0.0 109.414 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.39 -20.36 66.34 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.33 -27.41 61.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 tp -94.9 -27.59 15.62 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.061 0.944 . . . . 0.0 110.572 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -56.0 134.04 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -41.28 41.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.6 m95 60.95 5.79 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.88 2.072 . . . . 0.0 113.685 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.81 -19.92 14.11 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.889 1.275 . . . . 0.0 111.837 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -76.6 153.4 35.35 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.979 1.711 . . . . 0.0 108.771 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.66 113.84 9.35 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.027 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -53.91 147.57 16.26 Favored 'Cis proline' 0 CA--C 1.538 0.717 0 CA-C-N 120.199 1.107 . . . . 0.0 111.845 -10.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.32 129.37 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.8 t -80.37 97.98 7.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.2 pt -88.08 -15.98 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.374 1.469 . . . . 0.0 111.865 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 172.78 45.03 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 120.662 1.574 . . . . 0.0 113.028 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -105.87 129.62 54.0 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -97.2 113.91 25.56 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.45 127.54 35.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -103.52 129.52 50.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -103.57 133.6 48.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.99 129.2 55.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.7 tp -83.7 113.84 21.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.5 mm? -113.48 121.64 44.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 123.749 0.82 . . . . 0.0 109.619 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -83.56 137.19 33.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' HA2' ' A' ' 107' ' ' GLY . 73.4 mt -63.05 139.51 58.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.363 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.54 -25.0 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.515 1.126 . . . . 0.0 108.013 169.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.3 p -119.57 -61.82 1.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 110.381 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.545 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 80.4 -147.29 28.31 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -43.64 -36.44 2.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.476 1.91 . . . . 0.0 113.56 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.98 66.98 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -123.33 -16.39 6.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.352 1.461 . . . . 0.0 112.431 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.48 143.89 9.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -134.06 -48.02 0.79 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.043 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.0 mtt 58.86 -1.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.38 23.98 8.83 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.774 2.079 . . . . 0.0 111.262 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -35.64 66.51 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.023 2.529 . . . . 0.0 111.374 169.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.81 3.9 15.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.013 1.725 . . . . 0.0 112.717 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 70.15 -42.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 129.485 3.114 . . . . 0.0 114.483 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.5 p -133.51 34.67 0.26 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 113.914 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.77 160.99 40.09 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.746 1.659 . . . . 0.0 110.461 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.768 1.627 . . . . 0.0 113.609 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.05 144.46 42.99 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.398 0.618 . . . . 0.0 112.657 -168.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 -6.68 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.327 1.051 . . . . 0.0 113.62 -171.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.61 162.84 35.38 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -138.5 149.87 45.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.89 0.845 . . . . 0.0 111.417 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -150.55 128.07 11.49 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.815 1.646 . . . . 0.0 107.134 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -82.0 138.32 34.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.67 167.93 23.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.598 1.159 . . . . 0.0 110.459 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -49.03 144.74 4.52 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.198 0.999 . . . . 0.0 109.601 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -53.89 -36.91 63.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -94.17 -3.66 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.79 -45.8 96.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.011 -1.471 . . . . 0.0 111.974 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.11 -36.32 99.17 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.947 1.731 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -40.01 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -76.68 -29.38 56.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.822 1.192 . . . . 0.0 111.577 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.43 -28.09 46.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.02 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.45 156.04 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.547 1.067 . . . . 0.0 110.947 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.16 148.05 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.46 1.504 . . . . 0.0 111.88 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -58.75 -34.95 71.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.834 1.254 . . . . 0.0 113.911 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -71.36 -25.94 62.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.032 0.833 . . . . 0.0 111.437 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.67 -38.07 15.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.117 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -47.78 -47.48 30.76 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.082 1.31 . . . . 0.0 112.972 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.66 -35.79 81.01 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.383 0.538 . . . . 0.0 112.032 -174.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.64 -35.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.37 0.668 . . . . 0.0 110.596 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.91 -31.9 73.35 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.989 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -56.65 -37.32 70.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.119 169.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.63 -47.4 81.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.091 1.314 . . . . 0.0 108.886 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.22 -50.6 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.722 0.809 . . . . 0.0 109.307 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.8 mtt -65.69 -40.72 92.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.099 -0.477 . . . . 0.0 111.251 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -58.79 -39.77 82.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.444 1.098 . . . . 0.0 110.547 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.9 -23.26 62.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.704 0.402 . . . . 0.0 111.25 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -107.53 -9.6 15.89 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.28 16.98 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.473 1.033 . . . . 0.0 111.542 -169.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -62.81 -25.28 68.17 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.126 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.43 -43.52 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.59 -36.48 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -69.42 -35.81 76.08 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.835 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -59.58 -31.5 69.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.737 1.153 . . . . 0.0 112.031 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.25 -25.17 67.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.152 0.581 . . . . 0.0 111.361 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -104.65 -32.37 8.94 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.166 0.986 . . . . 0.0 110.987 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.34 -28.3 62.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.503 1.121 . . . . 0.0 111.262 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -99.65 79.98 2.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -39.26 68.6 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.25 1.02 . . . . 0.0 112.449 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.67 -16.41 52.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.628 2.885 . . . . 0.0 115.092 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.806 1.242 . . . . 0.0 110.357 -177.207 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 119.557 -0.258 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.03 143.39 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.83 -44.31 49.91 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.522 1.129 . . . . 0.0 111.306 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.8 -77.78 0.12 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.904 0.882 . . . . 0.0 111.138 170.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.55 -48.92 7.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.39 6.15 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.316 0.887 . . . . 0.0 115.316 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -96.93 134.33 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.35 1.575 . . . . 0.0 109.902 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -86.38 127.16 62.18 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.776 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.84 130.84 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.397 2.065 . . . . 0.0 108.624 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.48 177.2 11.74 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -130.59 135.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.71 136.23 12.86 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.48 142.23 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 118.94 1.37 . . . . 0.0 107.805 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.42 89.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -66.89 136.46 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -124.45 118.21 26.14 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -74.01 141.88 45.79 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -68.16 -9.66 48.37 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.07 -10.19 59.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.79 0.723 . . . . 0.0 111.328 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.13 39.2 3.35 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 125.926 1.727 . . . . 0.0 112.434 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -136.35 150.91 49.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.65 161.72 4.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.885 0.874 . . . . 0.0 112.68 -169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 128.51 36.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.006 1.322 . . . . 0.0 109.325 170.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.427 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 2.6 t-105 -160.23 128.81 4.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 168.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.1 148.45 41.74 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -69.08 140.68 54.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -77.77 119.86 21.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -44.61 126.33 5.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.544 1.938 . . . . 0.0 110.583 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.65 -2.05 25.75 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.532 1.063 . . . . 0.0 115.259 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -126.93 -24.72 3.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.032 1.416 . . . . 0.0 111.454 -172.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.66 14.29 8.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.284 1.833 . . . . 0.0 115.198 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.2 p -104.45 -143.18 0.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.98 1.312 . . . . 0.0 107.647 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.427 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 62.7 m95 -127.96 168.16 15.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.098 1.317 . . . . 0.0 109.946 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -152.44 150.77 30.0 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.147 0.979 . . . . 0.0 109.42 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -81.6 139.92 47.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.943 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.68 137.83 75.81 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.657 1.571 . . . . 0.0 111.642 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -157.55 147.83 20.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.729 1.212 . . . . 0.0 111.101 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.13 -126.38 5.56 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.523 1.059 . . . . 0.0 112.156 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.51 118.48 0.45 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.62 125.58 39.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -75.46 155.18 85.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.13 116.72 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.638 1.559 . . . . 0.0 111.039 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.25 7.75 87.3 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.079 1.323 . . . . 0.0 113.188 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -80.29 125.26 29.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.427 1.113 . . . . 0.0 108.601 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.72 157.34 37.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.483 1.113 . . . . 0.0 110.312 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.74 -41.09 69.99 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -169.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -71.58 -39.82 70.32 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -65.06 -44.26 89.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -27.03 69.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.383 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.466 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 17.0 tmm? -72.21 -43.74 64.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.411 1.005 . . . . 0.0 109.032 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -66.31 -30.99 71.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.114 0.87 . . . . 0.0 110.903 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -62.21 -49.2 76.72 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.659 -0.651 . . . . 0.0 109.607 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.06 77.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.145 0.978 . . . . 0.0 111.277 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.64 -39.98 95.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.183 1.393 . . . . 0.0 109.446 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.19 -50.87 59.43 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.866 0.866 . . . . 0.0 110.056 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.54 -40.94 88.89 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.521 1.055 . . . . 0.0 112.002 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -95.21 -49.36 5.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.287 0.635 . . . . 0.0 111.082 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.21 -17.7 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.4 0.68 . . . . 0.0 110.599 -169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.71 55.72 29.27 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -134.22 162.94 30.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.287 2.235 . . . . 0.0 106.507 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 m -119.0 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.356 0.662 . . . . 0.0 110.09 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -72.19 49.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.323 1.849 . . . . 0.0 114.503 -171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -163.4 -23.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.57 1.548 . . . . 0.0 112.294 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.27 1.1 52.15 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 m -149.05 171.16 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 109.727 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -138.91 124.53 19.55 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -79.91 131.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 120.655 1.571 . . . . 0.0 107.304 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -102.73 -45.94 4.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.51 169.3 19.86 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.88 0.872 . . . . 0.0 110.554 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -145.86 162.73 37.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 p -65.05 141.97 58.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -67.11 -22.03 65.83 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -170.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -141.85 177.58 8.08 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.523 1.529 . . . . 0.0 107.441 169.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -72.16 129.48 38.58 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 75' ' ' LEU . 4.2 mm? -79.85 160.04 26.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -156.61 151.86 26.49 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 108.345 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.06 172.91 12.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.001 1.72 . . . . 0.0 106.956 172.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -112.84 128.51 56.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.71 145.39 98.08 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -63.3 154.66 66.64 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 108.513 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.72 -29.94 68.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -73.22 -25.83 60.9 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.037 0.935 . . . . 0.0 112.728 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 tp -101.2 -19.38 15.73 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.815 0.846 . . . . 0.0 111.865 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.7 t -48.01 135.23 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -88.53 101.65 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.529 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.37 -2.33 57.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.363 0.665 . . . . 0.0 110.88 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.81 -30.55 40.53 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.636 -0.665 . . . . 0.0 110.096 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.4 161.12 23.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.564 1.146 . . . . 0.0 109.814 -173.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -137.26 114.63 9.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -59.18 153.58 43.04 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.004 1.037 . . . . 0.0 110.828 -10.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.49 138.12 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.7 t -97.56 120.8 38.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 pt -107.47 -10.18 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.282 1.033 . . . . 0.0 112.531 -169.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.97 168.63 40.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.158 0.89 . . . . 0.0 111.673 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -104.61 123.51 47.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -85.26 118.92 25.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 120.37 14.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.96 1.254 . . . . 0.0 113.164 -173.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -98.92 128.92 45.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -97.69 149.65 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 41.3 m-85 -119.53 126.79 52.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.3 111.58 19.54 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 102' ' ' LEU . 19.9 mt -107.48 131.23 54.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 124.465 1.103 . . . . 0.0 110.64 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.17 136.26 33.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.12 132.69 44.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -116.16 -37.8 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.7 m -85.2 -133.09 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.96 173.5 46.3 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 120.369 1.441 . . . . 0.0 111.403 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.4 -31.73 46.27 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.966 1.307 . . . . 0.0 112.859 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.45 -27.9 67.42 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.246 0.618 . . . . 0.0 112.431 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.86 -24.73 13.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.37 1.468 . . . . 0.0 110.908 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.46 142.54 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.724 1.61 . . . . 0.0 107.256 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -124.98 -38.77 2.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.51 -15.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.963 2.105 . . . . 0.0 116.173 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.94 27.94 8.98 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.849 1.659 . . . . 0.0 111.574 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -68.62 -36.98 79.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -91.76 6.39 46.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.074 0.949 . . . . 0.0 113.5 -169.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m 67.85 -36.1 0.29 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.489 2.716 . . . . 0.0 114.962 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -128.4 66.84 74.63 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.706 1.602 . . . . 0.0 108.33 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -77.05 -168.62 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.575 2.85 . . . . 0.0 110.467 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.7 -11.0 14.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.525 169.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.51 145.21 49.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 121.017 1.735 . . . . 0.0 114.03 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.62 116.66 25.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.003 2.921 . . . . 0.0 105.004 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.81 143.55 42.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.215 0.912 . . . . 0.0 113.277 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -114.44 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.035 0.934 . . . . 0.0 109.622 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -140.91 155.21 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.951 1.3 . . . . 0.0 110.106 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -79.68 149.6 31.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 161.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.842 0.857 . . . . 0.0 110.003 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -53.3 150.13 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.592 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.44 149.65 20.36 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.1 -15.08 0.13 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 -44.17 99.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 121.322 1.874 . . . . 0.0 111.937 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -63.99 -25.88 66.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.885 1.724 . . . . 0.0 114.702 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.48 -36.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.855 1.207 . . . . 0.0 108.928 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -83.39 -16.26 46.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 117.9 -1.047 . . . . 0.0 112.21 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -86.26 -31.1 21.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.977 1.262 . . . . 0.0 112.341 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -68.88 165.34 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.303 0.956 . . . . 0.0 111.755 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.55 151.24 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.9 1.28 . . . . 0.0 111.148 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -59.12 -34.49 72.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.104 1.362 . . . . 0.0 113.822 -169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -71.55 -26.02 62.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.025 0.829 . . . . 0.0 111.468 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -94.64 -29.32 14.9 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.14 0.976 . . . . 0.0 112.317 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -36.9 -53.71 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.721 2.009 . . . . 0.0 112.638 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -35.29 74.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.418 0.553 . . . . 0.0 110.977 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 75' ' ' LEU . 72.2 t -72.7 -36.04 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.648 -0.657 . . . . 0.0 109.682 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -68.15 -34.82 77.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.261 0.937 . . . . 0.0 110.791 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -58.01 -39.54 78.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.577 1.151 . . . . 0.0 111.373 169.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -64.31 -47.44 79.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.144 0.884 . . . . 0.0 109.618 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.31 -45.33 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.593 0.633 . . . . 0.0 109.603 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtt -65.49 -43.22 90.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.647 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -26.03 65.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.3 1.863 . . . . 0.0 112.315 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -65.31 -23.49 67.03 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.718 0.69 . . . . 0.0 110.358 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -116.09 -21.49 9.41 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.358 1.063 . . . . 0.0 113.442 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.1 -58.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.578 1.151 . . . . 0.0 110.607 -172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.5 m -66.17 -21.48 66.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.456 0.571 . . . . 0.0 111.995 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.76 -41.5 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.61 -48.72 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.1 mtt -66.52 -18.79 65.56 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.71 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.7 m -63.19 -24.22 67.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.713 1.142 . . . . 0.0 111.873 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.97 -49.72 27.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.671 0.668 . . . . 0.0 109.348 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.67 -23.42 56.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.704 0.402 . . . . 0.0 111.206 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -96.16 41.14 1.11 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.91 1.684 . . . . 0.0 109.808 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.76 30.96 5.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.977 0.911 . . . . 0.0 110.382 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.306 20.3 p 49.38 36.37 0.34 Allowed Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.463 1.905 . . . . 0.0 115.966 -173.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.54 -27.21 23.03 Favored 'Trans proline' 0 C--N 1.36 1.147 0 CA-C-N 121.835 1.691 . . . . 0.0 110.078 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.968 1.707 . . . . 0.0 109.346 -175.79 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 119.89 -0.1 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.4 136.16 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.02 162.13 29.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.379 1.472 . . . . 0.0 108.707 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.6 -36.48 64.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.9 5.96 26.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.23 31.24 14.58 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.792 1.187 . . . . 0.0 111.75 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 19.5 m-85 -108.42 134.57 51.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.892 1.346 . . . . 0.0 109.127 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -82.55 127.34 70.95 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.52 130.5 11.82 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.142 1.894 . . . . 0.0 109.322 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.6 160.65 39.37 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.728 1.211 . . . . 0.0 110.705 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.3 148.3 18.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.596 1.958 . . . . 0.0 106.431 169.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.14 131.06 6.11 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.44 127.29 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.53 91.78 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 mm -66.39 134.12 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 168.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.8 m -119.32 126.26 51.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 168.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -86.62 35.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.904 -0.498 . . . . 0.0 111.216 -169.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.265 13.7 ptp180 40.87 7.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.906 4.082 . . . . 0.0 116.558 -169.038 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -95.39 3.65 54.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.03 0.932 . . . . 0.0 111.471 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.31 64.34 Favored Glycine 0 N--CA 1.47 0.92 0 O-C-N 121.021 -1.049 . . . . 0.0 112.089 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -121.78 149.81 42.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.571 1.548 . . . . 0.0 107.005 -169.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.3 160.07 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.459 1.104 . . . . 0.0 113.204 -169.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ttt -58.31 134.61 56.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.332 1.453 . . . . 0.0 109.977 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -157.69 133.69 9.38 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 169.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.06 144.31 27.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.504 0.669 . . . . 0.0 110.458 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.92 132.35 36.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.229 1.411 . . . . 0.0 107.786 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -93.72 134.92 35.54 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.59 0.756 . . . . 0.0 109.248 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -47.55 132.79 13.65 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.832 1.253 . . . . 0.0 111.591 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.22 -23.08 0.75 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.615 1.102 . . . . 0.0 113.564 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.31 -37.75 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.923 0.862 . . . . 0.0 108.956 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.46 28.94 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.448 1.499 . . . . 0.0 112.262 -174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -149.78 175.82 11.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.28 1.832 . . . . 0.0 107.266 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -78.06 153.81 31.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.729 0.812 . . . . 0.0 112.639 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -146.48 162.29 38.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 109.37 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -84.67 151.1 57.85 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.886 2.074 . . . . 0.0 110.746 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -68.4 156.97 63.77 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.886 2.391 . . . . 0.0 113.022 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 179.96 148.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.921 2.488 . . . . 0.0 108.322 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 142.15 8.68 Favored Glycine 0 C--N 1.337 0.638 0 O-C-N 121.134 -0.978 . . . . 0.0 110.883 170.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.73 50.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.786 1.184 . . . . 0.0 111.027 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -87.42 134.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.387 1.075 . . . . 0.0 109.108 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -65.82 126.46 91.77 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.627 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.32 118.2 5.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.074 1.849 . . . . 0.0 111.585 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.87 0.17 75.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.577 1.56 . . . . 0.0 113.083 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -83.7 132.93 34.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.677 1.191 . . . . 0.0 108.048 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 159.39 34.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.984 0.913 . . . . 0.0 110.346 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.76 71.81 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.059 1.344 . . . . 0.0 112.315 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.38 -40.6 73.86 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -62.16 -43.5 98.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 108.967 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.956 0.502 . . . . 0.0 111.93 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -61.68 -44.71 96.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.883 0.765 . . . . 0.0 110.06 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -65.78 -29.3 69.78 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.961 1.255 . . . . 0.0 113.046 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -59.38 -50.67 73.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.237 1.381 . . . . 0.0 109.087 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.08 66.79 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.134 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.14 -43.32 99.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.832 -1.167 . . . . 0.0 108.455 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -66.51 -45.12 80.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.702 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -69.49 -48.88 59.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.523 1.51 . . . . 0.0 112.211 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -85.66 -29.59 23.88 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.124 0.97 . . . . 0.0 111.783 -168.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.35 -15.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.5 0.72 . . . . 0.0 110.379 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.25 11.33 70.97 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 120.746 -1.221 . . . . 0.0 113.12 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.37 151.41 21.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.131 0.966 . . . . 0.0 109.189 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -102.74 174.05 6.06 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.034 0.933 . . . . 0.0 108.909 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -70.42 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 115.065 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.41 -11.44 0.18 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.221 1.808 . . . . 0.0 112.705 -169.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -97.91 2.27 48.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.451 0.7 . . . . 0.0 110.96 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.88 171.89 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.751 1.221 . . . . 0.0 108.419 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -140.57 122.61 15.63 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 -171.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -75.47 129.82 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 -34.17 6.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.813 0.445 . . . . 0.0 110.702 176.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.7 166.5 32.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.679 1.192 . . . . 0.0 108.234 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -140.54 157.25 45.76 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -58.62 138.34 56.97 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 119.467 1.03 . . . . 0.0 108.474 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.46 -24.82 66.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.789 0.436 . . . . 0.0 112.074 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.48 174.16 11.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -61.7 126.64 28.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.12 131.31 45.19 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 170.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.37 134.66 52.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -143.02 131.6 22.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 117.51 24.63 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.18 147.47 80.98 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.866 1.266 . . . . 0.0 110.25 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.44 150.54 87.03 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.582 1.521 . . . . 0.0 109.015 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -48.83 -48.44 41.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.016 0.927 . . . . 0.0 113.367 -169.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.88 -16.48 63.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.197 0.999 . . . . 0.0 113.003 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -108.07 -3.75 18.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.169 1.388 . . . . 0.0 111.749 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.41 137.56 21.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 169.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -91.0 127.52 36.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -111.36 0.18 16.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.123 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.84 -17.59 35.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.106 0.562 . . . . 0.0 109.724 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.0 p -91.43 156.51 17.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.257 0.623 . . . . 0.0 109.328 -171.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -131.38 110.25 15.05 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.88 155.94 60.44 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.447 1.195 . . . . 0.0 112.117 -4.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.4 m -60.54 133.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 50.7 t -90.06 99.52 12.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.6 pt -88.89 -6.42 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.416 1.486 . . . . 0.0 112.027 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -158.43 153.72 24.86 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 120.514 1.506 . . . . 0.0 113.566 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.91 94.21 5.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -71.02 126.17 28.85 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.63 111.7 5.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.224 0.92 . . . . 0.0 110.273 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -89.3 125.81 35.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 169.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -98.27 146.8 25.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -123.87 126.14 45.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.815 1.246 . . . . 0.0 107.715 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.2 tp -78.46 111.12 14.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.7 mm? -106.84 121.92 45.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.022 0.929 . . . . 0.0 108.609 174.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -82.84 137.25 34.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.35 139.99 58.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.73 -41.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 m -136.41 142.56 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.3 -168.8 40.73 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.713 -0.617 . . . . 0.0 112.937 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.07 -56.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 131.443 3.897 . . . . 0.0 112.882 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.58 -35.44 24.71 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.174 0.99 . . . . 0.0 110.786 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -86.09 -18.72 31.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.405 0.682 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.94 138.8 22.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -153.69 84.81 1.17 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.5 mtt -70.79 24.67 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.249 0.62 . . . . 0.0 112.404 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -132.92 20.43 4.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.999 1.72 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.84 -51.46 50.99 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.926 2.09 . . . . 0.0 110.951 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 m -86.09 3.93 40.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.604 1.162 . . . . 0.0 112.869 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 63.01 117.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 128.07 2.548 . . . . 0.0 112.417 -169.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 p 34.78 53.06 1.49 Allowed Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 111.783 -2.462 . . . . 0.0 113.325 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.37 -54.15 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.898 1.732 . . . . 0.0 113.26 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -160.79 -45.54 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.846 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -115.52 135.92 53.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -169.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.64 -31.9 15.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.714 2.005 . . . . 0.0 112.007 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -170.77 156.63 27.06 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 123.896 0.76 . . . . 0.0 111.75 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -120.48 150.73 40.37 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.082 1.353 . . . . 0.0 111.39 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -150.05 130.1 13.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.758 1.623 . . . . 0.0 108.627 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -84.56 140.0 31.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.03 0.832 . . . . 0.0 108.934 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.17 166.88 17.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.943 1.297 . . . . 0.0 109.835 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -56.26 150.69 13.98 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.893 0.877 . . . . 0.0 111.927 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.42 149.26 34.63 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.5 m95 65.5 -16.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.3 1.84 . . . . 0.0 115.857 -170.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -65.22 -48.38 69.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 121.235 1.834 . . . . 0.0 110.898 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -59.55 -30.23 91.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 121.81 1.682 . . . . 0.0 113.391 173.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -39.45 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.544 -0.722 . . . . 0.0 110.027 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -73.16 -37.15 66.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 120.683 -1.261 . . . . 0.0 110.035 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -80.74 -24.92 38.37 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.49 156.92 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.172 0.896 . . . . 0.0 109.352 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.9 m -58.46 150.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.388 1.075 . . . . 0.0 110.711 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 m -59.79 -26.81 66.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.897 1.279 . . . . 0.0 114.406 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -72.06 -45.68 59.82 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.356 0.98 . . . . 0.0 110.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.54 -29.5 52.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.159 -1.4 . . . . 0.0 111.419 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -43.3 -48.17 6.75 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.564 1.529 . . . . 0.0 111.156 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -73.23 -22.29 60.46 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -79.26 -47.48 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.231 -0.918 . . . . 0.0 108.658 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -31.7 70.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.794 0.838 . . . . 0.0 110.568 -169.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -64.95 -33.76 76.8 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.268 -0.895 . . . . 0.0 111.264 172.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -69.92 -44.96 68.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.29 -46.87 85.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.171 0.588 . . . . 0.0 110.001 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 47.2 mtt -66.34 -40.49 89.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.203 -0.936 . . . . 0.0 110.987 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.11 -37.22 86.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.367 0.985 . . . . 0.0 111.01 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.84 -28.06 69.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.805 0.842 . . . . 0.0 110.985 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -113.94 -11.66 12.76 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.07 -54.8 38.46 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.94 1.245 . . . . 0.0 110.755 -170.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -81.12 25.63 0.47 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.615 0.766 . . . . 0.0 112.6 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.69 -18.31 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.164 1.786 . . . . 0.0 108.773 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 73.1 t -96.95 -52.79 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.768 1.227 . . . . 0.0 108.087 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.0 mmt -64.77 -16.41 62.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.283 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 m -48.92 -33.23 10.42 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.874 1.67 . . . . 0.0 113.194 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.9 mt -83.0 -29.58 28.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 110.509 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -96.87 -25.92 15.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.325 1.05 . . . . 0.0 112.189 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -106.52 26.68 9.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 109.592 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.43 -33.21 69.2 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.593 1.157 . . . . 0.0 112.456 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -57.25 2.85 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.728 1.211 . . . . 0.0 112.374 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.11 -30.41 20.71 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.157 2.571 . . . . 0.0 113.419 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--O 1.255 1.346 0 C-N-CA 124.883 1.273 . . . . 0.0 109.816 -171.607 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -137.19 140.16 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.97 145.81 48.15 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.635 1.574 . . . . 0.0 108.144 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -44.59 -37.49 3.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.058 1.874 . . . . 0.0 116.058 -168.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -81.96 2.13 32.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.51 24.85 11.57 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.776 1.655 . . . . 0.0 112.009 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -111.03 148.7 32.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.668 1.734 . . . . 0.0 110.843 -170.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -87.89 112.45 49.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.211 -1.555 . . . . 0.0 107.412 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.84 130.32 15.53 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.492 2.128 . . . . 0.0 109.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -154.84 170.99 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.465 1.106 . . . . 0.0 110.855 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.91 130.31 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.481 1.513 . . . . 0.0 108.796 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.33 126.63 8.98 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mm -91.5 104.12 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 81.35 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.9 mm -63.79 130.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.17 128.33 55.87 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.82 18.34 6.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 53.5 10.68 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.106 1.762 . . . . 0.0 115.341 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -109.87 6.97 23.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.304 1.041 . . . . 0.0 111.945 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.74 79.28 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.796 -1.19 . . . . 0.0 112.731 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -128.51 158.57 38.03 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.893 1.677 . . . . 0.0 106.851 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.37 167.61 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 128.2 32.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.347 1.859 . . . . 0.0 110.873 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.417 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -164.46 131.53 3.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 167.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.76 142.42 44.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -76.6 144.92 39.27 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -95.71 126.71 41.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -61.17 144.64 53.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.705 0.684 . . . . 0.0 110.586 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 -28.24 0.85 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.361 1.457 . . . . 0.0 114.158 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -97.06 -28.33 14.19 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.606 1.162 . . . . 0.0 110.357 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 65.13 -8.65 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.788 2.435 . . . . 0.0 115.213 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -178.66 6.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.263 1.025 . . . . 0.0 108.455 169.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.417 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 73.8 m95 -90.03 162.07 15.53 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.84 -1.163 . . . . 0.0 110.704 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -140.15 148.03 41.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.045 0.926 . . . . 0.0 110.848 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -79.76 164.9 50.95 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 127.335 2.254 . . . . 0.0 110.186 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.71 -92.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.664 2.91 . . . . 0.0 110.289 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 53.78 61.37 3.12 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.469 1.108 . . . . 0.0 111.563 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.81 117.27 4.46 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.1 142.71 27.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 125.997 1.76 . . . . 0.0 111.485 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.0 mt -77.4 139.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.994 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -77.71 136.06 63.57 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.356 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -54.99 118.27 4.96 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.631 1.554 . . . . 0.0 113.491 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.48 89.74 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.961 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -83.86 123.28 29.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.281 1.032 . . . . 0.0 108.513 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -72.59 160.52 32.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.269 1.028 . . . . 0.0 110.508 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.5 79.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.061 . . . . 0.0 111.129 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.5 12.82 3.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.633 0.773 . . . . 0.0 111.181 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -114.18 -54.21 2.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.408 1.883 . . . . 0.0 106.088 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -33.08 73.41 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.476 1.11 . . . . 0.0 112.335 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -61.29 -45.07 95.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -71.86 -27.87 63.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.617 -0.677 . . . . 0.0 111.292 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -62.19 -48.71 78.83 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.243 -0.91 . . . . 0.0 109.409 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.76 -32.93 73.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.801 0.728 . . . . 0.0 111.362 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 tp -60.34 -40.72 91.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.65 1.18 . . . . 0.0 109.419 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.34 -54.08 9.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.336 1.054 . . . . 0.0 111.456 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.97 -41.72 81.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.635 1.562 . . . . 0.0 110.834 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -92.96 -49.01 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.205 0.457 . . . . 0.0 110.836 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.15 -26.38 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.998 0.519 . . . . 0.0 110.583 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.69 58.84 6.55 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.747 -1.22 . . . . 0.0 110.074 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 mt -138.34 156.18 47.86 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.085 2.154 . . . . 0.0 107.834 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 m -116.75 -178.51 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.868 0.867 . . . . 0.0 111.513 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.74 41.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 128.368 2.667 . . . . 0.0 113.61 -174.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -164.72 -20.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.079 1.352 . . . . 0.0 112.361 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -87.59 -1.04 57.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -169.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.85 167.5 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.151 1.38 . . . . 0.0 108.925 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -138.78 121.37 16.24 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -74.84 130.94 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 120.104 1.32 . . . . 0.0 107.844 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -33.71 6.07 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.008 0.923 . . . . 0.0 111.162 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.74 169.18 25.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.362 1.465 . . . . 0.0 108.546 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 m -145.37 162.04 38.21 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.083 1.353 . . . . 0.0 107.833 172.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -62.06 149.1 42.05 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.425 1.011 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.5 -33.43 75.57 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.151 -0.343 . . . . 0.0 111.153 -169.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.17 -176.21 5.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.914 2.086 . . . . 0.0 106.395 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -61.38 120.17 9.94 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 160.01 29.28 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -161.33 163.2 30.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 120.704 -1.248 . . . . 0.0 111.118 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.49 159.69 41.23 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.145 1.378 . . . . 0.0 107.764 169.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -101.31 127.48 47.91 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 106.657 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -68.49 145.31 97.13 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.43 156.75 57.93 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.033 2.489 . . . . 0.0 110.104 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -52.02 -42.0 62.69 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 113.582 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -76.26 -23.95 54.47 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.285 1.034 . . . . 0.0 113.06 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.33 -24.56 19.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.009 0.524 . . . . 0.0 110.894 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.69 137.38 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -42.98 52.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.925 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.5 m95 59.52 5.21 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.304 2.241 . . . . 0.0 113.547 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.95 -21.84 14.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.367 1.467 . . . . 0.0 111.17 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -70.96 147.4 48.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.264 1.426 . . . . 0.0 108.53 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -134.38 113.43 12.19 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.27 154.83 30.92 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.069 1.06 . . . . 0.0 111.54 -10.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -62.87 128.95 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.7 t -89.79 108.94 19.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.2 pt -101.27 -6.28 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 112.835 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.94 178.3 48.74 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 119.851 1.205 . . . . 0.0 112.017 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -108.82 114.82 28.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -78.45 115.8 18.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.88 110.89 8.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.507 0.594 . . . . 0.0 111.818 -168.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -90.1 125.22 35.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -100.21 132.27 45.67 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.04 133.99 51.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.9 106.16 18.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -108.37 130.41 55.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.065 0.946 . . . . 0.0 109.494 -173.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.07 136.13 33.11 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.4 tp -78.32 124.64 28.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.52 -37.83 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.9 m -115.16 110.86 20.13 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.9 -167.36 9.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.96 1.266 . . . . 0.0 115.284 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -44.83 -33.0 1.76 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.702 2.001 . . . . 0.0 113.657 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.67 67.96 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.62 -25.46 11.32 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.359 1.464 . . . . 0.0 111.519 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.93 123.43 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -94.44 -46.53 6.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mtt 46.95 44.09 14.34 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 111.787 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 26.06 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.722 0.809 . . . . 0.0 112.971 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -44.53 63.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.329 1.452 . . . . 0.0 110.718 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 p -80.99 -15.94 54.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.939 1.696 . . . . 0.0 113.085 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.8 m 68.87 -30.27 0.18 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.714 2.406 . . . . 0.0 112.529 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -119.98 64.85 9.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.596 1.558 . . . . 0.0 111.621 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 -5.0 16.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.002 3.134 . . . . 0.0 114.474 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 65.42 -34.08 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.886 2.474 . . . . 0.0 114.359 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -70.5 128.97 37.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.933 0.788 . . . . 0.0 109.494 175.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.89 -14.8 53.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.515 1.126 . . . . 0.0 111.522 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.4 135.98 4.78 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -150.82 -129.74 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.781 0.432 . . . . 0.0 110.445 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -145.03 162.86 35.9 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.483 1.913 . . . . 0.0 108.508 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -82.14 152.84 26.32 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.338 0.399 . . . . 0.0 110.342 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.25 164.21 35.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.58 0.752 . . . . 0.0 110.718 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -54.11 145.94 15.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.355 1.062 . . . . 0.0 110.385 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -36.81 69.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.626 0.77 . . . . 0.0 111.904 -169.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -90.42 -5.39 56.17 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.05 -1.031 . . . . 0.0 112.639 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.5 -44.21 80.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.454 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.67 -33.82 92.86 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.14 1.8 . . . . 0.0 112.889 176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.59 -36.19 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 O-C-N 121.86 -0.525 . . . . 0.0 109.588 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -83.63 -15.68 48.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.349 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.52 -20.33 19.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.228 0.922 . . . . 0.0 112.982 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.21 165.27 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 119.616 1.098 . . . . 0.0 110.343 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.87 156.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 110.732 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -56.49 -33.22 65.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.312 -169.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -75.54 -30.68 59.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.131 0.878 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -79.24 -36.77 39.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.729 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -43.83 -50.6 7.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.237 1.415 . . . . 0.0 111.613 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.25 -33.52 76.19 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.731 0.412 . . . . 0.0 111.562 -172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.2 t -82.71 -37.94 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.383 0.673 . . . . 0.0 109.799 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -33.31 75.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.302 -0.874 . . . . 0.0 109.995 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -52.72 -40.48 63.06 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.227 1.011 . . . . 0.0 111.582 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.26 -47.43 79.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.43 -47.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.0 mmt -63.58 -47.09 82.91 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.779 0.718 . . . . 0.0 110.172 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -56.7 -46.15 81.4 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.181 0.992 . . . . 0.0 110.721 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.32 -16.36 63.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.073 0.549 . . . . 0.0 111.582 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.44 -5.58 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.132 1.373 . . . . 0.0 113.343 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.36 -59.0 3.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 112.198 -169.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.8 m -62.16 -26.19 68.19 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.703 0.401 . . . . 0.0 112.043 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.17 -28.91 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.061 0.944 . . . . 0.0 109.605 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.65 -41.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 17.0 mmt -63.92 -38.04 89.64 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.604 0.638 . . . . 0.0 110.751 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 63.0 m -61.98 -18.35 60.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.781 0.719 . . . . 0.0 112.698 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -76.19 -26.75 56.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.572 0.624 . . . . 0.0 110.584 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -107.56 -32.25 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.168 0.987 . . . . 0.0 111.002 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -82.59 16.08 2.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.185 2.194 . . . . 0.0 110.605 172.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.55 -34.26 77.84 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.74 1.616 . . . . 0.0 113.716 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -47.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 123.61 0.764 . . . . 0.0 111.421 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.33 -33.95 93.95 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.62 2.88 . . . . 0.0 114.391 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.9 tptt . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.938 -176.792 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.64 145.87 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.42 -47.12 57.92 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.14 0.576 . . . . 0.0 111.71 -171.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -153.17 -75.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.856 0.862 . . . . 0.0 110.413 171.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.45 -49.2 7.78 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -169.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.49 14.84 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.531 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -94.22 136.35 34.6 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.793 1.297 . . . . 0.0 110.281 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -86.03 114.03 54.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 173.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.62 134.22 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.967 1.778 . . . . 0.0 109.986 -177.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -159.4 176.01 12.64 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.201 1.001 . . . . 0.0 108.747 172.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.36 140.45 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.07 122.98 7.16 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 mm -73.04 121.73 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.68 88.39 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mm -67.34 131.22 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.5 m -114.72 119.76 37.79 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -83.86 136.46 34.11 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -63.82 -9.61 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.036 1.334 . . . . 0.0 114.367 -173.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.24 -12.26 61.36 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 110.841 169.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.78 34.18 4.75 Favored Glycine 0 C--N 1.346 1.09 0 C-N-CA 126.059 1.79 . . . . 0.0 112.685 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.43 151.7 51.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.96 164.15 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -168.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 tpp -50.96 127.26 18.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.243 1.817 . . . . 0.0 111.628 169.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -157.06 129.75 7.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.49 143.48 28.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.227 0.537 . . . . 0.0 110.014 -171.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -74.86 134.04 41.74 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -80.08 133.74 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.486 0.715 . . . . 0.0 109.269 -169.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.79 134.36 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.48 1.512 . . . . 0.0 109.95 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.1 16.32 76.77 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.993 -0.442 . . . . 0.0 112.513 177.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -139.85 163.34 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.124 2.169 . . . . 0.0 107.296 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -114.82 36.17 3.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 p -150.18 171.78 16.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.226 1.811 . . . . 0.0 108.735 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.99 155.34 22.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.997 1.319 . . . . 0.0 109.249 -171.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.38 146.14 41.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.093 0.949 . . . . 0.0 111.793 -170.509 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -57.14 143.29 72.98 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 0.0 108.549 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.56 152.79 78.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.973 1.782 . . . . 0.0 112.378 173.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -179.12 132.47 0.12 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.758 2.423 . . . . 0.0 107.173 173.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.11 -114.84 2.56 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.8 164.34 34.45 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.43 2.919 . . . . 0.0 106.758 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.53 124.21 72.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -73.76 136.97 76.92 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 116.895 -1.526 . . . . 0.0 107.615 171.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -56.13 117.68 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 121.857 1.699 . . . . 0.0 112.934 -172.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.58 87.16 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.355 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.37 125.62 31.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.49 1.116 . . . . 0.0 108.633 175.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.03 158.68 36.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 110.361 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.38 63.65 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 125.455 1.502 . . . . 0.0 113.859 -169.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.26 -45.08 61.67 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -60.2 -45.18 94.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.999 1.32 . . . . 0.0 108.307 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.56 67.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.196 0.999 . . . . 0.0 112.546 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -72.13 -42.3 66.18 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.653 1.115 . . . . 0.0 109.073 175.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.04 -26.87 67.71 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.971 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -67.35 -48.1 68.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.188 -0.945 . . . . 0.0 109.031 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.9 84.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 119.007 0.821 . . . . 0.0 110.795 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.13 -41.91 89.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.62 1.568 . . . . 0.0 109.38 178.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -46.97 65.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.859 0.863 . . . . 0.0 110.648 172.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.9 -37.18 86.77 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.676 1.126 . . . . 0.0 112.667 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -94.17 -44.02 8.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.524 0.73 . . . . 0.0 111.185 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 113' ' ' MET . 14.6 m -123.55 -2.48 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.04 75.69 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.172 -0.955 . . . . 0.0 111.598 177.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.0 mt -91.12 161.21 15.19 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 108.908 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -118.07 171.51 8.05 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.902 0.881 . . . . 0.0 109.603 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -72.43 57.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.161 1.784 . . . . 0.0 113.89 -171.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' H ' ' A' ' 64' ' ' ASP . 21.0 pttp -163.89 -25.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.618 1.967 . . . . 0.0 111.359 -172.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' H ' ' H ' ' A' ' 63' ' ' LYS . 65.6 m-20 -88.15 0.19 56.33 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -168.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 166.78 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.036 0.935 . . . . 0.0 109.792 -169.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -137.2 120.89 17.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -171.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.85 129.9 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.05 -34.87 6.48 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.316 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.93 169.48 22.53 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 109.356 -178.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.1 p -147.81 162.28 39.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 p -66.15 145.0 56.32 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.21 -20.97 63.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -170.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -148.94 171.95 15.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.958 1.703 . . . . 0.0 109.12 171.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -73.1 116.19 13.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.59 153.89 41.05 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.42 153.74 38.94 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.443 0.697 . . . . 0.0 109.204 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.63 164.81 30.57 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.871 1.268 . . . . 0.0 108.548 176.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -118.5 123.86 46.16 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -172.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.01 145.14 99.01 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.599 1.16 . . . . 0.0 108.937 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.0 152.2 80.67 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.463 2.109 . . . . 0.0 109.456 170.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -47.62 -49.08 28.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.548 1.139 . . . . 0.0 113.779 -169.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -64.71 -14.19 57.58 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.154 0.981 . . . . 0.0 113.228 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.77 -9.2 15.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.56 1.544 . . . . 0.0 111.53 -178.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.84 136.73 25.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.63 129.81 38.45 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -101.3 4.5 41.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.791 1.236 . . . . 0.0 109.782 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.15 -12.53 15.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.501 1.121 . . . . 0.0 111.588 -174.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 p -71.66 -33.88 69.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.327 0.651 . . . . 0.0 111.763 -174.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 41.78 89.22 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.906 2.482 . . . . 0.0 112.197 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.22 150.34 71.83 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-N 119.977 1.028 . . . . 0.0 114.761 10.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -54.41 122.17 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.7 t -92.53 105.3 17.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -172.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -102.84 -10.82 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 113.013 -170.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.73 175.65 46.65 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 120.075 1.307 . . . . 0.0 112.482 -174.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.29 126.56 55.38 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -87.27 120.89 29.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.15 128.56 21.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.974 1.261 . . . . 0.0 113.618 -176.397 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -106.23 134.98 48.52 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -104.85 144.79 31.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -117.67 126.46 52.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.07 107.59 16.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 175.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 102' ' ' LEU . 31.3 mt -103.4 133.99 47.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.823 175.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -93.6 135.6 34.71 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 168.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.615 HD22 ' HA2' ' A' ' 107' ' ' GLY . 67.7 mt -66.01 141.43 58.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.973 176.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.16 -27.05 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.316 1.047 . . . . 0.0 108.204 169.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -119.94 -53.42 2.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 175.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 69.02 -146.53 44.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 172.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -40.94 -34.15 0.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.786 2.034 . . . . 0.0 113.573 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.14 -25.73 68.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.794 0.838 . . . . 0.0 113.235 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -130.58 -8.71 4.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.942 1.297 . . . . 0.0 113.324 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.18 134.36 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.65 -31.72 0.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.395 -170.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 58' ' ' VAL . 36.1 mtt 64.82 -50.06 0.33 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 129.096 2.958 . . . . 0.0 113.141 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -84.21 20.06 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.255 1.022 . . . . 0.0 113.515 -171.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -63.09 -31.43 72.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 109.749 172.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -83.58 -0.65 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.556 1.143 . . . . 0.0 113.262 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 64.1 -34.21 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.609 2.764 . . . . 0.0 115.543 -175.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -132.28 71.06 79.88 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.942 1.697 . . . . 0.0 107.435 172.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.02 -166.32 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.737 2.958 . . . . 0.0 110.453 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.33 -3.83 26.54 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.401 169.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.79 155.75 49.4 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 121.662 2.028 . . . . 0.0 112.375 -172.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.03 -25.52 2.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.801 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.1 150.75 22.17 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -122.25 146.89 46.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 110.81 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -152.31 124.7 8.23 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.677 1.191 . . . . 0.0 107.89 169.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -76.88 143.94 39.31 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.745 0.702 . . . . 0.0 109.144 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.57 168.15 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.59 0.756 . . . . 0.0 109.692 -169.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.9 m -48.79 145.11 3.98 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.094 1.357 . . . . 0.0 111.054 -177.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -52.58 -38.8 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -168.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -95.92 -4.37 43.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.74 -43.23 91.33 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.156 -1.402 . . . . 0.0 112.31 -170.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -58.05 -34.23 98.2 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 122.173 1.812 . . . . 0.0 113.074 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.69 -45.8 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -64.16 -30.61 71.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.737 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -78.95 -30.94 44.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 112.154 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.27 157.34 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.869 0.758 . . . . 0.0 110.974 -170.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.69 148.68 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.517 1.527 . . . . 0.0 111.709 174.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -57.97 -34.34 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.179 1.392 . . . . 0.0 113.849 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -72.66 -28.11 62.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.815 0.734 . . . . 0.0 111.543 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -89.25 -31.95 17.63 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.141 174.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -47.21 -44.82 22.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.599 1.16 . . . . 0.0 112.24 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.88 -34.33 75.27 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 p -83.81 -32.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.954 -0.466 . . . . 0.0 110.549 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -31.99 73.17 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.054 -1.029 . . . . 0.0 110.306 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -53.24 -40.52 64.62 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.058 -1.026 . . . . 0.0 111.606 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -63.94 -46.4 84.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.26 0.936 . . . . 0.0 109.614 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -53.73 -50.22 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 109.447 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.9 mmt -64.33 -45.1 89.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.273 -177.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -57.6 -44.37 85.36 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.091 0.957 . . . . 0.0 111.091 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -64.63 -25.51 67.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.409 0.684 . . . . 0.0 110.845 -174.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -108.95 -8.82 15.17 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.811 1.245 . . . . 0.0 113.683 -175.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.52 -63.55 1.1 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.348 0.976 . . . . 0.0 112.056 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 m -63.25 -22.31 66.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.216 -0.302 . . . . 0.0 111.778 -178.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -76.1 -36.66 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 O-C-N 121.382 -0.824 . . . . 0.0 108.909 -175.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.43 -48.89 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.6 mtt -65.33 -22.33 66.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.624 0.647 . . . . 0.0 112.725 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.8 m -62.85 -26.79 68.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.458 1.026 . . . . 0.0 111.635 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.9 -51.22 58.03 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.72 -25.79 63.1 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.002 0.521 . . . . 0.0 111.132 -173.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.46 -21.15 62.82 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.065 0.946 . . . . 0.0 111.637 173.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -101.23 28.44 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 112.424 -169.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.6 p 45.98 47.48 4.18 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.55 1.14 . . . . 0.0 109.897 -172.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . 0.342 0.0 OUTLIER 25.71 48.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 127.173 5.249 . . . . 0.0 117.51 -168.507 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.252 1.233 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.541 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 3' ' ' ASP . 51.4 mm . . . . . 0 N--CA 1.446 -0.626 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 2' ' ' ILE . 59.9 t0 -66.93 152.16 46.24 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 165.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -36.3 -55.35 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.153 1.781 . . . . 0.0 114.684 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.01 -2.21 58.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.048 0.928 . . . . 0.0 112.976 -158.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.59 20.22 4.71 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.218 -1.551 . . . . 0.0 111.325 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.73 136.6 43.95 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.095 0.95 . . . . 0.0 109.135 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -85.13 122.74 73.97 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -72.06 133.19 20.97 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.302 1.335 . . . . 0.0 110.653 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . 0.261 2.2 m-80 -144.45 168.3 20.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.361 1.464 . . . . 0.0 110.349 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.39 130.98 70.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 126.182 1.793 . . . . 0.0 107.525 168.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.38 128.92 9.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -88.48 118.53 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.54 83.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 165.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.31 133.46 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 164.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 m -118.33 120.84 38.83 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -83.39 118.11 23.5 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 112.12 -2.309 . . . . 0.0 105.391 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' A' ' 18' ' ' ARG . 16.9 mtt180 -47.84 -1.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -76.55 -4.27 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 120.259 1.391 . . . . 0.0 111.548 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.508 ' C ' HE21 ' A' ' 21' ' ' GLN . . . 101.76 24.25 8.8 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 119.836 1.198 . . . . 0.0 113.323 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.508 HE21 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -133.47 162.59 31.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -166.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.93 165.21 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -165.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.4 tpt -53.28 129.42 31.55 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 112.629 -2.078 . . . . 0.0 110.101 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -158.63 134.85 9.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 161.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -147.05 141.71 26.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.023 0.916 . . . . 0.0 110.218 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -72.64 135.84 45.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -85.62 124.75 32.51 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.34 133.56 34.61 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.373 2.269 . . . . 0.0 110.911 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.4 -14.54 3.12 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 125.6 1.571 . . . . 0.0 114.133 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -105.44 -35.59 7.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.783 0.792 . . . . 0.0 111.447 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 66.66 27.36 9.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.767 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.78 171.63 14.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -84.15 161.04 20.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -148.12 150.29 33.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.501 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' NZ ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -65.76 158.8 73.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.432 165.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' PHE . 2.9 Cg_exo -77.43 154.67 31.8 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.039 3.826 . . . . 0.0 112.027 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 169.38 139.37 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 128.053 2.541 . . . . 0.0 105.808 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.86 141.43 11.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 156.52 53.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mt -87.8 138.72 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.253 51.1 t30 -85.71 139.21 35.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 125.089 1.356 . . . . 0.0 109.24 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.51 118.48 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.195 1.93 . . . . 0.0 113.636 -172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.19 89.62 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.036 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -87.63 123.91 32.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.861 1.33 . . . . 0.0 107.744 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.68 165.06 24.78 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.24 -44.11 71.46 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.295 1.038 . . . . 0.0 112.538 -168.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.93 -40.48 72.05 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.318 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -63.86 -44.26 93.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.347 0.659 . . . . 0.0 109.79 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.07 77.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.857 0.863 . . . . 0.0 111.553 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -60.75 -44.07 97.17 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.779 -0.576 . . . . 0.0 109.713 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -69.18 -26.25 64.75 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.884 -1.135 . . . . 0.0 112.539 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -61.65 -52.67 63.38 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.441 -0.787 . . . . 0.0 109.332 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.6 90.61 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.414 0.626 . . . . 0.0 109.848 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.3 tp -52.58 -43.81 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.798 -1.814 . . . . 0.0 111.031 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.15 -49.14 53.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.973 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.72 -33.93 77.13 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.008 1.277 . . . . 0.0 112.105 -174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.77 -45.83 5.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.59 0.709 . . . . 0.0 110.042 -169.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -15.62 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 121.797 -0.564 . . . . 0.0 110.401 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.88 37.21 94.02 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 117.093 -1.948 . . . . 0.0 112.209 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -113.87 158.81 20.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.544 1.172 . . . . 0.0 108.87 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -117.69 -177.87 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.881 -0.512 . . . . 0.0 110.209 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.72 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.282 1.833 . . . . 0.0 114.736 -174.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -161.15 -18.5 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.05 -1.031 . . . . 0.0 111.434 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.54 1.11 55.52 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.915 0.864 . . . . 0.0 111.008 -167.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 102' ' ' LEU . 27.9 m -152.42 169.48 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -168.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -142.25 117.49 10.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -167.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.97 130.62 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -36.04 6.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.007 0.923 . . . . 0.0 110.932 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.81 170.29 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.049 0.94 . . . . 0.0 108.715 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -145.99 164.29 32.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 109.475 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -63.57 140.2 58.85 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.764 0.792 . . . . 0.0 108.917 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -64.77 -29.51 70.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.351 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.44 174.22 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -65.47 115.47 5.74 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.673 0.789 . . . . 0.0 109.014 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 156.05 39.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -160.82 159.05 29.44 Favored 'General case' 0 CA--C 1.487 -1.481 0 O-C-N 120.683 -1.261 . . . . 0.0 108.13 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.3 p90 -159.91 170.03 22.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.61 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -109.38 129.88 55.52 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 111.921 -2.4 . . . . 0.0 106.059 -162.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -70.77 143.54 89.63 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -63.04 155.29 61.8 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -49.84 -45.62 50.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -71.77 -18.68 62.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.6 tp -102.47 -18.17 15.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.678 0.791 . . . . 0.0 111.764 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.3 t -52.0 140.49 6.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -76.21 -38.0 57.03 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.351 2.723 . . . . 0.0 118.351 -170.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.716 ' HA ' ' CG1' ' A' ' 91' ' ' VAL 0.326 10.2 m95 53.48 -8.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 -167.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.17 -27.86 11.32 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.397 1.453 . . . . 0.0 110.276 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.0 p -69.54 151.77 45.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -138.14 114.58 9.13 Favored Pre-proline 0 CA--C 1.499 -1.012 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -55.01 154.13 20.12 Favored 'Cis proline' 0 C--O 1.237 0.436 0 O-C-N 123.151 1.08 . . . . 0.0 113.45 -6.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -55.53 130.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.46 171.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 46.5 t -92.86 108.49 20.03 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 pt -101.77 -2.46 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.762 1.625 . . . . 0.0 111.608 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.24 43.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.597 1.09 . . . . 0.0 112.934 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 113.66 27.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.548 1.539 . . . . 0.0 107.178 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.79 122.56 26.77 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 132.6 26.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.582 1.083 . . . . 0.0 112.844 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -104.31 125.53 50.64 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 165.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -96.17 144.11 26.68 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -118.34 128.62 54.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.7 114.95 19.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 65' ' ' VAL . 3.3 mm? -110.46 122.16 47.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -79.17 136.73 37.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.472 HD21 ' HA2' ' A' ' 107' ' ' GLY . 19.1 tp -72.81 124.22 24.94 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.76 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.97 -41.15 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.255 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -89.73 -140.74 0.14 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.472 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . -179.84 -168.82 39.21 Favored Glycine 0 CA--C 1.487 -1.695 0 O-C-N 119.572 -1.955 . . . . 0.0 110.221 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -29.9 -41.26 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 126.846 2.059 . . . . 0.0 114.987 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.62 66.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 54.0 mm-40 -106.87 -23.4 12.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.195 1.798 . . . . 0.0 110.358 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mt -56.18 132.33 20.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.17 -25.89 4.81 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 119.127 -0.463 . . . . 0.0 112.173 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.5 mtt 41.0 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 119.338 3.088 . . . . 0.0 119.338 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -121.71 21.96 10.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 123.461 2.846 . . . . 0.0 110.926 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -37.49 82.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.731 2.012 . . . . 0.0 111.172 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.88 2.67 53.36 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.86 -0.591 . . . . 0.0 112.589 -166.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 m 66.31 -36.26 0.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 115.03 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -131.53 68.97 81.59 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 125.357 1.463 . . . . 0.0 107.169 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.07 -166.82 0.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.318 2.012 . . . . 0.0 109.927 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -110.3 -19.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.896 -1.049 . . . . 0.0 112.695 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -120.07 151.72 38.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.958 1.254 . . . . 0.0 111.309 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.9 -19.79 7.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.811 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.72 158.52 8.43 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 104.727 -3.349 . . . . 0.0 104.727 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.672 ' O ' ' CE3' ' A' ' 124' ' ' TRP 0.589 0.0 OUTLIER -138.76 -175.39 4.12 Favored 'General case' 0 C--N 1.294 -1.829 2 N-CA-C 126.538 5.755 . . . . 0.0 126.538 -154.136 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 124' ' ' TRP 0.254 12.3 ttt180 -169.54 131.78 1.17 Allowed 'General case' 0 CA--C 1.483 -1.634 1 O-C-N 115.477 -4.515 . . . . 0.0 102.967 171.065 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -72.95 133.66 44.42 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.6 161.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -51.21 151.35 2.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.587 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.413 ' O ' ' HD2' ' A' ' 132' ' ' PRO 0.331 12.5 t80 -45.66 -90.42 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.229 1.412 . . . . 0.0 112.715 -173.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -45.3 -4.19 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 120.459 3.503 . . . . 0.0 120.459 170.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.1 -51.66 78.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.833 2.561 . . . . 0.0 112.983 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 129' ' ' TYR . 58.2 Cg_exo -57.34 -32.57 94.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.165 1.91 . . . . 0.0 113.837 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 t -57.84 -39.61 72.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.642 ' HE ' ' HA ' ' A' ' 134' ' ' ARG . 1.4 mmm-85 -77.32 -26.81 52.56 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.054 -1.654 . . . . 0.0 114.074 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.571 ' HA ' ' OE1' ' A' ' 135' ' ' GLN . 3.9 mm-40 -78.46 -25.3 45.83 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 125.655 1.847 . . . . 0.0 114.499 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG11 ' HD2' ' A' ' 144' ' ' TYR 0.265 13.2 p -79.02 157.76 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 CA-C-O 122.853 1.311 . . . . 0.0 109.861 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.0 m -56.09 150.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.941 1.296 . . . . 0.0 111.03 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -60.21 -34.13 73.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -72.92 -30.77 64.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.828 0.74 . . . . 0.0 111.162 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' NZ ' ' CZ ' ' A' ' 35' ' ' PHE . 10.5 mttt -81.93 -32.21 30.94 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.533 ' CZ ' HH21 ' A' ' 134' ' ' ARG . 29.2 ttp180 -47.11 -48.53 22.98 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 124.77 1.294 . . . . 0.0 112.243 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.46 -45.62 93.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.128 0.966 . . . . 0.0 110.031 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 77' ' ' TYR . 1.1 t -69.3 -40.47 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 O-C-N 120.937 -1.102 . . . . 0.0 110.311 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.498 ' HD2' HG11 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -67.32 -31.9 72.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 110.502 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -53.17 -41.79 65.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.661 0.785 . . . . 0.0 112.627 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -66.87 -45.39 78.24 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -53.53 -49.42 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 O-C-N 124.312 1.007 . . . . 0.0 109.143 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -65.33 -41.99 93.4 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.742 -0.599 . . . . 0.0 111.203 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.637 -1.289 . . . . 0.0 111.389 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -61.44 -26.26 67.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.596 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.8 -6.9 11.52 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.906 0.775 . . . . 0.0 113.071 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.56 44.44 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.265 0.939 . . . . 0.0 110.504 -167.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.7 m -65.7 -23.67 66.82 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.924 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.39 -32.95 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 120.17 -1.581 . . . . 0.0 109.656 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.13 -43.07 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.14 -31.43 71.86 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 116.918 -1.515 . . . . 0.0 110.429 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -55.93 -28.83 58.65 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 120.411 1.46 . . . . 0.0 111.401 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -77.65 -20.29 54.03 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 114.695 -2.574 . . . . 0.0 112.244 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -108.16 -7.92 15.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.787 2.035 . . . . 0.0 110.056 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 1 CA--C 1.682 6.036 2 C-N-CA 137.261 6.224 . . . . 0.0 125.534 174.047 . . . . . . . . 2 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 CA--C 1.542 0.656 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.27 -45.93 71.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.29 0.636 . . . . 0.0 111.949 -170.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -152.01 -85.22 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.537 1.135 . . . . 0.0 109.963 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.3 -39.95 13.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -169.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.3 21.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.102 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.37 137.49 50.45 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.704 1.252 . . . . 0.0 109.796 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -109.93 118.76 49.17 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.163 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.05 135.06 45.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.258 1.972 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -145.41 158.87 43.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.398 1.879 . . . . 0.0 110.543 -172.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -136.44 76.25 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.707 2.003 . . . . 0.0 109.03 -173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.6 126.54 30.22 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mm -90.34 105.21 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.57 79.78 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -62.89 135.12 27.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.8 m -123.6 130.83 53.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 168.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -87.69 136.78 32.81 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.86 -10.01 8.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.188 1.795 . . . . 0.0 114.313 -174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.79 -13.26 62.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.128 0.876 . . . . 0.0 110.825 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.11 38.3 3.37 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.386 1.946 . . . . 0.0 112.163 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -136.38 149.49 48.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.67 167.03 3.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 112.764 -168.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 127.55 32.68 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.622 1.569 . . . . 0.0 110.509 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -156.97 134.63 10.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 168.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.81 146.34 25.63 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -71.32 127.99 34.39 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.25 128.42 34.48 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -53.25 136.97 35.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.429 1.492 . . . . 0.0 110.263 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.27 -37.85 2.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.8 1.19 . . . . 0.0 113.198 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.55 -39.05 25.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.149 0.975 . . . . 0.0 110.091 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.271 17.4 m170 58.92 34.27 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.04 1.736 . . . . 0.0 112.795 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -140.44 158.73 43.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.976 2.11 . . . . 0.0 106.742 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -65.86 152.25 44.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.183 0.993 . . . . 0.0 112.554 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -148.18 156.74 42.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.563 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -69.4 160.72 77.95 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.816 2.446 . . . . 0.0 111.748 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.64 147.12 95.2 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.017 2.478 . . . . 0.0 110.981 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -165.5 153.31 10.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.348 1.859 . . . . 0.0 107.745 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.89 136.84 3.75 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.76 168.83 54.88 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 118.235 1.018 . . . . 0.0 110.853 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.37 140.8 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 108.516 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -85.51 138.0 36.22 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.566 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -58.35 117.32 4.01 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.486 1.457 . . . . 0.0 112.876 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.45 -0.11 84.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.776 1.179 . . . . 0.0 113.046 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.5 120.05 34.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.652 1.226 . . . . 0.0 107.805 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -71.8 165.44 24.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.479 0.712 . . . . 0.0 111.37 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -46.61 64.89 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.239 1.416 . . . . 0.0 111.481 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.37 29.43 0.76 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.577 0.703 . . . . 0.0 110.301 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 -48.66 0.67 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.609 1.964 . . . . 0.0 106.51 170.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.6 74.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.828 1.251 . . . . 0.0 112.015 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -56.92 -45.45 82.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.9 m-85 -73.79 -28.5 61.68 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.027 -1.046 . . . . 0.0 112.052 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -61.39 -46.63 89.37 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.722 -1.236 . . . . 0.0 108.761 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.39 97.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 tp -54.9 -44.6 74.29 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.822 1.649 . . . . 0.0 110.243 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -44.51 88.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.909 0.884 . . . . 0.0 111.252 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.42 -29.08 66.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.781 1.173 . . . . 0.0 112.894 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.26 -48.08 6.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 111.465 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.17 0.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 119.819 1.19 . . . . 0.0 113.69 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 31.31 80.12 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.988 0.813 . . . . 0.0 112.002 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 mt -103.92 152.24 22.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -115.77 -177.29 3.12 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.381 0.673 . . . . 0.0 110.176 -173.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 18.2 ptp180 -71.92 47.55 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.744 2.018 . . . . 0.0 112.575 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -160.68 -19.34 0.05 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.375 1.47 . . . . 0.0 112.341 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -93.85 -0.1 55.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 112.124 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.37 169.33 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.011 0.924 . . . . 0.0 109.448 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -139.36 121.44 15.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.4 mt -74.82 128.01 36.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.92 -30.76 9.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.781 0.433 . . . . 0.0 110.794 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 166.56 29.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.134 0.974 . . . . 0.0 109.366 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.7 p -144.43 158.27 43.84 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.196 1.399 . . . . 0.0 108.244 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -62.95 140.73 58.87 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -60.29 -30.24 69.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -141.83 175.38 9.76 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.707 1.603 . . . . 0.0 106.773 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -66.56 133.51 50.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -87.79 152.3 22.22 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.126 0.97 . . . . 0.0 108.634 169.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -150.41 161.05 43.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -140.99 173.82 11.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.381 1.872 . . . . 0.0 106.822 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -97.99 130.75 44.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.32 145.75 98.99 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 170.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -64.93 155.07 69.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.384 2.056 . . . . 0.0 108.465 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -73.15 -24.67 60.62 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.97 0.908 . . . . 0.0 112.816 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.4 tp -99.24 -21.42 16.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.677 0.791 . . . . 0.0 111.727 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.95 141.16 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -75.83 -42.2 50.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 42.5 m95 56.31 9.74 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.868 2.467 . . . . 0.0 114.61 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.08 -17.42 5.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.003 0.921 . . . . 0.0 113.224 -169.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 p -73.5 -35.64 65.64 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.691 -0.631 . . . . 0.0 112.075 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 46.13 88.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.461 2.304 . . . . 0.0 112.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.83 143.69 51.54 Favored 'Cis proline' 0 C--N 1.353 0.775 0 CA-C-N 119.617 0.899 . . . . 0.0 113.699 9.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.6 t -56.64 121.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.08 1.352 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -89.48 120.0 30.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.4 pt -115.86 -4.16 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.02 1.328 . . . . 0.0 111.929 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.12 15.88 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.852 1.206 . . . . 0.0 111.074 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -85.69 127.73 34.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -85.31 115.07 22.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -122.95 122.74 39.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 120.187 1.358 . . . . 0.0 112.49 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -103.21 107.14 17.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 167.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -82.53 142.19 32.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.24 132.22 55.9 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.58 118.14 22.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.75 124.14 50.02 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.382 1.073 . . . . 0.0 109.366 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -86.58 134.74 33.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.74 136.63 57.97 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.85 -29.1 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -123.78 120.92 34.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.19 33.52 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 121.667 0.593 . . . . 0.0 113.166 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.46 -29.04 5.96 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.04 1.336 . . . . 0.0 113.251 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.64 68.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.127 0.571 . . . . 0.0 111.998 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -109.64 -11.79 14.72 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.2 mt -59.75 134.08 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.44 63.85 1.31 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.0 mtt -48.49 -26.48 2.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 114.157 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.52 24.67 2.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.945 1.248 . . . . 0.0 112.618 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -44.43 68.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.077 1.751 . . . . 0.0 111.762 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.7 m -96.97 9.67 41.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 m 67.54 -36.69 0.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.467 2.707 . . . . 0.0 114.825 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.2 p -126.53 73.21 73.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.04 1.736 . . . . 0.0 106.985 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -78.98 -165.81 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.783 2.989 . . . . 0.0 110.983 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -106.6 -19.18 13.75 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.609 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.23 157.76 29.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 121.64 2.018 . . . . 0.0 112.095 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.32 -25.88 1.31 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.617 1.567 . . . . 0.0 112.548 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.19 147.32 14.98 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -99.09 154.74 17.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.575 1.15 . . . . 0.0 111.091 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -156.04 112.25 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.166 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -78.17 134.98 37.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.163 1.347 . . . . 0.0 107.867 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.0 160.73 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.721 1.209 . . . . 0.0 109.903 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.34 150.09 3.69 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.523 0.678 . . . . 0.0 110.823 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.34 148.38 32.54 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.0 m95 66.06 -10.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -61.73 -50.74 80.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 121.748 2.067 . . . . 0.0 111.371 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -59.28 -31.26 94.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.037 1.825 . . . . 0.0 112.658 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.45 -37.21 78.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.652 0.781 . . . . 0.0 109.801 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mmm-85 -81.8 -27.98 33.4 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.771 1.168 . . . . 0.0 111.347 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -73.53 -30.43 63.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.873 0.76 . . . . 0.0 111.85 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.96 157.22 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 119.162 0.892 . . . . 0.0 111.74 -169.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -52.06 148.88 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.186 1.794 . . . . 0.0 112.401 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -63.26 -32.81 74.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 113.55 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -70.07 -29.88 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.307 0.958 . . . . 0.0 111.054 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -86.11 -40.22 15.92 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 117.45 -1.262 . . . . 0.0 112.212 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -40.7 -49.97 3.07 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.877 1.217 . . . . 0.0 113.675 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.93 -31.12 68.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 75' ' ' LEU . 24.3 t -78.6 -40.59 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.846 0.859 . . . . 0.0 110.314 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.24 -30.67 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -56.95 -41.24 77.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.987 -1.071 . . . . 0.0 110.802 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -66.59 -46.9 74.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.297 0.953 . . . . 0.0 109.026 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.73 -44.85 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.9 mtt -70.17 -38.17 75.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.447 -0.783 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -64.52 -37.02 86.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.209 0.913 . . . . 0.0 110.624 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.33 -28.06 66.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 110.592 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -113.31 -12.19 13.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.46 -58.1 8.32 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.663 1.119 . . . . 0.0 111.704 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.9 m -74.38 5.86 4.22 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.84 0.23 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.447 1.899 . . . . 0.0 109.401 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.2 t -118.38 -54.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.9 mtt -60.55 -22.15 63.33 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.889 1.275 . . . . 0.0 111.51 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.4 p -53.7 -40.67 66.23 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 111.844 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.19 -39.49 86.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.125 0.97 . . . . 0.0 109.785 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -84.34 -36.14 22.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.342 0.657 . . . . 0.0 111.093 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 123.653 0.781 . . . . 0.0 109.101 170.165 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.31 150.49 25.86 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.882 1.673 . . . . 0.0 110.062 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.41 -28.5 66.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.912 0.885 . . . . 0.0 113.03 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.94 2.34 43.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.262 1.025 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.72 29.06 11.18 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.575 1.559 . . . . 0.0 112.586 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -109.23 141.29 41.71 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.138 1.469 . . . . 0.0 110.932 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.65 127.45 52.38 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.33 135.66 34.74 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -143.03 159.17 42.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.106 1.762 . . . . 0.0 111.534 -169.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.674 1.59 . . . . 0.0 107.933 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.13 124.0 34.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mm -87.05 118.45 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.54 81.0 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -65.18 145.64 13.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -131.67 131.5 43.19 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 168.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.6 129.86 35.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -44.74 -27.86 0.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.112 1.765 . . . . 0.0 114.482 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.15 15.59 0.16 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.216 1.006 . . . . 0.0 112.561 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.09 17.48 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.212 1.387 . . . . 0.0 112.432 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -129.5 154.55 46.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.166 1.386 . . . . 0.0 108.147 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.19 161.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.511 0.725 . . . . 0.0 112.303 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.22 128.21 34.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.731 1.212 . . . . 0.0 109.813 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.43 133.27 8.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 168.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 121' ' ' PHE . . . -153.02 147.03 25.43 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -67.73 125.46 26.3 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -74.85 128.46 35.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.39 146.05 41.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 169.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.03 -44.4 2.6 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.113 0.863 . . . . 0.0 112.977 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -77.7 -34.48 52.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 109.219 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 54.65 39.48 31.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.654 1.982 . . . . 0.0 111.285 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 p -160.25 170.2 21.62 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -70.72 149.81 46.56 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.457 -0.777 . . . . 0.0 111.398 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -156.25 149.3 24.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.352 1.061 . . . . 0.0 108.6 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -47.79 137.48 10.09 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.583 1.953 . . . . 0.0 111.589 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.13 136.22 50.97 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.974 1.783 . . . . 0.0 109.802 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -162.13 139.76 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.184 2.194 . . . . 0.0 106.006 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.15 -97.75 1.44 Allowed Glycine 0 CA--C 1.531 1.072 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.63 167.31 23.89 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.4 mt -114.58 148.46 17.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -99.78 154.27 37.34 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.698 1.199 . . . . 0.0 110.275 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.27 117.91 4.74 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.939 1.759 . . . . 0.0 111.208 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.53 5.37 89.57 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.997 1.284 . . . . 0.0 112.809 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.48 127.04 34.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.41 160.71 29.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.175 0.99 . . . . 0.0 110.401 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.35 74.57 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.836 0.854 . . . . 0.0 112.92 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.8 -44.23 64.29 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.26 -43.08 96.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.8 1.24 . . . . 0.0 109.421 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.315 0.646 . . . . 0.0 111.509 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -60.14 -42.66 95.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.05 0.841 . . . . 0.0 109.307 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 89.7 m-85 -69.46 -24.53 63.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.604 1.093 . . . . 0.0 112.167 172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -66.99 -50.56 61.88 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.825 -1.172 . . . . 0.0 108.176 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.18 -30.52 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.187 0.903 . . . . 0.0 111.746 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.0 tp -57.3 -39.48 75.86 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -54.47 10.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.251 1.02 . . . . 0.0 110.915 172.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.78 -36.26 80.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.539 1.063 . . . . 0.0 111.893 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -95.72 -52.12 4.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.661 0.784 . . . . 0.0 111.36 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.37 -15.2 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.564 0.62 . . . . 0.0 112.375 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.01 56.46 24.55 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -173.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.4 mt -137.22 158.87 43.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.6 1.96 . . . . 0.0 106.537 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -125.45 -172.61 2.63 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.839 0.856 . . . . 0.0 111.312 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.0 mtt180 -64.99 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.968 3.307 . . . . 0.0 114.29 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -159.27 -14.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.185 0.994 . . . . 0.0 113.384 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -91.22 2.0 56.69 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.693 1.197 . . . . 0.0 113.093 -169.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.76 169.23 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.952 0.901 . . . . 0.0 110.498 -168.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -134.73 112.91 11.15 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 102' ' ' LEU . 45.4 mt -71.51 130.51 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 120.086 1.312 . . . . 0.0 107.515 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.88 -36.22 6.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.007 0.523 . . . . 0.0 111.762 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.76 173.2 16.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.721 1.209 . . . . 0.0 108.938 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 t -150.91 162.26 41.13 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 170.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -64.39 143.33 57.98 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.767 0.712 . . . . 0.0 109.665 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -63.54 -30.66 71.75 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.818 0.447 . . . . 0.0 111.888 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.63 168.86 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.652 1.581 . . . . 0.0 108.093 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -64.67 124.79 22.82 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.13 0.572 . . . . 0.0 109.465 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.93 158.66 27.98 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -142.34 137.35 30.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -145.53 154.48 42.24 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -100.17 146.41 26.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.37 140.82 60.83 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.46 154.2 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.156 1.904 . . . . 0.0 109.093 169.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -44.43 79.9 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.04 -1.038 . . . . 0.0 113.631 -169.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.5 -15.69 62.92 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.131 0.973 . . . . 0.0 112.559 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 tp -99.29 -6.59 27.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.476 1.51 . . . . 0.0 111.929 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.55 145.11 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 120.797 1.635 . . . . 0.0 107.765 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -77.95 -43.68 29.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.838 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.1 m95 59.3 4.17 0.45 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.924 2.49 . . . . 0.0 114.561 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -118.9 -18.12 8.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.599 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -74.23 -38.4 63.53 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.846 -0.534 . . . . 0.0 111.49 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 46.53 87.44 0.12 Allowed Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 127.73 2.412 . . . . 0.0 112.164 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -60.31 138.99 21.89 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.032 1.047 . . . . 0.0 114.305 9.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -57.31 120.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.658 1.583 . . . . 0.0 107.523 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 47.1 t -91.71 126.84 36.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -119.5 -3.19 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.898 1.679 . . . . 0.0 112.08 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.0 37.6 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 120.408 1.458 . . . . 0.0 112.627 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -100.98 125.76 47.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 171.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -89.48 110.69 21.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.81 127.27 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 120.719 1.599 . . . . 0.0 112.153 -171.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -101.11 123.1 44.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -98.3 124.49 42.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.25 136.57 36.55 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.92 116.31 28.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 67' ' ' ILE . 30.4 mt -111.67 136.28 51.11 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 110.591 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -93.92 136.9 33.72 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.7 tp -82.53 106.94 14.8 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -30.47 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 111.547 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 p -59.73 -60.96 3.01 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 111.436 171.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.54 176.01 38.66 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.166 0.889 . . . . 0.0 111.549 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -43.48 -37.09 2.25 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.441 1.497 . . . . 0.0 112.596 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.35 -21.26 61.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -129.74 -13.41 4.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.54 1.136 . . . . 0.0 112.77 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.57 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.23 50.16 1.62 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.116 0.966 . . . . 0.0 109.653 -169.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.7 mtt -45.46 -15.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 -169.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.06 22.53 10.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.958 1.708 . . . . 0.0 112.613 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 p -65.94 -32.22 73.59 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 112.073 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.58 -3.94 58.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -169.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m 66.33 -40.42 0.35 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.368 2.267 . . . . 0.0 113.072 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -128.15 79.24 74.24 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 126.932 2.093 . . . . 0.0 105.807 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.02 -161.94 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.781 2.987 . . . . 0.0 110.973 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -112.34 -38.41 4.7 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.55 -1.214 . . . . 0.0 112.557 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 43.1 m-85 -106.35 161.3 14.68 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.267 1.849 . . . . 0.0 111.31 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -128.68 -29.44 2.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.575 1.55 . . . . 0.0 112.418 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.57 152.5 22.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -104.3 160.44 14.89 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.066 0.946 . . . . 0.0 111.827 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -154.31 117.85 4.6 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.337 1.855 . . . . 0.0 106.451 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -79.41 130.98 35.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.357 1.435 . . . . 0.0 107.443 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.81 162.27 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.476 1.11 . . . . 0.0 110.268 -170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.8 m -53.64 148.82 9.06 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.703 0.763 . . . . 0.0 111.75 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.18 144.95 48.78 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.38 -1.17 1.3 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -68.44 -49.83 29.86 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 121.385 1.902 . . . . 0.0 111.201 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -63.9 -32.2 66.42 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 121.286 1.495 . . . . 0.0 114.453 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 m -61.29 -31.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 120.093 1.315 . . . . 0.0 111.575 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.22 -14.89 34.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.58 1.082 . . . . 0.0 111.737 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -75.59 -33.77 60.6 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 109.502 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.3 153.77 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.499 1.52 . . . . 0.0 110.377 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.11 149.91 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.438 1.495 . . . . 0.0 111.016 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 m -57.13 -35.63 69.73 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.023 1.329 . . . . 0.0 114.159 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -71.3 -27.55 63.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.102 0.864 . . . . 0.0 111.388 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -98.18 -22.12 16.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.188 0.995 . . . . 0.0 112.358 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -49.54 -43.05 45.54 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.033 0.933 . . . . 0.0 110.947 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.37 -45.55 87.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.669 0.668 . . . . 0.0 111.787 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.45 -35.51 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.743 -0.598 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.56 -30.76 67.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.215 -0.928 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -61.59 -38.63 88.25 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.552 -1.342 . . . . 0.0 109.646 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -64.45 -42.68 95.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.18 1.355 . . . . 0.0 109.937 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.83 -46.55 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 118.934 0.788 . . . . 0.0 109.214 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 46.7 mtt -68.97 -38.07 79.16 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.88 -0.513 . . . . 0.0 110.512 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -66.68 -33.82 76.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.333 1.053 . . . . 0.0 110.764 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.03 -26.04 67.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.355 0.662 . . . . 0.0 111.406 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -120.39 -6.12 9.83 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.39 -58.41 6.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.209 0.913 . . . . 0.0 111.48 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -64.03 -27.15 68.92 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.071 -0.393 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.19 -40.42 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.096 -1.002 . . . . 0.0 108.612 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.02 -41.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.529 0.732 . . . . 0.0 109.345 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 49.2 mtt -71.97 -25.55 61.9 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.04 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.1 m -50.74 -41.14 56.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.477 1.035 . . . . 0.0 111.874 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.02 -37.78 88.58 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -99.7 22.2 11.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.924 0.89 . . . . 0.0 111.97 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 CA--C 1.547 0.827 0 C-N-CA 126.247 1.819 . . . . 0.0 109.644 172.115 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.3 mm . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.15 149.25 48.84 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.731 1.612 . . . . 0.0 108.238 171.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.86 -32.1 19.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.92 1.35 35.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.05 35.54 7.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.581 1.562 . . . . 0.0 111.531 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 13.8 m-85 -116.43 139.99 49.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.394 1.097 . . . . 0.0 109.858 -174.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -90.99 122.21 66.95 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.106 -1.426 . . . . 0.0 107.337 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.94 130.83 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.994 1.796 . . . . 0.0 110.238 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -139.1 166.45 24.48 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.211 1.404 . . . . 0.0 109.716 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.75 138.07 50.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.16 123.38 6.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.44 111.72 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -92.52 82.74 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.66 129.27 27.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 169.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.4 m -114.66 121.03 42.12 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -80.54 139.8 36.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.78 -6.52 12.08 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -73.36 -1.82 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.109 0.868 . . . . 0.0 110.629 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.68 26.27 25.36 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 124.995 1.283 . . . . 0.0 112.49 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -124.82 161.97 25.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 0.0 108.409 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.59 163.66 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.2 tpt -53.1 134.16 38.63 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.849 2.06 . . . . 0.0 111.742 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -164.19 137.93 5.37 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 168.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.624 0.726 . . . . 0.0 110.056 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -75.8 135.33 40.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.273 1.429 . . . . 0.0 107.674 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -82.43 130.76 35.17 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -49.1 130.88 19.25 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.023 2.129 . . . . 0.0 110.658 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.26 -35.46 1.97 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.755 1.169 . . . . 0.0 113.539 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -85.13 -35.31 21.84 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.179 0.99 . . . . 0.0 110.337 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.289 91.6 m-70 56.04 34.01 22.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.961 1.705 . . . . 0.0 113.317 -174.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m -139.45 157.31 46.06 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.0 2.12 . . . . 0.0 106.288 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -65.92 158.36 28.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.548 1.139 . . . . 0.0 113.35 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.43 150.17 36.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 0.0 109.515 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -66.96 160.69 68.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.668 1.587 . . . . 0.0 111.157 169.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.73 -133.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.738 3.625 . . . . 0.0 110.05 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 76.2 116.92 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.278 2.231 . . . . 0.0 110.225 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.62 18.59 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 153.84 51.19 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.599 1.095 . . . . 0.0 112.888 -169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -90.27 139.01 18.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.839 1.656 . . . . 0.0 107.795 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.53 154.5 68.69 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.347 0.659 . . . . 0.0 110.629 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.82 117.63 4.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.884 1.722 . . . . 0.0 111.341 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.73 6.41 89.4 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.909 1.242 . . . . 0.0 112.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -81.59 130.22 34.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.78 160.37 28.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.409 1.084 . . . . 0.0 110.398 177.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.67 71.21 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 124.456 1.102 . . . . 0.0 112.445 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.05 -42.21 66.55 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.48 -42.57 96.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.869 1.268 . . . . 0.0 109.362 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -37.15 85.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 111.925 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -59.78 -44.94 93.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.122 0.873 . . . . 0.0 109.651 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.4 m-85 -70.31 -29.78 66.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.168 -0.958 . . . . 0.0 112.015 174.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -62.33 -47.6 83.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.502 1.046 . . . . 0.0 109.751 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.16 70.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.91 0.484 . . . . 0.0 111.008 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -58.31 -39.67 79.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.482 1.113 . . . . 0.0 109.939 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -74.07 -50.82 17.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.24 1.416 . . . . 0.0 111.661 175.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.94 -35.0 79.75 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.967 1.258 . . . . 0.0 112.027 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.58 -50.38 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.994 0.918 . . . . 0.0 111.816 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.4 -13.53 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.661 0.785 . . . . 0.0 111.469 -169.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.26 40.88 96.91 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.68 150.23 41.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 107.341 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.0 m -115.22 -175.61 2.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.008 0.923 . . . . 0.0 111.071 -169.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.3 mtt180 -66.09 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.356 2.663 . . . . 0.0 114.203 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -161.4 -16.23 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.773 1.229 . . . . 0.0 112.866 -169.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.59 -0.55 57.37 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.472 1.109 . . . . 0.0 112.484 -169.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.35 168.55 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.326 1.45 . . . . 0.0 108.326 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -137.83 119.97 15.62 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -74.6 129.65 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 120.23 1.377 . . . . 0.0 107.582 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.17 -32.12 7.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.81 0.444 . . . . 0.0 111.549 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.76 167.24 30.61 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.088 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 p -149.77 160.16 43.77 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.005 1.322 . . . . 0.0 107.915 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -63.62 148.22 49.49 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.734 -0.604 . . . . 0.0 110.791 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -64.84 -37.06 86.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.79 0.436 . . . . 0.0 111.253 -171.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.84 172.95 14.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.575 1.95 . . . . 0.0 107.39 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -63.36 125.68 24.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.588 0.755 . . . . 0.0 110.148 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.62 133.44 37.27 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.38 150.38 32.35 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.218 0.917 . . . . 0.0 110.273 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.57 160.36 43.86 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.47 1.108 . . . . 0.0 109.077 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -91.76 128.36 37.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.62 148.22 95.0 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.523 1.129 . . . . 0.0 109.282 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.21 155.7 68.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.671 2.247 . . . . 0.0 109.755 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -54.32 -35.21 62.43 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.79 -24.2 55.93 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.194 0.998 . . . . 0.0 112.971 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.49 -17.36 15.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.947 0.899 . . . . 0.0 111.759 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.4 t -49.01 132.75 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 168.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.74 107.19 16.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -89.21 -1.93 58.28 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.495 0.718 . . . . 0.0 111.021 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.98 -20.82 21.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.754 1.622 . . . . 0.0 110.013 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 p -87.24 162.93 17.17 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.815 0.846 . . . . 0.0 108.811 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -136.69 113.24 9.99 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -54.61 152.4 19.31 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-N 120.21 1.111 . . . . 0.0 113.116 -6.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.44 129.88 26.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.2 t -90.38 109.73 20.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.58 -6.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.825 1.25 . . . . 0.0 112.024 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.454 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -157.46 169.61 34.43 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.086 1.312 . . . . 0.0 113.014 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -115.18 122.91 47.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -101.98 134.06 45.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -152.78 146.74 25.33 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.904 1.229 . . . . 0.0 114.147 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -104.72 127.82 52.62 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 102.788 -3.042 . . . . 0.0 102.788 168.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -97.25 135.72 38.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -112.68 129.75 56.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 110.02 16.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -104.95 127.81 52.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -83.74 133.53 34.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.0 137.1 51.1 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.34 -38.88 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.7 p -60.56 -61.7 2.4 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.0 1.72 . . . . 0.0 112.145 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 172.24 38.65 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.847 1.259 . . . . 0.0 112.491 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.8 63.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.657 0.783 . . . . 0.0 112.878 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.35 -9.94 5.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.402 1.081 . . . . 0.0 112.744 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.47 130.93 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 169.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.04 49.42 1.66 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.14 0.976 . . . . 0.0 109.146 -170.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.5 ptp -64.53 28.81 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.467 2.307 . . . . 0.0 116.134 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -123.28 21.76 9.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.524 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -35.36 72.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.897 2.079 . . . . 0.0 111.873 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -5.81 56.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.063 1.745 . . . . 0.0 113.306 -170.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.3 m 68.16 -37.82 0.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 128.607 2.763 . . . . 0.0 113.389 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.7 p -124.9 73.14 64.24 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.72 -177.65 2.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.302 2.668 . . . . 0.0 110.979 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.4 -8.2 21.35 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.477 -1.249 . . . . 0.0 111.573 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.54 151.6 50.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 121.341 1.882 . . . . 0.0 112.876 -170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.58 -25.91 3.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.229 1.812 . . . . 0.0 112.648 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.65 157.71 29.97 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -106.99 159.97 15.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -150.47 120.89 7.37 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.047 1.739 . . . . 0.0 106.391 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -82.82 124.19 30.06 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.13 163.15 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.21 1.004 . . . . 0.0 110.953 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.6 m -50.12 144.94 6.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.629 0.772 . . . . 0.0 110.143 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -54.96 -36.12 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.888 0.475 . . . . 0.0 111.964 -169.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -100.39 12.19 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.85 -49.77 10.29 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.53 -32.54 88.07 Favored 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 121.842 1.693 . . . . 0.0 113.782 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -31.38 49.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 119.807 1.185 . . . . 0.0 111.242 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -86.05 -21.92 27.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.6 1.091 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -81.61 -31.1 32.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.69 0.677 . . . . 0.0 111.665 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.1 160.37 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.325 0.584 . . . . 0.0 110.448 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.86 149.01 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.109 0.964 . . . . 0.0 111.261 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -57.42 -35.04 69.56 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.999 1.319 . . . . 0.0 113.912 -169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -73.58 -27.03 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.788 0.722 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -82.53 -38.65 23.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.934 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -42.96 -50.64 5.82 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.874 1.215 . . . . 0.0 112.771 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.62 -26.25 60.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.2 -42.92 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.6 -32.67 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.576 -0.703 . . . . 0.0 110.774 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.11 -29.12 70.11 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.28 -0.888 . . . . 0.0 112.637 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -64.5 -47.89 77.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.714 1.143 . . . . 0.0 108.946 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.23 -44.79 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.1 mtt -64.67 -46.68 81.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.601 -1.19 . . . . 0.0 111.038 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -29.77 69.44 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 121.433 1.924 . . . . 0.0 111.068 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.81 -36.41 82.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.635 0.374 . . . . 0.0 110.357 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -100.02 -16.67 17.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.4 1.08 . . . . 0.0 113.366 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.4 6.87 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.995 1.318 . . . . 0.0 109.899 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -65.25 -21.51 66.75 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.3 -42.45 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.52 -39.37 40.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.2 mtt -72.58 -20.17 61.36 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.413 -0.804 . . . . 0.0 111.122 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.7 m -64.51 -20.27 66.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.865 1.212 . . . . 0.0 112.528 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.4 -29.0 47.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -98.2 -37.27 9.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.239 1.016 . . . . 0.0 111.224 -169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 126.767 2.027 . . . . 0.0 110.204 176.295 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.08 -44.7 68.55 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.126 0.57 . . . . 0.0 111.252 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -154.34 -86.22 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.429 1.092 . . . . 0.0 109.717 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 -45.92 13.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.94 15.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.943 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -99.32 125.57 45.0 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.637 1.718 . . . . 0.0 108.547 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -85.68 126.07 67.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 117.368 -1.301 . . . . 0.0 107.688 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.09 127.49 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.28 1.987 . . . . 0.0 109.244 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -137.27 166.34 24.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.218 1.407 . . . . 0.0 108.99 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.43 141.63 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 127.006 2.122 . . . . 0.0 105.84 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.76 132.71 10.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.89 129.37 48.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.61 86.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 168.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.48 135.84 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.08 124.2 46.32 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.33 127.32 32.62 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 170.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -53.75 -4.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.54 2.336 . . . . 0.0 116.088 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.35 -12.48 60.27 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.8 1.182 . . . . 0.0 111.423 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.42 41.83 2.67 Favored Glycine 0 C--N 1.342 0.916 0 C-N-CA 124.791 1.186 . . . . 0.0 111.811 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.69 155.47 44.91 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.41 162.18 13.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.182 0.993 . . . . 0.0 112.152 -169.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.8 tpp -53.54 130.67 36.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.037 1.735 . . . . 0.0 111.36 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' A' ' 24' ' ' TRP . 1.4 t-105 -159.27 131.11 6.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 166.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.19 26.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.194 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -83.62 134.72 34.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.65 130.6 35.11 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.79 145.19 56.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.396 0.679 . . . . 0.0 110.588 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.27 -43.57 2.05 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.947 1.26 . . . . 0.0 112.534 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -78.63 -37.97 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.377 1.071 . . . . 0.0 109.844 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.316 24.3 m170 57.84 43.61 21.41 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.807 2.043 . . . . 0.0 113.734 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 p -146.33 171.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 107.034 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -73.21 156.04 38.96 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.212 -0.93 . . . . 0.0 111.542 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.558 ' NE2' HE22 ' A' ' 37' ' ' GLN . 4.7 tt0 -147.54 145.67 29.17 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.605 0.762 . . . . 0.0 109.968 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.62 143.03 87.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.697 1.199 . . . . 0.0 109.965 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -69.75 139.08 39.38 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.455 2.103 . . . . 0.0 110.238 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.558 HE22 ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -167.48 151.33 6.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.422 1.889 . . . . 0.0 109.035 170.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.94 139.93 7.42 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 146.72 45.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 mt -80.7 138.89 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -96.64 154.77 38.36 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 123.911 0.884 . . . . 0.0 110.52 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.92 123.14 12.72 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.388 2.059 . . . . 0.0 114.703 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.76 4.52 66.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 113.991 -1.458 . . . . 0.0 113.244 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -86.17 123.94 32.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.646 1.223 . . . . 0.0 108.545 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -72.92 162.4 29.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.543 1.137 . . . . 0.0 110.846 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.86 79.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.4 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.84 9.4 6.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.81 . . . . 0.0 111.65 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -111.59 -54.11 2.64 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.19 72.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.541 1.136 . . . . 0.0 112.79 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -60.67 -42.76 97.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.037 0.835 . . . . 0.0 109.567 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -74.18 -24.45 59.37 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.523 -1.36 . . . . 0.0 111.771 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.6 -50.78 71.2 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.08 -1.012 . . . . 0.0 108.434 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.48 -35.66 81.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.102 0.561 . . . . 0.0 111.906 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.68 -41.21 76.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.935 1.294 . . . . 0.0 110.455 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -46.65 54.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.185 0.994 . . . . 0.0 110.551 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.32 -40.26 95.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.294 0.952 . . . . 0.0 111.788 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.44 -51.95 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.496 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.83 -9.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.32 64.38 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 120.938 -1.101 . . . . 0.0 112.339 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.6 mt -105.96 164.59 11.84 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.981 0.912 . . . . 0.0 108.62 171.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -126.96 -175.95 3.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.064 1.346 . . . . 0.0 111.005 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.95 41.24 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.853 2.061 . . . . 0.0 113.206 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -159.76 -21.26 0.07 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.319 0.648 . . . . 0.0 112.725 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -85.31 -0.12 53.76 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.19 168.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.42 1.088 . . . . 0.0 110.523 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -142.93 121.26 12.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 126.087 1.755 . . . . 0.0 106.853 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.89 130.53 36.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 120.808 1.64 . . . . 0.0 107.646 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.66 -34.71 7.23 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.38 0.672 . . . . 0.0 110.886 171.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.79 172.5 18.37 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.37 1.068 . . . . 0.0 109.225 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -149.31 160.58 43.28 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 p -66.13 142.2 57.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.921 0.782 . . . . 0.0 109.375 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -68.73 -22.55 64.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.933 0.493 . . . . 0.0 111.984 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.44 173.58 11.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.534 1.934 . . . . 0.0 107.725 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -76.8 117.15 18.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.49 137.53 52.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -147.35 147.29 30.17 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.745 -0.597 . . . . 0.0 109.795 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -150.76 163.42 38.62 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.109 1.363 . . . . 0.0 107.979 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -87.51 149.45 24.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.361 0.6 . . . . 0.0 109.889 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.49 137.35 32.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.55 151.81 75.14 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.662 2.241 . . . . 0.0 108.426 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -21.81 66.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -169.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.05 -28.45 62.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.823 0.849 . . . . 0.0 112.184 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.3 tp -97.12 -24.13 15.89 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.396 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -45.02 136.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -75.15 -42.51 55.92 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.976 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.3 m95 59.73 1.95 0.33 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.731 2.413 . . . . 0.0 114.156 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -97.57 -23.79 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.014 1.325 . . . . 0.0 111.51 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -73.13 153.41 40.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.868 1.667 . . . . 0.0 109.053 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.94 112.2 10.43 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 117.785 -1.103 . . . . 0.0 108.263 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.99 151.88 17.38 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 CA-C-N 120.509 1.217 . . . . 0.0 111.832 -10.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.35 131.55 27.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.5 p -90.35 127.96 36.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -169.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -105.96 -4.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.296 1.439 . . . . 0.0 110.986 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.15 30.91 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 118.969 0.804 . . . . 0.0 111.705 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.23 119.88 40.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -92.89 130.61 38.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 169.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 142.39 22.41 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.756 1.616 . . . . 0.0 114.447 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -101.77 130.97 48.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -95.38 141.93 28.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -111.44 135.19 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 108.392 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.1 tp -90.83 102.5 15.26 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.3 mt -100.44 127.33 46.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.219 0.608 . . . . 0.0 110.207 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -85.19 138.06 32.61 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 168.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -70.4 132.56 45.81 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -112.85 -41.22 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.0 m -139.01 127.7 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.92 -171.27 43.36 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.92 -51.39 0.19 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.416 3.086 . . . . 0.0 112.907 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.03 -34.57 22.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 111.102 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.66 -5.66 19.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.859 0.864 . . . . 0.0 112.536 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.84 142.86 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -132.07 -45.42 0.94 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -170.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mtt 60.17 0.01 0.27 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.85 25.9 3.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.645 2.02 . . . . 0.0 111.19 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.4 t -86.1 -30.31 22.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -85.14 168.38 14.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.176 1.791 . . . . 0.0 110.565 -169.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 m -70.95 -33.52 70.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.985 0.514 . . . . 0.0 111.533 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -142.77 88.55 8.47 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -67.16 -166.07 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.407 2.071 . . . . 0.0 113.547 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.28 -54.67 1.27 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.802 170.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -100.47 168.34 9.8 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.398 0.999 . . . . 0.0 112.561 -169.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.92 -8.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.377 1.071 . . . . 0.0 113.115 176.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.9 149.22 19.89 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -113.45 150.14 33.21 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.453 1.501 . . . . 0.0 110.226 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -148.82 114.02 5.52 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.569 1.547 . . . . 0.0 107.31 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -77.8 133.26 38.25 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.87 160.1 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.973 1.309 . . . . 0.0 109.322 -172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 m -53.65 152.94 4.74 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 110.725 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.41 151.19 13.55 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 67.39 -15.79 0.17 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -57.89 -45.58 99.78 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 121.284 1.856 . . . . 0.0 111.984 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -63.85 -25.44 67.68 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.769 1.646 . . . . 0.0 114.373 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.09 -37.23 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.691 1.132 . . . . 0.0 108.982 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -85.98 -15.9 40.04 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.125 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -82.72 -32.19 28.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.527 1.058 . . . . 0.0 111.955 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m -69.25 164.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 112.204 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.28 151.16 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.471 1.108 . . . . 0.0 110.652 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 m -57.37 -36.16 70.87 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.974 1.31 . . . . 0.0 113.371 -169.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -76.71 -24.72 53.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.183 0.901 . . . . 0.0 111.673 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -87.34 -27.49 22.8 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.431 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -42.83 -50.82 5.63 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.917 1.287 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.89 -37.62 79.12 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.157 0.435 . . . . 0.0 111.158 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.83 -45.46 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.62 -32.15 70.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.906 0.483 . . . . 0.0 110.339 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -57.65 -39.83 77.89 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.443 1.097 . . . . 0.0 110.301 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -63.44 -49.67 72.78 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.948 1.249 . . . . 0.0 108.97 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.46 -45.23 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.84 -47.11 82.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.126 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.18 66.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.181 1.809 . . . . 0.0 112.284 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -66.82 -29.51 69.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.47 0.577 . . . . 0.0 110.427 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -108.66 -21.67 12.59 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.09 0.956 . . . . 0.0 113.455 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.2 36.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.241 1.016 . . . . 0.0 109.816 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 m -65.35 -18.58 65.43 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.4 -34.47 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.004 0.82 . . . . 0.0 108.8 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 88.1 t -71.68 -40.79 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 mtt -59.22 -23.03 61.95 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.541 -1.218 . . . . 0.0 111.759 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.0 m -54.16 -31.34 52.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.822 1.646 . . . . 0.0 112.042 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.33 -28.96 21.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.277 1.031 . . . . 0.0 111.507 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 -30.52 8.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.082 . . . . 0.0 112.781 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 127.168 2.187 . . . . 0.0 109.777 178.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.5 mm . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.26 -40.7 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -166.74 104.67 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.772 0.829 . . . . 0.0 110.707 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t0 58.42 44.79 17.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.077 2.151 . . . . 0.0 113.301 169.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.95 34.26 18.78 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.845 -0.975 . . . . 0.0 112.32 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -115.89 132.04 56.76 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.588 1.194 . . . . 0.0 110.552 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -88.41 123.72 67.66 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 130.7 10.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.322 2.015 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.47 163.54 31.69 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.395 1.078 . . . . 0.0 110.655 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.21 130.79 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.667 1.987 . . . . 0.0 107.209 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.38 122.36 7.55 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.48 104.23 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.7 t -87.33 80.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.24 131.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -112.19 128.76 56.33 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -94.58 23.47 5.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 57.05 -1.13 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.651 1.98 . . . . 0.0 116.206 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -99.07 -1.62 39.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.76 0.709 . . . . 0.0 111.914 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.36 27.57 29.99 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 119.196 0.907 . . . . 0.0 111.169 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -141.38 156.2 45.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.992 1.717 . . . . 0.0 106.641 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.01 168.88 19.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.662 0.785 . . . . 0.0 112.712 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.5 tpt -48.1 127.03 11.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.119 2.168 . . . . 0.0 112.017 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -160.65 133.25 6.28 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 168.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.03 29.12 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.38 0.672 . . . . 0.0 109.981 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.9 ttm105 -75.14 140.59 43.48 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.674 1.19 . . . . 0.0 108.184 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -86.23 122.37 30.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.341 1.056 . . . . 0.0 109.679 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -53.98 138.19 37.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.809 1.643 . . . . 0.0 108.611 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.7 -37.19 1.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.07 1.319 . . . . 0.0 113.836 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -90.9 -29.91 17.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.504 1.152 . . . . 0.0 111.267 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 55.56 41.3 30.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.001 1.72 . . . . 0.0 112.602 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 p -145.43 169.76 17.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.055 1.342 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -83.48 148.31 27.31 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.754 -1.216 . . . . 0.0 111.048 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -148.81 156.88 42.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.974 0.893 . . . . 0.0 111.101 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -67.98 163.35 51.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.952 2.101 . . . . 0.0 110.007 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.71 -106.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.208 3.272 . . . . 0.0 110.808 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 63.83 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.185 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.03 144.25 18.34 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.48 148.77 45.91 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.19 133.69 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.71 126.61 87.04 Favored Pre-proline 0 C--O 1.232 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 108.567 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.02 119.23 6.16 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.982 1.788 . . . . 0.0 112.619 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.85 3.69 79.86 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.078 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.07 120.67 41.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -70.62 162.51 28.81 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.155 0.582 . . . . 0.0 111.483 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.25 -45.72 8.7 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 127.18 2.192 . . . . 0.0 113.412 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.7 -47.36 40.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.59 -37.9 82.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.306 0.642 . . . . 0.0 110.511 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.53 -34.97 76.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -60.15 -45.72 92.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -67.68 -27.4 66.81 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.293 -0.88 . . . . 0.0 112.844 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -65.17 -51.13 62.98 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 120.885 -1.135 . . . . 0.0 109.009 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.12 70.54 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.138 0.881 . . . . 0.0 110.911 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.93 -39.87 79.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.27 1.028 . . . . 0.0 109.371 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -52.08 14.83 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.321 1.049 . . . . 0.0 111.415 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.77 -36.98 84.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.236 0.925 . . . . 0.0 111.446 -172.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -104.02 -39.01 6.73 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.94 -20.12 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.255 0.622 . . . . 0.0 110.085 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.17 19.42 78.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.488 -1.382 . . . . 0.0 111.945 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 mt -102.22 151.64 21.98 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.521 1.128 . . . . 0.0 108.085 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -113.46 177.45 4.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.693 -0.629 . . . . 0.0 110.064 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -69.99 58.5 0.16 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.073 1.749 . . . . 0.0 112.744 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -163.44 -26.98 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.245 1.818 . . . . 0.0 111.319 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -89.23 -3.39 58.57 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.3 165.26 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.352 0.661 . . . . 0.0 109.741 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -135.43 119.73 17.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.3 mt -74.9 126.55 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -35.1 6.07 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.151 0.98 . . . . 0.0 110.697 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.63 171.67 19.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.353 1.461 . . . . 0.0 108.783 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -148.43 160.57 42.9 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 108.114 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -62.86 148.32 47.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.349 0.522 . . . . 0.0 110.341 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -62.16 -36.71 82.68 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.702 0.401 . . . . 0.0 111.308 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.35 175.03 11.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.4 1.88 . . . . 0.0 107.226 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.515 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 70.5 m95 -64.05 127.31 30.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.346 0.658 . . . . 0.0 109.572 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.43 141.21 39.85 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -153.47 151.18 29.56 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.686 -0.634 . . . . 0.0 110.208 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -155.94 160.87 40.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.743 1.617 . . . . 0.0 107.536 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 145.94 24.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.379 0.609 . . . . 0.0 109.593 172.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.74 151.85 93.38 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 125.556 1.542 . . . . 0.0 108.365 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -63.31 152.75 78.37 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 N-CA-C 108.028 -1.566 . . . . 0.0 108.028 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -49.4 -48.28 47.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.07 -17.93 64.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.09 0.956 . . . . 0.0 112.913 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.9 tp -102.57 -9.09 20.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.785 1.234 . . . . 0.0 111.838 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.9 t -56.49 142.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.47 -47.84 30.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -168.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.2 m95 55.36 11.23 0.55 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.9 2.08 . . . . 0.0 114.328 -170.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.46 -24.8 13.79 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.412 1.085 . . . . 0.0 111.175 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.6 p -90.89 168.84 11.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.078 0.951 . . . . 0.0 109.789 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.96 116.87 18.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -63.67 162.37 57.13 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.89 0.996 . . . . 0.0 109.952 -10.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.33 132.86 25.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -90.4 108.72 19.96 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.4 pt -94.12 -15.29 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.418 1.887 . . . . 0.0 111.596 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.25 172.8 34.13 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 120.099 1.318 . . . . 0.0 112.848 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -119.22 123.57 44.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 68.0 tttt -98.46 131.77 44.45 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 172.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.77 137.37 18.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.857 1.208 . . . . 0.0 113.089 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -100.81 131.73 46.55 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -100.28 132.92 45.38 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -109.14 131.34 55.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -86.94 108.4 18.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -107.09 125.07 50.58 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.885 0.874 . . . . 0.0 108.867 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -83.56 133.32 34.87 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 168.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.3 tp -68.74 124.46 23.71 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.15 -49.71 11.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -135.81 124.35 23.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.6 -163.07 15.56 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.81 -48.17 0.26 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 128.79 2.836 . . . . 0.0 113.175 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.7 -32.74 10.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.725 1.61 . . . . 0.0 112.023 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.78 -24.53 31.03 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.441 0.696 . . . . 0.0 110.695 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -64.76 131.3 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -134.95 -32.08 0.98 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.6 0.76 . . . . 0.0 111.691 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.5 mtt 64.6 -49.63 0.32 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.508 3.123 . . . . 0.0 113.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.48 25.22 2.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.654 1.182 . . . . 0.0 112.986 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -65.46 -28.3 69.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.143 0.577 . . . . 0.0 110.322 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -95.42 10.66 35.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.98 1.312 . . . . 0.0 113.127 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.28 -36.71 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 129.695 3.198 . . . . 0.0 115.793 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 p -128.28 60.88 50.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.74 1.616 . . . . 0.0 108.993 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -70.78 177.84 5.85 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.048 2.499 . . . . 0.0 110.29 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.46 -26.08 35.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.426 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -99.43 139.14 35.53 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.627 1.558 . . . . 0.0 112.684 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -112.53 -31.08 6.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.098 1.759 . . . . 0.0 112.397 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.67 151.81 16.09 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -102.2 155.59 18.11 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.87 0.868 . . . . 0.0 111.901 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -152.58 111.51 3.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.26 1.824 . . . . 0.0 106.947 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -74.17 138.51 43.85 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.874 0.761 . . . . 0.0 109.24 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.41 159.93 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.864 1.265 . . . . 0.0 109.158 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.8 m -55.28 152.55 8.19 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.953 0.501 . . . . 0.0 110.125 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 165.52 13.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.7 m95 65.88 -24.67 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.888 1.675 . . . . 0.0 115.075 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.97 -46.02 96.65 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 120.483 1.492 . . . . 0.0 111.691 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.98 -29.18 81.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 122.012 1.754 . . . . 0.0 113.263 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.42 -10.24 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 111.89 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -108.53 -23.08 12.0 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.898 -1.126 . . . . 0.0 110.97 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.91 -35.73 57.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.314 0.961 . . . . 0.0 111.68 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.89 166.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.869 0.759 . . . . 0.0 111.509 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.77 150.68 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.421 1.088 . . . . 0.0 110.565 174.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 p -53.33 -40.67 65.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.618 1.567 . . . . 0.0 113.633 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -70.33 -32.36 70.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.365 0.53 . . . . 0.0 110.611 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -72.95 -38.61 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -51.6 -48.21 63.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.519 1.054 . . . . 0.0 110.879 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.66 -26.04 62.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.9 -46.51 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.22 -0.925 . . . . 0.0 108.67 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -35.34 80.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 110.976 -170.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -61.19 -28.04 68.85 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.641 -1.287 . . . . 0.0 112.983 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -64.21 -46.76 82.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.3 t -60.81 -48.5 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 109.391 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 mtt -66.43 -37.07 84.38 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.093 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -47.29 82.02 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 119.456 1.025 . . . . 0.0 110.455 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -60.5 -32.58 71.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.264 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -107.8 4.01 25.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -57.44 10.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.476 1.489 . . . . 0.0 110.994 -169.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -59.71 -30.54 68.88 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.237 0.615 . . . . 0.0 111.715 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.02 -8.35 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.736 1.214 . . . . 0.0 111.038 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.22 -35.95 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 O-C-N 121.355 -0.841 . . . . 0.0 109.402 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 54.8 tpp -76.82 -45.33 29.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.269 0.628 . . . . 0.0 111.051 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.6 m -62.97 -31.09 72.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.93 -0.481 . . . . 0.0 111.61 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.48 -34.12 70.54 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.254 0.622 . . . . 0.0 109.868 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -99.25 0.81 43.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.977 0.911 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 CA--C 1.537 0.473 0 C-N-CA 124.592 1.157 . . . . 0.0 109.247 170.421 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.89 141.63 53.13 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 107.337 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -48.8 -30.29 5.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -168.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.37 -5.36 44.45 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.96 38.74 3.75 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 126.059 1.79 . . . . 0.0 110.663 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.0 139.77 53.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.095 1.447 . . . . 0.0 111.628 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -85.57 120.54 73.1 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 116.776 -1.583 . . . . 0.0 107.853 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.42 137.07 27.44 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 121.822 1.681 . . . . 0.0 111.037 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -145.6 157.51 43.97 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.153 1.381 . . . . 0.0 111.609 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.1 74.61 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.419 2.287 . . . . 0.0 107.934 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.77 128.26 44.77 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -86.42 110.11 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -16.26 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 116.89 -1.529 . . . . 0.0 114.742 -169.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm 19.24 109.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 129.127 2.971 . . . . 0.0 114.929 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.2 138.44 33.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -68.51 -4.56 15.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.98 -7.55 54.88 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.852 0.751 . . . . 0.0 110.56 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.86 37.71 4.35 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 126.131 1.824 . . . . 0.0 112.118 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -133.28 155.79 48.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.551 0.74 . . . . 0.0 109.038 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.68 156.89 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.31 1.044 . . . . 0.0 111.295 -168.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.98 131.44 44.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.124 1.769 . . . . 0.0 110.309 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -158.86 139.1 12.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.96 144.24 23.2 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -70.95 138.26 49.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -86.57 125.49 33.83 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.76 137.59 57.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.609 2.364 . . . . 0.0 109.996 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.13 -31.68 1.33 Allowed Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.062 1.315 . . . . 0.0 113.716 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -86.35 -34.15 20.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.453 1.101 . . . . 0.0 110.455 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 57.29 33.46 23.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.046 1.738 . . . . 0.0 112.575 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 p -149.87 -177.79 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.245 1.818 . . . . 0.0 107.231 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -80.46 160.43 25.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.029 -1.044 . . . . 0.0 112.975 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.1 147.74 27.45 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.216 1.006 . . . . 0.0 108.987 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -60.59 143.76 89.9 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.301 1.44 . . . . 0.0 110.21 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.22 153.08 55.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.306 2.004 . . . . 0.0 111.065 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -171.79 149.55 2.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 109.845 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.91 134.28 3.37 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.179 -2.369 . . . . 0.0 107.179 169.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.7 171.72 55.15 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.247 1.024 . . . . 0.0 111.639 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 mt -96.67 146.04 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.815 0.846 . . . . 0.0 109.064 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -87.61 131.71 42.86 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.565 1.546 . . . . 0.0 108.39 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.44 118.07 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.23 1.953 . . . . 0.0 114.08 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.48 3.57 90.03 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.037 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -86.98 131.67 34.02 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.063 0.945 . . . . 0.0 108.554 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.99 161.26 30.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.827 1.251 . . . . 0.0 110.685 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.17 -44.26 64.55 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 125.168 1.387 . . . . 0.0 112.992 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.24 -48.96 48.05 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.6 -39.59 77.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.597 1.159 . . . . 0.0 109.919 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 -34.42 63.86 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.044 0.938 . . . . 0.0 111.983 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -57.33 -39.87 76.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.95 0.795 . . . . 0.0 110.065 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.37 -26.39 66.44 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.742 1.155 . . . . 0.0 113.511 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.33 -49.9 69.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.153 1.342 . . . . 0.0 108.597 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.39 75.56 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 119.451 -0.309 . . . . 0.0 111.316 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.2 -44.9 84.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.753 1.221 . . . . 0.0 109.715 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.1 -47.3 80.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.634 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.72 -39.49 94.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.261 1.391 . . . . 0.0 112.772 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -82.47 -46.67 13.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.166 1.386 . . . . 0.0 110.577 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 m -132.16 1.03 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.348 1.059 . . . . 0.0 112.816 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.84 32.47 79.58 Favored Glycine 0 CA--C 1.521 0.447 0 O-C-N 120.909 -1.12 . . . . 0.0 112.164 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.78 154.54 18.82 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 m -117.49 179.03 4.17 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.842 0.857 . . . . 0.0 109.106 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -73.15 46.75 0.18 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.67 1.588 . . . . 0.0 115.242 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -163.42 -20.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.124 1.769 . . . . 0.0 111.785 -171.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.1 2.92 53.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.091 1.356 . . . . 0.0 112.961 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.75 170.19 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.506 1.522 . . . . 0.0 108.91 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -138.0 120.25 15.77 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.3 mt -77.66 128.37 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 120.658 1.572 . . . . 0.0 107.879 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -104.95 -34.8 7.9 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.842 0.857 . . . . 0.0 111.467 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 173.79 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.156 1.382 . . . . 0.0 108.493 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -150.49 160.88 43.46 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 m -56.02 133.39 51.76 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -66.14 -27.04 67.73 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -147.33 168.09 22.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.248 1.419 . . . . 0.0 108.61 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -68.73 117.93 11.06 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.9 156.7 31.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -143.46 154.35 43.58 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.918 1.687 . . . . 0.0 108.029 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -146.1 172.67 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.639 . . . . 0.0 107.721 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -105.45 133.15 50.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.2 mt -67.75 148.72 98.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.33 146.09 25.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.529 2.153 . . . . 0.0 108.287 169.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -56.07 -44.32 78.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.749 1.159 . . . . 0.0 113.146 -168.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.22 -15.19 62.2 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 112.783 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.18 -0.33 33.36 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.074 1.75 . . . . 0.0 111.618 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.61 141.22 13.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -86.61 128.51 35.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -107.57 -0.36 22.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.308 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -106.56 -12.23 15.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.28 1.032 . . . . 0.0 111.446 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.6 p -73.97 -35.92 64.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 111.535 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 40.47 87.98 0.1 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.164 2.585 . . . . 0.0 112.347 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.1 143.42 42.21 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.03 1.046 . . . . 0.0 114.148 10.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -62.58 131.55 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.9 t -94.01 112.31 24.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.3 pt -97.61 -8.89 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.179 0.991 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.23 176.33 48.01 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.867 1.212 . . . . 0.0 112.827 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -101.95 121.2 41.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -82.89 112.48 19.72 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 103.115 -2.92 . . . . 0.0 103.115 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.61 51.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.985 1.721 . . . . 0.0 112.93 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -120.87 113.72 20.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -85.64 149.63 25.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -112.36 130.02 56.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.86 90.58 5.3 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 102' ' ' LEU . 26.3 mt -88.68 122.7 32.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.807 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -84.61 136.4 33.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.33 140.81 57.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.47 -56.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -91.92 123.11 35.05 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.54 -170.89 40.73 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.587 0.613 . . . . 0.0 114.482 -169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -48.98 -32.91 9.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.799 1.64 . . . . 0.0 112.88 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -26.1 66.42 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.61 -25.21 13.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.332 1.453 . . . . 0.0 111.306 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 mt -56.05 139.8 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -141.57 85.92 1.98 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 122.252 1.025 . . . . 0.0 108.664 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 mtt -60.25 -12.84 9.9 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.968 0.907 . . . . 0.0 112.791 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -110.1 30.59 6.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.968 1.307 . . . . 0.0 110.304 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -76.39 -31.14 57.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.174 0.59 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -80.38 168.49 18.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.987 0.898 . . . . 0.0 109.319 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m -81.47 -28.37 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.627 1.571 . . . . 0.0 111.14 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -131.15 64.15 72.63 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.393 1.877 . . . . 0.0 108.21 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.34 176.27 5.84 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.71 2.94 . . . . 0.0 111.009 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -114.54 -22.23 9.9 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.185 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -123.09 145.07 48.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 121.404 1.911 . . . . 0.0 111.441 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.54 -40.0 6.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.132 1.373 . . . . 0.0 110.082 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.01 170.92 13.77 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.25 0.929 . . . . 0.0 111.871 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 20.1 t-105 -170.21 -125.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.973 1.709 . . . . 0.0 108.536 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 6.9 ptt180 -153.65 158.17 40.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.543 2.737 . . . . 0.0 106.589 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -80.33 141.38 35.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.004 0.82 . . . . 0.0 109.151 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.56 162.56 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.11 0.964 . . . . 0.0 111.048 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -51.79 151.12 3.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.814 0.846 . . . . 0.0 110.682 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.58 -40.92 69.28 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -96.47 6.55 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.45 0.7 . . . . 0.0 112.682 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.92 -46.44 15.43 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.339 -1.315 . . . . 0.0 111.633 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.94 -36.03 85.11 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.081 1.854 . . . . 0.0 113.685 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.46 -24.85 33.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 O-C-N 121.15 -0.969 . . . . 0.0 111.435 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.55 -17.25 34.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.396 0.998 . . . . 0.0 111.516 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -83.35 -30.72 27.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.55 1.068 . . . . 0.0 111.602 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.89 162.92 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.56 148.82 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.468 0.707 . . . . 0.0 111.427 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 m -56.93 -29.97 63.58 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.694 1.597 . . . . 0.0 114.848 -169.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -79.28 -43.0 24.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.444 1.02 . . . . 0.0 110.478 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -74.46 -27.37 60.56 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 111.157 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -42.07 -46.62 4.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.415 1.486 . . . . 0.0 111.252 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.39 -43.6 85.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.835 0.743 . . . . 0.0 111.396 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.02 -34.74 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.912 -0.493 . . . . 0.0 110.264 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.81 -31.75 70.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.186 -0.946 . . . . 0.0 110.053 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -58.5 -36.14 73.32 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.632 -1.292 . . . . 0.0 111.058 169.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -63.64 -44.36 94.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.211 1.368 . . . . 0.0 109.368 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.68 -45.87 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.096 0.862 . . . . 0.0 109.764 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.02 -45.3 94.21 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.769 -0.582 . . . . 0.0 109.633 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.85 -40.27 96.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.783 1.233 . . . . 0.0 111.034 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.48 -40.02 77.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.745 1.218 . . . . 0.0 110.601 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.57 -10.32 22.2 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.817 1.044 . . . . 0.0 113.817 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.61 -57.34 10.33 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.768 1.167 . . . . 0.0 111.131 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -80.36 15.84 1.48 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.9 t -110.37 -28.07 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.34 -65.94 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.0 109.146 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.4 mtp -59.26 -29.3 67.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.435 1.094 . . . . 0.0 111.231 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -58.37 -27.79 64.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.135 0.974 . . . . 0.0 113.32 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.54 -40.07 92.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.67 0.788 . . . . 0.0 109.479 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -83.91 -31.07 25.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.276 1.03 . . . . 0.0 110.406 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.147 1.379 . . . . 0.0 111.347 178.327 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.91 152.11 28.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.091 0.957 . . . . 0.0 109.644 171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.49 -30.88 68.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.35 7.7 31.19 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.773 0.829 . . . . 0.0 112.581 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 21.27 30.66 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.283 1.42 . . . . 0.0 113.636 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -101.27 144.68 29.82 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 119.038 1.419 . . . . 0.0 110.191 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.36 123.05 65.13 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-O 116.569 -1.682 . . . . 0.0 106.921 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -69.14 126.98 14.4 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.07 1.846 . . . . 0.0 111.03 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -139.86 159.59 41.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.164 1.786 . . . . 0.0 110.335 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.95 140.71 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 106.783 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.12 123.11 5.55 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.71 112.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.92 83.81 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.13 137.6 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -121.16 124.65 45.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 169.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.51 125.2 27.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 169.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -48.32 -18.62 0.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 116.025 -1.94 . . . . 0.0 115.73 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.3 7.06 1.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.619 1.554 . . . . 0.0 112.642 170.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.94 16.64 32.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.493 1.52 . . . . 0.0 113.702 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -121.18 163.49 18.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.136 0.974 . . . . 0.0 108.509 -168.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -105.99 161.66 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -167.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.53 129.92 42.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.23 1.812 . . . . 0.0 111.054 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -161.52 131.17 4.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.25 145.05 31.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -71.88 127.26 31.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -71.93 129.02 37.57 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -38.81 121.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.767 2.427 . . . . 0.0 111.112 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -1.64 21.43 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.567 1.08 . . . . 0.0 115.372 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -100.18 -24.3 14.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.314 1.557 . . . . 0.0 112.435 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 54.61 35.61 24.04 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.549 1.14 . . . . 0.0 112.142 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -146.98 -179.49 6.85 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.369 1.867 . . . . 0.0 107.348 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -117.08 156.46 27.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.236 0.925 . . . . 0.0 111.565 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -151.76 165.49 34.27 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.209 1.404 . . . . 0.0 109.051 -173.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -109.17 160.86 25.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.513 1.125 . . . . 0.0 112.147 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -74.4 69.84 4.94 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.774 2.983 . . . . 0.0 115.011 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -84.6 145.7 27.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.38 149.79 19.38 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.283 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.89 143.18 29.65 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.404 1.002 . . . . 0.0 111.915 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.91 137.23 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.39 146.07 49.79 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 118.777 0.717 . . . . 0.0 109.509 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -53.26 119.34 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.226 1.951 . . . . 0.0 113.731 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.36 7.56 87.45 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.002 1.286 . . . . 0.0 113.262 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.51 -40.15 64.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 112.444 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . 0.292 20.6 m 68.05 152.06 0.08 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.459 1.504 . . . . 0.0 112.543 -170.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.22 -45.03 72.18 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 125.055 1.342 . . . . 0.0 113.347 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.8 4.02 15.1 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.222 0.919 . . . . 0.0 111.904 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.09 -48.96 3.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.44 91.58 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.695 0.798 . . . . 0.0 112.136 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -58.85 -43.39 90.77 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.213 1.005 . . . . 0.0 109.371 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.03 -20.37 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -76.34 -47.68 22.64 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 109.279 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.1 77.71 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.217 0.917 . . . . 0.0 111.028 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.1 tp -48.06 -45.87 32.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 110.754 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -49.43 18.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.475 1.51 . . . . 0.0 111.689 176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.12 -37.31 87.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.804 1.184 . . . . 0.0 110.34 -170.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -94.31 -43.44 8.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.048 1.339 . . . . 0.0 111.006 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.99 -7.94 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.826 0.85 . . . . 0.0 112.451 -169.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.13 16.83 71.32 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 120.378 -1.451 . . . . 0.0 113.731 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.3 mt -95.26 152.07 18.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m -120.14 -176.69 3.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.883 0.873 . . . . 0.0 109.757 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.19 50.97 0.51 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.142 1.777 . . . . 0.0 112.684 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -164.54 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.666 1.586 . . . . 0.0 112.022 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.39 -6.54 58.9 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.256 1.022 . . . . 0.0 113.723 -168.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' A' ' 102' ' ' LEU . 33.5 m -147.29 170.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 123.875 0.87 . . . . 0.0 109.431 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -141.91 120.48 12.51 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -170.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.42 127.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.38 -35.13 6.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.579 0.752 . . . . 0.0 110.985 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.04 166.5 33.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.219 1.408 . . . . 0.0 108.627 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 163.69 34.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.145 0.978 . . . . 0.0 108.793 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -62.95 150.46 42.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.921 0.782 . . . . 0.0 110.836 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.726 0.411 . . . . 0.0 111.182 -171.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.9 173.69 13.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.496 1.918 . . . . 0.0 107.675 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.417 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 93.5 m95 -58.46 121.07 9.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 110.821 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.86 154.41 33.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 140.34 23.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.25 156.58 46.97 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -95.23 153.28 17.74 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.261 0.553 . . . . 0.0 110.91 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -84.16 150.23 57.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -65.69 156.88 61.61 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.685 2.257 . . . . 0.0 109.282 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -59.39 -30.03 68.14 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -74.85 -20.16 59.87 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.962 0.905 . . . . 0.0 113.238 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 tp -105.35 -22.13 13.1 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.704 1.202 . . . . 0.0 111.4 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.16 132.73 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 168.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -89.78 131.08 35.92 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -100.07 3.06 43.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.839 1.255 . . . . 0.0 109.453 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -98.31 -16.68 19.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 110.869 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -74.66 -36.06 62.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.384 -171.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 38.21 88.31 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 127.867 2.467 . . . . 0.0 112.111 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.77 141.81 21.28 Favored 'Cis proline' 0 C--N 1.356 0.932 0 N-CA-C 115.171 1.181 . . . . 0.0 115.171 10.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.45 124.5 8.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.62 92.62 9.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.5 pt -88.64 -12.01 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.912 -1.042 . . . . 0.0 112.025 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.85 43.4 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 120.483 1.492 . . . . 0.0 113.782 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 114.14 25.19 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 66.0 tttt -86.86 125.03 33.72 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 169.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.91 137.89 33.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -106.85 129.16 54.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -103.28 133.55 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.49 130.37 55.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.68 105.52 17.42 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.6 mm? -103.5 123.62 47.23 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.051 0.94 . . . . 0.0 109.225 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -80.49 138.22 36.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 106.95 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.92 -40.39 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.9 p -92.21 -114.51 0.09 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.9 -169.64 37.36 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.802 0.728 . . . . 0.0 111.911 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.84 -39.1 0.48 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.603 1.961 . . . . 0.0 113.492 171.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.63 69.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.2 -23.19 12.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.045 1.338 . . . . 0.0 111.785 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.06 131.87 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -143.99 77.72 1.56 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 122.348 1.07 . . . . 0.0 109.893 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.7 mtt -64.25 14.08 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.572 1.549 . . . . 0.0 113.244 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -131.29 21.09 4.8 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.648 1.567 . . . . 0.0 111.221 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 t -75.65 -28.04 58.59 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.229 1.012 . . . . 0.0 111.057 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -5.86 52.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.971 1.708 . . . . 0.0 114.519 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.2 m 68.13 -34.22 0.25 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.879 2.872 . . . . 0.0 114.153 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 p -124.04 72.08 54.25 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 169.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.49 -165.6 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.899 3.066 . . . . 0.0 112.027 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -120.48 -12.12 9.0 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.487 1.115 . . . . 0.0 111.893 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -134.59 152.16 51.58 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 120.913 1.688 . . . . 0.0 112.23 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.8 -35.25 5.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.927 1.691 . . . . 0.0 111.766 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -173.09 152.18 15.45 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -94.93 163.14 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.104 1.362 . . . . 0.0 111.354 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -152.92 120.23 5.9 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.889 1.676 . . . . 0.0 106.691 169.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -81.43 70.74 8.35 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.345 1.43 . . . . 0.0 109.247 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.29 156.02 5.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.242 1.417 . . . . 0.0 110.764 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -52.48 153.54 2.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.691 0.796 . . . . 0.0 111.909 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -57.02 152.31 13.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 m95 67.95 -28.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.449 1.9 . . . . 0.0 115.806 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.68 -47.0 98.07 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 121.155 1.798 . . . . 0.0 112.169 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.0 -18.05 62.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.592 1.604 . . . . 0.0 115.507 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.4 t -57.28 -38.11 60.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 120.08 1.309 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -92.64 -19.93 21.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.653 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -72.96 -21.28 60.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 121.297 1.862 . . . . 0.0 111.893 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.7 m -71.82 162.01 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 119.419 1.009 . . . . 0.0 111.034 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -60.6 151.67 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.133 0.973 . . . . 0.0 110.042 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 m -61.63 -29.27 69.95 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -73.87 -26.63 60.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.559 1.072 . . . . 0.0 111.508 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.98 -29.2 25.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.718 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -48.51 -52.13 23.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.566 1.076 . . . . 0.0 112.521 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.2 -41.44 97.05 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.316 0.507 . . . . 0.0 111.221 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -34.75 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.65 -32.8 74.36 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.03 -1.043 . . . . 0.0 110.643 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -57.28 -42.32 81.42 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.061 -1.024 . . . . 0.0 111.07 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.297 18.4 ptp180 -74.64 -34.18 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.908 1.231 . . . . 0.0 110.37 -176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.21 -47.69 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 109.253 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.62 -41.5 88.25 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.583 -0.698 . . . . 0.0 110.953 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -44.17 81.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 111.324 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.09 -27.65 69.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.727 0.411 . . . . 0.0 112.101 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -113.78 -3.97 13.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.57 69.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.71 1.141 . . . . 0.0 111.146 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 m -64.43 -25.79 68.16 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.01 -0.431 . . . . 0.0 111.616 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.17 -40.69 44.16 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.86 -47.04 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.658 0.783 . . . . 0.0 108.978 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.84 -15.8 63.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.929 0.786 . . . . 0.0 111.856 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.3 m -53.34 -38.84 63.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.758 1.163 . . . . 0.0 111.543 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.39 -30.48 71.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -94.44 -21.37 18.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.166 0.986 . . . . 0.0 111.857 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.45 1.1 . . . . 0.0 110.287 170.001 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.7 mm . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.21 148.06 52.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.813 1.245 . . . . 0.0 108.445 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.53 -28.29 53.84 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -79.11 -1.54 36.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.02 30.19 9.08 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.794 1.664 . . . . 0.0 111.825 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 23.2 m-85 -115.19 138.45 50.91 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.618 1.709 . . . . 0.0 110.379 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -81.49 128.44 69.74 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 127.63 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.907 1.738 . . . . 0.0 109.267 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -137.69 163.42 31.34 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.235 1.414 . . . . 0.0 109.963 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.92 135.4 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.709 2.004 . . . . 0.0 105.95 169.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.54 145.59 17.31 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.47 126.03 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 118.805 1.303 . . . . 0.0 107.799 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.65 86.59 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.13 130.45 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.38 121.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 169.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -97.6 40.85 1.14 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.221 1.008 . . . . 0.0 109.327 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 59.8 -70.42 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 130.5 3.52 . . . . 0.0 111.89 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -90.33 -15.58 30.88 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.225 0.953 . . . . 0.0 112.886 -169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.46 42.97 1.49 Allowed Glycine 0 C--N 1.336 0.572 0 CA-C-N 118.366 0.53 . . . . 0.0 113.469 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 57.32 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.168 1.787 . . . . 0.0 114.27 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.69 162.85 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -63.45 134.67 56.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.675 1.99 . . . . 0.0 110.347 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -159.64 134.9 8.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 167.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.2 145.0 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.187 0.595 . . . . 0.0 109.51 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.98 139.78 41.7 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -94.04 125.73 38.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -43.12 131.21 4.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.39 2.676 . . . . 0.0 110.992 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.84 -29.36 1.08 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.991 1.281 . . . . 0.0 113.817 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.35 -36.29 29.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.345 1.058 . . . . 0.0 110.004 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 57.19 31.05 19.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.899 1.68 . . . . 0.0 112.789 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p -150.32 175.28 11.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.089 1.756 . . . . 0.0 107.68 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -76.4 162.08 28.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.866 0.866 . . . . 0.0 112.02 -169.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -144.85 134.55 23.49 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.372 0.606 . . . . 0.0 110.984 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.09 121.93 59.2 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.844 2.057 . . . . 0.0 108.216 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -59.63 135.77 66.42 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.333 2.022 . . . . 0.0 112.689 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.52 145.26 7.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.004 1.321 . . . . 0.0 109.725 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.38 136.11 5.26 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.17 146.49 46.2 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -76.08 129.65 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.08 128.4 87.87 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.737 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -55.57 119.12 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.95 1.767 . . . . 0.0 113.177 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.52 84.21 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.01 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -101.53 119.04 38.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.41 165.35 23.96 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.299 0.639 . . . . 0.0 111.574 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.92 -45.93 60.6 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 125.258 1.423 . . . . 0.0 111.45 -172.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.67 25.41 0.91 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.508 -0.745 . . . . 0.0 110.728 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.06 -46.1 0.78 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.527 1.931 . . . . 0.0 107.091 170.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.83 76.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.882 1.273 . . . . 0.0 111.5 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.37 -44.03 84.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.646 0.778 . . . . 0.0 109.033 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -72.45 -28.61 63.04 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.512 -0.743 . . . . 0.0 112.01 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.76 -46.79 88.08 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.875 -1.14 . . . . 0.0 108.534 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.87 76.43 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.576 -0.703 . . . . 0.0 112.05 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.98 -41.36 78.23 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.36 -49.4 34.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.386 1.475 . . . . 0.0 111.609 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.78 -34.49 75.63 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.208 1.367 . . . . 0.0 112.579 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.9 -57.05 2.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 110.902 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.19 -23.98 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.667 1.187 . . . . 0.0 111.504 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 62.12 5.08 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -135.02 157.75 46.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.875 2.07 . . . . 0.0 106.776 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -121.96 -177.5 3.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.948 0.899 . . . . 0.0 110.811 -169.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -69.51 43.11 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.251 2.621 . . . . 0.0 113.127 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -166.55 -20.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.14 0.976 . . . . 0.0 113.202 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.292 0.496 . . . . 0.0 112.028 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 102' ' ' LEU . 29.1 m -148.41 168.45 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.448 1.099 . . . . 0.0 109.99 -169.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.15 121.68 15.16 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.847 2.059 . . . . 0.0 105.995 -171.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -73.88 129.58 36.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 -32.57 6.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.541 0.737 . . . . 0.0 111.554 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.71 169.86 23.68 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.33 1.052 . . . . 0.0 109.636 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -146.99 160.2 42.65 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.745 1.218 . . . . 0.0 109.592 171.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -65.29 143.95 57.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 109.435 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -66.61 -27.35 67.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -153.52 168.81 24.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.23 1.412 . . . . 0.0 109.459 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -63.25 121.01 12.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.785 0.834 . . . . 0.0 109.471 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.48 153.92 33.04 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 150.19 28.88 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.919 -0.488 . . . . 0.0 110.705 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.19 156.46 43.87 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.972 1.709 . . . . 0.0 106.626 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -90.98 145.71 24.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.889 0.313 . . . . 0.0 110.461 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.7 mt -73.4 141.1 79.83 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -60.87 158.05 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.137 1.892 . . . . 0.0 109.42 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -49.31 -48.01 46.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.17 -14.2 60.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.496 1.118 . . . . 0.0 113.091 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -112.85 -1.41 14.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.099 1.76 . . . . 0.0 111.353 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.5 137.24 23.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-N 120.813 1.642 . . . . 0.0 106.673 169.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -93.37 113.67 25.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.05 -9.13 26.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.101 0.96 . . . . 0.0 111.188 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.06 -25.69 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.039 0.936 . . . . 0.0 110.103 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.4 p -71.57 134.14 46.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -120.17 127.19 26.46 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -58.99 154.93 41.42 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.481 1.207 . . . . 0.0 110.907 -10.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -47.58 129.26 3.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.648 1.579 . . . . 0.0 107.959 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.83 113.85 27.68 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.05 -2.75 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 116.52 -1.705 . . . . 0.0 112.528 -170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -171.39 165.53 38.55 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 122.35 2.341 . . . . 0.0 113.066 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -96.48 120.34 36.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -85.6 120.91 27.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 168.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.26 133.52 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 120.8 1.636 . . . . 0.0 113.376 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -100.79 141.89 33.03 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -112.16 137.71 49.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -110.45 133.69 53.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 tt -88.54 123.35 32.96 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 170.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.4 mm? -117.09 123.99 48.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -81.6 134.04 35.45 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.84 106.66 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.54 -31.04 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.2 p -82.7 -114.16 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.048 0.539 . . . . 0.0 110.07 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.96 166.26 29.55 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.048 1.309 . . . . 0.0 110.445 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.43 -29.03 33.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.823 0.849 . . . . 0.0 112.881 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.25 63.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.271 0.629 . . . . 0.0 112.391 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.38 -23.53 11.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.959 1.703 . . . . 0.0 110.838 -173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -56.47 122.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -89.97 -52.09 5.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.3 mtt 59.78 5.46 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.795 1.638 . . . . 0.0 115.215 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 30.23 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.093 1.77 . . . . 0.0 111.621 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -43.72 69.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.949 1.699 . . . . 0.0 112.079 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.6 -4.47 57.72 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -168.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 66.31 -38.12 0.29 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.774 2.429 . . . . 0.0 113.03 -169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 p -123.32 75.06 52.01 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.871 2.068 . . . . 0.0 105.59 169.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.48 -179.3 4.33 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.182 3.255 . . . . 0.0 111.077 -172.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -100.71 -49.97 4.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.111 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -87.97 154.95 20.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 120.538 1.517 . . . . 0.0 111.521 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -133.47 -27.05 1.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.474 1.51 . . . . 0.0 111.761 -172.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.87 144.21 10.28 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -93.4 154.66 17.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.788 1.235 . . . . 0.0 110.825 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -155.55 109.14 2.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.044 1.338 . . . . 0.0 108.398 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -73.62 137.12 44.02 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.275 -0.891 . . . . 0.0 108.607 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.9 161.11 18.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.808 1.643 . . . . 0.0 108.623 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -53.65 154.43 3.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.31 1.044 . . . . 0.0 110.582 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -56.27 -37.89 70.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.946 0.899 . . . . 0.0 113.263 -168.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -96.73 -3.02 43.23 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.506 -0.746 . . . . 0.0 112.826 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -61.02 -47.64 94.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.734 -1.126 . . . . 0.0 111.709 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.82 -35.71 98.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.593 1.605 . . . . 0.0 112.462 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.63 -33.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 109.877 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -17.67 33.52 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 121.501 -0.75 . . . . 0.0 109.289 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -93.37 -22.91 18.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.135 0.272 . . . . 0.0 111.495 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.75 163.3 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.313 -0.867 . . . . 0.0 112.356 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 m -65.71 153.44 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.268 1.427 . . . . 0.0 110.648 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -57.66 -33.91 68.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.416 1.486 . . . . 0.0 114.361 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -74.76 -26.97 60.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.95 0.796 . . . . 0.0 111.497 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -86.82 -33.35 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -47.23 -48.65 24.17 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.249 1.42 . . . . 0.0 112.288 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.88 -35.22 79.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.735 0.243 . . . . 0.0 111.545 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.2 t -83.47 -33.37 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.227 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.01 -32.89 74.59 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.933 1.242 . . . . 0.0 110.408 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -54.28 -41.98 69.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.03 -1.043 . . . . 0.0 111.416 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -66.48 -44.41 82.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.73 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.64 -49.77 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.3 mmt -64.96 -44.43 89.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.609 0.641 . . . . 0.0 110.325 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -62.07 -37.11 83.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.046 0.839 . . . . 0.0 111.124 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.28 -20.99 58.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.432 0.693 . . . . 0.0 111.532 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.92 -9.03 3.92 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.2 63.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.704 1.593 . . . . 0.0 112.45 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -66.66 -17.98 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.19 -33.18 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.018 1.281 . . . . 0.0 109.827 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.25 -29.91 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.709 -1.244 . . . . 0.0 109.659 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mmt -65.63 -27.14 68.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.456 1.025 . . . . 0.0 110.64 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.4 m -56.07 -39.62 72.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.642 1.11 . . . . 0.0 111.023 172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.0 -52.4 9.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.953 0.901 . . . . 0.0 108.704 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -77.56 -7.64 56.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 CA--C 1.539 0.52 0 C-N-CA 124.008 0.923 . . . . 0.0 110.546 169.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.35 36.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.452 2.301 . . . . 0.0 111.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.96 -32.93 0.09 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 131.516 3.927 . . . . 0.0 116.66 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.06 13.77 24.09 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.448 1.099 . . . . 0.0 113.153 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 12.33 56.77 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.396 1.474 . . . . 0.0 113.1 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -102.25 138.88 38.6 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.903 1.351 . . . . 0.0 110.24 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -98.66 115.91 65.59 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.041 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.18 123.46 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.387 2.058 . . . . 0.0 110.863 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 95' ' ' GLN . 3.4 p30 -144.19 163.73 32.77 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.616 1.566 . . . . 0.0 108.593 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.24 136.81 59.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 130.82 10.26 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.5 112.88 26.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.32 85.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.31 137.62 24.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -125.11 121.69 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 168.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.95 48.0 1.58 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.496 -0.752 . . . . 0.0 109.169 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 18.0 ptt-85 38.13 23.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.241 3.417 . . . . 0.0 116.894 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.85 7.27 15.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.521 1.128 . . . . 0.0 111.925 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.7 71.08 Favored Glycine 0 N--CA 1.477 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 112.422 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -125.56 150.34 47.56 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.71 1.604 . . . . 0.0 107.049 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.95 165.06 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tpt -57.49 129.32 41.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.589 1.955 . . . . 0.0 111.133 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 7.9 t-105 -160.96 115.89 2.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.51 149.7 50.71 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -76.87 136.63 38.88 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.555 1.542 . . . . 0.0 108.203 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -90.12 128.31 36.3 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.925 0.49 . . . . 0.0 110.342 -169.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.47 135.45 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.096 1.758 . . . . 0.0 110.665 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.79 6.11 76.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.944 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -136.24 -38.89 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.525 1.53 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.28 17.1 m80 60.32 38.08 19.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.762 2.025 . . . . 0.0 112.666 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -133.45 161.01 35.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.206 2.202 . . . . 0.0 106.546 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -76.34 148.98 37.09 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.326 -0.859 . . . . 0.0 112.621 -171.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -148.54 160.72 42.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.515 1.15 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.79 167.15 39.13 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 128.18 2.592 . . . . 0.0 109.072 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.25 -110.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 124.167 3.244 . . . . 0.0 110.721 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 65.82 99.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.597 1.959 . . . . 0.0 112.046 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.79 126.01 6.05 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 144.46 22.18 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.003 1.763 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.32 137.0 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.02 135.87 62.47 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.35 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -58.91 117.53 4.28 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.423 1.415 . . . . 0.0 112.452 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.65 80.09 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.096 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 120.28 35.87 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.25 165.67 21.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.908 0.861 . . . . 0.0 111.455 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.13 -45.05 16.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.728 2.011 . . . . 0.0 115.224 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -44.6 21.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -55.06 -42.98 73.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.89 0.876 . . . . 0.0 110.056 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.09 66.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 112.078 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -62.75 -42.61 99.76 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 81.5 m-85 -68.7 -30.57 69.25 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.179 -1.576 . . . . 0.0 112.78 173.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -58.24 -47.02 84.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.251 0.932 . . . . 0.0 109.131 172.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.89 -44.02 86.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.316 0.646 . . . . 0.0 110.708 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.22 -44.18 64.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 111.034 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -48.28 34.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.75 -1.119 . . . . 0.0 111.809 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.65 -28.19 65.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -93.06 -60.22 1.85 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.095 0.958 . . . . 0.0 110.274 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.66 -17.61 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.769 0.827 . . . . 0.0 111.767 -169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 56.46 23.66 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.9 mt -132.13 157.24 44.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.351 2.261 . . . . 0.0 105.972 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -121.09 -172.93 2.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.793 0.724 . . . . 0.0 110.103 -170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 24.1 mtt180 -73.23 42.05 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.54 1.936 . . . . 0.0 113.271 -171.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -161.75 -23.62 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.88 0.872 . . . . 0.0 112.994 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.82 0.44 52.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.051 0.387 . . . . 0.0 111.86 -168.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HD12 ' A' ' 102' ' ' LEU . 34.9 m -146.7 165.24 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.782 1.233 . . . . 0.0 109.136 -171.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -136.64 121.47 18.67 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.357 1.863 . . . . 0.0 106.232 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.02 128.32 37.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.3 -37.87 6.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.43 168.98 25.78 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.154 0.982 . . . . 0.0 108.627 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -144.89 161.87 38.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -61.69 139.55 58.29 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -65.68 -25.68 67.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.35 175.07 12.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 108.542 169.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -71.61 113.87 9.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.296 0.638 . . . . 0.0 109.912 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.88 155.22 40.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 148.42 28.61 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -140.29 157.23 45.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.753 0.821 . . . . 0.0 108.805 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -94.14 126.87 39.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -68.53 148.04 98.1 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 158.69 56.83 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.641 2.227 . . . . 0.0 109.666 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -60.56 -33.7 73.07 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -77.99 -24.27 48.06 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.048 0.939 . . . . 0.0 113.07 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 tp -90.98 -24.49 20.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.213 0.461 . . . . 0.0 110.629 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.77 137.63 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -41.96 34.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.027 0.531 . . . . 0.0 111.987 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 21.8 m95 59.11 4.19 0.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.036 2.534 . . . . 0.0 113.811 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -99.6 -25.56 14.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -72.84 151.54 41.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 109.324 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -132.93 116.0 14.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.671 1.188 . . . . 0.0 107.941 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -58.35 155.44 37.11 Favored 'Cis proline' 0 CA--C 1.538 0.694 0 CA-C-N 120.177 1.099 . . . . 0.0 111.483 -10.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.71 131.85 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.0 t -91.88 106.83 18.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.3 pt -97.32 -8.35 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.505 0.722 . . . . 0.0 112.173 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.73 169.64 42.41 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.396 0.998 . . . . 0.0 111.764 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 10' ' ' ASN . 11.1 mp0 -110.05 119.33 38.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -80.95 125.49 30.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.75 142.56 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -116.98 128.68 55.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -101.51 147.35 26.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.74 129.45 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -80.14 115.11 19.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -112.54 125.47 54.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.929 0.892 . . . . 0.0 108.838 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.02 134.51 34.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -73.17 122.11 21.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.65 -50.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -128.31 135.44 49.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.15 -155.12 13.52 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 t70 64.55 -61.47 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.149 2.98 . . . . 0.0 111.792 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.26 -35.87 12.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 0.0 110.773 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -89.79 -12.72 38.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.841 0.856 . . . . 0.0 111.598 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.61 116.2 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -97.27 -35.04 10.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.498 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.0 mtt 58.91 -38.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 130.023 3.329 . . . . 0.0 115.532 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -102.56 33.63 3.1 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.898 1.679 . . . . 0.0 110.889 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -69.61 -51.42 35.2 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -74.7 145.2 43.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 m -70.08 -30.28 67.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.217 . . . . 0.0 111.81 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 p -127.23 75.14 77.14 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.177 1.391 . . . . 0.0 107.887 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.52 -175.1 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.709 2.939 . . . . 0.0 110.416 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.72 -29.86 11.25 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 116.695 -1.621 . . . . 0.0 113.366 171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 159.0 17.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 122.051 2.205 . . . . 0.0 112.271 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.91 -6.12 0.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.063 1.345 . . . . 0.0 113.542 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.6 156.88 28.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -119.05 151.65 37.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 111.42 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -145.01 119.49 9.67 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.888 1.675 . . . . 0.0 106.761 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -78.73 140.48 38.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.614 1.097 . . . . 0.0 108.96 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.71 162.43 32.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.799 0.84 . . . . 0.0 110.214 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.2 m -52.21 148.49 6.36 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.012 0.925 . . . . 0.0 109.865 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.45 -38.37 63.5 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -99.58 3.28 45.31 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.27 -44.6 88.98 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.914 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.82 -28.02 85.75 Favored 'Trans proline' 0 C--N 1.352 0.749 0 CA-C-N 122.005 1.752 . . . . 0.0 112.405 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.41 -10.52 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.901 1.28 . . . . 0.0 112.098 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -106.92 -32.12 8.04 Favored 'General case' 0 CA--C 1.526 0.057 0 O-C-N 120.736 -1.228 . . . . 0.0 110.328 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -79.93 -26.69 40.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.031 0.832 . . . . 0.0 112.503 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.05 160.0 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.088 0.858 . . . . 0.0 110.008 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.74 141.45 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.75 1.22 . . . . 0.0 111.623 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 m -56.78 -35.52 68.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.518 1.527 . . . . 0.0 113.867 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -67.97 -33.74 75.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.756 0.707 . . . . 0.0 110.765 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -88.54 -25.12 22.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.92 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -43.48 -46.49 6.87 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 119.935 1.243 . . . . 0.0 112.695 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.58 -49.44 73.36 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.905 0.775 . . . . 0.0 111.49 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.29 -31.3 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 122.002 -0.436 . . . . 0.0 110.3 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -33.54 75.92 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.554 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -64.24 -35.0 79.41 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 120.725 -1.235 . . . . 0.0 110.479 171.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -60.91 -46.45 90.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.6 1.546 . . . . 0.0 109.804 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.92 -48.22 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 118.764 0.711 . . . . 0.0 109.638 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.7 -36.77 84.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.546 -0.721 . . . . 0.0 110.825 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -65.61 -35.66 81.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.673 1.124 . . . . 0.0 110.72 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.78 -25.32 68.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.235 0.614 . . . . 0.0 111.181 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -118.66 -17.66 9.19 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -42.68 -65.18 0.5 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 -169.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -63.81 -25.81 68.34 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.77 -27.13 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.442 -0.786 . . . . 0.0 109.169 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.99 -41.2 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.83 0.852 . . . . 0.0 109.578 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.4 mtt -68.85 -33.31 73.6 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.028 -170.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.3 m -57.34 -31.55 65.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.849 0.75 . . . . 0.0 112.248 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.5 -30.95 71.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.111 0.414 . . . . 0.0 110.328 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -95.5 -44.06 7.69 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.21 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 CA--C 1.543 0.692 0 C-N-CA 123.78 0.832 . . . . 0.0 112.131 -177.222 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.97 150.41 45.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.361 1.065 . . . . 0.0 110.013 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.28 -28.16 67.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.56 0.1 35.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.348 0.522 . . . . 0.0 112.167 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.76 32.09 8.27 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.237 1.875 . . . . 0.0 112.06 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 25.3 m-85 -109.76 133.74 52.8 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.556 1.178 . . . . 0.0 110.176 -176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -80.85 129.28 68.49 Favored Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.4 121.65 6.94 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.196 1.931 . . . . 0.0 109.32 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.0 165.42 25.37 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.603 1.161 . . . . 0.0 109.787 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.33 146.22 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 127.051 2.14 . . . . 0.0 106.564 169.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.68 146.63 18.08 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.13 135.5 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.43 89.88 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -68.11 129.52 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.96 137.57 51.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 168.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -104.58 27.2 8.15 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 53.62 19.39 1.76 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.755 1.622 . . . . 0.0 115.179 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -118.33 5.86 11.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 110.707 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.24 80.78 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 120.848 -1.158 . . . . 0.0 112.312 -169.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -121.58 142.99 49.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.734 1.214 . . . . 0.0 107.727 -171.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.21 163.09 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.8 tpt -55.43 136.9 49.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.483 1.913 . . . . 0.0 111.808 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.41 136.5 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.84 144.89 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.47 140.22 48.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.51 119.7 21.46 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -49.94 132.57 22.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.771 2.029 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.3 -31.53 1.6 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.844 1.212 . . . . 0.0 114.027 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -87.07 -30.9 20.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.417 1.109 . . . . 0.0 110.706 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 58.61 35.0 24.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 p -145.19 169.92 17.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.594 1.958 . . . . 0.0 107.009 169.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.57 158.04 24.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.962 1.256 . . . . 0.0 111.84 -170.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -149.52 148.73 29.74 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.155 1.782 . . . . 0.0 107.489 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -80.57 158.96 70.52 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.607 0.639 . . . . 0.0 111.518 171.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -64.89 141.94 73.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.559 2.173 . . . . 0.0 112.456 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -167.88 142.49 3.61 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.833 1.653 . . . . 0.0 108.944 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.24 143.5 10.13 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.57 152.62 52.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.554 1.073 . . . . 0.0 110.698 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mt -82.01 137.19 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -80.5 137.94 51.55 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.747 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.02 117.52 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.408 1.405 . . . . 0.0 113.037 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.92 1.67 88.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.003 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.55 120.8 31.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.611 1.206 . . . . 0.0 107.799 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -71.24 162.6 29.16 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.143 0.577 . . . . 0.0 111.241 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.23 -44.96 16.73 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 126.936 2.094 . . . . 0.0 113.447 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.92 -49.22 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.13 -39.8 83.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.524 0.73 . . . . 0.0 110.387 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -35.51 79.99 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.195 0.998 . . . . 0.0 111.974 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -58.64 -46.91 86.1 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -66.38 -30.05 70.35 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.717 1.144 . . . . 0.0 112.659 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -59.37 -46.72 87.88 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.075 -1.016 . . . . 0.0 108.736 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.908 0.483 . . . . 0.0 111.566 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 tp -57.74 -39.63 77.78 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.891 -1.131 . . . . 0.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -72.93 -50.44 23.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.211 1.005 . . . . 0.0 111.297 174.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.59 -30.06 68.73 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.469 1.486 . . . . 0.0 112.075 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -97.67 -47.5 5.59 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.033 0.933 . . . . 0.0 111.576 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.23 -19.78 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.375 0.67 . . . . 0.0 110.975 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.21 35.15 82.41 Favored Glycine 0 CA--C 1.526 0.78 0 O-C-N 121.191 -0.943 . . . . 0.0 110.886 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.01 154.28 27.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.23 1.412 . . . . 0.0 108.296 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -116.52 -175.13 2.7 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.896 0.878 . . . . 0.0 110.365 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -73.74 41.14 0.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.286 1.834 . . . . 0.0 113.294 -169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -163.1 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.627 1.171 . . . . 0.0 112.919 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.26 -0.94 51.81 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.89 0.476 . . . . 0.0 111.809 -169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -148.5 171.38 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.949 1.7 . . . . 0.0 108.63 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -140.8 123.91 16.51 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.75 131.24 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 120.485 1.493 . . . . 0.0 107.932 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.63 -36.73 6.36 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.097 0.559 . . . . 0.0 111.324 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 171.45 19.92 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.465 1.106 . . . . 0.0 109.35 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -144.67 162.98 35.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -65.85 138.83 58.15 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -67.67 -19.7 65.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -146.56 170.38 17.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.222 1.809 . . . . 0.0 108.525 170.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -75.58 125.14 28.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.05 152.79 44.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 140.56 21.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -143.82 161.24 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.065 0.946 . . . . 0.0 108.486 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -101.23 133.0 46.46 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 107.571 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.56 143.06 81.75 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 108.452 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.88 155.83 21.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 0.0 110.471 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.82 -45.23 90.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.794 -1.192 . . . . 0.0 113.113 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.56 -12.73 55.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 112.596 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 0.16 26.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.031 1.732 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.15 135.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -90.96 114.88 27.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -100.19 -3.0 32.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.938 0.774 . . . . 0.0 111.694 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -89.43 -18.24 27.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.764 0.825 . . . . 0.0 110.554 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.49 154.57 21.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.537 1.535 . . . . 0.0 108.212 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -134.87 118.55 13.3 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.506 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.75 153.57 34.17 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 120.095 1.069 . . . . 0.0 110.985 -10.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -54.68 130.26 16.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.4 t -93.09 127.15 38.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.253 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.14 -5.4 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 111.807 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -155.85 161.21 30.53 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 121.192 1.815 . . . . 0.0 113.535 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -112.93 105.96 14.14 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -81.55 129.73 34.78 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 170.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.83 127.22 13.12 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 120.285 1.402 . . . . 0.0 112.843 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -98.9 138.5 35.93 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -107.04 144.96 32.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -116.55 131.63 56.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 114.84 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -111.41 127.93 55.83 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 108.641 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -87.38 134.04 33.63 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD21 ' HA2' ' A' ' 107' ' ' GLY . 55.1 tp -64.44 123.53 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.66 -37.88 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.1 m -88.69 -127.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.35 0.66 . . . . 0.0 109.913 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 177.25 178.63 47.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.837 1.199 . . . . 0.0 112.162 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.86 -30.66 15.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.785 1.634 . . . . 0.0 113.053 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.47 -29.23 67.8 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -98.35 -27.43 14.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.357 1.063 . . . . 0.0 111.212 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 143.68 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.722 1.209 . . . . 0.0 107.759 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.33 -41.58 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.549 0.74 . . . . 0.0 111.317 -170.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.7 mtt 55.51 7.35 0.23 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.14 17.83 5.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.741 1.61 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -31.6 72.73 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.705 2.002 . . . . 0.0 111.615 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -7.77 59.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.692 1.997 . . . . 0.0 113.672 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m 68.15 -35.46 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.305 2.642 . . . . 0.0 114.062 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 p -121.77 71.84 30.32 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.345 1.858 . . . . 0.0 106.398 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.56 -174.09 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.587 2.858 . . . . 0.0 111.958 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.98 -10.69 15.45 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.012 169.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.36 146.07 50.88 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.998 1.726 . . . . 0.0 114.99 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -115.96 114.25 24.38 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.767 3.227 . . . . 0.0 102.864 169.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.12 136.02 28.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.622 0.629 . . . . 0.0 113.157 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -131.67 -112.13 0.24 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.163 1.385 . . . . 0.0 109.946 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -150.08 163.06 39.15 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.776 1.23 . . . . 0.0 110.609 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -84.28 155.19 22.54 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.27 169.04 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 110.091 -169.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.2 m -57.45 151.67 16.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.34 0.591 . . . . 0.0 111.49 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -61.29 154.46 23.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.8 m95 66.36 -30.13 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.308 1.843 . . . . 0.0 115.559 -173.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -54.93 -46.28 99.61 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 120.773 1.624 . . . . 0.0 112.177 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -60.07 -26.65 83.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 121.732 1.654 . . . . 0.0 114.989 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.08 -34.11 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.956 1.253 . . . . 0.0 109.077 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -90.11 -19.0 24.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.945 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -80.33 -30.01 38.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.419 1.009 . . . . 0.0 111.988 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.18 163.13 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-N 118.56 0.618 . . . . 0.0 110.207 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.37 153.65 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.838 0.855 . . . . 0.0 111.603 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 m -54.87 -30.33 57.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.608 1.963 . . . . 0.0 115.594 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -84.31 -37.3 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.424 1.011 . . . . 0.0 111.374 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -70.41 -38.58 74.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.384 -0.822 . . . . 0.0 110.219 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -42.98 -45.71 5.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.599 1.56 . . . . 0.0 110.884 171.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.69 -34.8 78.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -173.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.8 -35.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 0.0 110.162 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.26 -32.2 73.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.825 0.739 . . . . 0.0 110.853 -171.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.38 -38.38 80.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.388 -0.82 . . . . 0.0 111.048 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -69.96 -46.47 65.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.46 -46.15 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.822 0.849 . . . . 0.0 109.3 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.3 mtt -69.59 -40.09 76.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.149 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.89 -40.85 94.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.821 1.191 . . . . 0.0 111.036 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.71 -28.13 68.41 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.132 0.973 . . . . 0.0 110.928 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -111.79 -9.18 14.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.09 0.956 . . . . 0.0 113.405 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.13 -59.61 4.0 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.124 0.97 . . . . 0.0 111.714 -169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 m -67.54 -23.03 65.39 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.878 -0.514 . . . . 0.0 111.518 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.75 -35.82 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.8 t -83.93 -42.07 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.719 0.808 . . . . 0.0 109.174 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.39 -30.6 69.55 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.623 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.6 m -55.41 -29.48 58.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.554 1.07 . . . . 0.0 112.122 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.87 -38.49 73.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.088 0.555 . . . . 0.0 110.443 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -92.25 -16.26 26.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.271 0.628 . . . . 0.0 111.02 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 126.18 1.792 . . . . 0.0 110.205 172.588 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 3.2 mp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.59 146.46 51.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -50.75 -31.81 17.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.05 -3.96 47.82 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.74 32.33 7.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.754 2.121 . . . . 0.0 110.578 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -111.27 146.4 37.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.976 1.388 . . . . 0.0 110.017 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.95 123.93 57.91 Favored Pre-proline 0 N--CA 1.467 0.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -68.97 130.6 20.62 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.348 2.032 . . . . 0.0 111.43 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.48 157.35 45.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.288 1.835 . . . . 0.0 111.837 -170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.4 120.52 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.511 1.925 . . . . 0.0 107.082 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 123.97 8.09 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.78 117.49 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 118.636 1.218 . . . . 0.0 108.722 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.33 85.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -66.74 136.52 26.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 168.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -121.74 121.91 38.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -74.36 125.07 27.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -43.6 -27.45 0.3 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.743 2.017 . . . . 0.0 114.456 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.19 2.87 1.37 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.29 30.42 7.38 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.023 1.296 . . . . 0.0 112.29 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.81 164.54 26.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.18 167.53 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 tpt -53.26 126.31 20.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.818 2.447 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -161.83 128.36 3.77 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.6 148.51 31.19 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.52 136.14 47.39 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.34 125.31 29.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -48.68 127.46 13.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 110.189 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 -24.14 1.77 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.133 1.349 . . . . 0.0 114.461 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.83 -32.28 23.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.389 1.076 . . . . 0.0 110.407 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 58.29 30.71 19.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 112.921 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -148.7 173.38 13.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.234 1.813 . . . . 0.0 107.19 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -75.05 163.26 27.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.316 0.962 . . . . 0.0 113.314 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.83 147.65 27.51 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.591 1.156 . . . . 0.0 108.889 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -61.64 150.98 79.89 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.0 1.72 . . . . 0.0 110.35 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.87 151.48 84.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.135 1.89 . . . . 0.0 110.88 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -173.43 168.18 4.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.205 1.802 . . . . 0.0 109.413 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.78 127.58 1.14 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.0 134.64 27.43 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.86 133.12 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.61 124.74 91.14 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.771 1.228 . . . . 0.0 108.875 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.76 118.42 5.19 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.929 1.753 . . . . 0.0 112.487 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.44 1.72 68.61 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.041 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.52 120.0 40.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 m -69.37 160.76 30.71 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 121.248 0.547 . . . . 0.0 111.09 -174.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.04 -42.14 12.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.767 2.027 . . . . 0.0 113.999 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -74.18 -47.69 33.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.49 -40.02 81.63 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 110.11 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.01 -32.92 72.81 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.309 1.044 . . . . 0.0 112.369 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.401 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.5 tmm? -59.51 -44.82 93.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -67.09 -27.68 67.55 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.748 -1.22 . . . . 0.0 112.649 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -64.75 -44.15 91.04 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.67 -1.269 . . . . 0.0 109.159 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.16 63.4 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 118.453 0.57 . . . . 0.0 110.544 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.99 -43.34 95.24 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 120.951 -1.093 . . . . 0.0 108.999 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -63.67 -57.3 10.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.652 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -25.5 60.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.104 1.774 . . . . 0.0 114.217 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.61 -11.02 12.43 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.927 -1.108 . . . . 0.0 112.654 -169.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.04 -16.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.18 0.992 . . . . 0.0 111.515 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.74 79.03 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 120.221 -1.549 . . . . 0.0 114.243 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -113.47 155.99 24.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.088 1.444 . . . . 0.0 109.104 -171.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -108.7 178.65 4.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.781 1.232 . . . . 0.0 110.227 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -72.77 37.58 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.399 1.88 . . . . 0.0 113.059 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -161.83 -14.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -106.06 18.24 22.35 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.457 1.026 . . . . 0.0 113.177 -168.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.22 175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.459 1.904 . . . . 0.0 109.42 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -140.91 114.39 8.77 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HA ' HD23 ' A' ' 102' ' ' LEU . 41.3 mt -72.94 132.51 33.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.07 -52.4 2.81 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.503 0.502 . . . . 0.0 109.673 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.86 174.19 11.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.57 0.748 . . . . 0.0 111.067 -171.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.5 p -145.82 177.31 9.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.944 1.298 . . . . 0.0 109.001 171.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 6.16 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.98 -16.53 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.014 2.526 . . . . 0.0 115.345 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.4 174.22 12.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.778 2.431 . . . . 0.0 108.674 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -79.16 121.81 25.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.669 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.18 160.95 17.51 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -140.52 141.88 35.27 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 108.838 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -144.83 153.02 41.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 168.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.98 156.19 17.06 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -88.53 141.52 30.44 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 154.77 72.2 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.804 2.336 . . . . 0.0 108.663 170.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -25.56 66.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -169.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.34 -26.6 58.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.124 0.97 . . . . 0.0 112.538 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.2 tp -96.56 -24.03 16.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.89 0.876 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.0 t -48.7 138.03 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.47 -45.36 46.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.493 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.3 m95 57.92 3.63 0.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.212 2.605 . . . . 0.0 114.034 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.95 -17.0 19.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.226 1.41 . . . . 0.0 110.658 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -80.63 143.64 32.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.609 1.564 . . . . 0.0 107.096 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.68 111.88 8.28 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 149.01 20.98 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 119.992 1.033 . . . . 0.0 112.77 -5.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.91 121.08 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.27 108.91 16.81 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.512 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 pt -90.36 -5.4 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.5 161.91 33.59 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -92.88 123.92 36.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -84.35 111.44 19.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 101.955 -3.35 . . . . 0.0 101.955 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.22 139.21 53.52 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.529 1.513 . . . . 0.0 113.162 -173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.55 124.83 52.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 169.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -104.68 143.44 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 61.1 m-85 -118.46 131.01 56.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.5 110.34 19.71 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 102' ' ' LEU . 15.3 mt -102.79 137.57 40.84 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 124.634 1.209 . . . . 0.0 109.422 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -93.35 127.14 38.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.6 112.09 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.2 t -81.25 -37.78 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 p -91.05 -115.3 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.158 0.583 . . . . 0.0 110.889 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.08 175.63 39.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.386 0.994 . . . . 0.0 111.021 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.69 -31.39 57.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.471 1.109 . . . . 0.0 112.321 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.78 65.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -109.66 -22.14 12.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.484 1.114 . . . . 0.0 111.104 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.38 143.24 12.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.0 1.32 . . . . 0.0 107.878 169.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -149.35 78.97 1.39 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.437 0.695 . . . . 0.0 109.404 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 mtt -68.58 16.49 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -116.34 22.97 12.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.438 1.472 . . . . 0.0 111.763 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -38.16 86.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.085 2.154 . . . . 0.0 112.096 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -3.43 50.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.444 1.097 . . . . 0.0 113.802 -169.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.65 -38.69 0.32 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.945 2.498 . . . . 0.0 113.726 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.8 p -126.04 73.01 71.08 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.532 1.933 . . . . 0.0 106.384 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -77.5 -167.41 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.89 3.06 . . . . 0.0 111.121 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.2 -11.32 14.91 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.241 -1.362 . . . . 0.0 112.49 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -135.24 148.41 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 121.703 2.047 . . . . 0.0 114.551 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -116.6 109.31 17.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.457 2.703 . . . . 0.0 103.943 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.13 148.64 32.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.563 1.078 . . . . 0.0 113.928 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -140.67 -119.62 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 0.0 111.333 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 150.19 38.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.134 1.773 . . . . 0.0 109.209 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -82.47 146.21 29.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.731 0.412 . . . . 0.0 110.129 -172.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.92 163.53 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.205 1.002 . . . . 0.0 110.398 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -53.01 154.25 3.02 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 111.382 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -60.81 150.99 30.94 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 64.87 -15.17 0.09 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.03 1.732 . . . . 0.0 115.027 -169.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -60.5 -43.62 93.29 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.706 2.048 . . . . 0.0 111.895 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -58.06 -34.74 98.79 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.712 1.608 . . . . 0.0 112.913 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.9 -51.99 59.75 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -68.97 -22.55 64.1 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.524 -0.735 . . . . 0.0 111.254 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -78.23 -18.32 55.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.65 161.28 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 119.631 1.105 . . . . 0.0 112.491 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.36 146.3 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.321 1.848 . . . . 0.0 112.115 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.1 m -61.83 -30.5 70.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -169.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -69.62 -31.02 68.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.607 1.094 . . . . 0.0 111.018 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -94.18 -32.09 13.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.7 0.8 . . . . 0.0 111.965 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.0 ttp-105 -48.41 -43.6 34.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.081 1.352 . . . . 0.0 113.121 -174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.3 -44.8 95.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.382 0.537 . . . . 0.0 110.867 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.9 t -73.99 -33.52 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.774 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -28.42 67.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.493 1.042 . . . . 0.0 110.437 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -42.9 98.61 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.893 -1.129 . . . . 0.0 109.725 169.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -64.95 -45.02 87.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.65 0.78 . . . . 0.0 110.089 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.7 t -51.27 -53.05 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.248 0.619 . . . . 0.0 109.485 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mtt -69.27 -41.84 76.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.438 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -51.83 -38.31 55.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.389 0.995 . . . . 0.0 111.454 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.46 -18.85 64.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.174 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.36 23.45 1.15 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.525 1.057 . . . . 0.0 113.834 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.26 78.56 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.212 -0.93 . . . . 0.0 110.663 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -60.46 -21.87 62.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.066 0.546 . . . . 0.0 111.707 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.02 -32.71 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.391 0.996 . . . . 0.0 108.373 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.9 t -72.31 -49.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.7 mmt -64.48 -29.52 70.57 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.645 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.5 m -48.82 -34.48 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.028 0.931 . . . . 0.0 112.064 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.22 -30.91 60.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.695 0.398 . . . . 0.0 110.426 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -114.37 -7.85 12.88 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 126.354 1.862 . . . . 0.0 109.004 169.609 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 C--O 1.237 0.436 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 160.42 29.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.284 1.434 . . . . 0.0 109.653 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -24.93 66.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -84.69 -33.88 23.08 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.684 -0.635 . . . . 0.0 111.136 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.03 17.24 0.91 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.323 1.44 . . . . 0.0 112.854 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -84.26 144.44 28.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.455 1.627 . . . . 0.0 109.753 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.413 ' HD2' HD21 ' A' ' 10' ' ' ASN . 1.1 tmt_? -88.73 124.08 66.38 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 170.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.12 131.4 11.89 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.278 1.985 . . . . 0.0 110.207 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.413 HD21 ' HD2' ' A' ' 8' ' ' ARG . 22.7 m-80 -144.09 162.39 36.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.34 1.056 . . . . 0.0 111.414 -173.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.38 143.36 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.693 2.397 . . . . 0.0 106.425 169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.01 126.46 6.32 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.58 138.86 19.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -118.93 89.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 168.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.65 138.64 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 m -126.11 123.84 39.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.93 144.07 32.17 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -66.34 -5.82 12.03 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.34 -11.59 60.54 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.928 0.786 . . . . 0.0 110.487 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.31 37.79 4.21 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 126.032 1.777 . . . . 0.0 112.426 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -138.01 157.89 45.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 108.844 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 m -100.61 161.25 3.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.5 ttt -58.07 132.38 53.33 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.381 1.472 . . . . 0.0 109.823 169.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.15 136.73 14.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.48 141.98 25.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.143 0.577 . . . . 0.0 110.118 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -71.13 140.26 50.54 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -75.39 142.75 43.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -62.18 125.73 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 109.797 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.25 14.31 71.3 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.281 -0.733 . . . . 0.0 114.387 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -148.5 131.97 16.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -87.7 48.7 1.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 111.819 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -153.37 -179.45 7.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.18 1.392 . . . . 0.0 108.906 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -108.53 155.07 21.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 108.408 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -134.9 143.19 46.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.246 0.93 . . . . 0.0 112.881 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -58.7 138.66 86.41 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.885 0.874 . . . . 0.0 109.785 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.77 145.83 81.97 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -169.65 157.84 7.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.748 1.619 . . . . 0.0 111.743 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.74 138.19 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.36 159.09 51.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.516 1.158 . . . . 0.0 111.515 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.1 mt -91.72 146.9 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 108.355 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -89.52 153.45 48.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.525 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.14 117.97 4.78 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.21 86.98 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.987 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.39 125.69 31.33 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.458 1.129 . . . . 0.0 108.333 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.74 157.63 36.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.746 1.218 . . . . 0.0 110.697 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -41.39 71.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.301 1.04 . . . . 0.0 113.244 -168.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -70.82 -47.18 60.79 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.46 -41.47 80.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.391 1.476 . . . . 0.0 110.01 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.06 81.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.696 0.68 . . . . 0.0 111.914 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -58.9 -44.94 91.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.934 0.788 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.87 -24.03 66.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.042 1.292 . . . . 0.0 113.405 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -63.75 -52.39 60.64 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.466 1.484 . . . . 0.0 108.949 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -36.16 82.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.562 0.345 . . . . 0.0 111.481 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.5 tp -57.23 -41.31 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 110.196 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.08 -45.88 46.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.288 1.035 . . . . 0.0 111.632 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.61 -36.73 79.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.799 1.181 . . . . 0.0 111.975 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.37 -47.77 7.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.126 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.55 -26.75 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.234 0.613 . . . . 0.0 111.142 -169.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.43 27.39 67.86 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.701 -0.624 . . . . 0.0 112.135 -170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.3 mt -105.05 157.63 17.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.547 1.139 . . . . 0.0 108.634 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -118.37 -174.45 2.67 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.614 1.166 . . . . 0.0 109.969 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.01 34.64 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.834 2.054 . . . . 0.0 114.343 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -159.26 -17.89 0.07 Allowed 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -87.02 -1.52 57.94 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.011 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.52 168.72 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.196 1.398 . . . . 0.0 109.203 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.12 122.48 16.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.0 mt -75.38 131.85 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 120.651 1.569 . . . . 0.0 107.497 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.58 -33.9 7.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.774 0.43 . . . . 0.0 111.671 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.28 168.09 28.41 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.016 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.2 p -146.73 159.53 43.36 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.879 1.272 . . . . 0.0 108.043 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -64.33 134.71 55.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -68.0 -18.36 64.7 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -149.06 165.89 30.35 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.307 1.443 . . . . 0.0 107.974 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -65.66 117.84 8.7 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.61 -53.85 29.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER 62.52 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 129.725 3.21 . . . . 0.0 112.775 -178.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -144.61 156.58 44.19 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.12 129.92 55.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.39 143.59 88.11 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.988 0.915 . . . . 0.0 109.257 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -66.72 154.34 74.82 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.837 2.358 . . . . 0.0 109.215 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -58.93 -31.36 68.59 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.55 -24.12 61.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.84 0.856 . . . . 0.0 112.95 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 tp -104.67 -17.2 14.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.19 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -45.68 136.86 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -72.58 -49.69 30.59 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.8 m95 58.86 3.18 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.139 2.575 . . . . 0.0 114.868 -169.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.59 -23.03 16.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.141 0.976 . . . . 0.0 111.52 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.48 158.63 18.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.338 1.855 . . . . 0.0 110.102 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -132.31 112.0 14.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 108.68 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -59.69 157.02 44.09 Favored 'Cis proline' 0 CA--C 1.537 0.668 0 CA-C-N 120.284 1.137 . . . . 0.0 110.51 -10.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.93 130.21 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.3 t -79.01 117.13 19.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.299 -1.319 . . . . 0.0 107.618 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.24 -2.12 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.283 1.433 . . . . 0.0 111.76 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 159.8 33.09 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 120.207 1.367 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -104.52 106.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.7 127.47 32.83 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 143.95 29.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.115 0.87 . . . . 0.0 111.723 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.19 135.2 55.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -108.71 147.76 31.48 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -121.29 124.96 45.88 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 tp -79.73 110.93 15.54 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.2 mm? -104.5 128.71 52.5 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.9 0.88 . . . . 0.0 109.364 176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -87.72 140.82 29.13 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 168.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -70.91 136.15 48.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.29 -41.31 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.1 m -136.07 136.13 39.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.62 176.61 46.89 Favored Glycine 0 C--N 1.331 0.303 0 O-C-N 121.514 -0.741 . . . . 0.0 113.378 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 t70 61.24 -46.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.719 3.608 . . . . 0.0 114.071 -172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.18 21.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.412 1.085 . . . . 0.0 111.389 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -90.81 -23.77 20.5 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.289 0.636 . . . . 0.0 111.193 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mt -66.12 139.43 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -135.18 -37.32 0.79 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.052 0.541 . . . . 0.0 112.071 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.4 mtt 56.85 17.46 3.27 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -132.91 25.4 4.3 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.621 1.1 . . . . 0.0 111.807 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -28.75 63.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.116 1.766 . . . . 0.0 111.436 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -7.0 57.8 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.254 1.821 . . . . 0.0 113.572 -170.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 67.69 -36.68 0.3 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.304 2.642 . . . . 0.0 113.66 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 p -124.29 75.06 60.63 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.58 -174.05 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.611 2.874 . . . . 0.0 111.238 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -107.57 -8.68 16.1 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.171 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.57 152.46 50.77 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 120.59 1.541 . . . . 0.0 112.43 -172.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -121.83 -31.2 3.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.632 1.573 . . . . 0.0 112.278 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.3 11.88 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -113.23 148.4 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.944 1.298 . . . . 0.0 110.847 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -152.05 129.17 11.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.793 1.237 . . . . 0.0 108.44 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -80.38 143.29 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 165.01 9.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.199 0.6 . . . . 0.0 110.233 -169.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -47.41 140.45 5.71 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -50.0 -41.45 47.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -94.12 -11.34 30.72 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -57.24 -44.99 99.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.428 -171.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.51 -23.89 77.32 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.554 1.503 . . . . 0.0 113.807 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -38.93 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 119.041 0.837 . . . . 0.0 109.605 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -87.71 -19.2 27.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.039 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.88 -27.73 66.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 121.032 1.742 . . . . 0.0 110.224 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.59 154.84 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.89 1.276 . . . . 0.0 110.641 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.66 150.23 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.811 1.245 . . . . 0.0 110.288 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -59.13 -31.58 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -168.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -75.25 -31.1 60.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.864 1.211 . . . . 0.0 110.691 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.98 -25.61 27.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.195 -0.907 . . . . 0.0 112.294 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -48.1 -47.98 34.01 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.372 1.442 . . . . 0.0 110.992 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.78 -43.94 87.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.375 0.534 . . . . 0.0 111.067 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.3 -33.96 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.937 -0.477 . . . . 0.0 110.267 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.79 -32.71 74.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.422 1.01 . . . . 0.0 109.522 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp-105 -59.76 -34.48 73.03 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 120.67 -1.269 . . . . 0.0 111.925 170.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -61.8 -46.55 89.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.281 1.4 . . . . 0.0 109.343 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.85 -52.14 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.2 mmt -60.55 -45.01 95.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -60.07 -38.67 83.54 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.239 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.11 -21.38 64.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.209 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -120.19 -22.82 6.46 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.24 64.09 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-N 119.896 1.226 . . . . 0.0 111.427 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -66.83 -25.95 66.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.071 0.85 . . . . 0.0 111.818 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.66 -37.4 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.1 -39.13 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.417 0.687 . . . . 0.0 110.198 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.5 mmt -72.55 -26.47 61.75 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.028 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.8 m -58.07 -32.92 68.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.621 1.1 . . . . 0.0 111.464 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.32 -29.17 69.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -94.45 -40.49 9.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.692 1.197 . . . . 0.0 109.682 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.962 1.305 . . . . 0.0 111.666 -177.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.02 144.32 50.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.672 1.589 . . . . 0.0 107.937 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -47.73 -32.53 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -168.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.74 -3.63 39.14 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.38 28.36 7.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.024 1.773 . . . . 0.0 111.418 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.69 145.38 39.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.125 1.462 . . . . 0.0 110.585 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 122.26 69.03 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 116.588 -1.672 . . . . 0.0 107.194 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.68 126.37 12.63 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.846 1.697 . . . . 0.0 110.111 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -140.37 166.7 23.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.476 1.11 . . . . 0.0 110.633 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.66 148.52 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.567 2.347 . . . . 0.0 106.668 169.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.95 12.1 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -102.57 117.32 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.47 82.25 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -62.62 130.9 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.8 127.39 53.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.75 136.49 32.97 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -66.6 -5.82 12.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.107 1.363 . . . . 0.0 114.317 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -75.41 -7.64 54.59 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.184 0.902 . . . . 0.0 110.496 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 33.7 4.55 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 125.103 1.335 . . . . 0.0 112.276 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -134.29 161.25 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.858 0.863 . . . . 0.0 109.131 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.49 162.61 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.727 0.811 . . . . 0.0 113.155 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.9 tpt -51.74 131.67 30.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.097 2.159 . . . . 0.0 112.085 171.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -161.91 143.88 11.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 167.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.09 143.98 21.84 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -78.07 145.89 35.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -77.9 125.1 28.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.59 140.69 57.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.153 1.381 . . . . 0.0 109.713 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 -40.92 1.73 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.512 1.053 . . . . 0.0 113.524 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.23 -31.95 24.75 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.499 1.149 . . . . 0.0 110.616 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.47 39.44 31.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.592 1.557 . . . . 0.0 112.402 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -135.2 173.87 11.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.591 1.956 . . . . 0.0 107.163 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -80.52 160.53 25.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.603 1.092 . . . . 0.0 111.77 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -151.39 146.88 26.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.675 1.19 . . . . 0.0 109.025 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.81 136.11 51.55 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.963 0.905 . . . . 0.0 110.731 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -65.41 141.28 67.24 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.602 2.201 . . . . 0.0 111.817 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -177.92 150.76 0.64 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.067 2.547 . . . . 0.0 106.337 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.84 142.75 9.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.02 154.62 53.42 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 118.323 1.061 . . . . 0.0 111.34 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.7 127.76 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -67.47 125.55 91.32 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 117.684 -1.15 . . . . 0.0 108.841 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.67 117.97 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.92 1.747 . . . . 0.0 112.803 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.08 0.42 77.52 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.404 1.478 . . . . 0.0 112.923 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -93.82 127.71 39.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.13 160.18 31.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.536 1.135 . . . . 0.0 110.811 -177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.9 64.06 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.063 1.345 . . . . 0.0 113.146 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -71.21 -48.57 50.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.13 -38.22 79.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.536 1.534 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.8 68.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.91 1.284 . . . . 0.0 111.738 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.457 ' HG3' ' CD1' ' A' ' 100' ' ' PHE . 18.2 tmm? -60.64 -43.06 98.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.54 -32.71 74.24 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.246 -0.908 . . . . 0.0 112.213 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -60.67 -46.57 89.83 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.848 -1.157 . . . . 0.0 109.517 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.6 67.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.802 0.728 . . . . 0.0 111.705 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -61.31 -40.84 95.66 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.037 -1.04 . . . . 0.0 108.531 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.85 -55.87 6.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.575 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.6 -38.22 83.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.947 1.703 . . . . 0.0 111.225 -170.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -94.66 -37.96 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.323 0.51 . . . . 0.0 112.041 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -109.63 -20.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.267 0.627 . . . . 0.0 110.668 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.55 48.46 56.72 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.499 -1.376 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 mt -127.68 156.12 42.87 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.831 1.652 . . . . 0.0 107.817 171.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -114.07 -177.16 3.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.142 0.977 . . . . 0.0 110.285 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -73.75 38.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.273 1.829 . . . . 0.0 113.14 -170.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -157.98 -18.69 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.987 1.315 . . . . 0.0 113.202 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -86.03 -2.01 57.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.993 0.517 . . . . 0.0 112.082 -169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HB ' HD12 ' A' ' 102' ' ' LEU . 27.5 m -149.14 168.02 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.13 -170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -137.51 121.4 17.64 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.51 126.55 35.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.87 -32.58 7.86 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.208 0.317 . . . . 0.0 111.271 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.81 162.06 39.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.506 1.122 . . . . 0.0 108.555 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 m -139.86 157.47 45.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -58.89 137.21 57.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.146 0.885 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -61.52 -31.34 71.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.771 0.429 . . . . 0.0 111.453 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -151.65 173.07 15.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.216 1.806 . . . . 0.0 106.754 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -60.08 125.19 22.72 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 109.471 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.98 50.11 1.91 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 127.52 2.328 . . . . 0.0 107.451 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 146.46 47.67 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -169.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -145.52 142.77 29.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.641 0.588 . . . . 0.0 110.199 -170.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -100.18 133.2 44.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.601 1.16 . . . . 0.0 108.536 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.7 148.83 73.55 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 124.428 1.091 . . . . 0.0 111.016 -174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 154.42 74.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.756 2.304 . . . . 0.0 109.265 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -53.59 -31.55 47.37 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -72.04 -32.01 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.519 1.127 . . . . 0.0 111.905 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.52 -24.11 18.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.975 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -58.05 130.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.19 -43.62 41.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.094 0.557 . . . . 0.0 112.361 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 24.8 m95 59.69 4.64 0.58 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 127.382 2.273 . . . . 0.0 113.432 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.78 -21.51 15.15 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.209 1.404 . . . . 0.0 111.066 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -73.78 147.09 43.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.455 1.502 . . . . 0.0 108.651 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -134.84 116.55 12.56 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.44 149.16 31.02 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.952 1.019 . . . . 0.0 111.161 -10.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.39 131.61 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.3 106.69 18.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.0 pt -102.06 -6.14 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.002 0.921 . . . . 0.0 112.409 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.7 163.71 37.22 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 120.232 1.378 . . . . 0.0 113.172 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.5 115.67 27.81 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -85.64 120.22 26.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 101.211 -3.626 . . . . 0.0 101.211 168.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -146.38 138.03 24.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.662 1.119 . . . . 0.0 111.435 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.21 122.67 45.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -98.91 141.34 31.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 50' ' ' MET . 58.5 m-85 -118.84 128.72 54.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 tt -82.59 121.22 26.53 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.443 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.5 mm? -113.47 122.05 46.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.667 -1.151 . . . . 0.0 107.991 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -80.85 133.89 35.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 tp -67.12 136.68 55.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -115.92 -38.15 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m -89.52 -130.5 0.08 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.486 0.714 . . . . 0.0 109.781 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.73 177.1 46.94 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 120.001 1.273 . . . . 0.0 111.914 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -52.67 -31.3 36.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.322 1.449 . . . . 0.0 112.554 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.88 -27.04 66.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -97.16 -28.28 14.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.167 0.987 . . . . 0.0 110.894 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.63 147.04 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.53 1.132 . . . . 0.0 108.025 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -127.17 -50.63 1.43 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.351 0.66 . . . . 0.0 109.684 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 mtt 63.33 -8.26 0.15 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.486 1.914 . . . . 0.0 115.179 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -109.54 24.53 12.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 121.248 1.84 . . . . 0.0 111.616 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -24.9 63.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.303 1.841 . . . . 0.0 112.19 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -6.69 59.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.981 1.713 . . . . 0.0 113.901 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.2 m 68.86 -34.02 0.26 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.387 2.675 . . . . 0.0 114.111 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.11 71.65 63.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.64 -170.21 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.525 2.816 . . . . 0.0 113.561 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -110.53 -42.56 4.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.252 1.021 . . . . 0.0 109.749 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.66 152.47 28.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.521 1.055 . . . . 0.0 113.568 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.16 14.36 13.96 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.473 1.509 . . . . 0.0 112.168 171.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.61 171.44 46.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.01 1.29 . . . . 0.0 113.348 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -164.65 -116.43 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.82 1.248 . . . . 0.0 109.741 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.8 mtp85 -145.81 160.81 41.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.267 3.027 . . . . 0.0 107.51 -170.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -85.77 132.95 34.03 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.51 168.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 110.793 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.4 m -52.7 147.24 8.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.729 0.695 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -52.46 -40.66 62.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -168.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -95.32 -3.73 46.78 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.71 -43.19 82.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.495 1.043 . . . . 0.0 111.765 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.2 -26.41 82.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.535 1.584 . . . . 0.0 113.085 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -12.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 O-C-N 121.435 -0.791 . . . . 0.0 111.374 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -35.73 7.66 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.808 1.186 . . . . 0.0 109.284 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -68.52 -26.54 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.733 1.151 . . . . 0.0 112.297 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.08 159.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 118.885 0.766 . . . . 0.0 110.459 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.3 149.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.574 0.75 . . . . 0.0 111.43 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 m -51.09 -39.01 55.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.035 1.734 . . . . 0.0 114.064 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.37 -40.3 58.22 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.735 0.698 . . . . 0.0 110.222 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -66.53 -32.76 74.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.212 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -44.97 -48.83 11.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.705 1.139 . . . . 0.0 110.789 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.94 -34.74 78.82 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.73 -38.42 19.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.948 -0.47 . . . . 0.0 109.955 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -33.18 75.41 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.961 -0.462 . . . . 0.0 109.837 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -56.22 -40.3 73.85 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.314 -1.327 . . . . 0.0 110.967 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.07 -45.02 90.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.838 1.654 . . . . 0.0 109.155 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.69 -41.68 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.8 mtt -72.0 -39.54 69.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.542 -0.724 . . . . 0.0 110.658 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.69 -37.13 86.18 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.45 -28.34 66.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.093 0.957 . . . . 0.0 111.466 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -122.98 2.68 9.36 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.67 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.414 1.461 . . . . 0.0 111.576 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 p -66.01 -23.03 66.49 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 t -69.39 -39.91 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.69 1.132 . . . . 0.0 108.841 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.02 -44.2 28.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mtt -66.08 -32.77 74.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.568 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.1 m -61.16 -22.13 64.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.521 1.055 . . . . 0.0 112.761 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.25 -21.57 39.35 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 111.546 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -109.53 -37.67 5.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.613 1.165 . . . . 0.0 109.93 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 CA--C 1.543 0.705 0 C-N-CA 126.733 2.013 . . . . 0.0 109.486 171.514 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.25 -44.88 71.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.132 0.573 . . . . 0.0 111.833 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -152.05 -80.73 0.1 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.69 0.796 . . . . 0.0 110.83 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.76 -47.48 8.6 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.06 12.64 0.05 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.644 -0.531 . . . . 0.0 114.123 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -96.72 130.67 43.92 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.498 1.149 . . . . 0.0 108.655 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -88.02 127.51 57.33 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.62 135.98 24.95 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.719 1.612 . . . . 0.0 109.92 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -140.65 153.47 46.02 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.709 1.604 . . . . 0.0 111.446 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.69 135.16 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.909 2.084 . . . . 0.0 105.533 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.69 125.92 6.69 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mm -95.49 110.33 24.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.59 86.14 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.68 129.97 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 155' ' ' VAL . 44.2 t -106.22 135.3 47.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 168.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.81 25.66 4.53 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 54.42 -2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.251 2.22 . . . . 0.0 116.726 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -95.58 14.8 21.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.043 0.838 . . . . 0.0 111.697 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.6 9.48 84.65 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 124.564 1.078 . . . . 0.0 113.112 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -125.45 172.9 9.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.441 1.12 . . . . 0.0 108.875 -169.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.18 170.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.3 tpt -53.13 136.22 36.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.5 2.32 . . . . 0.0 113.72 -170.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -163.1 135.6 5.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.813 1.245 . . . . 0.0 108.166 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.82 158.23 40.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.401 1.48 . . . . 0.0 109.104 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -93.05 130.79 38.53 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -78.92 123.35 27.18 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.887 0.875 . . . . 0.0 109.173 -169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -53.75 134.16 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.267 2.227 . . . . 0.0 110.222 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 -16.88 1.92 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.939 1.257 . . . . 0.0 114.773 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -105.75 -30.8 9.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 110.33 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 58.87 39.65 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.76 1.624 . . . . 0.0 112.791 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 p -140.53 171.29 14.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.712 1.605 . . . . 0.0 108.298 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -79.24 157.59 27.76 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.01 157.29 19.08 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.186 2.194 . . . . 0.0 113.742 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.83 96.47 5.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 168.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 146.25 89.69 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.307 1.338 . . . . 0.0 111.695 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 156.5 149.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.628 3.171 . . . . 0.0 108.231 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.03 143.87 14.64 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.61 144.34 35.35 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.7 mt -73.53 141.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.87 141.53 38.18 Favored Pre-proline 0 N--CA 1.465 0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.368 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -59.34 116.31 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.088 1.859 . . . . 0.0 111.971 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.43 2.39 87.42 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.056 1.312 . . . . 0.0 112.916 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -86.21 128.26 34.87 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.515 1.158 . . . . 0.0 107.996 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.52 157.42 38.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.488 1.115 . . . . 0.0 110.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.8 63.71 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.364 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 1.5 mp0 -64.12 -49.49 71.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -57.47 -36.22 71.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.169 1.388 . . . . 0.0 109.608 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.24 -35.17 66.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.645 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 47' ' ' GLU . 30.6 mtp -56.54 -47.22 79.87 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.369 1.44 . . . . 0.0 109.189 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.76 -26.57 67.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -65.87 -53.07 44.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.843 0.747 . . . . 0.0 109.549 170.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.63 82.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.113 0.87 . . . . 0.0 111.474 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 tp -56.33 -41.78 76.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.528 1.531 . . . . 0.0 110.345 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -44.13 56.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.57 1.148 . . . . 0.0 111.105 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.46 -37.79 83.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.291 0.95 . . . . 0.0 111.826 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.03 -75.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.017 0.927 . . . . 0.0 109.987 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.84 -6.59 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.76 49.78 61.97 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 mt -120.34 156.94 30.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.647 1.579 . . . . 0.0 107.111 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.5 m -112.68 173.63 6.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.158 0.983 . . . . 0.0 109.444 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.97 43.42 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.104 2.162 . . . . 0.0 114.508 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.66 -18.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.102 1.761 . . . . 0.0 112.171 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -88.99 -0.07 57.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.842 0.857 . . . . 0.0 111.71 -172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.37 169.96 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.862 1.265 . . . . 0.0 109.365 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -142.3 129.16 20.6 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 mt -81.34 127.85 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.124 1.329 . . . . 0.0 108.719 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.9 -35.37 6.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.716 0.807 . . . . 0.0 111.898 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.24 165.88 35.07 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.689 0.795 . . . . 0.0 109.848 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.5 p -144.92 160.06 41.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.251 1.02 . . . . 0.0 109.511 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 p -64.94 137.18 57.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -64.75 -25.27 67.85 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -151.16 170.21 19.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.971 1.309 . . . . 0.0 108.667 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -65.99 123.56 20.18 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.227 0.611 . . . . 0.0 109.467 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.43 167.8 19.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.62 154.67 33.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -139.26 162.94 33.77 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -103.82 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.3 mt -69.12 140.59 90.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 151.88 64.65 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.319 2.679 . . . . 0.0 109.294 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -65.5 -21.05 66.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -169.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.67 -27.83 61.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.954 0.901 . . . . 0.0 112.332 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.7 tp -94.46 -26.25 16.55 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.614 0.766 . . . . 0.0 110.929 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.35 136.8 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -42.47 42.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.523 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m95 61.81 3.38 0.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.164 2.185 . . . . 0.0 113.718 -169.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -16.69 18.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.245 1.418 . . . . 0.0 111.028 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -76.94 144.26 38.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.983 1.713 . . . . 0.0 107.259 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.79 116.41 9.0 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.468 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.31 150.96 22.04 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.105 1.073 . . . . 0.0 111.927 -10.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 m -57.72 129.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.8 t -88.82 107.37 18.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -111.65 -5.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.6 1.16 . . . . 0.0 112.257 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 168.76 41.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.128 0.876 . . . . 0.0 112.188 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -103.76 107.88 18.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -71.76 121.54 19.09 Favored 'General case' 0 N--CA 1.471 0.617 1 N-CA-C 100.185 -4.006 . . . . 0.0 100.185 167.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.89 132.9 33.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.621 1.555 . . . . 0.0 112.783 -168.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -112.37 128.11 56.2 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -104.25 147.14 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.68 130.05 48.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.2 tp -77.84 111.61 13.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -106.24 126.99 52.9 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -82.58 134.98 35.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.69 104.65 4.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.87 -33.9 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.8 p -83.6 -119.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.821 0.448 . . . . 0.0 109.848 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.8 174.37 42.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.998 1.285 . . . . 0.0 110.675 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -28.9 15.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.686 1.194 . . . . 0.0 113.012 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.423 0.556 . . . . 0.0 112.082 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.61 -22.04 13.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.551 1.141 . . . . 0.0 111.691 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.6 mt -62.38 102.99 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -92.47 -30.88 15.49 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.168 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.0 mtt 60.84 -44.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 130.093 3.357 . . . . 0.0 114.784 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.27 34.46 1.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.352 1.861 . . . . 0.0 110.469 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -71.21 -49.5 42.84 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -68.55 148.82 49.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -75.72 -27.06 58.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.936 1.695 . . . . 0.0 112.228 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 p -120.74 69.73 17.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.675 1.99 . . . . 0.0 106.58 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.62 -174.67 1.94 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.273 3.315 . . . . 0.0 111.292 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -116.2 -18.24 10.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.386 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.14 150.18 52.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 121.935 2.152 . . . . 0.0 112.067 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.08 -28.9 4.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.708 1.203 . . . . 0.0 112.492 -170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.44 150.41 20.02 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -96.73 156.88 16.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.945 1.298 . . . . 0.0 110.194 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -153.01 103.54 2.75 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -71.57 133.37 45.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.052 1.296 . . . . 0.0 108.658 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 153.8 27.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.909 1.284 . . . . 0.0 108.15 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.5 m -58.48 158.54 7.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.62 0.768 . . . . 0.0 112.672 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.18 151.02 13.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.2 m95 67.1 -23.41 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.171 1.788 . . . . 0.0 115.561 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.0 -47.56 95.08 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 121.059 1.754 . . . . 0.0 111.259 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.82 -32.92 86.58 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.875 1.717 . . . . 0.0 113.234 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.95 -33.02 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.512 0.725 . . . . 0.0 110.35 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -85.92 -26.63 25.45 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.166 0.894 . . . . 0.0 111.744 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -80.53 -27.6 37.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.773 0.715 . . . . 0.0 112.191 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.55 158.78 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.164 0.893 . . . . 0.0 110.097 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.29 148.51 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.215 1.006 . . . . 0.0 111.466 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 m -57.6 -35.67 70.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.956 1.302 . . . . 0.0 113.767 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -71.88 -25.41 61.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.178 0.899 . . . . 0.0 111.635 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -86.75 -40.82 14.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.775 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.27 -51.66 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 112.977 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -66.3 -33.07 74.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.463 0.574 . . . . 0.0 112.397 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.83 -35.24 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.349 0.66 . . . . 0.0 110.193 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.34 -31.98 73.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.532 1.06 . . . . 0.0 110.608 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -55.84 -40.87 73.44 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.368 -0.832 . . . . 0.0 110.559 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -64.36 -45.26 88.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 109.504 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.71 -47.19 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 mtt -66.32 -38.13 86.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.956 -0.465 . . . . 0.0 110.744 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.17 -37.9 89.05 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.021 -1.049 . . . . 0.0 110.286 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.11 -29.81 70.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 111.238 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -115.64 -13.97 11.47 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.79 39.84 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.322 1.419 . . . . 0.0 111.702 -169.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.4 m -64.02 -24.5 67.73 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.022 -0.424 . . . . 0.0 111.612 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.11 -40.95 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.437 HG13 ' SG ' ' A' ' 16' ' ' CYS . 39.8 t -68.63 -45.46 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.486 0.714 . . . . 0.0 110.238 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -71.04 -20.35 62.39 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.039 0.836 . . . . 0.0 111.491 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -59.48 -30.55 68.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.461 1.028 . . . . 0.0 111.824 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.45 -41.1 85.27 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.22 -29.83 22.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.928 -173.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.006 1.322 . . . . 0.0 111.441 178.219 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 mm . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.26 140.03 50.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.276 1.43 . . . . 0.0 108.198 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -31.94 -49.95 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.754 2.422 . . . . 0.0 116.577 -168.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -83.97 8.67 14.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.46 35.04 4.24 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.386 1.47 . . . . 0.0 112.258 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -115.61 143.76 44.88 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.613 1.206 . . . . 0.0 112.295 -171.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -82.85 115.86 60.92 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-O 117.435 -1.269 . . . . 0.0 107.817 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 125.29 7.13 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.119 1.88 . . . . 0.0 109.808 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.17 174.35 15.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.374 1.069 . . . . 0.0 109.919 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 50' ' ' MET . 31.4 m -119.94 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.92 9.04 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.33 128.01 38.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.085 0.943 . . . . 0.0 108.746 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.94 88.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.9 mm -67.57 137.21 25.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 168.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -125.57 120.21 30.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -78.14 138.9 38.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -65.22 -7.09 11.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.42 -11.27 60.61 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.125 0.875 . . . . 0.0 110.516 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.67 34.83 4.54 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.378 1.942 . . . . 0.0 112.225 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -131.9 148.01 52.51 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 m -104.98 162.89 4.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.9 tpt -56.39 130.06 43.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.097 1.759 . . . . 0.0 110.376 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -161.73 127.42 3.62 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.33 144.3 32.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -73.06 135.9 44.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -77.61 128.64 34.46 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.96 128.57 16.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.912 2.085 . . . . 0.0 110.44 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.32 -33.19 1.55 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.191 1.376 . . . . 0.0 114.067 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -37.14 21.92 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.415 1.108 . . . . 0.0 109.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.259 14.8 m170 59.21 33.12 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.657 1.583 . . . . 0.0 113.096 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -139.12 162.98 33.62 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.356 2.262 . . . . 0.0 105.805 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -74.19 164.86 26.1 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.405 1.002 . . . . 0.0 113.203 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -151.44 142.8 23.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.641 1.576 . . . . 0.0 108.474 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -73.14 144.94 85.35 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.587 0.755 . . . . 0.0 110.017 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.66 144.73 97.65 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.371 1.381 . . . . 0.0 112.435 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -172.79 138.09 0.8 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.518 2.327 . . . . 0.0 108.505 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.41 -114.09 3.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.272 0.939 . . . . 0.0 110.969 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.81 165.11 35.05 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 128.006 2.717 . . . . 0.0 107.443 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.89 135.08 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -84.44 158.23 60.66 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 119.011 -0.518 . . . . 0.0 109.855 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.7 117.21 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.817 1.678 . . . . 0.0 112.275 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.16 9.24 85.58 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.839 1.209 . . . . 0.0 112.909 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.05 125.19 29.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.361 1.08 . . . . 0.0 108.717 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 159.58 34.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.472 1.109 . . . . 0.0 110.815 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.68 68.76 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.703 1.201 . . . . 0.0 113.436 -169.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.17 -43.42 64.61 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.79 -44.21 97.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.493 1.117 . . . . 0.0 108.886 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.73 71.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.417 1.087 . . . . 0.0 112.292 172.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.402 ' HA ' HG21 ' A' ' 11' ' ' VAL . 15.6 tmm? -65.98 -43.09 88.84 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.211 0.914 . . . . 0.0 109.739 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -65.55 -25.48 67.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.211 1.369 . . . . 0.0 111.727 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.96 -49.61 64.89 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 120.063 1.301 . . . . 0.0 108.64 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.69 83.18 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.82 0.819 . . . . 0.0 110.239 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.45 -40.93 88.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.204 1.401 . . . . 0.0 109.646 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.17 -47.72 55.99 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.17 0.988 . . . . 0.0 111.196 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.44 -35.33 80.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.894 1.679 . . . . 0.0 112.053 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.32 -39.6 9.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.722 0.809 . . . . 0.0 110.422 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -17.35 7.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 111.01 -169.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.08 43.42 99.45 Favored Glycine 0 N--CA 1.451 -0.31 0 O-C-N 120.567 -1.333 . . . . 0.0 110.918 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -117.28 159.32 22.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.638 1.175 . . . . 0.0 108.183 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -122.36 -177.49 3.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.823 1.249 . . . . 0.0 110.271 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -67.93 40.42 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.177 2.591 . . . . 0.0 114.694 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -164.68 -22.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.343 1.057 . . . . 0.0 112.655 -169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.99 -3.92 58.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.446 0.698 . . . . 0.0 112.298 -169.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.4 168.97 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.921 1.288 . . . . 0.0 109.72 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -135.74 119.48 17.22 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 mt -75.76 131.79 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 120.069 1.304 . . . . 0.0 107.738 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.63 -50.72 3.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.262 0.483 . . . . 0.0 110.24 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.39 168.36 20.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.774 0.83 . . . . 0.0 110.618 -170.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.0 p -150.81 161.23 43.06 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.136 1.375 . . . . 0.0 108.23 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -62.49 146.29 52.03 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.936 0.789 . . . . 0.0 109.991 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.6 mtt-85 -64.62 -30.18 71.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.044 0.538 . . . . 0.0 111.523 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.56 172.18 13.96 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.691 1.596 . . . . 0.0 107.546 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -61.11 125.19 22.82 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.63 147.39 39.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -118.71 123.73 45.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.85 126.01 48.65 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.064 -0.969 . . . . 0.0 108.528 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -102.42 112.47 25.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.39 148.9 98.2 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.359 1.063 . . . . 0.0 110.738 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -66.96 151.57 81.9 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 108.333 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -25.25 66.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -74.81 -26.39 59.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.217 1.007 . . . . 0.0 112.432 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.05 -21.12 16.36 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.765 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.4 t -46.59 140.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 168.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -73.82 -44.88 54.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.8 m95 57.17 8.74 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.215 2.206 . . . . 0.0 114.719 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -120.84 -16.62 8.11 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.184 0.994 . . . . 0.0 112.649 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 p -75.08 -36.2 61.78 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 49.32 93.36 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 127.654 2.382 . . . . 0.0 112.271 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.54 147.68 73.09 Favored 'Cis proline' 0 C--N 1.352 0.728 0 CA-C-N 119.774 0.955 . . . . 0.0 111.315 6.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.53 129.36 27.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.1 t -91.87 112.56 24.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.57 -5.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 124.529 1.132 . . . . 0.0 111.808 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.64 43.06 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.818 1.19 . . . . 0.0 115.217 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -106.46 126.75 52.64 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 124.817 1.247 . . . . 0.0 107.739 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -91.64 116.22 28.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.53 108.86 6.12 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.606 0.567 . . . . 0.0 111.208 -168.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -93.44 128.96 39.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 168.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -95.72 135.28 37.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.47 128.43 56.33 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -87.84 109.79 20.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mm? -107.96 124.45 50.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.229 1.012 . . . . 0.0 109.899 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.19 131.66 34.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.88 135.69 51.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.44 -28.14 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.0 p -88.21 -126.81 0.05 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.211 1.004 . . . . 0.0 110.411 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.93 166.48 35.54 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.21 1.386 . . . . 0.0 110.026 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.24 -30.88 18.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.493 1.117 . . . . 0.0 112.773 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.48 65.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.079 0.552 . . . . 0.0 112.295 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -95.96 -31.83 12.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.775 1.23 . . . . 0.0 110.726 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.38 142.63 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.207 1.403 . . . . 0.0 108.177 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.59 -51.33 1.84 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.7 mtt 63.71 -18.42 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.42 1.888 . . . . 0.0 115.337 -171.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.36 25.33 7.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.836 2.107 . . . . 0.0 112.042 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -35.33 77.13 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.935 2.494 . . . . 0.0 111.698 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -3.58 55.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 113.471 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 m 65.98 -35.98 0.23 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.95 2.5 . . . . 0.0 114.126 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 p -125.95 68.15 62.86 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.739 2.016 . . . . 0.0 106.287 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.19 -172.59 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.017 3.145 . . . . 0.0 111.507 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.43 -17.84 13.89 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.306 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -129.25 146.47 51.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 121.915 2.143 . . . . 0.0 111.842 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.42 -49.04 3.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.382 0.673 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.51 153.25 6.22 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 123.38 0.514 . . . . 0.0 111.836 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 30.6 t-105 -156.41 -130.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.802 1.241 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -152.94 155.22 36.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.806 2.842 . . . . 0.0 106.942 -169.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.4 143.15 37.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 0.85 . . . . 0.0 110.285 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.5 164.76 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.039 0.936 . . . . 0.0 110.52 -169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.25 147.98 5.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.735 0.814 . . . . 0.0 110.011 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -54.14 -40.73 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -93.14 2.76 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.64 -47.82 75.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 120.767 -1.208 . . . . 0.0 111.126 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -64.97 -32.77 53.57 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.913 1.719 . . . . 0.0 112.886 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.65 -33.4 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 119.784 1.174 . . . . 0.0 109.931 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.43 -41.95 75.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.835 1.198 . . . . 0.0 110.063 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -83.83 -18.77 36.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.21 160.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.601 1.091 . . . . 0.0 109.714 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.4 m -51.69 143.59 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.649 1.18 . . . . 0.0 111.576 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.8 m -59.89 -30.97 69.37 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -69.96 -47.18 63.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.144 0.884 . . . . 0.0 109.696 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -75.84 -27.41 57.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.553 -174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -40.2 -49.27 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.556 1.142 . . . . 0.0 112.887 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.88 -38.56 91.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.47 0.577 . . . . 0.0 111.797 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.13 -34.31 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 O-C-N 121.751 -0.593 . . . . 0.0 110.009 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -31.34 72.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.132 0.878 . . . . 0.0 109.97 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -55.65 -36.67 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.231 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -61.67 -51.2 69.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.907 1.23 . . . . 0.0 108.764 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -54.78 -48.05 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.2 mtt -69.53 -41.12 76.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.229 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -58.86 -41.54 87.27 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.953 0.797 . . . . 0.0 110.128 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.63 -33.6 74.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.764 0.426 . . . . 0.0 110.85 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -98.35 -9.43 25.34 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.82 -57.97 7.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.695 1.134 . . . . 0.0 112.036 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.149 -0.345 . . . . 0.0 111.538 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.9 t -73.95 -39.67 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.52 -54.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -62.78 -26.27 68.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.53 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.5 m -57.73 -31.24 66.24 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.267 1.394 . . . . 0.0 111.848 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.23 -27.2 66.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.547 0.739 . . . . 0.0 110.946 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -96.98 -32.07 12.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.82 0.848 . . . . 0.0 110.976 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 124.376 1.071 . . . . 0.0 110.806 -179.809 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -124.18 166.48 15.75 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.477 2.311 . . . . 0.0 108.77 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 42.38 47.5 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.799 2.039 . . . . 0.0 114.517 170.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.34 18.71 8.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.741 2.016 . . . . 0.0 114.267 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.72 -1.14 0.1 OUTLIER Glycine 0 C--N 1.34 0.756 0 N-CA-C 116.611 1.405 . . . . 0.0 116.611 169.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.68 130.43 37.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 120.763 2.282 . . . . 0.0 110.531 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -78.9 115.53 52.95 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.325 -1.321 . . . . 0.0 108.387 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.4 118.02 5.02 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.545 2.163 . . . . 0.0 107.941 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 95' ' ' GLN . 4.9 p30 -144.83 167.86 21.59 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.688 0.795 . . . . 0.0 109.442 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.36 135.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.38 8.29 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.45 105.87 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.59 83.93 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.493 -2.039 . . . . 0.0 105.493 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.11 131.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -122.38 129.02 51.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.75 140.85 30.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -63.04 -0.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 115.101 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -81.36 0.42 37.38 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.999 0.818 . . . . 0.0 109.579 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.55 28.04 37.09 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 124.846 1.213 . . . . 0.0 112.11 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -122.09 154.9 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -113.94 163.02 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -168.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.6 tpt -50.87 130.58 25.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.008 2.123 . . . . 0.0 111.777 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 5.3 t-105 -163.73 124.16 2.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 169.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.56 142.74 45.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.857 1.313 . . . . 0.0 112.972 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.1 ttp85 -78.43 140.65 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.754 2.421 . . . . 0.0 107.902 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -88.0 151.27 22.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.135 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.24 156.62 24.91 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.439 1.495 . . . . 0.0 112.163 171.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.9 25.32 30.1 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.376 0.989 . . . . 0.0 110.88 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -10.0 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 131.294 3.837 . . . . 0.0 117.198 -167.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -151.35 6.64 0.49 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.181 168.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -154.68 147.66 24.61 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 109.058 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -121.08 131.87 54.53 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.18 -176.34 4.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.171 0.988 . . . . 0.0 111.665 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.69 156.64 52.31 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.95 2.1 . . . . 0.0 109.433 -170.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.94 155.11 71.11 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.595 2.864 . . . . 0.0 113.919 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 71.08 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.672 3.589 . . . . 0.0 105.716 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 121.63 7.29 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.481 1.038 . . . . 0.0 114.525 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.89 145.78 14.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.929 2.204 . . . . 0.0 113.445 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.96 136.45 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.632 1.173 . . . . 0.0 108.437 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -77.88 138.61 61.63 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 117.601 -1.19 . . . . 0.0 109.251 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.44 118.76 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.711 1.607 . . . . 0.0 112.678 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.56 89.79 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.109 176.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.95 129.32 35.28 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.08 159.6 34.42 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 124.685 1.194 . . . . 0.0 110.645 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -41.75 66.47 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.492 1.117 . . . . 0.0 113.841 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.76 -47.34 54.35 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.07 -40.61 85.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.149 1.38 . . . . 0.0 109.405 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.93 -27.89 62.12 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.0 1.32 . . . . 0.0 111.593 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.8 -40.85 95.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 79.0 m-85 -68.19 -30.4 69.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.217 -1.552 . . . . 0.0 112.838 172.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.829 -1.169 . . . . 0.0 109.954 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.5 -29.33 65.82 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.663 0.665 . . . . 0.0 112.134 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.84 -41.7 97.77 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.626 -1.296 . . . . 0.0 108.604 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.01 -53.75 34.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.327 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.62 -28.33 68.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.336 1.426 . . . . 0.0 113.378 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -115.14 -12.08 11.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.26 0.936 . . . . 0.0 113.278 -168.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.97 -20.45 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.092 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.66 55.24 31.64 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.35 -1.469 . . . . 0.0 110.126 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.2 159.51 41.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.499 1.92 . . . . 0.0 106.775 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 m -117.34 -177.18 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.502 1.121 . . . . 0.0 110.458 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 14.6 mtt180 -70.9 36.33 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.369 2.268 . . . . 0.0 113.578 -171.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.52 -19.83 0.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.965 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -83.39 -5.19 59.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 112.525 -169.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.66 167.63 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.583 1.153 . . . . 0.0 109.468 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -136.19 120.18 17.58 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.674 1.99 . . . . 0.0 105.926 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.99 128.92 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.07 -35.85 7.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.16 0.584 . . . . 0.0 111.215 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.16 163.8 39.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.218 1.007 . . . . 0.0 108.756 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -146.09 156.22 43.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 108.1 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 p -63.72 150.55 44.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.013 0.824 . . . . 0.0 109.991 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -70.29 -31.99 69.58 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.041 -0.412 . . . . 0.0 111.49 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.31 176.66 10.36 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.656 1.982 . . . . 0.0 108.077 172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -66.62 117.39 8.72 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.236 0.614 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.78 151.34 46.76 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -145.32 134.01 22.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -149.82 158.52 44.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -95.75 153.61 17.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.285 0.564 . . . . 0.0 111.308 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.25 148.16 46.64 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.05 153.4 67.62 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.37 2.713 . . . . 0.0 109.414 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.39 -20.36 66.34 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.33 -27.41 61.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 tp -94.9 -27.59 15.62 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.061 0.944 . . . . 0.0 110.572 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -56.0 134.04 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -41.28 41.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.6 m95 60.95 5.79 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.88 2.072 . . . . 0.0 113.685 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.81 -19.92 14.11 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.889 1.275 . . . . 0.0 111.837 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -76.6 153.4 35.35 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.979 1.711 . . . . 0.0 108.771 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.66 113.84 9.35 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.027 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -53.91 147.57 16.26 Favored 'Cis proline' 0 CA--C 1.538 0.717 0 CA-C-N 120.199 1.107 . . . . 0.0 111.845 -10.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.32 129.37 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.8 t -80.37 97.98 7.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.2 pt -88.08 -15.98 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.374 1.469 . . . . 0.0 111.865 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 172.78 45.03 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 120.662 1.574 . . . . 0.0 113.028 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.413 ' HB3' HD21 ' A' ' 10' ' ' ASN . 25.6 mm-40 -105.87 129.62 54.0 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -97.2 113.91 25.56 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.45 127.54 35.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -103.52 129.52 50.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -103.57 133.6 48.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.99 129.2 55.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.7 tp -83.7 113.84 21.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.5 mm? -113.48 121.64 44.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 123.749 0.82 . . . . 0.0 109.619 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -83.56 137.19 33.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' HA2' ' A' ' 107' ' ' GLY . 73.4 mt -63.05 139.51 58.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.363 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.54 -25.0 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.515 1.126 . . . . 0.0 108.013 169.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.3 p -119.57 -61.82 1.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 110.381 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.545 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 80.4 -147.29 28.31 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -43.64 -36.44 2.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.476 1.91 . . . . 0.0 113.56 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.98 66.98 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -123.33 -16.39 6.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.352 1.461 . . . . 0.0 112.431 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.48 143.89 9.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -134.06 -48.02 0.79 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.043 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.0 mtt 58.86 -1.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.38 23.98 8.83 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.774 2.079 . . . . 0.0 111.262 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -35.64 66.51 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.023 2.529 . . . . 0.0 111.374 169.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.81 3.9 15.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.013 1.725 . . . . 0.0 112.717 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 70.15 -42.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 129.485 3.114 . . . . 0.0 114.483 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.5 p -133.51 34.67 0.26 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 113.914 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.77 160.99 40.09 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.746 1.659 . . . . 0.0 110.461 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.768 1.627 . . . . 0.0 113.609 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.05 144.46 42.99 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.398 0.618 . . . . 0.0 112.657 -168.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 -6.68 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.327 1.051 . . . . 0.0 113.62 -171.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.61 162.84 35.38 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -138.5 149.87 45.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.89 0.845 . . . . 0.0 111.417 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -150.55 128.07 11.49 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.815 1.646 . . . . 0.0 107.134 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -82.0 138.32 34.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.67 167.93 23.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.598 1.159 . . . . 0.0 110.459 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -49.03 144.74 4.52 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.198 0.999 . . . . 0.0 109.601 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -53.89 -36.91 63.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -94.17 -3.66 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.79 -45.8 96.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.011 -1.471 . . . . 0.0 111.974 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.11 -36.32 99.17 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.947 1.731 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -40.01 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -76.68 -29.38 56.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.822 1.192 . . . . 0.0 111.577 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.43 -28.09 46.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.02 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.45 156.04 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.547 1.067 . . . . 0.0 110.947 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.16 148.05 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.46 1.504 . . . . 0.0 111.88 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -58.75 -34.95 71.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.834 1.254 . . . . 0.0 113.911 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -71.36 -25.94 62.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.032 0.833 . . . . 0.0 111.437 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.67 -38.07 15.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.117 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -47.78 -47.48 30.76 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.082 1.31 . . . . 0.0 112.972 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.66 -35.79 81.01 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.383 0.538 . . . . 0.0 112.032 -174.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.64 -35.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.37 0.668 . . . . 0.0 110.596 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.91 -31.9 73.35 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.989 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -56.65 -37.32 70.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.119 169.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.63 -47.4 81.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.091 1.314 . . . . 0.0 108.886 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.22 -50.6 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.722 0.809 . . . . 0.0 109.307 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.8 mtt -65.69 -40.72 92.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.099 -0.477 . . . . 0.0 111.251 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -58.79 -39.77 82.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.444 1.098 . . . . 0.0 110.547 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.9 -23.26 62.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.704 0.402 . . . . 0.0 111.25 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -107.53 -9.6 15.89 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.28 16.98 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.473 1.033 . . . . 0.0 111.542 -169.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -62.81 -25.28 68.17 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.126 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.43 -43.52 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.59 -36.48 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -69.42 -35.81 76.08 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.835 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -59.58 -31.5 69.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.737 1.153 . . . . 0.0 112.031 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.25 -25.17 67.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.152 0.581 . . . . 0.0 111.361 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -104.65 -32.37 8.94 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.166 0.986 . . . . 0.0 110.987 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 124.503 1.121 . . . . 0.0 111.262 -176.628 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.83 -44.31 49.91 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.522 1.129 . . . . 0.0 111.306 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.8 -77.78 0.12 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.904 0.882 . . . . 0.0 111.138 170.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.55 -48.92 7.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.39 6.15 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.316 0.887 . . . . 0.0 115.316 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -96.93 134.33 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.35 1.575 . . . . 0.0 109.902 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -86.38 127.16 62.18 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.776 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.84 130.84 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.397 2.065 . . . . 0.0 108.624 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.48 177.2 11.74 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -130.59 135.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.71 136.23 12.86 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.48 142.23 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 118.94 1.37 . . . . 0.0 107.805 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.42 89.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -66.89 136.46 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -124.45 118.21 26.14 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -74.01 141.88 45.79 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -68.16 -9.66 48.37 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.07 -10.19 59.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.79 0.723 . . . . 0.0 111.328 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.13 39.2 3.35 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 125.926 1.727 . . . . 0.0 112.434 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -136.35 150.91 49.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.65 161.72 4.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.885 0.874 . . . . 0.0 112.68 -169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 128.51 36.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.006 1.322 . . . . 0.0 109.325 170.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.427 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 2.6 t-105 -160.23 128.81 4.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 168.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.1 148.45 41.74 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -69.08 140.68 54.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -77.77 119.86 21.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -44.61 126.33 5.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.544 1.938 . . . . 0.0 110.583 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.65 -2.05 25.75 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.532 1.063 . . . . 0.0 115.259 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -126.93 -24.72 3.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.032 1.416 . . . . 0.0 111.454 -172.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.66 14.29 8.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.284 1.833 . . . . 0.0 115.198 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.2 p -104.45 -143.18 0.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.98 1.312 . . . . 0.0 107.647 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.427 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 62.7 m95 -127.96 168.16 15.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.098 1.317 . . . . 0.0 109.946 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -152.44 150.77 30.0 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.147 0.979 . . . . 0.0 109.42 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -81.6 139.92 47.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.943 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.68 137.83 75.81 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.657 1.571 . . . . 0.0 111.642 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -157.55 147.83 20.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.729 1.212 . . . . 0.0 111.101 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.13 -126.38 5.56 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.523 1.059 . . . . 0.0 112.156 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.51 118.48 0.45 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.62 125.58 39.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -75.46 155.18 85.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.13 116.72 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.638 1.559 . . . . 0.0 111.039 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.25 7.75 87.3 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.079 1.323 . . . . 0.0 113.188 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -80.29 125.26 29.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.427 1.113 . . . . 0.0 108.601 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.72 157.34 37.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.483 1.113 . . . . 0.0 110.312 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.74 -41.09 69.99 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -169.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -71.58 -39.82 70.32 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -65.06 -44.26 89.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -27.03 69.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.383 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.466 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 17.0 tmm? -72.21 -43.74 64.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.411 1.005 . . . . 0.0 109.032 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -66.31 -30.99 71.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.114 0.87 . . . . 0.0 110.903 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -62.21 -49.2 76.72 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.659 -0.651 . . . . 0.0 109.607 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.06 77.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.145 0.978 . . . . 0.0 111.277 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.64 -39.98 95.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.183 1.393 . . . . 0.0 109.446 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.19 -50.87 59.43 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.866 0.866 . . . . 0.0 110.056 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.54 -40.94 88.89 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.521 1.055 . . . . 0.0 112.002 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -95.21 -49.36 5.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.287 0.635 . . . . 0.0 111.082 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.21 -17.7 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.4 0.68 . . . . 0.0 110.599 -169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.71 55.72 29.27 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -134.22 162.94 30.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.287 2.235 . . . . 0.0 106.507 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 m -119.0 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.356 0.662 . . . . 0.0 110.09 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -72.19 49.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.323 1.849 . . . . 0.0 114.503 -171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -163.4 -23.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.57 1.548 . . . . 0.0 112.294 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.27 1.1 52.15 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 m -149.05 171.16 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 109.727 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -138.91 124.53 19.55 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -79.91 131.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 120.655 1.571 . . . . 0.0 107.304 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -102.73 -45.94 4.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.51 169.3 19.86 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.88 0.872 . . . . 0.0 110.554 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -145.86 162.73 37.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 p -65.05 141.97 58.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -67.11 -22.03 65.83 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -170.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -141.85 177.58 8.08 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.523 1.529 . . . . 0.0 107.441 169.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -72.16 129.48 38.58 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 75' ' ' LEU . 4.2 mm? -79.85 160.04 26.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -156.61 151.86 26.49 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 108.345 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.06 172.91 12.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.001 1.72 . . . . 0.0 106.956 172.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -112.84 128.51 56.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.71 145.39 98.08 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -63.3 154.66 66.64 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 108.513 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.72 -29.94 68.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -73.22 -25.83 60.9 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.037 0.935 . . . . 0.0 112.728 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 tp -101.2 -19.38 15.73 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.815 0.846 . . . . 0.0 111.865 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.7 t -48.01 135.23 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -88.53 101.65 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.529 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.37 -2.33 57.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.363 0.665 . . . . 0.0 110.88 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.81 -30.55 40.53 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.636 -0.665 . . . . 0.0 110.096 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.4 161.12 23.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.564 1.146 . . . . 0.0 109.814 -173.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -137.26 114.63 9.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -59.18 153.58 43.04 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.004 1.037 . . . . 0.0 110.828 -10.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.49 138.12 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.7 t -97.56 120.8 38.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 pt -107.47 -10.18 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.282 1.033 . . . . 0.0 112.531 -169.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.97 168.63 40.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.158 0.89 . . . . 0.0 111.673 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -104.61 123.51 47.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -85.26 118.92 25.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 120.37 14.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.96 1.254 . . . . 0.0 113.164 -173.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -98.92 128.92 45.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -97.69 149.65 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 41.3 m-85 -119.53 126.79 52.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.3 111.58 19.54 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 102' ' ' LEU . 19.9 mt -107.48 131.23 54.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 124.465 1.103 . . . . 0.0 110.64 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.17 136.26 33.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.12 132.69 44.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -116.16 -37.8 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.7 m -85.2 -133.09 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.96 173.5 46.3 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 120.369 1.441 . . . . 0.0 111.403 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.4 -31.73 46.27 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.966 1.307 . . . . 0.0 112.859 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.45 -27.9 67.42 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.246 0.618 . . . . 0.0 112.431 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.86 -24.73 13.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.37 1.468 . . . . 0.0 110.908 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.46 142.54 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.724 1.61 . . . . 0.0 107.256 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -124.98 -38.77 2.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.51 -15.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.963 2.105 . . . . 0.0 116.173 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.94 27.94 8.98 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.849 1.659 . . . . 0.0 111.574 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -68.62 -36.98 79.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -91.76 6.39 46.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.074 0.949 . . . . 0.0 113.5 -169.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m 67.85 -36.1 0.29 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.489 2.716 . . . . 0.0 114.962 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -128.4 66.84 74.63 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.706 1.602 . . . . 0.0 108.33 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -77.05 -168.62 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.575 2.85 . . . . 0.0 110.467 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.7 -11.0 14.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.525 169.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.51 145.21 49.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 121.017 1.735 . . . . 0.0 114.03 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.62 116.66 25.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.003 2.921 . . . . 0.0 105.004 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.81 143.55 42.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.215 0.912 . . . . 0.0 113.277 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -114.44 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.035 0.934 . . . . 0.0 109.622 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -140.91 155.21 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.951 1.3 . . . . 0.0 110.106 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -79.68 149.6 31.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 161.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.842 0.857 . . . . 0.0 110.003 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -53.3 150.13 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.592 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.44 149.65 20.36 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.1 -15.08 0.13 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 -44.17 99.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 121.322 1.874 . . . . 0.0 111.937 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -63.99 -25.88 66.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.885 1.724 . . . . 0.0 114.702 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.48 -36.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.855 1.207 . . . . 0.0 108.928 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -83.39 -16.26 46.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 117.9 -1.047 . . . . 0.0 112.21 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -86.26 -31.1 21.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.977 1.262 . . . . 0.0 112.341 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -68.88 165.34 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.303 0.956 . . . . 0.0 111.755 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.55 151.24 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.9 1.28 . . . . 0.0 111.148 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -59.12 -34.49 72.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.104 1.362 . . . . 0.0 113.822 -169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -71.55 -26.02 62.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.025 0.829 . . . . 0.0 111.468 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -94.64 -29.32 14.9 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.14 0.976 . . . . 0.0 112.317 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -36.9 -53.71 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.721 2.009 . . . . 0.0 112.638 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -35.29 74.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.418 0.553 . . . . 0.0 110.977 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 75' ' ' LEU . 72.2 t -72.7 -36.04 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.648 -0.657 . . . . 0.0 109.682 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -68.15 -34.82 77.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.261 0.937 . . . . 0.0 110.791 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -58.01 -39.54 78.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.577 1.151 . . . . 0.0 111.373 169.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -64.31 -47.44 79.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.144 0.884 . . . . 0.0 109.618 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.31 -45.33 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.593 0.633 . . . . 0.0 109.603 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtt -65.49 -43.22 90.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.647 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -26.03 65.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.3 1.863 . . . . 0.0 112.315 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -65.31 -23.49 67.03 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.718 0.69 . . . . 0.0 110.358 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -116.09 -21.49 9.41 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.358 1.063 . . . . 0.0 113.442 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.1 -58.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.578 1.151 . . . . 0.0 110.607 -172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.5 m -66.17 -21.48 66.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.456 0.571 . . . . 0.0 111.995 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.76 -41.5 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.61 -48.72 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.1 mtt -66.52 -18.79 65.56 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.71 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.7 m -63.19 -24.22 67.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.713 1.142 . . . . 0.0 111.873 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.97 -49.72 27.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.671 0.668 . . . . 0.0 109.348 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.67 -23.42 56.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.704 0.402 . . . . 0.0 111.206 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 125.91 1.684 . . . . 0.0 109.808 177.037 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.02 162.13 29.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.379 1.472 . . . . 0.0 108.707 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.6 -36.48 64.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.9 5.96 26.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.23 31.24 14.58 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.792 1.187 . . . . 0.0 111.75 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 19.5 m-85 -108.42 134.57 51.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.892 1.346 . . . . 0.0 109.127 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -82.55 127.34 70.95 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.52 130.5 11.82 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.142 1.894 . . . . 0.0 109.322 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.6 160.65 39.37 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.728 1.211 . . . . 0.0 110.705 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.3 148.3 18.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.596 1.958 . . . . 0.0 106.431 169.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.14 131.06 6.11 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.44 127.29 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.53 91.78 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 mm -66.39 134.12 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 168.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.8 m -119.32 126.26 51.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 168.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -86.62 35.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.904 -0.498 . . . . 0.0 111.216 -169.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.265 13.7 ptp180 40.87 7.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.906 4.082 . . . . 0.0 116.558 -169.038 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -95.39 3.65 54.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.03 0.932 . . . . 0.0 111.471 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.31 64.34 Favored Glycine 0 N--CA 1.47 0.92 0 O-C-N 121.021 -1.049 . . . . 0.0 112.089 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -121.78 149.81 42.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.571 1.548 . . . . 0.0 107.005 -169.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.3 160.07 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.459 1.104 . . . . 0.0 113.204 -169.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ttt -58.31 134.61 56.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.332 1.453 . . . . 0.0 109.977 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -157.69 133.69 9.38 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 169.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.06 144.31 27.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.504 0.669 . . . . 0.0 110.458 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.92 132.35 36.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.229 1.411 . . . . 0.0 107.786 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -93.72 134.92 35.54 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.59 0.756 . . . . 0.0 109.248 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -47.55 132.79 13.65 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.832 1.253 . . . . 0.0 111.591 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.22 -23.08 0.75 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.615 1.102 . . . . 0.0 113.564 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.31 -37.75 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.923 0.862 . . . . 0.0 108.956 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.46 28.94 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.448 1.499 . . . . 0.0 112.262 -174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -149.78 175.82 11.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.28 1.832 . . . . 0.0 107.266 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -78.06 153.81 31.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.729 0.812 . . . . 0.0 112.639 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -146.48 162.29 38.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 109.37 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -84.67 151.1 57.85 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.886 2.074 . . . . 0.0 110.746 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -68.4 156.97 63.77 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.886 2.391 . . . . 0.0 113.022 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 179.96 148.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.921 2.488 . . . . 0.0 108.322 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 142.15 8.68 Favored Glycine 0 C--N 1.337 0.638 0 O-C-N 121.134 -0.978 . . . . 0.0 110.883 170.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.73 50.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.786 1.184 . . . . 0.0 111.027 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -87.42 134.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.387 1.075 . . . . 0.0 109.108 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -65.82 126.46 91.77 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.627 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.32 118.2 5.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.074 1.849 . . . . 0.0 111.585 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.87 0.17 75.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.577 1.56 . . . . 0.0 113.083 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -83.7 132.93 34.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.677 1.191 . . . . 0.0 108.048 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 159.39 34.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.984 0.913 . . . . 0.0 110.346 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.76 71.81 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.059 1.344 . . . . 0.0 112.315 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.38 -40.6 73.86 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -62.16 -43.5 98.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 108.967 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.956 0.502 . . . . 0.0 111.93 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -61.68 -44.71 96.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.883 0.765 . . . . 0.0 110.06 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -65.78 -29.3 69.78 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.961 1.255 . . . . 0.0 113.046 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -59.38 -50.67 73.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.237 1.381 . . . . 0.0 109.087 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.08 66.79 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.134 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.14 -43.32 99.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.832 -1.167 . . . . 0.0 108.455 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -66.51 -45.12 80.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.702 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -69.49 -48.88 59.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.523 1.51 . . . . 0.0 112.211 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -85.66 -29.59 23.88 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.124 0.97 . . . . 0.0 111.783 -168.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.35 -15.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.5 0.72 . . . . 0.0 110.379 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.25 11.33 70.97 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 120.746 -1.221 . . . . 0.0 113.12 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.37 151.41 21.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.131 0.966 . . . . 0.0 109.189 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -102.74 174.05 6.06 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.034 0.933 . . . . 0.0 108.909 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -70.42 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 115.065 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.41 -11.44 0.18 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.221 1.808 . . . . 0.0 112.705 -169.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -97.91 2.27 48.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.451 0.7 . . . . 0.0 110.96 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.88 171.89 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.751 1.221 . . . . 0.0 108.419 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -140.57 122.61 15.63 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 -171.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -75.47 129.82 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 -34.17 6.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.813 0.445 . . . . 0.0 110.702 176.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.7 166.5 32.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.679 1.192 . . . . 0.0 108.234 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -140.54 157.25 45.76 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -58.62 138.34 56.97 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 119.467 1.03 . . . . 0.0 108.474 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.46 -24.82 66.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.789 0.436 . . . . 0.0 112.074 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.48 174.16 11.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -61.7 126.64 28.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.12 131.31 45.19 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 170.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.37 134.66 52.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -143.02 131.6 22.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 117.51 24.63 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.18 147.47 80.98 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.866 1.266 . . . . 0.0 110.25 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.44 150.54 87.03 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.582 1.521 . . . . 0.0 109.015 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -48.83 -48.44 41.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.016 0.927 . . . . 0.0 113.367 -169.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.88 -16.48 63.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.197 0.999 . . . . 0.0 113.003 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -108.07 -3.75 18.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.169 1.388 . . . . 0.0 111.749 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.41 137.56 21.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 169.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -91.0 127.52 36.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -111.36 0.18 16.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.123 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.84 -17.59 35.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.106 0.562 . . . . 0.0 109.724 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.0 p -91.43 156.51 17.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.257 0.623 . . . . 0.0 109.328 -171.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -131.38 110.25 15.05 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.88 155.94 60.44 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.447 1.195 . . . . 0.0 112.117 -4.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.4 m -60.54 133.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 50.7 t -90.06 99.52 12.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.6 pt -88.89 -6.42 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.416 1.486 . . . . 0.0 112.027 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -158.43 153.72 24.86 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 120.514 1.506 . . . . 0.0 113.566 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.91 94.21 5.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -71.02 126.17 28.85 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.63 111.7 5.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.224 0.92 . . . . 0.0 110.273 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -89.3 125.81 35.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 169.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -98.27 146.8 25.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -123.87 126.14 45.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.815 1.246 . . . . 0.0 107.715 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.2 tp -78.46 111.12 14.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.7 mm? -106.84 121.92 45.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.022 0.929 . . . . 0.0 108.609 174.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -82.84 137.25 34.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.35 139.99 58.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.73 -41.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 m -136.41 142.56 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.3 -168.8 40.73 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.713 -0.617 . . . . 0.0 112.937 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.07 -56.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 131.443 3.897 . . . . 0.0 112.882 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.58 -35.44 24.71 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.174 0.99 . . . . 0.0 110.786 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -86.09 -18.72 31.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.405 0.682 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.94 138.8 22.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -153.69 84.81 1.17 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.5 mtt -70.79 24.67 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.249 0.62 . . . . 0.0 112.404 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -132.92 20.43 4.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.999 1.72 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.84 -51.46 50.99 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.926 2.09 . . . . 0.0 110.951 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 m -86.09 3.93 40.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.604 1.162 . . . . 0.0 112.869 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 63.01 117.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 128.07 2.548 . . . . 0.0 112.417 -169.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 p 34.78 53.06 1.49 Allowed Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 111.783 -2.462 . . . . 0.0 113.325 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.37 -54.15 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.898 1.732 . . . . 0.0 113.26 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -160.79 -45.54 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.846 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -115.52 135.92 53.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -169.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.64 -31.9 15.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.714 2.005 . . . . 0.0 112.007 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -170.77 156.63 27.06 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 123.896 0.76 . . . . 0.0 111.75 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -120.48 150.73 40.37 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.082 1.353 . . . . 0.0 111.39 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -150.05 130.1 13.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.758 1.623 . . . . 0.0 108.627 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -84.56 140.0 31.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.03 0.832 . . . . 0.0 108.934 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.17 166.88 17.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.943 1.297 . . . . 0.0 109.835 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -56.26 150.69 13.98 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.893 0.877 . . . . 0.0 111.927 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.42 149.26 34.63 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.5 m95 65.5 -16.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.3 1.84 . . . . 0.0 115.857 -170.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -65.22 -48.38 69.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 121.235 1.834 . . . . 0.0 110.898 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -59.55 -30.23 91.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 121.81 1.682 . . . . 0.0 113.391 173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -39.45 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.544 -0.722 . . . . 0.0 110.027 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -73.16 -37.15 66.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 120.683 -1.261 . . . . 0.0 110.035 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -80.74 -24.92 38.37 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.49 156.92 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.172 0.896 . . . . 0.0 109.352 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.9 m -58.46 150.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.388 1.075 . . . . 0.0 110.711 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 m -59.79 -26.81 66.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.897 1.279 . . . . 0.0 114.406 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -72.06 -45.68 59.82 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.356 0.98 . . . . 0.0 110.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.54 -29.5 52.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.159 -1.4 . . . . 0.0 111.419 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -43.3 -48.17 6.75 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.564 1.529 . . . . 0.0 111.156 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -73.23 -22.29 60.46 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -79.26 -47.48 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.231 -0.918 . . . . 0.0 108.658 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -31.7 70.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.794 0.838 . . . . 0.0 110.568 -169.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -64.95 -33.76 76.8 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.268 -0.895 . . . . 0.0 111.264 172.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -69.92 -44.96 68.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.29 -46.87 85.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.171 0.588 . . . . 0.0 110.001 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 47.2 mtt -66.34 -40.49 89.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.203 -0.936 . . . . 0.0 110.987 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.11 -37.22 86.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.367 0.985 . . . . 0.0 111.01 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.84 -28.06 69.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.805 0.842 . . . . 0.0 110.985 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -113.94 -11.66 12.76 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.07 -54.8 38.46 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.94 1.245 . . . . 0.0 110.755 -170.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -81.12 25.63 0.47 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.615 0.766 . . . . 0.0 112.6 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.69 -18.31 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.164 1.786 . . . . 0.0 108.773 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 73.1 t -96.95 -52.79 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.768 1.227 . . . . 0.0 108.087 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.0 mmt -64.77 -16.41 62.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.283 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 m -48.92 -33.23 10.42 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.874 1.67 . . . . 0.0 113.194 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.9 mt -83.0 -29.58 28.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 110.509 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -96.87 -25.92 15.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.325 1.05 . . . . 0.0 112.189 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 109.592 176.679 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.97 145.81 48.15 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.635 1.574 . . . . 0.0 108.144 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -44.59 -37.49 3.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.058 1.874 . . . . 0.0 116.058 -168.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -81.96 2.13 32.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.51 24.85 11.57 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.776 1.655 . . . . 0.0 112.009 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -111.03 148.7 32.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.668 1.734 . . . . 0.0 110.843 -170.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -87.89 112.45 49.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.211 -1.555 . . . . 0.0 107.412 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.84 130.32 15.53 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.492 2.128 . . . . 0.0 109.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -154.84 170.99 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.465 1.106 . . . . 0.0 110.855 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.91 130.31 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.481 1.513 . . . . 0.0 108.796 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.33 126.63 8.98 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mm -91.5 104.12 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 81.35 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.9 mm -63.79 130.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.17 128.33 55.87 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.82 18.34 6.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 53.5 10.68 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.106 1.762 . . . . 0.0 115.341 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -109.87 6.97 23.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.304 1.041 . . . . 0.0 111.945 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.74 79.28 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.796 -1.19 . . . . 0.0 112.731 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -128.51 158.57 38.03 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.893 1.677 . . . . 0.0 106.851 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.37 167.61 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 128.2 32.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.347 1.859 . . . . 0.0 110.873 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.417 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -164.46 131.53 3.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 167.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.76 142.42 44.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -76.6 144.92 39.27 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -95.71 126.71 41.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -61.17 144.64 53.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.705 0.684 . . . . 0.0 110.586 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 -28.24 0.85 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.361 1.457 . . . . 0.0 114.158 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -97.06 -28.33 14.19 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.606 1.162 . . . . 0.0 110.357 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 65.13 -8.65 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.788 2.435 . . . . 0.0 115.213 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -178.66 6.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.263 1.025 . . . . 0.0 108.455 169.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.417 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 73.8 m95 -90.03 162.07 15.53 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.84 -1.163 . . . . 0.0 110.704 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -140.15 148.03 41.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.045 0.926 . . . . 0.0 110.848 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -79.76 164.9 50.95 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 127.335 2.254 . . . . 0.0 110.186 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.71 -92.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.664 2.91 . . . . 0.0 110.289 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 53.78 61.37 3.12 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.469 1.108 . . . . 0.0 111.563 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.81 117.27 4.46 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.1 142.71 27.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 125.997 1.76 . . . . 0.0 111.485 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.0 mt -77.4 139.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.994 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -77.71 136.06 63.57 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.356 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -54.99 118.27 4.96 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.631 1.554 . . . . 0.0 113.491 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.48 89.74 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.961 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -83.86 123.28 29.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.281 1.032 . . . . 0.0 108.513 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -72.59 160.52 32.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.269 1.028 . . . . 0.0 110.508 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.5 79.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.061 . . . . 0.0 111.129 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.5 12.82 3.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.633 0.773 . . . . 0.0 111.181 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -114.18 -54.21 2.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.408 1.883 . . . . 0.0 106.088 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -33.08 73.41 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.476 1.11 . . . . 0.0 112.335 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -61.29 -45.07 95.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -71.86 -27.87 63.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.617 -0.677 . . . . 0.0 111.292 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -62.19 -48.71 78.83 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.243 -0.91 . . . . 0.0 109.409 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.76 -32.93 73.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.801 0.728 . . . . 0.0 111.362 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 tp -60.34 -40.72 91.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.65 1.18 . . . . 0.0 109.419 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.34 -54.08 9.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.336 1.054 . . . . 0.0 111.456 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.97 -41.72 81.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.635 1.562 . . . . 0.0 110.834 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -92.96 -49.01 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.205 0.457 . . . . 0.0 110.836 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.15 -26.38 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.998 0.519 . . . . 0.0 110.583 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.69 58.84 6.55 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.747 -1.22 . . . . 0.0 110.074 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 mt -138.34 156.18 47.86 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.085 2.154 . . . . 0.0 107.834 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 m -116.75 -178.51 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.868 0.867 . . . . 0.0 111.513 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.74 41.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 128.368 2.667 . . . . 0.0 113.61 -174.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -164.72 -20.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.079 1.352 . . . . 0.0 112.361 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -87.59 -1.04 57.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -169.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.85 167.5 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.151 1.38 . . . . 0.0 108.925 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -138.78 121.37 16.24 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -74.84 130.94 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 120.104 1.32 . . . . 0.0 107.844 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -33.71 6.07 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.008 0.923 . . . . 0.0 111.162 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.74 169.18 25.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.362 1.465 . . . . 0.0 108.546 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 m -145.37 162.04 38.21 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.083 1.353 . . . . 0.0 107.833 172.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -62.06 149.1 42.05 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.425 1.011 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.5 -33.43 75.57 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.151 -0.343 . . . . 0.0 111.153 -169.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.17 -176.21 5.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.914 2.086 . . . . 0.0 106.395 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -61.38 120.17 9.94 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 160.01 29.28 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -161.33 163.2 30.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 120.704 -1.248 . . . . 0.0 111.118 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.49 159.69 41.23 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.145 1.378 . . . . 0.0 107.764 169.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -101.31 127.48 47.91 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 106.657 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -68.49 145.31 97.13 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.43 156.75 57.93 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.033 2.489 . . . . 0.0 110.104 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -52.02 -42.0 62.69 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 113.582 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -76.26 -23.95 54.47 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.285 1.034 . . . . 0.0 113.06 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.33 -24.56 19.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.009 0.524 . . . . 0.0 110.894 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.69 137.38 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -42.98 52.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.925 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.5 m95 59.52 5.21 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.304 2.241 . . . . 0.0 113.547 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.95 -21.84 14.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.367 1.467 . . . . 0.0 111.17 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -70.96 147.4 48.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.264 1.426 . . . . 0.0 108.53 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -134.38 113.43 12.19 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.27 154.83 30.92 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.069 1.06 . . . . 0.0 111.54 -10.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -62.87 128.95 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.7 t -89.79 108.94 19.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.2 pt -101.27 -6.28 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 112.835 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.94 178.3 48.74 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 119.851 1.205 . . . . 0.0 112.017 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -108.82 114.82 28.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -78.45 115.8 18.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.88 110.89 8.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.507 0.594 . . . . 0.0 111.818 -168.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -90.1 125.22 35.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -100.21 132.27 45.67 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.04 133.99 51.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.9 106.16 18.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -108.37 130.41 55.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.065 0.946 . . . . 0.0 109.494 -173.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.07 136.13 33.11 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.4 tp -78.32 124.64 28.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.52 -37.83 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.9 m -115.16 110.86 20.13 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.9 -167.36 9.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.96 1.266 . . . . 0.0 115.284 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -44.83 -33.0 1.76 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.702 2.001 . . . . 0.0 113.657 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.67 67.96 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.62 -25.46 11.32 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.359 1.464 . . . . 0.0 111.519 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.93 123.43 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -94.44 -46.53 6.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mtt 46.95 44.09 14.34 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 111.787 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 26.06 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.722 0.809 . . . . 0.0 112.971 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -44.53 63.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.329 1.452 . . . . 0.0 110.718 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 p -80.99 -15.94 54.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.939 1.696 . . . . 0.0 113.085 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.8 m 68.87 -30.27 0.18 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.714 2.406 . . . . 0.0 112.529 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -119.98 64.85 9.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.596 1.558 . . . . 0.0 111.621 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 -5.0 16.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.002 3.134 . . . . 0.0 114.474 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 65.42 -34.08 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.886 2.474 . . . . 0.0 114.359 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -70.5 128.97 37.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.933 0.788 . . . . 0.0 109.494 175.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.89 -14.8 53.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.515 1.126 . . . . 0.0 111.522 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.4 135.98 4.78 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -150.82 -129.74 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.781 0.432 . . . . 0.0 110.445 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -145.03 162.86 35.9 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.483 1.913 . . . . 0.0 108.508 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -82.14 152.84 26.32 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.338 0.399 . . . . 0.0 110.342 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.25 164.21 35.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.58 0.752 . . . . 0.0 110.718 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -54.11 145.94 15.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.355 1.062 . . . . 0.0 110.385 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -36.81 69.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.626 0.77 . . . . 0.0 111.904 -169.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -90.42 -5.39 56.17 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.05 -1.031 . . . . 0.0 112.639 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.5 -44.21 80.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.454 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.67 -33.82 92.86 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.14 1.8 . . . . 0.0 112.889 176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.59 -36.19 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 O-C-N 121.86 -0.525 . . . . 0.0 109.588 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -83.63 -15.68 48.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.349 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.52 -20.33 19.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.228 0.922 . . . . 0.0 112.982 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.21 165.27 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 119.616 1.098 . . . . 0.0 110.343 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.87 156.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 110.732 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -56.49 -33.22 65.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.312 -169.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -75.54 -30.68 59.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.131 0.878 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -79.24 -36.77 39.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.729 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -43.83 -50.6 7.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.237 1.415 . . . . 0.0 111.613 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.25 -33.52 76.19 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.731 0.412 . . . . 0.0 111.562 -172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.2 t -82.71 -37.94 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.383 0.673 . . . . 0.0 109.799 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -33.31 75.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.302 -0.874 . . . . 0.0 109.995 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -52.72 -40.48 63.06 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.227 1.011 . . . . 0.0 111.582 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.26 -47.43 79.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.43 -47.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.0 mmt -63.58 -47.09 82.91 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.779 0.718 . . . . 0.0 110.172 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -56.7 -46.15 81.4 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.181 0.992 . . . . 0.0 110.721 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.32 -16.36 63.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.073 0.549 . . . . 0.0 111.582 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.44 -5.58 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.132 1.373 . . . . 0.0 113.343 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.36 -59.0 3.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 112.198 -169.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.8 m -62.16 -26.19 68.19 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.703 0.401 . . . . 0.0 112.043 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.17 -28.91 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.061 0.944 . . . . 0.0 109.605 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.65 -41.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 17.0 mmt -63.92 -38.04 89.64 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.604 0.638 . . . . 0.0 110.751 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 63.0 m -61.98 -18.35 60.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.781 0.719 . . . . 0.0 112.698 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -76.19 -26.75 56.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.572 0.624 . . . . 0.0 110.584 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -107.56 -32.25 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.168 0.987 . . . . 0.0 111.002 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 127.185 2.194 . . . . 0.0 110.605 172.797 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.42 -47.12 57.92 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.14 0.576 . . . . 0.0 111.71 -171.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -153.17 -75.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.856 0.862 . . . . 0.0 110.413 171.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.45 -49.2 7.78 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -169.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.49 14.84 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.531 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -94.22 136.35 34.6 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.793 1.297 . . . . 0.0 110.281 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -86.03 114.03 54.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 173.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.62 134.22 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.967 1.778 . . . . 0.0 109.986 -177.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -159.4 176.01 12.64 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.201 1.001 . . . . 0.0 108.747 172.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.36 140.45 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.07 122.98 7.16 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 mm -73.04 121.73 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.68 88.39 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mm -67.34 131.22 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.5 m -114.72 119.76 37.79 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -83.86 136.46 34.11 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -63.82 -9.61 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.036 1.334 . . . . 0.0 114.367 -173.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.24 -12.26 61.36 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 110.841 169.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.78 34.18 4.75 Favored Glycine 0 C--N 1.346 1.09 0 C-N-CA 126.059 1.79 . . . . 0.0 112.685 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.43 151.7 51.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.96 164.15 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -168.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 tpp -50.96 127.26 18.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.243 1.817 . . . . 0.0 111.628 169.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -157.06 129.75 7.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.49 143.48 28.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.227 0.537 . . . . 0.0 110.014 -171.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -74.86 134.04 41.74 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -80.08 133.74 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.486 0.715 . . . . 0.0 109.269 -169.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.79 134.36 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.48 1.512 . . . . 0.0 109.95 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.1 16.32 76.77 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.993 -0.442 . . . . 0.0 112.513 177.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -139.85 163.34 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.124 2.169 . . . . 0.0 107.296 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -114.82 36.17 3.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 p -150.18 171.78 16.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.226 1.811 . . . . 0.0 108.735 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.99 155.34 22.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.997 1.319 . . . . 0.0 109.249 -171.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.38 146.14 41.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.093 0.949 . . . . 0.0 111.793 -170.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -57.14 143.29 72.98 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 0.0 108.549 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.56 152.79 78.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.973 1.782 . . . . 0.0 112.378 173.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -179.12 132.47 0.12 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.758 2.423 . . . . 0.0 107.173 173.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.11 -114.84 2.56 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.8 164.34 34.45 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.43 2.919 . . . . 0.0 106.758 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.53 124.21 72.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -73.76 136.97 76.92 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 116.895 -1.526 . . . . 0.0 107.615 171.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -56.13 117.68 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 121.857 1.699 . . . . 0.0 112.934 -172.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.58 87.16 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.355 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.37 125.62 31.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.49 1.116 . . . . 0.0 108.633 175.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.03 158.68 36.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 110.361 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.38 63.65 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 125.455 1.502 . . . . 0.0 113.859 -169.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.26 -45.08 61.67 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -60.2 -45.18 94.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.999 1.32 . . . . 0.0 108.307 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.56 67.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.196 0.999 . . . . 0.0 112.546 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -72.13 -42.3 66.18 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.653 1.115 . . . . 0.0 109.073 175.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.04 -26.87 67.71 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.971 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -67.35 -48.1 68.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.188 -0.945 . . . . 0.0 109.031 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.9 84.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 119.007 0.821 . . . . 0.0 110.795 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.13 -41.91 89.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.62 1.568 . . . . 0.0 109.38 178.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -46.97 65.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.859 0.863 . . . . 0.0 110.648 172.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.9 -37.18 86.77 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.676 1.126 . . . . 0.0 112.667 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -94.17 -44.02 8.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.524 0.73 . . . . 0.0 111.185 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 113' ' ' MET . 14.6 m -123.55 -2.48 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.04 75.69 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.172 -0.955 . . . . 0.0 111.598 177.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.0 mt -91.12 161.21 15.19 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 108.908 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -118.07 171.51 8.05 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.902 0.881 . . . . 0.0 109.603 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -72.43 57.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.161 1.784 . . . . 0.0 113.89 -171.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' H ' ' A' ' 64' ' ' ASP . 21.0 pttp -163.89 -25.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.618 1.967 . . . . 0.0 111.359 -172.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' H ' ' H ' ' A' ' 63' ' ' LYS . 65.6 m-20 -88.15 0.19 56.33 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -168.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 166.78 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.036 0.935 . . . . 0.0 109.792 -169.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -137.2 120.89 17.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -171.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.85 129.9 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.05 -34.87 6.48 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.316 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.93 169.48 22.53 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 109.356 -178.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.1 p -147.81 162.28 39.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 p -66.15 145.0 56.32 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.21 -20.97 63.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -170.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -148.94 171.95 15.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.958 1.703 . . . . 0.0 109.12 171.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -73.1 116.19 13.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.59 153.89 41.05 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.42 153.74 38.94 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.443 0.697 . . . . 0.0 109.204 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.63 164.81 30.57 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.871 1.268 . . . . 0.0 108.548 176.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -118.5 123.86 46.16 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -172.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.01 145.14 99.01 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.599 1.16 . . . . 0.0 108.937 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.0 152.2 80.67 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.463 2.109 . . . . 0.0 109.456 170.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -47.62 -49.08 28.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.548 1.139 . . . . 0.0 113.779 -169.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -64.71 -14.19 57.58 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.154 0.981 . . . . 0.0 113.228 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.77 -9.2 15.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.56 1.544 . . . . 0.0 111.53 -178.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.84 136.73 25.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.63 129.81 38.45 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -101.3 4.5 41.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.791 1.236 . . . . 0.0 109.782 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.15 -12.53 15.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.501 1.121 . . . . 0.0 111.588 -174.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 p -71.66 -33.88 69.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.327 0.651 . . . . 0.0 111.763 -174.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 41.78 89.22 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.906 2.482 . . . . 0.0 112.197 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.22 150.34 71.83 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-N 119.977 1.028 . . . . 0.0 114.761 10.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -54.41 122.17 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.7 t -92.53 105.3 17.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -172.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -102.84 -10.82 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 113.013 -170.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.73 175.65 46.65 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 120.075 1.307 . . . . 0.0 112.482 -174.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.29 126.56 55.38 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -87.27 120.89 29.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.15 128.56 21.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.974 1.261 . . . . 0.0 113.618 -176.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -106.23 134.98 48.52 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -104.85 144.79 31.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -117.67 126.46 52.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.07 107.59 16.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 175.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 102' ' ' LEU . 31.3 mt -103.4 133.99 47.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.823 175.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -93.6 135.6 34.71 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 168.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.615 HD22 ' HA2' ' A' ' 107' ' ' GLY . 67.7 mt -66.01 141.43 58.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.973 176.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.16 -27.05 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.316 1.047 . . . . 0.0 108.204 169.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -119.94 -53.42 2.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 175.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 69.02 -146.53 44.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 172.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -40.94 -34.15 0.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.786 2.034 . . . . 0.0 113.573 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.14 -25.73 68.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.794 0.838 . . . . 0.0 113.235 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -130.58 -8.71 4.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.942 1.297 . . . . 0.0 113.324 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.18 134.36 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.65 -31.72 0.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.395 -170.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 58' ' ' VAL . 36.1 mtt 64.82 -50.06 0.33 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 129.096 2.958 . . . . 0.0 113.141 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -84.21 20.06 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.255 1.022 . . . . 0.0 113.515 -171.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -63.09 -31.43 72.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 109.749 172.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -83.58 -0.65 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.556 1.143 . . . . 0.0 113.262 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 64.1 -34.21 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.609 2.764 . . . . 0.0 115.543 -175.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -132.28 71.06 79.88 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.942 1.697 . . . . 0.0 107.435 172.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.02 -166.32 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.737 2.958 . . . . 0.0 110.453 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.33 -3.83 26.54 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.401 169.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.79 155.75 49.4 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 121.662 2.028 . . . . 0.0 112.375 -172.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.03 -25.52 2.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.801 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.1 150.75 22.17 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -122.25 146.89 46.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 110.81 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -152.31 124.7 8.23 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.677 1.191 . . . . 0.0 107.89 169.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -76.88 143.94 39.31 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.745 0.702 . . . . 0.0 109.144 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.57 168.15 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.59 0.756 . . . . 0.0 109.692 -169.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.9 m -48.79 145.11 3.98 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.094 1.357 . . . . 0.0 111.054 -177.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -52.58 -38.8 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -168.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -95.92 -4.37 43.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.74 -43.23 91.33 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.156 -1.402 . . . . 0.0 112.31 -170.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -58.05 -34.23 98.2 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 122.173 1.812 . . . . 0.0 113.074 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.69 -45.8 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -64.16 -30.61 71.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.737 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -78.95 -30.94 44.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 112.154 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.27 157.34 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.869 0.758 . . . . 0.0 110.974 -170.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.69 148.68 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.517 1.527 . . . . 0.0 111.709 174.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -57.97 -34.34 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.179 1.392 . . . . 0.0 113.849 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -72.66 -28.11 62.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.815 0.734 . . . . 0.0 111.543 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -89.25 -31.95 17.63 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.141 174.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -47.21 -44.82 22.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.599 1.16 . . . . 0.0 112.24 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.88 -34.33 75.27 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 p -83.81 -32.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.954 -0.466 . . . . 0.0 110.549 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -31.99 73.17 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.054 -1.029 . . . . 0.0 110.306 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -53.24 -40.52 64.62 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.058 -1.026 . . . . 0.0 111.606 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -63.94 -46.4 84.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.26 0.936 . . . . 0.0 109.614 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -53.73 -50.22 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 109.447 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.9 mmt -64.33 -45.1 89.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.273 -177.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -57.6 -44.37 85.36 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.091 0.957 . . . . 0.0 111.091 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -64.63 -25.51 67.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.409 0.684 . . . . 0.0 110.845 -174.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -108.95 -8.82 15.17 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.811 1.245 . . . . 0.0 113.683 -175.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.52 -63.55 1.1 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.348 0.976 . . . . 0.0 112.056 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 m -63.25 -22.31 66.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.216 -0.302 . . . . 0.0 111.778 -178.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -76.1 -36.66 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 O-C-N 121.382 -0.824 . . . . 0.0 108.909 -175.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.43 -48.89 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.6 mtt -65.33 -22.33 66.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.624 0.647 . . . . 0.0 112.725 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.8 m -62.85 -26.79 68.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.458 1.026 . . . . 0.0 111.635 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.9 -51.22 58.03 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.72 -25.79 63.1 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.002 0.521 . . . . 0.0 111.132 -173.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 124.065 0.946 . . . . 0.0 111.637 173.385 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 3' ' ' ASP . 51.4 mm -125.58 138.8 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 2' ' ' ILE . 59.9 t0 -66.93 152.16 46.24 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 165.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -36.3 -55.35 0.81 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.153 1.781 . . . . 0.0 114.684 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.01 -2.21 58.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 122.048 0.928 . . . . 0.0 112.976 -158.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.59 20.22 4.71 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.218 -1.551 . . . . 0.0 111.325 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -104.73 136.6 43.95 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.095 0.95 . . . . 0.0 109.135 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -85.13 122.74 73.97 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -72.06 133.19 20.97 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 121.302 1.335 . . . . 0.0 110.653 173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . 0.261 2.2 m-80 -144.45 168.3 20.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.361 1.464 . . . . 0.0 110.349 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -127.39 130.98 70.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 126.182 1.793 . . . . 0.0 107.525 168.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.38 128.92 9.65 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -88.48 118.53 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.54 83.77 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 165.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.1 mm -59.31 133.46 24.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 164.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 m -118.33 120.84 38.83 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 164.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -83.39 118.11 23.5 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 112.12 -2.309 . . . . 0.0 105.391 173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HG3' ' H ' ' A' ' 18' ' ' ARG . 16.9 mtt180 -47.84 -1.45 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -76.55 -4.27 41.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 120.259 1.391 . . . . 0.0 111.548 166.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.508 ' C ' HE21 ' A' ' 21' ' ' GLN . . . 101.76 24.25 8.8 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 119.836 1.198 . . . . 0.0 113.323 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.508 HE21 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -133.47 162.59 31.47 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -166.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.93 165.21 14.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 122.095 0.95 . . . . 0.0 111.514 -165.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.4 tpt -53.28 129.42 31.55 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 112.629 -2.078 . . . . 0.0 110.101 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -158.63 134.85 9.19 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 161.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 124' ' ' TRP . . . -147.05 141.71 26.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.023 0.916 . . . . 0.0 110.218 -175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -72.64 135.84 45.55 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -85.62 124.75 32.51 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.34 133.56 34.61 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.373 2.269 . . . . 0.0 110.911 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.4 -14.54 3.12 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 125.6 1.571 . . . . 0.0 114.133 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -105.44 -35.59 7.44 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 117.783 0.792 . . . . 0.0 111.447 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 66.66 27.36 9.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.446 0.698 . . . . 0.0 111.767 175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.78 171.63 14.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -84.15 161.04 20.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -170.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -148.12 150.29 33.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.501 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.436 ' CZ ' ' NZ ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -65.76 158.8 73.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.432 165.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 35' ' ' PHE . 2.9 Cg_exo -77.43 154.67 31.8 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 125.039 3.826 . . . . 0.0 112.027 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 169.38 139.37 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 128.053 2.541 . . . . 0.0 105.808 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.86 141.43 11.3 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 106.579 -2.608 . . . . 0.0 106.579 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.49 156.52 53.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mt -87.8 138.72 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . 0.253 51.1 t30 -85.71 139.21 35.37 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 125.089 1.356 . . . . 0.0 109.24 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.51 118.48 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.195 1.93 . . . . 0.0 113.636 -172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.74 -0.19 89.62 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.8 -1.0 . . . . 0.0 113.036 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -87.63 123.91 32.97 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.861 1.33 . . . . 0.0 107.744 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.68 165.06 24.78 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.518 -0.739 . . . . 0.0 110.845 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.24 -44.11 71.46 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.295 1.038 . . . . 0.0 112.538 -168.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.93 -40.48 72.05 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.318 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -63.86 -44.26 93.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.347 0.659 . . . . 0.0 109.79 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.07 77.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.857 0.863 . . . . 0.0 111.553 176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.2 tmm? -60.75 -44.07 97.17 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.779 -0.576 . . . . 0.0 109.713 176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -69.18 -26.25 64.75 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.884 -1.135 . . . . 0.0 112.539 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.3 tpp180 -61.65 -52.67 63.38 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.441 -0.787 . . . . 0.0 109.332 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.6 90.61 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.414 0.626 . . . . 0.0 109.848 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.3 tp -52.58 -43.81 65.52 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 119.798 -1.814 . . . . 0.0 111.031 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.15 -49.14 53.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.973 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -64.72 -33.93 77.13 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.008 1.277 . . . . 0.0 112.105 -174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.77 -45.83 5.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.59 0.709 . . . . 0.0 110.042 -169.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -15.62 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 O-C-N 121.797 -0.564 . . . . 0.0 110.401 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.88 37.21 94.02 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 117.093 -1.948 . . . . 0.0 112.209 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.4 mt -113.87 158.81 20.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.544 1.172 . . . . 0.0 108.87 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -117.69 -177.87 3.35 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.881 -0.512 . . . . 0.0 110.209 -173.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.72 40.65 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.282 1.833 . . . . 0.0 114.736 -174.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -161.15 -18.5 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 O-C-N 121.05 -1.031 . . . . 0.0 111.434 -170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.54 1.11 55.52 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.915 0.864 . . . . 0.0 111.008 -167.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 ' CG2' HD12 ' A' ' 102' ' ' LEU . 27.9 m -152.42 169.48 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 O-C-N 121.282 -0.886 . . . . 0.0 109.775 -168.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -142.25 117.49 10.13 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -167.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.97 130.62 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.6 -36.04 6.29 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.007 0.923 . . . . 0.0 110.932 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.81 170.29 22.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.049 0.94 . . . . 0.0 108.715 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -145.99 164.29 32.54 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.623 1.169 . . . . 0.0 109.475 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -63.57 140.2 58.85 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.764 0.792 . . . . 0.0 108.917 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -64.77 -29.51 70.48 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.351 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -146.44 174.22 11.58 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -65.47 115.47 5.74 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.673 0.789 . . . . 0.0 109.014 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 156.05 39.58 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 166.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -160.82 159.05 29.44 Favored 'General case' 0 CA--C 1.487 -1.481 0 O-C-N 120.683 -1.261 . . . . 0.0 108.13 173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB3' HG21 ' A' ' 143' ' ' VAL . 8.3 p90 -159.91 170.03 22.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.61 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -109.38 129.88 55.52 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 111.921 -2.4 . . . . 0.0 106.059 -162.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.0 mt -70.77 143.54 89.63 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -63.04 155.29 61.8 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.012 -1.572 . . . . 0.0 108.012 168.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -49.84 -45.62 50.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -71.77 -18.68 62.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.6 tp -102.47 -18.17 15.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.678 0.791 . . . . 0.0 111.764 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.3 t -52.0 140.49 6.9 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -76.21 -38.0 57.03 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.351 2.723 . . . . 0.0 118.351 -170.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.716 ' HA ' ' CG1' ' A' ' 91' ' ' VAL 0.326 10.2 m95 53.48 -8.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 -167.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -105.17 -27.86 11.32 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.397 1.453 . . . . 0.0 110.276 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.0 p -69.54 151.77 45.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -138.14 114.58 9.13 Favored Pre-proline 0 CA--C 1.499 -1.012 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -55.01 154.13 20.12 Favored 'Cis proline' 0 C--O 1.237 0.436 0 O-C-N 123.151 1.08 . . . . 0.0 113.45 -6.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 86' ' ' TRP . 0.1 OUTLIER -55.53 130.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.46 171.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 46.5 t -92.86 108.49 20.03 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 12.8 pt -101.77 -2.46 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.762 1.625 . . . . 0.0 111.608 -174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.24 43.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.597 1.09 . . . . 0.0 112.934 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 113.66 27.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.548 1.539 . . . . 0.0 107.178 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -79.79 122.56 26.77 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 162.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.38 132.6 26.47 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.582 1.083 . . . . 0.0 112.844 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -104.31 125.53 50.64 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 165.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -96.17 144.11 26.68 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -118.34 128.62 54.82 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.7 114.95 19.95 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 65' ' ' VAL . 3.3 mm? -110.46 122.16 47.04 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -79.17 136.73 37.19 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.472 HD21 ' HA2' ' A' ' 107' ' ' GLY . 19.1 tp -72.81 124.22 24.94 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.76 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.97 -41.15 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.255 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.434 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 0.7 OUTLIER -89.73 -140.74 0.14 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.472 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . -179.84 -168.82 39.21 Favored Glycine 0 CA--C 1.487 -1.695 0 O-C-N 119.572 -1.955 . . . . 0.0 110.221 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -29.9 -41.26 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 126.846 2.059 . . . . 0.0 114.987 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.62 66.14 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.434 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 54.0 mm-40 -106.87 -23.4 12.38 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.195 1.798 . . . . 0.0 110.358 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.2 mt -56.18 132.33 20.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 168.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -122.17 -25.89 4.81 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 119.127 -0.463 . . . . 0.0 112.173 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.5 mtt 41.0 -7.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 119.338 3.088 . . . . 0.0 119.338 -173.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -121.71 21.96 10.65 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 123.461 2.846 . . . . 0.0 110.926 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -37.49 82.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.731 2.012 . . . . 0.0 111.172 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.88 2.67 53.36 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.86 -0.591 . . . . 0.0 112.589 -166.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 m 66.31 -36.26 0.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.017 1.727 . . . . 0.0 115.03 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -131.53 68.97 81.59 Favored Pre-proline 0 N--CA 1.457 -0.106 0 C-N-CA 125.357 1.463 . . . . 0.0 107.169 170.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.07 -166.82 0.34 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.318 2.012 . . . . 0.0 109.927 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -110.3 -19.3 13.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 117.896 -1.049 . . . . 0.0 112.695 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -120.07 151.72 38.62 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.958 1.254 . . . . 0.0 111.309 -172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.9 -19.79 7.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.811 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 151.72 158.52 8.43 Favored Glycine 0 N--CA 1.429 -1.824 0 N-CA-C 104.727 -3.349 . . . . 0.0 104.727 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.672 ' O ' ' CE3' ' A' ' 124' ' ' TRP 0.589 0.0 OUTLIER -138.76 -175.39 4.12 Favored 'General case' 0 C--N 1.294 -1.829 2 N-CA-C 126.538 5.755 . . . . 0.0 126.538 -154.136 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 124' ' ' TRP 0.254 12.3 ttt180 -169.54 131.78 1.17 Allowed 'General case' 0 CA--C 1.483 -1.634 1 O-C-N 115.477 -4.515 . . . . 0.0 102.967 171.065 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -72.95 133.66 44.42 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 104.061 -2.57 . . . . 0.0 104.061 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.6 161.51 37.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -51.21 151.35 2.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.719 -0.658 . . . . 0.0 109.587 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.413 ' O ' ' HD2' ' A' ' 132' ' ' PRO 0.331 12.5 t80 -45.66 -90.42 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.229 1.412 . . . . 0.0 112.715 -173.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -45.3 -4.19 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 120.459 3.503 . . . . 0.0 120.459 170.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -60.1 -51.66 78.89 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 122.833 2.561 . . . . 0.0 112.983 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 129' ' ' TYR . 58.2 Cg_exo -57.34 -32.57 94.22 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.165 1.91 . . . . 0.0 113.837 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 t -57.84 -39.61 72.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.642 ' HE ' ' HA ' ' A' ' 134' ' ' ARG . 1.4 mmm-85 -77.32 -26.81 52.56 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.054 -1.654 . . . . 0.0 114.074 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.571 ' HA ' ' OE1' ' A' ' 135' ' ' GLN . 3.9 mm-40 -78.46 -25.3 45.83 Favored 'General case' 0 CA--C 1.493 -1.212 0 O-C-N 125.655 1.847 . . . . 0.0 114.499 -177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG11 ' HD2' ' A' ' 144' ' ' TYR 0.265 13.2 p -79.02 157.76 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.582 0 CA-C-O 122.853 1.311 . . . . 0.0 109.861 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.0 m -56.09 150.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.941 1.296 . . . . 0.0 111.03 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.3 m -60.21 -34.13 73.22 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -166.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -72.92 -30.77 64.15 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.828 0.74 . . . . 0.0 111.162 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' NZ ' ' CZ ' ' A' ' 35' ' ' PHE . 10.5 mttt -81.93 -32.21 30.94 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.533 ' CZ ' HH21 ' A' ' 134' ' ' ARG . 29.2 ttp180 -47.11 -48.53 22.98 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 124.77 1.294 . . . . 0.0 112.243 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -60.46 -45.62 93.04 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.128 0.966 . . . . 0.0 110.031 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 77' ' ' TYR . 1.1 t -69.3 -40.47 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 O-C-N 120.937 -1.102 . . . . 0.0 110.311 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.498 ' HD2' HG11 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -67.32 -31.9 72.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 110.502 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -53.17 -41.79 65.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.661 0.785 . . . . 0.0 112.627 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -66.87 -45.39 78.24 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -53.53 -49.42 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 O-C-N 124.312 1.007 . . . . 0.0 109.143 175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 mtt -65.33 -41.99 93.4 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.742 -0.599 . . . . 0.0 111.203 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 120.637 -1.289 . . . . 0.0 111.389 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -61.44 -26.26 67.76 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.967 -0.54 . . . . 0.0 111.596 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -116.8 -6.9 11.52 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 118.906 0.775 . . . . 0.0 113.071 -171.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.56 44.44 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 119.265 0.939 . . . . 0.0 110.504 -167.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.7 m -65.7 -23.67 66.82 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.924 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.39 -32.95 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 O-C-N 120.17 -1.581 . . . . 0.0 109.656 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.13 -43.07 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.14 -31.43 71.86 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 116.918 -1.515 . . . . 0.0 110.429 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -55.93 -28.83 58.65 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 120.411 1.46 . . . . 0.0 111.401 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' A' ' 164' ' ' LYS . 1.3 mt -77.65 -20.29 54.03 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 114.695 -2.574 . . . . 0.0 112.244 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.528 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 35.3 mm-40 -108.16 -7.92 15.91 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.787 2.035 . . . . 0.0 110.056 177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.923 ' C ' ' HA ' ' A' ' 164' ' ' LYS . 3.5 tt0 -125.72 16.69 8.09 Favored 'General case' 1 CA--C 1.682 6.036 2 C-N-CA 137.261 6.224 . . . . 0.0 125.534 174.047 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 1.515 ' N ' ' CA ' ' A' ' 161' ' ' ASN . 8.2 t30 -51.25 -25.08 5.1 Favored 'General case' 2 CA--C 1.858 12.812 3 N-CA-C 136.321 9.378 . . . . 0.0 136.321 126.477 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 1.605 ' CA ' ' CB ' ' A' ' 162' ' ' THR 1.923 0.0 OUTLIER -175.72 106.03 0.25 Allowed Pre-proline 3 N--CA 1.665 10.282 5 C-N-CA 158.435 14.694 . . . . 0.0 80.495 158.427 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.751 ' HA ' ' CB ' ' A' ' 162' ' ' THR 0.835 0.0 OUTLIER -70.05 -34.21 3.18 Favored 'Cis proline' 1 C--N 1.555 11.405 3 C-N-CA 98.832 -11.737 . . . . 0.0 97.154 21.473 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 1.615 ' CA ' ' CB ' ' A' ' 164' ' ' LYS 1.073 15.1 mtmm . . . . . 2 N--CA 1.318 -7.047 3 C-N-CA 139.152 6.981 . . . . 0.0 94.55 107.403 . . . . . . . . 4 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.3 mm -137.27 148.19 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.27 -45.93 71.78 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.29 0.636 . . . . 0.0 111.949 -170.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -152.01 -85.22 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.537 1.135 . . . . 0.0 109.963 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.3 -39.95 13.13 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -169.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.3 21.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.117 -0.824 . . . . 0.0 114.102 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -112.37 137.49 50.45 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.704 1.252 . . . . 0.0 109.796 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -109.93 118.76 49.17 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 117.203 -1.38 . . . . 0.0 109.163 -170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -64.05 135.06 45.65 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.258 1.972 . . . . 0.0 112.515 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -145.41 158.87 43.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 126.398 1.879 . . . . 0.0 110.543 -172.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -136.44 76.25 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 126.707 2.003 . . . . 0.0 109.03 -173.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.6 126.54 30.22 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mm -90.34 105.21 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.57 79.78 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 169.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 mm -62.89 135.12 27.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 169.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.8 m -123.6 130.83 53.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 168.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -87.69 136.78 32.81 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.86 -10.01 8.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.188 1.795 . . . . 0.0 114.313 -174.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -68.79 -13.26 62.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 119.128 0.876 . . . . 0.0 110.825 169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 101.11 38.3 3.37 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.386 1.946 . . . . 0.0 112.163 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -136.38 149.49 48.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -105.67 167.03 3.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.389 1.075 . . . . 0.0 112.764 -168.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 127.55 32.68 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.622 1.569 . . . . 0.0 110.509 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -156.97 134.63 10.8 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 168.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.81 146.34 25.63 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -71.32 127.99 34.39 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.25 128.42 34.48 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -171.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -53.25 136.97 35.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.429 1.492 . . . . 0.0 110.263 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.27 -37.85 2.01 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.8 1.19 . . . . 0.0 113.198 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -81.55 -39.05 25.21 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.149 0.975 . . . . 0.0 110.091 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.271 17.4 m170 58.92 34.27 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.04 1.736 . . . . 0.0 112.795 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 m -140.44 158.73 43.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.976 2.11 . . . . 0.0 106.742 169.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -65.86 152.25 44.85 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.183 0.993 . . . . 0.0 112.554 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -148.18 156.74 42.94 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 110.563 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -69.4 160.72 77.95 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.816 2.446 . . . . 0.0 111.748 172.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.64 147.12 95.2 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.017 2.478 . . . . 0.0 110.981 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -165.5 153.31 10.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.348 1.859 . . . . 0.0 107.745 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.89 136.84 3.75 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 107.892 -2.083 . . . . 0.0 107.892 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.76 168.83 54.88 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 118.235 1.018 . . . . 0.0 110.853 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mt -94.37 140.8 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 108.516 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -85.51 138.0 36.22 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.566 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -58.35 117.32 4.01 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.486 1.457 . . . . 0.0 112.876 -173.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.45 -0.11 84.99 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.776 1.179 . . . . 0.0 113.046 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.5 120.05 34.14 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.652 1.226 . . . . 0.0 107.805 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -71.8 165.44 24.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.479 0.712 . . . . 0.0 111.37 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.97 -46.61 64.89 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.239 1.416 . . . . 0.0 111.481 -170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -86.37 29.43 0.76 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.577 0.703 . . . . 0.0 110.301 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 -48.66 0.67 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.609 1.964 . . . . 0.0 106.51 170.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.23 -32.6 74.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.828 1.251 . . . . 0.0 112.015 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -56.92 -45.45 82.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.9 m-85 -73.79 -28.5 61.68 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.027 -1.046 . . . . 0.0 112.052 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -61.39 -46.63 89.37 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.722 -1.236 . . . . 0.0 108.761 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.98 -41.39 97.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.611 -0.709 . . . . 0.0 109.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 tp -54.9 -44.6 74.29 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.822 1.649 . . . . 0.0 110.243 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -44.51 88.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.909 0.884 . . . . 0.0 111.252 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.42 -29.08 66.73 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.781 1.173 . . . . 0.0 112.894 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.26 -48.08 6.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.596 0.758 . . . . 0.0 111.465 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.17 0.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 119.819 1.19 . . . . 0.0 113.69 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.29 31.31 80.12 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 118.988 0.813 . . . . 0.0 112.002 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 mt -103.92 152.24 22.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -115.77 -177.29 3.12 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.381 0.673 . . . . 0.0 110.176 -173.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 18.2 ptp180 -71.92 47.55 0.15 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.744 2.018 . . . . 0.0 112.575 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -160.68 -19.34 0.05 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.375 1.47 . . . . 0.0 112.341 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -93.85 -0.1 55.95 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 112.124 -169.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.37 169.33 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.011 0.924 . . . . 0.0 109.448 -175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -139.36 121.44 15.73 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -171.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.4 mt -74.82 128.01 36.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.92 -30.76 9.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.781 0.433 . . . . 0.0 110.794 173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 166.56 29.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.134 0.974 . . . . 0.0 109.366 -177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.7 p -144.43 158.27 43.84 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.196 1.399 . . . . 0.0 108.244 169.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -62.95 140.73 58.87 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -60.29 -30.24 69.35 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -141.83 175.38 9.76 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.707 1.603 . . . . 0.0 106.773 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -66.56 133.51 50.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -87.79 152.3 22.22 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.126 0.97 . . . . 0.0 108.634 169.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -150.41 161.05 43.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -140.99 173.82 11.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.381 1.872 . . . . 0.0 106.822 172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -97.99 130.75 44.82 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.32 145.75 98.99 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 170.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -64.93 155.07 69.99 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.384 2.056 . . . . 0.0 108.465 169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -73.15 -24.67 60.62 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.97 0.908 . . . . 0.0 112.816 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.4 tp -99.24 -21.42 16.1 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.677 0.791 . . . . 0.0 111.727 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -47.95 141.16 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -75.83 -42.2 50.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -168.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 42.5 m95 56.31 9.74 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.868 2.467 . . . . 0.0 114.61 -172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -126.08 -17.42 5.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.003 0.921 . . . . 0.0 113.224 -169.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.1 p -73.5 -35.64 65.64 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.691 -0.631 . . . . 0.0 112.075 -170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt 46.13 88.77 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 127.461 2.304 . . . . 0.0 112.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -63.83 143.69 51.54 Favored 'Cis proline' 0 C--N 1.353 0.775 0 CA-C-N 119.617 0.899 . . . . 0.0 113.699 9.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.6 t -56.64 121.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.08 1.352 . . . . 0.0 107.479 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.3 t -89.48 120.0 30.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.4 pt -115.86 -4.16 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.02 1.328 . . . . 0.0 111.929 -172.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.57 152.12 15.88 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.852 1.206 . . . . 0.0 111.074 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -85.69 127.73 34.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -85.31 115.07 22.85 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -122.95 122.74 39.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 120.187 1.358 . . . . 0.0 112.49 -168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -103.21 107.14 17.84 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 101.898 -3.371 . . . . 0.0 101.898 167.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -82.53 142.19 32.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.24 132.22 55.9 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.58 118.14 22.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.75 124.14 50.02 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.382 1.073 . . . . 0.0 109.366 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -86.58 134.74 33.62 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.74 136.63 57.97 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.85 -29.1 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.1 m -123.78 120.92 34.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.92 -163.19 33.52 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 121.667 0.593 . . . . 0.0 113.166 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.46 -29.04 5.96 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.04 1.336 . . . . 0.0 113.251 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.28 -25.64 68.14 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.127 0.571 . . . . 0.0 111.998 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -109.64 -11.79 14.72 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.096 1.358 . . . . 0.0 111.776 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.2 mt -59.75 134.08 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.44 63.85 1.31 Allowed 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.0 mtt -48.49 -26.48 2.17 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.688 1.595 . . . . 0.0 114.157 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.52 24.67 2.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.945 1.248 . . . . 0.0 112.618 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -44.43 68.98 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.077 1.751 . . . . 0.0 111.762 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.7 m -96.97 9.67 41.33 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 m 67.54 -36.69 0.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.467 2.707 . . . . 0.0 114.825 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.2 p -126.53 73.21 73.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.04 1.736 . . . . 0.0 106.985 169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -78.98 -165.81 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.783 2.989 . . . . 0.0 110.983 -174.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -106.6 -19.18 13.75 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.609 169.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -121.23 157.76 29.55 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 121.64 2.018 . . . . 0.0 112.095 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.32 -25.88 1.31 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.617 1.567 . . . . 0.0 112.548 -170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -158.19 147.32 14.98 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -99.09 154.74 17.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.575 1.15 . . . . 0.0 111.091 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -156.04 112.25 3.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.79 1.636 . . . . 0.0 107.166 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -78.17 134.98 37.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.163 1.347 . . . . 0.0 107.867 173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.0 160.73 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.721 1.209 . . . . 0.0 109.903 -170.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.34 150.09 3.69 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.523 0.678 . . . . 0.0 110.823 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.34 148.38 32.54 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.0 m95 66.06 -10.45 0.24 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -61.73 -50.74 80.54 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 121.748 2.067 . . . . 0.0 111.371 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -59.28 -31.26 94.82 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.037 1.825 . . . . 0.0 112.658 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.45 -37.21 78.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.652 0.781 . . . . 0.0 109.801 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 36.9 mmm-85 -81.8 -27.98 33.4 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.771 1.168 . . . . 0.0 111.347 176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -73.53 -30.43 63.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.873 0.76 . . . . 0.0 111.85 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.96 157.22 6.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 119.162 0.892 . . . . 0.0 111.74 -169.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -52.06 148.88 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 126.186 1.794 . . . . 0.0 112.401 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.5 m -63.26 -32.81 74.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 113.55 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -70.07 -29.88 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.307 0.958 . . . . 0.0 111.054 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -86.11 -40.22 15.92 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 117.45 -1.262 . . . . 0.0 112.212 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -40.7 -49.97 3.07 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.877 1.217 . . . . 0.0 113.675 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -69.93 -31.12 68.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.501 HG13 HD12 ' A' ' 75' ' ' LEU . 24.3 t -78.6 -40.59 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.846 0.859 . . . . 0.0 110.314 174.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.24 -30.67 71.58 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -56.95 -41.24 77.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.987 -1.071 . . . . 0.0 110.802 169.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -66.59 -46.9 74.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.297 0.953 . . . . 0.0 109.026 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.73 -44.85 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.9 mtt -70.17 -38.17 75.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.447 -0.783 . . . . 0.0 110.895 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -64.52 -37.02 86.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.209 0.913 . . . . 0.0 110.624 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.33 -28.06 66.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.595 0.758 . . . . 0.0 110.592 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -113.31 -12.19 13.08 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.46 -58.1 8.32 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.663 1.119 . . . . 0.0 111.704 -169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.9 m -74.38 5.86 4.22 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.84 0.23 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 126.447 1.899 . . . . 0.0 109.401 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.2 t -118.38 -54.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 173.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 63.9 mtt -60.55 -22.15 63.33 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.889 1.275 . . . . 0.0 111.51 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.4 p -53.7 -40.67 66.23 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.92 1.288 . . . . 0.0 111.844 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.19 -39.49 86.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.125 0.97 . . . . 0.0 109.785 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -84.34 -36.14 22.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.342 0.657 . . . . 0.0 111.093 -174.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.1 -35.12 79.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.653 0.781 . . . . 0.0 109.101 170.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.46 -16.12 0.07 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 129.745 3.218 . . . . 0.0 116.623 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 p -77.3 -29.33 0.69 Allowed Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 169.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -67.68 -37.56 16.08 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.515 2.143 . . . . 0.0 112.756 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.8 mttm . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.016 1.726 . . . . 0.0 110.197 -176.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.68 137.62 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 170.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.31 150.49 25.86 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.882 1.673 . . . . 0.0 110.062 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.41 -28.5 66.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.912 0.885 . . . . 0.0 113.03 -173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.94 2.34 43.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.262 1.025 . . . . 0.0 112.365 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.72 29.06 11.18 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.575 1.559 . . . . 0.0 112.586 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -109.23 141.29 41.71 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.138 1.469 . . . . 0.0 110.932 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -90.65 127.45 52.38 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 171.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.33 135.66 34.74 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.416 2.077 . . . . 0.0 110.579 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -143.03 159.17 42.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.106 1.762 . . . . 0.0 111.534 -169.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.674 1.59 . . . . 0.0 107.933 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.13 124.0 34.7 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.9 mm -87.05 118.45 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.54 81.0 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -65.18 145.64 13.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 104.283 -2.488 . . . . 0.0 104.283 167.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -131.67 131.5 43.19 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 168.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.6 129.86 35.26 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -44.74 -27.86 0.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.112 1.765 . . . . 0.0 114.482 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.15 15.59 0.16 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.216 1.006 . . . . 0.0 112.561 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.36 31.09 17.48 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.212 1.387 . . . . 0.0 112.432 169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -129.5 154.55 46.9 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.166 1.386 . . . . 0.0 108.147 -169.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.19 161.8 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.511 0.725 . . . . 0.0 112.303 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.22 128.21 34.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.731 1.212 . . . . 0.0 109.813 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.43 133.27 8.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 168.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB3' ' CD1' ' A' ' 121' ' ' PHE . . . -153.02 147.03 25.43 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -67.73 125.46 26.3 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -74.85 128.46 35.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.39 146.05 41.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 169.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.03 -44.4 2.6 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.113 0.863 . . . . 0.0 112.977 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -77.7 -34.48 52.8 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 109.219 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 54.65 39.48 31.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.654 1.982 . . . . 0.0 111.285 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.6 p -160.25 170.2 21.62 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -70.72 149.81 46.56 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.457 -0.777 . . . . 0.0 111.398 -170.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -156.25 149.3 24.22 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.352 1.061 . . . . 0.0 108.6 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -47.79 137.48 10.09 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.583 1.953 . . . . 0.0 111.589 170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.13 136.22 50.97 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.974 1.783 . . . . 0.0 109.802 169.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -162.13 139.76 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.184 2.194 . . . . 0.0 106.006 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.15 -97.75 1.44 Allowed Glycine 0 CA--C 1.531 1.072 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.63 167.31 23.89 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.4 mt -114.58 148.46 17.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -99.78 154.27 37.34 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 124.698 1.199 . . . . 0.0 110.275 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.27 117.91 4.74 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.939 1.759 . . . . 0.0 111.208 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.53 5.37 89.57 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.997 1.284 . . . . 0.0 112.809 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.48 127.04 34.28 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.41 160.71 29.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.175 0.99 . . . . 0.0 110.401 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.35 74.57 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 123.836 0.854 . . . . 0.0 112.92 -169.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -71.8 -44.23 64.29 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.26 -43.08 96.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.8 1.24 . . . . 0.0 109.421 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.71 83.97 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.315 0.646 . . . . 0.0 111.509 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -60.14 -42.66 95.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.05 0.841 . . . . 0.0 109.307 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.45 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 89.7 m-85 -69.46 -24.53 63.81 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.604 1.093 . . . . 0.0 112.167 172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -66.99 -50.56 61.88 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.825 -1.172 . . . . 0.0 108.176 174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.18 -30.52 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.187 0.903 . . . . 0.0 111.746 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.0 tp -57.3 -39.48 75.86 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.817 -1.177 . . . . 0.0 110.526 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -54.47 10.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.251 1.02 . . . . 0.0 110.915 172.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.78 -36.26 80.55 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.539 1.063 . . . . 0.0 111.893 -172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -95.72 -52.12 4.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.661 0.784 . . . . 0.0 111.36 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -99.37 -15.2 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.564 0.62 . . . . 0.0 112.375 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.01 56.46 24.55 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -173.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.4 mt -137.22 158.87 43.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.6 1.96 . . . . 0.0 106.537 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -125.45 -172.61 2.63 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.839 0.856 . . . . 0.0 111.312 -171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.0 mtt180 -64.99 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 129.968 3.307 . . . . 0.0 114.29 -174.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -159.27 -14.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.185 0.994 . . . . 0.0 113.384 -169.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -91.22 2.0 56.69 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.693 1.197 . . . . 0.0 113.093 -169.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.76 169.23 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.952 0.901 . . . . 0.0 110.498 -168.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -134.73 112.91 11.15 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 102' ' ' LEU . 45.4 mt -71.51 130.51 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 120.086 1.312 . . . . 0.0 107.515 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.88 -36.22 6.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.007 0.523 . . . . 0.0 111.762 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.76 173.2 16.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.721 1.209 . . . . 0.0 108.938 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 t -150.91 162.26 41.13 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 170.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -64.39 143.33 57.98 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.767 0.712 . . . . 0.0 109.665 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -63.54 -30.66 71.75 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.818 0.447 . . . . 0.0 111.888 -171.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -150.63 168.86 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.652 1.581 . . . . 0.0 108.093 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -64.67 124.79 22.82 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.13 0.572 . . . . 0.0 109.465 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 75.0 mt -78.93 158.66 27.98 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -142.34 137.35 30.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -145.53 154.48 42.24 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -100.17 146.41 26.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.37 140.82 60.83 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.46 154.2 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.156 1.904 . . . . 0.0 109.093 169.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.31 -44.43 79.9 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.04 -1.038 . . . . 0.0 113.631 -169.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.5 -15.69 62.92 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.131 0.973 . . . . 0.0 112.559 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.3 tp -99.29 -6.59 27.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.476 1.51 . . . . 0.0 111.929 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -56.55 145.11 7.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 120.797 1.635 . . . . 0.0 107.765 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -77.95 -43.68 29.07 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.838 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.1 m95 59.3 4.17 0.45 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.924 2.49 . . . . 0.0 114.561 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -118.9 -18.12 8.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.811 0.844 . . . . 0.0 112.599 -169.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 p -74.23 -38.4 63.53 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.846 -0.534 . . . . 0.0 111.49 -170.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.1 mttm 46.53 87.44 0.12 Allowed Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 127.73 2.412 . . . . 0.0 112.164 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -60.31 138.99 21.89 Favored 'Cis proline' 0 C--N 1.356 0.97 0 CA-C-N 120.032 1.047 . . . . 0.0 114.305 9.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 78.5 t -57.31 120.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.658 1.583 . . . . 0.0 107.523 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 47.1 t -91.71 126.84 36.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -119.5 -3.19 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.898 1.679 . . . . 0.0 112.08 -175.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.0 37.6 Favored Glycine 0 CA--C 1.522 0.496 0 CA-C-N 120.408 1.458 . . . . 0.0 112.627 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -100.98 125.76 47.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 171.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -89.48 110.69 21.5 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 168.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.81 127.27 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 120.719 1.599 . . . . 0.0 112.153 -171.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -101.11 123.1 44.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 168.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -98.3 124.49 42.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -96.25 136.57 36.55 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -90.92 116.31 28.63 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 67' ' ' ILE . 30.4 mt -111.67 136.28 51.11 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.548 1.139 . . . . 0.0 110.591 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -93.92 136.9 33.72 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.7 tp -82.53 106.94 14.8 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -30.47 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.627 0.771 . . . . 0.0 111.547 175.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.2 p -59.73 -60.96 3.01 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.3 1.04 . . . . 0.0 111.436 171.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.54 176.01 38.66 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.166 0.889 . . . . 0.0 111.549 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -43.48 -37.09 2.25 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.441 1.497 . . . . 0.0 112.596 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.35 -21.26 61.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 112.883 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -129.74 -13.41 4.2 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.54 1.136 . . . . 0.0 112.77 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.57 128.93 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 169.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.23 50.16 1.62 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 124.116 0.966 . . . . 0.0 109.653 -169.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.7 mtt -45.46 -15.47 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 -169.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.06 22.53 10.21 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.958 1.708 . . . . 0.0 112.613 -174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 p -65.94 -32.22 73.59 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 112.073 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.58 -3.94 58.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -169.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m 66.33 -40.42 0.35 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.368 2.267 . . . . 0.0 113.072 -169.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -128.15 79.24 74.24 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 126.932 2.093 . . . . 0.0 105.807 169.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -80.02 -161.94 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.781 2.987 . . . . 0.0 110.973 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -112.34 -38.41 4.7 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.55 -1.214 . . . . 0.0 112.557 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 43.1 m-85 -106.35 161.3 14.68 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.267 1.849 . . . . 0.0 111.31 177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -128.68 -29.44 2.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.575 1.55 . . . . 0.0 112.418 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -164.57 152.5 22.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -104.3 160.44 14.89 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.066 0.946 . . . . 0.0 111.827 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -154.31 117.85 4.6 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.337 1.855 . . . . 0.0 106.451 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -79.41 130.98 35.94 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.357 1.435 . . . . 0.0 107.443 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.81 162.27 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.476 1.11 . . . . 0.0 110.268 -170.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.8 m -53.64 148.82 9.06 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.703 0.763 . . . . 0.0 111.75 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -60.18 144.95 48.78 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.38 -1.17 1.3 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -68.44 -49.83 29.86 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 121.385 1.902 . . . . 0.0 111.201 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -63.9 -32.2 66.42 Favored 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 121.286 1.495 . . . . 0.0 114.453 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.0 m -61.29 -31.19 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 120.093 1.315 . . . . 0.0 111.575 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.22 -14.89 34.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.58 1.082 . . . . 0.0 111.737 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -75.59 -33.77 60.6 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.319 0.963 . . . . 0.0 109.502 169.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.3 153.77 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.499 1.52 . . . . 0.0 110.377 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.11 149.91 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.438 1.495 . . . . 0.0 111.016 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 m -57.13 -35.63 69.73 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.023 1.329 . . . . 0.0 114.159 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -71.3 -27.55 63.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.102 0.864 . . . . 0.0 111.388 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -98.18 -22.12 16.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.188 0.995 . . . . 0.0 112.358 -176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.3 ttt-85 -49.54 -43.05 45.54 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.033 0.933 . . . . 0.0 110.947 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -64.37 -45.55 87.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.669 0.668 . . . . 0.0 111.787 -174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.45 -35.51 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 121.743 -0.598 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.56 -30.76 67.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.215 -0.928 . . . . 0.0 110.466 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -61.59 -38.63 88.25 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.552 -1.342 . . . . 0.0 109.646 169.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -64.45 -42.68 95.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.18 1.355 . . . . 0.0 109.937 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 67.7 t -54.83 -46.55 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 118.934 0.788 . . . . 0.0 109.214 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 46.7 mtt -68.97 -38.07 79.16 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.88 -0.513 . . . . 0.0 110.512 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -66.68 -33.82 76.49 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.333 1.053 . . . . 0.0 110.764 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.03 -26.04 67.34 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.355 0.662 . . . . 0.0 111.406 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -120.39 -6.12 9.83 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.39 -58.41 6.32 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.209 0.913 . . . . 0.0 111.48 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -64.03 -27.15 68.92 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.071 -0.393 . . . . 0.0 111.996 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.19 -40.42 65.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 O-C-N 121.096 -1.002 . . . . 0.0 108.612 -175.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 98.7 t -78.02 -41.97 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.529 0.732 . . . . 0.0 109.345 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 49.2 mtt -71.97 -25.55 61.9 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.04 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.1 m -50.74 -41.14 56.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 119.477 1.035 . . . . 0.0 111.874 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.02 -37.78 88.58 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -99.7 22.2 11.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.924 0.89 . . . . 0.0 111.97 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.34 8.06 5.46 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.247 1.819 . . . . 0.0 109.644 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -75.39 -26.69 58.66 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.516 -0.74 . . . . 0.0 110.081 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.4 p -140.7 161.39 54.6 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 131.402 3.881 . . . . 0.0 102.635 169.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.1 73.86 5.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.942 1.761 . . . . 0.0 110.014 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.457 ' HA ' ' HE2' ' A' ' 164' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.944 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.39 138.49 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.15 149.25 48.84 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.731 1.612 . . . . 0.0 108.238 171.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -50.86 -32.1 19.31 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.92 1.35 35.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.05 35.54 7.06 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.581 1.562 . . . . 0.0 111.531 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 13.8 m-85 -116.43 139.99 49.84 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.394 1.097 . . . . 0.0 109.858 -174.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -90.99 122.21 66.95 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 117.106 -1.426 . . . . 0.0 107.337 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.94 130.83 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 121.994 1.796 . . . . 0.0 110.238 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -139.1 166.45 24.48 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.211 1.404 . . . . 0.0 109.716 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.75 138.07 50.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.16 123.38 6.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.44 111.72 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.5 t -92.52 82.74 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 169.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.9 mm -63.66 129.27 27.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 169.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.4 m -114.66 121.03 42.12 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 170.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -80.54 139.8 36.16 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -65.78 -6.52 12.08 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -73.36 -1.82 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.109 0.868 . . . . 0.0 110.629 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.68 26.27 25.36 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 124.995 1.283 . . . . 0.0 112.49 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.8 mm-40 -124.82 161.97 25.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.893 1.277 . . . . 0.0 108.409 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.59 163.66 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.2 tpt -53.1 134.16 38.63 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.849 2.06 . . . . 0.0 111.742 177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -164.19 137.93 5.37 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 168.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.624 0.726 . . . . 0.0 110.056 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -75.8 135.33 40.25 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.273 1.429 . . . . 0.0 107.674 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -82.43 130.76 35.17 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -49.1 130.88 19.25 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.023 2.129 . . . . 0.0 110.658 172.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.26 -35.46 1.97 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.755 1.169 . . . . 0.0 113.539 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -85.13 -35.31 21.84 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.179 0.99 . . . . 0.0 110.337 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.289 91.6 m-70 56.04 34.01 22.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.961 1.705 . . . . 0.0 113.317 -174.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m -139.45 157.31 46.06 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.0 2.12 . . . . 0.0 106.288 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 26.3 m95 -65.92 158.36 28.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.548 1.139 . . . . 0.0 113.35 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -145.43 150.17 36.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.956 1.302 . . . . 0.0 109.515 174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -66.96 160.69 68.36 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.668 1.587 . . . . 0.0 111.157 169.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -81.73 -133.27 0.01 OUTLIER 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.738 3.625 . . . . 0.0 110.05 172.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 76.2 116.92 0.06 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.278 2.231 . . . . 0.0 110.225 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.72 146.62 18.59 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.3 153.84 51.19 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.599 1.095 . . . . 0.0 112.888 -169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.5 mt -90.27 139.01 18.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 125.839 1.656 . . . . 0.0 107.795 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -82.53 154.5 68.69 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.347 0.659 . . . . 0.0 110.629 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.82 117.63 4.42 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.884 1.722 . . . . 0.0 111.341 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.73 6.41 89.4 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.909 1.242 . . . . 0.0 112.998 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -81.59 130.22 34.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.78 160.37 28.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.409 1.084 . . . . 0.0 110.398 177.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.67 71.21 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 124.456 1.102 . . . . 0.0 112.445 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.05 -42.21 66.55 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.48 -42.57 96.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.869 1.268 . . . . 0.0 109.362 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -37.15 85.14 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.163 0.585 . . . . 0.0 111.925 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -59.78 -44.94 93.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.122 0.873 . . . . 0.0 109.651 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 85.4 m-85 -70.31 -29.78 66.59 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.168 -0.958 . . . . 0.0 112.015 174.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -62.33 -47.6 83.51 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.502 1.046 . . . . 0.0 109.751 174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.05 -34.16 70.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.91 0.484 . . . . 0.0 111.008 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -58.31 -39.67 79.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.482 1.113 . . . . 0.0 109.939 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -74.07 -50.82 17.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.24 1.416 . . . . 0.0 111.661 175.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.94 -35.0 79.75 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.967 1.258 . . . . 0.0 112.027 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.58 -50.38 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.994 0.918 . . . . 0.0 111.816 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.4 -13.53 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.661 0.785 . . . . 0.0 111.469 -169.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.26 40.88 96.91 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.0 mt -120.68 150.23 41.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 107.341 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.0 m -115.22 -175.61 2.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.008 0.923 . . . . 0.0 111.071 -169.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 96.3 mtt180 -66.09 32.89 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 128.356 2.663 . . . . 0.0 114.203 -177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -161.4 -16.23 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.773 1.229 . . . . 0.0 112.866 -169.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.59 -0.55 57.37 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.472 1.109 . . . . 0.0 112.484 -169.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.35 168.55 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.326 1.45 . . . . 0.0 108.326 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -137.83 119.97 15.62 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 105.771 -1.936 . . . . 0.0 105.771 -173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -74.6 129.65 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 120.23 1.377 . . . . 0.0 107.582 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.17 -32.12 7.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.81 0.444 . . . . 0.0 111.549 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.76 167.24 30.61 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.229 1.012 . . . . 0.0 109.088 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 p -149.77 160.16 43.77 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.005 1.322 . . . . 0.0 107.915 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -63.62 148.22 49.49 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.734 -0.604 . . . . 0.0 110.791 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -64.84 -37.06 86.35 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.79 0.436 . . . . 0.0 111.253 -171.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.84 172.95 14.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.575 1.95 . . . . 0.0 107.39 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -63.36 125.68 24.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.588 0.755 . . . . 0.0 110.148 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.62 133.44 37.27 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.38 150.38 32.35 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.218 0.917 . . . . 0.0 110.273 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.57 160.36 43.86 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.47 1.108 . . . . 0.0 109.077 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -91.76 128.36 37.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.62 148.22 95.0 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.523 1.129 . . . . 0.0 109.282 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.21 155.7 68.53 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.671 2.247 . . . . 0.0 109.755 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -54.32 -35.21 62.43 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.79 -24.2 55.93 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.194 0.998 . . . . 0.0 112.971 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.49 -17.36 15.81 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.947 0.899 . . . . 0.0 111.759 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.4 t -49.01 132.75 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 168.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -84.74 107.19 16.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -89.21 -1.93 58.28 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.495 0.718 . . . . 0.0 111.021 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.98 -20.82 21.72 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.754 1.622 . . . . 0.0 110.013 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 39.6 p -87.24 162.93 17.17 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.815 0.846 . . . . 0.0 108.811 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -136.69 113.24 9.99 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -54.61 152.4 19.31 Favored 'Cis proline' 0 C--N 1.351 0.663 0 CA-C-N 120.21 1.111 . . . . 0.0 113.116 -6.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.44 129.88 26.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.2 t -90.38 109.73 20.84 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.5 pt -93.58 -6.46 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 124.825 1.25 . . . . 0.0 112.024 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.454 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -157.46 169.61 34.43 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 120.086 1.312 . . . . 0.0 113.014 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -115.18 122.91 47.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -101.98 134.06 45.8 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -152.78 146.74 25.33 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.904 1.229 . . . . 0.0 114.147 175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -104.72 127.82 52.62 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 102.788 -3.042 . . . . 0.0 102.788 168.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -97.25 135.72 38.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -112.68 129.75 56.29 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.66 110.02 16.62 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 171.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -104.95 127.81 52.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -83.74 133.53 34.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 168.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.0 137.1 51.1 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.9 t -122.34 -38.88 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.7 p -60.56 -61.7 2.4 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.0 1.72 . . . . 0.0 112.145 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 172.24 38.65 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -42.08 -38.08 1.57 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.847 1.259 . . . . 0.0 112.491 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.68 -21.8 63.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.657 0.783 . . . . 0.0 112.878 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.35 -9.94 5.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.402 1.081 . . . . 0.0 112.744 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -60.47 130.93 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 169.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.04 49.42 1.66 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.14 0.976 . . . . 0.0 109.146 -170.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.5 ptp -64.53 28.81 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.467 2.307 . . . . 0.0 116.134 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -123.28 21.76 9.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.655 1.582 . . . . 0.0 111.524 169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.85 -35.36 72.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.897 2.079 . . . . 0.0 111.873 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -5.81 56.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.063 1.745 . . . . 0.0 113.306 -170.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.3 m 68.16 -37.82 0.35 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 128.607 2.763 . . . . 0.0 113.389 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.7 p -124.9 73.14 64.24 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.72 -177.65 2.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.302 2.668 . . . . 0.0 110.979 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.4 -8.2 21.35 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 117.477 -1.249 . . . . 0.0 111.573 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -130.54 151.6 50.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 121.341 1.882 . . . . 0.0 112.876 -170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.58 -25.91 3.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.229 1.812 . . . . 0.0 112.648 -169.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.65 157.71 29.97 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -106.99 159.97 15.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -150.47 120.89 7.37 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.047 1.739 . . . . 0.0 106.391 169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -82.82 124.19 30.06 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 m -115.13 163.15 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.21 1.004 . . . . 0.0 110.953 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.6 m -50.12 144.94 6.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.629 0.772 . . . . 0.0 110.143 174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -54.96 -36.12 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.888 0.475 . . . . 0.0 111.964 -169.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 52.9 m95 -100.39 12.19 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.391 1.076 . . . . 0.0 112.922 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.85 -49.77 10.29 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -61.53 -32.54 88.07 Favored 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 121.842 1.693 . . . . 0.0 113.782 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -31.38 49.31 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 119.807 1.185 . . . . 0.0 111.242 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.2 mmm-85 -86.05 -21.92 27.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.6 1.091 . . . . 0.0 111.281 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -81.61 -31.1 32.63 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.69 0.677 . . . . 0.0 111.665 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.1 160.37 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.325 0.584 . . . . 0.0 110.448 -175.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.6 m -62.86 149.01 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.109 0.964 . . . . 0.0 111.261 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.7 m -57.42 -35.04 69.56 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.999 1.319 . . . . 0.0 113.912 -169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -73.58 -27.03 61.09 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.788 0.722 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -82.53 -38.65 23.47 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.934 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -42.96 -50.64 5.82 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.874 1.215 . . . . 0.0 112.771 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.62 -26.25 60.69 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.8 t -74.2 -42.92 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -70.6 -32.67 70.13 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.576 -0.703 . . . . 0.0 110.774 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -62.11 -29.12 70.11 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.28 -0.888 . . . . 0.0 112.637 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -64.5 -47.89 77.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.714 1.143 . . . . 0.0 108.946 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.23 -44.79 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.1 mtt -64.67 -46.68 81.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.601 -1.19 . . . . 0.0 111.038 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -29.77 69.44 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 121.433 1.924 . . . . 0.0 111.068 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.81 -36.41 82.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.635 0.374 . . . . 0.0 110.357 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -100.02 -16.67 17.83 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.4 1.08 . . . . 0.0 113.366 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.4 6.87 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.995 1.318 . . . . 0.0 109.899 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.1 m -65.25 -21.51 66.75 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.9 t -73.3 -42.45 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.52 -39.37 40.47 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.2 mtt -72.58 -20.17 61.36 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 118.413 -0.804 . . . . 0.0 111.122 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.7 m -64.51 -20.27 66.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.865 1.212 . . . . 0.0 112.528 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.4 -29.0 47.01 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.355 0.662 . . . . 0.0 110.892 172.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -98.2 -37.27 9.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.239 1.016 . . . . 0.0 111.224 -169.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -94.35 19.58 9.35 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.767 2.027 . . . . 0.0 110.204 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -61.94 -31.1 71.4 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.145 1.378 . . . . 0.0 113.202 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -55.97 12.85 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 112.001 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.86 -18.28 21.95 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.383 2.722 . . . . 0.0 114.079 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.2 tttp . . . . . 0 C--O 1.256 1.415 0 CA-C-N 119.771 1.169 . . . . 0.0 109.59 176.635 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 46.6 mm -129.08 147.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.08 -44.7 68.55 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.126 0.57 . . . . 0.0 111.252 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -154.34 -86.22 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.429 1.092 . . . . 0.0 109.717 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -82.65 -45.92 13.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.94 15.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.507 -1.163 . . . . 0.0 114.943 -171.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -99.32 125.57 45.0 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 119.637 1.718 . . . . 0.0 108.547 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -85.68 126.07 67.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 117.368 -1.301 . . . . 0.0 107.688 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.09 127.49 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.28 1.987 . . . . 0.0 109.244 176.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -137.27 166.34 24.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.218 1.407 . . . . 0.0 108.99 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -119.43 141.63 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 127.006 2.122 . . . . 0.0 105.84 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.76 132.71 10.42 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.89 129.37 48.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -111.61 86.58 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 168.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.8 mm -65.48 135.84 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.7 m -119.08 124.2 46.32 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.33 127.32 32.62 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 170.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -53.75 -4.02 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.54 2.336 . . . . 0.0 116.088 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.35 -12.48 60.27 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.8 1.182 . . . . 0.0 111.423 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.42 41.83 2.67 Favored Glycine 0 C--N 1.342 0.916 0 C-N-CA 124.791 1.186 . . . . 0.0 111.811 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.69 155.47 44.91 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.41 162.18 13.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.182 0.993 . . . . 0.0 112.152 -169.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 30.8 tpp -53.54 130.67 36.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 126.037 1.735 . . . . 0.0 111.36 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.418 ' CE3' ' HA ' ' A' ' 24' ' ' TRP . 1.4 t-105 -159.27 131.11 6.4 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 166.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.19 26.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 110.194 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -83.62 134.72 34.78 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.65 130.6 35.11 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.79 145.19 56.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.396 0.679 . . . . 0.0 110.588 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.27 -43.57 2.05 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.947 1.26 . . . . 0.0 112.534 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -78.63 -37.97 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.377 1.071 . . . . 0.0 109.844 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.316 24.3 m170 57.84 43.61 21.41 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.807 2.043 . . . . 0.0 113.734 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.6 p -146.33 171.45 14.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 107.034 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -73.21 156.04 38.96 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.212 -0.93 . . . . 0.0 111.542 -172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.558 ' NE2' HE22 ' A' ' 37' ' ' GLN . 4.7 tt0 -147.54 145.67 29.17 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.605 0.762 . . . . 0.0 109.968 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.62 143.03 87.08 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.697 1.199 . . . . 0.0 109.965 169.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -69.75 139.08 39.38 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.455 2.103 . . . . 0.0 110.238 169.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.558 HE22 ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -167.48 151.33 6.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.422 1.889 . . . . 0.0 109.035 170.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.94 139.93 7.42 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 169.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 146.72 45.91 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.0 mt -80.7 138.89 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -96.64 154.77 38.36 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 123.911 0.884 . . . . 0.0 110.52 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.92 123.14 12.72 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.388 2.059 . . . . 0.0 114.703 -169.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.76 4.52 66.53 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 113.991 -1.458 . . . . 0.0 113.244 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -86.17 123.94 32.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.646 1.223 . . . . 0.0 108.545 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 p -72.92 162.4 29.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.543 1.137 . . . . 0.0 110.846 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.86 79.79 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 111.4 -170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.84 9.4 6.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.81 . . . . 0.0 111.65 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -111.59 -54.11 2.64 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.19 72.23 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.541 1.136 . . . . 0.0 112.79 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -60.67 -42.76 97.71 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.037 0.835 . . . . 0.0 109.567 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -74.18 -24.45 59.37 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.523 -1.36 . . . . 0.0 111.771 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.6 -50.78 71.2 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.08 -1.012 . . . . 0.0 108.434 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.48 -35.66 81.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.102 0.561 . . . . 0.0 111.906 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -56.68 -41.21 76.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.935 1.294 . . . . 0.0 110.455 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -46.65 54.1 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.185 0.994 . . . . 0.0 110.551 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.32 -40.26 95.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.294 0.952 . . . . 0.0 111.788 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.44 -51.95 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.496 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -111.83 -9.33 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.05 36.32 64.38 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 120.938 -1.101 . . . . 0.0 112.339 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.6 mt -105.96 164.59 11.84 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.981 0.912 . . . . 0.0 108.62 171.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -126.96 -175.95 3.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.064 1.346 . . . . 0.0 111.005 -169.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.95 41.24 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.853 2.061 . . . . 0.0 113.206 -174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -159.76 -21.26 0.07 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.319 0.648 . . . . 0.0 112.725 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -85.31 -0.12 53.76 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.19 168.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.42 1.088 . . . . 0.0 110.523 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -142.93 121.26 12.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 126.087 1.755 . . . . 0.0 106.853 -170.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.5 mt -75.89 130.53 36.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 120.808 1.64 . . . . 0.0 107.646 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.66 -34.71 7.23 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.38 0.672 . . . . 0.0 110.886 171.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.79 172.5 18.37 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.37 1.068 . . . . 0.0 109.225 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 p -149.31 160.58 43.28 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 p -66.13 142.2 57.84 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.921 0.782 . . . . 0.0 109.375 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -68.73 -22.55 64.32 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.933 0.493 . . . . 0.0 111.984 -170.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.44 173.58 11.88 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.534 1.934 . . . . 0.0 107.725 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -76.8 117.15 18.13 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.49 137.53 52.65 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 170.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -147.35 147.29 30.17 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.745 -0.597 . . . . 0.0 109.795 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -150.76 163.42 38.62 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.109 1.363 . . . . 0.0 107.979 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -87.51 149.45 24.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.361 0.6 . . . . 0.0 109.889 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -87.49 137.35 32.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -68.55 151.81 75.14 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.662 2.241 . . . . 0.0 108.426 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -21.81 66.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 -169.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.05 -28.45 62.33 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.823 0.849 . . . . 0.0 112.184 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.3 tp -97.12 -24.13 15.89 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.396 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -45.02 136.15 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -75.15 -42.51 55.92 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.976 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.3 m95 59.73 1.95 0.33 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.731 2.413 . . . . 0.0 114.156 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -97.57 -23.79 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.014 1.325 . . . . 0.0 111.51 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 p -73.13 153.41 40.77 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.868 1.667 . . . . 0.0 109.053 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -135.94 112.2 10.43 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-O 117.785 -1.103 . . . . 0.0 108.263 175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.99 151.88 17.38 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 CA-C-N 120.509 1.217 . . . . 0.0 111.832 -10.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -62.35 131.55 27.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.5 p -90.35 127.96 36.32 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -169.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -105.96 -4.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.296 1.439 . . . . 0.0 110.986 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.99 161.15 30.91 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 118.969 0.804 . . . . 0.0 111.705 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.23 119.88 40.61 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -92.89 130.61 38.42 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 169.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.13 142.39 22.41 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.756 1.616 . . . . 0.0 114.447 174.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -101.77 130.97 48.31 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -95.38 141.93 28.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -111.44 135.19 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 108.392 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.1 tp -90.83 102.5 15.26 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 102' ' ' LEU . 16.3 mt -100.44 127.33 46.81 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.219 0.608 . . . . 0.0 110.207 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -85.19 138.06 32.61 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 168.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -70.4 132.56 45.81 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.0 t -112.85 -41.22 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.0 m -139.01 127.7 23.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.92 -171.27 43.36 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t70 62.92 -51.39 0.19 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 129.416 3.086 . . . . 0.0 112.907 -169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.03 -34.57 22.29 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 111.102 172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -105.66 -5.66 19.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.859 0.864 . . . . 0.0 112.536 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.84 142.86 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 169.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -132.07 -45.42 0.94 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -170.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.3 mtt 60.17 0.01 0.27 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.85 25.9 3.98 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.645 2.02 . . . . 0.0 111.19 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.4 t -86.1 -30.31 22.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.4 p -85.14 168.38 14.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.176 1.791 . . . . 0.0 110.565 -169.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 m -70.95 -33.52 70.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.985 0.514 . . . . 0.0 111.533 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -142.77 88.55 8.47 Favored Pre-proline 0 N--CA 1.45 -0.439 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -67.16 -166.07 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.407 2.071 . . . . 0.0 113.547 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -128.28 -54.67 1.27 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.802 170.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -100.47 168.34 9.8 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.398 0.999 . . . . 0.0 112.561 -169.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.92 -8.34 0.81 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.377 1.071 . . . . 0.0 113.115 176.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.9 149.22 19.89 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -113.45 150.14 33.21 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.453 1.501 . . . . 0.0 110.226 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -148.82 114.02 5.52 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.569 1.547 . . . . 0.0 107.31 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -77.8 133.26 38.25 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.87 160.1 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 124.973 1.309 . . . . 0.0 109.322 -172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.2 m -53.65 152.94 4.74 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.375 0.607 . . . . 0.0 110.725 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.41 151.19 13.55 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 67.39 -15.79 0.17 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -57.89 -45.58 99.78 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 121.284 1.856 . . . . 0.0 111.984 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -63.85 -25.44 67.68 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.769 1.646 . . . . 0.0 114.373 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.09 -37.23 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 119.691 1.132 . . . . 0.0 108.982 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -85.98 -15.9 40.04 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.125 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -82.72 -32.19 28.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.527 1.058 . . . . 0.0 111.955 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m -69.25 164.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 118.978 0.808 . . . . 0.0 112.204 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.28 151.16 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.471 1.108 . . . . 0.0 110.652 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 m -57.37 -36.16 70.87 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.974 1.31 . . . . 0.0 113.371 -169.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -76.71 -24.72 53.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.183 0.901 . . . . 0.0 111.673 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -87.34 -27.49 22.8 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.431 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -42.83 -50.82 5.63 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.917 1.287 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.89 -37.62 79.12 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.157 0.435 . . . . 0.0 111.158 -175.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.83 -45.46 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.62 -32.15 70.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.906 0.483 . . . . 0.0 110.339 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -57.65 -39.83 77.89 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.443 1.097 . . . . 0.0 110.301 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -63.44 -49.67 72.78 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.948 1.249 . . . . 0.0 108.97 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.46 -45.23 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.84 -47.11 82.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.126 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -28.18 66.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.181 1.809 . . . . 0.0 112.284 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -66.82 -29.51 69.46 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.47 0.577 . . . . 0.0 110.427 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -108.66 -21.67 12.59 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.09 0.956 . . . . 0.0 113.455 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -54.2 36.54 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.241 1.016 . . . . 0.0 109.816 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 m -65.35 -18.58 65.43 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.4 -34.47 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 119.004 0.82 . . . . 0.0 108.8 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 88.1 t -71.68 -40.79 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 mtt -59.22 -23.03 61.95 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.541 -1.218 . . . . 0.0 111.759 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.0 m -54.16 -31.34 52.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.822 1.646 . . . . 0.0 112.042 174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.33 -28.96 21.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.277 1.031 . . . . 0.0 111.507 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.0 -30.52 8.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.082 . . . . 0.0 112.781 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -102.65 18.61 20.89 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.168 2.187 . . . . 0.0 109.777 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -58.77 -26.69 64.27 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.955 1.702 . . . . 0.0 113.366 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.36 -60.5 7.57 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.157 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.08 -25.68 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.28 2.653 . . . . 0.0 114.119 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt . . . . . 0 C--O 1.254 1.328 0 CA-C-N 119.495 1.043 . . . . 0.0 108.685 -178.14 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 111.43 0.159 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.5 mm -106.16 144.14 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 170.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -101.26 -40.7 7.02 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -166.74 104.67 0.59 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.772 0.829 . . . . 0.0 110.707 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 t0 58.42 44.79 17.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.077 2.151 . . . . 0.0 113.301 169.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.95 34.26 18.78 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 118.845 -0.975 . . . . 0.0 112.32 175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -115.89 132.04 56.76 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.588 1.194 . . . . 0.0 110.552 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -88.41 123.72 67.66 Favored Pre-proline 0 N--CA 1.468 0.452 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.05 130.7 10.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.322 2.015 . . . . 0.0 110.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -138.47 163.54 31.69 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.395 1.078 . . . . 0.0 110.655 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.21 130.79 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.667 1.987 . . . . 0.0 107.209 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.38 122.36 7.55 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 171.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mm -90.48 104.23 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.7 t -87.33 80.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 171.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.24 131.85 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.1 m -112.19 128.76 56.33 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -94.58 23.47 5.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 56.7 mtm-85 57.05 -1.13 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.651 1.98 . . . . 0.0 116.206 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -99.07 -1.62 39.14 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.76 0.709 . . . . 0.0 111.914 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.36 27.57 29.99 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 119.196 0.907 . . . . 0.0 111.169 -169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -141.38 156.2 45.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.992 1.717 . . . . 0.0 106.641 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.5 m -127.01 168.88 19.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.662 0.785 . . . . 0.0 112.712 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.5 tpt -48.1 127.03 11.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.119 2.168 . . . . 0.0 112.017 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -160.65 133.25 6.28 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 168.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.03 29.12 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.38 0.672 . . . . 0.0 109.981 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.9 ttm105 -75.14 140.59 43.48 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.674 1.19 . . . . 0.0 108.184 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -86.23 122.37 30.13 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.341 1.056 . . . . 0.0 109.679 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -53.98 138.19 37.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.809 1.643 . . . . 0.0 108.611 169.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.7 -37.19 1.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.07 1.319 . . . . 0.0 113.836 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -90.9 -29.91 17.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.504 1.152 . . . . 0.0 111.267 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 55.56 41.3 30.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.001 1.72 . . . . 0.0 112.602 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.3 p -145.43 169.76 17.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.055 1.342 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -83.48 148.31 27.31 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 120.754 -1.216 . . . . 0.0 111.048 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -148.81 156.88 42.95 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.974 0.893 . . . . 0.0 111.101 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -67.98 163.35 51.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.952 2.101 . . . . 0.0 110.007 168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.71 -106.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.208 3.272 . . . . 0.0 110.808 172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 63.83 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.605 1.962 . . . . 0.0 111.185 -174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.03 144.25 18.34 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.48 148.77 45.91 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.19 133.69 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -75.71 126.61 87.04 Favored Pre-proline 0 C--O 1.232 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 108.567 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -55.02 119.23 6.16 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.982 1.788 . . . . 0.0 112.619 -175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.85 3.69 79.86 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.078 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.07 120.67 41.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -70.62 162.51 28.81 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 123.155 0.582 . . . . 0.0 111.483 -173.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -44.25 -45.72 8.7 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 127.18 2.192 . . . . 0.0 113.412 -169.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.7 -47.36 40.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.59 -37.9 82.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.306 0.642 . . . . 0.0 110.511 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.53 -34.97 76.8 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.0 tmm? -60.15 -45.72 92.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -67.68 -27.4 66.81 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.293 -0.88 . . . . 0.0 112.844 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -65.17 -51.13 62.98 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 120.885 -1.135 . . . . 0.0 109.009 174.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.06 -31.12 70.54 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.138 0.881 . . . . 0.0 110.911 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.93 -39.87 79.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.27 1.028 . . . . 0.0 109.371 173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -52.08 14.83 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.321 1.049 . . . . 0.0 111.415 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.77 -36.98 84.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.236 0.925 . . . . 0.0 111.446 -172.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -104.02 -39.01 6.73 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -170.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.94 -20.12 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.255 0.622 . . . . 0.0 110.085 -174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.17 19.42 78.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.488 -1.382 . . . . 0.0 111.945 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.3 mt -102.22 151.64 21.98 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.521 1.128 . . . . 0.0 108.085 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -113.46 177.45 4.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.693 -0.629 . . . . 0.0 110.064 -174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -69.99 58.5 0.16 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.073 1.749 . . . . 0.0 112.744 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -163.44 -26.98 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.245 1.818 . . . . 0.0 111.319 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -89.23 -3.39 58.57 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -145.3 165.26 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.352 0.661 . . . . 0.0 109.741 -172.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -135.43 119.73 17.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.3 mt -74.9 126.55 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -35.1 6.07 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.151 0.98 . . . . 0.0 110.697 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.63 171.67 19.57 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.353 1.461 . . . . 0.0 108.783 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.7 p -148.43 160.57 42.9 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.227 1.411 . . . . 0.0 108.114 169.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -62.86 148.32 47.52 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.349 0.522 . . . . 0.0 110.341 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -62.16 -36.71 82.68 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.702 0.401 . . . . 0.0 111.308 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -148.35 175.03 11.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.4 1.88 . . . . 0.0 107.226 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.515 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 70.5 m95 -64.05 127.31 30.84 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.346 0.658 . . . . 0.0 109.572 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.43 141.21 39.85 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 170.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -153.47 151.18 29.56 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.686 -0.634 . . . . 0.0 110.208 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -155.94 160.87 40.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.743 1.617 . . . . 0.0 107.536 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.15 145.94 24.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.379 0.609 . . . . 0.0 109.593 172.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.74 151.85 93.38 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 125.556 1.542 . . . . 0.0 108.365 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -63.31 152.75 78.37 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 N-CA-C 108.028 -1.566 . . . . 0.0 108.028 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -49.4 -48.28 47.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.07 -17.93 64.87 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.09 0.956 . . . . 0.0 112.913 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.9 tp -102.57 -9.09 20.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.785 1.234 . . . . 0.0 111.838 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.9 t -56.49 142.18 12.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 170.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -74.47 -47.84 30.97 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -168.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.2 m95 55.36 11.23 0.55 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.9 2.08 . . . . 0.0 114.328 -170.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.46 -24.8 13.79 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.412 1.085 . . . . 0.0 111.175 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.6 p -90.89 168.84 11.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.078 0.951 . . . . 0.0 109.789 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.96 116.87 18.05 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -63.67 162.37 57.13 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 CA-C-N 119.89 0.996 . . . . 0.0 109.952 -10.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.33 132.86 25.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.9 t -90.4 108.72 19.96 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 30.4 pt -94.12 -15.29 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.418 1.887 . . . . 0.0 111.596 -176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.25 172.8 34.13 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 120.099 1.318 . . . . 0.0 112.848 -172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -119.22 123.57 44.62 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 68.0 tttt -98.46 131.77 44.45 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 172.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.77 137.37 18.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.857 1.208 . . . . 0.0 113.089 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -100.81 131.73 46.55 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 168.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -100.28 132.92 45.38 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -109.14 131.34 55.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -86.94 108.4 18.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.3 mm? -107.09 125.07 50.58 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.885 0.874 . . . . 0.0 108.867 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -83.56 133.32 34.87 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 168.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.3 tp -68.74 124.46 23.71 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 86.0 t -98.15 -49.71 11.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 175.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.8 m -135.81 124.35 23.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -163.6 -163.07 15.56 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.81 -48.17 0.26 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 128.79 2.836 . . . . 0.0 113.175 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.7 -32.74 10.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.725 1.61 . . . . 0.0 112.023 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.78 -24.53 31.03 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.441 0.696 . . . . 0.0 110.695 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 mt -64.76 131.3 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -134.95 -32.08 0.98 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.6 0.76 . . . . 0.0 111.691 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.5 mtt 64.6 -49.63 0.32 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.508 3.123 . . . . 0.0 113.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -89.48 25.22 2.02 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.654 1.182 . . . . 0.0 112.986 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -65.46 -28.3 69.12 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.143 0.577 . . . . 0.0 110.322 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 m -95.42 10.66 35.58 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.98 1.312 . . . . 0.0 113.127 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.28 -36.71 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 129.695 3.198 . . . . 0.0 115.793 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.8 p -128.28 60.88 50.3 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.74 1.616 . . . . 0.0 108.993 175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -70.78 177.84 5.85 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.048 2.499 . . . . 0.0 110.29 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -81.46 -26.08 35.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.426 169.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -99.43 139.14 35.53 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.627 1.558 . . . . 0.0 112.684 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -112.53 -31.08 6.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.098 1.759 . . . . 0.0 112.397 -175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.67 151.81 16.09 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -102.2 155.59 18.11 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.87 0.868 . . . . 0.0 111.901 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -152.58 111.51 3.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.26 1.824 . . . . 0.0 106.947 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -74.17 138.51 43.85 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.874 0.761 . . . . 0.0 109.24 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.41 159.93 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.864 1.265 . . . . 0.0 109.158 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.8 m -55.28 152.55 8.19 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.953 0.501 . . . . 0.0 110.125 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 165.52 13.65 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.7 m95 65.88 -24.67 0.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.888 1.675 . . . . 0.0 115.075 -169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.97 -46.02 96.65 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 120.483 1.492 . . . . 0.0 111.691 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.98 -29.18 81.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 122.012 1.754 . . . . 0.0 113.263 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -64.42 -10.24 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.14 1.376 . . . . 0.0 111.89 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -108.53 -23.08 12.0 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.898 -1.126 . . . . 0.0 110.97 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -76.91 -35.73 57.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.314 0.961 . . . . 0.0 111.68 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.89 166.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.869 0.759 . . . . 0.0 111.509 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.77 150.68 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.421 1.088 . . . . 0.0 110.565 174.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.0 p -53.33 -40.67 65.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.618 1.567 . . . . 0.0 113.633 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -70.33 -32.36 70.06 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.365 0.53 . . . . 0.0 110.611 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -72.95 -38.61 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.782 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -51.6 -48.21 63.32 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.519 1.054 . . . . 0.0 110.879 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.66 -26.04 62.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.9 -46.51 40.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.22 -0.925 . . . . 0.0 108.67 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -35.34 80.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 110.976 -170.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -61.19 -28.04 68.85 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.641 -1.287 . . . . 0.0 112.983 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -64.21 -46.76 82.47 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.3 t -60.81 -48.5 88.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.217 1.007 . . . . 0.0 109.391 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 mtt -66.43 -37.07 84.38 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.093 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -47.29 82.02 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 119.456 1.025 . . . . 0.0 110.455 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -60.5 -32.58 71.58 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.264 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -107.8 4.01 25.08 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.64 -57.44 10.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.476 1.489 . . . . 0.0 110.994 -169.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.7 m -59.71 -30.54 68.88 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.237 0.615 . . . . 0.0 111.715 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.02 -8.35 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.736 1.214 . . . . 0.0 111.038 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.22 -35.95 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 O-C-N 121.355 -0.841 . . . . 0.0 109.402 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 54.8 tpp -76.82 -45.33 29.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.269 0.628 . . . . 0.0 111.051 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.6 m -62.97 -31.09 72.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 121.93 -0.481 . . . . 0.0 111.61 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.48 -34.12 70.54 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.254 0.622 . . . . 0.0 109.868 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -99.25 0.81 43.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.977 0.911 . . . . 0.0 112.647 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -94.55 -31.84 13.72 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.592 1.157 . . . . 0.0 109.247 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -65.23 -33.52 76.2 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.505 1.922 . . . . 0.0 111.706 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.58 -56.91 22.33 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.397 -0.811 . . . . 0.0 112.434 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.34 -29.64 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.044 2.496 . . . . 0.0 112.534 174.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.587 1.555 . . . . 0.0 109.889 -173.541 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 26.5 mm -130.57 134.95 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -69.89 141.63 53.13 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.827 1.651 . . . . 0.0 107.337 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -48.8 -30.29 5.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 -168.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -75.37 -5.36 44.45 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.96 38.74 3.75 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 126.059 1.79 . . . . 0.0 110.663 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.0 139.77 53.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.095 1.447 . . . . 0.0 111.628 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -85.57 120.54 73.1 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 116.776 -1.583 . . . . 0.0 107.853 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -72.42 137.07 27.44 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 121.822 1.681 . . . . 0.0 111.037 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -145.6 157.51 43.97 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.153 1.381 . . . . 0.0 111.609 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.1 74.61 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.419 2.287 . . . . 0.0 107.934 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.77 128.26 44.77 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.1 mm -86.42 110.11 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.14 -16.26 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 116.89 -1.529 . . . . 0.0 114.742 -169.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm 19.24 109.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 129.127 2.971 . . . . 0.0 114.929 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.2 138.44 33.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -68.51 -4.56 15.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -171.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -75.98 -7.55 54.88 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.852 0.751 . . . . 0.0 110.56 169.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.86 37.71 4.35 Favored Glycine 0 C--N 1.349 1.252 0 C-N-CA 126.131 1.824 . . . . 0.0 112.118 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -133.28 155.79 48.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.551 0.74 . . . . 0.0 109.038 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -115.68 156.89 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.31 1.044 . . . . 0.0 111.295 -168.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.98 131.44 44.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.124 1.769 . . . . 0.0 110.309 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -158.86 139.1 12.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.96 144.24 23.2 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -70.95 138.26 49.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -86.57 125.49 33.83 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.76 137.59 57.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.609 2.364 . . . . 0.0 109.996 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.13 -31.68 1.33 Allowed Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.062 1.315 . . . . 0.0 113.716 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -86.35 -34.15 20.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.453 1.101 . . . . 0.0 110.455 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 57.29 33.46 23.33 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.046 1.738 . . . . 0.0 112.575 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 p -149.87 -177.79 6.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.245 1.818 . . . . 0.0 107.231 170.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -80.46 160.43 25.29 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.029 -1.044 . . . . 0.0 112.975 -169.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -151.1 147.74 27.45 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.216 1.006 . . . . 0.0 108.987 172.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -60.59 143.76 89.9 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.301 1.44 . . . . 0.0 110.21 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -59.22 153.08 55.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.306 2.004 . . . . 0.0 111.065 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -171.79 149.55 2.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.139 1.376 . . . . 0.0 109.845 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.91 134.28 3.37 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 107.179 -2.369 . . . . 0.0 107.179 169.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.7 171.72 55.15 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 118.247 1.024 . . . . 0.0 111.639 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.6 mt -96.67 146.04 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.815 0.846 . . . . 0.0 109.064 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -87.61 131.71 42.86 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 125.565 1.546 . . . . 0.0 108.39 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.44 118.07 4.28 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.23 1.953 . . . . 0.0 114.08 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.48 3.57 90.03 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.037 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -86.98 131.67 34.02 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.063 0.945 . . . . 0.0 108.554 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.99 161.26 30.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.827 1.251 . . . . 0.0 110.685 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.17 -44.26 64.55 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 125.168 1.387 . . . . 0.0 112.992 -169.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.24 -48.96 48.05 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.6 -39.59 77.19 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.597 1.159 . . . . 0.0 109.919 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.14 -34.42 63.86 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.044 0.938 . . . . 0.0 111.983 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -57.33 -39.87 76.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.95 0.795 . . . . 0.0 110.065 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -67.37 -26.39 66.44 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.742 1.155 . . . . 0.0 113.511 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -64.33 -49.9 69.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.153 1.342 . . . . 0.0 108.597 169.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.39 75.56 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-O 119.451 -0.309 . . . . 0.0 111.316 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.5 tp -57.2 -44.9 84.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.753 1.221 . . . . 0.0 109.715 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.1 -47.3 80.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.634 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -63.72 -39.49 94.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.261 1.391 . . . . 0.0 112.772 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -82.47 -46.67 13.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.166 1.386 . . . . 0.0 110.577 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 m -132.16 1.03 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.348 1.059 . . . . 0.0 112.816 -169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.84 32.47 79.58 Favored Glycine 0 CA--C 1.521 0.447 0 O-C-N 120.909 -1.12 . . . . 0.0 112.164 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 mt -101.78 154.54 18.82 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.3 m -117.49 179.03 4.17 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.842 0.857 . . . . 0.0 109.106 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -73.15 46.75 0.18 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.67 1.588 . . . . 0.0 115.242 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -163.42 -20.63 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.124 1.769 . . . . 0.0 111.785 -171.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -89.1 2.92 53.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.091 1.356 . . . . 0.0 112.961 -169.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.75 170.19 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.506 1.522 . . . . 0.0 108.91 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -138.0 120.25 15.77 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 33.3 mt -77.66 128.37 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 120.658 1.572 . . . . 0.0 107.879 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -104.95 -34.8 7.9 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.842 0.857 . . . . 0.0 111.467 172.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.66 173.79 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.156 1.382 . . . . 0.0 108.493 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -150.49 160.88 43.46 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 m -56.02 133.39 51.76 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -66.14 -27.04 67.73 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -147.33 168.09 22.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.248 1.419 . . . . 0.0 108.61 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -68.73 117.93 11.06 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.9 mt -76.9 156.7 31.89 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 173.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 mtp-105 -143.46 154.35 43.58 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.918 1.687 . . . . 0.0 108.029 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -146.1 172.67 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.639 . . . . 0.0 107.721 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -105.45 133.15 50.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.2 mt -67.75 148.72 98.49 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.33 146.09 25.56 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.529 2.153 . . . . 0.0 108.287 169.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -56.07 -44.32 78.81 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.749 1.159 . . . . 0.0 113.146 -168.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -65.22 -15.19 62.2 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.122 0.969 . . . . 0.0 112.783 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.18 -0.33 33.36 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.074 1.75 . . . . 0.0 111.618 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.61 141.22 13.79 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -86.61 128.51 35.0 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -107.57 -0.36 22.1 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.308 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -106.56 -12.23 15.66 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.28 1.032 . . . . 0.0 111.446 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.6 p -73.97 -35.92 64.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.65 -0.656 . . . . 0.0 111.535 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 40.47 87.98 0.1 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 128.164 2.585 . . . . 0.0 112.347 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.1 143.42 42.21 Favored 'Cis proline' 0 C--N 1.354 0.847 0 CA-C-N 120.03 1.046 . . . . 0.0 114.148 10.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -62.58 131.55 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.9 t -94.01 112.31 24.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.3 pt -97.61 -8.89 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.179 0.991 . . . . 0.0 112.089 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.23 176.33 48.01 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 119.867 1.212 . . . . 0.0 112.827 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 -101.95 121.2 41.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -82.89 112.48 19.72 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 103.115 -2.92 . . . . 0.0 103.115 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.6 138.61 51.36 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.985 1.721 . . . . 0.0 112.93 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -120.87 113.72 20.54 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m95 -85.64 149.63 25.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -112.36 130.02 56.1 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.2 tp -79.86 90.58 5.3 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 102' ' ' LEU . 26.3 mt -88.68 122.7 32.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.807 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -84.61 136.4 33.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.33 140.81 57.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.47 -56.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -91.92 123.11 35.05 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.54 -170.89 40.73 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.587 0.613 . . . . 0.0 114.482 -169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -48.98 -32.91 9.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.799 1.64 . . . . 0.0 112.88 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -26.1 66.42 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.61 -25.21 13.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.332 1.453 . . . . 0.0 111.306 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 mt -56.05 139.8 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 169.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -141.57 85.92 1.98 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 122.252 1.025 . . . . 0.0 108.664 169.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 35.7 mtt -60.25 -12.84 9.9 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.968 0.907 . . . . 0.0 112.791 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -110.1 30.59 6.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.968 1.307 . . . . 0.0 110.304 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -76.39 -31.14 57.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.174 0.59 . . . . 0.0 111.129 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -80.38 168.49 18.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.987 0.898 . . . . 0.0 109.319 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m -81.47 -28.37 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.627 1.571 . . . . 0.0 111.14 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 p -131.15 64.15 72.63 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.393 1.877 . . . . 0.0 108.21 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.34 176.27 5.84 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.71 2.94 . . . . 0.0 111.009 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -114.54 -22.23 9.9 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.185 172.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -123.09 145.07 48.88 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 121.404 1.911 . . . . 0.0 111.441 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -103.54 -40.0 6.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.132 1.373 . . . . 0.0 110.082 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.01 170.92 13.77 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.25 0.929 . . . . 0.0 111.871 172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.43 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 20.1 t-105 -170.21 -125.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.973 1.709 . . . . 0.0 108.536 168.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 6.9 ptt180 -153.65 158.17 40.69 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.543 2.737 . . . . 0.0 106.589 -169.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -80.33 141.38 35.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.004 0.82 . . . . 0.0 109.151 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.56 162.56 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.11 0.964 . . . . 0.0 111.048 -169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -51.79 151.12 3.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.814 0.846 . . . . 0.0 110.682 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -54.58 -40.92 69.28 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -169.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -96.47 6.55 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.45 0.7 . . . . 0.0 112.682 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.92 -46.44 15.43 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.339 -1.315 . . . . 0.0 111.633 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -60.94 -36.03 85.11 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.081 1.854 . . . . 0.0 113.685 -176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.46 -24.85 33.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 O-C-N 121.15 -0.969 . . . . 0.0 111.435 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.55 -17.25 34.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.396 0.998 . . . . 0.0 111.516 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -83.35 -30.72 27.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.55 1.068 . . . . 0.0 111.602 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.89 162.92 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.56 148.82 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 123.468 0.707 . . . . 0.0 111.427 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.1 m -56.93 -29.97 63.58 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.694 1.597 . . . . 0.0 114.848 -169.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -79.28 -43.0 24.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.444 1.02 . . . . 0.0 110.478 176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -74.46 -27.37 60.56 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.597 -0.689 . . . . 0.0 111.157 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -42.07 -46.62 4.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.415 1.486 . . . . 0.0 111.252 169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.39 -43.6 85.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.835 0.743 . . . . 0.0 111.396 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.02 -34.74 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.912 -0.493 . . . . 0.0 110.264 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.81 -31.75 70.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.186 -0.946 . . . . 0.0 110.053 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -58.5 -36.14 73.32 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.632 -1.292 . . . . 0.0 111.058 169.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -63.64 -44.36 94.11 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.211 1.368 . . . . 0.0 109.368 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.68 -45.87 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.096 0.862 . . . . 0.0 109.764 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 21.5 mmt -62.02 -45.3 94.21 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.769 -0.582 . . . . 0.0 109.633 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -63.85 -40.27 96.19 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.783 1.233 . . . . 0.0 111.034 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.48 -40.02 77.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.745 1.218 . . . . 0.0 110.601 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.57 -10.32 22.2 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.817 1.044 . . . . 0.0 113.817 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.61 -57.34 10.33 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.768 1.167 . . . . 0.0 111.131 -169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -80.36 15.84 1.48 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.9 t -110.37 -28.07 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.34 -65.94 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.308 1.043 . . . . 0.0 109.146 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.4 mtp -59.26 -29.3 67.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.435 1.094 . . . . 0.0 111.231 -169.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -58.37 -27.79 64.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.135 0.974 . . . . 0.0 113.32 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 46.4 mt -65.54 -40.07 92.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.67 0.788 . . . . 0.0 109.479 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -83.91 -31.07 25.86 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.276 1.03 . . . . 0.0 110.406 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.02 -17.83 64.53 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.147 1.379 . . . . 0.0 111.347 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.58 79.79 4.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -35.62 34.73 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -63.13 -17.14 58.71 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.761 2.974 . . . . 0.0 114.868 169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 124.826 1.25 . . . . 0.0 110.287 -175.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.8 mm -131.92 148.67 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.91 152.11 28.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.091 0.957 . . . . 0.0 109.644 171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -59.49 -30.88 68.86 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -88.35 7.7 31.19 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.773 0.829 . . . . 0.0 112.581 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.11 21.27 30.66 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.283 1.42 . . . . 0.0 113.636 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -101.27 144.68 29.82 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 119.038 1.419 . . . . 0.0 110.191 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.36 123.05 65.13 Favored Pre-proline 0 N--CA 1.475 0.815 0 CA-C-O 116.569 -1.682 . . . . 0.0 106.921 174.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -69.14 126.98 14.4 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.07 1.846 . . . . 0.0 111.03 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -139.86 159.59 41.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.164 1.786 . . . . 0.0 110.335 -175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.95 140.71 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 106.783 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.12 123.11 5.55 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 171.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.71 112.09 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.92 83.81 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.13 137.6 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -121.16 124.65 45.23 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 169.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -73.51 125.2 27.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 102.061 -3.311 . . . . 0.0 102.061 169.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -48.32 -18.62 0.23 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 116.025 -1.94 . . . . 0.0 115.73 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -70.3 7.06 1.1 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.619 1.554 . . . . 0.0 112.642 170.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.94 16.64 32.61 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.493 1.52 . . . . 0.0 113.702 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -121.18 163.49 18.39 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.136 0.974 . . . . 0.0 108.509 -168.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -105.99 161.66 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -167.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.9 tpt -56.53 129.92 42.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.23 1.812 . . . . 0.0 111.054 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -161.52 131.17 4.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.25 145.05 31.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -71.88 127.26 31.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -71.93 129.02 37.57 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -38.81 121.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.767 2.427 . . . . 0.0 111.112 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.75 -1.64 21.43 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.567 1.08 . . . . 0.0 115.372 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -100.18 -24.3 14.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.314 1.557 . . . . 0.0 112.435 -169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 54.61 35.61 24.04 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.549 1.14 . . . . 0.0 112.142 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -146.98 -179.49 6.85 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.369 1.867 . . . . 0.0 107.348 171.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 46.8 m95 -117.08 156.46 27.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.236 0.925 . . . . 0.0 111.565 -169.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -151.76 165.49 34.27 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.209 1.404 . . . . 0.0 109.051 -173.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -109.17 160.86 25.99 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 124.513 1.125 . . . . 0.0 112.147 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -74.4 69.84 4.94 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.774 2.983 . . . . 0.0 115.011 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -84.6 145.7 27.89 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.38 149.79 19.38 Favored Glycine 0 N--CA 1.465 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.283 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.89 143.18 29.65 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.404 1.002 . . . . 0.0 111.915 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.91 137.23 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.39 146.07 49.79 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 118.777 0.717 . . . . 0.0 109.509 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -53.26 119.34 5.99 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.226 1.951 . . . . 0.0 113.731 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.36 7.56 87.45 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.002 1.286 . . . . 0.0 113.262 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.51 -40.15 64.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 112.444 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . 0.292 20.6 m 68.05 152.06 0.08 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.459 1.504 . . . . 0.0 112.543 -170.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.22 -45.03 72.18 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 125.055 1.342 . . . . 0.0 113.347 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.8 4.02 15.1 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.222 0.919 . . . . 0.0 111.904 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.09 -48.96 3.37 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.44 91.58 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.695 0.798 . . . . 0.0 112.136 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -58.85 -43.39 90.77 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.213 1.005 . . . . 0.0 109.371 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.03 -20.37 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -76.34 -47.68 22.64 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 119.751 1.159 . . . . 0.0 109.279 169.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.76 -38.1 77.71 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.217 0.917 . . . . 0.0 111.028 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.1 tp -48.06 -45.87 32.81 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.69 1.596 . . . . 0.0 110.754 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -49.43 18.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.475 1.51 . . . . 0.0 111.689 176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.12 -37.31 87.06 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.804 1.184 . . . . 0.0 110.34 -170.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -94.31 -43.44 8.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.048 1.339 . . . . 0.0 111.006 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.99 -7.94 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.826 0.85 . . . . 0.0 112.451 -169.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.13 16.83 71.32 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 120.378 -1.451 . . . . 0.0 113.731 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.3 mt -95.26 152.07 18.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m -120.14 -176.69 3.25 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.883 0.873 . . . . 0.0 109.757 -174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -75.19 50.97 0.51 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.142 1.777 . . . . 0.0 112.684 -169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -164.54 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.666 1.586 . . . . 0.0 112.022 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -86.39 -6.54 58.9 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 124.256 1.022 . . . . 0.0 113.723 -168.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' A' ' 102' ' ' LEU . 33.5 m -147.29 170.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 123.875 0.87 . . . . 0.0 109.431 -170.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -141.91 120.48 12.51 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -170.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.42 127.84 34.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.38 -35.13 6.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.579 0.752 . . . . 0.0 110.985 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.04 166.5 33.15 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.219 1.408 . . . . 0.0 108.627 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -145.89 163.69 34.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.145 0.978 . . . . 0.0 108.793 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -62.95 150.46 42.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.921 0.782 . . . . 0.0 110.836 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -67.64 -38.33 83.69 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.726 0.411 . . . . 0.0 111.182 -171.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.9 173.69 13.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.496 1.918 . . . . 0.0 107.675 170.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.417 ' CG ' ' HE3' ' A' ' 96' ' ' LYS . 93.5 m95 -58.46 121.07 9.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 110.821 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.86 154.41 33.83 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 140.34 23.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.25 156.58 46.97 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -95.23 153.28 17.74 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.261 0.553 . . . . 0.0 110.91 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.3 mt -84.16 150.23 57.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -65.69 156.88 61.61 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.685 2.257 . . . . 0.0 109.282 170.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -59.39 -30.03 68.14 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -74.85 -20.16 59.87 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.962 0.905 . . . . 0.0 113.238 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 tp -105.35 -22.13 13.1 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.704 1.202 . . . . 0.0 111.4 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.4 t -50.16 132.73 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 168.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -89.78 131.08 35.92 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -100.07 3.06 43.83 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.839 1.255 . . . . 0.0 109.453 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -98.31 -16.68 19.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 110.869 -174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -74.66 -36.06 62.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.384 -171.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 38.21 88.31 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 127.867 2.467 . . . . 0.0 112.111 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.77 141.81 21.28 Favored 'Cis proline' 0 C--N 1.356 0.932 0 N-CA-C 115.171 1.181 . . . . 0.0 115.171 10.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.45 124.5 8.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.5 t -88.62 92.62 9.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 40.5 pt -88.64 -12.01 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 117.912 -1.042 . . . . 0.0 112.025 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.85 43.4 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 120.483 1.492 . . . . 0.0 113.782 -169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 114.14 25.19 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HE3' ' CG ' ' A' ' 74' ' ' TRP . 66.0 tttt -86.86 125.03 33.72 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 169.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.91 137.89 33.48 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -106.85 129.16 54.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 103.811 -2.663 . . . . 0.0 103.811 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -103.28 133.55 48.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.49 130.37 55.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -87.68 105.52 17.42 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.6 mm? -103.5 123.62 47.23 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.051 0.94 . . . . 0.0 109.225 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -80.49 138.22 36.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.8 tp -78.22 106.95 10.46 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.92 -40.39 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 59.9 p -92.21 -114.51 0.09 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 161.9 -169.64 37.36 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.802 0.728 . . . . 0.0 111.911 -172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -38.84 -39.1 0.48 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.603 1.961 . . . . 0.0 113.492 171.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.63 69.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -107.2 -23.19 12.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.045 1.338 . . . . 0.0 111.785 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -56.06 131.87 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -143.99 77.72 1.56 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 122.348 1.07 . . . . 0.0 109.893 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.7 mtt -64.25 14.08 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.572 1.549 . . . . 0.0 113.244 173.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -131.29 21.09 4.8 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.648 1.567 . . . . 0.0 111.221 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 t -75.65 -28.04 58.59 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.229 1.012 . . . . 0.0 111.057 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.75 -5.86 52.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.971 1.708 . . . . 0.0 114.519 -169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.2 m 68.13 -34.22 0.25 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.879 2.872 . . . . 0.0 114.153 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 p -124.04 72.08 54.25 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 169.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.49 -165.6 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.899 3.066 . . . . 0.0 112.027 -170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -120.48 -12.12 9.0 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.487 1.115 . . . . 0.0 111.893 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -134.59 152.16 51.58 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 120.913 1.688 . . . . 0.0 112.23 -170.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.8 -35.25 5.53 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.927 1.691 . . . . 0.0 111.766 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -173.09 152.18 15.45 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -94.93 163.14 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.104 1.362 . . . . 0.0 111.354 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -152.92 120.23 5.9 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.889 1.676 . . . . 0.0 106.691 169.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -81.43 70.74 8.35 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.345 1.43 . . . . 0.0 109.247 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.29 156.02 5.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.242 1.417 . . . . 0.0 110.764 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 m -52.48 153.54 2.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.691 0.796 . . . . 0.0 111.909 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -57.02 152.31 13.37 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 m95 67.95 -28.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.449 1.9 . . . . 0.0 115.806 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.68 -47.0 98.07 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 121.155 1.798 . . . . 0.0 112.169 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.0 -18.05 62.18 Favored 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 121.592 1.604 . . . . 0.0 115.507 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.4 t -57.28 -38.11 60.18 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 CA-C-N 120.08 1.309 . . . . 0.0 109.993 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -92.64 -19.93 21.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.653 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -72.96 -21.28 60.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 121.297 1.862 . . . . 0.0 111.893 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.7 m -71.82 162.01 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 119.419 1.009 . . . . 0.0 111.034 170.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -60.6 151.67 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.133 0.973 . . . . 0.0 110.042 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 m -61.63 -29.27 69.95 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -73.87 -26.63 60.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.559 1.072 . . . . 0.0 111.508 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.98 -29.2 25.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.718 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -48.51 -52.13 23.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.566 1.076 . . . . 0.0 112.521 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.2 -41.44 97.05 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.316 0.507 . . . . 0.0 111.221 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -34.75 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -66.65 -32.8 74.36 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.03 -1.043 . . . . 0.0 110.643 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -57.28 -42.32 81.42 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 121.061 -1.024 . . . . 0.0 111.07 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.297 18.4 ptp180 -74.64 -34.18 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.908 1.231 . . . . 0.0 110.37 -176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 73.3 t -57.21 -47.69 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.342 0.657 . . . . 0.0 109.253 169.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.3 mtt -66.62 -41.5 88.25 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.583 -0.698 . . . . 0.0 110.953 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -44.17 81.91 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 111.324 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.09 -27.65 69.54 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.727 0.411 . . . . 0.0 112.101 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -113.78 -3.97 13.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.57 69.32 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.71 1.141 . . . . 0.0 111.146 -171.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 m -64.43 -25.79 68.16 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.01 -0.431 . . . . 0.0 111.616 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.17 -40.69 44.16 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.86 -47.04 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.658 0.783 . . . . 0.0 108.978 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.84 -15.8 63.16 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.929 0.786 . . . . 0.0 111.856 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 37.3 m -53.34 -38.84 63.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.758 1.163 . . . . 0.0 111.543 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.1 mp -65.39 -30.48 71.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -94.44 -21.37 18.96 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.166 0.986 . . . . 0.0 111.857 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.74 -20.65 66.35 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.45 1.1 . . . . 0.0 110.287 170.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.18 80.75 5.59 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 p -46.95 -26.35 0.51 Allowed Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 118.713 2.857 . . . . 0.0 118.713 -168.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -62.13 -14.21 36.44 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.838 2.359 . . . . 0.0 114.075 169.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.392 1.477 . . . . 0.0 109.889 178.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 119.609 -0.234 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 24.7 mm -127.91 140.85 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.21 148.06 52.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.813 1.245 . . . . 0.0 108.445 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -55.53 -28.29 53.84 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -79.11 -1.54 36.41 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.02 30.19 9.08 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.794 1.664 . . . . 0.0 111.825 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 23.2 m-85 -115.19 138.45 50.91 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.618 1.709 . . . . 0.0 110.379 -172.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -81.49 128.44 69.74 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 127.63 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.907 1.738 . . . . 0.0 109.267 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -137.69 163.42 31.34 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 125.235 1.414 . . . . 0.0 109.963 -175.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.92 135.4 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.709 2.004 . . . . 0.0 105.95 169.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.54 145.59 17.31 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.47 126.03 65.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 118.805 1.303 . . . . 0.0 107.799 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.65 86.59 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.13 130.45 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 65.0 m -114.38 121.87 44.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 103.305 -2.85 . . . . 0.0 103.305 169.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -97.6 40.85 1.14 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.221 1.008 . . . . 0.0 109.327 -172.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 59.8 -70.42 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 130.5 3.52 . . . . 0.0 111.89 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -90.33 -15.58 30.88 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.225 0.953 . . . . 0.0 112.886 -169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.46 42.97 1.49 Allowed Glycine 0 C--N 1.336 0.572 0 CA-C-N 118.366 0.53 . . . . 0.0 113.469 -169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 57.32 -89.73 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.168 1.787 . . . . 0.0 114.27 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.69 162.85 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.6 tpt -63.45 134.67 56.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.675 1.99 . . . . 0.0 110.347 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -159.64 134.9 8.21 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 167.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.2 145.0 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.187 0.595 . . . . 0.0 109.51 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -75.98 139.78 41.7 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -94.04 125.73 38.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -43.12 131.21 4.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.39 2.676 . . . . 0.0 110.992 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.84 -29.36 1.08 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.991 1.281 . . . . 0.0 113.817 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -81.35 -36.29 29.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.345 1.058 . . . . 0.0 110.004 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 57.19 31.05 19.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.899 1.68 . . . . 0.0 112.789 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.3 p -150.32 175.28 11.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.089 1.756 . . . . 0.0 107.68 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 23.5 m95 -76.4 162.08 28.16 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.866 0.866 . . . . 0.0 112.02 -169.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -144.85 134.55 23.49 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.372 0.606 . . . . 0.0 110.984 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -59.09 121.93 59.2 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.844 2.057 . . . . 0.0 108.216 169.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -59.63 135.77 66.42 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.333 2.022 . . . . 0.0 112.689 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.52 145.26 7.94 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.004 1.321 . . . . 0.0 109.725 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.38 136.11 5.26 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.17 146.49 46.2 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.7 mt -76.08 129.65 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -73.08 128.4 87.87 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.737 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -55.57 119.12 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.95 1.767 . . . . 0.0 113.177 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.44 3.52 84.21 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.01 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -101.53 119.04 38.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -71.41 165.35 23.96 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.299 0.639 . . . . 0.0 111.574 -174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.92 -45.93 60.6 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 125.258 1.423 . . . . 0.0 111.45 -172.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -84.67 25.41 0.91 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.508 -0.745 . . . . 0.0 110.728 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.06 -46.1 0.78 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.527 1.931 . . . . 0.0 107.091 170.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.3 -33.83 76.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.882 1.273 . . . . 0.0 111.5 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -57.37 -44.03 84.05 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.646 0.778 . . . . 0.0 109.033 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -72.45 -28.61 63.04 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.512 -0.743 . . . . 0.0 112.01 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -61.76 -46.79 88.08 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.875 -1.14 . . . . 0.0 108.534 172.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.87 76.43 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.576 -0.703 . . . . 0.0 112.05 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.1 tp -56.98 -41.36 78.23 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.01 -1.056 . . . . 0.0 109.454 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -72.36 -49.4 34.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.386 1.475 . . . . 0.0 111.609 175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.78 -34.49 75.63 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.208 1.367 . . . . 0.0 112.579 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -89.9 -57.05 2.99 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.334 0.654 . . . . 0.0 110.902 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.19 -23.98 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.667 1.187 . . . . 0.0 111.504 -169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.55 62.12 5.08 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -169.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -135.02 157.75 46.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.875 2.07 . . . . 0.0 106.776 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -121.96 -177.5 3.6 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.948 0.899 . . . . 0.0 110.811 -169.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -69.51 43.11 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.251 2.621 . . . . 0.0 113.127 -174.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -166.55 -20.29 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.14 0.976 . . . . 0.0 113.202 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.66 -1.03 57.36 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.292 0.496 . . . . 0.0 112.028 -169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 102' ' ' LEU . 29.1 m -148.41 168.45 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.448 1.099 . . . . 0.0 109.99 -169.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.15 121.68 15.16 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.847 2.059 . . . . 0.0 105.995 -171.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -73.88 129.58 36.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.57 -32.57 6.42 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.541 0.737 . . . . 0.0 111.554 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.71 169.86 23.68 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.33 1.052 . . . . 0.0 109.636 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.2 p -146.99 160.2 42.65 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.745 1.218 . . . . 0.0 109.592 171.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -65.29 143.95 57.45 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.58 0.627 . . . . 0.0 109.435 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -66.61 -27.35 67.63 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -153.52 168.81 24.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.23 1.412 . . . . 0.0 109.459 170.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -63.25 121.01 12.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.785 0.834 . . . . 0.0 109.471 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -77.48 153.92 33.04 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.07 150.19 28.88 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.919 -0.488 . . . . 0.0 110.705 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -145.19 156.46 43.87 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.972 1.709 . . . . 0.0 106.626 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -90.98 145.71 24.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.889 0.313 . . . . 0.0 110.461 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.7 mt -73.4 141.1 79.83 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -60.87 158.05 35.36 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.137 1.892 . . . . 0.0 109.42 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -49.31 -48.01 46.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -65.17 -14.2 60.03 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.496 1.118 . . . . 0.0 113.091 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.4 tp -112.85 -1.41 14.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.099 1.76 . . . . 0.0 111.353 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.5 137.24 23.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-N 120.813 1.642 . . . . 0.0 106.673 169.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -93.37 113.67 25.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -98.05 -9.13 26.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.101 0.96 . . . . 0.0 111.188 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.06 -25.69 24.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.039 0.936 . . . . 0.0 110.103 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.4 p -71.57 134.14 46.23 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -120.17 127.19 26.46 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -58.99 154.93 41.42 Favored 'Cis proline' 0 CA--C 1.54 0.801 0 CA-C-N 120.481 1.207 . . . . 0.0 110.907 -10.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -47.58 129.26 3.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.648 1.579 . . . . 0.0 107.959 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.83 113.85 27.68 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 26.7 pt -107.05 -2.75 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 116.52 -1.705 . . . . 0.0 112.528 -170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -171.39 165.53 38.55 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 122.35 2.341 . . . . 0.0 113.066 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -96.48 120.34 36.61 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -85.6 120.91 27.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 168.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.26 133.52 31.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 120.8 1.636 . . . . 0.0 113.376 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -100.79 141.89 33.03 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 168.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -112.16 137.71 49.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -110.45 133.69 53.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 tt -88.54 123.35 32.96 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 170.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.464 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.4 mm? -117.09 123.99 48.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -175.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -81.6 134.04 35.45 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.6 tp -69.84 106.66 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.54 -31.04 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.2 p -82.7 -114.16 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.048 0.539 . . . . 0.0 110.07 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 170.96 166.26 29.55 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.048 1.309 . . . . 0.0 110.445 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.43 -29.03 33.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.823 0.849 . . . . 0.0 112.881 173.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.95 -20.25 63.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.271 0.629 . . . . 0.0 112.391 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -110.38 -23.53 11.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.959 1.703 . . . . 0.0 110.838 -173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 mt -56.47 122.59 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -89.97 -52.09 5.14 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.3 mtt 59.78 5.46 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.795 1.638 . . . . 0.0 115.215 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 30.23 4.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.093 1.77 . . . . 0.0 111.621 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.45 -43.72 69.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.949 1.699 . . . . 0.0 112.079 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.6 -4.47 57.72 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -168.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 66.31 -38.12 0.29 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.774 2.429 . . . . 0.0 113.03 -169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 p -123.32 75.06 52.01 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.871 2.068 . . . . 0.0 105.59 169.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.48 -179.3 4.33 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 124.182 3.255 . . . . 0.0 111.077 -172.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -100.71 -49.97 4.01 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 117.704 -1.141 . . . . 0.0 110.111 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -87.97 154.95 20.1 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 120.538 1.517 . . . . 0.0 111.521 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -133.47 -27.05 1.58 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.474 1.51 . . . . 0.0 111.761 -172.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -157.87 144.21 10.28 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -93.4 154.66 17.82 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.788 1.235 . . . . 0.0 110.825 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -155.55 109.14 2.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.044 1.338 . . . . 0.0 108.398 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -73.62 137.12 44.02 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.275 -0.891 . . . . 0.0 108.607 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.9 161.11 18.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.808 1.643 . . . . 0.0 108.623 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 m -53.65 154.43 3.72 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.31 1.044 . . . . 0.0 110.582 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -56.27 -37.89 70.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.946 0.899 . . . . 0.0 113.263 -168.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -96.73 -3.02 43.23 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.506 -0.746 . . . . 0.0 112.826 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -61.02 -47.64 94.78 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.734 -1.126 . . . . 0.0 111.709 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -58.82 -35.71 98.18 Favored 'Trans proline' 0 C--N 1.351 0.687 0 CA-C-N 121.593 1.605 . . . . 0.0 112.462 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.63 -33.38 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 109.877 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.52 -17.67 33.52 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 121.501 -0.75 . . . . 0.0 109.289 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -93.37 -22.91 18.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 123.135 0.272 . . . . 0.0 111.495 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.75 163.3 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.313 -0.867 . . . . 0.0 112.356 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.4 m -65.71 153.44 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.268 1.427 . . . . 0.0 110.648 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -57.66 -33.91 68.82 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.416 1.486 . . . . 0.0 114.361 -169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -74.76 -26.97 60.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.95 0.796 . . . . 0.0 111.497 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -86.82 -33.35 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -47.23 -48.65 24.17 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.249 1.42 . . . . 0.0 112.288 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -66.88 -35.22 79.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 117.735 0.243 . . . . 0.0 111.545 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 62.2 t -83.47 -33.37 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.227 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.01 -32.89 74.59 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.933 1.242 . . . . 0.0 110.408 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.7 ttp-105 -54.28 -41.98 69.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.03 -1.043 . . . . 0.0 111.416 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -66.48 -44.41 82.72 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.607 -0.711 . . . . 0.0 109.73 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.8 t -53.64 -49.77 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.3 mmt -64.96 -44.43 89.44 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.609 0.641 . . . . 0.0 110.325 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -62.07 -37.11 83.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.046 0.839 . . . . 0.0 111.124 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -59.28 -20.99 58.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.432 0.693 . . . . 0.0 111.532 176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -130.92 -9.03 3.92 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -169.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.63 -46.2 63.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.704 1.593 . . . . 0.0 112.45 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -66.66 -17.98 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.19 -33.18 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 120.018 1.281 . . . . 0.0 109.827 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -76.25 -29.91 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.709 -1.244 . . . . 0.0 109.659 170.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 20.4 mmt -65.63 -27.14 68.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.456 1.025 . . . . 0.0 110.64 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 18.4 m -56.07 -39.62 72.35 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.642 1.11 . . . . 0.0 111.023 172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.0 -52.4 9.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.953 0.901 . . . . 0.0 108.704 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -77.56 -7.64 56.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -86.55 -24.86 25.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.008 0.923 . . . . 0.0 110.546 169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -23.93 48.01 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.111 -0.993 . . . . 0.0 112.004 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.65 -53.13 30.4 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 112.019 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.33 -30.82 3.9 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.349 2.699 . . . . 0.0 112.91 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.845 1.658 . . . . 0.0 110.994 -171.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.463 0.173 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.2 mm -128.36 147.92 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.35 36.97 0.49 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.452 2.301 . . . . 0.0 111.846 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.96 -32.93 0.09 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 131.516 3.927 . . . . 0.0 116.66 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -95.06 13.77 24.09 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.448 1.099 . . . . 0.0 113.153 -170.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.88 12.33 56.77 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.396 1.474 . . . . 0.0 113.1 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -102.25 138.88 38.6 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 118.903 1.351 . . . . 0.0 110.24 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -98.66 115.91 65.59 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.041 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -68.18 123.46 10.63 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.387 2.058 . . . . 0.0 110.863 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 95' ' ' GLN . 3.4 p30 -144.19 163.73 32.77 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.616 1.566 . . . . 0.0 108.593 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.24 136.81 59.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 130.82 10.26 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.5 112.88 26.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.32 85.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.9 mm -63.31 137.62 24.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 169.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 91.5 m -125.11 121.69 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 168.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.95 48.0 1.58 Allowed 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.496 -0.752 . . . . 0.0 109.169 -174.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.275 18.0 ptt-85 38.13 23.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.241 3.417 . . . . 0.0 116.894 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.85 7.27 15.69 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.521 1.128 . . . . 0.0 111.925 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.7 71.08 Favored Glycine 0 N--CA 1.477 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 112.422 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -125.56 150.34 47.56 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.71 1.604 . . . . 0.0 107.049 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.95 165.06 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.2 tpt -57.49 129.32 41.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.589 1.955 . . . . 0.0 111.133 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 7.9 t-105 -160.96 115.89 2.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 169.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.51 149.7 50.71 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -76.87 136.63 38.88 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.555 1.542 . . . . 0.0 108.203 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -90.12 128.31 36.3 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.925 0.49 . . . . 0.0 110.342 -169.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.47 135.45 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.096 1.758 . . . . 0.0 110.665 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.79 6.11 76.84 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.944 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -136.24 -38.89 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.525 1.53 . . . . 0.0 109.59 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.28 17.1 m80 60.32 38.08 19.9 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.762 2.025 . . . . 0.0 112.666 175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.9 m -133.45 161.01 35.73 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.206 2.202 . . . . 0.0 106.546 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.409 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -76.34 148.98 37.09 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.326 -0.859 . . . . 0.0 112.621 -171.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -148.54 160.72 42.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.515 1.15 . . . . 0.0 110.856 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.79 167.15 39.13 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 128.18 2.592 . . . . 0.0 109.072 168.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.25 -110.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 124.167 3.244 . . . . 0.0 110.721 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 65.82 99.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.597 1.959 . . . . 0.0 112.046 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.79 126.01 6.05 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 144.46 22.18 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.003 1.763 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.32 137.0 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -78.02 135.87 62.47 Favored Pre-proline 0 N--CA 1.464 0.256 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.35 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -58.91 117.53 4.28 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.423 1.415 . . . . 0.0 112.452 -174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.65 80.09 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.096 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 120.28 35.87 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.25 165.67 21.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.908 0.861 . . . . 0.0 111.455 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.13 -45.05 16.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.728 2.011 . . . . 0.0 115.224 -169.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -44.6 21.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -55.06 -42.98 73.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.89 0.876 . . . . 0.0 110.056 174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.86 -29.09 66.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 112.078 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -62.75 -42.61 99.76 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 81.5 m-85 -68.7 -30.57 69.25 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.179 -1.576 . . . . 0.0 112.78 173.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -58.24 -47.02 84.83 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.251 0.932 . . . . 0.0 109.131 172.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.89 -44.02 86.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.316 0.646 . . . . 0.0 110.708 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.22 -44.18 64.66 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.379 1.472 . . . . 0.0 111.034 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 -48.28 34.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.75 -1.119 . . . . 0.0 111.809 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -69.65 -28.19 65.69 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 120.41 1.459 . . . . 0.0 112.568 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -93.06 -60.22 1.85 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.095 0.958 . . . . 0.0 110.274 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.66 -17.61 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.769 0.827 . . . . 0.0 111.767 -169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.2 56.46 23.66 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.9 mt -132.13 157.24 44.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.351 2.261 . . . . 0.0 105.972 169.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -121.09 -172.93 2.5 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.793 0.724 . . . . 0.0 110.103 -170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.41 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 24.1 mtt180 -73.23 42.05 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.54 1.936 . . . . 0.0 113.271 -171.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -161.75 -23.62 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.88 0.872 . . . . 0.0 112.994 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.82 0.44 52.97 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.051 0.387 . . . . 0.0 111.86 -168.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HB ' HD12 ' A' ' 102' ' ' LEU . 34.9 m -146.7 165.24 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.782 1.233 . . . . 0.0 109.136 -171.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -136.64 121.47 18.67 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.357 1.863 . . . . 0.0 106.232 -170.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.8 mt -76.02 128.32 37.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.3 -37.87 6.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.43 168.98 25.78 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.154 0.982 . . . . 0.0 108.627 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -144.89 161.87 38.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 169.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -61.69 139.55 58.29 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -65.68 -25.68 67.44 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -150.35 175.07 12.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.668 1.187 . . . . 0.0 108.542 169.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -71.61 113.87 9.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.296 0.638 . . . . 0.0 109.912 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -69.88 155.22 40.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 169.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.62 148.42 28.61 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 172.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -140.29 157.23 45.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.753 0.821 . . . . 0.0 108.805 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -94.14 126.87 39.63 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.706 -1.591 . . . . 0.0 106.706 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -68.53 148.04 98.1 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.8 158.69 56.83 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.641 2.227 . . . . 0.0 109.666 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -60.56 -33.7 73.07 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -169.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -77.99 -24.27 48.06 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.048 0.939 . . . . 0.0 113.07 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.1 tp -90.98 -24.49 20.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.213 0.461 . . . . 0.0 110.629 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -62.77 137.63 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -41.96 34.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.027 0.531 . . . . 0.0 111.987 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 21.8 m95 59.11 4.19 0.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 128.036 2.534 . . . . 0.0 113.811 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -99.6 -25.56 14.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.984 1.314 . . . . 0.0 111.165 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -72.84 151.54 41.96 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.962 1.705 . . . . 0.0 109.324 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -132.93 116.0 14.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.671 1.188 . . . . 0.0 107.941 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -58.35 155.44 37.11 Favored 'Cis proline' 0 CA--C 1.538 0.694 0 CA-C-N 120.177 1.099 . . . . 0.0 111.483 -10.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.71 131.85 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.0 t -91.88 106.83 18.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.3 pt -97.32 -8.35 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.505 0.722 . . . . 0.0 112.173 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.73 169.64 42.41 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.396 0.998 . . . . 0.0 111.764 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 10' ' ' ASN . 11.1 mp0 -110.05 119.33 38.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -80.95 125.49 30.2 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 103.653 -2.721 . . . . 0.0 103.653 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.75 142.56 30.98 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -116.98 128.68 55.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -101.51 147.35 26.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.74 129.45 55.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.2 tp -80.14 115.11 19.52 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 170.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -112.54 125.47 54.29 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.929 0.892 . . . . 0.0 108.838 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.02 134.51 34.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 168.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 tt -73.17 122.11 21.34 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.65 -50.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -128.31 135.44 49.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -178.15 -155.12 13.52 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.7 t70 64.55 -61.47 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 129.149 2.98 . . . . 0.0 111.792 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.26 -35.87 12.88 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.831 2.053 . . . . 0.0 110.773 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -89.79 -12.72 38.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.841 0.856 . . . . 0.0 111.598 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -68.61 116.2 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -97.27 -35.04 10.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.498 -174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.0 mtt 58.91 -38.16 0.06 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 130.023 3.329 . . . . 0.0 115.532 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -102.56 33.63 3.1 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.898 1.679 . . . . 0.0 110.889 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.3 m -69.61 -51.42 35.2 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.1 m -74.7 145.2 43.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.0 m -70.08 -30.28 67.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.744 1.217 . . . . 0.0 111.81 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.8 p -127.23 75.14 77.14 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.177 1.391 . . . . 0.0 107.887 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.52 -175.1 2.56 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.709 2.939 . . . . 0.0 110.416 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.72 -29.86 11.25 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 116.695 -1.621 . . . . 0.0 113.366 171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 159.0 17.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 122.051 2.205 . . . . 0.0 112.271 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.91 -6.12 0.99 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.063 1.345 . . . . 0.0 113.542 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.6 156.88 28.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 170.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -119.05 151.65 37.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.118 0.967 . . . . 0.0 111.42 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -145.01 119.49 9.67 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.888 1.675 . . . . 0.0 106.761 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -78.73 140.48 38.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.614 1.097 . . . . 0.0 108.96 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.71 162.43 32.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.799 0.84 . . . . 0.0 110.214 -170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.2 m -52.21 148.49 6.36 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.012 0.925 . . . . 0.0 109.865 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -53.45 -38.37 63.5 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -99.58 3.28 45.31 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.27 -44.6 88.98 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.914 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.82 -28.02 85.75 Favored 'Trans proline' 0 C--N 1.352 0.749 0 CA-C-N 122.005 1.752 . . . . 0.0 112.405 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.41 -10.52 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.901 1.28 . . . . 0.0 112.098 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -106.92 -32.12 8.04 Favored 'General case' 0 CA--C 1.526 0.057 0 O-C-N 120.736 -1.228 . . . . 0.0 110.328 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -79.93 -26.69 40.03 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.031 0.832 . . . . 0.0 112.503 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.2 p -69.05 160.0 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.088 0.858 . . . . 0.0 110.008 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.74 141.45 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.75 1.22 . . . . 0.0 111.623 172.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 m -56.78 -35.52 68.77 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.518 1.527 . . . . 0.0 113.867 -169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -67.97 -33.74 75.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.756 0.707 . . . . 0.0 110.765 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -88.54 -25.12 22.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.92 -175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -43.48 -46.49 6.87 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 119.935 1.243 . . . . 0.0 112.695 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.58 -49.44 73.36 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.905 0.775 . . . . 0.0 111.49 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.29 -31.3 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 122.002 -0.436 . . . . 0.0 110.3 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.49 -33.54 75.92 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.024 -1.047 . . . . 0.0 110.554 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -64.24 -35.0 79.41 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 120.725 -1.235 . . . . 0.0 110.479 171.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -60.91 -46.45 90.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.6 1.546 . . . . 0.0 109.804 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.92 -48.22 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 118.764 0.711 . . . . 0.0 109.638 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.7 -36.77 84.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.546 -0.721 . . . . 0.0 110.825 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -65.61 -35.66 81.45 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.673 1.124 . . . . 0.0 110.72 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.78 -25.32 68.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.235 0.614 . . . . 0.0 111.181 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -118.66 -17.66 9.19 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -42.68 -65.18 0.5 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.682 1.593 . . . . 0.0 112.69 -169.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.9 m -63.81 -25.81 68.34 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -174.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.77 -27.13 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 121.442 -0.786 . . . . 0.0 109.169 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.99 -41.2 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 123.83 0.852 . . . . 0.0 109.578 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.4 mtt -68.85 -33.31 73.6 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 118.779 -0.629 . . . . 0.0 111.028 -170.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.3 m -57.34 -31.55 65.84 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.849 0.75 . . . . 0.0 112.248 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.5 -30.95 71.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.111 0.414 . . . . 0.0 110.328 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -95.5 -44.06 7.69 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 123.021 0.528 . . . . 0.0 110.21 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -61.54 -23.54 66.01 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.78 0.832 . . . . 0.0 112.131 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -64.55 -38.84 92.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.528 1.131 . . . . 0.0 112.032 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.268 0.1 OUTLIER -135.23 -73.41 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.104 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.43 -27.32 33.81 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.908 2.405 . . . . 0.0 113.589 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? . . . . . 0 C--O 1.255 1.365 0 C-N-CA 127.242 2.217 . . . . 0.0 112.457 -176.398 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 119.55 -0.262 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm -129.82 142.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.97 150.41 45.2 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.361 1.065 . . . . 0.0 110.013 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.28 -28.16 67.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -170.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.56 0.1 35.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.348 0.522 . . . . 0.0 112.167 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.76 32.09 8.27 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.237 1.875 . . . . 0.0 112.06 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 25.3 m-85 -109.76 133.74 52.8 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-N 118.556 1.178 . . . . 0.0 110.176 -176.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -80.85 129.28 68.49 Favored Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.4 121.65 6.94 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.196 1.931 . . . . 0.0 109.32 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.0 165.42 25.37 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.603 1.161 . . . . 0.0 109.787 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.33 146.22 29.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 127.051 2.14 . . . . 0.0 106.564 169.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -119.68 146.63 18.08 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 169.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.13 135.5 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.43 89.88 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -68.11 129.52 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.96 137.57 51.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 168.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -104.58 27.2 8.15 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 53.62 19.39 1.76 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.755 1.622 . . . . 0.0 115.179 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -118.33 5.86 11.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 110.707 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.72 16.24 80.78 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 120.848 -1.158 . . . . 0.0 112.312 -169.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -121.58 142.99 49.55 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.734 1.214 . . . . 0.0 107.727 -171.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.21 163.09 5.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -168.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.8 tpt -55.43 136.9 49.25 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.483 1.913 . . . . 0.0 111.808 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -163.41 136.5 5.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 167.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.84 144.89 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.47 140.22 48.13 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.51 119.7 21.46 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -49.94 132.57 22.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.771 2.029 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.3 -31.53 1.6 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.844 1.212 . . . . 0.0 114.027 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -87.07 -30.9 20.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.417 1.109 . . . . 0.0 110.706 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 58.61 35.0 24.27 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.778 1.631 . . . . 0.0 113.151 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 p -145.19 169.92 17.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.594 1.958 . . . . 0.0 107.009 169.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -81.57 158.04 24.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.962 1.256 . . . . 0.0 111.84 -170.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -149.52 148.73 29.74 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.155 1.782 . . . . 0.0 107.489 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -80.57 158.96 70.52 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 118.607 0.639 . . . . 0.0 111.518 171.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -64.89 141.94 73.39 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.559 2.173 . . . . 0.0 112.456 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -167.88 142.49 3.61 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.833 1.653 . . . . 0.0 108.944 174.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.24 143.5 10.13 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.57 152.62 52.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.554 1.073 . . . . 0.0 110.698 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mt -82.01 137.19 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -80.5 137.94 51.55 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.747 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -59.02 117.52 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.408 1.405 . . . . 0.0 113.037 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.92 1.67 88.77 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.003 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -90.55 120.8 31.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.611 1.206 . . . . 0.0 107.799 171.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 m -71.24 162.6 29.16 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.143 0.577 . . . . 0.0 111.241 -175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.23 -44.96 16.73 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 126.936 2.094 . . . . 0.0 113.447 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -71.92 -49.22 39.52 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -59.13 -39.8 83.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.524 0.73 . . . . 0.0 110.387 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.07 -35.51 79.99 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.195 0.998 . . . . 0.0 111.974 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -58.64 -46.91 86.1 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -66.38 -30.05 70.35 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.717 1.144 . . . . 0.0 112.659 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -59.37 -46.72 87.88 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.075 -1.016 . . . . 0.0 108.736 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.908 0.483 . . . . 0.0 111.566 178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 tp -57.74 -39.63 77.78 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 120.891 -1.131 . . . . 0.0 109.698 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -72.93 -50.44 23.48 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.211 1.005 . . . . 0.0 111.297 174.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.59 -30.06 68.73 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.469 1.486 . . . . 0.0 112.075 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -97.67 -47.5 5.59 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.033 0.933 . . . . 0.0 111.576 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.23 -19.78 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.375 0.67 . . . . 0.0 110.975 -170.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.21 35.15 82.41 Favored Glycine 0 CA--C 1.526 0.78 0 O-C-N 121.191 -0.943 . . . . 0.0 110.886 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 mt -114.01 154.28 27.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.23 1.412 . . . . 0.0 108.296 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -116.52 -175.13 2.7 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.896 0.878 . . . . 0.0 110.365 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -73.74 41.14 0.12 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.286 1.834 . . . . 0.0 113.294 -169.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -163.1 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.627 1.171 . . . . 0.0 112.919 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -83.26 -0.94 51.81 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.89 0.476 . . . . 0.0 111.809 -169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.1 m -148.5 171.38 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.949 1.7 . . . . 0.0 108.63 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -140.8 123.91 16.51 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.75 131.24 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 120.485 1.493 . . . . 0.0 107.932 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -107.63 -36.73 6.36 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.097 0.559 . . . . 0.0 111.324 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 171.45 19.92 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.465 1.106 . . . . 0.0 109.35 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -144.67 162.98 35.32 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 p -65.85 138.83 58.15 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -67.67 -19.7 65.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -170.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -146.56 170.38 17.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.222 1.809 . . . . 0.0 108.525 170.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -75.58 125.14 28.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.05 152.79 44.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 140.56 21.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -143.82 161.24 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.065 0.946 . . . . 0.0 108.486 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -101.23 133.0 46.46 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 107.571 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.3 mt -73.56 143.06 81.75 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.132 1.373 . . . . 0.0 108.452 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -55.88 155.83 21.53 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.85 2.367 . . . . 0.0 110.471 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -58.82 -45.23 90.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.794 -1.192 . . . . 0.0 113.113 -169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.56 -12.73 55.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.208 1.003 . . . . 0.0 112.596 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.23 0.16 26.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.031 1.732 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.15 135.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -90.96 114.88 27.49 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -100.19 -3.0 32.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.938 0.774 . . . . 0.0 111.694 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -89.43 -18.24 27.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.764 0.825 . . . . 0.0 110.554 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.7 p -86.49 154.57 21.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.537 1.535 . . . . 0.0 108.212 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -134.87 118.55 13.3 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.506 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.75 153.57 34.17 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 120.095 1.069 . . . . 0.0 110.985 -10.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -54.68 130.26 16.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.4 t -93.09 127.15 38.52 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.253 -169.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.1 pp -113.14 -5.4 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 111.807 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -155.85 161.21 30.53 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 121.192 1.815 . . . . 0.0 113.535 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -112.93 105.96 14.14 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -81.55 129.73 34.78 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 170.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.83 127.22 13.12 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 120.285 1.402 . . . . 0.0 112.843 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -98.9 138.5 35.93 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 168.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -107.04 144.96 32.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -116.55 131.63 56.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 173.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 114.84 20.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 170.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -111.41 127.93 55.83 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 108.641 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -87.38 134.04 33.63 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD21 ' HA2' ' A' ' 107' ' ' GLY . 55.1 tp -64.44 123.53 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.66 -37.88 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 174.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.1 m -88.69 -127.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.35 0.66 . . . . 0.0 109.913 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 177.25 178.63 47.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 119.837 1.199 . . . . 0.0 112.162 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -50.86 -30.66 15.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.785 1.634 . . . . 0.0 113.053 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.47 -29.23 67.8 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -98.35 -27.43 14.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.357 1.063 . . . . 0.0 111.212 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 143.68 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.722 1.209 . . . . 0.0 107.759 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.33 -41.58 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.549 0.74 . . . . 0.0 111.317 -170.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.7 mtt 55.51 7.35 0.23 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -130.14 17.83 5.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.741 1.61 . . . . 0.0 111.653 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -31.6 72.73 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.705 2.002 . . . . 0.0 111.615 -177.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -7.77 59.63 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.692 1.997 . . . . 0.0 113.672 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.3 m 68.15 -35.46 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 128.305 2.642 . . . . 0.0 114.062 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 p -121.77 71.84 30.32 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.345 1.858 . . . . 0.0 106.398 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.56 -174.09 1.88 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.587 2.858 . . . . 0.0 111.958 -173.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -107.98 -10.69 15.45 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.59 -1.195 . . . . 0.0 112.012 169.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.36 146.07 50.88 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.998 1.726 . . . . 0.0 114.99 -169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -115.96 114.25 24.38 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.767 3.227 . . . . 0.0 102.864 169.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.12 136.02 28.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.622 0.629 . . . . 0.0 113.157 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -131.67 -112.13 0.24 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.163 1.385 . . . . 0.0 109.946 -173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -150.08 163.06 39.15 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.776 1.23 . . . . 0.0 110.609 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -84.28 155.19 22.54 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.27 169.04 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.527 1.131 . . . . 0.0 110.091 -169.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.2 m -57.45 151.67 16.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.34 0.591 . . . . 0.0 111.49 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -61.29 154.46 23.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 16.8 m95 66.36 -30.13 0.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.308 1.843 . . . . 0.0 115.559 -173.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -54.93 -46.28 99.61 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 120.773 1.624 . . . . 0.0 112.177 -174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -60.07 -26.65 83.04 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 121.732 1.654 . . . . 0.0 114.989 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.08 -34.11 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.956 1.253 . . . . 0.0 109.077 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmm-85 -90.11 -19.0 24.83 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.945 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -80.33 -30.01 38.06 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.419 1.009 . . . . 0.0 111.988 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.18 163.13 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 CA-C-N 118.56 0.618 . . . . 0.0 110.207 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.1 m -66.37 153.65 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.838 0.855 . . . . 0.0 111.603 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 m -54.87 -30.33 57.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.608 1.963 . . . . 0.0 115.594 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -84.31 -37.3 21.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.424 1.011 . . . . 0.0 111.374 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -70.41 -38.58 74.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.384 -0.822 . . . . 0.0 110.219 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -42.98 -45.71 5.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.599 1.56 . . . . 0.0 110.884 171.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -63.69 -34.8 78.67 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -173.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.8 -35.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 119.269 0.94 . . . . 0.0 110.162 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -67.26 -32.2 73.05 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.825 0.739 . . . . 0.0 110.853 -171.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -59.38 -38.38 80.36 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.388 -0.82 . . . . 0.0 111.048 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -69.96 -46.47 65.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.46 -46.15 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.822 0.849 . . . . 0.0 109.3 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.3 mtt -69.59 -40.09 76.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.626 -0.702 . . . . 0.0 110.149 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -60.89 -40.85 94.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.821 1.191 . . . . 0.0 111.036 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.71 -28.13 68.41 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.132 0.973 . . . . 0.0 110.928 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -111.79 -9.18 14.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.09 0.956 . . . . 0.0 113.405 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.13 -59.61 4.0 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.124 0.97 . . . . 0.0 111.714 -169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 m -67.54 -23.03 65.39 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.878 -0.514 . . . . 0.0 111.518 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.75 -35.82 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 65.8 t -83.93 -42.07 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.719 0.808 . . . . 0.0 109.174 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.39 -30.6 69.55 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.623 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.6 m -55.41 -29.48 58.64 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.554 1.07 . . . . 0.0 112.122 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.87 -38.49 73.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.088 0.555 . . . . 0.0 110.443 -178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -92.25 -16.26 26.38 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.271 0.628 . . . . 0.0 111.02 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -94.14 32.77 1.45 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.18 1.792 . . . . 0.0 110.205 172.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -107.44 31.22 5.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.261 1.024 . . . . 0.0 110.493 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.322 21.3 p 50.73 33.24 0.21 Allowed Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -72.1 -28.19 16.13 Favored 'Trans proline' 0 C--N 1.36 1.135 0 CA-C-N 122.405 1.895 . . . . 0.0 110.041 169.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.5 mttm . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.364 1.465 . . . . 0.0 109.255 -173.725 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 tpt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 119.526 -0.273 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 3.2 mp 72.54 136.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 127.367 2.267 . . . . 0.0 108.381 -169.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.59 146.46 51.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -50.75 -31.81 17.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -79.05 -3.96 47.82 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.74 32.33 7.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.754 2.121 . . . . 0.0 110.578 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -111.27 146.4 37.07 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 118.976 1.388 . . . . 0.0 110.017 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -93.95 123.93 57.91 Favored Pre-proline 0 N--CA 1.467 0.422 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -68.97 130.6 20.62 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.348 2.032 . . . . 0.0 111.43 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -140.48 157.35 45.64 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.288 1.835 . . . . 0.0 111.837 -170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.4 120.52 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.511 1.925 . . . . 0.0 107.082 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.15 123.97 8.09 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.78 117.49 27.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 118.636 1.218 . . . . 0.0 108.722 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -90.33 85.78 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 168.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -66.74 136.52 26.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 168.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -121.74 121.91 38.33 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -74.36 125.07 27.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.3 ptt-85 -43.6 -27.45 0.3 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.743 2.017 . . . . 0.0 114.456 -176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.19 2.87 1.37 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.29 30.42 7.38 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.023 1.296 . . . . 0.0 112.29 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -132.81 164.54 26.6 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.18 167.53 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -169.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 tpt -53.26 126.31 20.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.818 2.447 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -161.83 128.36 3.77 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.6 148.51 31.19 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -71.52 136.14 47.39 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.34 125.31 29.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -173.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -48.68 127.46 13.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.108 2.163 . . . . 0.0 110.189 175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.3 -24.14 1.77 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.133 1.349 . . . . 0.0 114.461 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -84.83 -32.28 23.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.389 1.076 . . . . 0.0 110.407 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 58.29 30.71 19.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.503 1.521 . . . . 0.0 112.921 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -148.7 173.38 13.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.234 1.813 . . . . 0.0 107.19 169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -75.05 163.26 27.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.316 0.962 . . . . 0.0 113.314 -169.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.83 147.65 27.51 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.591 1.156 . . . . 0.0 108.889 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -61.64 150.98 79.89 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.0 1.72 . . . . 0.0 110.35 169.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.87 151.48 84.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.135 1.89 . . . . 0.0 110.88 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -173.43 168.18 4.59 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.205 1.802 . . . . 0.0 109.413 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.78 127.58 1.14 Allowed Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.014 -2.034 . . . . 0.0 108.014 170.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.0 134.64 27.43 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.86 133.12 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -72.61 124.74 91.14 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 124.771 1.228 . . . . 0.0 108.875 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -55.76 118.42 5.19 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.929 1.753 . . . . 0.0 112.487 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.44 1.72 68.61 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.041 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -104.52 120.0 40.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 m -69.37 160.76 30.71 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 121.248 0.547 . . . . 0.0 111.09 -174.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.04 -42.14 12.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.767 2.027 . . . . 0.0 113.999 -169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -74.18 -47.69 33.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.49 -40.02 81.63 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.806 0.842 . . . . 0.0 110.11 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.01 -32.92 72.81 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.309 1.044 . . . . 0.0 112.369 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.401 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 15.5 tmm? -59.51 -44.82 93.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -67.09 -27.68 67.55 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.748 -1.22 . . . . 0.0 112.649 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -64.75 -44.15 91.04 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 120.67 -1.269 . . . . 0.0 109.159 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -30.16 63.4 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 118.453 0.57 . . . . 0.0 110.544 178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.6 tp -59.99 -43.34 95.24 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 120.951 -1.093 . . . . 0.0 108.999 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -63.67 -57.3 10.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.652 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.49 -25.5 60.48 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.104 1.774 . . . . 0.0 114.217 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.61 -11.02 12.43 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.927 -1.108 . . . . 0.0 112.654 -169.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.04 -16.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.18 0.992 . . . . 0.0 111.515 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.3 18.74 79.03 Favored Glycine 0 CA--C 1.523 0.589 0 O-C-N 120.221 -1.549 . . . . 0.0 114.243 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 mt -113.47 155.99 24.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.088 1.444 . . . . 0.0 109.104 -171.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -108.7 178.65 4.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.781 1.232 . . . . 0.0 110.227 -172.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -72.77 37.58 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.399 1.88 . . . . 0.0 113.059 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -161.83 -14.77 0.04 OUTLIER 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -168.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -106.06 18.24 22.35 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.457 1.026 . . . . 0.0 113.177 -168.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.22 175.79 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.459 1.904 . . . . 0.0 109.42 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -140.91 114.39 8.77 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HA ' HD23 ' A' ' 102' ' ' LEU . 41.3 mt -72.94 132.51 33.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.07 -52.4 2.81 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.503 0.502 . . . . 0.0 109.673 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.86 174.19 11.72 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.57 0.748 . . . . 0.0 111.067 -171.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.5 p -145.82 177.31 9.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.944 1.298 . . . . 0.0 109.001 171.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 6.16 0.62 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.98 -16.53 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.014 2.526 . . . . 0.0 115.345 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.4 174.22 12.22 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 127.778 2.431 . . . . 0.0 108.674 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -79.16 121.81 25.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.446 0.698 . . . . 0.0 109.669 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -88.18 160.95 17.51 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -140.52 141.88 35.27 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.246 1.018 . . . . 0.0 108.838 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -144.83 153.02 41.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 168.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -92.98 156.19 17.06 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -88.53 141.52 30.44 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 154.77 72.2 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.804 2.336 . . . . 0.0 108.663 170.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -25.56 66.71 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -169.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -75.34 -26.6 58.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.124 0.97 . . . . 0.0 112.538 176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.2 tp -96.56 -24.03 16.24 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.89 0.876 . . . . 0.0 111.034 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.0 t -48.7 138.03 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -74.47 -45.36 46.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.493 -168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.3 m95 57.92 3.63 0.24 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.212 2.605 . . . . 0.0 114.034 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.95 -17.0 19.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.226 1.41 . . . . 0.0 110.658 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.0 p -80.63 143.64 32.96 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.609 1.564 . . . . 0.0 107.096 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -138.68 111.88 8.28 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 149.01 20.98 Favored 'Cis proline' 0 C--N 1.349 0.599 0 CA-C-N 119.992 1.033 . . . . 0.0 112.77 -5.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.91 121.08 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.27 108.91 16.81 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.512 -175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 pt -90.36 -5.4 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.5 161.91 33.59 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -92.88 123.92 36.49 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -84.35 111.44 19.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 101.955 -3.35 . . . . 0.0 101.955 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.22 139.21 53.52 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.529 1.513 . . . . 0.0 113.162 -173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -114.55 124.83 52.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 103.409 -2.811 . . . . 0.0 103.409 169.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -104.68 143.44 33.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 61.1 m-85 -118.46 131.01 56.27 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 tp -86.5 110.34 19.71 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 102' ' ' LEU . 15.3 mt -102.79 137.57 40.84 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 124.634 1.209 . . . . 0.0 109.422 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -93.35 127.14 38.83 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.0 tp -73.6 112.09 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 69.2 t -81.25 -37.78 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.5 p -91.05 -115.3 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.158 0.583 . . . . 0.0 110.889 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 171.08 175.63 39.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.386 0.994 . . . . 0.0 111.021 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -54.69 -31.39 57.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.471 1.109 . . . . 0.0 112.321 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.78 65.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -109.66 -22.14 12.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.484 1.114 . . . . 0.0 111.104 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.38 143.24 12.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.0 1.32 . . . . 0.0 107.878 169.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -149.35 78.97 1.39 Allowed 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 123.437 0.695 . . . . 0.0 109.404 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.9 mtt -68.58 16.49 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -116.34 22.97 12.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.438 1.472 . . . . 0.0 111.763 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -38.16 86.11 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.085 2.154 . . . . 0.0 112.096 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -3.43 50.82 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.444 1.097 . . . . 0.0 113.802 -169.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.1 m 66.65 -38.69 0.32 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.945 2.498 . . . . 0.0 113.726 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.8 p -126.04 73.01 71.08 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.532 1.933 . . . . 0.0 106.384 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -77.5 -167.41 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.89 3.06 . . . . 0.0 111.121 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -109.2 -11.32 14.91 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.241 -1.362 . . . . 0.0 112.49 169.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -135.24 148.41 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 121.703 2.047 . . . . 0.0 114.551 -169.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -116.6 109.31 17.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.457 2.703 . . . . 0.0 103.943 169.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.13 148.64 32.48 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.563 1.078 . . . . 0.0 113.928 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -140.67 -119.62 0.11 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 0.0 111.333 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.61 150.19 38.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.134 1.773 . . . . 0.0 109.209 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -82.47 146.21 29.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 122.731 0.412 . . . . 0.0 110.129 -172.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.4 m -118.92 163.53 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.205 1.002 . . . . 0.0 110.398 -170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -53.01 154.25 3.02 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.718 0.807 . . . . 0.0 111.382 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -60.81 150.99 30.94 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 171.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.4 m95 64.87 -15.17 0.09 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.03 1.732 . . . . 0.0 115.027 -169.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -60.5 -43.62 93.29 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.706 2.048 . . . . 0.0 111.895 -176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -58.06 -34.74 98.79 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.712 1.608 . . . . 0.0 112.913 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -64.9 -51.99 59.75 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -68.97 -22.55 64.1 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.524 -0.735 . . . . 0.0 111.254 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -78.23 -18.32 55.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.65 161.28 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 119.631 1.105 . . . . 0.0 112.491 -169.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.36 146.3 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.321 1.848 . . . . 0.0 112.115 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.1 m -61.83 -30.5 70.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -169.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -69.62 -31.02 68.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.607 1.094 . . . . 0.0 111.018 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -94.18 -32.09 13.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.7 0.8 . . . . 0.0 111.965 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 26.0 ttp-105 -48.41 -43.6 34.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.081 1.352 . . . . 0.0 113.121 -174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.3 -44.8 95.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.382 0.537 . . . . 0.0 110.867 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 74.9 t -73.99 -33.52 36.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.774 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -28.42 67.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.493 1.042 . . . . 0.0 110.437 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -42.9 98.61 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.893 -1.129 . . . . 0.0 109.725 169.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 66.4 mtt-85 -64.95 -45.02 87.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.65 0.78 . . . . 0.0 110.089 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.7 t -51.27 -53.05 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.248 0.619 . . . . 0.0 109.485 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 32.4 mtt -69.27 -41.84 76.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.438 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -51.83 -38.31 55.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.389 0.995 . . . . 0.0 111.454 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -63.46 -18.85 64.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.174 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.36 23.45 1.15 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.525 1.057 . . . . 0.0 113.834 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.26 78.56 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.212 -0.93 . . . . 0.0 110.663 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.2 p -60.46 -21.87 62.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.066 0.546 . . . . 0.0 111.707 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.02 -32.71 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.391 0.996 . . . . 0.0 108.373 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.9 t -72.31 -49.84 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.7 mmt -64.48 -29.52 70.57 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.645 -172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.5 m -48.82 -34.48 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.028 0.931 . . . . 0.0 112.064 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.22 -30.91 60.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.695 0.398 . . . . 0.0 110.426 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -114.37 -7.85 12.88 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -111.23 25.02 12.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.354 1.862 . . . . 0.0 109.004 169.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.98 -32.93 71.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 111.197 -169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.9 p -139.59 167.6 18.09 Favored Pre-proline 0 N--CA 1.441 -0.923 0 C-N-CA 131.659 3.984 . . . . 0.0 102.649 169.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -77.45 58.28 6.26 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.168 1.912 . . . . 0.0 110.62 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt . . . . . 0 C--O 1.253 1.248 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.126 176.157 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.2 mm -125.36 146.87 30.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 170.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 160.42 29.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.284 1.434 . . . . 0.0 109.653 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -24.93 66.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -84.69 -33.88 23.08 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.684 -0.635 . . . . 0.0 111.136 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 135.03 17.24 0.91 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.323 1.44 . . . . 0.0 112.854 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -84.26 144.44 28.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 119.455 1.627 . . . . 0.0 109.753 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.413 ' HD2' HD21 ' A' ' 10' ' ' ASN . 1.1 tmt_? -88.73 124.08 66.38 Favored Pre-proline 0 N--CA 1.469 0.508 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 170.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -77.12 131.4 11.89 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.278 1.985 . . . . 0.0 110.207 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.413 HD21 ' HD2' ' A' ' 8' ' ' ARG . 22.7 m-80 -144.09 162.39 36.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.34 1.056 . . . . 0.0 111.414 -173.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.38 143.36 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.693 2.397 . . . . 0.0 106.425 169.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.01 126.46 6.32 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.58 138.86 19.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.1 t -118.93 89.84 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 168.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.65 138.64 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 m -126.11 123.84 39.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.93 144.07 32.17 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -66.34 -5.82 12.03 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.34 -11.59 60.54 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 118.928 0.786 . . . . 0.0 110.487 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.31 37.79 4.21 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 126.032 1.777 . . . . 0.0 112.426 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -138.01 157.89 45.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 108.844 -169.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.6 m -100.61 161.25 3.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 20.5 ttt -58.07 132.38 53.33 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.381 1.472 . . . . 0.0 109.823 169.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -155.15 136.73 14.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.48 141.98 25.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.143 0.577 . . . . 0.0 110.118 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -71.13 140.26 50.54 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -75.39 142.75 43.02 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -62.18 125.73 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.305 1.442 . . . . 0.0 109.797 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.25 14.31 71.3 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.281 -0.733 . . . . 0.0 114.387 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -148.5 131.97 16.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -87.7 48.7 1.68 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.411 0.684 . . . . 0.0 111.819 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -153.37 -179.45 7.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.18 1.392 . . . . 0.0 108.906 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.2 m95 -108.53 155.07 21.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 108.408 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -134.9 143.19 46.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.246 0.93 . . . . 0.0 112.881 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -58.7 138.66 86.41 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.885 0.874 . . . . 0.0 109.785 169.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.77 145.83 81.97 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.712 2.274 . . . . 0.0 112.347 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -169.65 157.84 7.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.748 1.619 . . . . 0.0 111.743 174.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.74 138.19 5.22 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.36 159.09 51.99 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.516 1.158 . . . . 0.0 111.515 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 83.1 mt -91.72 146.9 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.355 1.462 . . . . 0.0 108.355 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -89.52 153.45 48.14 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.525 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -58.14 117.97 4.78 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.903 1.735 . . . . 0.0 112.889 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.21 86.98 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.987 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.39 125.69 31.33 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.458 1.129 . . . . 0.0 108.333 174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.74 157.63 36.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.746 1.218 . . . . 0.0 110.697 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.0 -41.39 71.21 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.301 1.04 . . . . 0.0 113.244 -168.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -70.82 -47.18 60.79 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -57.46 -41.47 80.64 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.391 1.476 . . . . 0.0 110.01 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.06 81.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.696 0.68 . . . . 0.0 111.914 172.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -58.9 -44.94 91.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 118.934 0.788 . . . . 0.0 109.767 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -65.87 -24.03 66.78 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.042 1.292 . . . . 0.0 113.405 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -63.75 -52.39 60.64 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.466 1.484 . . . . 0.0 108.949 169.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.73 -36.16 82.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.562 0.345 . . . . 0.0 111.481 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.5 tp -57.23 -41.31 79.27 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 110.196 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.08 -45.88 46.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.288 1.035 . . . . 0.0 111.632 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.61 -36.73 79.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.799 1.181 . . . . 0.0 111.975 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.37 -47.77 7.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.126 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.55 -26.75 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.234 0.613 . . . . 0.0 111.142 -169.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.43 27.39 67.86 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 121.701 -0.624 . . . . 0.0 112.135 -170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.3 mt -105.05 157.63 17.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.547 1.139 . . . . 0.0 108.634 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -118.37 -174.45 2.67 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.614 1.166 . . . . 0.0 109.969 -173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.01 34.64 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.834 2.054 . . . . 0.0 114.343 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -159.26 -17.89 0.07 Allowed 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -169.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -87.02 -1.52 57.94 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.59 0.632 . . . . 0.0 111.011 -171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.52 168.72 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.196 1.398 . . . . 0.0 109.203 -170.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -140.12 122.48 16.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -171.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.0 mt -75.38 131.85 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 120.651 1.569 . . . . 0.0 107.497 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -106.58 -33.9 7.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.774 0.43 . . . . 0.0 111.671 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.28 168.09 28.41 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.21 1.004 . . . . 0.0 109.016 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.2 p -146.73 159.53 43.36 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.879 1.272 . . . . 0.0 108.043 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -64.33 134.71 55.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -68.0 -18.36 64.7 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -169.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -149.06 165.89 30.35 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.307 1.443 . . . . 0.0 107.974 169.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -65.66 117.84 8.7 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.61 -53.85 29.77 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.32 0.0 OUTLIER 62.52 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 129.725 3.21 . . . . 0.0 112.775 -178.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -144.61 156.58 44.19 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.12 129.92 55.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.39 143.59 88.11 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 123.988 0.915 . . . . 0.0 109.257 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -66.72 154.34 74.82 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.837 2.358 . . . . 0.0 109.215 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -58.93 -31.36 68.59 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -71.55 -24.12 61.88 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.84 0.856 . . . . 0.0 112.95 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 tp -104.67 -17.2 14.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 118.181 -0.914 . . . . 0.0 112.19 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.3 t -45.68 136.86 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -72.58 -49.69 30.59 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.871 1.064 . . . . 0.0 113.871 -168.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.8 m95 58.86 3.18 0.29 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.139 2.575 . . . . 0.0 114.868 -169.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.59 -23.03 16.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.141 0.976 . . . . 0.0 111.52 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.48 158.63 18.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.338 1.855 . . . . 0.0 110.102 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -132.31 112.0 14.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.422 1.089 . . . . 0.0 108.68 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -59.69 157.02 44.09 Favored 'Cis proline' 0 CA--C 1.537 0.668 0 CA-C-N 120.284 1.137 . . . . 0.0 110.51 -10.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.93 130.21 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.3 t -79.01 117.13 19.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.299 -1.319 . . . . 0.0 107.618 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 39.7 pt -111.24 -2.12 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.283 1.433 . . . . 0.0 111.76 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.39 159.8 33.09 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 120.207 1.367 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -104.52 106.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.7 127.47 32.83 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.2 143.95 29.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.115 0.87 . . . . 0.0 111.723 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.19 135.2 55.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 168.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -108.71 147.76 31.48 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -121.29 124.96 45.88 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.4 tp -79.73 110.93 15.54 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.2 mm? -104.5 128.71 52.5 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.9 0.88 . . . . 0.0 109.364 176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -87.72 140.82 29.13 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 168.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -70.91 136.15 48.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.29 -41.31 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.1 m -136.07 136.13 39.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 172.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.62 176.61 46.89 Favored Glycine 0 C--N 1.331 0.303 0 O-C-N 121.514 -0.741 . . . . 0.0 113.378 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 t70 61.24 -46.93 0.13 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 130.719 3.608 . . . . 0.0 114.071 -172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.18 21.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.412 1.085 . . . . 0.0 111.389 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -90.81 -23.77 20.5 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.289 0.636 . . . . 0.0 111.193 -177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 mt -66.12 139.43 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -135.18 -37.32 0.79 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.052 0.541 . . . . 0.0 112.071 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 31.4 mtt 56.85 17.46 3.27 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.962 1.468 . . . . 0.0 114.962 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -132.91 25.4 4.3 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.621 1.1 . . . . 0.0 111.807 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.29 -28.75 63.29 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.116 1.766 . . . . 0.0 111.436 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -7.0 57.8 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.254 1.821 . . . . 0.0 113.572 -170.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 67.69 -36.68 0.3 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.304 2.642 . . . . 0.0 113.66 -174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 p -124.29 75.06 60.63 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 169.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.58 -174.05 1.53 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.611 2.874 . . . . 0.0 111.238 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -107.57 -8.68 16.1 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.171 169.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.57 152.46 50.77 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 120.59 1.541 . . . . 0.0 112.43 -172.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -121.83 -31.2 3.99 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.632 1.573 . . . . 0.0 112.278 -172.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.3 11.88 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -113.23 148.4 35.59 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.944 1.298 . . . . 0.0 110.847 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -152.05 129.17 11.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.793 1.237 . . . . 0.0 108.44 170.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -80.38 143.29 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 165.01 9.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.199 0.6 . . . . 0.0 110.233 -169.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.3 m -47.41 140.45 5.71 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.035 1.334 . . . . 0.0 110.378 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -50.0 -41.45 47.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -168.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -94.12 -11.34 30.72 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -173.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -57.24 -44.99 99.95 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.785 -1.102 . . . . 0.0 112.428 -171.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -61.51 -23.89 77.32 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.554 1.503 . . . . 0.0 113.807 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.4 -38.93 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 119.041 0.837 . . . . 0.0 109.605 -170.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -87.71 -19.2 27.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.039 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.88 -27.73 66.92 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 121.032 1.742 . . . . 0.0 110.224 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.59 154.84 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.89 1.276 . . . . 0.0 110.641 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.66 150.23 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.811 1.245 . . . . 0.0 110.288 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -59.13 -31.58 69.07 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -168.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -75.25 -31.1 60.69 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.864 1.211 . . . . 0.0 110.691 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.98 -25.61 27.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.195 -0.907 . . . . 0.0 112.294 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -48.1 -47.98 34.01 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.372 1.442 . . . . 0.0 110.992 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.78 -43.94 87.27 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.375 0.534 . . . . 0.0 111.067 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.3 -33.96 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.937 -0.477 . . . . 0.0 110.267 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -65.79 -32.71 74.39 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.422 1.01 . . . . 0.0 109.522 173.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 10.8 ttp-105 -59.76 -34.48 73.03 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 120.67 -1.269 . . . . 0.0 111.925 170.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -61.8 -46.55 89.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.281 1.4 . . . . 0.0 109.343 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.8 t -55.85 -52.14 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.2 mmt -60.55 -45.01 95.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -60.07 -38.67 83.54 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.135 1.374 . . . . 0.0 111.239 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -69.11 -21.38 64.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.209 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -120.19 -22.82 6.46 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.78 -51.24 64.09 Favored 'General case' 0 N--CA 1.458 -0.036 0 CA-C-N 119.896 1.226 . . . . 0.0 111.427 -171.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 m -66.83 -25.95 66.68 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.071 0.85 . . . . 0.0 111.818 -177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.66 -37.4 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.1 -39.13 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.417 0.687 . . . . 0.0 110.198 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 24.5 mmt -72.55 -26.47 61.75 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.028 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.8 m -58.07 -32.92 68.51 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.621 1.1 . . . . 0.0 111.464 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.32 -29.17 69.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.793 -0.567 . . . . 0.0 110.651 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -94.45 -40.49 9.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.692 1.197 . . . . 0.0 109.682 -174.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -69.09 -26.57 65.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.962 1.305 . . . . 0.0 111.666 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -75.0 -45.84 39.22 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.35 -45.3 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -62.76 -36.85 59.95 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.953 2.435 . . . . 0.0 113.62 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.9 tptt . . . . . 0 C--O 1.253 1.26 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 175.693 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.8 mm -127.41 134.82 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.02 144.32 50.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.672 1.589 . . . . 0.0 107.937 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -47.73 -32.53 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -168.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.74 -3.63 39.14 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.38 28.36 7.2 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.024 1.773 . . . . 0.0 111.418 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -111.69 145.38 39.38 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 119.125 1.462 . . . . 0.0 110.585 -170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 122.26 69.03 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 116.588 -1.672 . . . . 0.0 107.194 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.68 126.37 12.63 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.846 1.697 . . . . 0.0 110.111 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -140.37 166.7 23.98 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.476 1.11 . . . . 0.0 110.633 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.9 m -125.66 148.52 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.567 2.347 . . . . 0.0 106.668 169.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.13 140.95 12.1 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 170.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -102.57 117.32 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -95.47 82.25 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -62.62 130.9 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.7 m -117.8 127.39 53.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -88.75 136.49 32.97 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -66.6 -5.82 12.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.107 1.363 . . . . 0.0 114.317 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -75.41 -7.64 54.59 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.184 0.902 . . . . 0.0 110.496 169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.0 33.7 4.55 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 125.103 1.335 . . . . 0.0 112.276 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -134.29 161.25 35.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.858 0.863 . . . . 0.0 109.131 -169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.9 m -119.49 162.61 17.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.727 0.811 . . . . 0.0 113.155 -169.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.9 tpt -51.74 131.67 30.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.097 2.159 . . . . 0.0 112.085 171.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -161.91 143.88 11.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 167.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.09 143.98 21.84 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -78.07 145.89 35.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -77.9 125.1 28.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.59 140.69 57.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.153 1.381 . . . . 0.0 109.713 177.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.11 -40.92 1.73 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.512 1.053 . . . . 0.0 113.524 177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.23 -31.95 24.75 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.499 1.149 . . . . 0.0 110.616 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 55.47 39.44 31.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.592 1.557 . . . . 0.0 112.402 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -135.2 173.87 11.24 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.591 1.956 . . . . 0.0 107.163 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -80.52 160.53 25.18 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.603 1.092 . . . . 0.0 111.77 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -151.39 146.88 26.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.675 1.19 . . . . 0.0 109.025 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.81 136.11 51.55 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.963 0.905 . . . . 0.0 110.731 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -65.41 141.28 67.24 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.602 2.201 . . . . 0.0 111.817 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -177.92 150.76 0.64 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.067 2.547 . . . . 0.0 106.337 169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.84 142.75 9.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 170.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.02 154.62 53.42 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 118.323 1.061 . . . . 0.0 111.34 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.7 127.76 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -67.47 125.55 91.32 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 117.684 -1.15 . . . . 0.0 108.841 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.67 117.97 4.67 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.92 1.747 . . . . 0.0 112.803 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.08 0.42 77.52 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.404 1.478 . . . . 0.0 112.923 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -93.82 127.71 39.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 170.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.13 160.18 31.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.536 1.135 . . . . 0.0 110.811 -177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.26 -42.9 64.06 Favored 'General case' 0 C--O 1.227 -0.081 0 C-N-CA 125.063 1.345 . . . . 0.0 113.146 -169.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -71.21 -48.57 50.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.13 -38.22 79.11 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.536 1.534 . . . . 0.0 109.928 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.45 -32.8 68.75 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.91 1.284 . . . . 0.0 111.738 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.457 ' HG3' ' CD1' ' A' ' 100' ' ' PHE . 18.2 tmm? -60.64 -43.06 98.0 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -66.54 -32.71 74.24 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.246 -0.908 . . . . 0.0 112.213 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -60.67 -46.57 89.83 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.848 -1.157 . . . . 0.0 109.517 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.6 67.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.802 0.728 . . . . 0.0 111.705 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -61.31 -40.84 95.66 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.037 -1.04 . . . . 0.0 108.531 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.85 -55.87 6.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 118.053 -0.975 . . . . 0.0 111.575 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.6 -38.22 83.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.947 1.703 . . . . 0.0 111.225 -170.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -94.66 -37.96 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.323 0.51 . . . . 0.0 112.041 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -109.63 -20.06 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.267 0.627 . . . . 0.0 110.668 -174.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.55 48.46 56.72 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.499 -1.376 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 mt -127.68 156.12 42.87 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.831 1.652 . . . . 0.0 107.817 171.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -114.07 -177.16 3.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.142 0.977 . . . . 0.0 110.285 -172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -73.75 38.1 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.273 1.829 . . . . 0.0 113.14 -170.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -157.98 -18.69 0.08 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.987 1.315 . . . . 0.0 113.202 -169.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -86.03 -2.01 57.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.993 0.517 . . . . 0.0 112.082 -169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HB ' HD12 ' A' ' 102' ' ' LEU . 27.5 m -149.14 168.02 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.504 1.522 . . . . 0.0 109.13 -170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -137.51 121.4 17.64 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 -172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.51 126.55 35.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.87 -32.58 7.86 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.208 0.317 . . . . 0.0 111.271 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.81 162.06 39.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.506 1.122 . . . . 0.0 108.555 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.0 m -139.86 157.47 45.66 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -58.89 137.21 57.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 119.146 0.885 . . . . 0.0 108.687 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -61.52 -31.34 71.33 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.771 0.429 . . . . 0.0 111.453 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -151.65 173.07 15.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.216 1.806 . . . . 0.0 106.754 169.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -60.08 125.19 22.72 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 109.471 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.98 50.11 1.91 Allowed 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 127.52 2.328 . . . . 0.0 107.451 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 146.46 47.67 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.228 -0.92 . . . . 0.0 109.443 -169.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -145.52 142.77 29.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 123.641 0.588 . . . . 0.0 110.199 -170.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -100.18 133.2 44.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.601 1.16 . . . . 0.0 108.536 -173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -78.7 148.83 73.55 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 124.428 1.091 . . . . 0.0 111.016 -174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.81 154.42 74.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.756 2.304 . . . . 0.0 109.265 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -53.59 -31.55 47.37 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -72.04 -32.01 66.7 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.519 1.127 . . . . 0.0 111.905 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.52 -24.11 18.88 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 118.627 -0.701 . . . . 0.0 110.975 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 91.8 t -58.05 130.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.19 -43.62 41.68 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.094 0.557 . . . . 0.0 112.361 -174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 24.8 m95 59.69 4.64 0.58 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 127.382 2.273 . . . . 0.0 113.432 -169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -100.78 -21.51 15.15 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.209 1.404 . . . . 0.0 111.066 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.2 p -73.78 147.09 43.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.455 1.502 . . . . 0.0 108.651 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -134.84 116.55 12.56 Favored Pre-proline 0 CA--C 1.536 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.44 149.16 31.02 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.952 1.019 . . . . 0.0 111.161 -10.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.39 131.61 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.0 t -91.3 106.69 18.68 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.0 pt -102.06 -6.14 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.002 0.921 . . . . 0.0 112.409 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.7 163.71 37.22 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 120.232 1.378 . . . . 0.0 113.172 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.5 115.67 27.81 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -85.64 120.22 26.83 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 101.211 -3.626 . . . . 0.0 101.211 168.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -146.38 138.03 24.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 119.662 1.119 . . . . 0.0 111.435 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -116.21 122.67 45.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -98.91 141.34 31.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.457 ' CD1' ' HG3' ' A' ' 50' ' ' MET . 58.5 m-85 -118.84 128.72 54.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 tt -82.59 121.22 26.53 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.443 HD12 ' HB ' ' A' ' 65' ' ' VAL . 3.5 mm? -113.47 122.05 46.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.667 -1.151 . . . . 0.0 107.991 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -80.85 133.89 35.67 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 tp -67.12 136.68 55.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -115.92 -38.15 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 39.7 m -89.52 -130.5 0.08 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.486 0.714 . . . . 0.0 109.781 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.73 177.1 46.94 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 120.001 1.273 . . . . 0.0 111.914 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -52.67 -31.3 36.49 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.322 1.449 . . . . 0.0 112.554 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.88 -27.04 66.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -97.16 -28.28 14.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.167 0.987 . . . . 0.0 110.894 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 mt -56.63 147.04 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.53 1.132 . . . . 0.0 108.025 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -127.17 -50.63 1.43 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.351 0.66 . . . . 0.0 109.684 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.3 mtt 63.33 -8.26 0.15 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.486 1.914 . . . . 0.0 115.179 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -109.54 24.53 12.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 121.248 1.84 . . . . 0.0 111.616 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -24.9 63.79 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.303 1.841 . . . . 0.0 112.19 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 -6.69 59.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.981 1.713 . . . . 0.0 113.901 -173.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.2 m 68.86 -34.02 0.26 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.387 2.675 . . . . 0.0 114.111 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.11 71.65 63.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.64 -170.21 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.525 2.816 . . . . 0.0 113.561 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -110.53 -42.56 4.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.252 1.021 . . . . 0.0 109.749 170.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.66 152.47 28.95 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.521 1.055 . . . . 0.0 113.568 -168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.16 14.36 13.96 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.473 1.509 . . . . 0.0 112.168 171.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.61 171.44 46.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.01 1.29 . . . . 0.0 113.348 174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -164.65 -116.43 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.82 1.248 . . . . 0.0 109.741 169.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 69.8 mtp85 -145.81 160.81 41.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.267 3.027 . . . . 0.0 107.51 -170.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -85.77 132.95 34.03 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.51 168.64 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.93 0.892 . . . . 0.0 110.793 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.4 m -52.7 147.24 8.99 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.729 0.695 . . . . 0.0 110.219 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -52.46 -40.66 62.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -168.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -95.32 -3.73 46.78 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.71 -43.19 82.7 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.495 1.043 . . . . 0.0 111.765 -173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.2 -26.41 82.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.535 1.584 . . . . 0.0 113.085 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -12.35 15.94 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 O-C-N 121.435 -0.791 . . . . 0.0 111.374 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 -35.73 7.66 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.808 1.186 . . . . 0.0 109.284 169.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -68.52 -26.54 65.49 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.733 1.151 . . . . 0.0 112.297 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.08 159.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 118.885 0.766 . . . . 0.0 110.459 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.3 149.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.574 0.75 . . . . 0.0 111.43 175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 m -51.09 -39.01 55.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.035 1.734 . . . . 0.0 114.064 -169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.37 -40.3 58.22 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.735 0.698 . . . . 0.0 110.222 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -66.53 -32.76 74.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 117.689 -1.148 . . . . 0.0 111.212 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -44.97 -48.83 11.43 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.705 1.139 . . . . 0.0 110.789 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.94 -34.74 78.82 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.73 -38.42 19.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 O-C-N 121.948 -0.47 . . . . 0.0 109.955 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.11 -33.18 75.41 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.961 -0.462 . . . . 0.0 109.837 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -56.22 -40.3 73.85 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 117.314 -1.327 . . . . 0.0 110.967 170.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.07 -45.02 90.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.838 1.654 . . . . 0.0 109.155 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.69 -41.68 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.8 mtt -72.0 -39.54 69.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.542 -0.724 . . . . 0.0 110.658 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.69 -37.13 86.18 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -59.45 -28.34 66.89 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.093 0.957 . . . . 0.0 111.466 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -122.98 2.68 9.36 Favored 'General case' 0 C--N 1.344 0.366 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.67 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.414 1.461 . . . . 0.0 111.576 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.2 p -66.01 -23.03 66.49 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.3 t -69.39 -39.91 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 119.69 1.132 . . . . 0.0 108.841 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.02 -44.2 28.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mtt -66.08 -32.77 74.43 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.568 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.1 m -61.16 -22.13 64.43 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.521 1.055 . . . . 0.0 112.761 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.7 mt -81.25 -21.57 39.35 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 111.546 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.2 mm-40 -109.53 -37.67 5.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.613 1.165 . . . . 0.0 109.93 -169.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -89.55 30.53 1.01 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.733 2.013 . . . . 0.0 109.486 171.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -75.74 -43.91 44.48 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.701 -0.624 . . . . 0.0 111.76 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.563 ' H ' ' CD ' ' A' ' 163' ' ' PRO . 7.9 p -129.7 -25.04 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.75 2.02 . . . . 0.0 115.124 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.563 ' CD ' ' H ' ' A' ' 162' ' ' THR . 51.9 Cg_exo -65.09 -27.41 57.29 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.598 2.198 . . . . 0.0 112.993 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt . . . . . 0 C--O 1.253 1.279 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 171.637 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 tpt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.395 0.141 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm -137.91 147.99 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.25 -44.88 71.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.132 0.573 . . . . 0.0 111.833 -173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -152.05 -80.73 0.1 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.69 0.796 . . . . 0.0 110.83 171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.76 -47.48 8.6 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.06 12.64 0.05 OUTLIER Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.644 -0.531 . . . . 0.0 114.123 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -96.72 130.67 43.92 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.498 1.149 . . . . 0.0 108.655 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -88.02 127.51 57.33 Favored Pre-proline 0 N--CA 1.466 0.375 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.62 135.98 24.95 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.719 1.612 . . . . 0.0 109.92 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -140.65 153.47 46.02 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.709 1.604 . . . . 0.0 111.446 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.69 135.16 51.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 126.909 2.084 . . . . 0.0 105.533 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.69 125.92 6.69 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mm -95.49 110.33 24.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.59 86.14 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.68 129.97 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 155' ' ' VAL . 44.2 t -106.22 135.3 47.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 168.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -95.81 25.66 4.53 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 54.42 -2.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.251 2.22 . . . . 0.0 116.726 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -95.58 14.8 21.68 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.043 0.838 . . . . 0.0 111.697 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.6 9.48 84.65 Favored Glycine 0 C--N 1.345 1.081 0 C-N-CA 124.564 1.078 . . . . 0.0 113.112 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -125.45 172.9 9.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.441 1.12 . . . . 0.0 108.875 -169.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.18 170.66 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.3 tpt -53.13 136.22 36.23 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.5 2.32 . . . . 0.0 113.72 -170.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 16.5 t-105 -163.1 135.6 5.4 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.813 1.245 . . . . 0.0 108.166 168.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.82 158.23 40.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.401 1.48 . . . . 0.0 109.104 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -93.05 130.79 38.53 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -78.92 123.35 27.18 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.887 0.875 . . . . 0.0 109.173 -169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -53.75 134.16 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.267 2.227 . . . . 0.0 110.222 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.11 -16.88 1.92 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.939 1.257 . . . . 0.0 114.773 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -105.75 -30.8 9.2 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.333 1.453 . . . . 0.0 110.33 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 58.87 39.65 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.76 1.624 . . . . 0.0 112.791 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.7 p -140.53 171.29 14.33 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.712 1.605 . . . . 0.0 108.298 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -79.24 157.59 27.76 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -62.01 157.29 19.08 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.186 2.194 . . . . 0.0 113.742 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.83 96.47 5.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 168.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.32 146.25 89.69 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.307 1.338 . . . . 0.0 111.695 -169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 156.5 149.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 129.628 3.171 . . . . 0.0 108.231 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.03 143.87 14.64 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.61 144.34 35.35 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.7 mt -73.53 141.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -84.87 141.53 38.18 Favored Pre-proline 0 N--CA 1.465 0.324 0 C-N-CA 124.887 1.275 . . . . 0.0 109.368 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -59.34 116.31 3.19 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.088 1.859 . . . . 0.0 111.971 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.43 2.39 87.42 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.056 1.312 . . . . 0.0 112.916 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -86.21 128.26 34.87 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.515 1.158 . . . . 0.0 107.996 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.52 157.42 38.05 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.488 1.115 . . . . 0.0 110.45 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.8 63.71 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.632 0.773 . . . . 0.0 111.364 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' SD ' ' A' ' 50' ' ' MET . 1.5 mp0 -64.12 -49.49 71.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -57.47 -36.22 71.16 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.169 1.388 . . . . 0.0 109.608 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.24 -35.17 66.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.645 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 47' ' ' GLU . 30.6 mtp -56.54 -47.22 79.87 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 120.369 1.44 . . . . 0.0 109.189 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.76 -26.57 67.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -65.87 -53.07 44.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.843 0.747 . . . . 0.0 109.549 170.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.63 82.05 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.113 0.87 . . . . 0.0 111.474 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 35.1 tp -56.33 -41.78 76.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.528 1.531 . . . . 0.0 110.345 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -44.13 56.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.57 1.148 . . . . 0.0 111.105 176.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -67.46 -37.79 83.48 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.291 0.95 . . . . 0.0 111.826 -177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.03 -75.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.017 0.927 . . . . 0.0 109.987 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.84 -6.59 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.76 49.78 61.97 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 mt -120.34 156.94 30.28 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.647 1.579 . . . . 0.0 107.111 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.5 m -112.68 173.63 6.28 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.158 0.983 . . . . 0.0 109.444 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.97 43.42 0.07 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.104 2.162 . . . . 0.0 114.508 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -157.66 -18.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.102 1.761 . . . . 0.0 112.171 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -88.99 -0.07 57.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.842 0.857 . . . . 0.0 111.71 -172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.6 m -147.37 169.96 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.862 1.265 . . . . 0.0 109.365 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -142.3 129.16 20.6 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 mt -81.34 127.85 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 120.124 1.329 . . . . 0.0 108.719 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -107.9 -35.37 6.66 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.716 0.807 . . . . 0.0 111.898 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.24 165.88 35.07 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.689 0.795 . . . . 0.0 109.848 -176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.5 p -144.92 160.06 41.91 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.251 1.02 . . . . 0.0 109.511 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 p -64.94 137.18 57.58 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -64.75 -25.27 67.85 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -151.16 170.21 19.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.971 1.309 . . . . 0.0 108.667 169.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -65.99 123.56 20.18 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.227 0.611 . . . . 0.0 109.467 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.43 167.8 19.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.62 154.67 33.38 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 169.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -139.26 162.94 33.77 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -103.82 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.3 mt -69.12 140.59 90.94 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 151.88 64.65 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.319 2.679 . . . . 0.0 109.294 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -65.5 -21.05 66.58 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -169.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -73.67 -27.83 61.44 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.954 0.901 . . . . 0.0 112.332 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.7 tp -94.46 -26.25 16.55 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.614 0.766 . . . . 0.0 110.929 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -57.35 136.8 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -42.47 42.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.523 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m95 61.81 3.38 0.89 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.164 2.185 . . . . 0.0 113.718 -169.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -16.69 18.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.245 1.418 . . . . 0.0 111.028 173.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -76.94 144.26 38.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.983 1.713 . . . . 0.0 107.259 173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.79 116.41 9.0 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 117.902 -1.047 . . . . 0.0 108.468 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.31 150.96 22.04 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.105 1.073 . . . . 0.0 111.927 -10.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 m -57.72 129.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 41.8 t -88.82 107.37 18.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.3 pp -111.65 -5.22 11.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 124.6 1.16 . . . . 0.0 112.257 -170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 168.76 41.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 119.128 0.876 . . . . 0.0 112.188 173.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -103.76 107.88 18.94 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -71.76 121.54 19.09 Favored 'General case' 0 N--CA 1.471 0.617 1 N-CA-C 100.185 -4.006 . . . . 0.0 100.185 167.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.89 132.9 33.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.621 1.555 . . . . 0.0 112.783 -168.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -112.37 128.11 56.2 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -104.25 147.14 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.68 130.05 48.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.2 tp -77.84 111.61 13.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.9 mm? -106.24 126.99 52.9 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -82.58 134.98 35.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 169.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.69 104.65 4.0 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 175.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.87 -33.9 16.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.8 p -83.6 -119.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.821 0.448 . . . . 0.0 109.848 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 175.8 174.37 42.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.998 1.285 . . . . 0.0 110.675 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -28.9 15.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.686 1.194 . . . . 0.0 113.012 173.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.21 66.89 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.423 0.556 . . . . 0.0 112.082 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.61 -22.04 13.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.551 1.141 . . . . 0.0 111.691 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.6 mt -62.38 102.99 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -92.47 -30.88 15.49 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.168 -171.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 41.0 mtt 60.84 -44.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 130.093 3.357 . . . . 0.0 114.784 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.27 34.46 1.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.352 1.861 . . . . 0.0 110.469 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.8 m -71.21 -49.5 42.84 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -68.55 148.82 49.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -75.72 -27.06 58.03 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.936 1.695 . . . . 0.0 112.228 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.9 p -120.74 69.73 17.23 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.675 1.99 . . . . 0.0 106.58 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.62 -174.67 1.94 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 124.273 3.315 . . . . 0.0 111.292 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -116.2 -18.24 10.61 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.269 -1.348 . . . . 0.0 113.386 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.14 150.18 52.22 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 121.935 2.152 . . . . 0.0 112.067 -172.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.08 -28.9 4.66 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.708 1.203 . . . . 0.0 112.492 -170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -161.44 150.41 20.02 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -96.73 156.88 16.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.945 1.298 . . . . 0.0 110.194 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -153.01 103.54 2.75 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -71.57 133.37 45.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.052 1.296 . . . . 0.0 108.658 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.93 153.8 27.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 124.909 1.284 . . . . 0.0 108.15 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 7.5 m -58.48 158.54 7.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.62 0.768 . . . . 0.0 112.672 -170.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.18 151.02 13.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 169.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 7.2 m95 67.1 -23.41 0.11 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.171 1.788 . . . . 0.0 115.561 -174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.0 -47.56 95.08 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 121.059 1.754 . . . . 0.0 111.259 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -55.82 -32.92 86.58 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.875 1.717 . . . . 0.0 113.234 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.95 -33.02 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.512 0.725 . . . . 0.0 110.35 178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -85.92 -26.63 25.45 Favored 'General case' 0 C--N 1.338 0.084 0 CA-C-N 119.166 0.894 . . . . 0.0 111.744 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -80.53 -27.6 37.59 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.773 0.715 . . . . 0.0 112.191 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 p -66.55 158.78 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 119.164 0.893 . . . . 0.0 110.097 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 m -60.29 148.51 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.215 1.006 . . . . 0.0 111.466 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 m -57.6 -35.67 70.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.956 1.302 . . . . 0.0 113.767 -169.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -71.88 -25.41 61.92 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.178 0.899 . . . . 0.0 111.635 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -86.75 -40.82 14.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.108 -0.948 . . . . 0.0 110.775 174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -39.27 -51.66 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 112.977 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -66.3 -33.07 74.92 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.463 0.574 . . . . 0.0 112.397 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 54.4 t -81.83 -35.24 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.349 0.66 . . . . 0.0 110.193 174.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -65.34 -31.98 73.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.532 1.06 . . . . 0.0 110.608 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -55.84 -40.87 73.44 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.368 -0.832 . . . . 0.0 110.559 169.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -64.36 -45.26 88.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.615 1.098 . . . . 0.0 109.504 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.71 -47.19 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 38.5 mtt -66.32 -38.13 86.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.956 -0.465 . . . . 0.0 110.744 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -63.17 -37.9 89.05 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.021 -1.049 . . . . 0.0 110.286 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.11 -29.81 70.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.325 0.65 . . . . 0.0 111.238 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -115.64 -13.97 11.47 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.79 39.84 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.322 1.419 . . . . 0.0 111.702 -169.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.4 m -64.02 -24.5 67.73 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.022 -0.424 . . . . 0.0 111.612 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.11 -40.95 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.437 HG13 ' SG ' ' A' ' 16' ' ' CYS . 39.8 t -68.63 -45.46 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.486 0.714 . . . . 0.0 110.238 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -71.04 -20.35 62.39 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 119.039 0.836 . . . . 0.0 111.491 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -59.48 -30.55 68.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.461 1.028 . . . . 0.0 111.824 175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.45 -41.1 85.27 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -86.22 -29.83 22.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.928 -173.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.25 -12.95 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.006 1.322 . . . . 0.0 111.441 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -95.13 76.77 3.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -37.12 30.34 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -169.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -66.93 -12.13 34.87 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.341 2.694 . . . . 0.0 115.321 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 60.0 tttp . . . . . 0 C--O 1.252 1.226 0 CA-C-N 120.612 1.551 . . . . 0.0 109.241 -179.634 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.339 0.114 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.3 mm -139.28 142.7 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.26 140.03 50.22 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.276 1.43 . . . . 0.0 108.198 170.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -31.94 -49.95 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.754 2.422 . . . . 0.0 116.577 -168.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -83.97 8.67 14.44 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.46 35.04 4.24 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 125.386 1.47 . . . . 0.0 112.258 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -115.61 143.76 44.88 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.613 1.206 . . . . 0.0 112.295 -171.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -82.85 115.86 60.92 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-O 117.435 -1.269 . . . . 0.0 107.817 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 125.29 7.13 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.119 1.88 . . . . 0.0 109.808 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.17 174.35 15.5 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.374 1.069 . . . . 0.0 109.919 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 50' ' ' MET . 31.4 m -119.94 141.52 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 169.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.59 126.92 9.04 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.5 mm -78.33 128.01 38.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 118.085 0.943 . . . . 0.0 108.746 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.94 88.02 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.9 mm -67.57 137.21 25.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 168.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.0 m -125.57 120.21 30.21 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -78.14 138.9 38.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -65.22 -7.09 11.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.42 -11.27 60.61 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.125 0.875 . . . . 0.0 110.516 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.67 34.83 4.54 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 126.378 1.942 . . . . 0.0 112.225 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -131.9 148.01 52.51 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -169.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 m -104.98 162.89 4.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -168.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.9 tpt -56.39 130.06 43.15 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.097 1.759 . . . . 0.0 110.376 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -161.73 127.42 3.62 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.33 144.3 32.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.1 ttp85 -73.06 135.9 44.9 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -77.61 128.64 34.46 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -48.96 128.57 16.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.912 2.085 . . . . 0.0 110.44 173.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.32 -33.19 1.55 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.191 1.376 . . . . 0.0 114.067 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -84.36 -37.14 21.92 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.415 1.108 . . . . 0.0 109.996 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . 0.259 14.8 m170 59.21 33.12 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.657 1.583 . . . . 0.0 113.096 -178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.2 m -139.12 162.98 33.62 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.356 2.262 . . . . 0.0 105.805 169.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -74.19 164.86 26.1 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.405 1.002 . . . . 0.0 113.203 -169.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -151.44 142.8 23.41 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.641 1.576 . . . . 0.0 108.474 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -73.14 144.94 85.35 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.587 0.755 . . . . 0.0 110.017 177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.66 144.73 97.65 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.371 1.381 . . . . 0.0 112.435 175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -172.79 138.09 0.8 Allowed 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.518 2.327 . . . . 0.0 108.505 174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.41 -114.09 3.83 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.272 0.939 . . . . 0.0 110.969 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.81 165.11 35.05 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 128.006 2.717 . . . . 0.0 107.443 -176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.89 135.08 64.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -84.44 158.23 60.66 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-O 119.011 -0.518 . . . . 0.0 109.855 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.7 117.21 3.89 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.817 1.678 . . . . 0.0 112.275 -176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.16 9.24 85.58 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.839 1.209 . . . . 0.0 112.909 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -81.05 125.19 29.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.361 1.08 . . . . 0.0 108.717 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.87 159.58 34.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.472 1.109 . . . . 0.0 110.815 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -41.68 68.76 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.703 1.201 . . . . 0.0 113.436 -169.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.17 -43.42 64.61 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -60.79 -44.21 97.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.493 1.117 . . . . 0.0 108.886 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.73 71.43 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.417 1.087 . . . . 0.0 112.292 172.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.402 ' HA ' HG21 ' A' ' 11' ' ' VAL . 15.6 tmm? -65.98 -43.09 88.84 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.211 0.914 . . . . 0.0 109.739 177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -65.55 -25.48 67.45 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.211 1.369 . . . . 0.0 111.727 174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.96 -49.61 64.89 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 120.063 1.301 . . . . 0.0 108.64 169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.69 83.18 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 121.82 0.819 . . . . 0.0 110.239 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.45 -40.93 88.4 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 125.204 1.401 . . . . 0.0 109.646 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -71.17 -47.72 55.99 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.17 0.988 . . . . 0.0 111.196 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.44 -35.33 80.04 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.894 1.679 . . . . 0.0 112.053 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.32 -39.6 9.15 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.722 0.809 . . . . 0.0 110.422 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.08 -17.35 7.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 123.053 0.541 . . . . 0.0 111.01 -169.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.08 43.42 99.45 Favored Glycine 0 N--CA 1.451 -0.31 0 O-C-N 120.567 -1.333 . . . . 0.0 110.918 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.5 mt -117.28 159.32 22.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.638 1.175 . . . . 0.0 108.183 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.0 m -122.36 -177.49 3.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.823 1.249 . . . . 0.0 110.271 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -67.93 40.42 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.177 2.591 . . . . 0.0 114.694 -170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -164.68 -22.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.343 1.057 . . . . 0.0 112.655 -169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -84.99 -3.92 58.95 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.446 0.698 . . . . 0.0 112.298 -169.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -145.4 168.97 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.921 1.288 . . . . 0.0 109.72 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -135.74 119.48 17.22 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 104.851 -2.278 . . . . 0.0 104.851 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 mt -75.76 131.79 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 120.069 1.304 . . . . 0.0 107.738 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.63 -50.72 3.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.262 0.483 . . . . 0.0 110.24 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.39 168.36 20.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.774 0.83 . . . . 0.0 110.618 -170.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.0 p -150.81 161.23 43.06 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.136 1.375 . . . . 0.0 108.23 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -62.49 146.29 52.03 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.936 0.789 . . . . 0.0 109.991 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.6 mtt-85 -64.62 -30.18 71.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.044 0.538 . . . . 0.0 111.523 -169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.56 172.18 13.96 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.691 1.596 . . . . 0.0 107.546 169.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -61.11 125.19 22.82 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.63 147.39 39.56 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -118.71 123.73 45.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.85 126.01 48.65 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.064 -0.969 . . . . 0.0 108.528 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -102.42 112.47 25.2 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.39 148.9 98.2 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.359 1.063 . . . . 0.0 110.738 -172.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -66.96 151.57 81.9 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 108.333 169.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -25.25 66.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -169.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -74.81 -26.39 59.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.217 1.007 . . . . 0.0 112.432 177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.6 tp -99.05 -21.12 16.36 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.455 -0.783 . . . . 0.0 111.765 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 51.4 t -46.59 140.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 168.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -73.82 -44.88 54.41 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.8 m95 57.17 8.74 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 127.215 2.206 . . . . 0.0 114.719 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -120.84 -16.62 8.11 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.184 0.994 . . . . 0.0 112.649 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.3 p -75.08 -36.2 61.78 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 49.32 93.36 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 127.654 2.382 . . . . 0.0 112.271 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.54 147.68 73.09 Favored 'Cis proline' 0 C--N 1.352 0.728 0 CA-C-N 119.774 0.955 . . . . 0.0 111.315 6.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -63.53 129.36 27.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 51.1 t -91.87 112.56 24.54 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.57 -5.6 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 124.529 1.132 . . . . 0.0 111.808 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.27 173.64 43.06 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.818 1.19 . . . . 0.0 115.217 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -106.46 126.75 52.64 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 124.817 1.247 . . . . 0.0 107.739 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -91.64 116.22 28.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 101.741 -3.429 . . . . 0.0 101.741 168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.53 108.86 6.12 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.606 0.567 . . . . 0.0 111.208 -168.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -93.44 128.96 39.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 168.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -95.72 135.28 37.62 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.47 128.43 56.33 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -87.84 109.79 20.02 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 102' ' ' LEU . 2.7 mm? -107.96 124.45 50.16 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.229 1.012 . . . . 0.0 109.899 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -84.19 131.66 34.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.9 tp -68.88 135.69 51.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -112.44 -28.14 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 170.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.0 p -88.21 -126.81 0.05 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.211 1.004 . . . . 0.0 110.411 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 179.93 166.48 35.54 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 125.21 1.386 . . . . 0.0 110.026 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.24 -30.88 18.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.493 1.117 . . . . 0.0 112.773 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.83 -27.48 65.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.079 0.552 . . . . 0.0 112.295 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -95.96 -31.83 12.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.775 1.23 . . . . 0.0 110.726 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.38 142.63 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.207 1.403 . . . . 0.0 108.177 169.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.59 -51.33 1.84 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.7 mtt 63.71 -18.42 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.42 1.888 . . . . 0.0 115.337 -171.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.36 25.33 7.05 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 121.836 2.107 . . . . 0.0 112.042 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -35.33 77.13 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.935 2.494 . . . . 0.0 111.698 -176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -3.58 55.68 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 113.471 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.0 m 65.98 -35.98 0.23 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.95 2.5 . . . . 0.0 114.126 -172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 p -125.95 68.15 62.86 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.739 2.016 . . . . 0.0 106.287 169.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.19 -172.59 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.017 3.145 . . . . 0.0 111.507 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -108.43 -17.84 13.89 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.145 -1.407 . . . . 0.0 112.306 169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -129.25 146.47 51.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 121.915 2.143 . . . . 0.0 111.842 -170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.42 -49.04 3.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.382 0.673 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 152.51 153.25 6.22 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 123.38 0.514 . . . . 0.0 111.836 174.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 125' ' ' ARG . 30.6 t-105 -156.41 -130.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.802 1.241 . . . . 0.0 109.024 171.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 124' ' ' TRP . 0.0 OUTLIER -152.94 155.22 36.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.806 2.842 . . . . 0.0 106.942 -169.272 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.4 143.15 37.05 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.07 0.85 . . . . 0.0 110.285 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.5 164.76 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.039 0.936 . . . . 0.0 110.52 -169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.3 m -51.25 147.98 5.14 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.735 0.814 . . . . 0.0 110.011 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -54.14 -40.73 67.68 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -169.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -93.14 2.76 56.55 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.64 -47.82 75.1 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 120.767 -1.208 . . . . 0.0 111.126 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -64.97 -32.77 53.57 Favored 'Trans proline' 0 C--N 1.351 0.684 0 CA-C-N 121.913 1.719 . . . . 0.0 112.886 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.65 -33.4 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 119.784 1.174 . . . . 0.0 109.931 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.43 -41.95 75.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.835 1.198 . . . . 0.0 110.063 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -83.83 -18.77 36.46 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.21 160.86 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.601 1.091 . . . . 0.0 109.714 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.4 m -51.69 143.59 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.649 1.18 . . . . 0.0 111.576 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.8 m -59.89 -30.97 69.37 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -69.96 -47.18 63.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.144 0.884 . . . . 0.0 109.696 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -75.84 -27.41 57.84 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.553 -174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -40.2 -49.27 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.556 1.142 . . . . 0.0 112.887 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -64.88 -38.56 91.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.47 0.577 . . . . 0.0 111.797 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.13 -34.31 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 O-C-N 121.751 -0.593 . . . . 0.0 110.009 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -65.26 -31.34 72.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.132 0.878 . . . . 0.0 109.97 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -55.65 -36.67 67.29 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.231 170.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -61.67 -51.2 69.41 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.907 1.23 . . . . 0.0 108.764 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.8 t -54.78 -48.05 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.2 mtt -69.53 -41.12 76.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.229 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -58.86 -41.54 87.27 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 118.953 0.797 . . . . 0.0 110.128 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.63 -33.6 74.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.764 0.426 . . . . 0.0 110.85 -174.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -98.35 -9.43 25.34 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -51.82 -57.97 7.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.695 1.134 . . . . 0.0 112.036 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.149 -0.345 . . . . 0.0 111.538 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.9 t -73.95 -39.67 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.52 -54.1 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.3 mmt -62.78 -26.27 68.64 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 118.013 -0.994 . . . . 0.0 112.53 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 72.5 m -57.73 -31.24 66.24 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.267 1.394 . . . . 0.0 111.848 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.23 -27.2 66.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.547 0.739 . . . . 0.0 110.946 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -96.98 -32.07 12.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.82 0.848 . . . . 0.0 110.976 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.78 -29.14 65.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.376 1.071 . . . . 0.0 110.806 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -113.93 81.39 1.52 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -40.85 79.88 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.004 0.921 . . . . 0.0 112.759 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -61.07 -16.73 47.67 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.902 3.068 . . . . 0.0 115.277 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.041 1.336 . . . . 0.0 109.945 -179.412 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 119.685 -0.198 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.8 149.52 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -124.18 166.48 15.75 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.477 2.311 . . . . 0.0 108.77 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 42.38 47.5 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.799 2.039 . . . . 0.0 114.517 170.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.34 18.71 8.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.741 2.016 . . . . 0.0 114.267 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.72 -1.14 0.1 OUTLIER Glycine 0 C--N 1.34 0.756 0 N-CA-C 116.611 1.405 . . . . 0.0 116.611 169.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.68 130.43 37.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 120.763 2.282 . . . . 0.0 110.531 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -78.9 115.53 52.95 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.325 -1.321 . . . . 0.0 108.387 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.4 118.02 5.02 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.545 2.163 . . . . 0.0 107.941 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 95' ' ' GLN . 4.9 p30 -144.83 167.86 21.59 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.688 0.795 . . . . 0.0 109.442 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.3 m -128.36 135.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.55 127.38 8.29 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -92.45 105.87 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.59 83.93 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.493 -2.039 . . . . 0.0 105.493 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.11 131.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -122.38 129.02 51.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.75 140.85 30.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -63.04 -0.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.334 1.854 . . . . 0.0 115.101 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -81.36 0.42 37.38 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.999 0.818 . . . . 0.0 109.579 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.55 28.04 37.09 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 124.846 1.213 . . . . 0.0 112.11 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -122.09 154.9 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 m -113.94 163.02 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -168.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.6 tpt -50.87 130.58 25.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.008 2.123 . . . . 0.0 111.777 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 33' ' ' TRP . 5.3 t-105 -163.73 124.16 2.2 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 169.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.56 142.74 45.39 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.857 1.313 . . . . 0.0 112.972 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.1 ttp85 -78.43 140.65 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.754 2.421 . . . . 0.0 107.902 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -88.0 151.27 22.9 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.135 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.24 156.62 24.91 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.439 1.495 . . . . 0.0 112.163 171.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.9 25.32 30.1 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.376 0.989 . . . . 0.0 110.88 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -10.0 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 131.294 3.837 . . . . 0.0 117.198 -167.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -151.35 6.64 0.49 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.181 168.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -154.68 147.66 24.61 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.032 1.333 . . . . 0.0 109.058 -170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -121.08 131.87 54.53 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 171.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -138.18 -176.34 4.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.171 0.988 . . . . 0.0 111.665 -169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -145.69 156.64 52.31 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.95 2.1 . . . . 0.0 109.433 -170.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.94 155.11 71.11 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.595 2.864 . . . . 0.0 113.919 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 71.08 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.672 3.589 . . . . 0.0 105.716 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 121.63 7.29 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.481 1.038 . . . . 0.0 114.525 -168.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.89 145.78 14.86 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.929 2.204 . . . . 0.0 113.445 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mt -78.96 136.45 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.632 1.173 . . . . 0.0 108.437 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -77.88 138.61 61.63 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 117.601 -1.19 . . . . 0.0 109.251 175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.44 118.76 5.64 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.711 1.607 . . . . 0.0 112.678 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.46 3.56 89.79 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 114.389 -1.278 . . . . 0.0 113.109 176.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.95 129.32 35.28 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.08 159.6 34.42 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 124.685 1.194 . . . . 0.0 110.645 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -41.75 66.47 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.492 1.117 . . . . 0.0 113.841 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.76 -47.34 54.35 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.07 -40.61 85.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.149 1.38 . . . . 0.0 109.405 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.93 -27.89 62.12 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.0 1.32 . . . . 0.0 111.593 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.8 -40.85 95.9 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 62' ' ' ARG . 79.0 m-85 -68.19 -30.4 69.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.217 -1.552 . . . . 0.0 112.838 172.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -58.88 -48.33 81.78 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.829 -1.169 . . . . 0.0 109.954 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.5 -29.33 65.82 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.663 0.665 . . . . 0.0 112.134 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.84 -41.7 97.77 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 120.626 -1.296 . . . . 0.0 108.604 176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.01 -53.75 34.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.327 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.62 -28.33 68.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.336 1.426 . . . . 0.0 113.378 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -115.14 -12.08 11.95 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.26 0.936 . . . . 0.0 113.278 -168.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 t -130.97 -20.45 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.266 1.026 . . . . 0.0 110.092 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.66 55.24 31.64 Favored Glycine 0 N--CA 1.447 -0.62 0 O-C-N 120.35 -1.469 . . . . 0.0 110.126 -173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.6 mt -136.2 159.51 41.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.499 1.92 . . . . 0.0 106.775 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.2 m -117.34 -177.18 3.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.502 1.121 . . . . 0.0 110.458 -171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 51' ' ' TYR . 14.6 mtt180 -70.9 36.33 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.369 2.268 . . . . 0.0 113.578 -171.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.52 -19.83 0.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.965 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -83.39 -5.19 59.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 112.525 -169.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.9 m -146.66 167.63 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.583 1.153 . . . . 0.0 109.468 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -136.19 120.18 17.58 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.674 1.99 . . . . 0.0 105.926 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.0 mt -73.99 128.92 36.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.07 -35.85 7.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.16 0.584 . . . . 0.0 111.215 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.16 163.8 39.17 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.218 1.007 . . . . 0.0 108.756 -173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -146.09 156.22 43.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.482 1.113 . . . . 0.0 108.1 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 p -63.72 150.55 44.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.013 0.824 . . . . 0.0 109.991 177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -70.29 -31.99 69.58 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.041 -0.412 . . . . 0.0 111.49 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.31 176.66 10.36 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.656 1.982 . . . . 0.0 108.077 172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -66.62 117.39 8.72 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.236 0.614 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.78 151.34 46.76 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -145.32 134.01 22.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -149.82 158.52 44.24 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -95.75 153.61 17.65 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.285 0.564 . . . . 0.0 111.308 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.25 148.16 46.64 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.05 153.4 67.62 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.37 2.713 . . . . 0.0 109.414 172.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -65.39 -20.36 66.34 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 -169.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -73.33 -27.41 61.5 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.8 tp -94.9 -27.59 15.62 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.061 0.944 . . . . 0.0 110.572 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -56.0 134.04 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 169.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -41.28 41.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.6 m95 60.95 5.79 1.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.88 2.072 . . . . 0.0 113.685 -169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.81 -19.92 14.11 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.889 1.275 . . . . 0.0 111.837 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.6 p -76.6 153.4 35.35 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.979 1.711 . . . . 0.0 108.771 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -137.66 113.84 9.35 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.027 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -53.91 147.57 16.26 Favored 'Cis proline' 0 CA--C 1.538 0.717 0 CA-C-N 120.199 1.107 . . . . 0.0 111.845 -10.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.32 129.37 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 172.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.8 t -80.37 97.98 7.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.2 pt -88.08 -15.98 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 125.374 1.469 . . . . 0.0 111.865 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -172.22 172.78 45.03 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 120.662 1.574 . . . . 0.0 113.028 -169.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.413 ' HB3' HD21 ' A' ' 10' ' ' ASN . 25.6 mm-40 -105.87 129.62 54.0 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -97.2 113.91 25.56 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.45 127.54 35.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -103.52 129.52 50.73 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 168.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -103.57 133.6 48.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.99 129.2 55.97 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.7 tp -83.7 113.84 21.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.5 mm? -113.48 121.64 44.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 123.749 0.82 . . . . 0.0 109.619 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -83.56 137.19 33.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.545 HD22 ' HA2' ' A' ' 107' ' ' GLY . 73.4 mt -63.05 139.51 58.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.363 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.54 -25.0 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.515 1.126 . . . . 0.0 108.013 169.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.3 p -119.57 -61.82 1.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.886 0.766 . . . . 0.0 110.381 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.545 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 80.4 -147.29 28.31 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -43.64 -36.44 2.16 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.476 1.91 . . . . 0.0 113.56 -172.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.57 -23.98 66.98 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -123.33 -16.39 6.89 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.352 1.461 . . . . 0.0 112.431 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.48 143.89 9.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -134.06 -48.02 0.79 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.043 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.0 mtt 58.86 -1.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.38 23.98 8.83 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 121.774 2.079 . . . . 0.0 111.262 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -35.64 66.51 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.023 2.529 . . . . 0.0 111.374 169.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.81 3.9 15.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.013 1.725 . . . . 0.0 112.717 -177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.8 m 70.15 -42.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 129.485 3.114 . . . . 0.0 114.483 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.5 p -133.51 34.67 0.26 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.42 1.088 . . . . 0.0 113.914 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.77 160.99 40.09 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.746 1.659 . . . . 0.0 110.461 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -57.76 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.768 1.627 . . . . 0.0 113.609 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -75.05 144.46 42.99 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.398 0.618 . . . . 0.0 112.657 -168.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -146.24 -6.68 0.56 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.327 1.051 . . . . 0.0 113.62 -171.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.61 162.84 35.38 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -138.5 149.87 45.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.89 0.845 . . . . 0.0 111.417 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -150.55 128.07 11.49 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.815 1.646 . . . . 0.0 107.134 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -82.0 138.32 34.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -129.67 167.93 23.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 124.598 1.159 . . . . 0.0 110.459 -169.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.6 m -49.03 144.74 4.52 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.198 0.999 . . . . 0.0 109.601 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -53.89 -36.91 63.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -94.17 -3.66 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.79 -45.8 96.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 117.011 -1.471 . . . . 0.0 111.974 -170.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.11 -36.32 99.17 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.947 1.731 . . . . 0.0 111.471 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -66.51 -40.01 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -76.68 -29.38 56.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.822 1.192 . . . . 0.0 111.577 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -78.43 -28.09 46.65 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.02 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.45 156.04 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.547 1.067 . . . . 0.0 110.947 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.16 148.05 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.46 1.504 . . . . 0.0 111.88 172.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.0 m -58.75 -34.95 71.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.834 1.254 . . . . 0.0 113.911 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -71.36 -25.94 62.59 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.032 0.833 . . . . 0.0 111.437 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -88.67 -38.07 15.06 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.419 -0.8 . . . . 0.0 111.117 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -47.78 -47.48 30.76 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.082 1.31 . . . . 0.0 112.972 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.66 -35.79 81.01 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.383 0.538 . . . . 0.0 112.032 -174.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.5 p -86.64 -35.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.37 0.668 . . . . 0.0 110.596 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.91 -31.9 73.35 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.279 -0.888 . . . . 0.0 109.989 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -56.65 -37.32 70.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.119 169.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.63 -47.4 81.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.091 1.314 . . . . 0.0 108.886 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.22 -50.6 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.722 0.809 . . . . 0.0 109.307 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.8 mtt -65.69 -40.72 92.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 119.099 -0.477 . . . . 0.0 111.251 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -58.79 -39.77 82.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.444 1.098 . . . . 0.0 110.547 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -70.9 -23.26 62.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.704 0.402 . . . . 0.0 111.25 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -107.53 -9.6 15.89 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.28 16.98 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.473 1.033 . . . . 0.0 111.542 -169.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 m -62.81 -25.28 68.17 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 118.944 -0.55 . . . . 0.0 112.126 -176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.43 -43.52 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.59 -36.48 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.5 mmt -69.42 -35.81 76.08 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.835 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -59.58 -31.5 69.5 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.737 1.153 . . . . 0.0 112.031 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.25 -25.17 67.94 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.152 0.581 . . . . 0.0 111.361 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -104.65 -32.37 8.94 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.166 0.986 . . . . 0.0 110.987 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -72.34 -28.3 62.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.503 1.121 . . . . 0.0 111.262 -176.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -99.65 79.98 2.31 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -39.26 68.6 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.25 1.02 . . . . 0.0 112.449 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -62.67 -16.41 52.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.628 2.885 . . . . 0.0 115.092 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt . . . . . 0 C--O 1.254 1.308 0 C-N-CA 124.806 1.242 . . . . 0.0 110.357 -177.207 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 119.557 -0.258 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.03 143.39 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -74.83 -44.31 49.91 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.522 1.129 . . . . 0.0 111.306 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -151.8 -77.78 0.12 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.904 0.882 . . . . 0.0 111.138 170.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.55 -48.92 7.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.39 6.15 0.05 OUTLIER Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.316 0.887 . . . . 0.0 115.316 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -96.93 134.33 40.42 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.35 1.575 . . . . 0.0 109.902 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -86.38 127.16 62.18 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.812 -1.09 . . . . 0.0 108.776 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.84 130.84 8.79 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.397 2.065 . . . . 0.0 108.624 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.48 177.2 11.74 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.151 -0.968 . . . . 0.0 109.294 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 m -130.59 135.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.71 136.23 12.86 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.48 142.23 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 118.94 1.37 . . . . 0.0 107.805 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 t -121.42 89.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 168.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -66.89 136.46 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 168.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -124.45 118.21 26.14 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -74.01 141.88 45.79 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -68.16 -9.66 48.37 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.07 -10.19 59.44 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.79 0.723 . . . . 0.0 111.328 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.13 39.2 3.35 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 125.926 1.727 . . . . 0.0 112.434 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -136.35 150.91 49.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.65 161.72 4.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.885 0.874 . . . . 0.0 112.68 -169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.01 128.51 36.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.006 1.322 . . . . 0.0 109.325 170.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.427 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 2.6 t-105 -160.23 128.81 4.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 168.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.1 148.45 41.74 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -69.08 140.68 54.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -77.77 119.86 21.86 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -44.61 126.33 5.43 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.544 1.938 . . . . 0.0 110.583 173.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.65 -2.05 25.75 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.532 1.063 . . . . 0.0 115.259 173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -126.93 -24.72 3.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.032 1.416 . . . . 0.0 111.454 -172.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.66 14.29 8.94 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.284 1.833 . . . . 0.0 115.198 172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.2 p -104.45 -143.18 0.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.98 1.312 . . . . 0.0 107.647 169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.427 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 62.7 m95 -127.96 168.16 15.65 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.098 1.317 . . . . 0.0 109.946 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -152.44 150.77 30.0 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 124.147 0.979 . . . . 0.0 109.42 -176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -81.6 139.92 47.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.943 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.68 137.83 75.81 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 121.657 1.571 . . . . 0.0 111.642 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -157.55 147.83 20.78 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.729 1.212 . . . . 0.0 111.101 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.13 -126.38 5.56 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.523 1.059 . . . . 0.0 112.156 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 168.51 118.48 0.45 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 106.38 -2.688 . . . . 0.0 106.38 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.8 mt -82.62 125.58 39.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -75.46 155.18 85.76 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.13 116.72 3.56 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.638 1.559 . . . . 0.0 111.039 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.25 7.75 87.3 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.079 1.323 . . . . 0.0 113.188 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -80.29 125.26 29.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.427 1.113 . . . . 0.0 108.601 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.72 157.34 37.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.483 1.113 . . . . 0.0 110.312 177.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.74 -41.09 69.99 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -169.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -71.58 -39.82 70.32 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -65.06 -44.26 89.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.33 -27.03 69.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.383 170.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.466 ' HG3' ' CG ' ' A' ' 100' ' ' PHE . 17.0 tmm? -72.21 -43.74 64.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 119.411 1.005 . . . . 0.0 109.032 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -66.31 -30.99 71.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 119.114 0.87 . . . . 0.0 110.903 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -62.21 -49.2 76.72 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.659 -0.651 . . . . 0.0 109.607 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.28 -34.06 77.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.145 0.978 . . . . 0.0 111.277 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.64 -39.98 95.7 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 125.183 1.393 . . . . 0.0 109.446 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.19 -50.87 59.43 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.866 0.866 . . . . 0.0 110.056 171.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -59.54 -40.94 88.89 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.521 1.055 . . . . 0.0 112.002 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -95.21 -49.36 5.52 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.287 0.635 . . . . 0.0 111.082 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.21 -17.7 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.4 0.68 . . . . 0.0 110.599 -169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.71 55.72 29.27 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -134.22 162.94 30.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 127.287 2.235 . . . . 0.0 106.507 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.8 m -119.0 179.13 4.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.356 0.662 . . . . 0.0 110.09 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -72.19 49.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.323 1.849 . . . . 0.0 114.503 -171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -163.4 -23.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.57 1.548 . . . . 0.0 112.294 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.27 1.1 52.15 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.064 0.946 . . . . 0.0 112.813 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.2 m -149.05 171.16 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.13 1.372 . . . . 0.0 109.727 -169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -138.91 124.53 19.55 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -79.91 131.79 33.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 120.655 1.571 . . . . 0.0 107.304 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -102.73 -45.94 4.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.51 169.3 19.86 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.88 0.872 . . . . 0.0 110.554 -173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.3 p -145.86 162.73 37.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.7 p -65.05 141.97 58.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -67.11 -22.03 65.83 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -170.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -141.85 177.58 8.08 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.523 1.529 . . . . 0.0 107.441 169.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -72.16 129.48 38.58 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 75' ' ' LEU . 4.2 mm? -79.85 160.04 26.23 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 169.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -156.61 151.86 26.49 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.584 1.154 . . . . 0.0 108.345 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.06 172.91 12.71 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.001 1.72 . . . . 0.0 106.956 172.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -112.84 128.51 56.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.2 mt -67.71 145.39 98.08 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -63.3 154.66 66.64 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.509 2.139 . . . . 0.0 108.513 170.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -59.72 -29.94 68.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.114 1.154 . . . . 0.0 114.114 -169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -73.22 -25.83 60.9 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.037 0.935 . . . . 0.0 112.728 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.1 tp -101.2 -19.38 15.73 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.815 0.846 . . . . 0.0 111.865 -177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.7 t -48.01 135.23 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -88.53 101.65 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.529 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.37 -2.33 57.97 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.363 0.665 . . . . 0.0 110.88 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -79.81 -30.55 40.53 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 121.636 -0.665 . . . . 0.0 110.096 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.4 161.12 23.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 124.564 1.146 . . . . 0.0 109.814 -173.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -137.26 114.63 9.8 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -59.18 153.58 43.04 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.004 1.037 . . . . 0.0 110.828 -10.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.49 138.12 23.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 30.7 t -97.56 120.8 38.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 13.4 pt -107.47 -10.18 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 124.282 1.033 . . . . 0.0 112.531 -169.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.97 168.63 40.12 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.158 0.89 . . . . 0.0 111.673 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -104.61 123.51 47.69 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -85.26 118.92 25.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 120.37 14.98 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.96 1.254 . . . . 0.0 113.164 -173.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -98.92 128.92 45.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -97.69 149.65 22.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.466 ' CG ' ' HG3' ' A' ' 50' ' ' MET . 41.3 m-85 -119.53 126.79 52.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.9 tp -84.3 111.58 19.54 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 102' ' ' LEU . 19.9 mt -107.48 131.23 54.53 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 124.465 1.103 . . . . 0.0 110.64 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -90.17 136.26 33.16 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.12 132.69 44.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -116.16 -37.8 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.7 m -85.2 -133.09 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.96 173.5 46.3 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 120.369 1.441 . . . . 0.0 111.403 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.4 -31.73 46.27 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.966 1.307 . . . . 0.0 112.859 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.45 -27.9 67.42 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.246 0.618 . . . . 0.0 112.431 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.86 -24.73 13.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.37 1.468 . . . . 0.0 110.908 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mt -59.46 142.54 14.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.724 1.61 . . . . 0.0 107.256 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -124.98 -38.77 2.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.51 -15.72 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.963 2.105 . . . . 0.0 116.173 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.94 27.94 8.98 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.849 1.659 . . . . 0.0 111.574 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 p -68.62 -36.98 79.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -91.76 6.39 46.19 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.074 0.949 . . . . 0.0 113.5 -169.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m 67.85 -36.1 0.29 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.489 2.716 . . . . 0.0 114.962 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -128.4 66.84 74.63 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.706 1.602 . . . . 0.0 108.33 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -77.05 -168.62 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.575 2.85 . . . . 0.0 110.467 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.7 -11.0 14.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.525 169.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -124.51 145.21 49.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 121.017 1.735 . . . . 0.0 114.03 -170.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.62 116.66 25.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 129.003 2.921 . . . . 0.0 105.004 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.81 143.55 42.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.215 0.912 . . . . 0.0 113.277 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -114.44 0.08 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.035 0.934 . . . . 0.0 109.622 -172.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -140.91 155.21 46.33 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.951 1.3 . . . . 0.0 110.106 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 21.9 m95 -79.68 149.6 31.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.14 161.98 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.842 0.857 . . . . 0.0 110.003 -170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.5 m -53.3 150.13 6.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.592 . . . . 0.0 110.921 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.44 149.65 20.36 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 5.6 m95 66.1 -15.08 0.13 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -57.44 -44.17 99.43 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 121.322 1.874 . . . . 0.0 111.937 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -63.99 -25.88 66.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 121.885 1.724 . . . . 0.0 114.702 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.48 -36.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 119.855 1.207 . . . . 0.0 108.928 176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -83.39 -16.26 46.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 117.9 -1.047 . . . . 0.0 112.21 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -86.26 -31.1 21.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.977 1.262 . . . . 0.0 112.341 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m -68.88 165.34 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.303 0.956 . . . . 0.0 111.755 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.55 151.24 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.9 1.28 . . . . 0.0 111.148 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -59.12 -34.49 72.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.104 1.362 . . . . 0.0 113.822 -169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -71.55 -26.02 62.46 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.025 0.829 . . . . 0.0 111.468 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -94.64 -29.32 14.9 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.14 0.976 . . . . 0.0 112.317 -173.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -36.9 -53.71 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.721 2.009 . . . . 0.0 112.638 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -35.29 74.92 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.418 0.553 . . . . 0.0 110.977 -170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.414 HG13 HD12 ' A' ' 75' ' ' LEU . 72.2 t -72.7 -36.04 51.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 O-C-N 121.648 -0.657 . . . . 0.0 109.682 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -68.15 -34.82 77.03 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.261 0.937 . . . . 0.0 110.791 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -58.01 -39.54 78.57 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.577 1.151 . . . . 0.0 111.373 169.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -64.31 -47.44 79.44 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.144 0.884 . . . . 0.0 109.618 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.31 -45.33 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.593 0.633 . . . . 0.0 109.603 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtt -65.49 -43.22 90.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.647 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -26.03 65.06 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.3 1.863 . . . . 0.0 112.315 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -65.31 -23.49 67.03 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.718 0.69 . . . . 0.0 110.358 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -116.09 -21.49 9.41 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.358 1.063 . . . . 0.0 113.442 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.1 -58.64 5.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.578 1.151 . . . . 0.0 110.607 -172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.5 m -66.17 -21.48 66.32 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.456 0.571 . . . . 0.0 111.995 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.76 -41.5 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.61 -48.72 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 50.1 mtt -66.52 -18.79 65.56 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.71 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.7 m -63.19 -24.22 67.78 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.713 1.142 . . . . 0.0 111.873 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.8 mp -72.97 -49.72 27.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.671 0.668 . . . . 0.0 109.348 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -75.67 -23.42 56.22 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.704 0.402 . . . . 0.0 111.206 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -96.16 41.14 1.11 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.91 1.684 . . . . 0.0 109.808 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -127.76 30.96 5.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.977 0.911 . . . . 0.0 110.382 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . 0.306 20.3 p 49.38 36.37 0.34 Allowed Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.463 1.905 . . . . 0.0 115.966 -173.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.54 -27.21 23.03 Favored 'Trans proline' 0 C--N 1.36 1.147 0 CA-C-N 121.835 1.691 . . . . 0.0 110.078 169.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.968 1.707 . . . . 0.0 109.346 -175.79 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 119.89 -0.1 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.4 136.16 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -71.02 162.13 29.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.379 1.472 . . . . 0.0 108.707 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.6 -36.48 64.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -84.9 5.96 26.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.23 31.24 14.58 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.792 1.187 . . . . 0.0 111.75 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 94' ' ' GLY . 19.5 m-85 -108.42 134.57 51.03 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.892 1.346 . . . . 0.0 109.127 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -82.55 127.34 70.95 Favored Pre-proline 0 N--CA 1.472 0.658 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.52 130.5 11.82 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.142 1.894 . . . . 0.0 109.322 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.6 160.65 39.37 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.728 1.211 . . . . 0.0 110.705 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.3 148.3 18.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.596 1.958 . . . . 0.0 106.431 169.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.14 131.06 6.11 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 169.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mp -95.44 127.29 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.5 t -99.53 91.78 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 103.898 -2.631 . . . . 0.0 103.898 168.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.5 mm -66.39 134.12 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 168.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.8 m -119.32 126.26 51.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 168.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -86.62 35.11 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.904 -0.498 . . . . 0.0 111.216 -169.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . 0.265 13.7 ptp180 40.87 7.92 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.906 4.082 . . . . 0.0 116.558 -169.038 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -95.39 3.65 54.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.03 0.932 . . . . 0.0 111.471 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.31 64.34 Favored Glycine 0 N--CA 1.47 0.92 0 O-C-N 121.021 -1.049 . . . . 0.0 112.089 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -121.78 149.81 42.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.571 1.548 . . . . 0.0 107.005 -169.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.3 160.07 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.459 1.104 . . . . 0.0 113.204 -169.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.9 ttt -58.31 134.61 56.72 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.332 1.453 . . . . 0.0 109.977 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -157.69 133.69 9.38 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 169.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.06 144.31 27.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.504 0.669 . . . . 0.0 110.458 -175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -79.92 132.35 36.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.229 1.411 . . . . 0.0 107.786 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -93.72 134.92 35.54 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.59 0.756 . . . . 0.0 109.248 -170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -47.55 132.79 13.65 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.832 1.253 . . . . 0.0 111.591 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.22 -23.08 0.75 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.615 1.102 . . . . 0.0 113.564 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.31 -37.75 43.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.923 0.862 . . . . 0.0 108.956 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 56.46 28.94 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.448 1.499 . . . . 0.0 112.262 -174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 p -149.78 175.82 11.27 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.28 1.832 . . . . 0.0 107.266 173.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -78.06 153.81 31.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.729 0.812 . . . . 0.0 112.639 -169.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -146.48 162.29 38.62 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.882 . . . . 0.0 109.37 170.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -84.67 151.1 57.85 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.886 2.074 . . . . 0.0 110.746 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -68.4 156.97 63.77 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.886 2.391 . . . . 0.0 113.022 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 179.96 148.49 0.3 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.921 2.488 . . . . 0.0 108.322 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 142.15 8.68 Favored Glycine 0 C--N 1.337 0.638 0 O-C-N 121.134 -0.978 . . . . 0.0 110.883 170.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.4 154.73 50.75 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.786 1.184 . . . . 0.0 111.027 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -87.42 134.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.387 1.075 . . . . 0.0 109.108 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -65.82 126.46 91.77 Favored Pre-proline 0 N--CA 1.468 0.435 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.627 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.32 118.2 5.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.074 1.849 . . . . 0.0 111.585 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.87 0.17 75.4 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.577 1.56 . . . . 0.0 113.083 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -83.7 132.93 34.83 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.677 1.191 . . . . 0.0 108.048 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 159.39 34.61 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.984 0.913 . . . . 0.0 110.346 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.76 71.81 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 125.059 1.344 . . . . 0.0 112.315 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.38 -40.6 73.86 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -62.16 -43.5 98.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 108.967 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.92 -31.54 71.38 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.956 0.502 . . . . 0.0 111.93 172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.4 tmm? -61.68 -44.71 96.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.883 0.765 . . . . 0.0 110.06 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -65.78 -29.3 69.78 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.961 1.255 . . . . 0.0 113.046 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -59.38 -50.67 73.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.237 1.381 . . . . 0.0 109.087 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.08 66.79 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.134 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.14 -43.32 99.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.832 -1.167 . . . . 0.0 108.455 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -66.51 -45.12 80.58 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.702 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -69.49 -48.88 59.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.523 1.51 . . . . 0.0 112.211 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -85.66 -29.59 23.88 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.124 0.97 . . . . 0.0 111.783 -168.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.35 -15.37 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.5 0.72 . . . . 0.0 110.379 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.25 11.33 70.97 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 120.746 -1.221 . . . . 0.0 113.12 -173.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.37 151.41 21.11 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.131 0.966 . . . . 0.0 109.189 -174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -102.74 174.05 6.06 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.034 0.933 . . . . 0.0 108.909 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -70.42 34.61 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 115.065 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -152.41 -11.44 0.18 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.221 1.808 . . . . 0.0 112.705 -169.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -97.91 2.27 48.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.451 0.7 . . . . 0.0 110.96 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.88 171.89 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.751 1.221 . . . . 0.0 108.419 -173.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -140.57 122.61 15.63 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 -171.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -75.47 129.82 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.26 -34.17 6.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.813 0.445 . . . . 0.0 110.702 176.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.7 166.5 32.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.679 1.192 . . . . 0.0 108.234 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -140.54 157.25 45.76 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -58.62 138.34 56.97 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 119.467 1.03 . . . . 0.0 108.474 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -61.46 -24.82 66.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.789 0.436 . . . . 0.0 112.074 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -146.48 174.16 11.64 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 168.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -61.7 126.64 28.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.12 131.31 45.19 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 170.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.37 134.66 52.79 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -143.02 131.6 22.42 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.7 117.51 24.63 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 176.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.18 147.47 80.98 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.866 1.266 . . . . 0.0 110.25 -173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -62.44 150.54 87.03 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 121.582 1.521 . . . . 0.0 109.015 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -48.83 -48.44 41.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.016 0.927 . . . . 0.0 113.367 -169.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -65.88 -16.48 63.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.197 0.999 . . . . 0.0 113.003 -176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -108.07 -3.75 18.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.169 1.388 . . . . 0.0 111.749 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -59.41 137.56 21.67 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 169.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -91.0 127.52 36.46 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -111.36 0.18 16.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.123 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -85.84 -17.59 35.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.106 0.562 . . . . 0.0 109.724 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.0 p -91.43 156.51 17.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 123.257 0.623 . . . . 0.0 109.328 -171.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -131.38 110.25 15.05 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 171.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.88 155.94 60.44 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.447 1.195 . . . . 0.0 112.117 -4.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.4 m -60.54 133.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 50.7 t -90.06 99.52 12.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.6 pt -88.89 -6.42 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.416 1.486 . . . . 0.0 112.027 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 7' ' ' TYR . . . -158.43 153.72 24.86 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 120.514 1.506 . . . . 0.0 113.566 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -105.91 94.21 5.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -71.02 126.17 28.85 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 170.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.63 111.7 5.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.224 0.92 . . . . 0.0 110.273 -169.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -89.3 125.81 35.26 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 169.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -98.27 146.8 25.29 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -123.87 126.14 45.89 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.815 1.246 . . . . 0.0 107.715 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.2 tp -78.46 111.12 14.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.7 mm? -106.84 121.92 45.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.022 0.929 . . . . 0.0 108.609 174.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -82.84 137.25 34.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -63.35 139.99 58.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.73 -41.0 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.6 m -136.41 142.56 43.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.3 -168.8 40.73 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.713 -0.617 . . . . 0.0 112.937 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.07 -56.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 131.443 3.897 . . . . 0.0 112.882 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.58 -35.44 24.71 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.174 0.99 . . . . 0.0 110.786 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -86.09 -18.72 31.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.405 0.682 . . . . 0.0 111.148 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.94 138.8 22.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -153.69 84.81 1.17 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.5 mtt -70.79 24.67 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.249 0.62 . . . . 0.0 112.404 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -132.92 20.43 4.14 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.999 1.72 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.84 -51.46 50.99 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.926 2.09 . . . . 0.0 110.951 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 m -86.09 3.93 40.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.604 1.162 . . . . 0.0 112.869 -173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 63.01 117.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 128.07 2.548 . . . . 0.0 112.417 -169.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.5 p 34.78 53.06 1.49 Allowed Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 111.783 -2.462 . . . . 0.0 113.325 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.37 -54.15 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.898 1.732 . . . . 0.0 113.26 -169.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -160.79 -45.54 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.846 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -115.52 135.92 53.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -169.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -91.64 -31.9 15.68 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.714 2.005 . . . . 0.0 112.007 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -170.77 156.63 27.06 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 123.896 0.76 . . . . 0.0 111.75 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -120.48 150.73 40.37 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.082 1.353 . . . . 0.0 111.39 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -150.05 130.1 13.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.758 1.623 . . . . 0.0 108.627 173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -84.56 140.0 31.72 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.03 0.832 . . . . 0.0 108.934 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.17 166.88 17.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.943 1.297 . . . . 0.0 109.835 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.9 m -56.26 150.69 13.98 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.893 0.877 . . . . 0.0 111.927 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.42 149.26 34.63 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.5 m95 65.5 -16.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.3 1.84 . . . . 0.0 115.857 -170.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -65.22 -48.38 69.23 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 121.235 1.834 . . . . 0.0 110.898 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -59.55 -30.23 91.91 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 121.81 1.682 . . . . 0.0 113.391 173.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -39.45 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.544 -0.722 . . . . 0.0 110.027 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -73.16 -37.15 66.68 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 120.683 -1.261 . . . . 0.0 110.035 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -80.74 -24.92 38.37 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -170.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.49 156.92 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 119.172 0.896 . . . . 0.0 109.352 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.9 m -58.46 150.5 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.388 1.075 . . . . 0.0 110.711 169.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.2 m -59.79 -26.81 66.04 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.897 1.279 . . . . 0.0 114.406 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -72.06 -45.68 59.82 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.356 0.98 . . . . 0.0 110.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.54 -29.5 52.34 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 117.159 -1.4 . . . . 0.0 111.419 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -43.3 -48.17 6.75 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.564 1.529 . . . . 0.0 111.156 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -73.23 -22.29 60.46 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -79.26 -47.48 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.231 -0.918 . . . . 0.0 108.658 170.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -31.7 70.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.794 0.838 . . . . 0.0 110.568 -169.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -64.95 -33.76 76.8 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.268 -0.895 . . . . 0.0 111.264 172.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -69.92 -44.96 68.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.29 -46.87 85.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.171 0.588 . . . . 0.0 110.001 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 47.2 mtt -66.34 -40.49 89.87 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.203 -0.936 . . . . 0.0 110.987 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -64.11 -37.22 86.67 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.367 0.985 . . . . 0.0 111.01 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.84 -28.06 69.22 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.805 0.842 . . . . 0.0 110.985 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -113.94 -11.66 12.76 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.07 -54.8 38.46 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.94 1.245 . . . . 0.0 110.755 -170.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -81.12 25.63 0.47 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.615 0.766 . . . . 0.0 112.6 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.69 -18.31 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.164 1.786 . . . . 0.0 108.773 169.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 73.1 t -96.95 -52.79 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 124.768 1.227 . . . . 0.0 108.087 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.0 mmt -64.77 -16.41 62.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.283 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 m -48.92 -33.23 10.42 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.874 1.67 . . . . 0.0 113.194 169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.9 mt -83.0 -29.58 28.82 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.041 0.936 . . . . 0.0 110.509 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -96.87 -25.92 15.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.325 1.05 . . . . 0.0 112.189 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -106.52 26.68 9.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 109.592 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -71.43 -33.21 69.2 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.593 1.157 . . . . 0.0 112.456 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.3 -57.25 2.85 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.728 1.211 . . . . 0.0 112.374 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.11 -30.41 20.71 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.157 2.571 . . . . 0.0 113.419 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 62.2 mttp . . . . . 0 C--O 1.255 1.346 0 C-N-CA 124.883 1.273 . . . . 0.0 109.816 -171.607 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm -137.19 140.16 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.97 145.81 48.15 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.635 1.574 . . . . 0.0 108.144 173.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -44.59 -37.49 3.62 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 116.058 1.874 . . . . 0.0 116.058 -168.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -81.96 2.13 32.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.51 24.85 11.57 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.776 1.655 . . . . 0.0 112.009 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -111.03 148.7 32.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.668 1.734 . . . . 0.0 110.843 -170.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -87.89 112.45 49.1 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.211 -1.555 . . . . 0.0 107.412 174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.84 130.32 15.53 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.492 2.128 . . . . 0.0 109.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -154.84 170.99 20.37 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.465 1.106 . . . . 0.0 110.855 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.91 130.31 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.481 1.513 . . . . 0.0 108.796 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.33 126.63 8.98 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mm -91.5 104.12 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.35 81.35 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 169.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.9 mm -63.79 130.27 28.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.3 m -111.17 128.33 55.87 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.82 18.34 6.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -168.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.7 mtm105 53.5 10.68 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.106 1.762 . . . . 0.0 115.341 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -109.87 6.97 23.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.304 1.041 . . . . 0.0 111.945 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.74 79.28 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 120.796 -1.19 . . . . 0.0 112.731 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -128.51 158.57 38.03 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.893 1.677 . . . . 0.0 106.851 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.37 167.61 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -169.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 128.2 32.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.347 1.859 . . . . 0.0 110.873 176.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.417 ' CD1' ' CE3' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -164.46 131.53 3.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 167.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.76 142.42 44.96 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 ttm-85 -76.6 144.92 39.27 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -95.71 126.71 41.17 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -172.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -61.17 144.64 53.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.705 0.684 . . . . 0.0 110.586 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.43 -28.24 0.85 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.361 1.457 . . . . 0.0 114.158 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -97.06 -28.33 14.19 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.606 1.162 . . . . 0.0 110.357 -176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 65.13 -8.65 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.788 2.435 . . . . 0.0 115.213 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -178.66 6.79 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.263 1.025 . . . . 0.0 108.455 169.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.417 ' CE3' ' CD1' ' A' ' 24' ' ' TRP . 73.8 m95 -90.03 162.07 15.53 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 120.84 -1.163 . . . . 0.0 110.704 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -140.15 148.03 41.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.045 0.926 . . . . 0.0 110.848 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -79.76 164.9 50.95 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 127.335 2.254 . . . . 0.0 110.186 169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.71 -92.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.664 2.91 . . . . 0.0 110.289 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 53.78 61.37 3.12 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.469 1.108 . . . . 0.0 111.563 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.81 117.27 4.46 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.1 142.71 27.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 125.997 1.76 . . . . 0.0 111.485 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.0 mt -77.4 139.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.994 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -77.71 136.06 63.57 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.356 172.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -54.99 118.27 4.96 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.631 1.554 . . . . 0.0 113.491 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.48 89.74 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.961 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -83.86 123.28 29.76 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.281 1.032 . . . . 0.0 108.513 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 p -72.59 160.52 32.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.269 1.028 . . . . 0.0 110.508 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.5 79.55 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.354 1.061 . . . . 0.0 111.129 -170.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.5 12.82 3.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.633 0.773 . . . . 0.0 111.181 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -114.18 -54.21 2.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.408 1.883 . . . . 0.0 106.088 170.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.74 -33.08 73.41 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.476 1.11 . . . . 0.0 112.335 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.4 tmm? -61.29 -45.07 95.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -71.86 -27.87 63.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.617 -0.677 . . . . 0.0 111.292 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -62.19 -48.71 78.83 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.243 -0.91 . . . . 0.0 109.409 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.76 -32.93 73.03 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.801 0.728 . . . . 0.0 111.362 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 23.1 tp -60.34 -40.72 91.7 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.65 1.18 . . . . 0.0 109.419 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.34 -54.08 9.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.336 1.054 . . . . 0.0 111.456 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.97 -41.72 81.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 120.635 1.562 . . . . 0.0 110.834 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -92.96 -49.01 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.205 0.457 . . . . 0.0 110.836 -169.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.15 -26.38 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.998 0.519 . . . . 0.0 110.583 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.69 58.84 6.55 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.747 -1.22 . . . . 0.0 110.074 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 mt -138.34 156.18 47.86 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.085 2.154 . . . . 0.0 107.834 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.7 m -116.75 -178.51 3.44 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.868 0.867 . . . . 0.0 111.513 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.74 41.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 128.368 2.667 . . . . 0.0 113.61 -174.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -164.72 -20.82 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.079 1.352 . . . . 0.0 112.361 -169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -87.59 -1.04 57.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -169.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.85 167.5 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.151 1.38 . . . . 0.0 108.925 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -138.78 121.37 16.24 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 54.5 mt -74.84 130.94 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 120.104 1.32 . . . . 0.0 107.844 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.54 -33.71 6.07 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.008 0.923 . . . . 0.0 111.162 177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.74 169.18 25.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.362 1.465 . . . . 0.0 108.546 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.3 m -145.37 162.04 38.21 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.083 1.353 . . . . 0.0 107.833 172.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -62.06 149.1 42.05 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.425 1.011 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -63.5 -33.43 75.57 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 122.151 -0.343 . . . . 0.0 111.153 -169.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.17 -176.21 5.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.914 2.086 . . . . 0.0 106.395 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -61.38 120.17 9.94 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 160.01 29.28 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -161.33 163.2 30.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 120.704 -1.248 . . . . 0.0 111.118 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -137.49 159.69 41.23 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.145 1.378 . . . . 0.0 107.764 169.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -101.31 127.48 47.91 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.898 1.679 . . . . 0.0 106.657 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -68.49 145.31 97.13 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.43 156.75 57.93 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.033 2.489 . . . . 0.0 110.104 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -52.02 -42.0 62.69 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.552 1.141 . . . . 0.0 113.582 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -76.26 -23.95 54.47 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.285 1.034 . . . . 0.0 113.06 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.33 -24.56 19.76 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.009 0.524 . . . . 0.0 110.894 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.69 137.38 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 169.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.41 -42.98 52.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.925 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 33.5 m95 59.52 5.21 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.304 2.241 . . . . 0.0 113.547 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -100.95 -21.84 14.95 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.367 1.467 . . . . 0.0 111.17 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.1 p -70.96 147.4 48.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.264 1.426 . . . . 0.0 108.53 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -134.38 113.43 12.19 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.27 154.83 30.92 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 CA-C-N 120.069 1.06 . . . . 0.0 111.54 -10.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.3 t -62.87 128.95 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.7 t -89.79 108.94 19.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.2 pt -101.27 -6.28 9.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 112.835 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.94 178.3 48.74 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 119.851 1.205 . . . . 0.0 112.017 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -108.82 114.82 28.92 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -78.45 115.8 18.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 103.013 -2.958 . . . . 0.0 103.013 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.88 110.89 8.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.507 0.594 . . . . 0.0 111.818 -168.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -90.1 125.22 35.35 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 168.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -100.21 132.27 45.67 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -108.04 133.99 51.55 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -91.9 106.16 18.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 102' ' ' LEU . 3.4 mm? -108.37 130.41 55.21 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 124.065 0.946 . . . . 0.0 109.494 -173.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.07 136.13 33.11 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.4 tp -78.32 124.64 28.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.2 t -105.52 -37.83 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.9 m -115.16 110.86 20.13 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.9 -167.36 9.09 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.96 1.266 . . . . 0.0 115.284 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -44.83 -33.0 1.76 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.702 2.001 . . . . 0.0 113.657 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 -26.67 67.96 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -107.62 -25.46 11.32 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.359 1.464 . . . . 0.0 111.519 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.5 mt -54.93 123.43 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -94.44 -46.53 6.97 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mtt 46.95 44.09 14.34 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 111.787 -169.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.91 26.06 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.722 0.809 . . . . 0.0 112.971 169.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -44.53 63.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.329 1.452 . . . . 0.0 110.718 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.0 p -80.99 -15.94 54.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.939 1.696 . . . . 0.0 113.085 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.8 m 68.87 -30.27 0.18 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.714 2.406 . . . . 0.0 112.529 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -119.98 64.85 9.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.596 1.558 . . . . 0.0 111.621 170.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 -5.0 16.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.002 3.134 . . . . 0.0 114.474 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 65.42 -34.08 0.18 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.886 2.474 . . . . 0.0 114.359 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 18.2 m-30 -70.5 128.97 37.97 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 118.933 0.788 . . . . 0.0 109.494 175.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.89 -14.8 53.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.515 1.126 . . . . 0.0 111.522 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.4 135.98 4.78 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -171.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 27.4 t-105 -150.82 -129.74 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.781 0.432 . . . . 0.0 110.445 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -145.03 162.86 35.9 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.483 1.913 . . . . 0.0 108.508 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -82.14 152.84 26.32 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.338 0.399 . . . . 0.0 110.342 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.25 164.21 35.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.58 0.752 . . . . 0.0 110.718 -169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.1 m -54.11 145.94 15.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.355 1.062 . . . . 0.0 110.385 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -36.81 69.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.626 0.77 . . . . 0.0 111.904 -169.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -90.42 -5.39 56.17 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.05 -1.031 . . . . 0.0 112.639 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -63.5 -44.21 80.92 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 117.767 -1.111 . . . . 0.0 112.454 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.67 -33.82 92.86 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 122.14 1.8 . . . . 0.0 112.889 176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.6 t -61.59 -36.19 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 O-C-N 121.86 -0.525 . . . . 0.0 109.588 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -83.63 -15.68 48.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.115 -0.945 . . . . 0.0 111.349 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.52 -20.33 19.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.228 0.922 . . . . 0.0 112.982 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.21 165.27 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 119.616 1.098 . . . . 0.0 110.343 169.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.87 156.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 110.732 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.9 m -56.49 -33.22 65.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.312 -169.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -75.54 -30.68 59.82 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.131 0.878 . . . . 0.0 111.107 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -79.24 -36.77 39.43 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.729 176.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -43.83 -50.6 7.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.237 1.415 . . . . 0.0 111.613 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -65.25 -33.52 76.19 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.731 0.412 . . . . 0.0 111.562 -172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.2 t -82.71 -37.94 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.383 0.673 . . . . 0.0 109.799 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -33.31 75.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.302 -0.874 . . . . 0.0 109.995 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -52.72 -40.48 63.06 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 124.227 1.011 . . . . 0.0 111.582 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -64.26 -47.43 79.63 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.43 -47.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.0 mmt -63.58 -47.09 82.91 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.779 0.718 . . . . 0.0 110.172 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -56.7 -46.15 81.4 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.181 0.992 . . . . 0.0 110.721 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.32 -16.36 63.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.073 0.549 . . . . 0.0 111.582 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -118.44 -5.58 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.132 1.373 . . . . 0.0 113.343 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.36 -59.0 3.51 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.762 1.225 . . . . 0.0 112.198 -169.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.8 m -62.16 -26.19 68.19 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.703 0.401 . . . . 0.0 112.043 -175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.0 t -68.17 -28.91 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.061 0.944 . . . . 0.0 109.605 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.65 -41.77 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 17.0 mmt -63.92 -38.04 89.64 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 118.604 0.638 . . . . 0.0 110.751 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 63.0 m -61.98 -18.35 60.16 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.781 0.719 . . . . 0.0 112.698 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 mt -76.19 -26.75 56.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.572 0.624 . . . . 0.0 110.584 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 -107.56 -32.25 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.168 0.987 . . . . 0.0 111.002 -178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -82.59 16.08 2.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.185 2.194 . . . . 0.0 110.605 172.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.55 -34.26 77.84 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.74 1.616 . . . . 0.0 113.716 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -47.67 20.13 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 123.61 0.764 . . . . 0.0 111.421 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -60.33 -33.95 93.95 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.62 2.88 . . . . 0.0 114.391 169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.9 tptt . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.938 -176.792 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.64 145.87 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 173.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.42 -47.12 57.92 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.14 0.576 . . . . 0.0 111.71 -171.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -153.17 -75.4 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.856 0.862 . . . . 0.0 110.413 171.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -86.45 -49.2 7.78 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -169.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.49 14.84 0.05 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.531 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -94.22 136.35 34.6 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.793 1.297 . . . . 0.0 110.281 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -86.03 114.03 54.95 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 173.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.62 134.22 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.967 1.778 . . . . 0.0 109.986 -177.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -159.4 176.01 12.64 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 124.201 1.001 . . . . 0.0 108.747 172.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.6 m -120.36 140.45 44.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -93.07 122.98 7.16 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 176.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 mm -73.04 121.73 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.68 88.39 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 169.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.1 mm -67.34 131.22 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.5 m -114.72 119.76 37.79 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 169.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -83.86 136.46 34.11 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -63.82 -9.61 15.77 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.036 1.334 . . . . 0.0 114.367 -173.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.24 -12.26 61.36 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 110.841 169.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.78 34.18 4.75 Favored Glycine 0 C--N 1.346 1.09 0 C-N-CA 126.059 1.79 . . . . 0.0 112.685 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -133.43 151.7 51.83 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -169.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 m -109.96 164.15 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -168.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.2 tpp -50.96 127.26 18.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.243 1.817 . . . . 0.0 111.628 169.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -157.06 129.75 7.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 167.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.49 143.48 28.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.227 0.537 . . . . 0.0 110.014 -171.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -74.86 134.04 41.74 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -80.08 133.74 36.13 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.486 0.715 . . . . 0.0 109.269 -169.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.79 134.36 56.79 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.48 1.512 . . . . 0.0 109.95 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.1 16.32 76.77 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.993 -0.442 . . . . 0.0 112.513 177.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -139.85 163.34 32.88 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.124 2.169 . . . . 0.0 107.296 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -114.82 36.17 3.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 108.636 173.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.6 p -150.18 171.78 16.37 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.226 1.811 . . . . 0.0 108.735 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -110.99 155.34 22.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.997 1.319 . . . . 0.0 109.249 -171.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.38 146.14 41.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.093 0.949 . . . . 0.0 111.793 -170.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -57.14 143.29 72.98 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 0.0 108.549 168.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -63.56 152.79 78.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 121.973 1.782 . . . . 0.0 112.378 173.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -179.12 132.47 0.12 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.758 2.423 . . . . 0.0 107.173 173.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.11 -114.84 2.56 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.8 164.34 34.45 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.43 2.919 . . . . 0.0 106.758 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.4 mt -117.53 124.21 72.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -73.76 136.97 76.92 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 116.895 -1.526 . . . . 0.0 107.615 171.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -56.13 117.68 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 CA-C-N 121.857 1.699 . . . . 0.0 112.934 -172.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.58 87.16 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.355 177.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -82.37 125.62 31.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.49 1.116 . . . . 0.0 108.633 175.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.03 158.68 36.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.686 1.194 . . . . 0.0 110.361 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.96 -40.38 63.65 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 125.455 1.502 . . . . 0.0 113.859 -169.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -72.26 -45.08 61.67 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -60.2 -45.18 94.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.999 1.32 . . . . 0.0 108.307 -179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.72 -25.56 67.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.196 0.999 . . . . 0.0 112.546 173.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -72.13 -42.3 66.18 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 119.653 1.115 . . . . 0.0 109.073 175.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -66.04 -26.87 67.71 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.971 172.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -67.35 -48.1 68.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.188 -0.945 . . . . 0.0 109.031 171.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.9 84.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 119.007 0.821 . . . . 0.0 110.795 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.13 -41.91 89.34 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.62 1.568 . . . . 0.0 109.38 178.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.34 -46.97 65.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.859 0.863 . . . . 0.0 110.648 172.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.9 -37.18 86.77 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.676 1.126 . . . . 0.0 112.667 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -94.17 -44.02 8.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.524 0.73 . . . . 0.0 111.185 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 113' ' ' MET . 14.6 m -123.55 -2.48 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -173.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.04 75.69 Favored Glycine 0 CA--C 1.524 0.624 0 O-C-N 121.172 -0.955 . . . . 0.0 111.598 177.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.0 mt -91.12 161.21 15.19 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 108.908 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -118.07 171.51 8.05 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.902 0.881 . . . . 0.0 109.603 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -72.43 57.97 0.4 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.161 1.784 . . . . 0.0 113.89 -171.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' H ' ' A' ' 64' ' ' ASP . 21.0 pttp -163.89 -25.62 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.618 1.967 . . . . 0.0 111.359 -172.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' H ' ' H ' ' A' ' 63' ' ' LYS . 65.6 m-20 -88.15 0.19 56.33 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -168.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 166.78 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.036 0.935 . . . . 0.0 109.792 -169.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -137.2 120.89 17.34 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -171.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.9 mt -74.85 129.9 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.05 -34.87 6.48 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.316 175.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.93 169.48 22.53 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.374 1.07 . . . . 0.0 109.356 -178.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.1 p -147.81 162.28 39.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 169.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 p -66.15 145.0 56.32 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtm180 -70.21 -20.97 63.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -170.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -148.94 171.95 15.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.958 1.703 . . . . 0.0 109.12 171.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -73.1 116.19 13.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.6 mt -72.59 153.89 41.05 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 169.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -148.42 153.74 38.94 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.443 0.697 . . . . 0.0 109.204 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -145.63 164.81 30.57 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.871 1.268 . . . . 0.0 108.548 176.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -118.5 123.86 46.16 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -172.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -66.01 145.14 99.01 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.599 1.16 . . . . 0.0 108.937 -178.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.0 152.2 80.67 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.463 2.109 . . . . 0.0 109.456 170.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -47.62 -49.08 28.03 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.548 1.139 . . . . 0.0 113.779 -169.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -64.71 -14.19 57.58 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.154 0.981 . . . . 0.0 113.228 -175.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.7 tp -108.77 -9.2 15.23 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.56 1.544 . . . . 0.0 111.53 -178.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.84 136.73 25.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 171.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.63 129.81 38.45 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -101.3 4.5 41.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.791 1.236 . . . . 0.0 109.782 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -106.15 -12.53 15.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.501 1.121 . . . . 0.0 111.588 -174.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 p -71.66 -33.88 69.24 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.327 0.651 . . . . 0.0 111.763 -174.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 41.78 89.22 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 127.906 2.482 . . . . 0.0 112.197 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.22 150.34 71.83 Favored 'Cis proline' 0 C--N 1.35 0.637 0 CA-C-N 119.977 1.028 . . . . 0.0 114.761 10.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -54.41 122.17 3.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 171.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 42.7 t -92.53 105.3 17.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -172.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.2 pp -102.84 -10.82 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.305 1.042 . . . . 0.0 113.013 -170.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.73 175.65 46.65 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 120.075 1.307 . . . . 0.0 112.482 -174.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.29 126.56 55.38 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -87.27 120.89 29.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 103.5 -2.778 . . . . 0.0 103.5 169.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.15 128.56 21.19 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.974 1.261 . . . . 0.0 113.618 -176.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -106.23 134.98 48.52 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 168.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -104.85 144.79 31.28 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -117.67 126.46 52.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.07 107.59 16.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 175.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 102' ' ' LEU . 31.3 mt -103.4 133.99 47.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.823 175.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -93.6 135.6 34.71 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 168.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.615 HD22 ' HA2' ' A' ' 107' ' ' GLY . 67.7 mt -66.01 141.43 58.18 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.973 176.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.16 -27.05 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.316 1.047 . . . . 0.0 108.204 169.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 m -119.94 -53.42 2.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 175.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.615 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 69.02 -146.53 44.84 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 172.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -40.94 -34.15 0.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.786 2.034 . . . . 0.0 113.573 -178.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.14 -25.73 68.22 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.794 0.838 . . . . 0.0 113.235 -177.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -130.58 -8.71 4.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.942 1.297 . . . . 0.0 113.324 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.3 mt -58.18 134.36 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 172.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.65 -31.72 0.72 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.395 -170.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 58' ' ' VAL . 36.1 mtt 64.82 -50.06 0.33 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 129.096 2.958 . . . . 0.0 113.141 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -84.21 20.06 1.7 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.255 1.022 . . . . 0.0 113.515 -171.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -63.09 -31.43 72.57 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 109.749 172.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -83.58 -0.65 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.556 1.143 . . . . 0.0 113.262 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.9 m 64.1 -34.21 0.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.609 2.764 . . . . 0.0 115.543 -175.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -132.28 71.06 79.88 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.942 1.697 . . . . 0.0 107.435 172.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.02 -166.32 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.737 2.958 . . . . 0.0 110.453 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.33 -3.83 26.54 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.401 169.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.79 155.75 49.4 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 121.662 2.028 . . . . 0.0 112.375 -172.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.03 -25.52 2.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.801 -169.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -156.1 150.75 22.17 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -122.25 146.89 46.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.047 1.339 . . . . 0.0 110.81 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -152.31 124.7 8.23 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.677 1.191 . . . . 0.0 107.89 169.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -76.88 143.94 39.31 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.745 0.702 . . . . 0.0 109.144 178.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -145.57 168.15 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 123.59 0.756 . . . . 0.0 109.692 -169.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.9 m -48.79 145.11 3.98 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 125.094 1.357 . . . . 0.0 111.054 -177.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -52.58 -38.8 60.72 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -168.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -95.92 -4.37 43.59 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -177.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -60.74 -43.23 91.33 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.156 -1.402 . . . . 0.0 112.31 -170.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -58.05 -34.23 98.2 Favored 'Trans proline' 0 C--N 1.352 0.748 0 CA-C-N 122.173 1.812 . . . . 0.0 113.074 175.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.69 -45.8 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 176.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -64.16 -30.61 71.66 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 118.579 -0.724 . . . . 0.0 110.737 177.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -78.95 -30.94 44.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 118.87 0.759 . . . . 0.0 112.154 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.27 157.34 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.869 0.758 . . . . 0.0 110.974 -170.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 m -54.69 148.68 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.517 1.527 . . . . 0.0 111.709 174.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -57.97 -34.34 69.84 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.179 1.392 . . . . 0.0 113.849 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -72.66 -28.11 62.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.815 0.734 . . . . 0.0 111.543 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -89.25 -31.95 17.63 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 118.765 -0.636 . . . . 0.0 112.141 174.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -47.21 -44.82 22.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.599 1.16 . . . . 0.0 112.24 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.88 -34.33 75.27 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 p -83.81 -32.94 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.954 -0.466 . . . . 0.0 110.549 177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -66.12 -31.99 73.17 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.054 -1.029 . . . . 0.0 110.306 177.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.8 ttp-105 -53.24 -40.52 64.62 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.058 -1.026 . . . . 0.0 111.606 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -63.94 -46.4 84.91 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.26 0.936 . . . . 0.0 109.614 -179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -53.73 -50.22 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.269 0.628 . . . . 0.0 109.447 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.9 mmt -64.33 -45.1 89.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.273 -177.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -57.6 -44.37 85.36 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.091 0.957 . . . . 0.0 111.091 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -64.63 -25.51 67.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.409 0.684 . . . . 0.0 110.845 -174.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -108.95 -8.82 15.17 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.811 1.245 . . . . 0.0 113.683 -175.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.52 -63.55 1.1 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.348 0.976 . . . . 0.0 112.056 -169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.4 m -63.25 -22.31 66.79 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.216 -0.302 . . . . 0.0 111.778 -178.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -76.1 -36.66 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 O-C-N 121.382 -0.824 . . . . 0.0 108.909 -175.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.43 -48.89 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.6 mtt -65.33 -22.33 66.81 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.624 0.647 . . . . 0.0 112.725 -169.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.8 m -62.85 -26.79 68.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.458 1.026 . . . . 0.0 111.635 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 10.5 mp -66.9 -51.22 58.03 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -70.72 -25.79 63.1 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.002 0.521 . . . . 0.0 111.132 -173.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.46 -21.15 62.82 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.065 0.946 . . . . 0.0 111.637 173.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -101.23 28.44 5.4 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 112.424 -169.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.6 p 45.98 47.48 4.18 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.55 1.14 . . . . 0.0 109.897 -172.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . 0.342 0.0 OUTLIER 25.71 48.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 1 C-N-CA 127.173 5.249 . . . . 0.0 117.51 -168.507 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.252 1.233 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.541 . . . . . . . . 0 0 . 1 stop_ save_